I. Catalyst development in asymmetric phase transfer catalysis employing QSAR methods II. Computational investigations on the stereochemical course of the addition of allylsilanes to aldehydes by Wolf, Lawrence
  
 
I. CATALYST DEVELOPMENT IN ASYMMETRIC PHASE TRANSFER CATALYSIS 
EMPLOYING QSAR METHODS 
II. COMPUTATIONAL INVESTIGATIONS ON THE STEREOCHEMICAL COURSE OF 
THE ADDITION OF ALLYLSILANES TO ALDEHYDES 
 
 
 
 
 
BY 
 
LAWRENCE M. WOLF 
 
 
 
 
 
 
 
 
DISSERTATION 
 
Submitted in partial fulfillment of the requirements 
 for the degree of Doctor of Philosophy in Chemistry 
 in the Graduate College of the  
University of Illinois at Urbana-Champaign, 2013 
 
 
 
 
Urbana, Illinois 
 
 
Doctoral Committee: 
 
 Professor Scott E. Denmark, Chair 
 Professor Martin D. Burke 
 Professor Paul J. Hergenrother 
 Professor Kenneth S. Suslick 
 
 
ii 
 
Abstract 
 
Part I of this dissertation describes the investigation in APTC employing a 
chemoinformatic analysis of the alkylation of a protected glycine imine with libraries of 
enantiomerically enriched quaternary ammonium ions. The synthesis of the quaternary 
ammonium ions follows a diversity oriented approach wherein the tandem inter[4+2]/intra[3+2] 
cycloaddition of nitroalkenes serves as the key transformation.. Catalyst activity and selectivity 
are rationalized in a qualitative way based on the effective positive potential of the ammonium 
ion. The next stage involved the development of quantitative structure -selectivity relationships 
(QSSR) for the alkylation of a protected glycine imine with libraries of quaternary ammonium 
ion catalysts. The variation in the observed enantioselectivity was rationalized employing a 
comparative molecular field analysis (CoMFA) using both the steric and electrostatic fields of 
the catalysts. A qualitative analysis of the developed model reveals preferred regions for catalyst 
binding to afford both configurations of the alkylated product. 
In Part II, the diastereoselectivity of the addition allylsilanes to aldehydes is investigated 
using density functional theory. The interaction-distortion/activation-strain model of reactivity is 
used to rationalize the origin of the selectivity. Consistent with experimental model systems, the 
synclinal transition states are determined to be preferred over the antiperiplanar transition states 
in the electrophilic-activated manifolds and vice versa for the fluoride-activated manifold. The 
selectivity for the syn diastereomer in the electrophilic activation manifolds is accounted for by 
increased electrostatic and orbital interactions for a particular synclinal transition state at the 
expense of increased steric interactions relative to antiperiplanar transition states. The selectivity 
for the anti diastereomer in the nucleophilic manifold is explained by the lesser electrostatic 
repulsion in the antiperiplanar transition states which are favored relative to the synclinal 
transition states. Comparison of the transition states at constant distortion also reveals the origin 
of the variation in distortion in the transition states in terms of components of the interaction 
energy. 
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Chapter 1:  Introduction and Background to Phase Transfer 
Catalysis 
1.1. Phase Transfer Catalysis and Catalyst Types. 
Phase Transfer Catalysis (PTC) is an immerging methodology in organic synthesis that 
not only provides experimentally practical and environmentally benign alternatives to traditional 
techniques for performing ionic chemical reactions, but also exhibits the potential for addressing 
unsolved methodological problems. At the core, PTC can be loosely defined as a process that 
includes chemical reactions taking place in more than one phase.1 The more typical application 
of PTC is toward the activity enhancement of nucleophilic anion reactants in the presence of a 
neutral electrophile (a nucleophilic activation mode). This mode of activation is in stark contrast 
to the much more common electrophilic mode of activation using conventional Lewis acids.2 The 
overall reactivity enhancement is thought to arise in two general forms which are (1) increased 
collision frequency via interfacial transport (between phases) and (2) enhancement of negative 
partial charge on the anionic nucleophile through increased charge separation. A variety of phase 
transfer agents have been implemented for these purposes and among the most useful include 
ammonium salts, phosphonim salts, and crown ethers (Chart 1). Ammonium salts have received 
the most widespread use, due in part to their compatibility with a wider pKa range, and are the 
focus in this dissertation. 
Chart 1. 
 
1.1.1. Early Demonstration of Synthetic Utility. 
The reactions of hard nucleophilic anions with neutral (usually lipophilic) electrophiles in 
homogeneous media is burdened by poor solubility of the nucleophilic partner in typical organic 
solvents. In these situations of poor solubility, the effective concentration of the anion is very 
low which usually equates to little to no observed reactivity. The traditional solution is to use of 
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very polar aprotic solvents3 (DMF, HMPA, DMSO, etc.) to solubilize the hard anionic 
nucleophile. However, the toxicity of such solvents is not particularly attractive and difficulties 
encountered with isolation are not uncommon, particularly if the desired product exhibits 
appreciable water solubility.  
Alternatively, a biphasic system can be used (ie. toluene/water) in which each phase 
adequately dissolves each of the reactants (hard, hydrophilic anion dissolves in water and 
lipophilic electrophile dissolves in toluene). An example that illustrates this is the SN2 
displacement of an alkyl chloride with sodium cyanide (Scheme 1a). Although, in the absence of 
any other agents, the reactants will not be able to locate each other if there is no path for either of 
the reactants to traverse the boundary between the phases (interphase). The inclusion of an agent 
that is capable of modifying the properties of either of the reactants in such a way as to 
temporarily increase its affinity for the phase occupied by the other reactant would exponentially 
increase the collision frequency, effecting the desired chemical reaction. Modification of the 
alkyl chloride is not advantageous on account of the lack of strong intermolecular interactions 
inherent in alkyl halides. The ionic interaction between Na+ and CN- renders sodium cyanide 
more suitable for modification. If the hard, hydrophilic Na+ can be exchanged with a more 
lipophilic cation, the associated CN- would be theoretically more susceptible toward traversing 
the interfacial boundary to the organic layer where the desired reaction can occur.  
Scheme 1. 
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This has been performed and is among the earlier synthetically useful PTC reactions 
studied in detail in which an ammonium salt, (C6H13)4N
+Cl- (1wt%), was used as the phase 
transfer agent for the displacement of 1-chlorooctane (neat) with aqueous sodium cyanide.4 
Through counterion exchange of the ammonium chloride (Q+Cl-) with the sodium cyanide in the 
aqueous layer (K2), Q
+CN- is generated and this more lipophilic CN- source is transported into 
the organic layer where the desired reaction can take place. The mechanism above outlines the 
extraction mechanism and will be discussed in more detail in Chapter 2.  
1.1.2. PTC as an Alternative to Strong Base Chemistry. 
 Much of the synthetic potential of PTC can be manifested in the capacity to perform 
chemistry that typically requires strong base (pka > 15) under considerably milder conditions 
using inorganic hydroxide or carbonate bases. The Williamson ether synthesis5 typically calls for 
the application of strong hydride bases (NaH or KH) in homogenous polar aprotic media. 
Alternatively, this reaction can be performed just as effectively using aqueous sodium hydroxide 
with an ammonium salt as the catalyst which greatly expands upon the rigorous conditions of the 
standard Williamson ether synthesis protocol (Scheme 2a).6 Similarly, the alkylation of carbon-
based acids such as phenylacetylnitrile (pka > 25) (Scheme 2b) is typically performed using 
strong hydride or lithium amide bases. The application of an ammonium salt in aqueous sodium 
hydroxide is sufficient for performing this reaction successfully. The formation of a stereogenic 
center in this case allows for the opportunity for enantioselectivie catalysis which greatly 
expands upon the synthetic utility and is the focus of a separate section.       
Scheme 2. 
 
 The rationale for the ability of PTC to access higher pKa ranges can be attributed to 
chemistry taking place in the interfacial region is both catalyst and hydroxide rich. This 
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additional phase confers an added dimension of complexity to the overall mechanism and is 
discussed in greater detail in Chapter 2.  
1.2.  Catalyst Activity. 
1.2.1. Catalyst Influence on Rate. 
The efficacy of a PTC catalyst is thought to be linked to two principle components of a 
PTC process. The transfer or net delivery of the nucleophilic anion from the aqueous phase into 
the phase occupied by the electrophile, typically the organic phase, is one of these components. 
This overall transfer process may be comprised of numerous equilibria which depends on the 
mechanism operative. For the NaCN displacement of 1-clorooctane (Scheme 1), the transfer 
process is comprised of equilibria K1, K2, and K3. The second component is the reaction of the 
quaternary ammonium cation/reacting anion ion pair with the organic substrate in the organic 
phase. This step is termed the intrinsic reaction . Any one of these components or a continuum 
thereof can limit the rate of a PTC reaction.  
One can attain a rudimentary understanding on how these processes are interlinked via a 
mnemonic developed by Starks coined the PTC reaction rate matrix (Figure 2).7 The PTC matrix 
consists of a plot of intrinsic reaction rate versus transfer. This plot is then divided into four 
quadrants. The fast quadrant in the upper right represents reactions in which both the transfer and 
intrinsic reactions are comparably fast. Reactions in this region need little optimization with 
respect to catalyst design. PTC reactions that are inherently slow for both transfer and intrinsic 
reaction belong in the lower left quadrant. Careful choice of catalyst as well as reaction 
optimization is necessary for these types of reactions. The lower-right and upper-left quadrants 
represent reactions where the overall reaction rate is limited by the intrinsic and transfer steps 
respectively.  
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Figure 1.. PTC reaction rate matrix. 
 
1.2.2.  Mechanism of Hydroxide Initiated PTC 
The broad utility of PTC has motivated numerous investigations from fields as for 
reaching as synthetic chemistry, chemical engineering, computational chemistry, physical 
chemistry and chemoinformatics. PTC reactions that use aqueous bases to generate carbanions 
are termed hydroxide-initiated PTC.8 The mechanism of hydroxide-initiated PTC reactions is an 
intensely investigated subject that has been thoroughly reviewed from both a chemical9 and 
engineering10 perspective. Pioneering studies by Makosza11 and Starks12 led to two distinct 
mechanistic descriptions, later termed the interfacial (Makosza) and extraction (Starks) 
mechanisms. The mechanisms differ in the mode in which the substrate·ammonium ion pair 
enters the organic phase (Figure 2). Numerous studies have provided experimental support for 
both the extraction13,14  and interfacial mechanisms.15,16,17 These studies have accumulated a 
number of phenomenological observables that are used as indicators to decipher which 
mechanism is dominant.9b Reactions governed by the extraction mechanism show little 
dependence on stirring rate and first order kinetic behavior in substrate and catalyst. On the other 
hand, PTC reactions governed by the interfacial mechanism show a strong dependence on 
stirring rate, complex kinetic order in substrate, and fractional order in catalyst. The current 
understanding of hydroxide-initiated PTC reactions suggests a mechanistic continuum that is 
strongly dependent on substrate pKa and catalyst structure.9b To summarize, the extraction 
mechanism is dominant at the two extremes of substrate acidity (pKa < 16 and pKa > 23) and the 
interfacial mechanism is dominant when the pKa of the substrate is between 16-23. The rational 
is that reactions with highly acidic substrates are rate limited in extraction of the substrate 
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enolate and non-acidic substrates are rate limited by the rate of hydroxide extraction. Thus, the 
interfacial mechanism is proposed to be most relevant for enolate alkylations.18 
 
Figure 2. Simplified mechanistic views of the interfacial and extraction based mechanisms 
1.2.3.  Guidelines for the Design of Active Catalysts 
The quaternary ammonium ion catalyst is the most critical element of a PTC reaction the 
selection of the “optimal” catalyst is crucial.19,9b The fact that there are two possible mechanisms, 
in combination with the possibility of many “off-cycle” pre-equilibria, all of which are a function 
of substrate and catalyst combination, has made identifying simple structure activity 
relationships difficult.9a For reactions strictly following an extraction mechanism (e.g. SN
2 
displacements with N3
-, CN-, SCN-, etc.) catalyst activity correlates well with lipophilicity.14,13,20 
No such generalizable structure activity relationships exist for hydroxide-initiated PTC reactions. 
For hydroxide-initiated PTC reactions small hydrophilic ammonium ions are often 
superior catalysts, which is a compounding source of confusion.21,22 For example, 
triethylbenzylammonium, a small hydrophilic quaternary ammonium ion is an efficient catalyst 
for a myriad of PTC enolate alkylations (e.g. nitriles, esters, ketones…etc.).23 One approach has 
been to correlate a macroscopic observable such as interfacial surface tension to catalytic activity 
which unfortunately does not address the question of what catalyst attributes confer high 
activity.24 In a rare SAR study, the ammonium ion accessibility (or size) and solubility were 
varied simultaneously and the most active symmetrical catalyst for alkylations was 
tetraethylammonium bromide.25 A useful quantitative correlation of structure to catalyst activity 
was subsequently derived, namely the structural parameter, q (Equation 1).26 The q parameter is 
defined as the sum of the reciprocals of the number of carbons on each chain.27 For hydroxide-
initiated PTC reactions, such as the alkylation of enolates, q values between 1.5 and 2.0 are 
optimal. This analysis is useful for simple quaternary ammonium ions containing only alkyl 
chains (C1-4) but extension to catalysts containing functional groups, changes in hybridization, 
rings, branch points, or stereogenic centers has not been reported. 
7 
 
 
Equation 1. nx (x=1,2,3,4) is the number of carbon atoms minus 1 along x of the 4 linear chains  
 
1.3.  Asymmetric Phase Transfer Catalysis 
1.3.1.  Enantioselective Alkylation Methods 
The requirements for a catalytic, enantioselective, enolate alkylation are the in-situ 
generation of an enolate, alkylation in the presence of a stereochemical controlling element and 
stereochemical stability of the product (Scheme 3). Although auxiliary-based methods for the 
diastereoselective alkylation of enolates truly revolutionized the practice of organic synthesis in 
the 1970’s.28,29 A general and selective processes for catalytic enantioselective alkylations 
remains elusive.30 In contrast to other carbon-carbon bond forming reactions of enolates 
(compare to e.g. aldol and Michael reactions), the rate of enolate alkylation is significantly less 
than addition to a π-system, thus the use of soft-enolization techniques which are crucial for 
catalytic π-addition reactions cannot be utilized for enolate alkylations.31 The use of more 
reactive enolates, and strong bases to generate them, introduces a host of compatibility issues 
thus preventing the implementation of similar stereocontrol elements under catalytic conditions.  
Phase transfer catalysis relieves some of these compatibility issues and is thus ideally suited for 
approaching this problem. 
Scheme 3. 
 
1.3.2.  Early Examples of APTC 
Phase transfer catalysis has already proven to be a broadly applicable and general method 
to perform strong base chemistry in a catalytically.32 In particular, the catalytic, enantioselective 
alkylation of enolates has been extensively investigated in the context of APTC. In a landmark 
publication, the Merck Process Group reported the enantioselective alkylation of an indanone 
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under PTC conditions employing an N-4-trifluoromethylbenzyl cinchona alkaloid derivative.33 
Their detailed optimizations revealed a number of useful insights: (1) the use of a non-polar, 
polarizable solvent such as benzene or toluene was critical to achieving high enantioselectivity, 
(2) the enantioselectivity exhibited a small temperature dependence, while the reaction rate 
exhibited a large temperature dependence and (3) the presence of electron withdrawing groups 
on the N-benzyl substituent resulted in enhanced enantioselectivities.33c 
Efforts to develop toward the development of synthetic routes to enantioenriched α-
amino acids lead to a second critical advance in 1989 when O’Donnell demonstrated the 
selective alkylation of glycine imines under similar conditions (Scheme 4).34 This discovery 
represented the first practical synthesis of enantioenriched α-amino acids through phase transfer 
catalysis. Conveniently, the different diastereomers, cinchonidine and cinchonine, were found to 
be enantio-complimentary in that each enantiomer of the product could be accessed in good 
enantioselectivity using each diastereomer. O’Donnell’s alkylation has proven to be an 
operationally simple method for α-amino acid synthesis and has since served as a benchmark for 
the development of new asymmetric phase transfer catalysts.35 
Scheme 4. 
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In the intervening 20 years many variations of cinchona alkaloid catalysts have been 
reported. The first notable advances were from independent studies by Lygo36 and Corey,37 in 
which the incorporation of a 9-anthracenylmethyl moiety as the nitrogen substituent markedly 
improved the enantioselectivity (Chart 1). Analogously, Park and Jew developed a tri-fluorinated 
N-benzyl quaternary ammonium catalysts38a and dimeric, meta-bridged cinchoninium 
catalysts.38b In recent years, Maruoka and Ooi have introduced a large number of novel, non-
cinchona alkaloid catalyst systems based on a binaphthyl scaffold which allows introduction of 
substituents in the 3,3’ positions.39 Similarly, employing an in situ generation and screening 
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process, Lygo has discovered a useful locally C2 (at the nitrogen) symmetric catalyst.
36c 
Shibasaki/Ohshima,40 Sasai,41 Arai/Nishida,42 and others have independently developed two-
centered (and higher) APTC’s by incorporation of quaternary ammonium ions, about a Cn axis. 
In addition to extensive catalyst development, significant advances in other typically strong-
base-promoted reactions have been recorded including double alkylation of glycine imines, 
ketone alkylations, Michael, aldol, Mannich, and Darzens reactions as well as epoxidations and 
aziridinations.32k,l,m,n 
Chart 2. 
 
1.4.  Stereochemical Models for Enantioselectivity (chinchona alkaloid-derived) 
The rationalization of enantioselectivity and reduction to design criteria is of preeminent 
importance to the study of catalytic processes.43 The alkylation of O’Donnell’s imine is by far 
the most studied enolate alkylation and two general  models have been proposed to rationalize 
the enantioselectivity observed with cinchona alkaloid derived catalysts (Figure 3).44 In an early, 
thorough computational study, O’Donnell and Lipkowitz analyzed the enolate molecular 
recognition event and origin of enantioselectivity of this important transformation.45 
Computational results suggest selective binding of the catalyst to the Si face of the Z-enolate (a). 
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Subsequently, it has been proposed that catalysts bearing a 9-methylanthracenyl group on 
nitrogen react through the E-enolate (b).  
 
Figure 3 Stereochemical models using cinchona derived PTC catalysts. 
The preferred region for anion association for the cinchona alkaloid derived catalysts has 
been performed using nOe correlations. 46 Using borohydride and fluoride as the counteranions, 
the nOe correlations suggested a stronger association with the left face (Figure 4a) on account of 
correlations with the H bound to C(1) and the quinoline hydrogens. The lack of strong 
correlations with the hydrogens bound to C(2) suggested only weak association with this region. 
These studies provide good support for strong hydrogen bonding interactions of the type 
N+CH•••O- in solution which has also been identified in the solid state by X-ray crystallographic 
analysis of quaternary ammonium-enolate ion pairs.47 High level calculations by Houk and 
Cannizarro further corroborate that in solution, ammonium ion ester enolates tend to orient “π-
facial” to one of the faces of the ammonium (Figure 4b).44b The combination of these analyses 
lends to a useful design mnemonic by inscribing the ammonium nitrogen in a tetrahedron (red) 
where the vertices are the four carbons bound to it. The face proximal to the oxygen is the 
energetically more accessible region than the remaining three faces of the tetrahedron. 
 
Figure 4. a) analysis of selectivie tetrahedral faces of cinchona-derived quaternary ammonium 
salts. b) facial association of enolate with ammonium cation 
 
 Very recently, a full DFT transition state modeling study has been performed on the 
cinchonidinium PTC enolate allylation to further refine the origins of enantioselectivity.48 An 
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ensemble of several hundred transition states were searched systematically for both π-facial and 
oxyanion approaches of the enolate. The lowest energy transition state states exhibited oxyanion 
type binding rather than π-facial type (Figure 4b) as is observed for the ground state ion pairs. 
The change of binding from ground state to the transition state is consistent with the removal of 
negative partial atomic charge from the carbon atom toward the allyl electrophile. An important 
conformational controlling element in the transition state is purported to be a CH•••π interaction 
between the arene C-H of the out of plane phenyl group of the enolate with the π-system of the 
quinoline moiety. Increased Coulombic interaction is also believed to favor the lowest energy 
transition state through decreased separation between the oxygen of the enolate and the 
ammonium center due to the adoption of a sterically less encumbering conformation relative to 
the next closest in energy transition states. The increased enantioselectivity with the 9-
anthracenyl group relative to groups with less π-surface area can be explained by creating a more 
well defined pocket for the enolate rather than exhibiting additional π-stacking interactions with 
the enolate as previously believed. The results are consistent with previous computational 
studies.45 
 
Figure 5. Lowest energy transition state for asymmetric alkylation with cinchona-derived 
catalyst. 
 
 The stereochemical models discussed help rationalize the enantioselecitivity for catalyst 
systems that perform well. However, the design criteria that can be learned from these studies 
may not translate as well to different enolate substrates, electrophiles, or alternative reaction 
types. Notwithstanding, the models do yield the most convenient and apparent starting guides for 
catalyst development. Methods that can be more intimately weaved in the catalyst development 
process may provide better opportunities for design and synthesis of more desirable catalysts. In-
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as-such these methods should be capable of generating models that meet the pace at which the 
experimental data is accumulated. Strategies in chemoinformatics and quantitative structure-
activity relationships are particularly useful for these purposes.  
1.5.  QSAR Modeling for Enantioselectivity. 
Enantioselectivity in general has been modeled using geometrical descriptors such as 
steric size,49 topological indices,50 continuous chirality quantification methods51 that indirectly 
account for 3-dimensionality, as well as various molecular interaction field (MIF) analyses. A 
MIF based approach was chosen to initiate these studies as it typically provides a more direct and 
more information-rich representation of the 3-dimensional features necessary to reflect the 
enantiotopic differentiating capacity of chiral catalysts.  
MIF based approaches52 are standard 3D-QSAR techniques employed in drug design. 
MIF algorithms encode variation in structure by positioning a probe atom and/or a point charge 
at fixed grid points around each molecule of interest and the interaction energies with the probe 
are recorded at each grid point. The dependent variable (typically a free energy of binding) is 
then linearly correlated with the interaction energies for which the coefficients are extracted from 
a multivariate linear regression analysis, commonly by Partial Least Squares (PLS) method. 
Although MIF approaches have enjoyed a long-standing history of greater than 20 years in 
medicinal chemistry for the development of drug candidates, only relatively recently (< 8 years) 
have they been applied to problems relating to asymmetric catalysis. 
 The most commonly employed MIF approach is Comparative Molecular Field Analysis 
(CoMFA). The method uses a molecular mechanics based force field to approximate van der 
Waals interactions and the standard Coulombic potential is used for electrostatic interactions for 
which the partial atomic charges are determined at the desired level of theory.53 The appeal of 
this method stems from its predictive capacity and ability to allow one to visualize the developed 
model in terms of regions where field variation (either electrostatic or steric in origin) within the 
data set leads to a change in the dependent variable. In the field of asymmetric catalysis, this 
method was first applied in the analysis of the Diels-Alder reaction between cyclopentadiene and 
a 3-vinyloxazolidin-2-one using copper(II) Lewis acids with differing bisoxazoline and 
phosphinooxazoline ligands.54 Methods that incorporate semi-empirical55 as well as ab-initio 
quantum mechanical56 interaction energies have also been developed and have found application 
in analyzing asymmetric diethylzinc additions using varying chiral amino alcohols57 as well as 
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asymmetric lithiation using varying chiral sparteine surrogates.56  
 Two seminal reports employing CoMFA in the context of PTC involved the asymmetric 
alkylation of a protected glycine imine tert-butyl ester using different catalyst systems (Scheme 
5).58 In the first report,58a a model was developed employing varying cinchona alkaloid derived 
catalysts. In the second report,58b a model was generated for the same reaction while using 
different catalyst scaffolds developed by Lygo and coworkers.59 The contributions of steric and 
electrostatic interactions to the variation in enantioselectivity were found to be roughly 
equivalent but the implications of electrostatic interactions were not discussed in detail in these 
reports, which are considered to be the predominate forces responsible for the ion-pair 
interaction strength.60 Despite these important contributions, ambiguity is still present as to the 
dependence of electrostatic interactions on the observed enantioselectivity.  
Scheme 5. 
 
1.6.  Research Objectives. 
Part I of this dissertation involves the application of computer-aided design strategies 
toward the synthesis of enantioselective phase transfer catalysts. An enolate alkylation reaction 
was chosen for these studies for three reasons: (1) it is one of the oldest and most useful methods 
to form carbon-carbon bonds (2) many examples of PTC enolate alkylations are on record and 
(3) the methods to perform enolate alkylations in a catalytic enantioselective manner are very 
limited. The goals of this project involved a sequence of stages which involved: (1) synthesis of 
libraries of structurally diverse ammonium ions (2) collect rate and enantioselectivity data (3) 
construct mathematical models to reveal structural features that impart desirable 
enantioselectivity and activity (4) from these models develop mechanistic hypothesis and apply 
toward the synthesis of more active and enantioselective catalysts.  
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In Chapter 2 the synthesis of the catalyst librarires is discussed in detail. Synthetic 
strategies and protocols introduced that facilitate combinatorial synthesis. The collection of 
activity, in the form of half lives, and enantioselectivity data is elaborated. A discussion of the 
trends by qualitative analysis is also presented. 
Chapter 3 concerns the development of QSAR/QSSR models. QSSR models for 
enantioselectivity were developed using the CoMFA method and the resulting models are 
discussed. Qualitative application of these models is presented. 
The last chapter for Part I of this dissertation involves the development and application of 
alternative 3D-QSAR methods. The methods are discussed and applied to current data sets. 
Application of these models toward the synthesis of new catalysts is presented.  
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Chapter 2:  Synthesis and Evaluation of Catalysts 
2.1.  Introduction. 
Without testable hypotheses about what structural features will be dominant in conferring 
high phase transfer catalyst activity and selectivity, this project was necessarily initiated as a 
discovery oriented program. The initial focus was set on (1) identifying a suitable scaffold (or 
scaffolds) that could be prepared in enantiopure fashion and would allow for substitution in 
multiple positions followed by (2) developing suitably flexible parallel synthesis procedures for 
the elaboration of the scaffold to a diverse library of quaternary ammonium ions. Concurrently 
the scaffold and most easily substituted positions were evaluated in the context of known 
quaternary ammonium design principles. A strategy that was quickly identified as a reaction that 
embodies all of these requisite characteristics for scaffold selection was the tandem [4+2] / [3+2] 
cycloaddition of nitroalkenes, a methodology extensively studied in these laboratories (Scheme 
6).61 
Scheme 6. 
 
2.2. Synthetic Strategy. 
2.2.1.  Tandem [4+2]/[3+2] Cycloaddition. 
In the tandem cycloaddition of nitroalkenes, three key components, a nitroalkene, a 
dienophile and a dipolarophile combine to construct a new six-carbon unit forging four bonds, up 
to six contiguous stereogenic centers, and four rings (Scheme 7). Lastly, the newly minted 
skeleton is transformed by hydrogenolysis, which proceeds by reductive N-O bond cleavage, 
followed by intramolecular reductive amination and lastly closure of the remaining ring to 
construct a pyrrolizidine ring system. Of the four possible permutations of inter- and 
intramolecularity, the tandem inter [4+2] / intra [3+2] family wherein the dipolarophile and 
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nitroalkene are covalently tethered is the most powerful (Scheme 7).62 Tethering the 
dipolarophile to either the α- or β-position of the dienophile results in bridged cycloadducts and 
generates primary amines after hydrogenolysis. Tethering the dipolarophile to the nitroalkene 
results in either a spiro-mode (1-position) or a fused-mode (2-position) cycloaddition and 
generates tertiary lactams after hydrogenolysis. Extensive investigation of this family has 
revealed many advantages including: (1) ease of preparation of the precursors, (2) flexibility in 
the electronic nature and configuration of the components, (3) high levels of absolute 
stereocontrol with chiral dienophiles, and (4) diversity of product structure.63  
Scheme 7. 
 
 A key challenge to systematic investigation of APTC is the availability of catalyst 
scaffolds that allow for facile modification of sites proximal to the quaternary ammonium ion 
center.64,65 Both the spiro- and fused-mode cycloadditions create skeletons where the nitrogen is 
fixed in a central position of a rigid ring system thereby providing potential for the controlled 
installation of groups in the vicinity of the nitrogen. The fused mode, tandem inter [4+2] / intra 
[3+2] cycloaddition with a two-carbon tether was chosen for initial studies. In this mode the 
tandem cycloaddition/hydrogenolysis sequence generates a tricyclic cyclopentapyrrolizidin-2-
one ring system bearing a hydroxy group at C(1) and a substituent at C(5) (Scheme 7). Prior to 
elaboration of a detailed parallel synthesis strategy, the local environment around the ammonium 
nitrogen was considered in the context of known design principles. 
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2.2.2.  Parallel Synthesis Design. 
The tandem inter [4+2] / intra [3+2] cycloaddition of nitroalkenes in the fused mode 
allows for the stereoselective introduction of groups at C(5) (R1) and a hydroxy group at C(1) 
while preserving the relative configuration of the scaffold ring system (Scheme 8). The variable 
groups R1, R2, and R4 are situated on the convex face allowing for the evaluation of many 
different combinations of substituents. Because the C(5)-substituent (R1) is the first point of 
diversification its variation was limited (either H or Me), thereby reducing the synthetic 
investment required for this initial survey. Moreover, the configuration of the C(1) center is 
dictated by the geometry of the dipolarophile thus introducing an additional element for 
diversification. After introduction of groups at C(1) and C(5) the scaffolds will be elaborated by 
means of parallel synthesis. 
Scheme 8. 
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The forward synthetic analysis from the scaffold is outlined in Scheme 8. The hydroxyl 
group at C(1) was targeted for the next two points of diversification. Simple oxidation followed 
by addition of an organometallic reagent (R2-M) would allow for the introduction of groups 
directly in the vicinity of the C(2)-C(7b)-C(9) face. Also, alkylation of the resulting alcohol (or 
the original secondary alcohol) with simple alkyl halides (R3-X) would serve as a facile method 
for introducing groups on the concave face. Lastly, the nitrogen substituent (R4) is installed by a 
second alkylation to afford the final quaternary ammonium salts. This analysis served as a 
general framework from which the order of synthetic steps suitable for parallel synthesis was 
worked out experimentally. 
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2.2.3.  Library Design. 
To facilitate description of the libraries, the catalysts are divided into focused sets of 
increasing substitution (I-V,Chart 3). The simplest members of this group (Library I) bear no 
oxygen containing functionality and vary only in the nitrogen substituent (R4). Oxygen 
functionality is introduced in Libraries II and III whereas additional steric and conformation 
influencing groups are introduced in Libraries IV and V. Quaternary ammonium ion library 
members will be referred to by Roman numeral (Libraries I-V) followed by a braced number set 
designating the order and number of groups introduced {X-X,X-X}. For example, in Scheme 8 
the intermediate free amine X{R1,R2,R3} will be converted to library V{ R1,R2,R3,X-X} through 
the action of reagents {X-X}. 
Chart 3. 
 
2.3.  Synthesis Results. 
2.3.1.  Synthesis of Nitroalkenes. 
To accurately determine the rate and enantioselectivity for each catalyst (ca. 3 
runs/catalyst), approximately 30 mg of each quaternary ammonium salt would be required, thus 
mandating the synthesis of gram quantities of the scaffolds for Libraries I-V. Thus, the first 
phase of this investigation was to develop robust, scalable routes to the cycloaddition precursors 
(nitroalkenes (E,E)-1 and (E,Z)-1 and chiral vinyl ethers 2 and 3, Scheme 8, above) in decagram 
quantities. 
Nitroalkene (E,E)-1 was synthesized by a known route with minor changes upon scale-up 
(Scheme 9). Thus, Wittig olefination of readily available 2-hydroxytetrahydrofuran66 established 
the E-alkene geometry as well as the primary alcohol function in (E)-6. Oxidation by the Parikh 
von-Doering protocol,67 (rather than the previously reported use of PCC), followed by immediate 
reaction of the aldehyde 7 under the standard Henry reaction conditions with nitroethane and 
19 
 
subsequent dehydration furnished nitroalkene (E)-1 in excellent overall yield (86% over three 
steps). This route provided rapid access to tens of grams of nitroalkene (E)-1. 
Scheme 9 
 
Large-scale preparation of the nitroalkene (E,Z)-1 for these studies proved significantly 
more challenging. The previous synthesis of (E,Z)-1 employed a Still-modified Horner-
Wadsworth-Evans type olefination (Scheme 10).68 Unfortunately, this method required tedious 
chromatographic purification to remove the minor geometrical isomer even on a sub-gram scale. 
Therefore, a new route to the enone (Z)-6 was sought wherein the Z-double bond configuration 
would be controlled by inclusion in a 7-membered ring (Scheme 10). Thus, methanolysis of 
caprolactenone 8 was targeted. Sufficient quantities of the enoate 8 for the investigation of the 
methanolysis step were prepared by selenoxide elimination of caprolactone following the 
methods of either Reich or Fleming.69,70 
Scheme 10. 
 
Because the acid-catalyzed alcoholysis of 7-membered lactones finds ample precedent,71 
a number of acids were surveyed (Table 1). Weak acids (pKa > 4) afforded little to no reaction 
within 24 h (entries 1 and 2). Stronger acids (pKa <4) such as sulfonic acids (entries 3 and 4) or 
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trifluoroacetic acid (entry 5) resulted in isomerization of the double bond at a rate competitive 
with ring opening. Reactions with hydrochloric acid (pKa <0) or silica gel or afforded the 
product with no apparent isomerization (entry 6, 8) however, neither reaction scaled well (entry 
7). Treatment of the lactone with methanolic base led to a significantly faster reaction (on the 
order of minutes) in contrast to hours or days for acid promoters (both with 0.1 equiv). Whereas 
sodium methoxide led to rapid polymerization (entry 9), the use of a milder base such as 
potassium carbonate rapidly furnished the desired product with no apparent double bond 
isomerization or decomposition (entry 10). Fortunately, this process could be run on multigram 
scale to afford the geometrically pure enone 8 in good yield (entry 11). Upon scale-up, a small 
amount of a side product originating from conjugate addition of methanol could be detected (~5-
10%). The use of sodium carbonate effectively suppressed the conjugate addition allowing for 
isolation of geometrically pure enone in good yield without the need for chromatographic 
purification (entry 12). With a robust method for alcoholysis of 8 in hand, the focus turned to 
developing a more scalable method for the preparation of the key lactenone 8. 
Table 1. Optimization of transesterifaction of lactone 8. 
 
entry additive time, h scale, g Z/Eb yield, %c 
1 2-NO2C6H4OH 24 0.050 −
 NRd 
2 AcOH 24 0.050 − NR 
3 TsOH 20 0.050 4:3 NDd 
4 CSA 20 0.050 4/1 ND 
5 CF3CO2H 20 0.050 4/1 ND 
6 silica gel 24 0.050 >10/1 ND 
7 silica gel 24 0.473 >10/1 52 
8 HCl 2 0.050 >10/1 ND 
9 NaOMe 0.2 0.050 − -e 
10 K2CO3 0.2 0.050 >10/1 ND 
11 K2CO3 0.5 5.20 >10/1 87 
12 Na2CO3 0.5 10.0 >10/1 97 
a General conditions: 50 mg 8, 1 mL MeOH, 0.1 equiv acid or base, room temperature. b 
By 1H-NMR integration. c Yield of chromatographically homogeneous material. d NR = 
no reaction and ND = not determined. e Only polymer was observed. 
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The preparation of caprolactenone 8 has been reported numerous times.72 The method 
employed for the exploratory work (vide supra) was the selenoxide elimination of 9 developed 
by Reich and later scaled-up by Fleming and Chow (Scheme 11).69,70 The advantages of this 
method are: (1) the full, contiguous carbon chain is readily available as caprolactone (~$0.07/g, 
Aldrich) (2) both terminal carbons of caprolactone are functionalized and (3) the sequence had 
already been scaled to 15 g (~6 mmol). Nevertheless, a more easily scalable route to this key 
intermediate was sought to avoid the use of selenium reagents and minimize the number of 
chromatographic purifications. For these reasons, a catalytic oxidation of silyl ketene acetal 10 
was investigated (Scheme 11). The requisite ketene acetal 10 was prepared by deprotonation of 
caprolactone with LDA in the presence of TMSCl in 83% yield.73 Notably, the process could be 
scaled to 20 g and the product directly purified by fractional distillation. 
Scheme 11. 
 
The dehydrogenation of silyl ketene acetals to provide lactones utilizing Pd(OAc)2 (10 
mol%) and allyl methyl carbonate as the oxidant has been reported by Tsuji.74 To apply a 
palladium catalyzed dehydrogenation protocol on a large scale, a lower catalyst loading was 
required. Initially, a limited number of palladium sources and loadings were surveyed (Table 2). 
The desired product 8 was not detectable within 2 h with palladium (II) chloride (entry 1). 
Palladium (II) acetate gave a good yield that was enhanced slightly by the addition of an external 
ligand (entries 2-4). The preformed complex Pd(dba)2 provided the best result with near 
quantitative conversion within 2 h (entry 6). Moreover, with Pd(dba)2 the temperature could be 
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lowered and catalyst loading decreased to 1 mol % without a significant reduction in yield 
(entries 7 and 8). Under the optimal conditions, the reaction could be performed on decagram 
scale and the product isolated in greater than 95% yield. 
Table 2. Optimization of Saegusa Oxidation. 
O
OTMS
Pd Source
O OMe
O
O
O
8
CH3CN
(2.0 equiv)
10  
entry Pd, source Pd, mol% yield, %b 
1 PdCl2 10 <1 
2 Pd(OAc)2 5 78 
3 Pd(OAc)2 10 84 
4c Pd(OAc)2 5 87 
5c,d Pd(OAc)2 5 77 
6 Pd(dba)2 5 96 
7 Pd(dba)2  1 95 
8e Pd(dba)2  1 94 
a Reaction conditions: 0.54 mmol of silyl ketene acetal, 0.2 M, 
80 oC, 2 h. b Determined by 1H-NMR spectroscopy. c 20 mol% 
DMSO added. d 0.8 M. e 40 oC. 
 
2.3.2.  Chiral Vinyl Ether Preparations. 
Previous studies on the stereochemical course of the tandem cycloaddition of 
nitroalkenes identified (1R,2S)-2-phenylcyclohexanol 11 as an excellent chiral dienophile for this 
process.75 Vinyl ether 2 has been prepared in 75% yield by equilibrium exchange with a donor 
vinyl ether (30 equiv) promoted by mercuric acetate (0.5 equiv).76 Subsequent studies showed 
the same result could be obtained with only 0.05 equiv of Schlaf’s catalyst (Pd(OAc)2/1,10-
phenanthroline).77 Fortunately, the starting material 11 and product 2 are easily separated. (E)-
Propenyl ether 3 was prepared following the published method.75 
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Scheme 12. 
 
2.4.  Scaffold Preparations by Tandem [4+2]/[3+2] Cycloaddition. 
The centerpiece of the library synthesis was the use of the tandem cycloaddition of 
nitroalkenes to cast the polycyclic skeletons that will serve as parallel synthesis scaffolds. 
Known α-hydroxy lactam 4 was prepared in racemic form by tandem [4+2]/[3+2] cycloaddition 
of nitroalkene (E,E)-1 with n-butyl via the intermediacy of nitronate 12 and nitroso acetal 13 
(Scheme 13). Reductive hydrogenolysis afforded the tricyclic lactam 4a in excellent overall yield 
(86% over three steps). 
Scheme 13. 
 
Likewise, α-hydroxy lactams 4a and 5 were prepared as previously described in non-
racemic form via the tandem cycloaddition with chiral vinyl and propenyl ethers 2 and 3 
respectively (Scheme 14).75,76 In this process, a standard set of reaction conditions was 
employed, namely exposure of a solution of nitroalkene and dienophile to TiCl2(Oi-Pr)2 at –78 
oC to afford the intermediate nitronate. Subsequent, thermal cycloaddition occurred over the 
course of 2-3 h upon standing at room temperature. The resulting nitroso acetals were 
immediately subjected to hydrogenolysis with Raney nickel in methanol to afford the lactams in 
76% and 89% respectively (three steps) with high enantioselectivity (e.r. 96:4).78 The epimeric 
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α-hydroxy lactam 4b (not previously described), was readily prepared in 63% yield following 
the standard protocol (e.r. 96:4). The elaboration of these scaffolds to the Libraries I-V 
respectively is detailed in the next section. 
Scheme 14. 
 
The next phase of these studies involved the development of a suitably versatile parallel 
synthesis route to allow for the introduction of various substituents on the core scaffold. The 
simplest scaffold (Library I), containing only a single site of variation, was first targeted to 
address the introduction of groups in the key N-alkylation step. 
To complete the synthesis of the Cs symmetric scaffold, reduction of the two oxygen 
functional groups was required. Removal of the hydroxyl group was accomplished by activation 
as a phenyl(thiono)carbonate 14 followed by Barton type deoxygenation under the action of 
Bu3SnH/AIBN to afford lactam 15 in good overall yield (64%, two steps) (Scheme 15).
79 
Reduction of lactam 15 with borane•THF afforded the fully deoxygenated scaffold 16 for 
Library I as its borane adduct in 80% yield. With large quantities of borane adduct 16 in hand, 
N-quaternization conditions suitable for parallel synthesis could be investigated. 
To facilitate the throughput of material, a method for the direct conversion of the amine 
borane adduct to the desired quaternary ammonium salts was sought that avoided the need for 
purification of intermediates. Heating amine⋅borane 16 in methanol in the presence of 1 M aq 
HCl led cleanly to the intermediate amine hydrochloride. The free base was liberated by 
partitioning the salt between 0.1 M aq NaOH and ether. Exposure of the free amine to a slight 
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excess of benzylic and primary aliphatic bromides {1-6} in acetonitrile at room temperature led 
smoothly to the quaternary ammonium ions I{1-6} in 72-90%. The excess electrophile could 
easily be removed by either filtration through silica gel or trituration with ether analogous to the 
methods of Dehmlow80 and Maruoka respectively.81 Ultimately, it was decided that silica gel 
plug filtration followed by trituration with ether could be used as the general conditions for 
purification for other ammonium salts. 
Scheme 15. 
 
2.5.  Preparation of Libraries II and III. 
The next level of complexity called for the synthesis of libraries of chiral, non-racemic 
ammonium salts to study their effectiveness as asymmetric phase transfer catalysts. The 
construction of Libraries II and III introduces a second parallel synthesis step, namely O-
alkylation. These two libraries embodied three objectives aimed at investigating both 
enantioselectivity and rate: (1) to introduce groups with variable solubilizing abilities (rate) and 
(2) introduce variable π-surfaces and steric bulk (selectivity) and (3) investigate the effect of 
configuration at C(1) (selectivity). 
The diastereomeric lactams 4a and 4b were reduced to the pyrrolizidines 17a and 17b 
with BH3⋅THF (>10 equiv) in good to excellent yield (Scheme 16). These amines were also 
isolated as their borane adducts, thus protecting the amine from air oxidation82 and subsequent 
alkylation in the next step. This sequence allowed for the preparation of multi-gram quantities of 
borane complexes 17a and 17b as crystalline solids which was a convenient stage for storage of 
material. Application of standard Williamson ether synthesis conditions83 (NaH, DMF) to borane 
complexes 17a and 17b allowed for facile elaboration to intermediates chemsets II{1-5} and 
26 
 
III{1-5}. The introduction of simple hydrophobic groups (n-hexyl), hydrophilic groups 
(methoxyethoxymethyl, MEM) as well as aromatic carbocycles and heterocycles, in good yield 
under a standard set of reaction conditions. It is noteworthy that the inclusion of a MEM ether in 
these series required the use of either neutral or base-promoted deborylation conditions because 
of the acid lability of this group. Accordingly, aq. HCl was replaced with aq. Na2CO3 under 
otherwise identical reaction conditions. Elaboration of the intermediate borane adducts as 
described in section 4.1 proceeded smoothly to afford quaternary ammonium salt libraries II{1-
5,1-6} and III{1-5,1-6} in good yields over the three step process. 
Scheme 16. 
 
2.6.  Preparation of Libraries IV and V. 
2.6.1.  Introduction of R
2
 Substituents. 
The presence of the hydroxyl group at C(1) allows for further diversification. This site 
was targeted for the introduction of different aliphatic and aromatic groups by organometallic 
addition to the corresponding C(1) ketone. Accordingly, Parikh von-Doering oxidation67 of 17a 
furnished the desired ketone 19 in 98% yield (Scheme 17). However, ketone 19 was not stable 
and was immediately carried on to the organometallic addition step. The increased acidity of the 
α-hydrogens, likely as a consequence of nitrogen complexation,84 required the use of softer, less 
Brønsted basic organocerium reagents.85 The resulting additions took place (40-98% yield) to 
form 21{2,3,5} with complete β-diastereoselection as a consequence of the bowl shape of the 
core scaffold. Likewise, lactam 5 (an inseparable 12:1 mixture of C(5) diastereomers from 
cycloaddition with a propenyl ether) underwent the cerium-mediated addition to afford the 
tertiary alcohols 22{2.3.5} in similar yields. 
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Scheme 17. 
 
However, the inability to introduce bulky groups as well as poor reproducibility led to a 
modification of the synthetic route. Oxidation of alcohol 5 to α-keto lactam 23 afforded two 
important benefits over the initial route. First, the addition of Grignard reagents to this highly 
active dicarbonyl compound proceeded reproducibly and in excellent yields (95-97%) even with 
bulky nucleophiles. Second, the minor C(5) diastereomer could be removed by a single 
recrystallization. However, reduction of the resulting lactams 24{4,6,7} required elevated 
temperatures, presumably a consequence of the additional steric bulk proximal to the site of 
reduction. In this way, the corresponding amine⋅borane adducts 21 and 22 could be isolated in 
respectable yields (72-85%) without increasing the number of steps in the synthetic route. 
2.6.2.  Parallel Synthesis Toward Libraries IV and V. 
Extension of the developed parallel synthesis route to the more hindered tertiary alcohol 
at C(1) found in Libraries IV and V was straightforward (Scheme 18). The R3 substituents in 
Libraries IV and V were limited to unfunctionalized aliphatic groups, electron rich (4-MeOC6H4) 
and electron deficient (3,5-(CF3)2C6H3) aromatic groups. Also, the 9-anthrylmethyl group at R
4 
was removed from this set,86 but a larger number of groups of varying electronic makeup and 
size were introduced for R4 in Libraries IV and V. 
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Scheme 18. 
 
2.7.  Summary of Library Synthesis.  
A library of over 160 catalysts sharing the same core scaffold has been generated that 
incorporates the substituents below (Scheme 19). Although this number represents only a small 
fraction of the complete matrix of >1200 possible the library represents a good approximation on 
the basis of preliminary data. The groups shown reflect the need to evaluate the roles of steric 
and electronic contributions, π-surface, lipophilicity, and polar surface area on the catalyst 
structure for a given phase transfer catalyzed reaction. 
Scheme 19. 
 
2.8.  Collection of Kinetic Data. 
2.8.1.  Refining a Kinetic Analysis. 
The base-promoted benzylation of glycine benzophenone imine tert-butyl ester 25 has 
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become the benchmark reaction for investigation of new catalyst structures.32m As such, a 
standard set of reaction conditions has been established, namely the use 50% aq. KOH solution 
and toluene.34 Given the intrinsic biphasic nature of PTC reactions, efficient mixing is essential 
to promote efficient transport and to minimize the errors associated with precipitation. For these 
reasons, a 4-mL (1 cm x 3.5 cm) cylindrical vial was chosen as the reaction vessel together with 
a 1.5 cm egg-shaped stir bar. This stir bar was large enough such that it traversed the interface 
and yet was small enough to ensure mixing as a consistent shearing motion.25,87 The scale of the 
reactions was dictated by the need to conduct multiple kinetic runs using 80-120 mg of starting 
ester 25 (thus dictating a minimally measurable amount of catalyst (4-8 mg)) and to maintain a 
reaction concentration of 0.33 M.  
Under these conditions, orienting experiments utilizing 5 mol % of a catalyst at room 
temperature resulted in rapid reaction; most were complete within 1-3 min. Clearly this range of 
rates was not amenable to providing reproducible results. Decreasing the catalyst loading to 2.5 
mol % and decreasing the temperature to 2-4 oC successfully slowed the reaction to a point 
where a range of rates could be obtained.88 
Scheme 20. 
 
Initial experiments with tetrabutylammonium bromide allowed for an examination of 
sampling methods to ensure reproducibility. Sampling from the bulk mixture gave inconsistent 
results and the sampling needle clogged frequently. A more reliable protocol involved stopping 
the agitation momentarily to allow the biphasic mixture to separate (~2 s), and sampling from the 
organic layer. Utilizing this protocol the reaction profile was reproducible; two sample runs are 
shown in Figure 6a. 
An important decision was to choose an appropriate value to represent the rate data (e.g. 
ki, kobs, t1/2, …etc). Upon initial testing catalyst I{1}, a significant induction period was observed 
over the course of the first 5% conversion (Figure 7, red squares). This type of behavior has 
previously been reported as a function of ammonium counterion.18,89 The induction period was 
seen under the protocol wherein the base was added last. However, if the order of addition of 
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reagents was changed such that the alkylating agent was added last, then the converse was 
observed and appearance of product was rapid at first, but quickly declined (a kinetic “burst”). 
Most importantly, regardless of the order of operations, the “time course” of the two reactions 
converges to a single rate (within 1%, Figure 6b). The implications of this observation will be 
discussed in the following section. 
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Figure 6. a) Kinetic profile of a TBAB catalyzed reaction. b) Affect of order of addition with 
catalyst I{1}. 
 
Given the significant variation at the onset of the reaction, it was decided to extract data 
that would be independent of the initial rate, namely t1/2. Although this determination is labor 
intensive, since it would require monitoring each reaction to greater than 50% conversion, it has 
the added advantage of showing the entire reaction profile. 
2.9.  Stir Rate Dependence. 
The last critical decision to be made was a stirring rate that would sufficiently minimize 
errors from salting out and still allow for the differences in catalyst activities to be observed. 
Hydroxide initiated-PTC reactions can exhibit a rate dependence on stirring speed in excess of 
~2000 rpm. At high enough stirring speeds there is little dependence which is consistent with the 
proposal that the influence of mixing is to increase the surface area to volume ratio (effectively 
concentration) of the biphase,90  and that phase transfer reagents can decrease the interfacial 
surface tension.91 
To determine a suitable stirring speed for application to the standard protocol, the 
dependence of catalytic activity on stirring speed was determined for a variety of variably active 
quaternary ammonium ions. Reaction half-lives were determined following the experimental 
 parameters noted above employing a range 
observed half lives are plotted as a log/log in analogy to a dose
The top two curves represent catalysts with low catalytic activity while the two lower curves 
represent catalysts among the highest activity. Importantly, there is a sufficient range of stirring 
speeds, along which the activities of all of the catalysts surveyed a
on mixing rate. In choosing the stir rate with which all of the kinetic experiments were to be 
carried out, the important considerations were: (1) sufficient and consistent mixing, (2) 
operationally accessible, and (3) that th
dependence was still observed. The stir rate of 1600 rpm fit within all three of these criteria 
(represented by the black vertical dotted line in 
kinetic data were collected at this stir rate. 
Figure 7. Effect of stir rate on reaction half
 
2.10.  Summary of the Kinetic Data
2.10.1.  Statistical Description. 
With a working analytical method in hand, a large subset of the ammonium salts was 
evaluated for their kinetic competence, represented as half
by interpolation of the kinetic plot of percentage of product formation as a function of time. The 
reported half-life values represent averages over two runs with and average error of 4.5%.
from kinetic runs that resulted in errors exceeding 20% 
of less than 20% was observed. 
To date, half-lives for 102 of the 160 catalysts have been collected. The observed half
of stir rates (1038 – 2500 rpm). The resulting 
-response graph (
re dependent (non
e stir rate existed in a region where a reaction rate 
Figure 7 and therefore, all of the remaining 
 
 
-life with catalysts of varying structure and activity.
. 
-lives. The half-lives were determi
was discarded and repeated until an error 
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94 Data 
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 data covers four orders of magnitude of activity that 
investigation of the structural effects of catalyst on rate. The half
experiments ranged from 5 min to over 15 h and is summarized in logarithmic 
(Figure 8). Of the 98 catalysts surveyed to date 52 of them exhibited half
Twenty-three catalysts make up the data between 20 min and 1 h, and the half
remaining 23 catalysts range from 1 h to 15 h.
Figure 8 Histogram of t1/2 data in logarithmic form.
 
2.10.2.  Reaction Rates Results for Library I.
The half-life data for Library 
fairly poor catalytic activity exhibiting half
the catalyst containing an n-hexyl nitrogen substituent. In this case the half
only 13 min. 
 
 
 
 
was deemed suitable for 
-life data collected from these 
-lives of 20 min or less. 
 
 
 
 
I is summarized in Table 3. These ammonium ions showed 
-lives in the range of 5 to 12 h. The one exception was 
-life observed was 
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Table 3. Half-life Data for Library I. 
 
entry Library # R4 t1/2, min 
1 I{1} C6H5 940 
2 I{2} 1-naphthyl 730 
3 I{3} 2-naphthyl na 
4 I{4} 9-anthryl 324 
5 I{5} 3,5-(CF3)2C6H3 na 
6 I{6} n-hexyl 12.8 
 
2.10.3.  Reaction Rates for Libraries II and III. 
The half-life data for Libraries II and III is summarized in Table 4. These ammonium 
salts are generally more active catalysts than those lacking an oxygen substituent and exhibited 
half-life range from 6 min to 5.7 h. Catalysts containing a non-hydrogen substituent at R3 are 
generally more active than the corresponding catalysts with hydrogen at R3. However, no clear 
dependence of the nature of the R3 substituent on catalyst activity was discernable. When R3 = H, 
the rate was markedly dependent on the configuration at C(1) (entries 5 vs. 6). However, when 
R3 ≠ H, the half-life was nearly independent on the C(1) configuration (entries 10 vs. 11, 12 vs. 
13, 16 vs. 17, 21 vs. 22, and 23 vs. 24). 
2.10.4.  Reaction Rates for Libraries IV and V. 
The half-life data for Libraries IV and V is summarized in  
Table 5. The activity of these catalysts appears to be largely dependent on the R2 
substituent within the series. Comparing catalysts with fixed R1, R3, and R4, substituents, but 
with varying R2 substituents, the following trend in rates holds: R2 = i-Pr > Me > Ph. However, 
there are important exceptions. For example, catalysts containing R4 = 3,5-(CF3)2C6H3, R
1 = Me, 
R3 = benzyl, the following trend in half-life holds for R2: Me > i-Pr > t-Bu > Ph (entries 13, 26, 
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35, 39). Evidently, a compelling, but complex dependence of the bis(trifluoromethyl)phenyl 
group at R4 on the catalyst activity is observed. Moreover, ammonium salts containing R3 = n-
hexyl are generally more active than catalysts with R3 ≠ n-hexyl with all other substituents held 
constant, which suggests a dependence on lipophilicity. 
Table 4 Half-life Data for Library II and III. 
 
entry Library # R3 R4 
C(1)- 
configuration 
t1/2, min 
1 II{1,1} H C6H5 α 181 
2 II{1,2} H 1-naphthyl α 179 
3 II{1,4} H 9-anthryl α 298 
4 II{1,5} H 3,5-(CF3)2C6H3 α 346 
5 II{1,3} H 2-naphthyl α 245 
6 III{1,3} H 2-naphthyl β 72 
7 II{2,1} C6H5 C6H5 α 10 
8 II{2,2} C6H5 1-naphthyl α 18 
9 II{2,3} C6H5 2-naphthyl α 12.1 
10 II{3,1} n-hexyl C6H5 α 11.7 
11 III{3,1} n-hexyl C6H5 β 14.8 
12 II{3,2} n-hexyl 1-naphthyl α 6.6 
13 III{3,2} n-hexyl 1-naphthyl β 9.5 
14 III{3,3} n-hexyl 2-naphthyl β 13.5 
15 II{3,5} n-hexyl 3,5-(CF3)2C6H3 α 12.7 
16 II{3,6} n-hexyl n-hexyl α 4.6 
17 III{3,6} n-hexyl n-hexyl β 5.5 
18 II{4,1} MEM C6H5 α 17.5 
19 II{4,2} MEM 1-naphthyl α 12.3 
20 II{4,3} MEM 2-naphthyl α 22.8 
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Table 4. (cont.) 
21 II{5,1} 2-pyridyl C6H5 α 17.1 
22 III{5,1} 2-pyridyl C6H5 β 11.1 
23 II{5,2} 2-pyridyl 1-naphthyl α 6.6 
24 III{5,2} 2-pyridyl 1-naphthyl β 11 
25 II{5,3} 2-pyridyl 2-naphthyl α 12.7 
26 II{5,4} 2-pyridyl 9-anthryl α 21.1 
27 II{5,5} 2-pyridyl 3,5-(CF3)2C6H3 α 31.8 
 
Table 5. Half-life Data for Library IV and V. 
 
entry Library # R1 R2 R3 R4 
C(1)-
configuration 
t1/2, min 
1 IV{2,2,1} H Me C6H5 C6H5 α 93.5 
2 IV{2,2,2} H Me C6H5 1-naphthyl α 51.1 
3 IV{3,2,1} H i-Pr C6H5 C6H5 α 19.5 
4 IV{3,2,5} H i-Pr C6H5 3,5-(CF3)2C6H3 α 26.1 
5 IV{5,2,5} H C6H5 C6H5 3,5-(CF3)2C6H3 α 16.3 
6 V{1,2,1} Me H C6H5 C6H5 α 32.5 
7 V{1,2,8} Me H C6H5 4-(MeO)C6H4 α 51.8 
8 V{1,2,8} Me H C6H5 4-(MeO)C6H4 β 53.9 
9 V{1,2,7} Me H C6H5 3,5-(t-Bu)2C6H3 β 9.78 
10 V{1,2,6} Me H C6H5 n-hexyl α 24.7 
11 V{2,2,1} Me Me C6H5 C6H5 α 20.7 
12 V{2,2,3} Me Me C6H5 2-naphthyl α 23.0 
13 V{2,2,5} Me Me C6H5 3,5-(CF3)2C6H3 α 899.7 
14 V{2,2,8} Me Me C6H5 4-(MeO)C6H4 α 19.9 
15 V{2,2,7} Me Me C6H5 3,5-(t-Bu)2C6H3 α 15.1 
16 V{2,2,6} Me Me C6H5 n-hexyl α 28.1 
17 V{2,3,1} Me Me n-hexyl C6H5 α 23.0 
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Table 5. (cont.) Half-life Data for Library IV and V. 
18 V{2,3,2} Me Me n-hexyl 1-naphthyl α 75.8 
19 V{2,3,3} Me Me n-hexyl 2-naphthyl α 30.7 
20 V{2,3,5} Me Me n-hexyl 3,5-(CF3)2C6H3 α 236.0 
21 V{2,3,8} Me Me n-hexyl 4-(MeO)C6H4 α 26.5 
22 V{2,3,7} Me Me n-hexyl 3,5-(t-Bu)2C6H3 α 28.9 
23 V{2,3,6} Me Me n-hexyl n-hexyl α 21.1 
24 V{2,7,1} Me Me 
4-
(MeO)C6H4 
C6H5 α 17.9 
25 V{3,2,1} Me i-Pr C6H5 C6H5 α 132.1 
26 V{3,2,5} Me i-Pr C6H5 3,5-(CF3)2C6H3 α 122.1 
27 V{3,2,7} Me i-Pr C6H5 3,5-(t-Bu)2C6H3 α 28.6 
28 V{3,3,1} Me i-Pr n-hexyl C6H5 α 41.8 
29 V{3,3,3} Me i-Pr n-hexyl 2-naphthyl α 20.3 
30 V{3,3,5} Me i-Pr n-hexyl 3,5-(CF3)2C6H3 α 62.4 
31 V{3,3,8} Me i-Pr n-hexyl 4-(MeO)C6H4 α 42.7 
32 V{3,2,6} Me i-Pr C6H5 n-hexyl α 86.0 
33 V{3,7,5} Me i-Pr 
4-
(MeO)C6H4 
3,5-(CF3)2C6H3 α 60.9 
34 V{3,7,8} Me i-Pr 
4-
(MeO)C6H4 
4-(MeO)C6H4 α 249.4 
35 V{4,2,5} Me t-Bu C6H5 3,5-(CF3)2C6H3 α 95.8 
36 V{5,2,1} Me C6H5 C6H5 C6H5 α 10.6 
37 V{5,2,2} Me C6H5 C6H5 1-naphthyl α 12.2 
38 V{5,2,3} Me C6H5 C6H5 2-naphthyl α 10.3 
39 V{5,2,5} Me C6H5 C6H5 3,5-(CF3)2C6H3 α 9.5 
40 V{5,2,8} Me C6H5 C6H5 4-(MeO)C6H4 α 17.5 
41 V{5,2,9} Me C6H5 C6H5 (4-CF3)C6H4 α 16.0 
42 V{5,2,10} Me C6H5 C6H5 (4-CN)C6H4 α 14.4 
43 V{5,3,1} Me C6H5 n-hexyl C6H5 α 9.5 
44 V{5,3,2} Me C6H5 n-hexyl 1-naphthyl α 18.7 
45 V{5,3,3} Me C6H5 n-hexyl 2-naphthyl α 13.1 
46 V{5,3,5} Me C6H5 n-hexyl 3,5-(CF3)2C6H3 α 4.9 
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Table 5. (cont.) (cont.) Half-life Data for Library IV and V. 
47 V{5,3,8} Me C6H5 n-hexyl 4-(MeO)C6H4 α 9.9 
48 V{5,3,7} Me C6H5 n-hexyl 3,5-(t-Bu)2C6H3 α 8.5 
49 V{5,6,1} Me C6H5 
3,5-
(CF3)2C6H3 
C6H5 α 7.9 
50 V{5,6,5} Me C6H5 
3,5-
(CF3)2C6H3 
3,5-(CF3)2C6H3 α 7.0 
51 V{5,6,8} Me C6H5 
3,5-
(CF3)2C6H3 
4-(MeO)C6H4 α 6.9 
52 V{5,7,1} Me C6H5 
4-
(MeO)C6H4 
C6H5 α 19.9 
53 V{5,7,2} Me C6H5 
4-
(MeO)C6H4 
1-naphthyl α 19.2 
54 V{5,7,3} Me C6H5 
4-
(MeO)C6H4 
2-naphthyl α 12.0 
55 V{5,7,5} Me C6H5 
4-
(MeO)C6H4 
3,5-(CF3)2C6H3 α 18.6 
56 V{5,7,7} Me C6H5 
4-
(MeO)C6H4 
3,5-(t-Bu)2C6H3 α 14.6 
57 V{7,2,1} Me 1-naphthyl C6H5 C6H5 α 13.7 
58 V{7,2,5} Me 1-naphthyl C6H5 3,5-(CF3)2C6H3 α 28.7 
59 V{7,2,8} Me 1-naphthyl C6H5 4-(MeO)C6H4 α 11.3 
60 V{7,2,9} Me 1-naphthyl C6H5 (4-CF3)C6H4 α 11.8 
61 V{7,2,10} Me 1-naphthyl C6H5 (4-CN)C6H4 α 48.6 
62 V{6,2,1} Me 
2,4,6-
(CH3)2C6H2 
C6H5 C6H5 α 12.2 
63 V{6,2,8} Me 
2,4,6-
(CH3)2C6H2 
C6H5 4-(MeO)C6H4 α 11.8 
 
2.10.5.  Other Quaternary Ammonium Ions. 
Varying the substituents on a common scaffold allowed for observation of a large range 
of rates. To determine how much of the “total possible” range of activity was being sampled 
tetramethylammonium bromide (TMAB, q = 4.0) was tested and exhibited a half-life of 1200 
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min (Table 6).95 The similarly hydrophilic, but less accessible tetraethylammonium bromide (q = 
2.0) exhibited a 20-fold rate increase over TMAB. The more lipophilic, but similarly accessible 
cation cetyltrimethyl (C19 total, q = 3.06) ammonium bromide was only three times faster than 
TMAB (entry 3). The rate increase from tetramethyl- to tetraethylammonium bromide was also 
seen in the use of tributylbenzylammonium bromide, which caused a further 20-fold rate 
increase. To directly address this dramatic effect of ammonium accessibility with catalysts more 
closely related to the common scaffold, one other small set of quaternary ammonium ions was 
constructed that replaces one of the pyrrolidine rings of the scaffold with an azetidine. As 
expected, the ammonium ions containing an azetidine ring exhibited overall poor catalytic 
activity with half-lives ranging from 900 to 1000 min. 
Table 6.  Half-life Data for other Quaternary Ammonium Ions. 
 
entry Library # catalyst R4 t1/2, min 
1 - Me4N - 12,000 
2 - Et4N - 480 
3 - Me3NC16H33 - 2800 
4 - n-Bu3NBn - 21 
5 VI{1} - C6H5 890 
6 VI{2} - 1-naphthyl 1000 
7 VI{3} - 2-naphthyl 1090 
 
2.11.  Enantioselectivity of the Catalysts. 
In addition to determining the substituent effects on rate, those structural features that 
most strongly affect enantioselectivity were of equal interest. Summarized below is the 
enantioselectivity data for all 143 chiral, non-racemic catalysts constructed to date. The 
enantiomeric ratio of benzylated product 21 was measured by purifying a sample by silica gel 
chromatography from a separate experiment at 2-4 oC with 2.5 mol % catalyst loading. The 
enantiomeric ratios were determined by CSP-HPLC. 
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2.11.1.  Enantioselectivity for Library II. 
The enantioselectivity data for the α-series (Library II, R1 = R2 = H) is summarized in 
Table 7. For this series, when the oxygen substituent (R3) was hydrogen, a small, but detectable 
selectivity for the S enantiomer was seen. However, this effect was only seen when the N-
substituent was branched (entries 1 and 3 vs. 2, 4-6). Substituting R3 with aliphatic (entries 7-12) 
and ethereal (entries 13-18) substituents did not result in a significant difference in the 
enantioselectivity. Installation of the 2-pyridyl group at the R3 position led to a minor enrichment 
in the R enantiomer. The inclusion of a benzyl group at R3 (entries 19-24) led to poor selectivity 
irrespective of the nitrogen substituent. In summary, only poor to moderate enrichment of the S 
enantiomer was observed with variable R3 and R4 substituents and where R1 = R2 = H whereas 
catalysts with R1 = Me in conjunction with R4 bearing a 3,5-substitution pattern gave slightly 
higher selectivities in this series. 
2.11.2.  Enantioselectivity for Library III. 
The enantioselectivity data for the β-series (Library III, R2 = H) is summarized in Table 
8. As was seen with the α-series, catalysts with R3 = H produced low to moderate enrichment of 
the S enantiomer of 21 with R4 = 3,5-(CF3)2C6H3 (entry 4, e.r. 57:43) exhibiting the largest 
selectivity. Relative to the α-series, catalysts with R3 = aliphatic consistently produced the S 
enantiomer in slightly greater enrichment (entries 7-12). Additionally, moderate 
enantioselectivity was observed in catalysts containing a 2-pyridyl group (where the point of 
attachment is the sp2 carbon of the heteroaromatic ring) at R3 (entries 19, 22, and 24) with the 
largest selectivity observed when R4 = 1-naphthyl. Similar results were observed in catalysts 
with R3 = benzyl within this series, apart from when R4 = Ph (entry 18) which resulted in 
decreased selectivity. Overall, the enantioselectivity data for the catalysts in Library III was 
greater than their diastereomeric counterparts Library II. 
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Table 7. Enantioselectivity of Library II. 
 
entry Library # R3 R4 er, S:R 
1 II{1,2} H 1-naphthyl 54:46 
2 II{1,3} H 2-naphthyl 51:49 
3 II{1,4} H 9-anthryl 54:46 
4 II{1,5} H 3,5-(CF3)2C6H3 53:47 
5 II{1,6} H n-hexyl 51:49 
6 II{1,1} H C6H5 52:48 
7 II{3,2} n-hexyl 1-naphthyl 52:48 
8 II{3,3} n-hexyl 2-naphthyl 51:49 
9 II{3,4} n-hexyl 9-anthryl 51:49 
10 II{3,5} n-hexyl 3,5-(CF3)2C6H3 51:49 
11 II{3,6} n-hexyl n-hexyl 53:47 
12 II{3,1} n-hexyl C6H5 52:48 
13 II{4,2} MEM 1-naphthyl 50:50 
14 II{4,3} MEM 2-naphthyl 51:49 
15 II{4,4} MEM 9-anthryl 50:50 
16 II{4,5} MEM 3,5-(CF3)2C6H3 50:50 
17 II{4,6} MEM n-hexyl 50:50 
18 II{4,1} MEM C6H5 51:49 
19 II{2,2} C6H5 1-naphthyl 50:50 
20 II{2,3} C6H5 2-naphthyl 48:52 
21 II{2,4} C6H5 9-anthryl 50:50 
22 II{2,5} C6H5 3,5-(CF3)2C6H3 50:50 
23 II{2,6} C6H5 n-hexyl 51:49 
24 II{2,1} C6H5 C6H5 47:53 
25 II{5,2} 2-pyridyl 1-naphthyl 46:54 
26 II{5,3} 2-pyridyl 2-naphthyl 48:52 
27 II{5,4} 2-pyridyl 9-anthryl 45:55 
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Table. 7 (cont.) Enantioselectivity of Library II. 
28 II{5,5} 2-pyridyl 3,5-(CF3)2C6H3 50:50 
29 II{5,6} 2-pyridyl n-hexyl 48:52 
30 II{5,1} 2-pyridyl C6H5 47:53 
 
  
42 
 
Table 8. Enantioselectivity of Library II. 
 
entry Library # R3 R4 er, S:R 
1 III{1,2} H 1-naphthyl 48:52 
2 III{1,3} H 2-naphthyl 55:45 
3 III{1,4} H 9-anthryl 50:50 
4 III{1,5} H 3,5-(CF3)2C6H3 57:43 
5 III{1,6} H n-hexyl 52:48 
6 III{1,1} H C6H5 55:45 
7 III{3,2} n-hexyl 1-naphthyl 48:52 
8 III{3,3} n-hexyl 2-naphthyl 55:45 
9 III{3,4} n-hexyl 9-anthryl 47:53 
10 III{3,5} n-hexyl 3,5-(CF3)2C6H3 52:48 
11 III{3,6} n-hexyl n-hexyl 53:47 
12 III{3,1} n-hexyl C6H5 54:46 
13 III{2,2} C6H5 1-naphthyl 64:36 
14 III{2,3} C6H5 2-naphthyl 48:52 
15 III{2,4} C6H5 9-anthryl 44:56 
16 III{2,5} C6H5 3,5-(CF3)2C6H3 57:43 
17 III{2,6} C6H5 n-hexyl 58:42 
18 III{2,1} C6H5 C6H5 53:47 
19 III{5,2} 2-pyridyl 1-naphthyl 64:36 
20 III{5,3} 2-pyridyl 2-naphthyl 48:52 
21 III{5,4} 2-pyridyl 9-anthryl 54:46 
22 III{5,5} 2-pyridyl 3,5-(CF3)2C6H3 58:42 
23 III{5,6} 2-pyridyl n-hexyl 57:43 
24 III{5,1} 2-pyridyl C6H5 60:40 
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2.11.3.  Enantioselectivity for Libraries IV and V. 
The enantioselectivities for catalysts with variable R2, R3, and R4 groups while holding 
R1 constant as a methyl group (excluding entry 1) are summarized in Table 9. Entries with the 
highest selectivities are highlighted. Introducing a methyl group at R1 while maintaining a 
hydrogen and a benzyl group at R2 and R3 respectively did not lead to significant differences in 
the enantioselectivity apart from when the R4 group was a 3,5-substited aryl ring (entries 7 and 
8). In this case, inversion of the C(1) configuration resulted in a comparable enantioselectivity 
(entry 14). 
The results for the catalysts with R2 = Me are similar to those catalysts with R2 = H. 
Likewise, catalysts with a 3,5-substitution pattern on the aryl ring of R4 consistently resulted in 
the highest selectivities independent of the R3 substituent (entries 1, 17, 21, 24, 28, 31, and 32). 
Increasing the size of the R2 substituent to isopropyl and tert-butyl resulted in a reversal in the 
selectivity (entries 33-54). As was the case with catalysts with R2 = Me, the catalysts exhibiting a 
3,5-substitution pattern on the aryl ring of R4 with R2 = i-Pr and t-Bu produced the highest 
selectivities. Catalysts containing R2 = phenyl are displayed in entries 55-76. These catalysts 
were variably selective for either the S or R enantiomer, apart from when R4 was a 3,5-
disubstitued aryl group. However, the maximum enantioselectivity was observed when R4 = 3,5-
(CF3)C6H3 (entries 63, 69 and 74) This effect is independent of the oxygen substituent (R
3). 
Additionally, the substitution pattern of the trifluoromethyl groups on the aryl ring (R4) proved to 
be important, as having groups at the 3- and 5- aryl position consistently resulted in greater 
enantioselectivity than having substituents at the 2- and 4-aryl positions (entry 64) or just the 4-
aryl position (entry 65). Moreover, the presence of an alkyl group at R1 (Me) is imperative as the 
analogous catalyst with R1 = H afforded significantly decreased enantioselectivity (entry 1, e.r. 
56:44). The installation of different groups at R2 with π-surfaces while maintaining R3 = 3,5-
(CF3)C6H3 produced similar results (1-naphthyl and mesityl, entries 77 and 83). When R
2 = i-
propyl or t-butyl (entry 41) the enantioselectivity is significantly diminished in comparison to 
catalysts that contain an aromatic group is in this position. Together these results attest to the 
importance of π-surface rather than steric bulk at R2 for higher enantioselectivity. 
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Table 9. Enantioselectivity of Libraries IV and V. 
 
entry Library # R1 R2 R3 R4 
C(1)-
configuration 
er, S:R 
1 IV{1,2,5} H Ph C6H5 3,5-(CF3)2C6H3 α 56:44 
2 V{1,2,2} Me H C6H5 1-naphthyl α 54:46 
3 V{1,2,3} Me H C6H5 2-naphthyl α 52:48 
4 V{1,2,1} Me H C6H5 C6H5 α 52:48 
5 V{1,2,3} Me H C6H5 n-hexyl α 50:51 
6 V{1,2,8} Me H C6H5 4-(MeO)C6H4 α 52:48 
7 V{1,2,5} Me H C6H5 3,5-(CF3)2C6H3 α 56:44 
8 V{1,2,7} Me H C6H5 3,5-(t-Bu)2C6H3 α 60:40 
9 V{1,2,2} Me H C6H5 1-naphthyl β 49:51 
10 V{1,2,3} Me H C6H5 2-naphthyl β 55:45 
11 V{1,2,5} Me H C6H5 3,5-(CF3)2C6H3 β 63:37 
12 V{1,2,3} Me H C6H5 n-hexyl β 51:49 
13 V{1,2,8} Me H C6H5 4-(MeO)C6H4 β 56:44 
14 V{1,2,7} Me H C6H5 3,5-(t-Bu)2C6H3 β 51:49 
15 V{2,3,2} Me Me n-hexyl 1-naphthyl α 48:52 
16 V{2,3,3} Me Me n-hexyl 2-naphthyl α 47:53 
17 V{2,3,5} Me Me n-hexyl 3,5-(CF3)2C6H3 α 57:43 
18 V{2,3,3} Me Me n-hexyl n-hexyl α 53:47 
19 V{2,3,8} Me Me n-hexyl 4-(MeO)C6H4 α 45:55 
20 V{2,3,1} Me Me n-hexyl C6H5 α 46:54 
21 V{2,3,7} Me Me n-hexyl 3,5-(t-Bu)2C6H3 α 58:42 
22 V{2,2,2} Me Me C6H5 1-naphthyl α 45:55 
23 V{2,2,3} Me Me C6H5 2-naphthyl α 49:51 
24 V{2,2,5} Me Me C6H5 3,5-(CF3)2C6H3 α 57:43 
25 V{2,2,3} Me Me C6H5 n-hexyl α 51:49 
26 V{2,2,8} Me Me C6H5 4-(MeO)C6H4 α 47:53 
27 V{2,2,1} Me Me C6H5 C6H5 α 47:53 
28 V{2,2,7} Me Me C6H5 3,5-(t-Bu)2C6H3 α 57:43 
29 V{2,7,2} Me Me 4-(MeO)C6H4 1-naphthyl α 48:52 
30 V{2,7,3} Me Me 4-(MeO)C6H4 2-naphthyl α 48:52 
31 V{2,7,5} Me Me 4-(MeO)C6H4 3,5-(CF3)2C6H3 α 59:41 
32 V{2,7,7} Me Me 4-(MeO)C6H4 3,5-(t-Bu)2C6H3 α 57:43 
33 V{3,3,2} Me i-Pr n-hexyl 1-naphthyl α 43:57 
34 V{3,3,3} Me i-Pr n-hexyl 2-naphthyl α 42:58 
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Table 9. (cont.) Enantioselectivity of Libraries IV and V. 
35 V{3,3,5} Me i-Pr n-hexyl 3,5-(CF3)2C6H3 α 39:62 
36 V{3,3,3} Me i-Pr n-hexyl n-hexyl α 51:49 
37 V{3,3,8} Me i-Pr n-hexyl 4-(MeO)C6H4 α 40:60 
38 V{3,3,1} Me i-Pr n-hexyl C6H5 α 40:60 
39 V{3,3,7} Me i-Pr n-hexyl 3,5-(t-Bu)2C6H3 α 40:60 
40 V{3,2,2} Me i-Pr C6H5 1-naphthyl α 42:58 
41 V{3,2,3} Me i-Pr C6H5 2-naphthyl α 44:56 
42 V{3,2,5} Me i-Pr C6H5 3,5-(CF3)2C6H3 α 36:64 
43 V{3,2,3} Me i-Pr C6H5 n-hexyl α 43:57 
44 V{3,2,8} Me i-Pr C6H5 4-(MeO)C6H4 α 44:56 
45 V{3,2,1} Me i-Pr C6H5 C6H5 α 43:57 
46 V{3,2,7} Me i-Pr C6H5 3,5-(t-Bu)2C6H3 α 38:62 
47 V{3,7,2} Me i-Pr 4-(MeO)C6H4 1-naphthyl α 41:59 
48 V{3,7,3} Me i-Pr 4-(MeO)C6H4 2-naphthyl α 42:58 
49 V{3,7,5} Me i-Pr 4-(MeO)C6H4 3,5-(CF3)2C6H3 α 40:60 
50 V{3,7,3} Me i-Pr 4-(MeO)C6H4 n-hexyl α 41:59 
51 V{3,7,8} Me i-Pr 4-(MeO)C6H4 4-(MeO)C6H4 α 40:60 
52 V{3,7,1} Me i-Pr 4-(MeO)C6H4 C6H5 α 44:56 
53 V{3,7,7} Me i-Pr 4-(MeO)C6H4 3,5-(t-Bu)2C6H3 α 39:61 
54 V{4,2,5} Me t-Bu C6H5 3,5-(CF3)2C6H3 α 37:63 
55 V{5,3,2} Me C6H5 n-hexyl 1-naphthyl α 48:52 
56 V{5,3,3} Me C6H5 n-hexyl 2-naphthyl α 49:51 
57 V{5,3,5} Me C6H5 n-hexyl 3,5-(CF3)2C6H3 α 79:21 
58 V{5,3,8} Me C6H5 n-hexyl 4-(MeO)C6H4 α 42:58 
59 V{5,3,1} Me C6H5 n-hexyl C6H5 α 45:55 
60 V{5,3,7} Me C6H5 n-hexyl 3,5-(t-Bu)2C6H3 α 61:39 
61 V{5,2,2} Me C6H5 C6H5 1-naphthyl α 49:51 
62 V{5,2,3} Me C6H5 C6H5 2-naphthyl α 51:49 
63 V{5,2,5} Me C6H5 C6H5 3,5-(CF3)2C6H3 α 81:19 
64 V{5,2,11} Me C6H5 C6H5 (2,4-CF3)2C6H3 α 56:44 
65 V{5,2,9} Me C6H5 C6H5 (4-CF3)C6H4 α 49:51 
66 V{5,2,10} Me C6H5 C6H5 (4-CN)C6H4 α 50:50 
67 V{5,2,8} Me C6H5 C6H5 4-(MeO)C6H4 α 44:56 
68 V{5,2,1} Me C6H5 C6H5 C6H5 α 48:52 
69  V{5,6,5}    Me        C6H5 3,5-(CF3)2C6H3 3,5-(CF3)2C6H3 α                81:19 
70 V{5,6,8} Me C6H5 3,5-(CF3)2C6H3 4-(MeO)C6H4 α 46:54 
71 V{5,6,1} Me C6H5 3,5-(CF3)2C6H3 C6H5 α 49:51 
72 V{5,7,2} Me C6H5 4-(MeO)C6H4 1-naphthyl α 50:50 
73 V{5,7,3} Me C6H5 4-(MeO)C6H4 2-naphthyl α 51:49 
74 V{5,7,5} Me C6H5 4-(MeO)C6H4 3,5-(CF3)2C6H3 α 81:19 
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Table 9. (cont.) Enantioselectivity of Libraries IV and V. 
75 V{5,7,1} Me C6H5 4-(MeO)C6H4 C6H5 α 48:52 
76 V{5,7,7} Me C6H5 4-(MeO)C6H4 3,5-(t-Bu)2C6H3 α 63:37 
77 V{7,2,5} Me 1-naphthyl C6H5 3,5-(CF3)2C6H3 α 81:19 
78 V{7,2,9} Me 1-naphthyl C6H5 (4-CF3) C6H4 α 54:46 
79 V{7,2,10} Me 1-naphthyl C6H5 (4-CN)C6H4 α 52:48 
80 V{7,2,8} Me 1-naphthyl C6H5 4-(MeO)C6H4 α 48:52 
81 V{7,2,1} Me 1-naphthyl C6H5 C6H5 α 51:49 
82 V{6,2,8} Me mesityl C6H5 4-(MeO)C6H4 α 47:54 
83 V{6,2,5} Me mesityl C6H5 3,5-(CF3)2C6H3 α 76:24 
 
2.12.  Discussion. 
2.12.1.  Summary of Ammonium Ion Preparations and Synthetic Strategies. 
Since the discovery of asymmetric phase transfer catalysis with cinchona alkaloid 
derivatives, a significant level of effort has been devoted to the introduction of novel synthetic 
catalyst structures. Most of the synthetic endeavors fall into one of the following two synthetic 
strategies: (1) elaboration of a readily available source of chiral material by appending a non-
stereogenic quaternary ammonium ion or (2) incorporation of a quaternary ammonium into a 
molecule in such a way that it lies on a symmetry axis. Although each of these approaches has 
seen some success, the synthetic strategy presented herein is significantly different and warrants 
discussion. 
The approach presented here is unique in that the synthetic effort was focused on 
systematically varying the steric and electronic environment around a central stereogenic 
quaternary ammonium ion. To this end, the synthetic investment was divided into two different 
parts. The first part involved preparation of a nitrogen containing scaffold (a 
cyclopentapyrrolizidine) on a significant scale which was readily accomplished by application of 
the tandem inter [4+2]/intra [3+2] cycloaddition of nitroalkenes with only minor changes to the 
previously published routes. Notably, the tandem cycloaddition also served as a diversifying 
element in that it was in this step that the configuration at C(1) was set (Libraries II and III) and 
the R1 group was introduced stereoselectively, which subsequently proved to be a critical catalyst 
structural feature. 
The second synthetic component involved development of procedures amenable to 
parallel synthesis that introduced a variety of groups in the vicinity of the ammonium nitrogen. 
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Ultimately, three operationally simple bond forming reactions were utilized to accomplish this 
goal that allowed for the catalysts to be prepared in a parallel fashion. The tandem cycloaddition 
naturally installs a hydroxyl group at C(1) which served as a functional handle for two parallel 
synthesis steps; a Grignard addition and an O-alkylation, leaving only N-quaternization as the 
final parallel synthesis step. Including the previously installed R1 substituent a total of four 
variable groups were introduced. The diversity and number of groups utilized was greatest for 
the positions that could be incorporated in parallel (R2,
 6; R3, 7; R4, 11) and the least for the 
group that required a recast skeleton (R1, 2). A good appreciation for the shape of the catalyst(s) 
and disposition of the variable groups in relation to the ammonium nitrogen is necessary to 
facilitate a thorough analysis of the effect of each group (and combinations thereof) on catalytic 
activity and selectivity. 
2.12.2.  Summary of Results. 
A brief summary of the rate and enantioselectivity data is necessary to facilitate the 
following discussion. The kinetic results are summarized in bar graph format in Figure 9. In 
general catalysts that bear an oxygen substituent at C(1) are more active than catalysts without 
this oxygen substituent, and the configuration of the oxygen functional group does not influence 
the reaction rate significantly. However, the catalytic activity is greater for ethers compared to 
alcohols. In addition, there is a decrease in catalytic activity when the substituent bonded to the 
nitrogen is strongly electron withdrawing (e.g. R4 = (3,5-CF3)2C6H3). This effect is large when 
the R2 substituent is small and aliphatic (R2 = H, Me) and moderate when R2 is bulky and 
aliphatic (R2 = i-Pr, t-Bu). Significantly less dependence on the nitrogen substituent was 
observed when R2 was aromatic (Ph, mesityl, 1-naphthyl). Quaternary ammonium ions 
containing a four membered ring (Library VI) displayed comparable activity to the parent 
scaffold (Library I). The catalytic activity of these unfunctionalized ring systems are not as high 
as tetraethylammonium but better than cetyltrimethyl ammonium in activity. 
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Figure 9. Structural Clustering of Kinetic Data. 
 
Given the large volume of data presented herein, a concise statistical summary provides a 
good indication of which data is the most interesting and worthy of detailed analysis. The 
relative contribution of the groups to the variation in the observed data is estimated by examining 
the standard deviation as a function of each group (R1-R4).96 That is the larger deviation in the 
observed rate (or selectivity) as a function of group positional substitution, then the greater is the 
relationship of that substituent (R2-R4) to the observed effect (rate or selectivity, Figure 10). 
Therefore, the variation approximates the sensitivity of the rate and selectivity to a structural 
change at the indicated substituent. Both catalyst activity and rate are influenced the most by the 
groups R2 and R4, with the greatest dependence on R4. Also, in both cases, the R3 group has the 
least influence. The R1 group was not sufficiently varied for interpretation by this analysis. 
The observation that the enantioselectivity is affected in a similar manner to the reaction 
rate may lead to interesting mechanistic interpretation. For instance, a possible consequence that 
is consistent with this analysis (but not unambiguously supported) is the direct relationship 
between the rate determining step and the selectivity-determining step (formation of a stable 
chiral ion-pair and/or alkylation of the enolate). 
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Figure 10. Variation in rate and selectivity as a function of positional group substitution. 
 
2.12.3.  Influence of the Alkoxy Group. 
The presence of an oxygen at C(1) is a natural consequence of the tandem cycloaddition 
utilized to construct the scaffolds. However, inclusion of an oxygen substituent beta to the 
ammonium center appears to have an important effect on the catalytic activity (compare 
Libraries I and II). Similar observations have been reported previously for β-hydroxy quaternary 
ammonium ion phase transfer catalysts and rationalized by invoking a hydrogen bond donating 
interaction from the catalyst.97 This analysis is consistent with the observation that β-hydroxy 
ammonium ions exhibit a high affinity for hydroxide ion.98 Indeed, a β-oxygen substituent is a 
common structural motif employed in many asymmetric quaternary ammonium phase transfer 
catalysts.99 Importantly, this substituent is a natural structural component of the cinchona 
alkaloids, but its inclusion in many other synthetic catalysts is likely a consequence of synthetic 
accessibility or serendipity. Because the rate enhancement that arises β-oxygenated ammonium 
ion catalysts has been observed previously and because it is a structural feature shared with 
cinchona derived catalysts, a more detailed analysis of the effect of β-oxygen substitution was 
sought. Insight to the origin of the rate enhancement effect could be gleaned by application of 
quantitative structure-activity relationships and will be discussed in the accompanying paper. 
However, changes in the local electronic environment of the ammonium upon inclusion of a β-
oxygen substituent required some analysis to provide a stolid framework for even a qualitative 
rationalization of the rate and selectivities observed in this data set. 
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The electronic perturbation caused by an oxygen atom two carbons removed from the 
ammonium center is manifested in two related electronic effects, the electrostatic potential 
interaction and the direction of the dipole. Some insight is gleaned by comparison of the 
electrostatic potential maps of the oxygenated and unoxygenated catalyst scaffolds (Figure 11). 
For computational simpliﬁcation, a methyl group is used at R3. The directions of the dipoles are 
illustrated. The diﬀerence in the maximum electrostatic potential energies of the left and right 
faces of the oxygenated scaﬀold is 3.0 kcal/mol and 0 kcal/mol for the unoxygenated scaﬀold 
(Cs symmetric). In the Cs symmetric ammonium salts (Library I), the charge distribution is 
equally dispersed between the two convex faces, even though, in reality the lowest energy 
conformer (depicted) is not Cs symmetric. In contrast, inclusion of an alkoxy group two carbons 
removed from the ammonium nitrogen results in a considerable polarization of the positive 
potential toward the face to which it is attached (Library II, methoxy is included for simplicity). 
That is, the two convex faces of the ammonium ion are differentiated electronically, such that a 
greater positive potential resides on the left face. The same change in electronic distribution is 
manifested in the direction of the dipole vector (Figure 11). The dipole vector in the Cs 
symmetric scaffold bisects the R4 substituent (the only polarizable group), reflecting the equal 
distribution of charge on the left and right faces of the pyrrolizidine unit. The dipole in the 
oxygenated analog is rotated 60o clockwise such that the positive end is projected toward the left 
convex face of the ammonium ion. This analysis is consistent with a stronger electrostatic 
interaction with the left convex face than the right, which, in turn, is consistent with the 
experimental observation fact that the R2 substituent has a large effect on the observed rate and 
selectivity. Since both rate and selectivity are highly dependent on the R2 group and little to no 
selectivity is observed when R1 = H, our data seems most consistent with a selective associations 
of the enolate to the left convex face of the ammonium. That is, the oxygen serves to increase the 
positive potential on the left convex face and the R1 group acts to sterically shield the right 
convex face of the ammonium ion. 
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Figure 11. Electrostatic potential (ESP) maps (M062X/6-31G(d)) of scaﬀolds for Library I 
(unoxygenated) and Library II (oxygenated) where C(6) C(7) and N(3) C(9) dihedrals are 
constrained to 0 in the geometry optimization to exclude bias of a speciﬁc twist conformer. ESPs 
are mapped onto electron density isosurfaces (0.002 electrons/au3). Legend is in units of kJ/mol.  
 
2.13.  Rate as a Function of Ammonium Ion Accessibility. 
The reaction rate of PTC alkylation processes has been correlated with the accessibility of the 
ammonium nitrogen (in terms of q), where an optimum accessibility is found.27 The observation 
of a maximum catalyst activity as a function of ammonium accessibility has two similar 
explanations. In the first, the accessibility of the ammonium nitrogen is related to the rate of 
exchange of anions, a kinetic phenomenon.25 In the second, the accessibility of the ammonium 
nitrogen is related to the ability of the catalyst to decrease the interfacial tension and thereby 
facilitate enolate transfer, a thermodynamic phenomenon.24,100 
The data collected herein are largely consistent with these proposals, with the added 
complexity that the magnitude of the exposed positive potential (δ+) should be considered as 
well. On the basis of the analysis above, the accessibility of the positive potential (δ+, left convex 
face) should be correlated with the steric bulk of the R2 substituent. Regardless of the 
interpretation, the sensitivity of the rate to the R2 substituent discussed above (Figure 10) 
advocates a strong dependence of the overall reaction rate on the nitrogen accessibility (steric 
nature of R2). 
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The form of the observed dependence is partially revealed by examining the reaction 
half-lives as a function of the R2 substituent for selected R4 groups (Table 10, MR = molar 
refractivity).101 The dependence is weak when the electronic character of R4 is neutral to 
moderately electron rich (R4 = C6H5, 4-MeOC6H4). However, a much stronger dependence is 
seen for catalysts containing the R4 = 3,5-(CF3)2C6H3 group. In these catalysts an increase in 
steric bulk from i-Pr to t-Bu does not lead to a significant rate enhancement relative to the 
enhancement from Me to i-Pr. However, an increase in activity is observed for R2 = Ph, which is 
somewhat diminished when the R2 group is a larger aromatic group (mesityl or naphthyl). This 
disparity may be rationalized by ammonium accessibility, such that catalysts with R2 = Ph have 
an optimum accessibility. Alternatively, the additional steric bulk on the left face of the 
pyrrolizidine unit may cause the enolate to associate more favorably on the right face of the 
scaffold when the R2 substituent is larger than the R1 substituent. The stereochemical course of 
the alkylation with these catalysts also support the latter rationale as a reversal in absolute 
configuration of the product was observed. However, it is not clear whether the enolate 
extraction step or the alkylation step is stereochemistry determining, or whether they occur in 
concert. 
 
Table 10. Half-lives (min) of Selected Catalysts with R1 = Me, R3 = Ph and Variable R2 and R4. 
 
   R4  
R2 MRa C6H5 3,5-(CF3)2C6H3 4-(MeO)C6H4 
Me 6.88 21 900 18 
i-Pr 16.08 132 122 174 
t-Bu 20.85 - 96 - 
phenyl 25.28 11 10 18 
mesityl 42.97 12 62 12 
1-naphthyl 42.45 14 29 11 
aMR = molar refractivity of the R2 substituent calculated by 
Chemdraw. 
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Rationalizing the effect of the R2 substituent in terms of steric bulk makes intuitive sense 
because placing groups in this position modulates the relative accessibility of the positive 
potential at the two convex faces. However, other explanations are possible. For example, one 
could argue that the major structural perturbation upon replacing a branched aliphatic group with 
an aromatic group is the introduction of a π-surface. This line of reasoning is worth considering 
since the physical interpretation is different, which leads to a distinctly different conclusion. If 
introduction of a π-surface in the catalyst adds an additional binding force for the substrate anion 
(π-π interactions), then one may conclude that the equilibrium between catalyst+X- (Br- or HO-) 
and catalyst+enolate- ion pair is shifted toward the enolate complex. Therefore, the net rate 
enhancement could possibly be attributed to a greater proportion of catalyst being bound to 
enolate, a strictly thermodynamic phenomenon. 
All of the comparisons in this section have been made with catalysts containing a 3,5-
(CF3)2C6H3 group at R
4. The same interpretations cannot be readily applied to catalysts without a 
3,5-(CF3)2C6H3 group at R
4. Most consistent with the above analysis of charge polarization, the 
3,5-(CF3)2C6H3 group must impart sufficient charge polarization to amplify the effect of the 
variable R2 group. Interpretation of these observations in the context of a transfer rate limiting 
regime has led to the conclusion that an optimum ammonium accessibility, or charge exposure is 
likely. In other words, a greater charge exposure will increase the ammonium ions association 
with the anionic hydroxide surface. However, if the exposed δ+ area or charge density is too 
great, then the catalyst will not dissociate away from the interface as readily. 
Three important elements can be inferred from the discussion of rate: 
(1) the observed increase in catalyst activity upon the inclusion of an oxygen substituent 
is attributed to the increase in the rate of ion pair formation and/or a decrease in 
interfacial tension, 
(2) the observed decrease in catalyst activity upon the inclusion of the 3,5-(CF3)2C6H3 
group at R
4 for small groups at R2 (H, Me, i-Pr) is attributed to a diminished tendency 
of the ion-pair to transport from the interface to the organic phase for alkylation due 
to greater charge density at the ammonium center, 
(3) the observed increase in catalyst activity upon the inclusion of aryl groups at R2 with 
R4= 3,5-(CF3)2C6H3 is attributed to an enhanced ability of the ion-pair to transport 
from the interface into the organic phase for alkylation because of an optimum 
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surface exposure of the ammonium ion (kinetic) or a change in enolate binding 
equilibrium (thermodynamic). 
2.13.1.  Enantioselectivity. 
The intermolecular forces that have been proposed to contribute to enantioselectivity in 
APTC reactions include: (1) ROH•••–O–CR=CR2 hydrogen bonding
33a,c (2) R3N
+-CHR–H•••–O–
CR=CR2 (α-CH hydrogen bonding)
44b (3) π-π interactions.33a,c The most selective catalysts in this 
study do not contain OH hydrogen bond donating sites, therefore intermolecular force (1) can be 
eliminated as a stereocontrolling element. The results here support the operation of interactions 
(2) and potentially (3).  
 The unique structural features of the catalyst scaffold include the intrinsic shielding of 
two of the four faces of the imaginary tetrahedron encompassing the nitrogen and the capacity to 
differentiate the two remaining exposed faces (c.f. Figure 12). The second feature arises from the 
modular nature of the cycloaddition-based construction which allows both exposed front faces to 
be differentiated electronically (β-oxygenation) and sterically (relative steric bulk of R1 and R2). 
Although those factors that control the topicity of the enolate reactivity are difficult to predict, 
the factors that dictate the relative binding strengths of the enolate to each of the tetrahedral faces 
are more easily controlled and predicted. Initially, these factors were the primary focus for the 
design and construction of the libraries. 
 The observed enantioselectivities are largely dependent on the substituents that influence 
the binding of the anion to the face of the hypothetical tetrahedron around the ammonium ion 
with the largest concentration of positive potential (R2 and R4, Figure 12). The observation that 
the enantioselectivity is greatest for catalysts that bear strongly electron withdrawing groups on 
the nitrogen is consistent with the need for one or both of the following potential interactions: (1) 
α-CH-hydrogen bonding or (2) a tighter ion pair resulting from increased Coulombic interaction. 
Additionally, a π-surface is necessary at the R2 substituent, presumably to engage in π-stacking 
interactions with the phenyl rings of the reacting enolate. Moreover, the presence of an alkyl 
group at R1 is necessary to decrease the accessibility of the right hand face of the pyrrolizidine 
moiety because in its absence, the enantioselectivity is poor. This observation suggests that 
binding to the right hand face leads to lower selectivity because of the pseudo-enantiotopic local 
chirality. The aforementioned interactions seem to operate in concert as the absence of one of the 
interactions leads to significantly diminished enantioselectivities. 
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2.14.  Conclusions. 
A synthetic strategy for the synthesis of diverse libraries of quaternary ammonium ions 
has been developed. The key feature of the synthetic strategy was to divide the preparative work 
into two distinct stages: (1) scaffold preparation and (2) diversity oriented parallel synthesis. In 
this way, a total of 160 structurally diverse quaternary ammonium ions were prepared that share 
a common scaffold constructed by a tandem inter[4+2]/intra[[3+2] cycloaddition of a 
nitroalkene. A method was developed for the collection of kinetic data of a biphasic reaction that 
is applicable over a wide range of catalyst activities (half-lives ranging from days to minutes). 
The range of data collected covers many orders of magnitude and therefore is well suited for 
analysis by the application of quantitative structure-activity relationships. Inclusion of an oxygen 
atom in the vicinity of the quaternary ammonium ion affects the catalytic activity. The catalyst 
enantioselectivity is strongly dependent on the substituent attached to the same carbon as the 
oxygen atom. These observations were rationalized in terms of a selective polarization of the 
positive potential on one of the faces of the tetrahedral ammonium over the other. The inclusion 
of a 3,5-substituted aromatic substituent on nitrogen proved crucial for catalyst 
enantioselectivity. With strongly electron withdrawing 3,5-trifluoromethyl groups, the previously 
observed dependencies on rate were amplified. The proposed dependencies of rate on the 
ammonium accessibility are consistent with the data reported herein with the added complexity 
that the magnitude of the “ammonium charge” or charge density should be considered as well. 
Quantitative models have been developed to describe both the reactivity and selectivity trends 
discussed herein and constitute the focus of the following sections. 
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Chapter 3:  Ion-Pair QM Modeling and the Development of 
CoMFA Models for Enantioselectivity 
3.1.  Introduction. 
The formulation of relationships between molecular structure and chemical function has 
always been and remains area of intense research within the physical and life sciences. Relating 
single substituent effects on reactivity has been widely studied in the form of linear free energy 
relationships (LFER) pioneered by Hammett.102 However, these analyses are limited to minor 
structural changes, namely single substitution patterns. Methods to correlate function with a 
myriad of molecular properties, i.e. descriptors, have been developed in the form of multi-
dimensional QSAR103 due in part to the seminal contributions from Hansch104 and Wilson.105 
Medicinal chemistry has benefitted immensely since the advent of these techniques. While 
QSAR methods have found the widest utility in relating the activity of a drug to its structure, 
theoretically, the same principles can be applied toward correlating function with any response, 
even the rate or selectivity of a chemical reaction. 
Not until recently have such methods been used in correlating structure with 
enantioselectivity.
43f Such methods include comparative molecular field analysis (CoMFA),54 
stereocartography,43b functional group mapping43c and others.43f These methods have been 
implemented for a number of systems and were found to provide some success in predicting the 
selectivity of catalysts with good predictability. New applications of simple LFER’s has also 
recently been implemented toward rationalizing43i,49,106,107 and predicting108 catalysts. 
Nevertheless, PTC has received only moderate attention employing such approaches and is the 
focus of the following sections in this chapter.58 But before doing so, it will be beneficial to gain 
an understanding of the preferred arrangement of an ammonium cation and the enolate in the ion 
pair geometry. This knowledge will facilitate the formulation of stereochemical models for 
which future catalyst design criteria can be based from. 
3.2. Ion-Pair Modeling 
Information on the geometry of the ground state ammonium enolate ion pair is crucial to 
understanding asymmetric induction. Because less than a handful of computational studies on 
ammonium enolate ion pairs exist in the literature,44b,45,48 it was deemed worthwhile to establish 
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some principles on the geometry of the ion pair computationally. The ion pair between 
timethylammonium and methyl acetate enolate has been investigated computationally and a 
facial orientation was obtained.44b The enolate studied here is complicated by considerable 
delocalization and the presence of an additional electronegative atom (imine nitrogen) relative to 
a simple ester enolate. Consequentially, its own investigation was warranted. 
The lowest energy ion pairs should be those that maximize the number of C-H•••-En 
interactions.44b Four possible ion pair arrangements can be envisioned when including the E/Z 
geometry of the enolate (Scheme 21). The enolate can either orient in a facial manner ((Z/E)-
face) or in a manner by which the plane of the enolate bisects the plane created by the three α-
hydrogens ((Z/E)-edge).  
Scheme 21. 
 
 Three of the four ion pair arrangements were located using the M06-2X density 
functional (Figure 12). The Z-face-H geometry could not be located as it converged to the Z-
edge-H geometry. The lowest energy geometry is Z-edge-H by 3.0 kcal/mol over E-face-H. E-
edge-H is the highest energy geometry at ∆Erel = 5.4 kcal/mol. The edge geometries are tilted 
causing them to be between planar and orthogonal with respect to the plane adopted by the three 
hydrogen atoms and the plane of the enolate. Interestingly, the geometry with the smallest 
separation between the charged oxygen of the enolate and the three hydrogen atom of the 
ammonium ion is E-edge-H which possesses the highest energy. The origins of the differences 
in energy can be illuminated by decomposing the binding energy between the ammonium cation 
and the enolate for each geometry into unique energy terms. 
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Figure 12. Ammonium enolate ion-pair geometries. Distances are in Å. Energies (∆Erel) are in 
kcal/mol. Calculated at the CPCM(toluene)-M06-2X/6-311+G(2d,2p)//CPCM(toluene)-M06-
2X/6-31+G(d,p). Values in red represent NBO partial atomic charges. 
 
 A localized molecular orbital based energy decomposition analysis (LMO-EDA)109 is 
implemented for interpreting the origin of the differences in energy of the complexes. The results 
of the energy decomposition analysis are illustrated in Table 11. The energy required to distort 
the fragments to the geometry of the complex is low throughout (< 2 kcal/mol) which is 
consistent with the resulting low geometrical distortion from the isolated fragments (which can 
be observed by qualitative inspection). Complex Z-edge-H is energetically preferred over E-
edge-H in large part due to the difference in the electrostatic term (∆∆Ees = -10.9 kcal/mol) 
which is likely due to additional Coulombic attraction between the nitrogen of the imine and the 
α-hydrogen atoms. Complex E-edge-H exhibits the most polarized charge distribution relative to 
the uncomplexed enolate which is consistent with only the oxygen atom of the enolate 
interacting significantly with the ammonium cation. Complex E-edge-H is preferred over E-
face-H by electrostatic interactions (∆∆Ees = -11.6 kcal/mol) at a cost of unfavorable orbital 
interactions (∆∆Eorb = 4.7 kcal/mol), which can be mostly attributed to polarization.  
Table 11. LMO-EDA Analysis. Calculated at the CPCM(toluene)-M06-2X/6-311+G(2d,2p). 
Energies are in units of kcal/mol. ∆E =  ∆Eint + ∆Ed. 
 ∆Ees ∆Eexrep ∆Eorb ∆Edisp ∆Ed ∆Eint ∆E 
E-edge-H
 -26.1 28.1 -29.5 -14.0 1.7 -41.5 -39.8 
E-face-H -25.4 27.4 -26.8 -18.6 1.1 -43.4 -44.5 
Z-edge-H -37.0 32.3 -24.8 -17.4 1.9 -46.9 -45.0 
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 The influence of phenyl substitution on the imine was probed next to more closely mimic 
the actual substrate (Table 12). For purposes of computational efficiency, only the trans-phenyl 
ring is added since that is the ring that is likely to be in conjugation. The cis-phenyl ring is 
expected to be out of plane (thus a much lower degree of conjugation) on account of A1,3 strain. 
Complex Z-edge-ph is still the favored complex but to a lower extent relative to the complexes 
lacking the phenyl substitution (Figure 12). The lower preference for Z-edge-ph can be traced 
back to decreased electrostatic interactions. The inclusion of the phenyl ring causes the nitrogen 
to be further away from the α-hydrogen atoms thus leading to a decreased Coulombic attraction. 
Increased dispersion interactions compensates for the electrostatic difference between E-edge-ph 
and Z-edge-ph causing the difference in energy to be nearly equivalent (∆E(Z-edge-ph − E-edge-ph) = -
5.4 kcal/mol; ∆E(Z-edge- − E-edge) = -5.2 kcal/mol). The smaller difference between E-face-ph and 
Z-edge-ph can be attributed to a more favorable dispersion component for E-face-ph and a less 
favorable electrostatic component for Z-edge-ph. The significantly smaller electrostatic 
preference (∆Ees(Z-edge-ph − E-edge-ph) = -7.5 kcal/mol; ∆Ees(Z-edge- − E-edge) = -12.4 kcal/mol) can be 
attributed to Me3N
+-CH2-H
….π type interactions as there is some curvature present in the enolate 
in complex E-face-ph causing a slight folding around the ammonium cation. Since Z-edge-ph is 
the energetically preferred complex in both systems investigated, this arrangement was applied 
toward the study of model systems of the 5-5-5 scaffold. 
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Table 12. Ammonium enolate ion-pair geometries. Distances are in Å. Energies (∆Erel) are in 
kcal/mol. Calculated at the CPCM(toluene)-M06-2X/6-311+G(2d,2p)//CPCM(toluene)-M06-
2X/6-31+G(d,p). Values in red represent NBO partial atomic charges. 
 
 ∆Ees ∆Eexrep ∆Eorb ∆Edisp ∆Ed ∆Eint, ∆E 
E-edge-ph
 -24.5 26.4 -29.6 -13.2 3.5 -40.8 -37.3 
E-face-ph -26.3 29.3 -25.4 -21.4 2.5 -43.7 -41.2 
Z-edge-ph -33.8 31.4 -24.8 -18.3 2.8 -45.5 -42.7 
 
With the knowledge that complex Z-edge is the lowest energy arrangement, a model 
system for the core 555 scaffold (introduced in Chapter 2) can be investigated computationally. 
Two faces of the catalysts are considered to be available for enolate association based on 
electrostatic potential arguments (Figure 11 from Chapter 2). The complex that results from 
enolate association with the left face (cat-L) is 1.7 kcal/mol lower in energy than the complex 
that results from enolate association with the right face (cat-R). Most of this energy difference 
can be attributed to electrostatic interactions (∆∆Ees(L-R) = −2.8 kcal/mol) (which is very close to 
the value based on qualitative inspection of the ESP maps (Figure 11 from Chapter 2)) which is 
the energy component that exhibits the largest difference. This difference provides the most 
compelling support for the polarization of electrostatic potential induced by the β-alkoxy group 
and its ability to lower the energy of complex formation. The concepts established from this 
investigation will aid in future catalyst design in combination with results from the next sections.  
61 
 
Table 13. Ammonium enolate ion-pair geometries. Energies (∆Erel) are in kcal/mol. Calculated 
at the CPCM(toluene)-M06-2X/6-311+G(2d,2p)//CPCM(toluene)-M06-2X/6-31+G(d,p).  
 
 ∆Ees ∆Eexrep ∆Eorb ∆Edisp ∆Ed ∆Eint, ∆E 
cat-L -36.3 36.5 -26.5 -21.3 3.3 -47.6 -44.3 
cat-R -33.5 34.8 -26.7 -20.8 3.1 -45.5 -42.4 
∆∆E(L-R) -2.8 1.2 0.2 -0.5 0.2 -2.1 -1.9 
 
3.3.  QSAR Modeling. 
Quantitative models for activity and enantioselectivity were developed in parallel in this 
investigation. The reader is referred to the dissertation of Nathan Duncan-Gould for a detailed 
account of quantitative structure-activity relationships employing relevant 2-d descriptors such as 
clogP, XSA, electrostatic potential, molar refractivity, and others as applied to interpreting 
catalyst activity data.110 
3.3.1.  Conformations of Catalysts. 
The choice of catalyst conformation is relevant for descriptors that are conformer-
dependent including principle moment of inertia, dipole, surface area, and the spatial distribution 
of the interaction energies in the CoMFA analysis. Some ambiguity arises when considering the 
appropriate ring flip geometry for each catalyst, and thus a conformational analysis proved 
necessary. Minimum conformers for each catalyst were generated using the MMFF force field 
and a Monte-Carlo based conformation search as implemented in Spartan ’08 v1.2.0.111. To 
ensure that the MMFF conformers were converging to reasonably stable minima, full geometry 
optimizations were carried out at B3LYP/6-31G(d) for each ring-flip conformer obtained from 
the MMFF conformation distribution analysis which resulted in 3 stable local minima using 
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MMFF. Gratifyingly, none of the three optimizations changed the ring flip conformations 
identified by MMFF. Moreover, the local minima maintained the same relative energies, 
validating the use of the MMFF conformers (See Experimental Section). Additionally, single 
point energies were determined including and excluding solvation (SM8112 solvation model) in 
the absence of a counterion, again, the energetic ordering of the conformers was equivalent. 
The lowest energy conformers of the isolated cations may not accurately reflect the major 
reactive conformation for the ammonium ion in the reaction medium. To address this deficiency, 
CoMFA analyses were performed on multiple conformer libraries with varying scaffold 
geometries obtained from the MMFF minimizations. The consequences of each developed model 
will be addressed in the Results Section. 
3.3.2.  Enantioselectivity Model Development. 
Models for enantioselectivity were generated using CoMFA to generate the interaction 
fields and Partial Least Squares regression for the model development as implemented in 
SYBYL-X 1.1. The dependent variable was represented as a free energy term, ∆G = -RT ln 
(R/S), because it is expressed as a linear combination of energy terms in the PLS model. 
Although representation of the data as enantiomeric excess (%ee)50,54 would suffice given the 
nearly linear relationship with ∆G within the energy range of this study (1.2 kcal/mol), the model 
would not translate well in extrapolating to higher enantioselectivities where the linear 
relationship breaks down. Therefore, the representation of the dependent variable as an energy 
seemed appropriate and fundamentally justified. 
The electrostatic fields were calculated from the partial atomic charges on all of the 
atoms. During preliminary studies, different partial charge methods were investigated including 
MMFF, Gasteiger-Marsili, and semi-empirical methods (AM1, MNDO, and PM3). Models using 
MNDO charges generally provided better correlations. CoMFA models developed from semi-
empirical based charges have been demonstrated to provide consistently more predictive models 
than models developed from Partial Equalization of Orbital Electronegativity (PEOE, Gasteiger) 
and molecular mechanics based methods.113 Thus, all of the remaining discussion of CoMFA 
model development will have incorporated MNDO ESP based partial atomic charges as 
determined from single point calculations on the MMFF conformers.  
The structures were aligned employing a simple RMS rigid-body alignment. The rigidity 
of the scaffold led to a relatively straightforward decision on how to align the molecules in an 
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effort to minimize the variation in their fields (maximize the ratio of variation accountable versus 
variation that is unaccountable). The common substructure used for the alignment is represented 
by the nine atoms that make up the core 5-5-5 ring scaffold. An example of an alignment for one 
of the conformation libraries (in the Results Section) is illustrated (Figure 13). 
 
Figure 13. Rigid RMS alignment for a representative conformation library (101 catalysts) from 
two perspectives. The core 5-5-5 scaffold is highlighted in yellow. 
 
The electrostatic and steric fields were calculated using two separate methods: Tripos 
Standard and Indicator field114 classes. Under the Tripos Standard field method, the potentials at 
each lattice point are evaluated from the Lennard-Jones (6-12) and the Coulomb potentials. 
Cutoff energies are applied so that energies are not evaluated well within the Van der Waals 
surface of the atoms. Under the indicator field method, grid points are assigned as having either 
the pre-assigned cutoff value or zero. If the energy is calculated (by the LJ or Coulomb 
potentials) to be above the cutoff value, the energy at that grid point is set to the cutoff value. If 
the energy is calculated to be below the cutoff value, the energy at that grid point is set to zero. 
The indicator field method has the advantage of selecting only grid points of intermediate energy 
and has a tendency to reduce model noise.58 
The resultant CoMFA models were further refined by placing weights on grid points that 
were more pertinent to the model through the region focusing technique as implemented in 
Sybyl-X 1.1. The grid points were weighted by the discriminate power option which weights 
each grid point by its contribution to the variation in the components of the model. This 
effectively enhances grid points with larger contributions while attenuating grid points that are 
less pertinent to the model. The exponent that gauges the steepness of the applied weights was 
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varied between 0.2 and 0.8. Application of the region focusing procedure was carried out 
iteratively until no improvement in the q2LOO was observed. 
3.4.  Model Validation. 
The predictive capacity of the models was assessed through internal and external cross-
validation.115 The internal cross-validation was performed employing the leave-one-out (LOO) 
and leave-multiple-out (LMO) cross-validation methods. The q2LMO is subject to variation, 
especially for smaller training and prediction set splits. Thus, 100 LMO cross-validation runs 
were performed and the corresponding q2LMO is reported as the average over the 100 runs. 
External validation was performed upon the judicious division of the entire data set into training 
and test sets. This method will be discussed in more detail in the ensuing results section.  
The model robustness was assessed through y-scrambling analysis.116 The dependent 
variable data were completely scrambled such that each half-life or enantioselectivity value is 
paired up with the incorrect set of descriptors that are calculated for a particular catalyst. This 
process was performed 100 times and the average R2 and q2LOO are reported. 
3.5.  Results. 
The CoMFA modeling required multiple stages of development. The first stage involved 
the choice of conformers to use to represent each catalyst. Preliminary CoMFA modeling was 
then performed on each conformer library to obtain knowledge on the optimal representations of 
the catalysts for which the greatest variation in selectivity may be explained by the variation in 
their fields. Since both the rate and enantioselectivity models include conformation-dependent 
descriptors, the conformations identified from the preliminary CoMFA modeling may be used 
for the model development for reaction rate. After the ideal conformational representations for 
each catalyst was established from preliminary CoMFA modeling, the different CoMFA 
parameters (cutoff energies, field types, dielectric, etc.) were explored on the optimal conformer 
library to generate the best models as determined from internal cross-validation methods. To 
further validate the model, external cross-validation was then performed. 
3.5.1.  Establishing Catalyst Conformations. 
Choosing appropriate conformational representations often represents a significant 
challenge for 3-D QSAR development and various approaches have been adopted.117 The 
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catalysts studied herein have relatively few degrees of freedom at ambient temperature (within 
the scaffold) allowing for a relatively unambiguous conformational investigation. The most 
significant conformational differences are those represented as the “up” and “dn” conformers 
(Table 14). The preference for ring a to be in the “down” conformation is large enough that the 
“up” conformer for this ring need not be considered.118 The preference for either the up or dn 
conformation as shown is primarily a function of the identities of the R1 and R2 substituents and 
the libraries in Table 14 (Libraries, A thru E) are organized as such. A first approximation of 
reasonable conformations was the global minimum for each catalyst (Library A, Table 14).119 
The geometry optimization for each catalyst was carried out in the absence of a counterion and 
thus the probability with which they represent active conformations is uncertain. Hence, 
alternative conformational representations and different combinations thereof were investigated. 
Taking into consideration the minimal energy difference between the “up” and “dn” 
conformers,119 two additional conformer libraries were generated; one with all of the catalysts in 
the “dn” conformation (Library B), and another with all of the catalysts in the “up” 
conformation (Library C). The investigation of libraries D and E only became apparent after the 
initial CoMFA modeling was carried out and will be described in that order. 
Table 14. Two primary conformational representations of catalysts and table of libraries 
representing differing combinations of conformers up and dn dependent on R1 and R2. 
 
R2/R1 
Library H/H H/Me Me/Me (i-Pr or t-Bu)/Me Aryla/Me 
A
b 
up
c up dn dn dn 
B dn dn dn dn dn 
C up up up up up 
D up up up dn up 
E dn dn dn up up 
 
CoMFA modeling of the enantioselectivity was carried out using a limited number of 
cutoff energy combinations (15 or 30 kcal/mol) for both electrostatic and steric fields of standard 
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or indicator field types. An example of a rigid body alignment is illustrated in Figure 13 
(conformer Library D). A condensed summary of these results in terms of their coefficients of 
determination (R2/q2LOO) is compiled in Table 15. Generally, MNDO semi-empirical based ESP 
partial charges provided models with the highest correlations and are considered here in 
calculating the electrostatic energies for the CoMFA analysis (Table 15).120 The correlations for 
libraries A, B, and C fall short of the minimum for statistically significant predictions (q2LOO ≥ 
0.6). Inspection of the residuals for the cross-validated runs (q2LOO) revealed that catalysts with 
R2 = i-Pr and the most selective catalysts (R2 = aryl, R4 = 3,5-bis(trifluoromethyl)benzyl) 
exhibited the largest error in the predictions. Although, Library C does contain one model with a 
q2LOO > 0.6, the result is quite sensitive to the cutoff energies. Therefore, additional conformer 
libraries were envisioned to address the low correlations. 
 
Table 15. CoMFA modeling  (R2 / q2LOO) of different conformer libraries from Table 
14 with varying cutoff energies and field types (standard and indicator).  
Cutoff 
Energy 
(field type) 
Conformation Librarya 
A
 
B C D E 
30/30b Stdc 0.728d/0.547e 0.697/0.465 0.711/0.493 0.815/0.612 0.794/0.574 
30/15 Std 0.729/0.551 0.700/0.481 0.711/0.485 0.814/0.598 0.794/0.586 
15/30 Std 0.734/0.545 0.705/0.498 0.709/0.460 0.803/0.641 0.812/0.636 
30/30 Indf 0.724/0.474 0.697/0.423 0.712/0.477 0.835/0.648 0.768/0.527 
30/15 Ind 0.797/0.484 0.754/0.442 0.835/0.619 0.924/0.778 0.782/0.474 
15/30 Ind 0.711/0.462 0.693/0.416 0.724/0.466 0.810/0.604 0.795/0.557 
a See Table 1. b Steric cutoff energy (kcal/mol) / electrostatic cutoff energy (kcal/mol) 
c Standard Tripos field. d R2. e q2LOO
. f Indicator field.   
  
Conformer library D (Table 14), in which R2 ≠ i-Pr or t-Bu possesses the up conformation 
while catalysts with R2 = i-Pr or t-Bu possesses the dn conformation, was envisioned to address 
the error in predictions for these catalysts. Additionally, Library E which possesses the opposite 
ring-flip geometries with respect to Library D, was investigated for purposes of comparison. 
Clearly conformer library D consistently provided the highest correlations, with one model 
(30/15; Indicator field) exhibiting a correlation that may be statistically relevant (q2LOO > 0.778). 
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Interestingly conformer library E (possessing conformers opposite to that of D) provided the 
second highest correlations, alluding to the importance of the conformational difference between 
ring a and ring b of the catalysts at the extremes of the e.r. spectrum. The physical justification 
for the nature of the conformations in library D will be addressed in the Discussion Section. 
 To attest to the statistical prevalence of the conformations present in Library D, 500 
libraries of random (but unique) distributions of up and dn conformers were generated. The 
average q2LOO over the 500 runs was 0.409 with a maximum q
2
LOO of 0.679. Reassuringly, the 
library with q2LOO = 0.679 contained conformers that closely mimicked that present in Library D 
in that the most selective catalysts (> 75:25) possessed the up conformation and the most 
selective in the opposite direction (< 38:62) possessed the dn conformation.  
3.5.2.  Internal Cross-validation. 
With conformations that lead to models possessing statistically significant correlations 
(represented by Library D, Table 14), optimization of the various CoMFA parameters (cutoff 
energies, dielectric, exponent of the repulsive term in the Lennard-Jones potential, etc.) can be 
carried out. Models incorporating both indicator and standard field types were generated. 
Additionally, models incorporating only the electrostatic or steric field, individually, were 
generated. The assumption in the development of models with individual fields is that all of the 
interaction responsible for the variation in enantioselectivity is either electrostatic or steric in 
origin. As it is conceivable that there can be overlap in these fields (an interaction energy at a 
grid point may be interpreted as steric but also be interpreted as electrostatic and vice-versa), 
analysis of models constructed from individual fields may be informative.  
 In a typical CoMFA analysis, the descriptors significantly outnumber the dependent 
variables, thus rigorous cross-validation methods are necessary to substantiate the predictive 
capacity of the models. Accordingly, different internal cross-validation methods were carried out 
(q2LOO and q
2
LMO) in conjunction with y-scrambling (which assesses model robustness) (Table 
16). The coefficients in the absence and in the presence of region focusing are presented. The 
results clearly show that indicator fields provide models that exhibit better overall correlations. 
The y-scrambling results (low average R2 and q2 over 100 runs) suggest that the models are 
statistically significant and are not subject to chance correlation between the randomized 
enantioselectivities and the descriptors as the q2LOO,scramb for each model is never a positive value 
and the corresponding R2scramb
 values are minimal (R2scramb. < R
2/2). Additionally, external cross-
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validation has been performed through analysis of successive training and test set splits and 
further supports the sufficient predictive capacity of the model (R2test,avg
 = 0.880).121 
Table 16. CoMFA  models with optimal cutoff energies, standard and indicator field types,  
internal cross-validation , y-scrambling, with and without the application of region focusing. 
 
Field(s)_field 
type 
Cutoff 
energya 
(steric/elec.) 
 
R2 
 
q2LOO
                 
 
q2LMO
b 
 
y-scramb.c           
R2scramb. 
 
y-scramb.            
q2LOO,scramb. 
Bothd_STDe 35/5 0.846f/ 
0.875g 
0.669/ 
0.738 
0.615/ 
0.705 
0.383/ 
0.338 
-0090/ 
-0.050 
elech_STDi 15/30 0.865j 0.543 0.506 0.413 -0.073 
Sterick_STD 40 0.794/ 
0.829 
0.605/ 
0.710 
0.583/ 
0.697 
0.350/ 
0.301 
-0.103/ 
-0.084 
Both_INDl 20/5 0.940/ 
0.944 
0.794/ 
0.890 
0.760/ 
0.878 
0.579/ 
0.429 
-0.137/ 
-0.096 
elec_IND 10/5 0.923/ 
0.887 
0.750/ 
0.799 
0.705/ 
0.766 
0.594/ 
0.388 
-0.069/ 
-0.030 
steric_IND 25 0.840/ 
0.867 
0.648/ 
0.749 
0.627/ 
0.732 
0.431/ 
0.378 
-0.122/ 
-0.102 
a kcal/mol. b Leave 20% out cross-validation average over 100 runs c average correlation 
coefficient over 100 completely scrambled iterations. d Both = electrostatic and steric fields. f R2 
for model constructed from an unfocused region. g R2 for model constructed from a focused 
region. h electrostatic field only. i STD = Standard Tripos Field. j Unfocused region only. Region 
focusing did not improve the correlations. k steric field only. l IND = Indicator field   
 
3.6. Discussion. 
3.6.1.  Conformation from CoMFA Modeling. 
As noted previously, the catalysts in this study exhibit two primary conformational 
preferences manifested as the up and dn conformers (Table 14). The distribution of the 
conformers in a given library significantly impacts the integrity of the CoMFA models as 
illustrated in Table 15. These conformational preferences in the CoMFA models necessitate 
further analysis and physical justification.  
The underlying hypothesis is that the preference for the catalyst to exist in the up or dn 
conformation depends largely on the face of the catalyst to which the enolate associates. As 
illustrated in the accompanying paper, the oxygen substituent at C(1) polarizes a larger amount 
of positive potential to the face over ring a relative to the face over ring b of the catalyst scaffold. 
Thus, association of the enolate with the face over ring a would be expected with small groups as 
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the R2 substituent (Table 14). If R2 is isopropyl or tert-butyl, it may be expected that the enolate 
would associate preferentially with the face over ring b of the catalyst as less positive potential is 
“screened” by a methyl group (at R1) relative to the isopropyl or tert-butyl groups (at R2). 
Association with the face over ring b would require the catalyst to exist in the dn conformation 
to maximize exposed positive potential and hence the Coulombic interaction. The 
conformational preference (dn or up) for catalysts with R2 not equal to isopropyl or tert-butyl 
does not have a strong Coulombic component and may primarily be dictated by the energy 
intrinsic to the scaffold geometry. These energy differences vary depending on R1, but it is not 
expected to greatly influence the enantioselectivity. 
When taking the reaction medium into consideration, it is unlikely that the strength of the 
interaction with the enolate (when R2 is not equal to isopropyl or tert-butyl) would be affected by 
the conformation of ring b significantly if the catalyst is in the toluene layer. On the other hand, 
if the catalyst is present in the aqueous or interfacial layer, it is probable that the catalyst would 
prefer to adopt the dn conformation to enable partial solvation with water molecules. However, 
of primary concern is the thermodynamic preference of the ammonium enolate in the toluene 
layer as that is primarily the medium where the intrinsic alkylation step (and also the 
stereodetermining step) is believed to occur. 
The complication of unknown reactive conformations may be alleviated by including a 
distribution of both conformers weighted by their corresponding energies. However, this 
approach would require modeling in the presence of an anion as the energies would not reflect 
the desired Boltzmann distributions in the absence of an anion (since the dn conformation would 
be largely preferred if the enolate is associating with the face over ring b which is presumed to 
be occurring for catalysts with R2 = i-Pr, t-Bu), which would be outside the computational rigor 
intended for this study.  
3.6.2.  Contour Maps. 
The CoMFA models may be physically interpreted in the form of contours encompassing 
the catalysts. The most common method for illustrating the contours are as products of the 
standard deviation of the interaction action energies and the coefficients in the PLS model at 
each grid point (StDev*Coeff). This product represents regions where and how the variation in 
the interaction energies can be explained by the variation in the enantioselectivity. The contours 
produced can be physically interpreted as spatial regions encompassing the catalyst where an 
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increase or decrease in steric bulk (green for increase, yellow for decrease) and positive charge 
(blue for increase, red for decrease) leads to an increase and decrease in enantioselectivity 
respectively. Both the steric and electrostatic contour maps derived from indicator fields (boxed 
model in Table 16) are illustrated below (Figure 14 and Figure 15). It is noteworthy that contour 
maps from models derived from Tripos standard fields display information that is similar to the 
contour maps derived from indicator based fields below. 
3.6.3.  Steric Contour Maps. 
Upon inspection of the steric contour maps (Figure 14), the relationship between the 
substitution pattern and the contours becomes immediately apparent. A catalyst among the most 
selective is illustrated to serve as a template for interpreting how the contours are manifested. 
Two 3-D representations of different perspectives are illustrated for gauging relative depth. The 
location of the contours will be discussed with respect to the perspective of the left illustration in 
which the 5-5-5 scaffold is presented. The green contour on the front of ring b overlaps with the 
methyl group which is necessary for higher selectivity. The data is consistent with the hypothesis 
that this methyl group is necessary to shield the right front of ring b from anion association. The 
green contours overlapping with the substituents at the 3 and 5 positions of the phenyl ring of the 
benzyl group attached to the nitrogen atom are consistent with increased enantioselectivity with 
substitution at those positions. Only tert-butyl and trifluoromethyl groups were explored with 
latter groups bestowing greater enantioselectivity. The green contour in the back, overlapping 
with the phenyl ring of the benzyl group attached to the oxygen atom is an indirect indicator of 
the presence of a non-hydrogen group at the R2 substituent. If the R2 substituent is hydrogen, the 
benzyl group attached to the oxygen atom occupies the region of space after rotation of ~90o 
counterclockwise about the O- CH2Ph bond with respect to the conformation adopted by the 
corresponding catalyst with R2 ≠ hydrogen.122 All catalysts possessing a hydrogen atom at R2 
exhibit poor enantioselectivity in which case the phenyl ring would not overlap with the green 
contour of interest. The yellow contours surrounding the group attached to the nitrogen atom 
(R4) reflect substitution patterns (1-naphthyl, hexyl, and 9-anthracenyl groups) unfavorable for 
enantioselectivity. The large yellow contour over ring A may reflect both unfavorable 
interactions with the 9-anthracenyl substituent as well as bulky aliphatic groups at the R2 position 
(i-Pr and t-Bu groups). The effect of this steric contour will be further rationalized in conjunction 
with the electrostatic contours as discussed below. 
 Figure 14. Steric contour maps from two different perspectives. Green contours indicate regions 
where increased steric bulk leads to increased enantioselectivity while yellow contours indica
regions where decreased steric bulk leads to increased enantioselectivity.
 
3.6.4.  Electrostatic Contour Maps
Although the steric contours enabled the rationalization of the direct influence of specific 
substitution patterns, the electrostatic contours tend 
to stereocontrolling features including differential binding affinities. After eliminating the grid 
points with minimal field variation (1.3 kcal/mol column filtering), only two primary contours 
remain. The presence of a large blue contour over ring 
serve as a reasonable binding site for the reactive enolate. This conclusion is consistent with the 
fact that the largest degree of positive potential is localized over this
electrostatic potential (ESP) maps determined using ab
additionally reflect the enantioselectivity enhancing effects of an aryl group at the R
the quadrupole moment of arenes result
of the ring and may serve as an indicator for the regression analysis.
should reflect this region of increased positive potential (relative to catalysts with 
which is thus detected by the indicator fields. The red contour is coincident with a 
trifluoromethyl group on the right side and is consonant with the enantioselectivity enhancing 
effects of this group in conjunction with previously mentioned substi
necessary for enantioselectivity. Interestingly, a red contour does not overlap with the 
trifluoromethyl group on the left hand side which may be a result of the nearby blue contour and 
it having a larger contribution to the model. The 
suggest the undesirable negative electrostatic potential and that the enantioselectivity might be 
 
. 
to reveal more indirect information relating 
a suggests the potential for this region to 
 ring in accordance with 
-initio theory.123 The blue contour may 
s in a region of positive potential along the circumference 
124 The ESP partial charges 
tution requirements 
absence of a contour in this position may 
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te 
1 position as 
R2 ≠ arene) 
 enhanced in its absence. These two electrostatic contours may also reveal an intrinsic dipole 
preference of the catalyst for enantioselectivity. The yellow steric contour on the front of ring 
in Figure 14 is complementary to the electrostatic contours in that incr
and decreased steric potential should lead to a more favorable binding interaction with an 
associating anion. The combined effects of the steric and electrostatic contours are supportive of 
the conclusion that the most favorable bi
convex side of ring a for an associating enolate.
Figure 15. Electrostatic contour maps from two different perspectives. Blue contours indicate 
regions where increased positive charge leads to increased enantioselectivity while red contours 
indicate regions where decreased positive charge (increased negative charge) leads to increased 
enantioselectivity. 
 
The information revealed by considering both the steric and electros
some generalizations to be drawn regarding the mode with which the enolate should associate 
with the catalyst that leads to increased enantioselectivity. The blue contour coincident with the 
R2 group (Figure 15), the green contour coincident with the R
large yellow contour on the front of ring 
preferred region of the catalyst for association that leads to increased enantioselectivity to be the 
front of ring a of the catalyst scaffold. The red contour (
dipole orientation of the catalyst for aligning the enolate. 
 The observed enantioselectivity may be explained by considering one of two limiting 
scenarios assuming a thermodynamic dependence of the outcome: (1) the binding of the enolate 
to the catalyst is completely selective for one of the four faces of the imagin
inscribing the ammonium nitrogen and the enantioselectivity is directly related to the capacity of 
eased positive potential 
nding site for increased enantioselectivity is that on the 
 
tatic fields allows 
1 substituent (Figure 
a of the catalyst (Figure 14) are all consistent with the 
Figure 15) may enforce a preferred 
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14), and the 
ary tetrahedron 
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the face of the catalyst in question to differentiate the Re or Si faces of the enolate or (2) the 
capacity with which the catalyst differentiates the Re or Si faces of the enolate with respect to the 
faces of the ammonium ion is maximal (each face selects either Re or Si completely), and the 
enantioselectivity is directly related to the binding selectivity of the enolate to one of the four 
faces of the catalyst. A combination of (1) and (2) is likely operative, however the observation 
that bulky aliphatic groups at R2 result in a reversal in enantioselectivity suggests that a large 
portion of the observed enantioselectivity is governed by limiting scenario (2). 
Assuming that limiting scenario (2) is primarily operative, some generalizations about 
relative binding affinities and enantioselectivity can be drawn.  Both the electrostatic and steric 
contours are then consistent with the relative association preferences outlined below (Figure 16). 
Because of the polarization effects of the oxygen substituent, association mode (A) is preferred 
in structures of type 5 and to a lesser extent for 1, 2, and 3 (preferred pathway is indicated by a 
larger arrow). When the face over ring a is significantly sterically hindered, as in structures of 
type 4, association mode (B) is preferred even though the electrostatic preference favors 
association mode (A). The ordering outlined in Figure 16 is most consistent with the 
enantiomeric ratios when R4 is significantly electron withdrawing such as a 
bis(trifluoromethyl)phenyl group. Presumably, this group serves to create a stronger Coulombic 
interaction (decreased separation distance) with the enolate which enhances the steric influence 
of the R1 and R2 substituents with respect to catalysts with less electron withdrawing groups at 
R4. The stronger interaction for catalysts with R2 = aryl is not likely a consequence of increased 
steric or Coulombic interactions but may be attributed to the intervention of π-stacking 
interactions. An alternative to this analysis (limiting scenario (1)), would be that the erosion of 
enantioselectivity may be attributed to decreased enantiotopic differentiation of the faces of ring 
a or ring b of the catalyst for the Re and Si faces of the enolate which lends to a more 
challenging stereochemical rationalization. 
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Figure 16. Association preferences for the enolate (En-) as a function of the R1 and R2 groups. 
Although the highest enantioselectivity observed in this report (e.r. = 81:19) does not 
currently allow for the development of a well-defined stereochemical model for this catalyst 
system, the contour maps do allow the generation of qualitative assessments of how to increase 
the enantioselectivity further by introducing substituents that render the interactions noted above 
even more favorable. The model may also be used to make semi-quantitative predictions 
regarding the extent of enantioselectivity to which certain substituents may provide. While such 
extrapolation can be susceptible to erroneous predictions, some confidence may be placed in the 
predictions if the catalysts identified to be more selective are proximal to the structural and 
dependent variable domain of the training set. For example, this model would be incapable of 
predicting enantioselectivities imparted by cinchona derived quaternary ammonium ions and any 
catalysts that furnish enantioselectivities significantly greater than 81:19. 
3.6.5.  Summary of CoMFA Analysis. 
Correlations of the enantioselectivity with the steric and electrostatic fields (55% steric; 
45% electrostatic) of the catalysts were statistically significant as determined by rigorous cross-
validation. The model was readily interpreted qualitatively as relating to the differential binding 
preferences of the reactive enolate for the catalyst in accordance with contour maps represented 
as multiplicative products of coefficients of the model and the variation in the molecular 
interaction fields of the catalysts. The steric field revealed differential van der Waals repulsive 
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interactions between the two active faces of the catalysts available for binding as being relevant 
in explaining the observed reversal in enantioselectivity with the inclusion of bulky aliphatic 
groups shielding one of the two faces. The electrostatic field revealed that higher 
enantioselectivity for the (S) configured product is obtained by further differentiating one face 
over the other through charge polarization. The inclusion of aryl groups at one of the faces 
selectively introduces positive potential in this region as a result of the quadrupole moment 
imparted by arenes, which enforces the preference for the (S) configured product. This 
observation may indicate an important role for π-stacking interactions at this position for this 
reaction system. Additionally, the inclusion of a region of preferred negative potential for the (S) 
configured product, coupled with the region of preferred positive potential, may reveal a 
preferred dipole orientation that allows for facial discrimination of the enolate. Future 
development of more enantioselective catalysts based on the current scaffold would involve 
enhancing substrate interaction with the desired face for binding through the qualitative and 
quantitative application of the QSSR model developed here. The principles borne from this 
QSSR study may serve as criteria for the rational design of future APTC catalysts. 
3.6.6.  Proposals for Stereochemical Model. 
The results from density functional ion pair modeling and the CoMFA analysis suggests 
that a stronger preference for the enolate exists to associate with the left face of the catalyst, and 
that this is the region where the enanioselectivity is most sensitive to structural variation. Upon 
accepting this to be the case, four ion-pair arrangements can be envisioned which have been 
optimized at the PM6 semiempirical level to provide only qualitative insight (the relative 
energies do not warrant discussion due to inaccuracy from poor inclusion of dispersion and 
solvation effects) (Figure 17). Only the Z-enolates have been considered here on the basis of 
earlier findings (Section 3.2).  
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Figure 17. Geometries of ion-pairs optimized at the PM6 semiempirical level. 
 
Ion pairs IP-1 and IP-2 are expected to lead to opposite enantiomers predominately. The 
Re face of the enolate in IP-1 is shielded by the aryl group at R2, thus the S-configured product is 
expected to form predominately, consistent with experimental results. IP-1 also appears to be 
capable of engaging in π-stacking interactions between one of the phenyl groups of the enolate 
with the aryl group at R2 of the catalyst. Conversely, the Si face of the enolate in IP-2 is hindered 
by both the aryl group at R2 and the aryl group at R4 thus favoring the R-configured product. An 
apparent π-stacking interaction could exist between one of the electron-rich phenyl rings of the 
enolate with the electron poor 3,5-bis-trifluoromethylphenyl group at R4 of the catalyst. 
Nevertheless this ion pair seems to favor the opposite enantiomer which is inconsistent with the 
observed positive influence of the 3,5-bis-trifluoromethyl phenyl group.  
The preferred enantiomer formed from alkylation of ion pairs IP-3 and IP-4 is not as 
clear. Ion pair IP-3 is expected to be higher in energy since the oxygen of the enolate is furthest 
from the ammonium nitrogen. Ion pair IP-4 would furnish the observed product if the 
electrophile approached from the direction of the aryl group at R2. This ion pair seems 
energetically feasible as there appears to be an available ArH....π interaction between the π 
electrons of the enolate and one of the C(sp2)-H bonds of the phenyl ring ring at R2.  
Overall, ion pairs IP-1 and IP-4 appear to be the arrangements most consistent with the 
experimental results. Future catalyst design criteria would then reflect modifications in the 
catalyst that would increase the facial selectivity of ion pairs IP-1 and IP-4. This effect would 
entail introducing varying degrees electronic perturbations of the π-surface areas electronics at 
R2 and modification of the electronic properties of the aryl group at R4.  
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Chapter 4:  Synthesis of New catalysts Guided by Quantitative 
Models 
4.1.  Synthesis of New Catalysts. 
According to the structure activity relationships introduced in the previous chapter, the 
catalyst scaffold requires highly specific substituent patterns to obtain reasonable 
enantioselectivity. The substituent at R1 should be a non-hydrogen group, although only methyl 
and hydrogen have been explored up to this point. The R2 group needs to contain an arene. The 
enantioselectivity is relatively independent of the R3 group. Lastly, the enantioselectivity is quite 
sensitive to the R4 group which is should be 3,5-(CF3)2C6H3 for moderate enantioselectivity from 
the groups explored. Groups R2 and R4 were initially chosen for further exploration since R1 
would require a greater synthetic investment as its introduction is at the earliest stage of the four 
groups.  
 
Figure 18. Conditions on R groups for e.r. > 80:20. 
 
The variation envisioned at the R2 for further exploration was based on electronic 
contributions and π-surface area. The catalysts displayed in Figure 19 represent a brief 
investigation on this variation. Catalysts 23 and 24 exhibit some modification of electronic 
properties of the substituent at the R2 position. The levels of enantioselectivity are similar to 
those for the analogous catalysts with a phenyl or 1-naphthyl group at this position with all other 
groups held constant. Upon introduction of alternative groups at R4 with varying electronic 
properties, significant reduction in enantioselectivities are observed throughout relative to R4= 
3,5-(CF3)2C6H3. Catalyst 29 with a 2,4-(CF3)2C6H3 exhibited no reactivity. This result is likely 
due to the decomposition of the catalyst because of pKa lowering of the alpha hydrogens of the 
benzylic hydrogens.  
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Figure 19. Predicted and observed enantiomeric ratios. The predicted values are based on the 
best CoMFA model from Table 16 (Chapter 3). 
 
From this initial set of newly acquired data, it is not clear how the current stereochemical 
model can be improved. Thus, to move forward, inspiration was sought from alternative, 
effective catalyst scaffolds such as the cinchona alkaloids. From Figure 20, it is apparent that a 
common substitution pattern exists that contains the ammonium nitrogen, the alkoxy group and 
the aryl group (quinoline group). In an effort to better resemble the cinchona alkaloid structure in 
this aspect, a quinoline group was considered for introduction at R2 in the 5-5-5 system. 
However, because of restrictions in the synthetic sequence, a nucleophilic quinoline source is 
necessary for addition to the electrophilic α-keto amide (Scheme 7), and methods are lacking for 
this construction. With this in mind, the 3-quinoline substituted catalyst was sought instead. 
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Figure 20. Comparison between 5-5-5 scaffold and a cinchona alkallid derived catalyst. The 
substitution pattern of the ammonium nitrogen, the alkoxy group, and the aryl group (quinoline 
group) is the same. 
 
 The synthesis departs significantly from the established protocol (Scheme 17). The 
Grignard addition was replaced by an organolithium addition. Reduction of the amide required 
some additional exploration. Applying the standard BH3•THF reduction protocol led to a 
complex mixture of products that included reduction of the quinoline group. A lithium aluminum 
hydride reduction was attempted on both the hydroxyamide 30 and the benzylated amide 31 but 
furnished only complex mixtures. A fundamentally different strategy was adopted which first 
involved benzylation of the hydroxyl group via the standard Williamson ether synthesis 
conditions. In view of the failure of nucleophilic hydride reduction, hydrogenolytic reduction 
was envisioned. An attractive option was to incorporate carbon-sulfur bonds because their 
lability toward hydrogen mediated cleavage. In this regard, the amide was first converted to the 
thioamide using Lawesson’s reagent.125 The addition of DMAP was found to be necessary for 
liberating any excess Lawesson’s reagent that was bound to the qunoline nitrogen. Cleavage of 
the carbon-sulfur double bond proceeded in modest yield (50%) to furnish the desired amine. 
The final quaternization was carried out at room temperature over an extended period of time to 
avoid over benzylation of the quinoline nitrogen, which account for the diminished yield (38%).     
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Scheme 22. 
 
 
 The resulting quinoline-substituted catalyst 34 was next applied in the model PTC 
reaction and afforded an enantiomeric ratio of 87:13 which is greater than the maximum 
observed previously (82:18 − 83:17 e.r.) (Scheme 23). To probe whether the quinoline group is 
important or if the presence of the π-surface was sufficient, the 2-naphthyl group was introduced 
via the established sequence (Scheme 17). Interestingly, the same enantioselectivity was 
oberserved for this catalyst 36 as the quinoline substituted catalyst 35 (Scheme 23). These results 
suggest that the presence of the π-surface is more relevant and the effects of the nitrogen atom 
are inconsequential. This development caused our strategy to focus more on variation in π-
surface area.    
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Scheme 23. 
 
 Before the investigation of new catalysts, a modeling strategy that might be more 
amenable toward small extrapolations was pursued. The currently used CoMFA method is not 
well suited for extrapolation, because of the generation of highly parameterized models (very 
large number of descriptors). Thus, a strategy that is capable of isolating only a handful of 
descriptors that are the most relevant to a 3D-QSAR model was explored.   
4.2. Development and Application of an Alternative 3D-QSAR Approach. 
4.2.1.  Descriptor Types. 
In the standard CoMFA approach, the electrostatic energies and steric energies are 
determined from the Coulomb potential and the Lennard-Jones potential respectively. The 
Coulomb energy terms are determined using partial atomic charges. These partial atomic charges 
are typically derived by molecular mechanics or from semi-empirical methods. Rarely are 
quantum mechanical methods used since the error associated with using partial atomic charges 
for determining the electrostatic energy is comparable to the error between semi-empirical and 
QM partial charges.  
An alternative, more accurate approach to determine the electrostatic energy is to use the 
electron density ρ, rather than partial charges, which is calculated from the square of the QM 
wavefunction ρ = ∫ψ2dr. The electrostatic potential V(r) can then be expressed as the following;                                  
 = Z	
 − 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where Zi and Ri are the charge and the position of the nucleus i, n is the total number of nuclei,  
ρ(r′) is the electron density at position r′, and r is the position of the test charge. The first term 
represents the electrostatic potential felt by a test charge due to all of the nuclei and the second 
term is the potential due to the electronic distribution. (It should be mentioned that the quantity 
defined in eq.1 is the potential, not the potential energy of the interaction with the test charge. 
The actual potential energy is obtained by multiplying V(r) by the magnitude of the test charge, 
U(r) = qtestV(r). Because the test charge typically has a magnitude of one, and since the 
electrostatic potential is used solely for comparing energies at points within the same molecule, 
the inclusion of qtest is inconsequential.) 
The van der Waals potential is complex, and more accurate models have been empirically 
derived to approximate this energy term. Instead of using the Lennard-Jones 6-12 potential, for 
the purposes of this investigation, a “Buffered-14-7” form of the potential was used as 
implemented in the MMFF94 force field.126 The MMFF94 force field provides relatively low 
errors and was deemed suitable. A description of how these models are performed and the 
corresponding scripts are provided in the experimental section. 
4.2.2.  Descriptor Selection.  
The CoMFA model is quite adept at explaining the variation within a training set, 
however the complexity (large number of grid points) of the model precludes confident 
application towards extrapolation due to possible over-parameterization. Therefore, a strategy 
that includes a smaller number of descriptors of greater quality (quantum mechanical) was 
adopted. The descriptor selection procedure relies on a simulated annealing based algorithm. The 
optimization algorithm was built to select combinations of grid points that lead the best models 
according to a procedure merging PLS with cross validation. This allows the effective selection 
of only the most pertinent grid points rather than the entire grid point pool (i.e. CoMFA). The 
number of PLS components used is dependent of the number of chosen descriptors.    
The strategy developed draws parallels to both CoMFA and QMQSAR55 where the 
electrostatic interaction energies are determined from the ESP maps derived from DFT electron 
densities and the van der Waals interaction energies (vdW) are derived from the vdW potential 
function of the MMFF94 force field126 where the probe atom is a C(sp2) atom. The model may 
represent either of the following forms: 
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where for eq. 3, at each grid point the calculated electrostatic and vdW energies are summed with 
a scaling factor operating on the vdW term, which is determined from the regression. This 
operation ensures that the grid point energy is analogous or proportional to a total interaction 
energy (elec + vdW) and the ratio of the steric and electrostatic terms is not altered in the 
regression. The model from eq. 4 is similar to the CoMFA approach in the sense that the 
electrostatic and van der Waals energy terms contain unique regression coefficients.  
4.2.3.  Test Applications. 
The newly developed models were applied to a test set of 50 catalysts from the library 
that contained only a phenyl group at R3 since the enantioselectivity was insensitive to variation 
at this group. Both descriptor selection methods were applied to garner how well the resulting 
models would compare to the CoMFA models and whether they correspond well with qualitative 
expectations (Figure 21). The correlation statistics and the number of PLS components are 
provided. The position of the grid points of the best model overlaid with the most 
enantioselective catalyst is shown.  
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Method Comp. R2 QLOO
2 esp:vdw  
eq. 3 2 0.826 0.781 45:55  
eq. 4 4 0.817 0.772 -  
Figure 21. The model from eq. 2 is illustrated graphically with the location of the grid points 
overlaid with the most enantioselective catalyst. 
 
 The electrostatic grid points are confluent with qualitative expectations and differ 
somewhat from the CoMFA model which is not surprising considering data points not included 
in the CoMFA model have been included in these models (catalysts 35 and 36). The red spheres 
represent the requirement for having electronegative groups at the 3,5 positions of the aromatic 
ring of R2. The green sphere on the right indicates the requirement for a non-hydrogen group at 
R1. The yellow contour may represent the enantioselectivity decreasing influence of an 9-
anthracenyl group at R4. Finally, the lower red sphere indicates a preference for π-electron 
density at the R2 group. Also, the contributions of the electrostatic and steric fields to the model 
are similar to that from the CoMFA model (esp:vdw = 45:55).  
 The extrapolative potential for this modeling strategy was evaluated with a reduced 
training set size of 12 catalysts. Only the catalysts with R4 = 3,5-(CF3)2C6H3 were retained since 
this group produced the most significant variation in enantioselectivity and since groups that 
have greater electron withdrawing capacity would likely lead to catalyst decomposition. The top 
2 catalysts were removed from the training set from the training set and a model, employing the 
strategy from eq. 1, was developed. The resulting 2 grid point model exhibited an R2 = 0.965 and 
Q2 = 0.819. The top two predictions, based on this model, are provided (Figure 22). It is 
important to emphasize that these 2 catalysts were not included in the model development. The 
prediction for the 2-naphthyl catalyst is close to the observed value. However, the prediction for 
3-quinonline substituted catalyst was poor.  
Blue:
inc. (+) → inc. e.r.
Red: 
inc. (-) → inc. e.r.
Green:
inc. (vdw) → inc. e.r.
Yellow:
dec. (vdw) → inc. e.r.
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R2 e.r.obs e.r.pred 
 
87:13 88.6:11.4 
 
86.5:12.5 60:40 
Figure 22. Two Grid point model with a training set size of 10 catalysts. R2 = 0.965, Q2LOO = 
0.819.  
 
The poor prediction for catalyst 35 suggests that this catalyst is too far removed from the 
training set. This breakdown can be understood from difference in electrostatic potential between 
these two catalysts at the left grid point that is not accounted for by a corresponding difference in 
enantioselectiviy (Table 17). The model take the following form; ln(R/S) = 0.597 − 0.586(g1) + 
0.175(g2) where g1 and g2 are each the sum of the electrostatic and steric energies at the left grid 
point and right grid point respectively. The values for the catalyst with R2 = Ph is provided for 
reference purposes. The quinoline substituted catalyst exhibits a much lower esp (-2.6 kcal/mol) 
which indicates that a positive point charge interacts less favorably than with either the 2-
naphthyl or Ph substituted catalysts. The less favorable interaction is due to the electron deficient 
nature of the quinoline π-system. A model was then developed with a training set that includes 
the top two catalysts. The left grid point in this model is now relocated to a region that does not 
lead to a significant variation in the electrostatic potential. This process of prediction and 
inclusion illustrates how the training set can be trained with the incorporation of newly acquired 
data. 
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Table 17. Relative electrostatic potential energy values (kcal/mol) for models excluding catalysts 
(n=10) and including (n=12) the top two catalysts. (R1 = Me, R3 = Ph, R4 = 3,5-(CF3)2C6H3). R
2 
= 0.965, Q2LOO = 0.938. 
R2 n=10 n=12 e.r.pred 
 
4.3 0.9 87.5:12.5 
 
-2.6 1.3 85.7:14.3 
 
0 0  
  
4.2.4.  Prediction and Synthesis of New Catalysts. 
The π-surface at R2 is clearly important and thus additional catalysts with variation at this 
position were envisioned that were readily synthetically accessible (Table 18). Catalysts that 
could not be synthesized are not discussed here. Groups that possessed greater degrees of π-
surface and π-electron density were explored. Each new catalyst is predicted to have a greater 
e.r. than the maximum in the training set. However, the observed values were lower than that 
predicted, closer to the maximum values in the training set.  These were somewhat disappointing 
results and as a consequence the R1 group was chosen for further elaboration.     
 
Table 18. Predicted and observed enantiomeric ratios. The predicted values are based on the 
model from Table 18. 
Catalyst R2 e.r.pred e.r.obs 
37 
 
91:9 87:13 
38 
 
91:9 85:15 
39 
 
91:9 85:15 
 
 The hypothesis at this point was that the catalyst may still experience some association 
with the enolate on the right face which may result in erosion of enantioselectivity. A slightly 
altered strategy for the modeling was necessary to accommodate the new catalysts. First, the fact 
that both the ethyl and isopropyl substituted catalysts can exist in different conformations needed 
to be factored in. This adjustment was done by taking the sum of the Boltzmann weighted 
electrostatic and steric energies at each grid point. The Boltzmann weighting was determined 
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from the overall energies of the cations from the single point B3LYP/6-31G(d,p) calculations. 
Second, to avoid accepting grid points too close to the van der Waals surface of the t-Bu group 
(grid points could be selected within this surface since both the ethyl and isopropyl groups have 
hydrogens that are within this surface), a cutoff distance was applied. The predictions of the 
resulting models are shown (Table 19).  
Table 19. Predicted enantiomeric ratios. The predicted values are based on the model from Table 
18. 
Catalyst R2 R1 e.r.pred 
40 
 
Et 91:9 
41 
 
i-Pr 92:8 
42 
 
t-Bu 97:3 
 
 The synthesis of the ethyl substituted catalyst follows the same sequence as the methyl 
substituted catalyst and is provided in the experimental section. The isopropyl and tert-butyl 
substituted catalysts required different routes for preparation of the chiral alkenyl ethers for the 
[4+2]/[3+2] sequence.  
A number of sequences have been explored for the isopropyl substituted alkenyl ether 
and most consisted of either less than desirable length or yields. The sequence that was finally 
accepted (Scheme 25. first involved prenylation of chiral alcohol 11 to form 43. The double bond 
was then isomerized to 44 following a modified protocol using Wilkinson’s catalysts.127 
Unfortunately this step was very low yielding (20% yield) as unreacted starting material 
remained and side products including equal amounts of the (Z)-isomer and the saturated product 
from over reduction. The remaining unreacted starting material was a consequence of a small 
equilibrium constant for this reaction as added catalyst and longer reaction times only led to the 
formation of more of the saturated product. Nevertheless, this sequence was accepted in view of 
the practicality relative to other investigated routes. The synthesis of the final catalysts follows 
the same protocol used for the synthesis of the catalyst with R1 = Me and is provided in the 
experimental section.  
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Scheme 24. 
 
 The synthesis of the tert-butyl substituted chiral enol ether first involved diazotization of 
pinacolone via the use of a diazo-transfer reagent. The diazo ketone 46 is than added to chiral 
alcohol 11 through an indium triflate catalyzed O-H insertion.128 The carbonyl is then reduced 
with the aid of sodium borohydride. The hydroxyl group is then eliminated following a modified 
Chugaev protocol129 that involves first generation of the thiocarbonate followed by thermal 
elimination to furnish enol ether 51. The synthesis of the final catalyst follows precisely that for 
the catalyst with R2 = Me which is provided in the experimental section.  
Scheme 25. 
 
 
 The catalysts from Table 19 were employed in the model PTC alkylation reaction and the 
enantioselectivity was measured. The observed results were again quite different than the 
predicted values (Table 20). The ethyl and isopropyl substituted catalysts furnished the same e.r. 
as the methyl substituted catalyst. Interestingly, the tert-butyl substituted catalyst furnished a 
lower e.r. than the methyl substituted catalyst. These results suggest that the enolate is not 
associating with the right face of the catalyst to a significant extent. The negative influence of the 
tert-butyl group may suggest a conformational dependence of the R4 group. If the enolate is 
primarily associating with the right face, the R4 group may need to rotate to the right to 
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accommodate this association. Moreover, the tert-butyl group may compress the R4 group 
toward the left face thus impeding enolate association. This effect may suggest that ion pair 
model IP-4 (Figure 17) might be operative since it exhibits some rotation of the R4 group toward 
the right face.     
Table 20. Predicted and observed enantiomeric ratios. The predicted values are based on the 
model from Table 18. 
Catalyst R2 R1 e.r.pred e.r.obs 
40 
 
Et 91:9 87:13 
41 
 
i-Pr 92:8 86:14 
42 
 
t-Bu 97:3 70:30 
 
4.3.  Hammett-Type Analysis. 
The 3,5-(CF3)2C6H3 group at R
4 is obviously important for enantioselectivity, however 
the nature of this influence is unclear. To provide additional insight on whether the origin is 
related to inductive or resonance effects, a Hammett-type analysis was performed. The additional 
catalysts in Figure 23 were prepared for this analysis.  A plot of the energy associated with the 
enantioselectivity as a function of sigma constant reveals a much stronger correlation with σp 
over σm. The difference in correlation suggests that influence of the substituents on the arene at 
the R4 group is better associated with ability of the group to donate electron density into the π-
system rather than the inductive influence.   
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Catalyst X e.r. σp σm 
49 OMe 45:55 -0.27 0.12 
50 F 66.3:33.8 0.06 0.34 
51 Me 55.8:44.2 -0.17 -0.07 
36 CF3 87:13 0.54 0.43 
 
Figure 23. Enantioselectivity data for catalysts with variable groups at the 3,5 positions of the 
arene at R4 and  plot of the free energy versus different Hammett constants. 
 
 These results suggest that groups that withdraw more electron density would lead to 
higher enantioselectivity. Substituents that are more electron withdrawing than CF3 include CN 
and NO2. The 3,5-(CN)2C6H3 catalyst was prepared but was not an effective catalyst for the 
reaction as there was no observed product formation over a number of hours. It is likely that 
group is too electron withdrawing thus causing the catalyst to decompose via Hoffmann 
elimination  
 
4.4.  Summary and Future Directions. 
The objective outlined in the chapter was to improve the enantioselectivity induced by 
the 5-5-5 scaffold on the model PTC reaction using quantitative models. Initially, the CoMFA 
model was used for purposes of qualitative design. Focus was directed on the R2 group and the 2-
σp
σm
∆G
(kcal/mol)
σ
y = 6.1983x + 1.3659
R² = 0.9926
-1
0
1
2
3
4
5
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naphthyl group provided the highest enantioselectivity to date (e.r. = 87:13). Alternative 
modeling strategies were developed with the intent on increasing chances for minor extrapolation 
as the CoMFA model may exhibit over parameterization of the training set that diminishes the 
opportunity for extrapolation. These modeling strategies provided similar insight as the CoMFA 
model, which served to validate these approaches.  
The models formulated from these new strategies were applied toward prediction of new 
catalysts. Modifications to the R2 group were initially investigated (Table 18). The new modeling 
methods that predicted catalysts with additional π-surface area and greater π-electron density to 
have enantiomeric ratios greater than the maximum observed in the training set (87:13). 
However, the experimentally determined values were very close to the maximum of 87:13 from 
the training set. This result may suggest that the arene at R2 is simply provided a cleft for th 
association of the enolate. Any additional π-surface beyond what is necessary for serving as a 
cleft will not result in an e.r. increase (e.g. 2-anthracenyl group in Table 18). Only modest 
changes in the electronic properties were made in R2, but the e.r. appears to be relatively 
insensitive this aspect of the π-surface.  
Attention was directed toward structural variation at the R1 substituent. Increasing steric 
bulk at this position was predicted to lead to an increase in enantioselectivity. However, the 
observed values for R1 = Et and iPr were both very close to the corresponding catalyst with R1 = 
Me. Moreover, the enantioselectivity actually diminished for the catalyst with R1 = t-Bu (e.r. = 
70:30). This result is also consistent with ion pair model IP-4 as the R4 group is slightly tilted to 
the right face. The t-Bu group would disfavor this tilt because of its considerable steric bulk.      
If further improvements in this catalyst scaffold were to be pursued, focus should likely 
be placed on investigating how to differentiate the enantiotopic faces of the enolate in ion-pair 
model IP-4 since this model appears to most coincide with experimental observation. If ion pair 
model IP-1 is believed to be operative, a 9-anthracenyl group may be sufficient for blocking the 
Re face of the enolate. 
In retrospect, the method by which this project was initially approached may not have 
been the most efficient demonstration of a computer model guided strategy. A very large library 
was constructed with less than ideal rational design elements. The kind of groups worked well 
for other catalyst systems were understood, and these types of groups were introduced in the 5-5-
5 scaffold. Moreover, a significant portion of the structural space was already sampled without 
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the aid of a computer model. A more efficient demonstration would be to design an initial 
training set based on structural diversity, with a common core scaffold, which can be measured 
by similarity metrics130 such as Tanimoto similarity. A computer model can be constructed from 
this initial training set and used to guide the synthesis of more optimal catalysts (Figure 24). 
From the initial training set model, a virtual screen of catalysts with structural variation at the 
location of the model coefficients (ie. grid points) is performed. The large virtual library is then 
filtered based on a combination of predicted e.r. and the similarity to the training set (higher e.r. 
and higher similarity to the training set). The filtered catalysts are then synthesized and evaluated 
based on the predicted enantiomeric ratio. If the e.r. is less than the maximum observed in 
previous iterations, then a new training set is devised based on e.r. and similarity including the 
newly acquired catalyst data and the cycle is repeated. If a number of iterations (k) have been 
completed without an increase in e.r., then a new, more diverse training set needs to be 
constructed or a new scaffold should be explored. If the maximum e.r. is greater than previous 
iterations and is the optimal e.r. desired, then the cycle is complete. This procedure would ideally 
allow the research to reach the ideal catalyst more quickly with less synthetic investment. 
 
Figure 24. Optimization flowchart representing the proposed strategy. i=iterations; ni=i
th training 
set; mi=i
th set filtered from the in-silico screen; f(∆Gpred) represents a function of the e.r. and f(T) 
is a function of the Tanimoto similarity metric; ∆Gmax,obs(mi) represents the maximum e.r. 
oberseved within the mi set; k=pre-defined limit without an increase in observed e.r. 
 
 These strategies can be applied toward the optimization of any reaction. The methods 
outlined here would probably be more suitable for catalysts that operate by noncovalent 
interactions as strong orbital interactions may not be described readily by electrostatic and steric 
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fields alone. For applications that make use of strong orbital interactions, HOMO and LUMO 
fields (or any orbital of appropriate symmetry for the desired reaction) could be applied.  
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Chapter 5:  Introduction to Allylation of Aldehydes with 
Allylsilanes 
The controlled construction of contiguous stereocenters is of primary importance in the 
synthesis of natural and non-natural products. A significant number of methods developed for 
this purpose involve the combination of two π systems, specifically those of electron-rich 
alkenes with aldehydes and ketones. The stereochemical course of the bond-forming event is 
dictated by the relative topicity of prostereogenic carbons in the transition state (Scheme 1). Each 
pairwise combination leads to a unique stereoisomer, for which three, limiting, staggered 
arrangements of the double bonds are possible, antiperiplanar, (+)-synclinal and (–)-synclinal. 
The ability to reliably predict the stereochemical outcome of such reactions is vital for synthetic 
planning and requires an understanding of the physical origins underlying the way in which the 
structural and electronic properties of the two π systems (A, D, R1, R2) influence their relative 
orientations in the competing transition structures. Effective stereocontrol mechanisms often rely 
on strong organizational elements that enforce propinquity of the reacting components such as 
metal coordination or dative association with directing groups. On the other hand, some of the 
most challenging reactions to rationalize are typically those that are believed to proceed through 
open transition state structures, in which selectivity controlling factors pertain primarily to 
nonbonding interactions. Such reactions are the focus of this study. 
 
Scheme 26. 
 
 
An early phenomenological analysis of the stereochemical course of these types of reactions 
formulated a set of topological rules,131 which are summarized here because they will be referred 
to frequently in the following sections (Scheme 2): 
i. All vicinal bonds are staggered  
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ii. A synclinal arrangement of the donor (C=D) and acceptor (C=A) bonds is preferred 
iii. The smaller group on the donor (H) is placed antiperiplanar with respect to the C=A bond 
iv. The synclinal orientation adopted is that which positions the donor and acceptor atoms in 
the closest possible proximity 
Rules i and iii address the minimization of steric interactions whereas rules ii and iv have 
electronic implications. Rule ii has received the most scrutiny experimentally. 
Scheme 27. 
 
A host of interactions have been suggested to explain these preferences, including 
minimization and/or maximization of unlike and like charge separation respectively 
(Coulombic),132 steric effects,133 orbital control,134 and dispersion forces.135 However, the 
dominant selectivity-controlling interactions that are related to the structure of the π systems still 
remain unclear. Each of the suggested effects is to some extent associated with the components 
of the interaction energy of the two fragments in the transition state. The aim of this investigation 
was to computationally identify the interactions that are most accountable for the 
diastereoselective preference in pathways thought to proceed through open transition states using 
theoretical methods. 
 The addition of electron rich π systems to activated carbonyl groups constitutes a large 
body of reactions.136 The stereochemical course of these reactions is often highly predictable 
through the use of cyclic transition state models. Conversely, a physical understanding of 
stereochemical control in acyclic transition structures is less well developed. However, this has 
not prevented the accumulation of substantial amounts of experimental data that have allowed 
for the formulation of rules and generalities that possess some qualitative predictive capacity.137 
The immense synthetic utility of the addition of allylsilanes to aldehydes made it ideally suited to 
serve as the platform for this study. 
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5.1. Background. 
5.1.1.  Experimental Studies. 
Beyond the edifice of preparative studies on the Lewis acid mediated addition of 
allylsilanes to aldehydes, the reaction mechanism and stereochemical course have been 
extensively investigated. Thorough stereochemical studies have established that the reaction of 
allylic trialkylsilanes proceeds through acyclic (open) transition states (Scheme 3).138 This 
behavior is in contrast to the reactions of allylboron reagents that proceed through closed 
transition states because of the Lewis acidic nature of the tricoordinate boron atom.139 
Consequently, six limiting transition structures can be envisioned that possess staggered 
orientations of all bonds to minimize steric interactions (rule i). Additionally, the Lewis acid is 
coordinated to the aldehyde oxygen on the side of the hydrogen atom as has been amply 
demonstrated in spectroscopic and computational studies.140  
Scheme 28. 
 
 
The silicon group and the electrophile are located on opposite sides of the allyl moiety 
(i.e. anti SE2’) which established the open nature of the transition state.
138 A syn disposition 
(established for allyl trihalosilanes)141 would likely perturb the energies of the synclinal 
transition states more profoundly. 
Scheme 29. 
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The syn diastereomer is often produced in these reactions with high diastereoselectivity. 
A common rationale for the observed diastereoselectivity invokes the minimization of steric 
repulsion by proceeding through antiperiplanar transition states.136f The antiperiplanar transition 
state leading to the anti diastereomer (anti-1, Scheme 3) is considered to exhibit more severe 
gauche interactions between R1 and R2 than the corresponding synclinal transition state (syn-1, 
Scheme 3). Unfortunately, for intermolecular reactions, it is impossible to determine the precise 
orientation of the reactants that lead to the observed products. Accordingly, to unambiguously 
determine the relative orientation of the reactants, a number of models that incorporate both 
reactants in a single molecule have been devised and examined.  
 The two most studied models are the subject of a number of detailed investigations from 
these laboratories (Scheme 4).142 Model system A was designed to probe the preference between 
transition structures syn-3 and anti-1 in the reaction of an E-crotylsilane whereas model system 
B was designed to probe the analogous Z-crotylsilane system. The results of these studies 
revealed that the Lewis acid promoted reactions afforded predominately the product resulting 
from a synclinal disposition of double bonds in the transition state. The fluoride-promoted 
pathway was also investigated and, interestingly, the product resulting from the antiperiplanar 
transition state is generated in greater amounts. This intriguing divergence in selectivity clearly 
suggests that multiple factors are operative. Clearly, model systems of this type will be limited in 
the number of different transition states that can be accessed given the structural constraints of 
intramolecularity.  
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Scheme 30. 
 
 
5.1.2.  Computational Studies. 
The allylation of activated carbonyl compounds has also been investigated 
computationally using quantum mechanical methods.143 An early gas phase DFT study using 
BFH2 as the Lewis acid and trihydridoallylsilane suggests a pseudo-cyclic transition state in 
which the fluorine atom is closely associated with the silicon atom.144 Intrinsic reaction 
coordinate (IRC) calculations imply bond formation between the silicon and the fluorine atoms. 
Only synclinal transition states could be located which is a direct consequence of the proposed 
Si---F interaction. The model simplifications introduce an unjustified bias toward a cyclic 
transition state due to a lack of solvation (unquenched potential on the fluorine atom) and the use 
of a less hindered, electron deficient silicon atom than used experimentally. Moreover, the 
conclusion of such an interaction is invalidated by the experimental demonstration of an anti 
SE2’ process for allylsilane additions.
142d  
A thorough, combined computational and experimental study on the crotylation of O-
methyloxocarbenium ions has also been reported.145 Canonical ensembles of the calculated 
B3LYP transition states are relatively consistent with the experimentally observed 
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diastereoselectivities that, for the most part, favor the syn diastereomer. Steric repulsion 
primarily accounts for the formation of the major syn diastereomer. The relative agreement 
between the predicted and the experimental diastereoselectivities suggests a stepwise process. 
 3. Goals of this Study. The nature and magnitude of the interactions governing the 
selectivity preferences in open transition structures remains obscure. The deconstruction of the 
interaction energies in the transition state and/or along the reaction coordinate into physically 
recognizable quantities such as steric, electrostatic, orbital, and dispersion should provide 
additional insights into the stereochemical controlling factors. Such a decomposition process was 
conceived146 and implemented147 by Kitaura and Morukuma a number of years ago. This method 
essentially teases out the electrostatic ∆Eelec, polarization ∆Epol, charge transfer ∆ECT exchange 
repulsion ∆Eexrep and dispersion ∆Edisp energetic contributions from the total interaction energy 
∆Eint of the interacting components; 
 ∆Eint = ∆Eelec + ∆Epol + ∆Eexrep + ∆ECT + ∆Edisp  
 Although energy decomposition analysis (EDA) methods have been applied to 
understand weak and strong chemical binding and bonding,148 the method has seen only limited 
application toward understanding reactivity and selectivity in chemical reactions. Bickelhaupt 
and Houk have pioneered the activation-strain model149 or synonymously the activation-
distortion model150 of reactivity to analyze a number of chemical reactions. This method 
decomposes the energy difference between a point along the reaction coordinate and the 
minimum from which it originates ∆E(ξ) (ξ, extent of reaction) to the sum of the interaction 
energy of the distorted reactants (∆Eint) and the energy required to distort the fragments to that 
geometry in the absence of any interaction (∆Edist). 
 ∆E(ξ) = ∆Eint + ∆Edist  
 A significant number of reactions have been investigated for which ∆E(ξ) as a function of 
structure is more strongly correlated with the distortion energy rather than the energy of 
interaction ∆Eint. This situation will most often obtain for reactions with late transition states and 
those that have high frequency bending modes along the reaction coordinate.150a,150b Reactions 
with earlier transition states are expected to better correlate with the interaction energy 
component of the total energy (FMO theory).  
 The goal of this study was to reveal which components of the interaction energy 
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contributed most to the observed diastereoselectivity for the addition of (E)-2-
butenyltrimethylsilane to acetaldehyde under activation by BF3, hydronium ion, and fluoride ion. 
The first stage in the program required locating the six staggered transition structures for which 
density functional theory was the chosen theoretical approach. Next, the energies for each 
transition structure were decomposed along their respective reaction coordinates employing a 
recently-developed localized molecular orbital EDA method.151 Then for each reaction, the 
components of the interaction energy that contributed most to the diastereoselectivity were 
identified and the EDA results were validated through assessment of geometrical and electron 
density properties. The analysis would ideally provide a better understanding of the selectivity 
controlling factors in the allylation of aldehydes and other open transition state reactions such as 
Mukaiyama-type aldol152 and Michael153 addition reactions.  
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Chapter 6:  Computational Investigations on the Addition of 
Allylsilanes to Aldehydes 
6.1. Reaction Mechanism. 
6.1.1.  BF3-Promoted Addition. 
Previous computational studies on the reaction mechanism of BF3-promoted addition of 
(E)-2-butenyltrimethylsilane to acetaldehyde (Scheme 31) have focused on simplified systems 
and did not probe the entire transformation from reactants to products. For example, side 
processes such as oxetane154 formation have not been accounted for and the desilylation step 
remains uninvestigated. Moreover, the experimentally documented formation of 
fluorotrimethylsilane at a temperature of -80 oC needs to be reconciled.155 More importantly, the 
potential influence of steps subsequent to carbon-carbon bond formation on the 
diastereoselectivity has not been considered in detail. 
Scheme 31. 
 
 
A potential energy diagram was mapped out for the BF3-promoted crotylation of 
acetaldehyde (Figure 25) to gain a better understanding of the reaction mechanism, particularly 
the fate of the intermediate after C-C bond formation. Initial complexation of BF3•OMe2 to 
acetaldehyde is thermodynamically unfavorable (∆G1→2a = 3.3 kcal/mol; ∆G1→2b = 4.7 kcal/mol) 
which is consistent with the stronger Lewis basicity of ethers relative to aldehydes156 and more 
than compensates for the partial charge delocalization from aldehyde complexation. Formation 
of the anti isomer 2a157 is more favorable than the corresponding syn isomer 2b (∆∆G = 1.4 
kcal/mol). This well-established thermodynamic preference158 together with the attendant, 
enhanced activation of the carbonyl group (evidenced by the greater LUMO lowering (~0.04 eV) 
of 2a compared to 2b, resulting from more effective complexation), suggests that the reaction is 
primarily proceeding through anti isomer, 2a. 
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Figure 25. Energy diagram illustrating reaction pathways investigated for the BF3•OMe2 
promoted crotylation of acetaldehyde. Relative energy values are represented as free energies G 
(kcal/mol) and are calculated at the CPCM(CH2Cl2)-M06-2X/6-311+G(2d,2p)//CPCM(CH2Cl2)-
M06-2X/6-31+G(d,p) level. Energies in brackets represent enthalpies H (kcal/mol). 
Thermodynamic quantities are determined at 195 K.   
 
Association of the aldehyde-BF3 complex 2a with (E)-2-butenyltrimethylsilane results in 
the formation of pre-transition state complex 3. A transition state connecting 2a to 3 was not 
investigated. The physical nature of complex 3 was probed through an energy decomposition 
analysis of the reactants (Figure 26). The primary intermolecular NBO donor-acceptor 
stabilization interaction is the πC=C → π*C=O and amounts to 9.3 kcal/mol. No other intermolecular 
NBO donor-acceptor interactions were found that are greater than 0.5 kcal/mol. The NBO charge 
transfer (∆q), which is likely exclusively associated with the πC=C → π*C=O interaction, amounts to 
0.06 e. The angle of approach of the aldehyde (110o) is close to that for optimal frontier orbital 
overlap (107o, Burgi-Dunitz approach).159 Complex 3 is sterically and electrostatically 
unfavorable, however, through orbital interactions and dispersion forces, an overall favorable 
electronic interaction energy results (∆Eint = −8.1 kcal/mol). A low level of distortion (∆Ed = 1.42 
kcal/mol) is necessary to form complex 3 from the isolated optimized reactants. Thus, orbital 
 interactions and dispersion forces more than compensate for the unfavorable electrostatic, steric, 
and distortion components of the overall energy. Complex
transfer / van der Waals complex since both favorable energetic components (
are nearly equal. However, the overall enthalpy of association (
kcal/mol) is not sufficient to offset
overall Gibbs free energy of association to be positive (
Similar pre-transition state complexes have been invoked in the structurally similar Mukaiyama 
aldol reaction in gas phase computational studies,
polarity in view of the smaller frontier orbi
crotylation examined in this study (
∆Ees ∆Este ∆Eorb 
2.9 26.5 -19.3 
Figure 26. Geometry of complex 
units of kcal/mol. a ∆E = ∆Eint + 
donor-acceptor stabilization energy.
 
Complex 3 next proceeds through transition state 
considerably endergonic step (∆
through at least six readily accessible pathways (
actually the lowest energy pathway with a barrier of only 
5 is necessary to proceed toward the observed pr
envisioned to effect this process. Intramolecular transfer of the silyl group to the fluorine atom 
with concomitant Si-F cleavage via an eight
and fluorotrimethylsilane directly is the highest energy pathway (
thus less likely to contribute. This finding is in contrast to previous computational studies 
 3 can best be described as a charge 
∆
∆H = ∆E + 
 the entropic penalty of −T∆S = 8.7 kcal/mol which causes the 
∆G = ∆E + ∆Hcorr − T∆S
160 but should also exist in solution of moderate 
tal energy difference in the reactants relative to 
εHOMO(silyl enol ether) > εHOMO(crotylsilane)).  
 
∆Edisp ∆Eint ∆Ed ∆E
a ∆Hcorr
b −T∆S π→π*c
-18.2 -8.1 1.4 -6.7 1.5 8.7 9.3 
3 and an energy decomposition analysis. Energy values are in 
∆Ed. 
 b Enthalpic correction including zero point energy. 
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suggesting direct fluorine to silicon transfer.155 Intramolecular transfer of the silyl group to the 
oxygen atom via a six-membered transition state 8‡ is a more favorable pathway (∆G‡5→8 = 4.0 
kcal/mol) but there are still accessible lower energy pathways. Alternatively, external 
nucleophiles can serve as desilylating agents in bimolecular steps. However, the only stable 
nucleophiles present in solution are the aldehyde reactant and the dimethyl ether that is 
decomplexed. Free fluoride ion is unlikely to be present in solution to effect desilylation. 
Desilylation carried out by dimethyl ether (∆G‡5→11 = 2.3 kcal/mol) or acetaldehyde (∆G
‡
5→9 = 
3.1 kcal/mol) provide lower energy alternatives to the intramolecular transfer via 7‡ and 8‡.    
Acetaldehyde and dimethyl ether serve to shuttle the silyl group to the oxygen via intermediate 
ion pairs 13 and 12 respectively to form highly stable product 14. Conversion of ion pairs 12 and 
13 to product 14 is expected to be near barrierless, and thus transition states were not 
investigated that lead to 14.  
The formation of fluorotrimethylsilane suggests the need for the conversion of product 14 
to product 15. Deprotection of silyl ethers with BF3 can be performed experimentally supporting 
the conversion of 14 to 15. Product 15 likely either dimerizes161 or coordinates with dimethyl 
ether to increase the thermodynamic preference.   
6.1.2.  Pathways Toward Active BF3 Consumption. 
Experimental evidence for the formation of fluorotrimethylsilane and the requirement for 
a stoichiometric amount of BF3•OEt2 for full conversion of the aldehyde, requires the 
consumption of product 13. The transfer of the BF3 group from 13 to 14 is more preferred 
(∆G13→14 = −1.1 kcal/mol) which is consistent with the stronger lewis basicity of dialkyl ethers 
relative to silyl thers.162Two pathways for consumption of product 13 have been considered and 
investigated here. The first involves progression via a 4-membered σ-bond metathesis transition 
state 15‡ to generate product 18. Similar transition states have been invoked in the deprotection 
of t-butyldimethylsilyl ethers with BF3•OEt2.
163 However, this is a high barrier process 
(∆G‡13→15 = 24.0 kcal/mol) and is only mildly exergonic (∆G13→15 = −0.9 kcal/mol). An 
alternative pathway involves first association of BF3 with one of the fluorine atoms on 13 to 
generate 16 which then can undergo fluorine transfer to the silicon group via a six membered 
transition state 17‡. This pathway is also high in energy (∆G13→16 = 15.8 kcal/mol and ∆G
‡
16→17 = 
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24.8 kcal/mol) and is not expected to occur at low temperatures. Decomposition through a 
bimolecular process may provide a lower energy pathway but was not investigated.  
There is not a strong thermodynamic driving force for the formation of 
fluorotrimethylsilane and product 18 (∆G13→18 = -0.9 and ∆G14→18 = 0.2 kcal/mol). The potential 
of the tricoordinate boron atom in 18 can be quenched by either dimerization to form 19 
(∆G18→19 = -0.2 kcal/mol) or coordination with dimethylether (∆G18→20 = -2.5 kcal/mol). 
Dimerization is highly enthalpically favorable (∆G18→19 = −11.0 kcal/mol) but a low driving 
force due to the high entropic cost (−T∆S18→19 = 10.8 kcal/mol). Hence, coordination with 
dimethylether is probably the most viable pathway for deactivation of any source of active BF3. 
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Figure 27. Energy diagram for consumption of active BF3. 
 
6.1.3.  Formation of Side Products. 
Experimentally, side products have been observed in this reaction that include 
oxetanes154, acetals164, tetrahydrofurans165 and tetrahydropyrans166 the formation of which are all 
highly dependent on the substrate and reaction conditions. Each of these side products contains 
the silyl group and thus their formation is favorable if desilylation is inhibited, usually achieved 
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by the use of sterically bulky silyl groups. Oxetane formation provides a low energy pathway 
from intermediate 5 via transition state 6‡ (∆G‡5→6 = 2.9 kcal/mol) to intermediate 10 which is 
considerably exergonic (∆G5→10 = −11.6 kcal/mol) and which is competitive with desilylation via 
8
‡, 9‡, and 11‡. Because the barrier to reversion (∆G‡10→6 = 14.5 kcal/mol) is similar to the barrier 
from uncomplexed acetaldehyde to intermediate 5 via 4‡ (∆G‡1→4=14.1 kcal/mol), oxetane 10 is 
expected to funnel to product 14 and eventually 15, as long as an energetically feasible pathway 
exists between 14 and 15.    
6.1.4.  Minimum Energy Pathway. 
The lowest energy pathway from the diagram in Figure 25 is reproduced in Scheme 32. 
After initial coordination of acetaldehyde to BF3 to generate complex 2a, crotylsilane associates 
to form pre-transition state complex 3. Complex 3 proceeds through the C-C bond forming 
transition state 4‡ to form intermediate 5. Although a number of pathways are accessible to 
intermediate 5, the lowest energy is desilylation promoted by dimethyl ether via transition state 
11
‡ to form intermediate ion pair 13 which quickly transfers the silyl group to the oxygen atom to 
form intermediate 14. The experimental requirement for stoichiometric quantities of BF3•OEt2 
suggests that intermediate 14 is converted to final product 15 through a mechanism that is 
beyond the scope of the present discussion.167    
Scheme 32. 
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6.1.5.  TiCl4-Promoted Addition. 
The broad energy landscape accessible to intermediate 5 equates to a complex 
dependence of the diastereoselectivity on the energies of multiple stationary points including 
transition state energies to C-C bond formation that lead to 5 and the transition state energies of 
desilylation. To address the impact of these factors on the diastereoselectivity of addition, a 
different Lewis acid was evaluated in the hope that the energy landscape would be more 
favorable (less likely to revert). 
Titanium (IV) tetrachloride is another commonly used Lewis acid for this reaction which 
furnishes higher diastereoselectivities than BF3•OEt2.
136k The TiCl4-mediated crotylation 
reaction was also modeled to understand the origins of the higher diastereoselectivity with TiCl4 
relative to BF3•OEt2.  
 Titanium (IV) chloride carbonyl complexes can exist in various titanium/carbonyl 
stoichiometries including 1:1, 1:2, 2:1, and 2:2.168 The 1:1 complex is chosen for this study on 
the basis of likely greater reactivity as well as computational efficiency. The TiCl4 promoted 
pathway begins with an exergonic (∆G‡16→17 = −2.5 kcal/mol) association with acetaldehyde 
which translates to a near stoichiometric complexation consistent with experimental 
observation168 (Figure 28). The effective concentration of the activated aldehyde is thus greater 
in the TiCl4 pathway compared to the BF3•OEt2 pathway. However, the barrier to C-C bond 
formation (∆G‡17→19 = 11.8 kcal/mol) is not much different than that for the BF3•OEt2 pathway 
(∆G‡2a→4 = 10.8 kcal/mol). This difference is seemingly contradictory with the lower LUMO of 
the activated aldehyde•TiCl4 complex 17 (−3.46 eV) compared with the aldehyde•BF3 complex 
2a (−2.54 eV) (Figure 29). However, the LUMO of aldehyde•TiCl4 complex 17 is considerably 
more delocalized through mixing of the π*C=O with an empty d orbital on the titanium metal 
center. Additionally, the NBO and electrostatic potential fitted charges on the carbon atom of the 
aldehyde are both more positive for the aldehyde•BF3 complex (q(C)NBO = 0.587, q(C)ESP = 
0.601) compared to the aldehyde•TiCl4 complex (q(C)NBO = 0.560, q(C)ESP = 0.539).     
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Figure 28. Energy diagram illustrating reaction pathways investigated for the 
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It is important to note that the barrier to reversion is significantly greater in the TiCl
promoted pathway (∆G‡20→19 = 5.6 kcal/mol) compared to the BF
kcal/mol, Figure 25). Moreover, the ground state energy difference is less unfavorable for TiCl
(∆G17→20 = 6.2 kcal/mol) than for BF
(∆∆G‡ = 3.8 kcal/mol) may have important consequences for diastere
desilylation of intermediate 20 
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desilylation of 5 since the lability of the silyl group is unlikely to be dependent on the group 
bound to the oxygen atom. Intermediate 20 is likely to be consumed by chloride-promoted 
desilylation.169 Even though the BF3-promoted pathway may be complicated by reversibility, the 
critical, stereodetermining C-C bond forming step was investigated more thoroughly with respect 
to the topological approach of the activated aldehyde as a model for systems that do not exhibit 
potential reversibility such as was found for TiCl4. 
 
6.2.  Computational Investigation on the Selectivity of Model Systems. 
Model system B (Scheme 30) and a simplified intermolecular system were modeled using 
density functional theory for purposes of comparison and to judge whether or not the 
intramolecular case introduces unwanted bias for the synclinal conformation (Scheme 33).170 It 
was judged that if the calculated energy difference between the synclinal and antiperiplanar 
transition states for the intramolecular and intermolecular cases were similar to each other as 
well as to the experimental values, model system 5 would indeed be suggested to intrinsically 
reflect the synclinal preference in the transition state. 
Scheme 33. 
 
Initially moldel system B (Scheme 30) was computed in which CF3SO3H was substituted 
with H3O
+. The preferred transition state is predicted to proceed through the synclinal 
conformation (TS-a, ∆G‡=2.1 kcal/mol) in qualitative agreement with the experimental results 
(∆G‡=1.14 kcal/mol). The electronic energy difference in the intermolecular analogue (TS-b, 
∆E‡=1.1 kcal/mol) qualitatively compares well to the calculated electronic intramolecular case 
(TS-a, ∆E‡=1.9 kcal/mol). This agreement suggests that the intramolecular case reflects the 
electronic preference for the synclinal orientation in the intermolecular case satisfactorily. The 
internal nuclear coordinates of the relevant atoms are also similar. The distance of the forming 
 bond is smaller by ~0.2 Å likely reflecti
transition state.  
Figure 30. Relative free energies (kcal/mol) at 195 K and electronic energies in parentheses; 
structures TS-a are relative to TS
distances are labeled in Å; CPCM
 
Perhaps, a more relevant comparison can be made with 
system of the allylsilane approaching th
differential steric interactions would be minimal. There does appear to be much better agreement 
to the predicted free energy difference in this case (
counter argument for this being a relevant comparison is that the arrangement allows for 
secondary orbital overlap which may control the synclinal preference. To address this counter 
argument, previous work from the authors empl
in TS-c was retained (Model system A, Scheme 30
if stabilizing, afforded the same degree of synclinal preference as model system 
kcal/mol), in which the secondary orbital overlap of consideration is geometrically unavailable. 
These results clearly suggest that secondary orbital overlap can only be at most a minor 
contributor to the selectivity.  
ng minor intramolecular constraints rather than an earlier 
-a2; structures TS-b and TS-c are relative to 
-M06-2X/6-311++G(2d,2p)//M06-2X/6-31+G(d,p). 
TS-c in which the face of the 
e aldehyde is switched (Figure 25). The presence of 
TS-c, ∆G‡=2.4 kcal/mol).  However, a 
oying a model system in which the constitution 
), leaving secondary orbital overlap available 
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While the difference between the predicted and experimental selectivity in 5 may be 
considered significant (0.96 kcal/mol), the correctly predicted conformation as well as the 
excellent agreement between the predicted selectivity in 5 and TS-c supports a lack of bias in the 
probing interactions of 5. Additionally, the fact that TS-c2 is predicted to be the lowest energy 
transition state by 1.5 kcal/mol provides further support for the relevance of comparing TS-c to 
5. Collectively, this investigation suggests that the selectivity in 5 is reflective of the intrinsically 
preferred synclinal preference in the transition state.            
 
6.3.  Stereodetermining Transition States for Addition of (E)-2-Butenyltrimethylsilane to 
Acetaldehyde. 
6.3.1.  BF3-Promoted Pathway. 
All six transition state structures for the BF3-promoted crotylation of acetaldehyde were 
located and are provided in Figure 31. For the synclinal conformations, all bonds are arranged 
with roughly staggered orientations. The anti conformations are perturbed slightly from the 
idealized 180o dihedral angle for staggered orientations displaying dihedral angles of 173o and 
176o. The distances between the carbon atoms undergoing bond formation are very similar (1.97 
± 0.02 Å). The predicted energies reveal a preference for the transition states leading to the syn 
diastereomer, particularly through transition state syn-T3-L171 that possesses a synclinal 
arrangement of double bonds. The two antiperiplanar transition states (syn-T1-L and anti-T1-
L), which are commonly invoked as providing lower energy channels because of minimized 
steric interactions,136f possess the highest energies of the six structures. These relative energy 
values suggest that steric interactions may not be important contributors to the overall 
diastereoselectivity compared to other energetic components.    
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∆G‡ [∆H‡]a d b θ c ϕ d 
syn-T1-L 4.2 [4.7] 1.99 101.7 187.2 
syn-T2-L
 0.8 [0.9] 1.96 108.7 273.2 
syn-T3-L
 0.0 [0.0] 1.95 110.9 66.9 
anti-T1-L
 2.0 [2.1] 1.96 102.1 184.5 
anti-T2-L 3.0 [3.1] 1.96 112.1 296.9 
anti-T3-L 1.0 [1.8] 2.00 113.3 42.6 
Figure 31. Six transition states for BF3-promoted crotylation. 
a
 Relative transition state energies 
(∆G‡ and ∆H‡) in kcal/mol. b C(1)-C(2) bond distance (Å). c Approach angle (deg). d Dihedral 
angle (deg). 
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6.3.2.  Brønsted Acid Promoted Pathway. 
The crotylsilane addition through Brønsted acid activation was also investigated. This 
mode effectively removes any steric influence that the Lewis acid may impart. A single water 
molecule was used to attenuate its level of activation as relaxed coordinate scans in the absence 
of a water molecule suggest a barrierless bond formation. The location of the proton in the 
activated carbonyl group presents some ambiguity, however its position has little influence on 
the energies of either the reactants or the transition states.172 To be geometrically consistent with 
other Lewis acids, the proton is situated synperiplanar to the aldehydic hydrogen.173   
 Some of the transition states deviate from idealized staggered conformations (Figure 32). 
Antiperiplanar transition state syn-T1-H adopts a 170o dihedral angle, likely in an effort to 
relieve unfavorable interaction between the methyl group of the aldehyde and the TMS-CH2 
group. Whereas all the synclinal transition states for the BF3-mediated allylation exhibit a 
smaller dihedral angle in which the oxygen atom is positioned close to the partially positively 
charged carbon atom of the crotylsilane, all of the synclinal conformations for the proton-
mediated pathway deviate from this orientation by maximizing the distance between the 
protonated oxygen and carbon atom C(1) gaining the positive charge. This preference likely 
results from electrostatic repulsion considering the fact that anti-T3-H positions the two methyl 
groups in a near eclipsed conformation to provide sufficient distance between the partially 
positively charged atoms. The electrostatic gain in energy by avoiding repulsion more than 
compensates for the loss in energy from unfavorable steric interactions.  
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∆G‡ [∆H‡] d θ  ϕ  
syn-T1-H 3.0 [3.0] 2.16 98.4 189.9 
syn-T2-H
 1.7 [1.6] 2.08 104.9 256.0 
syn-T3-H
 0.0 [0.0] 2.24 106.9 76.9 
anti-T1-H
 2.8 [2.2] 2.13 98.7 175.8 
anti-T2-H 1.8 [1.6] 2.16 107.5 281.9 
anti-T3-H 3.1 [2.6] 2.13 103.1 92.8 
Figure 32. Six transition states for Brønsted acid-promoted crotylation. See Figure 31 for legend. 
6.3.3.  Fluoride-Promoted Pathway. 
The fluoride-promoted pathway was next investigated to identify how a different mode of 
activation (nucleophilic as opposed to electrophilic) influences the topology of the approach. 
This investigation is intended to embody characteristics of the Brønsted acid activated pathway 
because of the lack of a bulky group bound to the aldehyde oxygen atom but representing 
opposing electronic activation modes.     
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 The fluoride-promoted pathway illustrates interesting contrasts with the BF3 and 
Brønsted acid-promoted pathways (Figure 33). Both antiperiplanar transition states are lower in 
energy than all four synclinal transition states, in contradistinction to the Lewis acid containing 
transition states. As was seen in the Lewis acid promoted reactions, anti-T1-F is the lower 
energy of the two antiperiplanar transition states. Generally the dihedral angles more closely 
resemble those of the BF3 bound transition states. Structure syn-T3-F is the lowest energy 
synclinal transition state as was also observed for both Lewis acid bound transition states. 
 
∆G‡ [∆H‡] d  θ  ϕ  
syn-T1-F 1.1 [0.9] 2.30 105.6 206.1 
syn-T2-F
 2.4 [2.3] 2.28 108.6 265.6 
syn-T3-F
 1.4 [1.4] 2.22 109.4 68.5 
anti-T1-F
 0.0 [0.0] 2.23 105.0 175.0 
anti-T2-F 2.5 [2.3] 2.22 110.2 284.9 
anti-T3-F 4.0 [3.7] 2.30 113.2 27.5 
Figure 33. Six transition states for F- promoted crotylation. See Figure 31 for legend. 
116 
 
To summarize this section, the activation energies reveal that the electrophilically-
activated pathways show a preference for the formation of the syn diastereomer specifically 
through the syn-T3 transition state. The formation of the competing anti diastereomer takes place 
via anti-T2-L and anti-T1-H. In comparison, the nucleophilically-activated pathway exhibits a 
preference for formation of the anti diastereomer via the antiperiplanar anti-T1-F transition 
state. These results are in accord with experimental findings.136k The factors that influence the 
reactivity differences in each pathway as well as the divergence in diastereoselectivity between 
the electrophilically and nucleophilically activated pathways will be addressed using energy 
decomposition analysis in the following sections. 
6.4.  Energy Decomposition Analysis (EDA) of Transition States. 
The interaction energies between the aldehyde and allylsilane partners for all transition 
states were decomposed to reveal the relative contributions of the individual components of the 
interaction energy as well as the distortion energy to the total energy ∆E‡. For completeness, the 
energies of distortion of each reactant are also included in the analysis. With the inclusion of 
reactant distortion energies, the total electronic activation barrier ∆E‡ can be expressed as ∆E‡ = 
∆Eint
‡
 + ∆Ed
‡(A) + ∆Ed
‡(B).174  
 The transition states for the BF3-promoted reaction are the latest along the reaction 
coordinate as well as being the most endergonic, hence a greater degree of distortion is necessary 
to achieve suitable levels of interaction as is observed (Table 21). The lowest energy transition 
state syn-T3-L does possess the second highest interaction energy behind syn-T2-L as well as 
the lowest energy of distortion of the crotylsilane component ∆Ed(B). Transition state anti-T1-L, 
however, has the next lowest energy required to distort the crotylsilane component ∆Ed(B). The 
antiperiplanar transition states syn-T1-L and anti-T1-L have the lowest steric contribution ∆Este
‡ 
which is the traditional rationale for its status as the preferred transition state.136f Although syn-
T1-L is sterically the most preferred transition state, it suffers from a relatively low preference in 
terms of orbital ∆Eorb
‡ and electrostatic interactions ∆Ees
‡. Overall, the energetic preference for 
transition state syn-T3-L, can be attributed to a combination of favorable electrostatic 
interactions, orbital interactions, and a low energy of distortion of the allylsilane component.  
The energy breakdown in the Brønsted acid mediated pathway is similar to the BF3-
mediated pathway. A marked distinction is the earlier nature of the lowest energy transition state 
117 
 
syn-3-H (d = 2.24 Å) which is the lowest energy transition state. Counterintuitively, syn-T3-H 
also possesses the most unfavorable interaction energy. For every component of the interaction 
energy, excluding a substantially favorable steric component (∆Este
‡), syn-T3-H exhibits the 
weakest interaction. The smaller favorable energies in syn-T3-H are compensated for by highly 
favorable distortion energies for both the aldehyde and allylsilane components.   
 The fluoride-promoted pathway generally has high reaction barriers, but the reaction is 
concerted, after pre-equilibrium formation of a pentacoordinated fluorosilicate. The lowest 
energy transition states are antiperiplanar (syn-T1-F and anti-T1-F) with anti-T1-F being 
slightly lower (0.9 kcal/mol). Analysis of the energetic contributions of this pathway is complex 
because all components of the interaction energy influence ∆E‡ to a similar extent. However, the 
antiperiplanar transition states do appear to benefit from decreased steric (∆Este
‡) and favorable 
electrostatic (∆Ees
‡) interactions whereas the synclinal transition states syn-T3-F and anti-T2-F 
exhibit the strongest orbital interactions (∆Eorb
‡). The electrostatic preference for antiperiplanar 
TS’s contrasts the electrophilically activated pathways in which the synclinal transition states are 
electrostatically preferred. The role of distortion energy is not as significant in the fluoride 
promoted pathway. 
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Table 21. Energy decomposition analysis of reactants in transition states for all three modes of 
activation. 
TS ∆Ees
‡
 ∆Este
‡ ∆Eorb
‡ ∆Edisp
‡ ∆Ed
‡(A)a ∆Ed
‡(B)b ∆Eint
‡ ∆E‡c 
syn-T1-L
d -34.2 120.5 -84.6 -29.6 21.8 10.2 -27.9 4.1 
syn-T2-L -44.5 143.7 -98.2 -33.2 24.0 8.0 -32.2 -0.2 
syn-T3-L -42.0 137.8 -96.5 -30.8 23.1 7.5 -31.5 -0.9 
anti-T1-L -38.6 128.3 -90.1 -28.7 22.4 7.8 -29.1 1.1 
anti-T2-L -42.9 139.7 -96 -31.3 23.9 9.1 -30.5 2.4 
anti-T3-L -33.3 122.9 -86.4 -31.3 21.4 8.3 -28.1 1.6 
syn-T1-H
e 11.5 84 -91.9 -25.0 14.0 5.5 -21.4 -1.9 
syn-T2-H  -4.21 120.1 -117.7 -27.7 21.5 4.0 -29.5 -4.0 
syn-T3-H 15.5 77.2 -86.4 -24.0 10.3 2.3 -17.7 -5.0 
anti-T1-H 9.7 89.9 -96.7 -24.9 14.3 4.1 -22.0 -3.6 
anti-T2-H 7.2 94.5 -97.6 -26.9 14.7 4.3 -22.7 -3.7 
anti-T3-H 0.9 107.0 -106.7 -28.0 19.0 4.8 -26.8 -3.0 
syn-T1-F
f 5.8 74.8 -71.7 -20.5 6.5 10.0 -11.6 4.9 
syn-T2-F 4.9 78.3 -74.2 -19.9 7.2 9.9 -10.9 6.2 
syn-T3-F 7.9 83.9 -81.3 -21.7 7.5 9.0 -11.2 5.2 
anti-T1-F 3.6 80.3 -74.6 -21.6 7.2 9.0 -12.2 4.0 
anti-T2-F 2.1 86.9 -78.3 -21.4 7.9 9.4 -10.7 6.6 
anti-T3-F 13.5 72.8 -76.7 -19.5 6.8 10.4 -9.9 7.2 
All energies are in units of kcal/mol a Distortion energy of aldehyde component b Distortion 
energy of crotylsilane component c ∆E‡ = ∆Ed
‡ (A) + ∆Ed
‡ (B) + ∆Eint
‡
 
d BF3-promoted 
pathway e Bronsted acid promoted pathway f Fluoride-promoted pathway 
 
In summary, for the BF3-promoted pathway, the antiperiplanar transition states are 
preferred sterically whereas the synclinal transition states are preferred through electrostatic and 
orbital interactions. The combination of these factors renders syn-T3-L the energetically 
preferred transition state overall. The Brønsted acid promoted pathway is complicated by 
significant variation in distortion energy. For the fluoride-promoted pathway antiperiplanar 
transition states are preferred overall because of favorable steric and electrostatic (contrary to the 
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BF3-promoted pathway) interactions while favoring the synclinal transition states through orbital 
interactions. 
6.4.1.  Rationalization of Diastereoselectivity. 
To a first approximation, the overall diastereoselectivity can be rationalized by the 
difference between the lowest energy transition state leading the syn diastereomer and the lowest 
energy transition state leading to the anti diastereomer (Table 21). Each bar in the graphs in 
Figure 34 represents the difference for the indicated component of the overall energy (∆E‡) 
between the lowest energy syn transition state versus the lowest energy anti transition state 
(∆∆Ex < 0 reflects a preference for the syn transition state for energy component x while ∆∆Ex > 
0 reflects an anti preference).  
The transition states for the BF3-promoted process exhibit a small difference in distortion 
energy (∆Ed
‡) reflecting similar extents of bond formation at the transition state. Although 
sterically unfavorable, transition state syn-T3-L benefits from considerably favorable 
electrostatic and orbital interactions. The diastereoselectivity for the BF3-promoted process is 
thus largely attributed to favorable electrostatic ∆Ees and orbital ∆Eorb terms for syn-T3-L.  
For the Brønsted acid promoted pathway, the lowest energy transition state is particularly 
early (dC(1)-C(2) = 2.24 Å) compared to all other transition states for this pathway (Figure 32). The 
early nature is reflected in a smaller ∆Ed. The low energy of distortion and steric interactions for 
syn-T3-H account for the diastereoselectivity observed in the Brønsted acid promoted pathway. 
The origin of the favorable distortion level for syn-T3-H is the subject of a forthcoming section.    
The diastereoselectivity in the fluoride-promoted reaction is largely accounted for by the 
difference in the energies of the antiperiplanar transition states. The greatest energetic 
contributor to the transition state energy difference is steric interactions (∆Este) in preference for 
transition state syn-T1-F. However the combination of favorable electrostatic (∆Ees), orbital 
(∆Eorb), and dispersion (∆Edisp) terms results in the overall energetic preference for anti-T1-F.      
 Figure 34. Differences in components of interaction energy betw
transition states in each activation mode in kcal/mol
(electrostatic), ste (steric), orb (orbital), disp (dispersion), d (distortion), int (interaction).
 
The variation in distortion has a significant impact on the energies of competing 
transition state conformations and consequentially the diastereoselectivity. Decomposition of the 
interaction energy alone is not sufficient for a complete understanding of t
Uncovering the origin of the variation in the distortion energies would provide a more complete 
rationalization of the observed diastereoselectivities and is the focus of the following sections. 
6.5.  Origin of Variation in Distortion.
The appearance of reaction barriers depends on a balance between both
The amount of energy necessary to distort the nuclei in the transition state is dependent on how 
much energy from interaction is gained from this distortion. Once the point at whic
infinitesimal gain in interaction energy is balanced by an infinitesimal loss in the energy from 
distortion, the downward slope of the transition state is initiated. With these considerations in 
mind, points along respective reaction coordinates (
compared with respect to ∆Eint and its components. As long as the change in energy from 
∆E(ξ) is small, this comparison is possible. The comparison of the 
(∆Eint,d) among multiple transition states is an option when a linear relationship exists between 
∆Eint,d and ∆E
‡. This allows the investigation of the components of the interaction energy close to 
the transition state that best account for the variation in 
een two lowest energy different 
: (a) BF3, (b) H
+, (c) F
 
∆E(ξ)) at constant levels of distortion may be 
∆Eint at constant distortion 
∆Ed(ξ). 
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 For each transition state, an EDA was performed on selected points along the reaction 
coordinate. Each component of the energy was plotted as a function of ∆Ed(ξ) and fitted to a 
parabolic curve. The energies were interpolated on the basis of a parabolic fit (all fits contained ≥ 
5 points with R2>0.99, see Supporting Information). The optimal ∆Ed(ξ) was chosen based on 
the correlation between ∆E‡ and ∆Eint,d(ξ)+∆Ed(ξ) for all of the pathways. The interaction energy 
components at the interpolated transition states are listed in Table 22. 
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Table 22. Energetic Components at Constant Levels of Distortion.a, b, c 
TS ∆Ees,d
‡
 ∆Este,d
‡ ∆Eorb,d
‡ ∆Edisp,d
‡ ∆Eint,d
‡ 
syn-T1-L
a -35.3 123.2 -87.1 -29.5 -28.9 
syn-T2-L -45.7 146.7 -101.0 -33.4 -33.2 
syn-T3-L -44.4 144.1 -102.4 -31.1 -33.9 
anti-T1-L -41.6 135.8 -97.0 -29.1 -31.8 
anti-T2-L -43.1 140.1 -96.2 -31.4 -30.6 
anti-T3-L -36.7 131.3 -94.1 -31.8 -31.3 
syn-T1-H
b 13.5 79.4 -87.9 -24.6 -19.6 
syn-T2-H  7.0 94.7 -97.8 -25.9 -21.9 
syn-T3-H 8.0 94.2 -99.3 -25.6 -22.7 
anti-T1-H 10.6 87.9 -95.0 -24.8 -21.3 
anti-T2-H 8.9 90.9 -94.5 -26.6 -21.4 
anti-T3-H 9.7 87.6 -91.7 -26.4 -20.8 
syn-T1-F
c 2.9 80.0 -75.1 -20.8 -13.1 
syn-T2-F 2.8 81.9 -76.4 -20.2 -11.8 
syn-T3-F 4.9 89.2 -85.0 -22.0 -12.9 
anti-T1-F 0.4 86.1 -78.6 -21.9 -14.0 
anti-T2-F 0.5 89.6 -80.1 -21.5 -11.5 
anti-T3-F 12.4 73.6 -77.0 -19.6 -10.6 
a Values for BF3 pathway are interpolated at ∆Ed(ξ) = 33.0 
kcal/mol. b Values for Brønsted acid pathway are interpolated 
at ∆Ed(ξ) = 17.7 kcal/mol. 
c Values for fluoride pathway are 
interpolated at ∆Ed(ξ) = 18.1 kcal/mol.  
 
A linear relationship is expected between ∆E‡ and ∆Eint,d(ξ)+∆Ed(ξ) if the change in 
energy from distortion at small variations in ξ near the transition state is approximately equal to 
the energy gained by interaction (dEint/dξ ≈ −dEd/dξ) for all transition states (low curvature at the 
transition state). All three pathways exhibit ∆Ed(ξ) values in the range of the distortion levels at 
the transition states ∆Ed
‡ for their respective reactions (Figure 35). The strong linear trends 
 validate the comparison of the components of the interaction energy (
constant levels of distortion.  
Figure 35. Plots of ∆E‡ versus ∆
with ∆Ed(ξ)=17.7; R
2=0.996 (c) F
 
Conceptually different conclusions can be inferred
distortion compared to variable distortion when the conversion of energy between distortion and 
interaction is not equal via all pathways (Figure 36
components for the lowest energy transition states leading to the syn and anti diastereomers at 
constant distortion are compared to those at 
left bar, labeled with a d, corresponds to the difference in the energy at th
Table 22 while the right bar correspon
the difference in the distortion energy at the transition states is only 0.4 kcal/mol favoring 
T1-L ([∆Ed
‡(A) + ∆Ed
‡(B)]anti-T1
distortion energy is distributed among the different interaction energies and results in only a 
small lowering in each of the energy components for 
 The difference in distortion for the Brønsted acid mediated pathway between the 
synclinal transition state pathways 
kcal/mol (Table 21 and Figure 
distortion leads to a very different interaction energy landscape at constant distortion than at the 
distortion level of the transition state (Figure 
favor syn-T3-H at the transition state are 
∆Eint) at the corresponding 
E(ξ)int,d. (a) BF3 with ∆Ed(ξ) = 33.0 kcal/mol; R
- with ∆Ed(ξ)=18.1; R
2=0.998. 
 from the interaction at constant 
). The differences in the interaction energy 
variable distortion in Figure 36 (for each 
e distortion l
ds to the energies from Table 21). For the BF
-L – [∆Ed
‡(A) + ∆Ed
‡(B)]syn-T3-L
 = 0.4 kcal/mol
syn-T3-L compared to anti
syn-T3-H and anti-T2-H is significant at 
34) favoring the syn-T3-H pathway. This large differen
36b). Whereas, the only energy components that 
∆Este and ∆Ed (6.4 kcal/mol, Figure 34b
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2=0.9999 (b) H+ 
∆∆Ex, the 
evel from 
3 pathways, 
anti-
, Table 21). This 
-T1-L.  
a value of 6.4 
ce in 
), all of the 
 energy components favor syn-T3
origin of the large distortion energy difference favoring 
accounted for mostly by a large favorable orbital term 
for the fluoride mediated pathway at the transition states between 
only 0.3 kcal/mol and hence only a small difference in the interaction energy components 
Figure 36. Left bar of for each colored pair (labeled with a 
to ∆∆Ex at distortion energy from Figure 9
BF3, (b) H
+, (c) F–. 
 
To summarize, the activation energy is readily correlated with the interaction energy at 
constant levels of distortion. A necessary condition is that 
the transition states that are being compared. The rationalizations 
the BF3- and fluoride-promoted reactions do not change very much because the difference in 
distortion energy between the lowest energy transition states leading to each diastereomer is 
small.  
However, this situation is not 
the difference in distortion energy between the lowest energy transition states leading to each 
diastereomer is significant and different conclusions can be reached. The analysis shows that the 
origin of the large difference in distortion of the nuclei in the Brønsted acid promoted pathway 
can be mostly attributed to a more favorable change in the orbital interaction energy (
which is a distinctly different conclusion than would otherwise be d
at the transition states (Table 21). 
-H at constant distortion except for ∆Este and 
syn-T3-H at the transition state is 
∆Eorb. The difference in distortion energy 
syn-T1-F and 
d for constant distortion)
 while right bar corresponds to ∆∆Ex from Figure 8; 
dEint/dξ ≈ −dEd/dξ in the vicinity of 
for the diastereoselectivity in 
the case for the Brønsted acid promoted reaction in which 
rawn from the energy values 
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∆Edisp. Thus, the 
anti-T1-F is 
results. 
 
 corresponds 
(a) 
∆Eorb), 
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The origin of the enhanced orbital interactions favoring syn-T3 for all activation manifolds 
remains unclear at this point.175 A frontier orbital energy analysis can be used to dissect the 
orbital interactions into contributions from orbital overlap and frontier orbital energy differences 
in the reacting components, which is the focus of the following sections 
6.6.  Orbital Energy Analysis. 
6.6.1. Rationalizing Synclinal Selectivity. 
The foregoing analysis revealed that: (1) in the electrophilic activation manifolds, the 
preference for syn-T3-L and syn-3T-H pathways is attributed to increased orbital interactions 
and to a lesser extent, electrostatic interactions and (2) in the nucleophilic activation manifold, 
the preference for antiperiplanar anti-T1-F is attributed to decreased steric and electrostatic 
repulsion. Nevertheless, the most favorable transition state leading to a syn product, syn-T3-F, 
possesses greater orbital interactions. Thus, the three most favorable synclinal transition states 
(T3) are characterized by greater orbital interactions. The origin of this increased orbital 
interaction term for those synclinal transition states is next elucidated by a frontier orbital energy 
analysis. 
 The figure (a) in Table 23 depicts the orbital energy diagram for the BF3-promoted and 
Brønsted acid-promoted pathways and figure (b) depicts the fluoride-promoted pathway. The 
HOMO for the undistorted crotylsilane is shown on the far left and the LUMO of the undistorted 
aldehyde component is shown on the far right in both figures. The nuclei are then allowed to 
distort to the transition state geometries and the energies of the resulting distorted orbitals are 
then determined. The resulting distorted orbitals are allowed to mix causing the orbital splitting 
in the transition states which is shown in the center of the diagrams, corresponding to HOMO‡ 
and LUMO‡.     
 Table 23. Orbital Energy Differences (
syn-T1 
∆L
‡
 1.39 
∆L 4.18 
∆qL 0.473 
∆H
‡
 1.59 
∆H 4.08 
∆qH 0.363 
∆F
‡
 0.64 
∆F 3.81 
∆qF 0.316 
a Frontier orbital energy difference of distorted reactants (eV)                
b  Difference in energy between HOMO of the distorted reactant and                                             
the HOMO of the transition state (eV). 
from NBO charges 
Under second order perturbation theory
relative to the HOMO of the crotylsilane component (
LUMO gap (∆x) of the reactants, the resonance energy associated with the overlap region, and 
the exchange-corrected Coulombic
in the transition state from the crotylsilane to the activated aldehyde component
23. The charge transfer includes effects from both resonance energy from orbital overlap and 
 In comparing synclinal transition state 
T1-L the orbital energy differences 
equivalence means that the distortion of the reactants leads to equivalent frontier orbital energy 
∆x
a and ∆x
‡b) and Charge Transfer (∆qx
c). 
syn-T2 syn-T3 anti-T1 anti-T2 anti-
1.50 1.60 1.54 1.47 1.50
4.18 4.07 4.07 4.18 4.19
0.528 0.541 0.522 0.526 0.525
1.72 1.75 1.67 1.66 1.63
4.00 4.02 4.02 4.08 4.08
0.395 0.406 0.389 0.393 0.373
0.60 0.69 0.71 0.53 0.64
3.81 3.85 3.79 3.98 3.80
0.315 0.330 0.318 0.326 0.293
c charge transfer determine
 
176, the amount that the HOMO‡ energy is lowered 
∆x
‡) is dependent on both the HOMO
 repulsion contributions. The amount of charge transfer 
 
syn-T3-L to antiperiplanar transition state 
∆L are equivalent (∆L(syn-T3) = ∆L(anti-T1)
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T3 
 
 
 
 
 
 
 
 
 
d   
-
(∆qx) 
is listed in Table 
∆x. 
anti-
, Table 23). This 
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separation. However, the charge transfer is greater for syn-T3-L (∆qL = 0.541) than for anti-T1-
L (∆qL = 0.522). This greater charge transfer is confluent with the lowering of the HOMO
‡ for 
syn-T3-L (∆L
‡ = 1.60 eV) compared to anti-T1-L (∆L
‡ = 1.54 eV). Thus, the preference for the 
syn-T3-L transition state arises from greater charge transfer which is in turn due to greater 
orbital overlap rather than a narrowing of the frontier orbital energy gap of the distorted 
reactants.177  
 Within the Brønsted acid-promoted manifold, the lowest energy transition states leading 
to the anti diastereomer are similar (∆E‡(anti-T1-H) = -3.6 kcal/mol ; ∆E‡(anti-T2-H) = -3.7 
kcal/mol, Table 1). Thus it is necessary to compare both of these transition states to the lowest 
energy transition state leading to the syn diastereomer (syn-T3-H) to gain a more complete 
understanding of the diastereoselectivity. Both syn-T3-H and anti-T1-H possess the same 
orbital energy gap ∆H and similar differences in ∆∆qH (0.017 e), ∆∆H
‡
 (0.08 eV), and ∆∆Eorb (-4.3 
kcal/mol) as compared to the BF3-promoted manifold. Thus, roughly half of the 
diastereoselectivity is controlled by greater charge transfer from orbital overlap rather than from 
FMO energy differences for syn-T3-H and anti-T1-H. For comparison of syn-T3-H to anti-T2-
H, all three descriptors in Table 3 (∆∆qH = 0.013 e, ∆∆H = -0.06, ∆∆H
‡
 = 0.09 eV) favor syn-T3-
H. Thus, the remaining contribution to the diastereoselectivity arises from the orbital preference 
for syn-T3-H over anti-T2-H which may be derived from orbital overlap or decreased orbital 
energy difference (∆H). 
 Under fluoride activation, the energetically preferred pathways are both antiperiplanar, 
syn-T1-F and anti-T1-F with a slight preference for anti-T1-F (∆∆E‡ = 0.9 kcal/mol, Table 1). 
Pathway anti-T1-F has a slightly smaller ∆F (∆∆F = −0.02 eV), slightly larger charge transfer ∆qF 
(∆∆qF = 0.002 e), and a larger ∆F
‡ (∆F
‡ = 0.07 eV) which all contribute to an overall preference 
for anti-T1-F. Although syn-T3-F is less favorable than both antiperiplanar transition states, it 
still has the greatest overall charge transfer (∆qF = 0.330 e) illustrating its superior overlap 
energy. Thus, the primary contributors to the diastereoselectivity in the fluoride-promoted 
pathway are: (1) the steric and electrostatic repulsions that disfavor all four synclinal transition 
states and (2) the enhanced orbital interactions in anti-T1-F compared to syn-T1-F that favor 
formation of the anti diastereomer. 
  Although enhanced orbital interactions accompany all three (
T3), the reasons for this preferred arrangement are not certain
identified: (1) greater intrinsic overlap in the primary interacting orbitals or (2) in
of orbitals not engaged in primary interaction (secondary or
1986, Ahn and Thanh suggested that secondary orbital overlap could be responsible for the 
preferred synclinal arrangement of double bonds in the aldol addition reaction.
following section, the importance of this
6.7.  Do Secondary Orbital Interactions Contribute to the Preference for syn
Secondary orbital interactions (SOIs) are characterized by in
between atoms not directly involved in bonding in the HOMO of t
of the syn-3T transition states for each reaction type qualitatively suggests a region of in
overlap between the oxygen atom of the aldehyde and the methylene grou
(Figure 37). If this overlap is suf
charge transfer and/or a larger 
interaction. 
Figure 37. HOMO of transition states (HOMO
isodensity = 0.03 au. 
 
The approximate contribution from SOIs can be teased out by making relevant transition 
state comparisons as illustrated in Figure 38
and their determinations are shown at the bottom of Figure 38
–)-synclinal pathways (
. Two possible contributors can be 
bital overlap). In fact, as early as 
 contribution is investigated.   
-phase orbital overlap 
he transition state. The HOMO 
p of the crotylsilane 
ficiently energetically stabilizing, one might expect enhanced 
∆L
‡ compared to transition states that do not possess this 
 
‡) for syn-3T-L, syn-3T-H, and syn
. The quantities that may gauge SOI contributions 
 (∆qSOI, ∆‡,SOI
128 
syn-
-phase overlap 
178 In the 
-T3? 
-phase 
-3T-F with 
, ∆Eorb
SOI, and 
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∆Eint
SOI).179 The difference in energy between syn-T3 and anti-T2 could furnish the contribution 
from SOIs because they are both synclinal transition states and the former contains overlap 
between the aldehyde oxygen and the silylmethylene whereas the latter does not. However, they 
also experience different contributions to the four parameters alluded to above because of 
different steric interactions. These different contributions are: (a) the gauche relationship of the 
methyl groups in syn-T3 and (b) the gauche relationship of the methyl group and the Lewis acid 
in anti-T2 and (c) the steric interaction between the methyl and silylmethylene groups in anti-
T2. To adumbrate the existence of SOIs, the contributions that these parameters make can be 
factored out by: (1) subtracting the contributions that they make to anti-T1 from the 
contributions they make to synT-3 to account for interaction (a) above, (2) subtracting the 
contributions that they make to syn-T1 from the contributions they make to anti-T2 to account 
for interactions (b) and (c) above.180  
 
Figure 38. Scheme for determining the contribution from secondary orbital interactions. 
 
The comparison of the syn-T3 and anti-T2 transition states for the BF3 pathway provides 
the following results: ∆qL
SOI = -0.034 e, ∆L
‡,SOI = -0.02 eV, ∆Eorb
SOI = 3.7 kcal/mol, ∆Eint
SOI = -
0.4 kcal/mol. All of these descriptors except ∆Eint
SOI indicate that SOIs do not make a stabilizing 
contribution to transition state syn-T3.181  Similar data is obtained from the Brønsted acid-
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promoted manifold; ∆qH
SOI = -0.013 e, ∆H
‡,SOI = 0.01 eV, ∆Eorb
SOI = 2.3 kcal/mol, ∆Eint
SOI = 0.4 
kcal/mol. From these results, it can be concluded that SOIs do not contribute significantly to the 
synclinal preference for syn-T3.  
The elimination of SOIs as a significant contributor to the diastereoselectivity suggests 
that the preference can be attributed to enhanced, primary orbital interactions. To identify the 
contribution of primary orbital interactions, inspection of the transition state geometries provides 
valuable insights. For example, differences in geometrical coordinates between two transition 
states may reveal how achieving optimal primary orbital interactions (as reflected in the near 
equality of the orbital interaction energies (∆∆Eorb
‡
(anti-T2-L − syn-T3-L) = 0.5 kcal/mol)) requires 
different levels of distortion. Inspection of the crotylsilane fragment in the transition state reveals 
that an additional amount of distortion is present in anti-T2-L that is absent in syn-T3-L 
(∆∆Ed
‡
(anti-T2-L − syn-T3-L) = 1.6 kcal/mol), namely the distortion of the π-system (Figure 39).
182 
This distortion in the crotylsilane is necessary so that the aldehyde can adopt an appropriate 
approach trajectory in anti-T2-L for ideal overlap. The distortion is induced by the steric 
interaction between the methyl group of the aldehyde and the silylmethylene group. This 
observation explains why the orbital interactions at a constant level of distortion favor syn-T3-L 
more significantly (∆∆Eorb,d
‡
(anti-T2-L − syn-T3-L) = 6.2 kcal/mol). These conclusions are also 
consistent with the results from model systems investigated experimentally (Scheme 30).138c  
In summary, the overall transition state energy for syn-T3-L is lower than anti-T2-L 
because a lesser degree of distortion is required in syn-T3-L to achieve the same level of primary 
orbital overlap compared to anti-T2-L. Similar conclusions are reached upon comparing 
Brønsted acid mediated transition states (syn-T3-H and anti-T2-H).   
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Figure 39. Transition states for syn-T3-L and anti-T2-L from the perspective of the internuclear 
axis of the C-C bond of the alkene from the silylmethylene bound carbon. 
 
6.8. Which Orbital Interactions Favor Synclinal Over Antiperiplanar Transition States? 
The origin of the enhanced orbital interactions present in synclinal transition state syn-T3 
compared to anti-T1 or anti-T2 compared to syn-T1 has not yet been fully addressed. The 
contribution of SOI’s involving an in-phase interaction between the oxygen of the aldehyde and 
the silylmethylene carbon was ruled out because of insignificant energetic contributions. 
A reasonable alternative for the enhanced orbital overlap could be differential primary 
π→π* interactions. The differences in the orbital overlap of the FMO’s can be seen qualitatively 
from Figure 40. The distorted FMO’s for syn-T3-L (a) and anti-T1-L (b) as well as the 
corresponding transition state HOMO’s are shown. The HOMO’s of the crotylsilane are very 
similar for both syn-T3-L and anti-T1-L. The major difference is the approach of the aldehyde. 
The portion of the electrophile LUMO localized on the carbonyl carbon in syn-T3-L is directed 
inward, toward the alkene π-system because of the tilted approached of the aldehyde. The 
corresponding portion of the electrophile LUMO localized on the carbonyl carbon in anti-T1-L 
is directed away from the alkene π-system. The requirement for a Burgi-Dunitz approach angle 
imposes additional geometrical constraints in antiperiplanar transition states that diminsh overlap 
of the carbonyl carbon with the internal alkene carbon relative to synclinal transition states. The 
difference in overlap is also borne out by inspection of the transition state HOMO’s. The overlap 
between the aldehyde carbon and the alkene π-system of the crotylsilane is more centered while 
that for anti-T1-L is more off-centered which may be expected to translate to a decreased 
overlap energy for anti-T1-L. 
 Figure 40. Distorted HOMO of crotylsilane, distorted LUMO of crotylsilane and transition state 
HOMO for a) syn-T3-L and b) anti
= 0.06 while the transition state HOMO’s have
 
 The π→π* interaction of interest can be quantified using second order perturbation 
theory through an NBO analysis. The separation of the reactants in the transition state is too 
small to accurately quantify this interaction using t
interaction was quantified at earlier points along the reaction coordinate for each pathway (
T3-L and anti-T1-L), where extensive orbital polarization and mixing has not yet taken place, to 
approximate the π→π* interaction difference at the transition state (Figure 12). Graph a) is a plot 
of the energy difference (∆∆Eπ→
respectively. The energy difference increases to 
approaches dc-c = 2.28Å. The energy difference also favors 
function of distortion (Figure 12, graph b). The energy difference 
6.0 kcal/mol, favoring syn-T3-L
of the two curves. Thus, as a function of both distance and distortion, the 
exhibits a greater π→π* interaction energy than the 
be drawn when comparing synclinal 
 
-T1-L. The HOMO’s and LUMO’s have values of isodensity 
 an isodensity = 0.05. 
he NBO localization scheme. Thus, the 
π*) between the π→π* interaction for syn-T3-L
∆∆Eπ→π* = 5.3 kcal/mol as the dista
syn-T3-L upon comparison as a 
∆∆Eπ→π* is approximated to be 
, at a distortion level of ∆Ed = 11.0 kcal/mol based on linear fits 
syn
anti-T1-L pathway. Similar conclusions can 
anti-T2-L to antiperiplanar syn-T1-L. 
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π→π* 
syn-
 and anti-T1-L 
nce 
-T3-L pathway 
 Figure 41. a) ∆∆Eπ→π* (kcal/mol) = 
versus dc-c (Å). b) ∆Eπ→π* (kcal/mol) as a function of the distortion energy 
 
In conclusion, the enhanced orbital interactions in synclinal versus antiperiplanar 
transition states is attributed to increased primary 
explained by the tilted trajectory of the activated aldehyde in synclina
directs the aldehyde LUMO toward the center of the 
geometrical mandates of the Burgi
antiperiplanar transition states to engage in addi
the internal alkene carbon atom resulting in diminished overall orbital overlap relative to 
synclinal transition states. 
6.9.  Summary and Conclusions
 The diastereoselectivity in the additions of nucleophilic 
ketones that proceed through open transition states has historically been challenging to 
rationalize because strong, directionality
origin of diastereoselectivity in the crotyl
decomposition based theoretical methods. The BF
by potential reversible carbon-carbon bond formation. Alternative Lewis acids, TiCl
higher barrier to reversion ameliorating concerns about and might account for higher, 
experimentally observed diastereoselectivities. 
 Under electrophilic activation (BF
experimentally with high selectivity and that
particular, the preferred pathway proceeds via (
activation modes. Under nucleophilic activation (fluoride), the anti diastereomer is observed 
∆Eπ→π*(syn-T3-L) − ∆Eπ→π*(anti-T1-L
∆Ed (kcal/mol).
π→π* interactions. This greater overlap can be 
l transition states which 
π system of the crotylsilane. Moreover, the 
-Dunitz approach trajectory prevent the aldehyde in 
tional overlap between the carbonyl carbon and 
. 
π-systems to aldehydes and 
-controlling interactions are absent. In this study, the 
ation of acetaldehyde has been examined by energy 
3-promoted crotylation reaction is complicated 
 
3 and Brønsted acid), the syn diastereomer is obtained 
 selectivity is reproduced in these calculations. In 
–)-synclinal transition state syn
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) and is plotted 
 
4, exhibited a 
-T3 for both 
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experimentally and is also found computationally. However, unlike in the electrophilic activation 
modes, the antiperiplanar transition states are preferred. 
 The most informative transition state comparisons (from the data in Tables 21 and 22) 
illustrated in Figure 40. 
 
Figure 42. Most relevant transition state comparisons for crotylation of aldehydes. 
 
The comparisons of the transition state illustrated in Figure 40 are summarized as follows 
(the letters beginning each paragraph correspond to the letters labeling the comparisons in Figure 
40): 
 (a) The observed syn diastereoselectivity in the BF3-promoted pathway arises from the 
energetic preference for syn-T3 compared to anti-T1. Transition state syn-T3 is favored 
electrostatically and through orbital interactions but disfavored sterically relative to anti-T1. The 
preferred orbital interactions for syn-T3 can be accounted for by favorable orbital overlap 
conducive to greater charge transfer since the orbital energy difference of the separated reactants 
is identical in the two transition states (∆∆L=0). The reader should make careful note that these 
two transition states correspond precisely to the synclinal and antiperiplanar transition states 
evaluated in the Denmark model system A, Scheme 30. The computationally validated discovery 
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that these two limiting transition states are actually those most relevant to acyclic stereoselection 
provides a highly satisfying vindication of the significance of that model system. At the time of 
its disclosure in 1983, the model was heavily criticized as being flawed because it did not 
compare the synclinal and antiperiplanar transition states that were believed to be relevant in 
acyclic systems (see (b) below).  
(b) The reigning dogma in the field of allylmetal aldehyde additions136f posited that the 
diastereoselectivity could be explained by the difference in energy of the limiting antiperiplanar 
transition states on the basis of steric considerations. The calculated results suggest otherwise as 
the lower energy antiperiplanar transition state (anti-T1) leads to the anti diastereomer (∆∆E‡(anti-
T1-L − syn-T1-L) = −3.0 kcal/mol; ∆∆E
‡
(anti-T1-H − syn-T1-H) = −1.7 kcal/mol), not the observed syn 
diastereomer under electrophilic activation. Although the steric contribution to these transition 
states does indeed favor syn-T1-L (∆∆Este
‡
(syn-T1-L − anti-T1-L) = –7.8 kcal/mol), this preference 
does not compensate for the additional contribution from the electrostatic (∆∆Ees
‡
(anti-T1-L − syn-T1-
L) = –4.4 kcal/mol) and orbital interactions (∆∆Eorb
‡
(anti-T1-L − syn-T1-L) = –5.5 kcal/mol) that favor 
anti-T1-L. The origin of the lesser electrostatic and orbital interaction energies for the sterically 
favored syn-T1-L transition state can be ascribed to the greater π-distortion of the crotylsilane 
component present in syn-T1-L (Figure 41). Compared to anti-T1-L, the energy required to 
distort the crotylsilane component is higher (∆∆Eorb,d
‡
(syn-T1-L − anti-T1-L) = 2.4 kcal/mol) and 
causes an unfavorable alignment of the primary orbitals in the individual components, thus 
reducing the stabilizing interactions. Similar conclusions are reached by comparing the 
analogous Brønsted acid transition states (anti-T1-H and syn-T1-H) albeit with a lesser 
magnitude. 
The greater distortion in transition state syn-T1-L arises from the attempted avoidance of 
steric interactions between the aldehyde methyl group and the silylmethylene group. However, 
this causes a tilt that leads to an unfavorable compression between the methyl group of the 
crotylsilane and the BF3 unit. Because of this second compression, a favorable orbital alignment 
cannot be achieved thus accounting for the considerable orbital interaction and electrostatic 
energy difference. In transition state anti-T1-L, the distortion arises from avoidance of the steric 
interactions between the aldehyde and crotylsilane methyl groups. However, in this case, that 
interaction causes a tilt that compresses the two gauche hydrogens and the BF3 unit thus 
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requiring less distortion to achieve transition state. This tilt is easily seen in the acute dihedral 
angle between the silylmethylene (C-C) bond and the forming sigma bond (Figure 41).  
 
Figure 43. Transition states for anti-T1-L and syn-T1-L from the perspective of the internuclear 
axis of the C-C bond of the alkene from the silylmethylene bound carbon. 
 
(c) According to the empirical rules developed by Seebach (Scheme 27),131 either the 
syn-T2 or the syn-T3 transition states should be the most favored for these reactions (depending 
upon whether Rule iii or Rule iv is dominant). Interestingly, these two transition states are very 
close in energy (∆∆E‡(syn-T3-L − syn-T2-L) = −0.7 kcal/mol; ∆∆E
‡
(syn-T3-H − syn-T2-H) = −1.0 kcal/mol) 
and are both lower in energy than the lowest energy transition states leading to the anti 
diastereomer. It is interesting to note that at the transition states, both syn-T3-L and syn-T3-H 
exhibit less favorable interaction energies as compared to syn-T2-L and syn-T2-H and it is the 
lower distortion energies that cause the syn-T3 transition states to be energetically favorable 
overall. The lower degree of distortion in syn-T3 is manifested in lower steric and orbital 
interactions in syn-T3-L (∆∆Este,d = -2.6 kcal/mol; ∆∆Eorb,d = -1.4 kcal/mol) and mostly orbital 
interactions in syn-T3-H (∆∆Eorb,d = -1.5 kcal/mol) (Table 2). Thus, the modest preference for 
syn-T3-L arises from the significantly lower steric repulsion energy that more than compensates 
for slightly unfavorable electrostatic and orbital interaction energies.   
  (d) and (e) The observed syn diastereoselectivity in the Brønsted acid-promoted pathway 
arises from the energetic preference for syn-T3 compared to anti-T1 and anti-T2. In this case 
anti-T2-H is a more important contributor to this pathway than anti-T2-L is to the BF3 
promoted pathway. This change is a consequence of the lesser steric interactions between the H+
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on the aldehyde oxygen and the methyl group of the crotylsilane compared to the same 
interaction of the BF3 moiety in anti-T2-L.  The rationalization for the preference of syn-T3-H 
compared to anti-T1-H is similar to that for the comparison made in (a).  
 Transition state syn-T3-H is favored over anti-T2-H mostly through orbital interactions 
that are accounted for through a decreased frontier orbital energy difference in the separated 
reactants rather than an enhanced spatial orbital overlap (Table 23). The orbital energy separation 
may be a result of unfavorable distortion arising from the steric interaction between the aldehyde 
methyl group and the crotylsilane methylene group (Figure 39). These conclusions are similar to 
those drawn from the discussion of SOIs (Section 6.7). 
 (f) The observed anti diastereoselectivity in the fluoride-promoted pathway arises from 
the energetic preference for anti-T1-F compared to syn-T1-F. The basis for this preference 
mirrors the analysis for the energetic differences between the antiperiplanar transition states in 
the electrophilically activated additions (b). An interesting comparison can be made between 
anti-T1-F and syn-T3-F because the latter is close in energy to syn-T1-F and is favored in both 
electrophilic activation modes. Whereas synclinal transition structure syn-T3-F does exhibit 
increased charge transfer and orbital interactions, the electrostatic repulsion between the 
negatively charged oxygen atom and the negatively charged silylmethylene group in syn-T3-F 
offsets the stabilizing effects from increased orbital interactions and charge transfer. Thus, the 
repulsion in transition state syn-T3-F leads to an overall energetic preference for antiperiplanar 
transition structure anti-T1-F. This conclusion is supported by the experimentally observed 
preference for the anti-T1-F transition state in model system A (Scheme 4). 
 The results of this investigation can be extended to the qualitative design or 
rationalization of systems for the addition of other π-donors including enamines, silyl enol 
ethers, or silyl ketene acetals, to aldehydes, nitroalkenes or other π-acceptors. 
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Chapter 7:  Experimental Section 
7.1.  General Experimental. 
All reactions were performed in oven-dried (145 °C) or flame-dried glassware under an 
inert atmosphere of dry N2.  Reaction solvents THF (Fisher, HPLC grade), Et2O (Fisher, BHT 
stabilized ACS grade) and methylene chloride (Fisher, unstabilized HPLC grade) were dried by 
percolation through two columns packed with neutral alumina under a positive pressure of argon.  
Reaction solvents hexane (Fisher, OPTIMA grade) and toluene (Fisher, ACS grade) were dried 
by percolation through a column packed with neutral alumina and a column packed with Q5 
reactant, a supported copper catalyst for scavenging oxygen, under a positive pressure of argon.  
Reactions were carried out at the temperature indicated (internal temperature) as measured by an 
internal thermocouple device unless otherwise indicated.  Parallel synthesis was performed on a 
Buchi Synchor reactor fittet with a 96 well block and a standard Argon/vacuum manifold. 
Column chromatography was performed using Merck grade 9385, 60 Å silica gel. 
Visualization was accomplished by UV light, ceric ammonium molybdate (CAM), potassium 
permanganate (KmnO4), sulfuric acid (H2SO4), ceric ammonium nitrate (CAN), or iodine (I2) as 
indicated. Analytical and preparative thin-layer chromatography was performed on Merck silica 
gel plates with F-254 indicator.  Distillations were performed using a short-path with a 3 cm, 
Vigreux column.  Bulb-to-bulb distillations were conducted using a Buchi GKR-50 Kugelrohr 
apparatus at the pressure specified and air bath temperature (ABT). 
1H NMR and 13C NMR spectra were acquired at 500 MHz and 126 MHz respectively and 
referenced to residual solvent (CHCl3 at 7.26 (
1H) and 77.00 (13C) or MeOH (3.31 (1H), 49.00 
(13C) ppm).  Assignments were obtained by reference to COSY and HETCOR and DEPT(135) 
correlations.  Chemical shifts are reported in ppm ; multiplicities are indicated by s (singlet), d 
(doublet), t (triplet), q (quartet), p, (pentet), m (multiplet) and br (broad).  Coupling constants, J, 
are reported in Hertz.  Mass Spectrometry was performed by the University of Illinois Mass 
Spectrometer Center.  EI mass spectra were performed on a 70-VSE spectrometer.  CI mass 
spectra were performed on a 70-VSE-B spectrometer with methane as the carrier gas.  ESI mass 
spectra were performed on a Waters Q-Tof Ultima instrument.  Data are reported in the form of 
m/z (intensity relative to base peak = 100).  Infared spectra (IR) were recorded on a Mattson 
Galaxy 5020 spectrophotometer using NaCl plates.  Peaks are reported in cm-1 with indicated 
139 
 
relative intensities: s (strong, 67-100%); m (medium, 34-66%); w (weak, 0-33%).  Analytical 
capillary gas chromatography (GC) was performed using a gas chromatograph fitted with a 
flame ionization detector (H2 carrier gas, 1 mL/min).  GC Method 1: Injections were made onto a 
Hewlett-Packard HP-5 50-m cross-linked 5%-phenyl methyl silicone gum phase column. The 
detector temperature was 300 °C. The column temperatures was maintained at 140 oC isotherm 
over 20 min then ramped to 250 oC over 10 min.  Analytical high pressure liquid 
chromatography (HPLC) was performed using a Hewlett Packard 1090L Chromatograph 
equipped with a variable wavelength diode array detector and an autosampler.  The 
chromatograph was equipped with a reverse phase Phenomenex Luna C18(2) column (3µm, 
4.6x150mm, lampcurrent = 1).  Method 1: Linear Gradient; flow rate = 1.0 mL/min, λ = 254 nm, 
solvent = CH3CN/H2O (30/70) to CH3CN/H2O (90/10) over 10 min, then isocratic for 7 min.  A 
3 min re-equilibration time was utilized between runs.  The water eluent contained 0.1% v/v 
acetic acid.  Chiral Stationary phase HPLC (CSP-HPLC) Method 1: R,R-Welk-O, 1.0 mL/min, 
IPA/Hexanes 5:95.  Analytical supercritical fluid chromatography (SFC) was performed on a 
Berger Instruments SFC with spectrophotometric detector (220 nm) using Daicel Chiralpak AD, 
AS, OD, OJ, and Welk-O columns.  Optical rotations were measured in Fischer Optima grade 
EtOH, MeOH and CH2Cl2 and are reported as follows: concentration (c = g/dL), and solvent.  
Melting points were conducted in vacuum-sealed glass tubes using a Thomas-Hoover Uni-
Melt™ melting point apparatus and are corrected. 
 
7.2. Literature Procedures 
 The following compounds were synthesized following the published procedures:  Ethyl 
pent-4-enoate, 4-penten-1-ol, 1-bromomethylnaphthalene, 2-bromomethylnaphthalene, 9-
bromomethylanthracene, N,N,N,N-tributyl-(1-benzyl) quaternary ammonium bromide, 
Phenylselenenyl chloride, (E)-methyl 6-hydroxyhex-2-enoate (E-6), tert-butyl 2-
(diphenylmethyleneamino) acetate (25), dichlorotitanium diisopropoxide, (1S,3R,5aS,7aS,7bR)-
Octahydro-1-[N-(3,5-dinitrophenyl)carbamoxy]-7b-methyl-2H-cyclopenta[gh]pyrrolizin-2-one. 
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7.3.  Experimental Procedures for Chapter 2 
7.3.1.  Tandem Cycloaddition Precursors and Scaffolds 
Scale up of Alcohol (Z)-6. Preparation of Trimethyl(4,5,6,7-tetrahydrooxepin-2-yloxy)silane 
(10) 
 
A jacketed 500-mL, three-necked, liquid addition flask fitted with a  a nitrogen inlet 
adaptor, and two rubber septa was fitted to a 1-L, two-necked, round-bottomed flask fitted with a 
magnetic stir bar, a rubber septum and an internal temperature probe (through rubber septum).  
To the addition flask was added diisopropylamine (36.5 mL, 209 mmol, 1.3 equiv) and THF 
(300 mL).  The resulting solution was cooled to -78 oC (bath temp) by addition of an 
acetone/CO2(s) bath to the jacket reservoir.  Then, n-butyllithium (2.56 M in hexanes, 81.8 mL, 
1.3 equiv) was added dropwise over 20 min.  To the 1-L, two-necked, flask was added ε-
caprolactone (18.4 g, 161 mmol), THF (150 mL) and trimethylsilyl chloride (26.5 mL, 209 
mmol, 1.3 equiv) via syringe.  The reaction vessel was brought to < -80 oC by immersion in a 
hexanes/N2 bath.  The freshly generated solution of LDA (above) was added dropwise at a rate 
that maintained an internal temperature < –75 oC (ca. 1 h).  The resulting turbid solution was 
allowed to warm to –25 oC, and was then concentrated by rotary evaporation (15 mm Hg, 20-25 
oC).  The resulting mixture was triturated with pentane (~100 mL) and filtered (Celite).  The 
filtrate was again concentrated by rotary evaporation (15 mm Hg, 20-25 oC).  Purification by 
distillation (0.5 mm Hg, 43 oC) afforded ketene acetal 10 (24.8 g, 83%) as a clear colorless oil. 
 Data for 10: 
 bp: 58-60 ˚C / 2-3 torr 
 1H-NMR: (500 MHz, CDCl3) 
4.12 (t, J = 5.9, 1 H, HC(3)), 3.99 (dd, J = 5.4, 5.6, 2 H, H2C(7)), 2.02 (dd, J 
= 5.9, 11.6, 2 H, H2C(4)) 1.83 (ddd, J = 5.7, 10.7, 11.5, 2 H, H2C(6)), 1.65-
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1.59 (m, 2 H, H2C(5)), 0.22 (s, 9 H, H3C(5’)) 
 13C-NMR: (126 MHz, CDCl3) 
160.0 (C(2)), 83.1 (C(3)), 71.5 (C(7)), 31.3 (C(4)), 26.2 (C(6)), 23.3 (C(5)), 
0.16 (C(5’)) 
 IR: (neat, NaCl plate) 
2931 (s), 2837 (m), 1682 (s), 1455 (m), 1355 (m) 
 MS: (ESI, Q-tof) 
187 (21) [M+1], 171 (38), 147 (14), 132 (12), 129 (13), 117 (30), 75 (100), 69 
(32), 55 (23), 54 (23) 
 TLC: Rf  0.77  (hexanes/Et2O, 4:1) [UV, KmnO4] 
 
Palladium Catalyzed Oxidation Silyl Ketene Acetal 10. Preparation of 6,7-dihydro-5H-
oxepin-2-one (8). 
 
 
To a 1.0-L, one-necked, round-bottomed flask fitted with a reflux condenser, a magnetic 
stir bar, and a nitrogen inlet adapter, fitted with a rubber septum, was added sequentially, 
palladium(0)bisdibenzylideneacetone (309 mg, 0.537 mmol, 0.01 equiv), allyl methyl carbonate 
(12.2 mL, 107 mmol, 2.0 equiv), and acetonitrile (268 mL).  Silyl ketene acetal 10 (1.0 g, 21.5 
mmol) was then added via syringe.  The resulting solution was placed in an oil bath pre-heated to 
40oC and allowed to stir.  After being stirred for 30 min at 40 oC, the reaction mixture was 
removed from the oil bath and allowed to cool to room temperature.  The solution was 
concentrated to approximately one-quarter of the total volume (~70 mL).  This solution was 
passed through a plug of silica gel (20mm x 5 cm) using hexanes/Et2O (1:4, 3 x 50 mL).  The 
filtrate was concentrated by rotary evaporation (15 mm Hg, 20-25oC) to afford 5.13 g (97%) of 8 
as a pale-yellow oil.  This material is carried on to the next step without further purification. 
 Data for 8: 
 bp: 70 oC @ 0.1 mm Hg 
O
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O OMe
O
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 1H-NMR: (500 MHz, CDCl3) 
6.41 (td, J = 4.4, 12.1, 1 H, HC(4)), 5.98 (d, J = 12.4, 1 H, HC(3)),4.28 (m, 2 
H, H2C(7)), 2.50 (dd, J = 5.4, 10.2, 2 H, H2C(5)), 2.12 (td, J = 6.6, 12.9, 2 H, 
H2C(6)) 
 13C-NMR: (126 MHz, CDCl3) 
169.2 (C(2)), 144.0 (C(4)), 121.9 (C(3)), 67.3 (C(7)), 30.1 (C(5)), 27.0 (C(6)) 
 TLC: Rf  0.20  (pentane/MTBE, 1:1) [KMNO4] 
 
Methanolysis of ε-Caprolactenone 8. Preparation of (Z)-Methyl 6-Hydroxy-2-hexenoate 
((Z)-6) 
 
To a 100-mL, one-necked, round-bottomed flask fitted with a rubber septum, a large a 
magnetic stir bar, and a nitrogen inlet adaptor, was added ester 8 (4.5 g, 40.1 mmol) via syringe. 
Methanol (80 mL) was then added followed by potassium carbonate (554 mg, 4 mmol, 0.1 
equiv).  The suspension was stirred vigorously for 20 min, during which the solution gradually 
became opaque. The resulting suspension was poured into a 500-mL separatory funnel 
containing water (100 mL) and diluted with dichloromethane (100 mL).  The layers were 
separated and the aqueous was extracted with dichloromethane (5 x 50 mL). The combined 
organic extracts were dried (MgSO4), filtered (cotton plug), and concentrated via rotary 
evaporation (15 mm Hg, 20-25 oC). The resulting clear oil was filtered through a small plug of 
silica gel (1.8 cm x 2 cm) with 25 mL EtOAc to remove any remaining base impurities.  
Concentration of the resulting solution yielded 5.19 g (89%) of geometrically pure (Z)-6 as 
determined by 1H-NMR analysis. 
Data for (Z)-6: 
 1H-NMR: (500 MHz, CDCl3) 
6.24 (td, J = 8.3, 11.5, 1 H, HC(4)), 5.87 (td, J = 1.4, 11.5, 1 H, HC(5)), 3.72 
(s, 3 H, H3C(7)), 3.61 (t, J = 5.9, 2 H, H2C(1)), 2.74 (dt, J = 1.4, 8.2, 2 H, 
H2C(C(3)), 1.73 (td, J = 8.3, 11.5, 1 H, H2C(2)) 
4
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 13C-NMR: (126 MHz, CDCl3) 
167.5 (C(6)), 149.8 (C(4)), 120.2 (C(5)), 61.1 (C(1)), 51.3 (C(7)), 31.2 (C(2)), 
25.1 (C(3)) 
 IR: (neat) 
3423 (br), 2950 (m), 2870 (m), 2343 (w), 2361 (w), 1723 (s), 1645 (m), 
1439 (s), 1408 (m), 1202 (s), 1173 (s) 
 MS: (ESI, Q-tof) 
167(100), 145(35), 127(15) 
 TLC: Rf  0.22 (hexanes/EtOAc, 4:1) [UV, KmnO4] 
A. Preparation of Nitroalkenes (E,Z)-1 and (E,E)-1. Preparation of Methyl (2Z,6E)-7-
Nitro-2,6-octadienoate ((E,Z)-1) 
 
To a 500-mL, two-necked, round-bottomed flask fitted with a rubber septum and a 
nitrogen inlet adaptor was added alcohol (Z)-6 (3.0 g, 20.8 mmol) along with CH2Cl2 and DMSO 
(100 mL each).  Triethylamine (17.4 mL, 125 mmol, 6.0 equiv) was added and the flask was 
immersed in a ice/NaCl(s) bath.  Once the internal temperature reached –5 oC, SO3•pyridine 
complex was added in a single portion (5.5 g, 31 mmol, 1.5 equiv).  After two hours at < 0 oC an 
additional portion of SO3•pyridine complex (5.5 g, 31 mmol, 1.5 equiv) was added.  After 
another 2 h the reaction was quenched by pouring into a 500-mL separatory funnel containing 
100 mL sat. aq. NH4Cl.  The organic phase was diluted with another 100 mL of CH2Cl2 and 
rinsed with NH4Cl (3 x 50 mL) followed by CuSO4 (1 x 50 mL), brine (100 mL) and H2O (100 
mL).  The combined organic extracts were dried (MgSO4), filtered over a silica gel plug (3 x 1 
cm) and concentrated to afford 2.98 g (89%) of crude intermediate aldehyde as a light-yellow oil.  
The aldehyde was carried on directly to nitroalkene (E,Z)-1 without further purification as 
previously described.183 
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Data for (E,Z)-1: 
 1H-NMR: (500 MHz, CDCl3) 
7.10 (t, J = 7.8, 1 H, HC(3)), 6.19 (dd, J = 8.2, 10.9, 1 H, HC(6)), 5.85 (d, J = 
11.4, 1 H, HC(7)), 3.70 (s, 3 H, H3C(9)), 2.84 (dq, J = 1.6, 7.6, 2 H, H2C(4)), 
2.38 (m, 2 H, H2C(5)), 2.16 (s, 3 H, H3C(1)) 
 13C-NMR: (126 MHz, CDCl3) 
166.4 (C(8)), 147.1 (C(2)), 134.6 (C(6)), 121.1 (C(3)), 51.2 (C(7)), 27.3 (C(9, 
1)), 12.5 (C(4,5)) 
 IR: (neat) 
3054 (w), 2987 (w), 2954 (w), 2254 (m), 1719 (s), 1650 (m), 1521 (s), 1440 
(m) 
 MS: (EI, 70eV) 
197 (5), 182 (12), 168 (25), 150 (42), 149 (45), 93 (100), 91 
 TLC: Rf  0.57  (hexanes/EtOAc, 4:1) [UV, KmnO4] 
 
Preparation of Methyl (2E,6E)-7-Nitro-2,6-octadienoate ((E,E)-1) 
 
To a 1-L, three-necked, round-bottomed flask fitted with two rubber septa and a nitrogen 
inlet adaptor and an internal temperature probe (through a septum) was added alcohol (E,E)-6 
(21 g, 147 mmol) along with CH2Cl2 and DMSO (147 mL each).  Triethylamine (12 mL, 874 
mmol, 6.0 equiv) was added and the flask was immersed in a ice/NaCl(s) bath.  Once the internal 
temperature reached –5 oC, SO3•pyridine complex was added in a single portion (29.4 g, 184 
mmol, 1.25 equiv).  After two hours at < 0 oC an additional portion of SO3•pyridine complex 
(29.4 g, 184 mmol, 1.25 equiv) was added.  After another 2 h the reaction was quenched by 
pouring into a 1-L separatory funnel containing 200 mL sat. aq. NH4Cl.  The organic phase was 
diluted with 150 mL of Et2O and rinsed with NH4Cl (3 x 100 mL) followed by CuSO4 (2 x 100 
mL), brine (100 mL) and sat. aq, NaHCO3 (100 mL).  The combined organic extracts were dried 
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(MgSO4), filtered over a silica gel plug (3 x 1 cm) and concentrated to afford the crude aldehyde 
(E)-7 as a light-yellow oil.  The aldehyde was carried on directly to the nitroalkene without 
further purification as previously described to give 22.9 g (80%) of nitroalkene (E,E)-1 as a light-
yellow oil. The data collected was consistent with that previously reported. 
Data for (E,E)-1: 
 1H-NMR: (500 MHz, CDCl3) 
7.14 (t, J = 7.7, 1 H, HC(6)), 6.19 (td, J = 11.4, J = 7.6, 1 H, HC(3)), 5.85 (d, J 
= 11.9, 1 H,HC(2)), 3.70 (s, 3 H, H3C(9)), 2.85 (m, 2 H), 2.38 (m, 2 H), 2.16 
(s, 3 H, H3C(8)). 
 13C-NMR: (126 MHz, CDCl3) 
166.5 (C(8)), 148.4 (C(2)), 146.2 (C(6)), 133.9 (C(3)), 122.5 (C(7)), 51.6 
(C(9)), 26.5 (C(4)), 22.4 (C(5)), 12.6 (C(1)) 
 IR: (neat) 
2992 (w), 2953 (w), 2843 (w), 2255 (m), 1721 (s), 1662 (m), 1523 (s), 1438 
(m), 1391 (m), 1334 (s), 1284 (m), 1213 (m), 1173 (m), 1042 (w), 971 (w), 
906 (s) 
 TLC: Rf  0.6  (hexanes/EtOAc, 4:1) [UV, KMnO4] 
 
Preparation of (1S,3R,5aS,7aS,7bR)-Octahydro-1-hydroxy-7b-methyl-2Hcyclopenta[gh]   
pyrrolizin•Borane (17a) 
 
To a 50-mL, two-necked, round-bottomed flask fitted with a rubber septum, a nitrogen 
inlet adaptor, a magnetic stir bar and an internal temperature probe (inserted through a rubber 
septum) was added lactam 4a (181 mg, 1.0 mmol) and THF (1 mL). The flask was cooled to 0 ºC 
in an ice bath, and BH3•THF complex (5.0 equiv, 1.0 M solution, 5 mL) was added dropwise 
over 10 min (bubbling observed).  The cooling bath was removed and the resulting clear solution 
was stirred for 2 h.  The reaction was quenched by the addition of 20 mL of MeOH and the 
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mixture was concentrated by rotary evaporation (15 mm Hg, 20-25 oC).  This process was 
repeated three more times to afford the crude product as a white solid.  Purification by silica gel 
column chromatography ((2 cm x 7 cm), hexanes/EtOAc, 95:5, 85:15, 3:1, 150 mL each) 
afforded ~185 mg of 17a.  Recrystallization from hexanes/MTBE (5:1) afforded 175 mg (96%) 
of the borane complex 17a as white needles. 
Data for 17a: 
 mp: 164-165˚C (MTBE/hexanes) 
 1H-NMR: (500 MHz, CDCl3) 
4.75 (dd, J = 8.1, 15.3, 1 H, HC(1)), 3.44 (dd, J = 6.5, 10.9, 1 H, HC(2)), 3.28 
(ddd, J = 2.5, 6.7, 12.1, 1 H, HC(4)), 3.16 (dt, J = 6.6, 11.7, 1 H, HC(4)), 3.03 
(m, 1 H, HC(2)), 2.39 (m, 2 H HC(5a), HC(7a)), 2.07-2.00 (m, 1 H, HC(7)), 
1.99-1.90 (m, 1 H, HC(6)), 1.89-1.73 (m, 2 H, HC(6), HC(5)), 1.74-1.58 (M, 2 
H, HC(7), HC(5)), 2.10-1.25 (s, broad, 3 H, H3B), 1.48 (s, 3 H, H3C(8)) 
 13C-NMR: (126 MHz, CDCl3) 
87.8 (C(7b)), 69.4 (C(1)), 66.0 (C(2)), 63.1 (C(4)), 55.1 (C(7a)), 53.1 (C(5a)), 
32.1 (C(5)), 28.0 (C(7)), 26.4 (C(6)), 25.2 (C(8)) 
 IR: (NaCl plate, film) 
3018 (m), 2969 (m), 2872 (w), 2367 (m), 2363 (m), 2333 (m), 2276 (w), 1215 
(s) 
 MS: (ESI, Q-tof) 
180 (42), 167 (21), 152 (100), 96 (59) 
 Opt. rot.: [α]-./ -1.74o (c = 1.0, CH2Cl2) 
 TLC: Rf  0.33  (hexanes/EtOAc, 3:1) [I2] 
 Analysis: C10H20BNO  (181.08) 
Calcd: C, 66.33; H, 11.13; N, 7.73 
Found: C, 66.05; H, 10.95; N, 7.52 
 
Preparation of Scaffold for Library IV. 
Preparation of (3R,5aS,7aS,7bR)-Octahydro-7b-methyl-2Hcyclopenta[gh]pyrrolizin-1-one 
•Borane (19) 
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To a 100-mL, three-necked, round-bottomed flask fitted with a nitrogen inlet adapter, a 
magnetic stir bar, and an internal temperature probe was added 17a (500 mg, 2.76 mmol), 
CH2Cl2 (11.5 mL), and DMSO (2.3 mL).  The resulting solution was cooled to –12
 oC in an 
ice/salt bath.  To this solution was added diisopropylethylamine (2.41 mL, 13.8 mmol, 5.0 equiv) 
followed by a solution of SO3•pyridine complex (1.32 g, 8.28 mmol, 3.0 equiv) in DMSO (4.6 
mL) at rate such that the internal temperature remained < –5 oC (~5 min).  After stirring for an 
additional 20 min at –10 oC, the cooling bath was removed and the solution was allowed to warm 
to room temperature (~10 min), then cooled to 0 oC by re-immersion in the ice/salt bath.  The 
solution was diluted with Et2O (10 mL) and quenched with H2O (10 mL).  This mixture was 
poured into a 250-mL separatory funnel and the layers were separated.  The aqueous extract was 
washed with Et2O (2 x 25 mL).  The organic extracts were washed with sat. aq. CuSO4 solution 
(2 x 25 mL), sat. aq. NaHCO3 solution (1 x 25 mL), brine (25 mL), the combined organic 
extracts dried over MgSO4, filtered through Celite (20 mm x 5 cm), and rinsed with TBME (3 x 
10 mL).  The filtrate was concentrated by rotary evaporation (15 mm Hg, 20-25 oC) to afford 498 
mg (99%) of 19 as a white solid without further purification.  
Data for 19: 
 1H-NMR: (500 MHz, CDCl3) 
3.89 (d, J = 17.6, 1 H, HC(2)), 3.55 (ddd, J = 7.6, 7.6, 12.2, 1 H, HC(4)), 3.48 
(d, J = 17.6, 1 H, HC(2)), 3.16 (ddd, J = 6.5, 1 H, HC(4)), 2.63-2.57 (m, 2 H, 
HC(7a), HC(5a)), 2.40 (147et, J = 6.0, 7.4, 9.4, 13.6, 1 H, HC(5)), 2.16-2.03 
(m, 3 H, HC(7), HC(7)), 1.65 (s, 3 H, H3C(8)), 1.65-1.58 (m, 2 H, HC(5)), 
1.48-1.41 (m, 1 H, HC(6)), 0.8-2.5 (br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
212.1 (C(1)), 86.5 (C(7b)), 70.0 (C(2)), 64.9 (C(4)), 58.4 (C(7a)), 51.8 
(C(5a)), 35.1 (C(6)), 32.3 (C(7)), 29.9 (C(5)), 24.4 (C(8)) 
 IR: (NaCl plate, thin film) 
2964 (s), 2865 (w), 2381 (s), 2333 (s), 2273 (s), 1755 (s), 1468 (m), 1419 (w), 
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1383 (m), 1195 (s), 1164 (s), 1071 (m), 913 (s), 732 (s) 
 MS: (EI, 70eV) 
179 (12), 178 (100), 165 (28), 150 (24), 137 (48), 121 (15), 108 (16), 95 (27) 
 Mol. Formula: C10H18BNO  (179.07) 
 HRMS: C10H17ONB
+: (179.1403) 
 Calcd:  179.1403 
 Found:  178.1406 
 TLC: Rf  0.35  (hexanes/EtOAc, 3:2) [I2, CAM] 
 
Preparation of Scaffold for Library V (via 20 and 21).  
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-5-methyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizin-2-one ((+)-5) 
 
To a 100-mL, three-necked, round-bottomed flask fitted with two rubber septa, a 
magnetic stir bar, a nitrogen inlet adaptor and an internal temperature probe, was added 
nitroalkene (E,E)-1 (1.0 g, 5.02 mmol) and chiral propenyl ether 3 (1.63 g, 7.53 mmol, 1.5 equiv) 
via syringe.  The resulting yellow oil was then evacuated under high vacuum (~0.1 mm Hg) for 
30 min.  The flask was backfilled with N2 and charged with CH2Cl2 (22 mL).  The solution was 
cooled to –85 oC (internal temperature) using hexanes/N2 bath.  This yellow solution was sirred 
for 15 min, then freshly prepared TiCl2(Oi-Pr)2 solution (1.2 M in CH2Cl2, 12.6 mL, 15.1 mmol, 
3.0 equiv) was added dropwise via syringe while maintaining an internal temperature ≤ –70 oC 
(ca. 15 min).  After addition of the Lewis acid, the cooling bath was replaced with an 
acetone/CO2(s) bath and the resulting bright yellow solution was stirred for another 5 h while 
maintaining an internal temperature ≤ –75 oC.  During the course of the reaction, the yellow 
color gradually faded and a white precipitate formed.  After 5 h the reaction was quenched with 
triethylamine (30.6 mL, 6.1 equiv, 1 M in MeOH) via syringe while maintaining an internal 
temperature of < –40 oC.  The cooling bath was then removed and the reaction mixture was 
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allowed to warm to 0 oC (ca. 15 min).  The resulting white suspension was then diluted with 
ethyl acetate (50 mL) and poured onto a biphasic mixture of sat. aq. NH4Cl and ethyl acetate (75 
mL) in a 500-mL separatory funnel.  The aqueous extract was washed with ethyl acetate (3 x 75 
mL).  The organic extracts were washed with sat. aq. NH4Cl solution (2 x 50 mL), H2O (2 x 50 
mL) and brine (2 x 50 mL).  The combined organic extracts were dried over NaHCO3/MgSO4 
(1/1), filtered (cotton plug), and concentrated by rotary evaporation (15 mm Hg, 20-25 oC).  The 
resulting residue was filtered through a pad of silica gel (3 x 3 cm), eluting with ethyl acetate 
(100 mL) to remove any remaining amine impurities.  The resulting clear solution was 
concentrated by rotary evaporation (15 mm Hg, 20-25 oC) to a pale-yellow residual oil in a 1-L 
one-necked, round-bottomed flask.  TBME (100 mL) was added followed by NaHCO3 (5 g, 50.0 
mmol, 10.0 equiv).  The flask was equipped with a nitrogen inlet adaptor, a magnetic stir bar, 
and evacuated and backfilled with N2 (3x).  The suspension was stirred at room temperature for 
12 h, then filtered through Celite (3 x 3 cm, cotton plug) and concentrated by rotary evaporation 
(15 mm Hg, 20-25 oC).  The resulting mixture of nitroso acetals was diluted in EtOAc/MeOH 
(9:1, 25 mL) and added to a test tube (6 cm x 14 cm) containing a spatula tip (~200 mg) of 
Raney Ni (previously washed with H2O, MeOH, and EtOAc, 2 x 15 mL each) along with a 
magnetic stir bar.  The tube was placed in a steel autoclave, which was then pressurized with H2 
(350 psi).  After 2 days the autoclave was carefully vented in a fume hood and the solution was 
filtered through a plug of Celite (5 cm x 5 cm, cotton plug) with EtOAc (100 mL).  The resulting 
clear solution was concentrated by rotary evaporation (15 mm Hg, 20-25 oC) and purified by 
silica gel column chromatography (2 cm x 8 cm, hexanes/EtOAc, 9:1, 4:1, 7:3, 2:3, 1:4, 100 mL 
each) affording 870 mg (89%) of a mixture of epimeric α-hydroxy lactams 5 and S2 as a white 
solid (11:1 by 1H-NMR analysis). 
Data for 5: 
 1H-NMR: (500 MHz, CDCl3) 
4.63 (dd, J = 6.8, 1.5, 1 H, HC(4)), 4.05 (dd, J = 11.8, 7.4, 1 H, HC(4)), 2.73 
(br, s, 1 H, OH), 2.59-2.46 (m, 2 H), 1.86–1.73 (m, 3 H), 1.67–1.55 (m, 1 H), 
1.53–1.40 (m, 2 H), 1.34 (s, 3 H, H3C(8)), 1.07 (d, J = 6.7, 3 H, H3C(9)). 
 13C-NMR:  (126 MHz, CDCl3) 
176.0 (C(2)), 75.4 (C(7b)), 72.4 (C(1)), 58.1 (C(5a)), 51.9 (C(7a)), 50.5 
(C(4)), 42.1 (C(5)), 30.8 (C(6)), 25.2 (C(7)), 24.8 (C(9)), 17.5 (C(8)) 
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 IR:  (NaCl plate, film) 
3338 (br), 2959 (s), 2870 (s), 1685 (s), 1462 (m), 1412 (m), 1334 (m), 1269 
(w), 1223 (s), 1142 (m), 1115 (w), 1097 (w), 1044 (w), 964 (w), 880 (w) 
 MS:  (ESI, Q-tof) 
195.1 (67), 180.1 (100), 167.1 (12), 152.1 (56), 138.1 (14), 111 (43), 96.1 
(15), 81.1 (24) 
 TLC:  Rf  0.20  (Hexanes/EtOAc, 1:1) [I2] 
 Analysis:  C11H17NO2 (195.26) 
Calcd: C, 67.66; H, 8.78; N, 7.17 
Found: C, 67.41; H, 9.05; N, 7.19 
 
Preparation of (1R,3R,5R,5aS,7aS,7bR)-Octahydro-1-[N-(3,5-Dinitrophenyl)carbamoxy]-
7b-methyl-2H-cyclopenta[gh]pyrrolizin-2-one  (S7) 
 
A 25 mL round-bottomed flask (A) was fitted with a reflux condenser, a nitrogen inlet 
adaptor, a rubber rubber septum and a magnetic stir bar. The apparatus was opened and 3,5-
dinitrobenzoylazide (25 mg, 0.11 mmol, 1.1 equiv) was added as a solid. The apparatus was 
evacuated and backfilled with N2 three times and toluene (4.8 mL) was added. The clear solution 
was immersed in a preheated (115 oC) oil bath and stirred at reflux for 30 min. In a separate, 
two-neck, 5 mL conical flask (B) fitted with a triangular a magnetic stir bar, rubber septum and a 
nitrogen inlet adaptor the starting alcohol was added (18.9 mg, 0.096 mmol) followed by toluene 
(1.0 mL). The resulting solution (B) was transferred to flask (A) via cannula. The resulting light 
yellow solution was heated to reflux for 2 h and then allowed to cool to room temperature. The 
reaction mixture was concentrated in vacuo, and the crude product was purified by column 
chromatography (hexane/EtOAc (3/1, 1/1)) to afford 38 mg (98%) of enantioenriched S7 as a 
white solid. The sample was compared to racemate as previously described.  
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Data for S7: 
 1H-NMR: (500 MHz, CDCl3) 
9.90 (s, 1 H, NH), 8.61 (s, 1 H, HC(14)), 8.56 (s, 2 H, HC(12)), 5.89 (d, J = 
6.7, 1 H, HC(1)), 4.12 (dd, J = 7.4, 11.9, 1 H, HC(4)), 2.71 (dd, J = 9.5, 14.1, 
1 H), 2.69 (dd, J = 10.7, 23.5, 1 H), 1.96 (dd, J = 7.0, 7.0, 1 H), 1.93-1.81 (m, 
2 H), 1.63-1.50 (m, 3 H), 1.46 (s, 3 H, H3C(9)),  1.14 (d, J = 6.7, 3 H, 
H3C(15)) 
 13C-NMR: (126 MHz, CDCl3) 
220.6, 171.5, 152.6, 148.8, 141.2, 118.3, 118.2, 112.6, 75.9, 75.0, 58.3, 50.9, 
42.7, 31.3, 26.3, 24.3, 17.7   
 TLC: Rf  0.34  (hexanes/EtOAc, 3:1) [I2] 
 CSFC:  tR= 7.98 min (1%) and 9.88 (99%) (Chiralpak AD, 125 bar, 40 °C, 15 % 
MeOH in CO2, 3.0 mL/min, 220 nm)  
 
Preparation of (3R,5aS,7aS,7bR)-Octahydro-5-methyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizin-1-one  (20) 
 
To a 50-mL, three-necked, round-bottomeded flask fitted with a nitrogen inlet adapter, a 
magnetic stir bar, and an internal temperature probe was added 18 (505 mg, 2.59 mmol), CH2Cl2 
(10.8 mL), and DMSO (2.2 mL).  The resulting solution was cooled to –12 oC in an ice/NaCl 
bath.  To this solution was added diisopropylethylamine (2.25 mL, 12.9 mmol, 5.0 equiv) 
followed by the dropwise addition of a solution of SO3•pyridine complex (1.24 g, 7.76 mmol, 3 
equiv) in DMSO (4.3 mL) while maintaining an internal temperature < –5 oC.  After being stirred 
for 20 min at –10 oC, the cooling bath was removed and the mixture was allowed to warm to 
room temperature.  This mixture was poured into a 250-mL separatory funnel and the layers 
were separated.  The aqueous extract was washed with Et2O (2 x 25 mL).  The organic extracts 
were washed with sat. aq. CuSO4 solution (2 x 25 mL), sat. aq. NaHCO3 solution (1 x 25 mL), 
brine (25 mL), the combined organic extracts dried over MgSO4, filtered through a Celite (20 
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mm x 5 cm, cotton plug), and rinsed with TBME (3 x 10 mL).The filtrate is concentrated in 
vacuo (15 mm Hg, 20-25 oC) to afford 498 mg (99%) of 20 as a white solid.  
Data for 20: 
 1H-NMR: (500 MHz, CDCl3) 
3.98 (d, J = 18.1, 1 H, HC(2)), 3.49 (d, J = 18.1, 1 H, HC(2)), 3.39 (dd, J = 
6.4, 12.8, 1 H, HC(4)), 3.23 (dd, J = 12.4, 12.4, 1 H, HC(4)), 2.59 (d, J = 8.1, 
1 H, HC(7a)), 2.28-2.23 (m, 1 H, HC(7)), 2.15-2.07 (m, 2 H, HC(6), HC(5a)), 
2.09-1.96 (m, 2 H, HC(7), HC(5)), 1.66 (s, 3 H, H3C(8)), 1.46-1.38 (m, 1 H, 
HC(6)), 1.10 (d, J = 6.5, 3 H, H3C(9)), 0.8-2.5 (br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
212.4 (C(1)), 87.3 (C(7b)), 72.0 (C(4)), 70.3 (C(2)), 60.9 (C(5a)), 57.9 
(C(7a)), 38.1 (C(5)), 32.54 (C(7 or 6)), 32.45 (C(7 or 6)), 24.8 (C(8)), 17.5 
(C(9)) 
 IR: (NaCl plate, film) 
2965 (s), 2964(s), 2963 (s), 2962 (m), 1757 (s), 1457 (w), 1383 (w), 1215 (s), 
1163 (s), 745 (s)  
 MS: (EI, 70 eV) 
192 (100), 180 (50), 166 (32), 151 (71), 149 (67), 136 (32), 123 (19), 95 (44), 
81 (100) 
 Mol. Formula: C11H20BNO (193.09) 
 HRMS: C11H19BNO
+: (192.1560) 
 Calcd: 193.1560 
 Found:  192.1560 
 TLC: Rf  0.45  (CH2Cl2/Et2O, 19:1) [I2, CAM] 
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Preparation of Scaffold for Library V via (α-Keto Lactam 23).  
Preparation of (3R,5S,5aS,7aS,7bR)-Octahydro-5-methyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizin-1,2-one (23) 
 
To a 50-mL, three-necked, round-bottomed flask fitted with a nitrogen inlet adapter, a 
magnetic stir bar, and an internal temperature probe was added 5 (491 mg, 2.51 mmol), CH2Cl2 
(10.5 mL), and DMSO (2.1 mL).  The resulting solution was cooled to –12 oC in an ice/salt bath.  
To this solution was added diisopropylethylamine (2.2 mL, 12.6 mmol, 5.0 equiv) followed by 
the dropwise addition of a solution of SO3•pyridine complex (1.2 g, 7.54 mmol, 3.0 equiv) in 
DMSO (5.2 mL) while maintaining an internal temperature < –5 oC.  After being stirred for 20 
min at –10 oC, the mixture was allowed to warm to room temperature.  The mixture was then 
cooled to 0 oC and diluted with CH2Cl2 (25 mL) and H2O (25 mL).  This mixture was poured into 
a 250-mL separatory funnel and the layers were separated.  The aqueous extract was washed 
with CH2Cl2 (2 x 25 mL).  The organic extracts were washed with sat. aq. CuSO4 solution (2 x 
25 mL), sat. aq. NaHCO3 solution (1 x 25 mL), brine (25 mL), the combined organic extracts 
dried over MgSO4, filtered (cotton plug), and rinsed with TBME (3 x 10 mL).  The resulting 
pale-yellow oil was purified by silica gel column chromatography ((10 mm x 10 cm column,) 
gradient elution, hexanes/EtOAc, 3:1, 1:1, 1:3, 1:9, 100 mL each) followed by recrystallization 
(hexanes/TBME, 1:1, 25 mL) to afford 485 mg (82%) of 23 as white needles and as a single 
diastereomer. 
Data for 23: 
 mp: 83-84 oC (MTBE/Hexanes) 
 1H-NMR: (500 MHz, CDCl3) 
4.36 (ddd, J = 1.2, 7.7, 12.3, 1 H, HC(4)), 2.98 (dd, J = 7.8, 12.0, 1 H, HC(4)), 
2.71 (dd, J = 5.6, 9.0, 1 H, HC(7a)), 2.13-2.04 (m, 1 H, HC(7)), 2.06-1.97 (m, 
3 H, HC(6), HC(5a), HC(5)), 1.77-1.70 (m, 1 H, HC(7)), 1.45 (s, 3 H, 
H3C(8)), 1.40-1.32 (m, 1 H, HC(6)), 1.20 (d, J = 5.9, 3 H, H3C(9))  
 13C-NMR: (126 MHz, CDCl3) 
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203.6 (C(1)), 160.4 (C(2)), 74.4 (C(7b)), 57.0 (C(5a)), 55.8 (C(7a)), 51.9 
(C(4)), 41.0 (C(5)), 32.8 (C(6)), 30.7 (C(7)), 25.1 (C(8)), 19.8 (C(9)) 
 IR: (NaCl plate, film) 
3496 (w), 3404 (w), 2961 (s), 2873 (s), 1760 (s), 1713 (s), 1462 (s), 1401 (s), 
1332 (w), 1226 (s), 1180 (s), 1084 (m), 678 (w) 
 MS: (EI, 70 eV) 
193 (26), 165 (26), 150 (32), 122 (6), 107 (11), 93 (5), 81 (100) 
 TLC: Rf  0.35  (hexanes/EtOAc, 3:1) [I2] 
 Analysis: C11H15N:  (193.24) 
 Calcd:  C, 68.37; H, 7.82; N, 7.25 
 Found:  C, 68.57; H, 8.02; N, 7.31 
 
Preparation of (1R,3R,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-5-methyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizin•Borane (18) and (1S,3R,5S,5aS,7aS,7bR)-Octahydro-1-
hydroxy-5-methyl -7b-methyl-2Hcyclopenta[gh]pyrrolizin•Borane (S3) 
 
To a 25-mL, two-necked, round-bottomed flask equipped with a nitrogen adapter, a 
rubber septum and a magnetic stir bar was added sequentially 20 (63 mg, 0.326 mmol), THF (1.6 
mL, 0.2 M), and BH3•THF complex (1.6  mL, 1.0 M solution, 5.0 equiv) dropwise over 5 min 
during which gas evolution was observed.  After being stirred for 2 h at room temperature, the 
reaction was quenched with methanol (5 mL) and the resulting solution was concentrated by 
rotary evaporation (15 mm Hg, 20-25oC) to afford crude S3 as a mixture of diastereomers (5/9, 
1H-NMR).  The crude mixture was purified by silica gel column chromatography (1.8 cm x 8 cm 
column, gradient elution, CH2Cl2/ether,  99:1, 49:1, 24:1, 47:3, 9:1, 25 mL each) to afford 22 mg 
(35%) of S3 as a white solid. 
Data for S3: 
 1H-NMR: (500 MHz, CDCl3) 
3.88 (dd, J = 4.4, 10.6, 1 H, HC(1)), 3.74 (d, J = 10.8, 1 H, OH)), 3.56 (d, J = 
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12.7, 1 H, HC(2)), 3.37 (dd, J = 4.4, 12.7, 1 H, HC(2)), 3.24 (dd, J = 5.2, 12.7, 
1 H, HC(4)), 2.85 (dd, J = 12.2, 12.2, 1 H, HC(4)), 2.39 (dd, J = 9.1, 9.1, 1 H, 
HC(7a)), 2.11-2.04 (m, 1 H, HC(7)), 1.91-1.84 (m, 2 H, HC(5a), HC(5)), 
1.77-1.68 (m, 1 H, HC(6)), 1.66-1.63 (m, 1 H, HC(6)), 1.60 (s, 3 H, H3C(8)), 
1.41-1.32 (m, 1 H, HC(7)), 1.01 (d, J = 5.8, 3 H, H3C(9)), 0.8-2.5 (br, 3 H, 
(H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
88.5 (C(7b)), 76.0 (C(1)), 71.1 (C(4)), 69.2 (C(2)), 62.1 (C(5a)), 61.4 (C(7a)), 
34.8 (C(5)), 31.2 (C(7)), 29.6 (C(6)), 26.0 (C(8)), 16.5 (C(9)) 
 IR: (CDCl3) 
3492 (s), 2964 (s), 2922 (s), 2869 (s), 2369 (s), 2318 (s), 2270 (s), 1454 (s), 
1412 (m), 1381 (m), 1348 (m), 1250 (m), 1186 (s), 1160 (m) 1121 (m), 1048 
(s), 1023 (m), 996 (m), 973 (m), 925 (m), 869 (m), 844 (w), 818 (w), 802 (w) 
 MS: (EI, 70 eV) 
194.2 (78), 181 (24), 166 (100), 150 (3), 138 (12), 124 (10), 110 (44), 96 (11), 
84 (14) 
 Mol. Formula: C11H22BNO  (195.11) 
 HRMS: C11H21BNO, (194.1716) 
 Calcd:  194.1716 
  Found:  194.1720 
 TLC: Rf  0.61  (CH2Cl2/ether, 9:1) [I2] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-5-methyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizin•Borane (18) 
 
To a 250-mL round-bottomed flask equipped with a nitrogen inlet adapter, a rubber 
septum and a magnetic stir bar was added sequentially 5 (931 mg, 4.77 mmol), THF (23.9 mL, 
0.2 M), and BH3•THF complex (23.9 mL, 1.0 M solution, 10.0 equiv) dropwise over 5 min 
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during which gas evolution was observed.  After being stirred for 4 h at room temperature, the 
reaction was quenched with methanol (40 mL) and the mixture was concentrated by rotary 
evaporation (15 mm Hg, 20-25 oC).  The resulting colorless oil was purified by silica gel column 
chromatography (2 cm x 15 cm column, gradient elution, CH2Cl2/ether, 99:1, 49:1, 24:1, 47:3, 
9:1, 100 mL each) to afford 875 mg (94%) of 18 as a white solid. 
Data for 18: 
 mp: 86.5-87.5 oC 
 1H-NMR: (500 MHz, CDCl3) 
4.81 (ddd, J = 7.2, 7.2, 10.5, 1 H, HC(1)), 3.46 (dd, J = 6.6, 10.3, 1 H, 
HC(2)), 3.17 (dd, J = 6.2, 12.5, 1 H, HC(4)), 3.02 (dd, J = 10.5, 10.5, 1 H, 
HC(2)), 2.82 (dd, J = 12.5, 12.5, 1 H, HC(4)), 2.34 (dd, J = 8.2, 17.0, 1 H, 
HC(7a)), 2.11-2.01 (m, 1 H, HC(5)), 1.94-1.85 (m, 2 H, HC(7), HC(5a)), 
1.81-1.76 (m, 1 H, HC(6)), 1.76-1.67 (m, 2 H, HC(7), HC(6)), 1.56 (br, s, 1 H, 
OH), 1.50 (s, 3 H, H3C(8)), 1.03 (d, J = 6.4, 3 H, H3C(9)), 0.8-2.5 (br, 3 H, 
(H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
88.1 (C(7b)), 70.0 (C(4)), 68.8 (C(1)), 65.7 (C(2)), 62.0 (C(5a)), 55.1 (C(7a)), 
34.6 (C(5)), 29.7 (C(7)), 26.4 (C(6)), 25.7 (C(8)), 16.4 (C(9)) 
 IR: (CHCl3 film) 
3447 (br), 2962 (s), 2963 (s), 2964 (s), 2965 (m), 2378 (s), 2377 (s), 2375 (s), 
1474 (m), 1457 (m), 1381 (w), 1214(s), 1166 (s), 1118 (m), 1088 (m), 141 
(w), 1010 (w), 995 (w), 946 (w), 755 (s),  
 MS: (EI, 70 eV) 
194 ([M+-1],8), 181 (16), 166 (100), 110 (60), 96 (12), 82 (8) 
 TLC: Rf  0.36  (CH2Cl2/ether, 9:1) [I2] 
 Analysis: C11H22BNO,  (195.1095) 
Calcd: C, 67.71; H, 11.37; N, 7.18 
Found: C, 67.8%; H, 11.31; N, 7.06 
 Opt. Rot.: [α]-./ -11.14o ( c = 1.0, CHCl3) 
 
III. Parallel Syntheses:  Library Intermediates and Quaternary Ammonium Bromides.  
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7.3.2. A. Variable Group R
2
:  Organometal Ketone Additions. 
Cerium-Mediated Additions to Keto Amine 19.  Preparation of (1S,3S,5aS,7aS,7bR)-
Octahydro-1-hydroxy-1-methyl-7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (21{2}) 
 
To a 25-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added CeCl3•7H2O (559 mg, 1.50 mmol, 1.5 equiv).  
The flask was immersed in a preheated oil bath (140 oC) under vacuum (< 0.1 mm Hg) for 2 h.   
The flask was backfilled with nitrogen, allowed to cool to room temperature, and then immersed 
in an ice bath.  To the solid was added THF (4.0 mL), via syringe, and the resulting milky, 
heterogenous mixture was allowed to stir vigorously at room temperature for 2 h.  The mixture 
was then sonicated and stirred intermittently for 15 min intervals over a 2 h time period.  The 
flask was then immersed in an ice bath and methylmagnesium bromide (2.7 M, 556 µL, 1.5 
mmol, 1.5 equiv) was added via syringe.  The ice bath was removed and the solution was stirred 
at room temperature for 1.5 h.  The flask was immersed in an ice bath and ketone 19 (179 mg, 
1.0 mmol) was added as a solution in THF (1.0 mL) via syringe.  After stirring for 30 min while 
immersed in an ice bath, the reaction was quenched with sat. aq. NH4Cl solution (5.0 mL).  The 
biphasic mixture was poured into a 125-mL separatory funnel containing sat. aq. NH4Cl solution 
(20 mL) and Et2O (20 mL).  The layers were separated and the aqueous extract was washed with 
Et2O (2 x 25 mL).  The organic extracts were washed with sat. aq. NaHCO3 (1 x 25 mL), brine (1 
x 25 mL), and the combined organic extracts were dried over MgSO4, filtered (cotton plug), and 
concentrated by rotary evaporation (15 mm Hg, 20-25oC).  The resulting pale-yellow oil was 
purified by silica gel column chromatography (2 cm x 8 cm, gradient elution, CH2Cl2/EtOAc, 
1:0, 99:1, 49:1, 19:1, 50 mL each) to afford 21{2} (134 mg, 68%) as a white solid. 
Data for 21{2}: 
 1H-NMR: (500 MHz, CDCl3) 
3.88 (ddd, J = 6.3, 10.6, 10.3, 1 H, HC(4)), 3.37 (d, J = 13.4, 1 H, HC(2)), 
3.33 (d, J = 13.6, 1 H, HC(2)), 3.31-3.27 (m, 1 H, HC(4)), 2.35-2.34 (m, 1 H, 
HC(5a), HC(5)), 2.16-2.13 (m, 1 H, HC(7a)), 1.96-1.89 (m, 2 H, HC(7), 
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HC(6)), 1.80-1.68 (m, 2 H, HC(7), HC(6)), 1.54-1.49 (m, 1 H, HC(5)), 1.50 
(s, 3 H, H3C(8), 1.41 (s, 3 H, H3C(9)), 0.8-2.5 (br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
89.2 (C(7b)), 78.1 (C(1)), 74.7 (C(2)), 63.7 (C(7a)), 63.6 (C(4)), 52.2 (C(5a)), 
34.6 (C(6)), 30.5 (C(8 or 9)), 29.6 (C(5)), 27.3 (C(7)), 25.8 (C(8 or 9)) 
 IR: (thin film) 
3503 (s), 2383 (s), 2329 (s), 2277 (s), 1301 (m), 1258 (m), 1178 (m), 1124 
(w), 1070 (m), 1018 (w), 953 (w), 850 (w) 
 
 MS: (EI, 70eV) 
194.2 (93), 181 (34), 166 (50), 138 (6), 110 (57), 96 (100), 81 (18) 
 Mol. Formula: C11H22BNO  (195.18) 
 HRMS: C11H21BNO
+ (194.1716) 
  Calcd:  194.1716 
  Found:  194.1714 
 TLC: Rf  0.25  (CH2Cl2/EtOAc, 19:1) [I2, CAM] 
 
Preparation of (1S,3S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-isopropyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizine•Borane (21{3}) 
 
To a 25-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added CeCl3•7H2O (559 mg, 1.50 mmol, 1.5 equiv).  
The flask was immersed in a preheated oil bath (140 oC) and stirred under vacuum (< 0.1 torr) 
for 2 h.  The flask was backfilled with nitrogen, allowed to cool to room temperature, and then 
immersed in an ice bath.  To the solid was added THF (4.0 mL), and the resulting milky, 
heterogenous mixture was allowed to stir vigorously at room temperature for 2 h.  The mixture 
was then sonicated and stirred intermittently for 15 min intervals over a 2 h time period.  The 
flask was then immersed in an ice bath and isopropylmagnesium chloride (1.9 M, 811 µL, 1.5 
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mmol, 1.5 equiv) was added via syringe.  The ice bath was removed and the solution was stirred 
at room temperature for 1.5 h.  The flask was immersed in an ice bath and ketone 19 (179 mg, 
1.0 mmol) was added as a solution in THF (1.0 mL) via syringe.  After stirring for 30 min while 
immersed in an ice bath, the reaction was quenched with sat. aq. NH4Cl solution (5.0 mL).  The 
biphasic mixture was poured into a 125-mL separatory funnel containing sat. aq. NH4Cl solution 
(20 mL) and Et2O (20 mL).  The layers were separated and the aqueous extract was washed with 
Et2O (2 x 25 mL).  The organic extracts were washed with sat. aq. NaHCO3 (1 x 25 mL), brine (1 
x 25 mL), and the combined organic extracts were dried over MgSO4, filtered (cotton plug), and 
concentrated by rotary evaporation (15 mm Hg, 20-25oC).  The resulting pale-yellow oil was 
purified by silica gel column chromatography (1.8 cm x 8 cm, gradient elution, CH2Cl2/EtOAc, 
1:0, 99:1, 49:1, 19:1, 50 mL each) to afford 21{3} (89 mg, 40%) as a white solid. 
Data for 21{3}: 
 1H-NMR: (500 MHz, CDCl3) 
3.98 (ddd, J = 6.6, 11.1, 11.5, 1 H, HC(4)), 3.39 (d, J = 13.8, 1 H, HC(2)), 
3.35 (d, J = 9.0, 1 H, HC(2)), 3.34-3.31 (m, 1 H, HC(4)), 2.46-2.43 (m, 2 H, 
HC(5a), HC(5)), 2.20-2.17 (m, 1 H, HC(7a)), 2.00-1.90 (m, 2 H, HC(7), 
HC(6)), 1.80 (m, 1 H, HC(6)), 1.74-1.67 (m, 1 H, HC(7)), 1.67-1.60 (m, 1 H, 
HC(9)), 1.53-1.49 (m, 1 H, HC(5)), 1.48 (s, 3 H, H3C(8)), 1.40 (br, s, 1 H, 
OH), 0.91 (d, J = 2.4, 3 H, H3C(10), 0.90 (d, J = 2.5, 3 H, H3C(10’)), 0.8-2.5 
(br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
89.0 (C(7b), 82.4 (C(1)), 74.2 (C(2)), 63.2 (C(4)), 62.5 (C(7a)), 51.4 (C(5a)), 
39.7 (C(9)), 35.5 (C(6)), 30.0 (C(5)), 27.9 (C(7)), 25.5 (C(8)), 16.9 (C(10)), 
16.7 (C(10`)) 
 
 IR: (thin film) 
3433 (s), 2411 (m), 2319 (s), 2270 (s), 1309 (w), 1280 (S), 1162 (m), 1070 
(w), 988 (m), 975 (w), 849 (w), 703 (w) 
 MS: (ESI, Q-tof) 
222 (89), 209 (50), 194 (34), 178 (18), 166 (16), 124 (21), 110 (65), 96 (100), 
81 (20) 
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 Mol. Formula: C13H26BNO (223.16) 
 HRMS: C13H25BNO (222.2029) 
  Calcd:  222.2029 
  Found:  222.2030 
 TLC: Rf  0.40  (hexanes/EtOAc, 4:1) [I2, CAM] 
 
Preparation of (1S,3S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-phenyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizine•Borane (21{5}) 
 
To a 25-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added CeCl3•7H2O (559 mg, 1.50 mmol, 1.5 equiv).  
The flask was immersed in a preheated oil bath (140 oC) and stirred under vacuum (< 0.1 torr) 
for 2 h.   The flask was backfilled with N2, allowed to cool to room temperature, and then 
immersed in an ice bath.  To the solid was added THF (4.0 mL), and the resulting milky, 
heterogenous mixture was allowed to stir vigorously at room temperature for 2 h.  The mixture 
was then sonicated and stirred intermittently for 15-min intervals over a 2 h time period.  The 
flask was then immersed in an ice bath and phenylmagnesium bromide (3.0 M, 500 µL, 1.5 
mmol, 1.5 equiv).  The ice bath was removed and the solution was stirred at room temperature 
for 1.5 h.  The flask was immersed in an ice bath and ketone 19 (179 mg, 1.0 mmol) was added 
as a solution in THF (1.0 mL) via syringe.  After stirring for 30 min while immersed in an ice 
bath, the reaction was quenched with sat. aq. NH4Cl solution (5.0 mL).  The biphasic mixture 
was poured into a 125-mL separatory funnel containing sat. aq. NH4Cl solution (20 mL) and 
Et2O (20 mL).  The layers were separated and the aqueous extract was washed with Et2O (2 x 25 
mL).  The organic extracts were washed with sat. aq. NaHCO3 (1 x 25 mL), brine (1 x 25 mL), 
and the combined organic extracts were dried over MgSO4, filtered (cotton plug), and 
concentrated by rotary evaporation (15 mm Hg, 20-25oC).  The resulting pale-yellow oil was 
purified by silica gel column chromatography (1.8 cm x 8 cm, gradient elution, CH2Cl2/EtOAc, 
1:0, 99:1, 49:1, 19:1, 50 mL each) to afford 21{5} (131 mg, 51%) as a white solid. 
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Data for 21{5}: 
 1H-NMR: (500 MHz, CDCl3) 
7.42-7.36 (m, 4 H, HC(10), HC(11)), 7.33-7.28 (m, 1 H, HC(12)), 4.28-4.20 
(m, 1 H, HC(4)), 3.81 (d, J = 13.9, 1 H, HC(2)), 3.68 (d, J = 13.9, 1 H, 
HC(2)), 3.45-3.40 (m, 1 H, HC(4)), 2.75 (dd, J = 3.0, 8.3, 1 H, HC(7a)), 2.45-
2.36 (m, 2 H, HC(5a), HC(5)), 2.12-2.02 (m, 2 H, HC(7), HC(6)), 1.94-1.78 
(m, 3 H, HC(7), HC(6), OH), 1.63-1.58 (m, 1 H, HC(5)), 1.58 (s, 3 H, 
H3C(8)), 0.8-2.5 (br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
145.1 (C(9)), 129.0 (C(10 or 11)), 128.0 (C(10 or 11)), 124.9 (C(12)), 89.2 
(C(7b)), 82.1 (C(1)), 74.9 (C(2)), 64.3 (C(7a)), 63.3 (C(4)), 52.2 (C(5a)), 35.2 
(C(6)), 29.7 (C(5)), 27.3 (C(7)), 25.9 (C(8)) 
 IR: (thin film) 
3433 (s), 2411 (m), 2319 (s), 2270 (s), 1309 (w), 1280 (S), 1162 (m), 1070 
(w), 988 (m), 975 (w), 849 (w), 703 (w) 
 MS: (EI, 70 eV) 
254.2 (62), 243.2 ([M+], 66), 228 (20), 210 (10), 178 (8), 158 (48), 149 (15), 
138 (11), 123 (46), 110 (100) 
 Mol. Formula: C16H24BNO; 257.18 
 HRMS: C16H21NO: (243.1623) 
  Calcd:  243.16232 
  Found:  243.16251 
 TLC: Rf  0.20  (CH2Cl2/EtOAc, 19:1) [I2, CAM]
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Cerium Mediated Additions to 20. Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-
hydroxy-1-methyl-5-methyl-7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (22{2}) 
 
To a 100-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added CeCl3•7H2O (2.30 g, 8.70 mmol, 1.5 equiv).  
The flask was immersed in a preheated oil bath (140 oC) and stirred under vacuum (~0.1 torr).  
After 2 h the flask was backfilled with nitrogen, allowed to cool to room temperature, and then 
immersed in an ice bath.  To the solid was added THF (25 mL), and the resulting milky, 
heterogenous mixture was allowed to stir vigorously at room temperature for 2 h.  The mixture 
was then sonicated and stirred intermittently for 15 min intervals over a 2 h time period.  The 
flask was then immersed in an ice bath and methylmagnesium bromide (3.0 M, 3.0 mL, 1.50 
mmol, 1.5 equiv).  The ice bath was removed and the solution was stirred at room temperature 
for 1.5 h.  The flask was immersed in an ice bath and ketone 20 (1.12 g, 5.80 mmol) was added 
as a solution in THF (4.0 mL).  After being stirred for 30 min while immersed in an ice bath, the 
reaction was quenched with sat. aq. NH4Cl solution (20 mL).  The biphasic mixture was poured 
into a 250-mL separatory funnel containing sat. aq. NH4Cl solution (30 mL) and Et2O (40 mL).  
The layers were separated and the aqueous extract was washed with Et2O (2 x 50 mL).  The 
organic extracts were washed with sat. aq. NaHCO3 (1 x 50 mL), brine (1 x 50 mL), and the 
combined organic extracts were dried over MgSO4, filtered (cotton plug), and concentrated by 
rotary evaporation (15 mm Hg, 20-25oC).  The resulting pale-yellow oil was purified by silica 
gel column chromatography (2 cm x 12 cm, gradient elution, CH2Cl2/ether, 1:0, 99:1, 49:1, 24:1, 
9:1, 4:1, 100 mL each) to afford 22{2} (1.1 g, 87%) as a white solid. 
Data for 22{2}: 
 mp: 84-85 oC (MTBE:Hexanes) 
 1H-NMR: (500 MHz, CDCl3) 
3.43 (d, J = 12.0, 1 H, HC(2)), 3.28 (dd, J = 6.8, 12.6, 1 H, HC(4)), 3.25 (d, J 
= 12.3, 1 H, HC(2)), 2.97 (dd, J = 12.2, 12.2, 1 H, HC(4)), 2.13 (162et, J = 
4.8, 8.1, 9.6, 12.7, 1 H, HC(5)), 2.06 (ddd, J = 8.2, 8.2, 7.8, 1 H, HC(7a)), 
2.02-1.96 (m, 1 H, HC(7)), 1.85 (dd, J = 7.0, 7.0, 1 H, HC(5a)), 1.83-1.70 (m, 
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3 H, HC(7), HC(6), HC(6)), 1.61 (s, 3 H,H3C(9)), 1.52 (s, 3 H, H3C(8)), 1.38 
(d, J = 4.7, 1 H, OH), 0.99 (d, J = 6.5, 3 H, H3C(10)), 0.8-2.5 (br, 3 H, 
(H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
88.9 (C(7b)), 75.5 (C(1)), 74.9 (C(2)), 73.4 (C(4)), 61.9 (C(7a)), 61.8 (C(5a)), 
34.0 (C(5)), 31.0 (C(9)), 29.7 (C(6)), 27.1 (C(7)), 26.0 (C(8)), 16.5 (C(10)) 
 
 IR: (CHCl3) 
3969 (br), 2962 (s), 2870 (s), 2380 (s), 2331 (s), 2276 (s), 1459 (s), 1381 (s), 
1340 (m), 1180 (s), 1134 (s), 1064 (s), 1049 (w), 1019 (w), 960 (s), 871 (w), 
826 (m) 
 MS: (EI, 70 eV) 
208 (4), 195 (16), 180 (48), 124 (28), 110 (100), 96 (16), 81 (8) 
 Mol. Formula: C12H24BNO (209.14) 
 HRMS: C12H23BNO: (208.1873) 
  Calcd:  208.1873 
  Found:  208.1875 
 TLC: Rf  0.33  (CH2Cl2/Et2O, 19:1) [I2, CAM] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-isopropyl-5-methyl-7b-
methyl-2Hcyclopenta[gh]pyrrolizine•Borane (22{3}) 
 
To a 100-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added CeCl3•7H2O (2.90 g, 7.77 mmol, 1.5 equiv).  
The flask was immersed in a preheated oil bath (140 oC) and stirred under vacuum (~0.1 torr).  
After 2 h the flask was backfilled with nitrogen, allowed to cool to room temperature, and then 
immersed in an ice bath.  To the solid was added THF (22 mL), and the resulting milky, 
heterogenous mixture was allowed to stir vigorously at room temperature for 2 h.  The mixture 
N
H H
MeO
Me
BH3
7a 5a
N1
2 4
5
7 6
H H
Me
8
Me
BH3
9
HO
Me
Me
11
CeCl3
i-PrMgCl
THF 0 oC
22{3}20
164 
 
was then sonicated and stirred intermittently for 15 min intervals over a 2 h time period.  The 
flask was then immersed in an ice bath and isopropyl magnesium chloride (1.8 M, 4.3 mL, 1.50 
mmol, 1.5 equiv) was added via syringe.  The ice bath was removed and the solution was stirred 
at room temperature for 1.5 h.  The flask was immersed in an ice bath and ketone 20 (1.0 g, 5.18 
mmol) was added as a solution in THF (4.0 mL).  After stirring for 30 min while immersed in an 
ice bath, the reaction was quenched with sat. aq. NH4Cl solution (20 mL).  The biphasic mixture 
was poured into a 250-mL separatory funnel containing sat. aq. NH4Cl solution (30 mL) and 
Et2O (40 mL).  The layers were separated and the aqueous extract was washed with Et2O (2 x 50 
mL).  The organic extracts were washed with sat. aq. NaHCO3 (1 x 50 mL), brine (1 x 50 mL), 
and the combined organic extracts were dried over MgSO4, filtered (cotton plug), and 
concentrated by rotary evaporation (15 mm Hg, 20-25oC).  The resulting pale-yellow oil was 
purified by silica gel column chromatography (2 cm x 10 cm, gradient elution, CH2Cl2/ether, 1:0, 
99:1, 49:1, 24:1, 47:3, 9:1, 17:3, 100 mL each) to afford 22{3} (931 mg, 79%) as a pale yellow 
oil. 
Data for 22{3}: 
 1H-NMR: (500 MHz, CDCl3) 
3.60 (d, J = 13.5, 1 H, HC(2)), 3.51 (dd, J = 7.9, 12.2, 1 H, HC(4)), 3.31 (d, J 
= 13.5, 1 H, HC(2)), 3.16 (dd, J = 10.7, 12.1, 1 H, HC(4)), 2.42–2.32 (m, 1 H, 
HC(5)), 2.18 (dd, J = 7.0, 9.1, 1 H, HC(7a)), 2.09–1.98 (m, 1 H, HC(7)), 
1.89–1.83 (m, 3 H, HC(6), HC(6), HC(5a)), 1.82–1.69 (m, 2 H, HC(7), 
HC(9)), 1.49 (s, 3 H, H3C(8)), 1.37 (br, s, 1 H, OH), 0.99 (d, J = 6.6, 3 H, 
H3C(12)), 0.91 (d, J = 6.8, 3 H, H3C(10)), 0.87 (d, J = 6.9, 3 H, H3C(11)), 
0.8–2.5 (br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
89.4 (C(7b)), 80.2 (C(1)), 77.1 (C(2)), 74.1 (C(4)), 60.9 (C(7a)), 60.0 (C(5a)), 
38.3 (C(9)), 34.5 (C(5)), 31.3 (C(6)), 25.4 (C(7)), 25.3 (C(8)), 17.6 (C(12)), 
17.0 (C(10)), 16.8 (C(11)), 
 IR: (CHCl3) 
3507 (br), 2964 (s), 2866 (m), 2380 (s), 2326 (s), 2268 (s), 1465 (m), 1171 
(m), 1000 (w) 
 MS: (EI, 70 eV) 
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236 (18), 234 (24), 223 (23), 208 (30), 192 (7), 180 (15), 124 (36), 110 (100), 
96 (12), 81 (10) 
 Mol. Formula: C14H28BNO  (237.19) 
 HRMS: C14H27BNO: (236.2186) 
  Calcd:  236.2186 
  Found:  236.2183 
 TLC: Rf  0.40  (CH2Cl2/ether, 19:1) [I2, CAM] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-phenyl-5-methyl-7b-
methyl-2Hcyclopenta[gh]pyrrolizine•Borane (22{5}) 
 
To a 50-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added CeCl3•7H2O (1.74 g, 4.66 mmol, 1.5 equiv).  
The flask was immersed in a preheated oil bath (140 oC) and stirred under vacuum (~0.1 torr).  
After 2 h the flask was backfilled with nitrogen, allowed to cool to room temperature, and then 
immersed in an ice bath.  To the solid was added THF (14 mL), and the resulting milky, 
heterogenous mixture was allowed to stir vigorously at room temperature for 2 h.  The mixture 
was then sonicated and stirred intermittently for 15 min intervals over a 2 h time period.  The 
flask was then immersed in an ice bath and phenylmagnesium bromide (2.9 M, 1.6 mL, 1.50 
mmol, 1.5 equiv) was added via syringe.  The ice bath was removed and the solution was stirred 
at room temperature for 1.5 h.  The flask was immersed in an ice bath and ketone 20 (600 mg, 
3.11 mmol) was added as a solution in THF (2.0 mL) via syringe.  After stirring for 30 min while 
immersed in an ice bath, the reaction was quenched with sat. aq. NH4Cl solution (15 mL).  The 
biphasic mixture was poured into a 250-mL separatory funnel containing sat. aq. NH4Cl solution 
(30 mL) and Et2O (40 mL).  The layers were separated and the aqueous extract was washed with 
Et2O (2 x 50 mL).  The organic extracts were washed with sat. aq. NaHCO3 (1 x 50 mL), brine (1 
x 50 mL), and the combined organic extracts were dried over MgSO4, filtered (cotton plug), and 
concentrated by rotary evaporation (15 mm Hg, 20-25oC).  The resulting pale-yellow oil was 
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purified by silica gel column chromatography (1.8 cm x 10 cm, gradient elution, hexanes/TBME, 
9:1, 4:1, 7:3, 1:1, 1:4, 50 mL each) to afford 22{5} (828 mg, 98%) as a white solid. 
Data for 22{5}: 
 mp: 81.5-82 oC (MTBE:Hexanes) 
 1H-NMR: (500 MHz, CDCl3) 
7.37 (d, J = 4.3, 1 H, HC(10), HC(11)), 7.31 (m, 1 H, HC(12)), 4.10 (d, J = 
13.7, 1 H, HC(2)), 3.70 (d, J = 13.6, 1 H, HC(2)), 3.68 (dd, J = 8.3, 12.0, 1 H, 
HC(4)), 3.29 (dd, J = 10.8, 12.1, 1 H, HC(4)), 2.75 (dd, J = 6.1, 9.3, 1 H, 
HC(7a)), 2.64–2.55 (m, 1 H, HC(5)), 2.34–2.37 (m, 1 H, HC(5a)), 1.99–1.93 
(m, 3 H, H2C(7), HC(6)), 1.93–1.83 (m, 1 H, HC(6)), 1.80 (br, s, 1 H, OH), 
1.55 (s, 3 H, H3C(8)), 1.02 (d, J = 6.6, 3 H, H3C(13)), 0.8–2.5 (br, 3 H, 
(H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
146.0 (C(9)), 128.9 (C(11)), 128.0 (C(12)), 125.1 (C(10)), 89.6 (C(7b), 79.3 
(C(1)), 78.8 (C(2)), 74.5 (C(4)), 62.6 (C(5a)), 59.8 (C(7a)), 34.7 (C(5)), 31.5 
(C(7)), 25.1 (C(8)), 24.1 (C(6)), 17.7 (C(13)) 
 IR: (CHCl3 film) 
3475 (br), 2960 (s), 2871 (s), 2377 (s), 2327 (s), 2271 (s), 1494 (w), 1447 (m), 
1266 (w), 1172 (s), 1131 (m), 1067 (w), 1004 (m), 954 (w), 876 (w), 700 (s) 
 MS: (EI, 70 eV) 
268.2 (24), 257.2 (23), 242.1 (11), 224.1 (3), 192.1 (4), 178.1 (4), 158 (14), 
137.1 (11), 124.1 (26), 110.1 (100) 
 Mol. Formula: C17H26BNO (271.21) 
 HRMS: C17H23NO: (257.1780) 
  Calcd: 257.1780 
  Found: 257.1775 
 TLC: Rf  0.58  (hexanes/TBME, 1:1) [I2, CAM] 
 
Grignard Additions to Keto Amide 23. Preparation of (1R,3S,5S,5aS,7aS,7bR)-Octahydro-
1-hydroxy-1-(tert-butyl)-5-methyl-7b-methyl-2Hcyclopenta[gh]pyrrolizin-2-one (24{4}): 
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To a 25-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added 23 (100 mg, 0.518 mmol) followed by THF 
(5.0 mL).  The flask was immersed in an acetone/CO2(s) and stirred for 20 min.  Then, t-BuLi 
(1.6 M, 648 µL, 2.0 equiv) was added dropwise over 5 min via syringe.  After being stirred for 
10 min, the acetone/CO2(s) bath was replaced with an ice bath and the reaction was stirred for 1 
hr.  The reaction was quenched by the dropwise addition of sat. aq. NH4Cl solution (15 mL) and 
further diluted with Et2O (10 mL).  The biphasic mixture was poured into a 125-mL separatory 
funnel containing sat. aq. NH4Cl solution (10 mL) and Et2O (30 mL).  The layers were separated 
and the aqueous extract was washed with Et2O (2 x 25 mL).  The organic extracts were washed 
with H2O (1 x 25 mL), brine (1 x 25 mL), and the combined organic extracts were dried over 
Na2SO4, filtered (cotton plug), and concentrated by rotary evaporation (15 mm Hg, 20-25
oC).  
The resulting pale-yellow oil was purified by silica gel column chromatography (1.8 cm x 6cm, 
gradient elution, hexanes/TBME, 17:3, 5:1, 3:1, 3:1, 3:2, 25 mL each) to afford 24{4} (43 mg, 
33%) as a white solid. 
Data for 24{4}: 
 1H-NMR: (500 MHz, CDCl3) 
4.30 (dd, J = 8.6, 12.2, 1 H, HC(4)), 2.63 (dd, J = 7.3, 12.2, 1 H, HC(4)), 2.55 
(s, 1 H, HC(OH)), 2.38 (d, J =8.0, 1 H, HC(7a)), 2.07 (dd, J = 5.3, 12.7, 1 H, 
HC(7)), 1.99 (dd, J = 7.3, 15.3, 1 H, HC(5)), 1.86 (ddd, J = 6.4, 6.4, 12.8, 1 
H, HC(6)), 1.78 (ddd, J = 2.1, 7.4, 9.8, 1 H, HC(5a)), 1.64–1.56 (m, 1 H, 
HC(7)), 1.40 (s, 3 H, H3C(8) ), 1.11 (d, J = 7.1, 3 H, H3C(11)), 1.09–1.02 (m, 
1 H, HC(6)), 0.97 (s, 9 H, H3C(10)) 
 13C-NMR: (126 MHz, CDCl3) 
179.3 (C(2)), 83.2 (C(1 or 7b)), 76.6 (C(1 or 7b)), 59.3 (C(5a)), 51.4 (C(4)), 
49.6 (C(7a)), 37.8 (C(5)), 37.3 (C(10)), 33.9 (C(6)), 29.8 (C(7)), 25.0 (C(11)), 
23.9 (C(8)), 21.3 (C(9)) 
 IR: (CDCl3, film) 
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3404 (br), 2958 (s), 2865 (s), 2248 (w), 1678 (s), 1464 (m), 1395 (m), 1365 
(m), 1340 (m), 1230 (w), 1181 (w), 1147 (w), 1115 (w), 1087 (w), 1057 (w), 
1015 (w), 994 (w), 910 (w), 766 (w)  
 MS: (EI, 70 eV) 
251.2 (1), 236.2 (1.8), 218 (1.9), 195.1 (100), 166.1 (2.7), 152.1 (3.1), 140.1 
(2.8), 110.1 (8.7)  
 Mol. Formula: C15H25NO2  (251.36) 
 HRMS: C21H23NO2, (251.1885) 
  Calcd:  251.1885 
  Found:  251.1883 
 TLC: Rf  0.25  (hexanes/TBME, 3:1) [I2] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(2,4,6-trimethly-phenyl)-5-
methyl-7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (24{6}) 
 
To a 25-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added 23 (100 mg, 0.517 mmol) followed by THF 
(2.7 mL).  The flask was immersed in an ice bath and mesitylmagnesium bromide (0.39 M, 2.0 
mL, 1.5 equiv) was added dropwise via syringe.  After being stirred for 10 min, the cooling bath 
was removed and the solution was stirred at room temperature for 20 min.  The reaction flask 
was immersed in an ice bath and the reaction was quenched with sat. aq. NH4Cl solution (15 
mL).  The biphasic mixture was poured into a 125-mL separatory funnel containing sat. aq. 
NH4Cl solution (10 mL) and Et2O (30 mL).  The layers were separated and the aqueous extract 
was washed with Et2O (2 x 25 mL).  The organic extracts were washed with H2O (1 x 25 mL), 
brine (1 x 25 mL), and the combined organic extracts were dried over MgSO4, filtered (cotton 
plug), and concentrated by rotary evaporation (15 mm Hg, 20-25oC).  The resulting pale-yellow 
oil was purified by silica gel column chromatography (1.8 cm x 8 cm, gradient elution, 
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hexanes/EtOAc, 9:1, 4:1, 7:3, 1:1, 25 mL each) to afford 24{6} (157 mg, 97%) as a white solid. 
Data for 24{6}: 
 mp: 101-102 oC (hexanes:EtOAc) 
 1H-NMR: (500 MHz, CDCl3) 
6.92 (s, 1 H, HC(11)), 6.68 (s, 1 H, HC(11)), 4.17 (dd, J = 7.3, 11.7, 1 H, 
HC(4)), 3.47 (s, 1 H, OH), 2.65 (dd, J = 7.6, 10.1, 1 H, HC(4)), 2.64 (dd, J = 
10.4, 11.6, 1 H, HC(5)), 2.48 (s, 3 H, H3C(8, 13, or 14), 2.41 (s, 3 H, H3C(8, 
13, or 14)), 2.22 (s, 3 H, H3C(8, 13, or 14)), 1.98-1.92 (m, 1 H, HC(7)), 1.84-
1.79 (m, 1 H, HC(7a)), 1.78-1.66 (m, 3 H, HC(7), HC(6), HC(5a)), 1.55-1.48 
(m, 1 H, HC(6)), 1.09 (d, J = 6.7, 3 H, H3C(15)), 1.08 (s, 3 H, H3C(8, 13, or 
14)) 
 13C-NMR: (126 MHz, CDCl3) 
179.1 (C(2)), 139.4 (C(9)), 138.3 (C(10 or 12)), 136.6 (C(10 or 12)), 133.9 
(C(10 or 12)), 131.9 (C(11)), 130.8 (C(11)), 82.3 (C(1)), 75.3 (C(7b)), 60.2 
(C(5)), 58.9 (C(7a)), 50.9 (C(4)), 41.7 (C(5a)), 29.9 (C(6)), 27.1 (C(7)), 23.8 
(C(8, 13 or 14)), 22.3 (C(8, 13, or 14)), 21.2 (C(8, 13, or 14)), 20.7 (C(8, 13, 
or 14)), 17.7 (C(15)) 
 IR: (NaCl plate, film) 
3404 (br), 3000 (s), 2959 (s), 2922 (s), 2870 (s), 1693 (s), 1610 (m), 1560 (w), 
1460 (s), 1407 (s), 1379 (m), 1351 (m), 1280 (w), 1232 (m), 1120 (m), 1072 
(m), 1035 (m), 978 (w), 851 (m) 
 MS: (EI, 70 eV) 
313 (10), 295 (84), 285 (4), 280 (6), 270 (3), 252 (5), 147 (100), 138 (10), 124 
(21), 119 (29), 110 (90) 
 Mol. Formula: C20H27NO2 (313.43) 
 HRMS: C20H27NO2: (313.2042) 
  Calcd: 313.2042 
  Found: 313.2045 
 TLC: Rf  0.32  (hexanes/EtOAc, 3:1) [I2, CAM] 
 
Preparation of (1R,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-[1]naphthyl-5-methyl-7b-
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methyl-2Hcyclopenta[gh]pyrrolizin-2-one (24{7}): 
 
To a 25-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added 23 (100 mg, 0.517 mmol) followed by THF 
(2.7 mL).  The flask was immersed in an ice bath and 1-naphthylmagnesium bromide (0.4 M, 2.0 
mL, 1.5 equiv) was added dropwise via syringe.  After being stirred for 10 min, the cooling bath 
was removed and the reaction was stirred at room temperature for 20 min.  The biphasic mixture 
was poured into a 125-mL separatory funnel containing sat. aq. NH4Cl solution (10 mL) and 
Et2O (30 mL).  The layers were separated and the aqueous extract was washed with Et2O (2 x 25 
mL).  The organic extracts were washed with H2O (1 x 25 mL), brine (1 x 25 mL), and the 
combined organic extracts were dried over MgSO4, filtered (cotton plug), and concentrated by 
rotary evaporation (15 mm Hg, 20-25oC).  The resulting pale-yellow oil was purified by silica 
gel column chromatography (1.8 cm x 8 cm, gradient elution, hexanes/EtOAc, 9:1, 4:1, 7:3, 1:1, 
25 mL each) to afford 24{7} (157 mg, 95%) as a white solid. 
Data for 24{7}: 
 mp: 150-151 oC (hexanes/EtOAc) 
 1H-NMR: (500 MHz, CDCl3) 
8.43 (d, J = 8.4, 1 H, HC(11)), 7.87 (d, J = 7.9, 1 H, HC(14)), 7.78 (d, J = 7.9, 
1 H, HC(16)), 7.56-7.48 (m, 2 H, HC(12), HC(13)), 7.34-7.28 (m, 2 H, 
HC(17), HC(18)), 4.27 (dd, J = 6.8, 11.5, 1 H, HC(4)), 3.44 (br, s, 1 H, OH), 
2.96 (dd, J = 7.6, 10.1, 1 H, HC(7a)), 2.69 (dd, J = 10.0, 11.5, 1 H, HC(4)), 
2.21-2.14 (m, 1 H, HC(7)), 2.00-1.92 (m, 1 H, HC(7)), 1.83-1.73 (m, 3 H, 
HC(6), HC(5a), HC(5)), 1.60-1.55 (m, 1 H, HC(6)), 1.11 (d, J = 6.4, 3 H, 
H3C(19)), 0.87 (s, 3 H, H3C(8)) 
 13C-NMR: (126 MHz, CDCl3) 
177.2 (C(2)), 138.9 (C(9)), 135.0 (C(15)), 131.1 (C(10)), 129.3 (C(16)), 129.1 
(C(14)), 126.6 (C(11)), 126.0 (C(12 or 13)), 125.7 (C(12 or 13)), 124.7 (C(17 
or 18)), 124.7 (C(17 or 18)), 84.1 (C(1 or 7b)), 75.9 (C(1 or 7b)), 58.9 (C(5a)), 
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57.9 (C(7a)), 51.2 (C(4)), 41.9 (C(5)), 30.0 (C(6)), 27.0 (C(7)), 24.4 (C(8)), 
17.7 (C(19)) 
 IR: (NaCl plate, film) 
3386 (s), 3050 (w), 3007 (m), 2959 (s), 2871 (s), 1693 (s), 1596 (w), 1509 
(m), 1461 (s), 1411 (s), 1352 (m), 1376 (m), 1330 (m), 1280 (m), 1230 (s), 
1213 (m), 1174 (w), 1131 (s), 1074 (s), 1030 (w), 967 (w), 915 (w), 862 (w), 
802 (s)  
 MS: (EI, 70 eV) 
321 (19), 293 (6), 183 (9), 165 (13), 155 (68), 127 (46), 110 (100) 
 Mol. Formula: C21H23NO2 (321.41) 
 HRMS: C21H23NO2: (321.1729) 
  Calcd: 321.1729 
  Found: 321.1732 
 TLC: Rf  0.28  (hexanes/EtOAc, 3:1) [I2, CAM] 
 
Preparation of (1R,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(tert-butyl)-5-methyl-7b-
methyl-2Hcyclopenta[gh]pyrrolizine•Borane (22{4}): 
 
To a 25-mL, single-necked, round-bottomed flask equipped with a nitrogen inlet adapter, 
a rubber septum, a reflux condenser, and a magnetic stir bar was added sequentially 24{4} (29 
mg, 0.115 mmol), THF (200 µL), and BH3•THF complex (3.3 mL, 1.0 M solution, 20 equiv).  
The reaction flask was immersed in an oil bath and heated to reflux (70 oC).  After being stirred 
for 12 h at reflux, the solution was allowed to reach room temperature, then quenched by 
dropwise addition of methanol (10 mL) and then concentrated by rotary evaporation (15 mm Hg, 
20-25oC).  The resulting colorless oil was purified by silica gel column chromatography (1.8 cm 
x 8 cm column, gradient elution, hexanes/TBME, 19:1, 9:1, 3:1, 3:2, 25 mL each) to afford 27 
mg (93%) of 22{4} as a white solid. 
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Data for 22{4}: 
 1H-NMR: (500 MHz, CDCl3) 
3.80 (d, J = 13.9, 1 H, HC(2)), 3.63 (dd, J =8.5, 12.0, 1 H, HC(4)), 3.23 (d, J 
=13.8, 1 H, HC(2)), 3.23–3.18 (m, 1 H, HC(4)), 2.48–2.40 (m, 1 H, HC(7a)), 
2.41 (dd, J = 6.8, 9.2, 1 H, HC(5)), 2.09–1.99 (m, 1 H, HC(7)), 1.91–1.84 (m, 
3 H, H2C(6), HC(5a)), 1.72–1.63 (m, 1 H, HC(7)), 1.62 (br, s, 1 H, HO), 1.46 
(s, 3 H, H3C(8)), 0.99 (d, J = 6.6, 3 H, H3C(9)), 0.92 (s, 3 H, H3C(11)), 0.8–
2.5 (br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
89.7 (C(1 or 7b)), 83.0 (C(1 or 7b)), 75.7 (C(2)), 74.6 (C(4)), 59.6 (C(5a)), 
56.5 (C(7a)), 37.5 (C(10)), 35.0 (C(5)), 32.1 (C(6)), 25.5 (C(10)), 25.4 (C(7)), 
24.7 (C(8)), 18.1 (C(11)) 
 IR: (CDCl3 film) 
3503 (s), 2961 (s), 2872 (s), 2376 (s), 2327 (s), 2271 (s), 1465 (m), 1400 (w), 
1378 (m), 1335 (w), 1267 (w), 1174 (m), 1140 (m), 1091 (w), 1057 (w), 1002 
(w), 980 (w), 958 (w), 940 (w), 910 (s), 882 (w), 841 (w), 733 (s), 649 (w) 
 MS: (ESI, Q-tof) 
422.2 (10), 344.2 (25), 318.2 (40), 308.2 (100) 
 Mol. Formula: C15H30BNO (251.22) 
 HRMS: C21H26NO: (308.2014) 
  Calcd:  308.2014 
  Found:  308.2011 
 TLC: Rf  0.27  (hexanes/TBME, 3:1) [I2, CAM] 
 
Preparation of (1R,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-mesityl-5-methyl-7b-
methyl-2Hcyclopenta[gh]pyrrolizine•Borane (22{6}): 
 
To a 25-mL round-bottomed flask equipped with a nitrogen inlet adapter, a rubber 
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septum, a reflux condenser, and a magnetic stir bar was added sequentially 24{6} (50 mg, 0.160 
mmol), THF (200 µL), and BH3•THF complex (3.2 mL, 1.0 M solution, 20 equiv).  The reaction 
flask was immersed in an oil bath and heated to reflux (70 oC).  After being stirred for 12 h at 
reflux, the solution was allowed to reach room temperature and was quenched with methanol (5 
mL) and concentrated by rotary evaporation (15 mm Hg, 20-25oC).  The resulting colorless oil 
was purified by silica gel column chromatography (1.8 cm x 8 cm column, gradient elution, 
hexanes/TBME, 19:1, 9:1, 4:1, 3:1,25 mL each) to afford 36 mg (72%) of 22{6} as a white solid. 
Data for 22{6}: 
 mp: 131-132 oC (MTBE/hexanes) 
 1H-NMR: (500 MHz, CDCl3) 
6.81 (s, 2 H, HC(11)), 4.09 (d, J = 14.1, 1 H, HC(9)), 4.02 (d, J = 14.1, 1 H, 
HC(9)), 3.72 (dd, J = 8.2, 12.1, 1 H, HC(4)), 3.29 (dd, J = 9.9, 12.0, 1 H, 
HC(4)), 3.10 (dd, J = 6.0, 8.5, 1 H, HC(7a)), 2.62–2.52 (m, 1 H, HC(5)), 2.52 
(s, 6 H, H3C(13), H3C(13)), 2.40–2.31 (m, 1 H, HC(7)), 2.22 (s, 3 H, 
H3C(14)), 2.06–1.98 (m, 1 H, HC(7)), 1.99–1.93 (m, 3 H, H2C(6), HC(5a)), 
1.51 (s, 3 H, H3C(8)), 1.04 (d, J = 6.7, 3 H, H3C(14)), 0.8–2.5 (br, 3 H, 
(H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
139.1 (C(12)), 136.9 (C(9)), 136.4 (C(10)), 132.5 (C(11)), 88.4 (C(7b)), 82.4 
(C(1)), 79.9 (C(2)), 75.1 (C(4)), 62.5 (C(7a)), 60.6 (C(5a)), 35.4 (C(5)), 31.8 
(C(6)), 27.0 (C(7)), 25.6 (C(8)), 25.1 (C(13 or 14)), 20.4 (C(13 or 14)), 18.2 
(C(15)) 
 IR: (thin film) 
3508 (s), 2383 (s), 2319 (s), 2274 (s), 1606 (m), 1378 (s), 1309 (w), 1287 (w), 
1187 (s), 1128 (w), 1071 (m), 1034 (m), 943 (m), 860 (w), 734 (w) 
 
 MS: (ESI, Q-tof) 
314.2 (12), 300.2 (30), 296.2 (100), 268.2 (25) 
 Mol. Formula: C20H32BNO (313.29) 
 HRMS: C20H30NO: (300.2327) 
  Calcd: 300.2327 
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  Found: 300.2332 
 TLC: Rf  0.33  (hexanes/TBME, 9:1) [I2, CAM] 
 
Preparation of (1R,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-[1]naphthyl-5-methyl-7b-
methyl-2Hcyclopenta[gh]pyrrolizine•Borane (22{7}): 
 
To a 25-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a rubber 
septum, a reflux condenser, and a magnetic stir bar was added sequentially 24{7} (50 mg, 0.156 
mmol), THF (200 µL), and BH3•THF complex (3.1 mL, 1.0 M solution, 20 equiv).  The reaction 
flask was immersed in an oil bath and heated to reflux (70 oC).  After being stirred for 12 h at 
reflux, the solution was allowed to reach room temperature, then quenched with methanol (5 mL) 
and then concentrated by rotary evaporation (15 mm Hg, 20-25oC).  The resulting colorless oil 
was purified by silica gel column chromatography (1.8 cm x 8 cm column, gradient elution, 
hexanes/TBME, 19:1, 9:1, 3:1, 3:2, 25 mL each) to afford 42 mg (85%) of 22{7} as a white 
solid. 
Data for 22{7}: 
 mp: 151-153 oC (MTBE:Hexanes) 
 1H-NMR: (500 MHz, CDCl3) 
8.44 (d, J = 8.5, 1 H, HC(11)), 7.87 (d, J = 7.9, 1 H, HC(14)), 7.81 (d, J = 8.2, 
1 H, HC(16)), 7.67 (d, J = 7.3, 1 H, HC(18)), 7.55–7.47 (m, 2 H, HC(12), 
HC(17)), 7.40 (dd, J = 7.8, 7.8, 1 H, HC(13)), 4.23 (d, J = 13.4, 1 H, HC(2)), 
4.04 (d, J = 13.5, 1 H, HC(2)), 3.66 (dd, J = 7.5, 12.2, 1 H, HC(4)), 3.25–3.19 
(m, 2 H, HC(7a), HC(4)), 2.60–2.50 (m, 1 H, HC(5)), 2.40–2.32 (m, 1 H, 
HC(7)), 2.22 (br, s, 1 H, OH), 2.10–2.01 (m, 1 H, HC(7)), 2.00–1.93 (m, 3 H, 
H2C(6), HC(5a)), 1.54 (s, 3 H, H3C(8)), 1.05 (d, J = 6.5, 3 H, H3C(19)), 0.8–
2.5 (br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
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139.2 (C(9)), 135.3 (C(15)), 131.2 (C(10)), 130.0 (C(16)), 129.6 (C(14)), 
126.4 (C(11)), 126.3 (C(12 or 17)), 125.9 (C(12 or 17)), 124.8 (C(13)), 124.2 
(C(18)), 88.1 (C(7b)), 80.9 (C(1)), 76.5 (C(2)), 74.6 (C(4)), 61.3 (C(5a)), 60.4 
(C(7a)), 34.8 (C(5)), 31.0 (C(6)), 26.8 (C(7)), 25.7 (C(8)), 17.5 (C(19)) 
 IR: (thin film) 
3475 (m), 2383 (s), 2332 (s), 2269 (s), 1596 (w), 1444 (w), 1309 (w), 1202 
(w), 1163 (m), 1134 (m), 1067 (w), 1040 (w), 1000 (w), 933 (w), 872 (w), 808 
(m), 782 (s)  
 MS: (ESI, Q-tof) 
422.2 (10), 344.2 (25), 318.2 (40), 308.2 (100) 
 Mol. Formula: C21H28BNO (321.26) 
 HRMS: C21H26NO, (308.2014) 
  Calcd: 308.2014 
  Found: 308.2011 
 TLC: Rf  0.39  (hexanes/TBME, 3:1) [I2, CAM] 
 
7.3.3. B. Variable Group R
3
:  Williamson Ether Synthesis 
General Procedure (I) for the Preparation of Library Intermediates 
 
To a two-necked, 25-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added sequentially alcohol X (X mg, 0.X mmol) and 
DMF (2.74 mL, ~0.35 M).  The flask was then immersed in an ice/NaCl bath for 15 min.  
Sodium hydride (xx mg, 0.xx mmol, 1.2 equiv) was weighed into a vial in a glove box then 
transferred to the flask in one portion (bubbling was observed).  The resulting solution was 
allowed to stir for 15 min then alkyl bromide (X µL, 0.X mmol, 1.2 equiv) was added via syringe 
in a single portion.  The resulting cloudy mixture was stirred for 2 h, then quenched by pouring 
onto onto ice water (20 mL). This mixture was transferred to a 125-mL separatory funnel where 
an additional 20 mL of water was added and the aqueous phase was extracted with 
dichloromethane (3 x 20 mL). The organic extracts were washed with water (2 x 20 mL), and 
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brine (2x 20 mL), then the combinded organic extracts were dried (MgSO4).  The floculant 
suspension was filtered through a small pad of Celite (1 cm x 2 cm) and concentrated by rotary 
evaporation (15 mm Hg, 20-25oC) to afford a thick oil.  Purification by silica gel 
chromatography (1.8 cm x 8 cm column, gradient elution, hexanes/EtOAc, 1:9, 1:3, 1:1) afforded 
X mg (XX%) of ether X{x}.  
 
Preparation of Amino•Borane Intermediates IV{2-5, 2-3}.  Preparation of 
(1S,3S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-methyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizine•Borane (IV{2,2}) 
 
Following General Procedure I, to a two-necked, 10-mL round-bottomed flask equipped 
with a nitrogen inlet adapter, rubber septum and a magnetic stir bar was added sequentially 
alcohol 21{2} (49 mg, 0.250-mmol), dimethylformamide (2.5 mL, ~0.1 M), then sodium hydride 
(9.0 mg, 0.375 mmol, 1.2 equiv) at 0 oC.  After 15 min, benzyl bromide (60 µL, 0.500 mmol, 1.2 
equiv) was added via syringe.  The solution was stirred for 2 hr then quenched onto ice water (10 
mL).  Extraction and purification by silica gel column chromatography as described in General 
Procedure I afforded 64 mg (89%) of benzyl ether IV{2,2} as a clear, viscous oil. 
Data for IV{2,2}: 
 1H-NMR: (500 MHz, CDCl3) 
7.37–7.26 (m, 5 H, HC(12), HC(13), HC(14)), 4.40 (s, 2 H, H2C(10)), 3.64 
(dd, J = 6.7, 10.3, 1 H, HC(4)), 3.56 (d, J = 13.5, 1 H, HC(2)), 3.25 (dd, J = 
4.5, 11.0, 1 H, HC(4)), 3.24 (d, J = 13.4, 1 H, HC(2)), 2.39–2.33 (m, 1 H, 
HC(5a)), 2.29–2.22 (m, 2 H, HC(7a), HC(5)), 2.22–2.13 (m, 1 H, HC(7)), 
1.86–1.78 (m, 1 H, HC(6)), 1.77–1.69 (m, 2 H, HC(7), HC(6)), 1.49 (s, 3 H, 
H3C(8 or 9)), 1.47 (s, 3 H, H3C(8 or 9)), 1.47–1.43 (m, 1 H, HC(5)), 0.8–2.5 
(br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
N
H HMe
BH3
HO
Me
NaH, BnBr
DMF
7a
7b
6
N
1
2 3
5
7 6
H H8
Me
BH3
O
Me
9
10
11
12
13
14
IV{2}
177 
 
139.0 (C(11)), 129.0 (C(12, 13, or 14)), 128.0 (C(12, 13, or 14)), 127.0 (C(12, 
13, or 14)), 88.7 (C(7b)), 81.8 (C(1)), 70.8 (C(2)), 65.3 (C(10)), 64.4 (C(7a)), 
64.0 (C(4)), 52.1 (C(5a)), 34.3 (C(6)), 29.5 (C(5)), 27.3 (C(7)), 25.6 (C(8 or 
9)), 25.5 (C(8 or 9)), 
 IR: (NaCl plate, film) 
2966 (s), 2858 (m), 2375 (s), 2326 (s), 2279 (s), 1454 (m), 1382 (m), 1172 (s), 
1087 (m), 1028 (m), 933 (w) 905 (w), 855 (w), 754 (s) (696 (m) 
 MS: (EI, 70 eV) 
284 (5), 271 (1), 256 (2), 180 (100), 165 (28), 149 (3), 138 (2), 122 (4), 109 
(8) 
 Mol. Formula: C18H28BNO (285.23) 
 HRMS: C18H27BNO,  (284.2186) 
Calcd: 284.2186 
Found: 284.2184 
 TLC: Rf  0.23  (hexanes/TBME, 9:1) [I2, CAM] 
 
Preparation of (1S,3S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-methyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizine•Borane (IV{2,3}) 
 
To a one-necked, round-bottomed flask equipped with a nitrogen inlet adapter, rubber 
septum and a magnetic stir bar is added sequentially 21{2} (49 mg, 0.250 mmol), 
dimethylformamide (2.5 mL, 0.1 M) and sodium hydride (6 mg, 0.250 mmol).  After being 
stirred for 15 min, 1-bromohexane (41 µL, 0.250 mmol) was added.  After being stirred for 2 h, 
NaH (6 mg, 0.250 mmol) was added.  After being stirred for 15 min, 1-bromohexane (41 µL, 
0.250 mmol) was added.  After being stirred for 2 h, NaH (6 mg, 0.250 mmol) was added.  After 
being stirred for 15 min, 1-bromohexane (41 µL, 0.250 mmol) was added.  After 2 h, the reaction 
was quenched with water (10 mL) at 0 oC.  Extraction and purification by silica gel column 
chromatography as described in General Procedure I afforded 47 mg (69%) of hexyl ether 
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IV{2,3} as a clear, viscous oil. 
Data for IV{2,3}: 
 1H-NMR: (500 MHz, CDCl3) 
3.64 (ddd, J = 6.5, 10.2, 10.0, 1 H, HC(4)), 3.48 (d, J = 13.4, 1 H, HC(2)), 
3.29 (ddd, J = 1.6, 6.6, 6.6, 2 H, H2C(10)), 3.28 (m, 1 H, HC(4)), 3.14 (d, J = 
13.4, 1 H, HC(2)), 2.33 (m, 1 H, HC(5a)), 2.25 (m, 1 H, HC(5)), 2.15 (dd, J = 
6.3, 8.1, 1 H, HC(7a)), 2.07 (ddd, J = 6.2, 6.2, 13.1, 1 H, HC(7)), 1.85 (dddd, 
J = 7.3, 7.3, 7.2, 12.6, 1 H, HC(6)), 1.77–1.71 (m, 1 H, HC(6)), 1.71–1.64 (m, 
1 H, HC(6)),1.54–1.49 (m, 3 H, HC(5), H2C(11))  1.49 (s, 3 H, H3C(8)), 1.35 
(s, 3 H, H3C(9)), 1.35–1.25 (m, 6 H, H2C(12), H2C(13), H2C(14)), 0.88 (dd, J 
= 6.9, 6.9, 3 H, H3(15)), 0.8–2.5 (br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
88.6 (C(7b)), 81.1 (C(1)), 70.3 (C(2)), 64.6 (C(7a)), 63.7 (C(4)), 62.9 (C(10)), 
52.1 (C(5a)), 34.5 (C(6)), 31.8 (C(13)), 30.3 (C(11)), 29.6 (C(5)), 27.0 (C(7)), 
26.1 (C(12 or 14)), 25.7 (C(8)), 25.1 (C(9)), 22.7 (C(12 or 14)), 14.2 (C(15)) 
 IR: (NaCl plate, film) 
2931 (s), 2865 (s), 2376 (s), 2326 (s), 2279 (s), 1456 (s), 1378 (s), 1301 (m), 
1172 (s), 1086 (s), 1021 (m), 965 (w), 924 (w), 851 (w), 756 (s) 
 MS: (EI, 70 eV) 
278 (13), 265 (6), 250 (16), 194 (10), 180 (100), 165 (38), 150 (6), 138 (10), 
123 (13), 110 (41) 
 Mol. Formula: C17H34BNO (279.27) 
 HRMS: C17H33BNO, (278.2655) 
  Calcd: 278.2655 
  Found: 278.2656 
 TLC: Rf  0.35  (hexanes/TBME, 9:1) [I2, CAM] 
 
Preparation of (1S,3S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-isopropyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizine•Borane (IV{3,2}) 
179 
 
 
Following General Procedure I, to a two-necked, 10-mL round-bottomed flask equipped 
with a nitrogen inlet adapter, rubber septum and a magnetic stir bar was added sequentially 
alcohol 21{3} (30 mg, 0.134 mmol), dimethylformamide (1.3 mL, ~0.1 M), then sodium hydride 
(4.8 mg, 0.202 mmol, 1.5 equiv) at 0 oC.  After 15 min, benzyl bromide (24 µL, 0.202 mmol, 1.5 
equiv) was added via syringe.  The solution was stirred for 2 hr then quenched onto ice water (10 
mL).  Extraction and purification by silica gel column chromatography as described in General 
Procedure I afforded 39 mg (92%) of benzyl ether IV{3,2} as a clear, viscous oil. 
Data for IV{3,2}: 
 1H-NMR: (500 MHz, CDCl3) 
7.37–7.33 (m, 4 H, HC(13), HC(14)), 7.31–7.27 (m, 1 H, HC(15)), 4.49 (d, J 
= 11.3, 1 H, HC(11)), 4.42 (d, J = 11.3, 1 H, HC(11)), 3.84–3.77 (m, 1 H, 
HC(4)), 3.63 (d, J = 14.5, 1 H, HC(2)), 3.39 (d, J = 14.5, 1 H, HC(1)), 3.29 
(dd, J  = 8.5, 8.5, 1 H, HC(4)), 2.41–2.32 (m, 3 H, HC(7a), HC(5a), HC(5)), 
2.27–2.20 (m, 1 H, HC(6)), 2.22–2.16 (m, 1 H, HC(9)), 1.96–1.88 (m, 1 H, 
HC(7)), 1.78–1.66 (m, 2 H, HC(7), HC(6)), 1.49 (s, 3 H, H3C(8)), 1.44–1.40 
(m, 1 H, HC(5)), 1.00 (d, J = 6.8, 3 H, H3C(10)), 0.96 (d, J = 6.8, 3 H, 
H3C(10’)), 0.8–2.5 (br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
138.5 (C(12)), 128.7 (C(13)), 127.6 (C(15)), 127.1 (C(14)), 88.6 (C(1)), 87.5 
(C(7b)), 65.1 (C(11)), 64.1 (C(2)), 63.1 (C(4)), 58.4 (C(7a)), 51.5 (C(5a)), 
35.9 (C(7)), 30.6 (C(9)), 30.4 (C(5)), 28.3 (C(6)), 25.1 (C(8)), 18.4 (C(10)), 
17.6 (C(11)) 
 IR: (CHCl3) 
3071 (w), 3028 (w), 2964 (s), 2379 (s), 2326 (s), 2278 (s), 2234 (w), 1957 
(w), 1876 (w), 1812 (w), 1727 (w), 1599 (w), 1496 (m), 1468 (m), 1454 (s), 
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1379 (s), 1330 (w), 1264 (m), 1168 (s), 1085 (s), 1063 (s), 1028 (m), 970 (w), 
912 (s), 850 (w), 794 (w), 734 (s), 697 (s) 
 
 MS: (EI, 70 eV) 
312 (41), 299 (4), 268 (6), 256 (8), 220 (5), 208 (100), 193 (27), 164 (8), 149 
(16), 126 (24)  
 Mol. Formula: C20H32BNO  (313.29) 
 HRMS: C20H31BNO,  (312.2499) 
Calcd: 312.2499 
Found: 312.2497 
 TLC: Rf  0.25  (hexanes/TBME, 4:1) [I2, CAM] 
 
Preparation of (1R,3S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-phenyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizine•Borane (IV{5,2}) 
 
Following General Procedure I, to a two-necked, 10-mL round-bottomed flask equipped 
with a nitrogen inlet adapter, rubber septum and a magnetic stir bar was added sequentially 
alcohol 21{5,2} (60 mg, 0.233 mmol), dimethylformamide (2.3 mL, ~0.1 M), then sodium 
hydride (8.4 mg, 0.350 mmol, 1.5 equiv) at 0 oC.  After 15 min, benzyl bromide (42 µL, 0.350 
mmol, 1.5 equiv) was added via syringe.  The solution was stirred for 2 hr then quenched onto 
ice water (10 mL).  Extraction and purification by silica gel column chromatography as 
described in General Procedure I afforded 80 mg (98%) of benzyl ether IV{5,2} as a clear, 
viscous oil. 
Data for IV{5,2}: 
 1H-NMR: (500 MHz, CDCl3) 
7.41–7.36 (m, 4 H), 7.34–7.30 (m, 3 H), 7.30–7.23 (m, 3 H), 4.32 (d, J = 11.5, 
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1 H, HC(2)), 4.01 (ddd, J = 14.3, 14.3, 14.2, 2 H, HC(13)), 3.98 (d, J = 11.9, 1 
H, HC(2)), 4.00–3.95 (m, 1 H, HC(4)), 3.46–3.42 (m, 1 H, HC(4)), 2.68 (dd, J 
= 3.9, 8.3, 1 H, HC(7a)), 2.58–2.53 (m, 1 H, HC(7)), 2.44–2.46 (m, 2 H, 
HC(5a), HC(5)), 2.05–2.01 (m, 1 H, HC(6)), 1.94–1.83 (m, 2 H, HC(7), 
HC(6)), 1.57 (dd, 7.9, 10.5, 1 H, HC(5)), 1.51 (s, 3 H, H3C(8)), 0.8–2.5 (br, 3 
H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
142.2 (C(9)), 138.1 (C(14)), 128.9, 128.5, 128.1, 127.5, 127.0, 126.0, 88.6 
(C(7b)), 85.9 (C(1)), 66.1 (C(2)), 65.6 (C(13)), 65.4 (C(4)), 62.7 (C(7a), 52.0 
(C(5a)), 35.5 (C(6)), 29.9 (C(5)), 27.2 (C(7)), 25.7 (C(8)) 
 IR: (CHCl3) 
30064 (w), 3031 (w), 2965 (s), 2869 (m), 2376 (s), 2332 (s), 2277 (s), 2243 
(m), 1497 (m), 1448 (m), 1379 (w), 1177 (s), 1132 (w), 1088 (m), 1059 (s), 
1027 (w), 911 (s), 849 (w), 732 (s), 699 (s) 
 MS: (EI, 70 eV) 
333.2 (1), 332.2 (1), 318.2 (1), 242.1 (100), 227.1 (9), 105 (32) 
 Mol. Formula: C23H30BNO (347.30) 
 HRMS: C23H27NO, (333.2093) 
  Calcd: 333.20927 
  Found: 333.20927 
 TLC: Rf  0.28  (hexanes/TBME, 9:1)  [I2, CAM] 
 
Preparation of Amino•Borane Intermediates V{2-7, 2-7}. Preparation of 
(1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-5-methyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizine•Borane (V{1,2}) 
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Following General Procedure I, to a two-necked, 10-mL round-bottomed flask equipped 
with a nitrogen inlet adapter, rubber septum and a magnetic stir bar was added sequentially 
alcohol 18 (30 mg, 0.154 mmol), dimethylformamide (1.5 mL, ~0.1 M), then sodium hydride 
(5.5 mg, 0.231 mmol, 1.2 equiv) at 0 oC.  After 15 min, benzyl bromide (27 µL, 0.231 mmol, 1.2 
equiv) was added via syringe.  The solution was stirred for 2 hr then quenched onto ice water (10 
mL).  Extraction and purification by silica gel column chromatography as described in General 
Procedure I afforded 40 mg (91%) of benzyl ether V{1,2} as a clear, viscous oil. 
Data for V{1,2}: 
 1H-NMR: (500 MHz, CDCl3) 
7.33 (m, 5 H, HC(11), HC(12), HC(13)), 4.53 (ddd, J = 6.6, 6.6, 10.7, 1 H, 
HC(1)), 4.51 (d, J = 11.7, 1 H, HC(1)), 4.45 (d, J = 11.4, 1 H, HC(9)), 3.51 
(dd, J = 6.5, 10.4, 1 H, HC(2)), 3.16 (dd, J = 6.1, 12.5, 1 H, HC(4)), 3.06 (dd, 
J = 10.6, 10.6, 1 H, HC(2)), 2.82 (dd, J = 12.5, 12.5, 1 H, HC(4)), 2.42 (dd, J 
= 8.0, 17.0, 1 H, HC(7a)), 2.09–2.00 (m, 1 H, HC(5)), 2.00–1.92 (m, 1 H, 
HC(7)), 1.89–1.85 (m, 1 H, HC(5a)), 1.82–1.76 (m, 1 H, HC(7)), 1.75–1.70 
(m, 2 H, H2C(6)), 1.51 (s, 1 H, H3C(8)), 1.02 (d, J = 6.4, 3 H, H3C(14)), 0.8–
2.5 (br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
138.1 (C(10)), 128.6 (C(13)), 128.0 (C(12)), 127.8 (C(11)), 88.1 (C(7b)), 76.0 
(C(1)), 72.0 (C(9)), 70.0 (C(4)), 64.3 (C(2)), 62.0 (C(5a)), 53.3 (C(7a)), 34.6 
(C(5)), 29.6 (C(6)), 26.7 (C(7)), 25.9 (C(8)), 16.4 (C(16)) 
 IR: (NaCl plate, film) 
3064 (w), 3021 (w), 2960 (s), 2922 (s), 2872 (s), 2379 (s), 2326 (s), 2276 (s), 
2234 (w), 1654 (w), 1497 (w), 1472 (m), 1456 (s), 1380 (m), 1364 (s), 1326 
(w), 1305 (w), 1234 (w), 1186 (s), 1167 (s), 1142 (s), 1124 (s), 1054 (m), 
1018 (w), 991 (m), 956 (w), 913 (s), 844 (w), 810 (w), 698 (s) 
 MS: (EI, eV) 
284 (18), 256 (19), 228 (5), 180 (100), 165 (31), 110 (30), 91 (71), 84 (13) 
 Mol. Formula: C18H28BNO  (285.23) 
 HRMS: C18H27BNO,  (284.2186) 
  Calcd:  284.21858 
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  Found:  284.21909 
 TLC: Rf  0.25  (hexanes/TBME, 9:1) [I2, CAM] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-1-methyl-5-methyl-7b-
methyl-2Hcyclopenta[gh]pyrrolizine•Borane (V{2,2}): 
 
Following General Procedure I, to a two-necked, 10-mL round-bottomed flask equipped 
with a nitrogen inlet adapter, rubber septum and a magnetic stir bar was added sequentially 
alcohol 22{2} (42 mg, 0.200 mmol), dimethylformamide (2.0 mL, ~0.1 M), then sodium hydride 
(7.2 mg, 0.300 mmol, 1.5 equiv) at 0 oC.  After 15 min, benzyl bromide (48 µL, 0.4 mmol, 2.0 
equiv) was added via syringe.  The solution was stirred for 2 hr then quenched onto ice water (10 
mL).  Extraction and purification by silica gel column chromatography as described in General 
Procedure I afforded 58 mg (97%) of benzyl ether V{2,2} as a clear, viscous oil. 
Data for V{2,2}: 
 1H-NMR: (500 MHz, CDCl3) 
7.36–7.27 (m, 5 H, HC(12), HC(13), HC(14)), 4.43 (d, J = 11.1, 1 H, 
HC(10)), 4.35 (d, J = 11.1, 1 H, HC(10)), 3.50 (d, J = 11.6, 1 H, HC(2)), 3.35 
(d, J = 11.6, 1 H, HC(2)), 3.23 (dd, J = 6.3, 12.5, 1 H, HC(4)), 2.96 (dd, J = 
12.4, 12.4, 1 H, HC(4)), 2.21–2.12 (m, 2 H, HC(7a), HC(7)), 2.10–2.01 (m, 1 
H, HC(5)), 1.88–1.83 (m, 2 H, HC(5a), HC(7)), 1.78–1.74 (m, 1 H, HC(6)), 
1.75 (s, 3 H, H3C(9)), 1.71–1.64 (m, 1 H, HC(6)), 1.57 (s, 3 H, H3C(8)), 0.99 
(d, J = 6.4, 3 H, H3C(15)), 0.8–2.5 (br, 3 H, (H3B)
3) 
 
 13C-NMR: (126 MHz, CDCl3) 
138.7 (C(11)), 128.5 (C(13)), 127.6 (C(12)), 127.2 (C(14)), 88.7 (C(7b)), 79.9 
(C(1)), 73.5 (C(4)), 73.3 (C(2)), 65.8 (C(10)), 62.1 (C(5a)), 61.3 (C(7a)), 33.5 
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(C(5)), 29.0 (C(6)), 27.3 (C(7)), 26.3 (C(8)), 25.9 (C(9)), 16.0 (C(15)) 
 IR: (CHCl3) 
2961 (s), 2398 (s), 2282 (s), 1497 (w), 1457 (s), 1384 (m), 1152 (s), 1063 (m), 
1028 (m), 956 (w), 697 (m) 
 MS: (EI, 70 eV) 
298 (4), 270 (4), 194 (100), 179 (20), 110 (28), 91 (28) 
 Mol. Formula: C19H30BNO (299.26) 
 HRMS: C19H29BNO,  (298.2342) 
  Calcd: 298.2342 
  Found: 298.2341 
 TLC: Rf  0.30  (hexanes/TBME, 9:1) [I2, CAM] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxybenzyloxy)-1-methyl-5-
methyl-7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (V{2,7}) 
 
Following General Procedure I, to a two-necked, 10-mL round-bottomed flask equipped 
with a nitrogen inlet adapter, rubber septum and a magnetic stir bar was added sequentially 
alcohol 22{2} (42 mg, 0.200 mmol), dimethylformamide (2.0 mL, ~0.1 M), then sodium hydride 
(7.2 mg, 0.300 mmol, 1.5 equiv) at 0 oC.  After 15 min, 4-methoxybenzyl bromide (32 µL, 0.220 
mmol, 1.1 equiv) was added via syringe.  The solution was stirred for 2 hr then quenched onto 
ice water (10 mL).  Extraction and purification by silica gel column chromatography as 
described in General Procedure I afforded 58 mg (86%) of 4-methoxybenzyl ether V{2,7} as a 
clear, viscous oil. 
Data for V{2,7}: 
 1H-NMR: (500 MHz, CDCl3) 
7.23 (d, J = 8.6, 2 H, HC(13)), 6.87 (d, J = 8.7, 2 H, HC(12)), 4.35 (d, J = 
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10.6, 1 H, HC(10)), 4.26 (d, J = 10.6, 1 H, HC(10)), 3.80 (s, 1 H, H3C(13)), 
3.48 (d, J = 11.6, 1 H, HC(2)), 3.32 (d, J = 11.6, 1 H, HC(2)), 3.21 (dd, J = 
6.3, 12.4, 1 H, HC(4)), 2.95 (dd, J = 12.4, 12.4, 1 H, HC(4)), 2.19–2.10 (m, 2 
H, HC(7a), HC(7)), 2.08–2.00 (m, 1 H, HC(5)), 1.90–1.82 (m, 2 H, HC(7), 
HC(5a)), 1.77–1.74 (m, 1 H, HC(6)), 1.74 (s, 3 H, H3C(9)), 1.70–1.62 (m, 1 
H, HC(6)), 1.56 (s, 3 H, H3C(8)), 0.98 (d, J = 6.4, 3 H, H3C(16)), 0.8–2.5 (br, 
3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
159.2 (C(14)), 130.7 (C(11)), 128.9 (C(13)), 113.9 (C(12)), 88.7 (C(7b)), 79.8 
(C(1)), 73.5 (C(4)), 73.3 (C(2)), 65.5 (C(10)), 62.1 (C(5a)), 61.2 (C(7a)), 55.4 
(C(15)), 33.4 (C(5)), 29.0 (C(6)), 27.3 (C(7)), 26.3 (C(8)), 25.9 (C(9)), 16.0 
(C(16)) 
 
 IR: (NaCl plate, film) 
2958 (s), 2929 (s), 2835 (s), 2396 (s), 2330 (s), 2282 (s), 1612 (s), 1586 (w), 
1514 (s), 1457 (s), 1384 (s), 1349 (w), 1337 (w), 1302 (m), 1249 (s), 1166 (s), 
1152 (s), 1108 (w), 1092 (m), 1064 (s), 1036 (s), 956 (m), 910 (w), 873 (w), 
823(s) 
 MS: (EI, 70 eV) 
328 (8), 194 (100), 179 (49), 164 (3), 151 (3), 121 (52), 110 (34) 
 Mol. Formula: C20H32BNO2  (329.28) 
 HRMS: C20H31BNO2,  (328.2448) 
  Calcd: 328.2448 
  Found: 328.2448 
 TLC: Rf  0.28  (hexanes/TBME, 9:1) [I2, CAM] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-methyl-5-methyl-7b-
methyl-2Hcyclopenta[gh]pyrrolizine•Borane (V{2,3}) 
186 
 
 
To a one-necked, round-bottomed flask equipped with a nitrogen inlet adapter, rubber 
septum and a magnetic stir bar is added sequentially 22{2} (40 mg, 0.191 mmol), 
dimethylformamide (1.9 mL, 0.1 M) and sodium hydride (5 mg, 0.191 mmol).  After being 
stirred for 15 min, 1-iodohexane (28 µL, 0.191 mmol) was added.  After being stirred for 2 h, 
NaH (5 mg, 0.191 mmol), was added.  After being stirred for 15 min, 1-iodoohexane (28 µL, 
0.191 mmol) was added.  After being stirred for 2 h, NaH (5 mg, 0.191 mmol) was added.  After 
being stirred for 15 min, 1-iodohexane (28 µL, 0.191 mmol) was added.  After 2 h, the reaction 
was quenched with water (10 mL) at 0 oC.  Extraction and purification by silica gel column 
chromatography as described in General Procedure I afforded 31 mg (55%) of hexyl ether 
V{2,3} as a clear, viscous oil. 
Data for V{2,3}: 
 1H-NMR: (500 MHz, CDCl3) 
3.40 (d, J = 11.7, 1 H, HC(2)), 3.25 (m, 4 H, HC(10), HC(2), HC(4)), 2.95 
(dd, J = 12.4, 12.4, 1 H, HC(4)), 2.11–2.02 (m, 3 H, HC(7a), HC(7), HC(5)), 
1.81 (dd, J = 6.4, 9.8, 1 H, HC(5a)), 1.73 (m, 2 H, HC(7), HC(6)), 1.69–1.62 
(m, 1 H, HC(6)), 1.59 (s, 1 H, H3C(9)), 1.52 (s, 3 H, H3C(8)), 1.52–1.46 (m, 2 
H, HC(11)), 1.33–1.22 (m, 6 H, HC(12), HC(13), HC(14)), 0.98 (d, J = 6.4, 3 
H, H3C(16)), 0.88 (dd, J = 6.9, 6.9, 3 H, H3C(15)), 0.8–2.5 (br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
88.65 (C(9)), 79.08 (C(2)), 73.55 (C(1 or 12)), 73.36 (C(1 or 12)), 63.69 
(C(8)), 62.05 (C(3)), 61.47 (C(6)), 33.56 (C(7)), 31.85 (C(14, 15 or 16), 30.37 
(C(13)), 29.11 (C(5)), 26.89 (C(4)), 26.24 (C(10)), 26.05 (C(14, 15, or 16)), 
25.63 (C(11)), 22.74 (C(14, 15, or 16)), 16.12 (C(18)), 14.19 (C(17)) 
 IR: (CDCl3, film) 
2957 (s), 2931 (s), 2872 (s), 2396 (s), 2284 (s), 2241 (w), 1730 (w), 1459 (s), 
1381 (m), 1348 (w), 1184 (s), 1168 (s), 1149 (s), 1064 (m), 913 (s) 
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 MS: (ESI, 70 eV) 
292 (51), 279 (7), 264 (20), 250 (5), 222 (3), 208 (13), 194 (100), 184 (30), 
179 (41), 164 (8), 137 (6), 124 (22), 110 (67) 
 Mol. Formula: C18H36BNO (293.30) 
 HRMS: C18H35BNO,  (292.2812) 
  Calcd:  292.28118 
  Found:  292.28154 
 TLC: Rf  0.35  (hexanes/TBME, 9:1) [I2, CAM] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-isopropyl-5-methyl-7b-
methyl-2Hcyclopenta[gh]pyrrolizine•Borane (V{3,2}) 
 
Following General Procedure I, to a two-necked, 10-mL round-bottomed flask equipped 
with a nitrogen inlet adapter, rubber septum and a magnetic stir bar was added sequentially 
alcohol 22{3} (59 mg, 0.250 mmol), dimethylformamide (2.5 mL, ~0.1 M), then sodium hydride 
(9.0 mg, 0.375 mmol, 2.0 equiv) at 0 oC.  After 15 min, benzyl bromide (60 µL, 0.500 mmol, 2.0 
equiv) was added via syringe.  The solution was stirred for 2 hr then quenched onto ice water (10 
mL).  Extraction and purification by silica gel column chromatography as described in General 
Procedure I afforded 80 mg (98%) of benzyl ether V{3,2} as a clear, viscous oil. 
Data for V{3,2}: 
 1H-NMR: (500 MHz, CDCl3) 
7.37–7.28 (m, 5 H, HC(13), HC(14), HC(15)), 4.51 (d, J = 11.1, 1 H, 
HC(11)), 4.38 (d, J = 11.1, 1 H, HC(11)), 3.63 (d, J = 14.3, 1 H, HC(2)), 3.60 
(d, J = 14.3, 1 H, HC(2)), 3.36 (dd, J = 8.3, 12.1, 1 H, HC(4)), 3.14 (dd, J = 
10.3, 12.1, 1 H, HC(4)), 2.45–2.38 (m, 1 H, HC(7)), 2.37 (dd, J = 7.7,16.4, 1 
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H, HC(7a)), 2.29–2.21 (m, 1 H, HC(5)), 2.21–2.13 (m, 1 H, HC(9)), 1.84–1.77 
(m, 3 H, H2C(6), HC(5a)), 1.67–1.61 (m, 1 H, HC(7)) ,1.48 (s, 3 H, H3C(8)), 
0.99 (d, J = 6.8, 1 H, H3C(10)), 0.93 (d, J = 6.8, 3 H, H3C(10’)), 0.84 (d, J = 
6.7, 3 H, H3C(16)), 0.8–2.5 (br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
138.3 (C(12)), 128.6 (C(13) or C(15)), 127.6 (C(14)), 127.3 (C(13) or C(15)), 
88.8 (C(7b) or C(1)), 85.1 (C(7b) or C(1)), 74.0 (C(4)), 69.4 (C(2)), 64.8 
(C(11)), 59.6 (C(5a)), 57.1 (C(7a)), 34.7 (C(5)), 31.6 (C(6)), 30.3 (C(9)), 24.8 
(C(7)), 24.7 (C(8)), 18.2 (C(10)), 17.7 (C(10’)), 17.6 (C(16)) 
 IR: (CDCl3, film) 
2962 (s), 2922 (s), 2870 (s), 2374 (s), 2327 (s), 2272 (s), 1497 (w), 1454 (s), 
1379 (m), 1170 (s), 1147 (m), 1131 (m), 1057 (m), 1027 (m), 868 (w), 697 
(m) 
 MS: (EI, 70 eV) 
326 (6), 234 (6), 270 (11), 222 (s), 207 (21) 
 Mol. Formula: C21H34BNO  (327.31) 
 HRMS: C21H33BNO,  (326.2655) 
  Calcd: 326.2655 
  Found: 326.2652 
 TLC: Rf  0.24  (hexanes/TBME, 9:1) [I2] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-isopropyl-5-methyl-7b-
methyl-2Hcyclopenta[gh]pyrrolizine•Borane (V{3,3}) 
 
To a one-necked, round-bottomed flask equipped with a nitrogen inlet adapter, rubber 
septum and a magnetic stir bar is added sequentially 22{3} (59 mg, 0.250 mmol), 
dimethylformamide (2.5 mL, 0.1 M) and sodium hydride (6 mg, 0.250 mmol).  After being 
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stirred for 15 min, 1-bromohexane (35 µL, 0.250 mmol) was added.  After being stirred for 2 h, 
NaH (6 mg, 0.250 mmol), was added.  After being stirred for 15 min, 1-bromohexane (35 µL, 
0.250 mmol) was added.  After being stirred for 2 h, NaH (6 mg, 0.250 mmol) was added.  After 
being stirred for 15 min, 1-bromohexane (35 µL, 0.250 mmol) was added.  After 2 h, the reaction 
was quenched with water (10 mL) at 0 oC.  Extraction and purification by silica gel column 
chromatography as described in General Procedure I afforded 37 mg (44%) of hexyl ether 
V{3,3} as a clear, viscous oil. 
Data for V{3,3}: 
 1H-NMR: (500 MHz, CDCl3) 
3.51 (d, J = 14.2, 1 H, HC(2)), 3.45 (d, J = 14.2, 1 H, HC(2)), 3.40-3.26 (m, 3 
H, HC(4), H2C(14), 3.18 (dd, J = 10.5, 12.0, 1 H, HC(4)), 2.42-2.32 (m, 2 H, 
HC(7), HC(5)), 2.27 (dd, J = 7.0, 9.3, 1 H, HC(7a)), 2.01 (hept, J = 6.8, 1 H, 
HC(9)), 1.87-1.77 (m, 3 H, H2C(6), HC(5a)), 1.60-1.51 (m, 3 H, HC(7), 
H2C(13)), 1.45 (s, 3 H, H3C(8)), 1.38-1.32 (m, 2 H, H2C(14)), 1.36-1.25 (m, 4 
H, H2C(15), H2C(16)), 0.96 (d, J = 6.7, 3 H, H3C(10)), 0.91 (d, J = 6.8, 3 H, 
H3C(10)), 0.89 (dd, J = 6.9, 6.9, 3 H, H3C(11)), 0.82 (d, J = 6.8, 3 H, 
H3C(17)), 0.8-2.5 (br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
88.7 (C(1) or C(7b)), 84.1 (C(1) or C(7b)), 74.2 (C(4)), 69.3 (C(2)), 62.1 
(C(12)), 59.6 (C(5a)), 57.0 (C(7a)), 34.7 (C(5)), 31.9 (C(15)), 31.6 (C(6)), 
30.2 (C(13)), 29.9 (C(9)), 26.2 (C(14)), 24.6 (C(8)), 24.4 (C(7)), 22.7 (C(16)), 
18.2 (C(10) or C(11)), 17.6 (C(10) or C(11) or C(17)), 17.6 (C(10) or C(11) or 
C(17)), 14.2 (C(16)) 
 IR: (CDCl3, film) 
2957 (s), 2230 (s), 2870 (s), 2376 (s), 2327 (s), 2273 (s), 1457 (s), 1378 (s), 
1270 (w), 1170 (s), 1147 (m), 1084 (s), 
 MS: (EI, 70 eV) 
320 (25), 318 (50), 307 (7), 292 (6), 278 (9), 276 (10), 264 (49), 236 (9), 222 
(100), 207 (47), 192 (19), 180 (17), 164 (13), 137 (7), 124 (30), 110 (77)   
 Mol. Formula: C20H40BNO  (321.35) 
 HRMS: C20H39BNO, (320.3125) 
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  Calcd: 320.3125 
  Found: 320.3125 
 TLC: Rf  0.34  (hexanes/TBME, 9:1) [I2] 
Preparation of (1R,3S,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-phenyl-5-methyl-7b-
methyl-2Hcyclopenta[gh]pyrrolizine•Borane (V{5,2}) 
 
Following General Procedure I, to a two-necked, 10-mL round-bottomed flask equipped 
with a nitrogen inlet adapter, rubber septum and a magnetic stir bar was added sequentially 
alcohol 22{5}(68 mg, 0.250 mmol), dimethylformamide (2.5 mL, ~0.1 M), then sodium hydride 
(9.0 mg, 0.375 mmol, 2.0 equiv) at 0 oC.  After 15 min, benzyl bromide (60 µL, 0.500 mmol, 2.0 
equiv) was added via syringe.  The solution was stirred for 2 hr then quenched onto ice water (10 
mL).  Extraction and purification by silica gel column chromatography as described in General 
Procedure I afforded 80 mg (89%) of benzyl ether V{5,2} as a clear, viscous oil. 
Data for V{5,2}: 
 1H-NMR: (500 MHz, CDCl3) 
7.39 (m, 4 H), 7.33 (m, 3 H), 7.28 (d, J = 7.1, 1 H), 7.21 (d, J = 6.8, 2 H), 4.17 
(d, J = 11.3, 1 H, HC(13)), 4.14 (d, J = 13.8, 1 H, HC(2)), 3.97 (d, J = 11.1, 1 
H, HC(13)), 3.96 (d, J = 13.5, 1 H, HC(2)), 3.46 (dd, J = 7.9, 12.3, 1 H, 
HC(4)), 3.21 (dd, J = 11.2, 12.2, 1 H, HC(4)), 2.79 (dd, J = 8.0, 8.0, 1 H, 
HC(7a)), 2.73–2.63 (m, 1 H, HC(7)), 2.52–2.42 (m, 1 H, HC(5)), 1.97–1.88 
(m, 4 H, HC(7), H2C(6), HC(5a)), 1.52 (s, 3 H, H3C(8)), 0.96 (d, J = 6.6, 3 H, 
H3C(18)), 0.8–2.5 (br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
141.8 (C(9) or C(14)), 138.0 (C(9) or C(14)), (128.7, 128.5, 128.1, 127.6, 
127.4, 126.4) (C(10), C(11), C(12), C(15), C(16), C(17)), 88.8 (C(1) or 
C(7b)), 83.4 (C(1) or C(7b)), 73.6 (C(4)), 70.6 (C(2)), 66.3 (C(13)), 62.2 
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(C(7a)), 60.3 (C(5a)), 34.4 (C(5)), 30.9 (C(6)), 25.0 (C(8)), 24.2 (C(7)), 17.3 
(C(18)) 
 IR: (NaCl plate, film) 
2960 (s), 2329 (s), 1497 (m), 1172 (s), 1136 (w), 1058 (s), 931 (w), 700 (s) 
 MS: (EI, 70 eV) 
358.2 (3), 256.1 (100), 241.1 (11), 105 (35) 
 Mol. Formula: C24H32BNO (361.33) 
 HRMS: C24H29BNO, (358.2342) 
  Calcd: 358.2342 
  Found: 358.2336 
 TLC: Rf  0.25  (hexanes/TBME, 9:1) [I2] 
 
Preparation of (1R,3S,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxy-benzyloxy)-1-phenyl-5-
methyl-7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (V{5,7}) 
 
Following General Procedure I, to a two-necked, 10-mL round-bottomed flask equipped 
with a nitrogen inlet adapter, rubber septum and a magnetic stir bar was added sequentially 
alcohol 22{5} (68 mg, 0.250 mmol), dimethylformamide (2.5 mL, ~0.1 M), then sodium hydride 
(9.0 mg, 0.375 mmol, 2.0 equiv) at 0 oC.  After 15 min, 4-methoxybenzyl bromide (40 µL, 0.275 
mmol, 1.1 equiv) was added via syringe.  The solution was stirred for 2 hr then quenched onto 
ice water (10 mL).  Extraction and purification by silica gel column chromatography as 
described in General Procedure I afforded 89 mg (91%) of 4-methoxybenzyl ether V{5,7} as a 
clear, viscous oil. 
Data for V{5,7}: 
 1H-NMR: (500 MHz, CDCl3) 
7.39 (m, 4 H, HC(10), HC(11)), 7.33 (m, 1 H, HC(12)), 7.11 (d, J = 8.7, 2 H, 
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HC(15)), 6.84 (d, J = 8.7, 2 H, HC(16)), 4.12 (d, J = 13.4, 1 H, HC(13)), 4.09 
(d, J = 10.7, 1 H, HC(2)), 3.94 (d, J = 13.4, 1 H, HC(13)), 3.89 (d, J = 10.6, 1 
H, HC(2)), 3.79 (s, 3 H, H3C(18)), 3.45 (dd, J = 7.9, 12.3, 1 H, HC(4)), 3.20 
(dd, J = 11.2, 12.1, 1 H, HC(4)), 2.77 (dd, J = 7.9, 7.9, 1 H, HC(7a)), 2.70–
2.61 (m, 1 H, HC(7)), 2.50–2.40 (m, 1 H, HC(5)), 1.96–1.83 (m, 4 H, HC(7), 
H2C(6), HC(5a)), 1.51 (s, 3 H, H3C(8)), 0.96 (d, J = 6.6, 3 H, H3C(19)) 
 13C-NMR: (126 MHz, CDCl3) 
159.2 (C(19)), 141.9 (C(11)), 130.1 (C(16)), 129.0 (C(17)), 128.7 (C(12) or 
C(11)), 128.1 (C(12)), 126.5 (C(10) or C(11)), 113.9 (C(16)), 88.8 (C(1) or 
C(7b)), 83.2 (C(1) or C(7b)), 73.6 (C(4)), 70.6 (C(13)), 66.0 (C(2)), 62.0 
(C(7a)), 60.3 (C(5a)), 55.4 (C(18)), 34.4 (C(5)), 30.8 (C(6)), 25.0 (C(8)), 24.1 
(C(7)), 17.3 (C(19)), 0.8-2.5 (br, 3 H, (H3B)
3) 
 
 IR: (CDCl3, film) 
2957 (s), 2922 (s), 2869 (s), 2369 (s), 2329 (s), 2274 (s), 1613 (s), 1585 (w), 
1514 (s), 1457 (s), 1379 (m), 1301 (m), 1249 (s), 1173 (s), 1136 (m), 1116 
(w), 1033 (s), 823 (m), 756 (s), 700 (s) 
 MS: (EI, 70 eV) 
388.2 (1), 256.2 (100), 241.2 (17), 105 (38) 
 Mol. Formula: C25H34BNO2 (391.35) 
 HRMS: C25H31BNO2, (388.2448) 
  Calcd: 388.2448 
  Found: 388.2444 
 TLC: Rf  0.22  (hexanes/TBME, 9:1) [I2] 
 
Preparation of (1R,3S,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-phenyl-5-methyl-7b-
methyl-2Hcyclopenta[gh]pyrrolizine•Borane (V{5,3}) 
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To a one-necked, round-bottomed flask equipped with a nitrogen inlet adapter, rubber 
septum and a magnetic stir bar is added sequentially 22{5} (64 mg, 0.236 mmol), 
dimethylformamide (2.4 mL, 0.1 M) and sodium hydride (6 mg, 0.250 mmol).  After being 
stirred for 15 min, 1-bromohexane (33 µL, 0.236 mmol) was added.  After being stirred for 2 h, 
NaH (6 mg, 0.250 mmol), was added.  After being stirred for 15 min, 1-bromohexane (33 µL, 
0.236 mmol) was added.  After being stirred for 2 h, NaH (6 mg, 0.250 mmol) was added.  After 
being stirred for 15 min, 1-bromohexane (33 µL, 0.236 mmol) was added.  After 2 h, the reaction 
was quenched with water (10 mL) at 0 oC.  Extraction and purification by silica gel column 
chromatography as described in General Procedure I afforded 63 mg (75%) of hexyl ether 
V{5,3} as a clear, viscous oil. 
Data for V{5,3}: 
 1H-NMR: (500 MHz, CDCl3) 
7.33 (dd, J = 7.3, 7.3, 2 H, HC(10)), 7.29–7.24 (m, 3 H, HC(11), HC(12)), 
4.03 (d, J = 13.6, 1 H, HC(2)), 3.85 (d, J = 13.6, 1 H, HC(2)), 3.45 (dd, J = 
8.1, 12.2, 1 H, HC(4)), 3.24 (dd, J = 11.1, 12.0, 1 H, HC(4)), 3.13 (ddd, J = 
6.4, 6.4, 8.9, 1 H, HC(13)), 2.82 (ddd, J = 6.5, 6.5, 8.9, 1 H, HC(13)), 2.70–
2.61 (m, 2 H, HC(7a), HC(7)), 2.59–2.50 (m, 1 H, HC(5)), 1.90 (m, 4 H, 
HC(7), H2C(6), HC(5a)), 1.47 (s, 3 H, H3C(8)), 1.47–1.41 (m, 2 H, H2C(14)), 
1.32–1.20 (m, 4 H, H2C(15), H2C(16)), 1.23–1.15 (m, 2 H, H2C(17)), 1.00 (d, 
J = 6.6, 3 H, H3C(19)), 0.86 (t, J = 7.2, 3 H, H3C(18)), 0.8–2.5 (br, 3 H, 
(H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
142.3 (C(9)), 128.5 (C(10)), 127.8 (C(11)), 126.3 (C(12)), 88.8 (C(7b) or 
C(1)), 82.4 (C(7b) or C(1)), 73.8 (C(4)), 70.2 (C(2)), 63.8 (C(13)), 63.2 
(C(7a)), 56.0 (C(5a)), 34.5 (C(5)), 31.7 (C(7b)), 31.1 (C(6)), 29.9 (C(14)), 
26.1 (C(16)), 24.9 (C(8)), 23.4 (C(7)), 22.7 (C(15)), 17.4 (C(18)), 14.1 (C(19)) 
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 IR: (NaCl plate, film) 
2950 (s), 2929 (s), 2869 (s), 2377 (s), 2329 (s), 2274 (s), 1457 (s), 1337 (m), 
1379 (m), 1173 (s), 1137 (m), 1092 (m), 1064 (m), 924 (w), 868 (w), 751 (w), 
700 (s) 
 MS: (EI, 70 eV) 
352.2 (3), 341.2 (6), 326.2 (4), 270.1 (4), 256.1 (100), 241.1 (29), 110.1 (24) 
 Mol. Formula: C23H38BNO (355.36) 
 HRMS: C23H35NO (341.2719) 
  Calcd: 341.2719 
  Found: 341.2722 
 TLC: Rf  0.35  (hexanes/TBME, 9:1) [I2] 
 
Preparation of (1R,3S,5S,5aS,7aS,7bR) Octahydro-1-(3,5-bistrifluoromethyl-benzyloxy)-1-
phenyl-5-methyl-7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (V{5,6}) 
 
To a two-necked, 25-mL round-bottomed flask equipped with a nitrogen inlet adapter, 
rubber septum and a magnetic stir bar was added sequentially alcohol 22{5} (105 mg, 0.287 
mmol), THF (2.0 mL, 0.1 M), then potassium hydride (19 mg, 0.474 mmol, 1.22 equiv).  The 
flask was immersed in an ice/NaCl cooling bath.  To the resulting mixture was added 3,5-
bis(trifluoromethyl)benzyl bromide dropwise, via syringe, as a solution in THF (2.0 mL).  The 
bath was removed and the reaction was allowed to reach room temperature.  After being stirred 
for 2 h at room temperature, the flask was immersed in an ice bath and the reaction was 
quenched with sat. aq. ammonium chloride (5.0 mL).   Extraction and purification by silica gel 
column chromatography as described in General Procedure I afforded 146 mg (76%) of 3,5-
bis(trifluomethyl)benzyl ether V{5,6} as a clear, viscous oil. 
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Data for V{5,6}: 
 1H-NMR: (500 MHz, CDCl3) 
7.75 (s, 1 H, HC(17)) , 7.60 (s, 2 H, HC(15)), 7.39-7.38 (m, 4 H, HC(10), 
HC(11)), 7.36-7.31 (m, 1 H, HC(12)), 4.24 (d, J = 12.4, 1 H, HC(13)), 4.16 (d, 
J = 13.2, 1 H, HC(2)), 4.07 (d, J = 12.4, 1 H, HC(13)), 3.93 (d, J = 13.2, 1 H, 
HC(2)), 3.42 (dd, J = 7.7, J = 12.4, 1 H, HC(4)), 3.21 (dd, J = 11.8, J = 11.8, 1 
H, HC(4)), 2.91 (dd, J = 8.4, J = 8.4, 1 H, HC(7a)), 2.64-2.55 (m, 1 H, 
HC(7)), 2.45-2.35 (m, 1 H, HC(5)), 2.03-2.87 (m, 4 H, HC(7), H2C(6), 
HC(5a)), 1.53 (s, 3 H, H3C(8)), 1.00 (d, J = 6.5, 3 H, H3C(20)), 0.8-2.5 (br, 3 
H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
140.9 (C(9 or 14)), 140.8 (C(9 or 14)), 130.2 (q, J = 33.2, C(19)), 127.1 
(C(10)), 127.1 (C(11)), 127.1 (C(12), 126.7 (C(15)), 121.5 (hept, J = 3.8, 
C(17)), 88.9 (C(7b)), 84.1 (C(1)), 73.4 (C(4)), 71.2 (C(2)), 65.1 (C(13)), 60.6 
(C(7a or 5a)), 60.6 (C(7a or 5a)), 34.5 (C(5)), 30.7 (C(6)), 25.1 (C(7)), 25.0 
(C(8)), 17.0 (C(20)) 
 IR: (CDCl3, film) 
3063 (w), 2962 (s), 2931 (s), 2874 (s), 2376 (s), 2331 (s), 2277 (s), 2243 (s), 
1808 (w), 1624 (m), 1497 (m), 1461 (s), 1448 (s), 1366 (s), 1279 (s), 1174 (s), 
1134 (s), 1091 (s), 1016 (m), 994 (m), 957 (w), 911 (s), 844 (s), 812 (w), 704 
(s) 
 MS: (ESI, Q-tof) 
494.2 (75), 484.2 (100) 
 Mol. Formula: C26H30BF6NO  (497.32) 
 HRMS: C26H28NOF6,  (484.2075) 
  Calcd: 484.2075 
  Found: 484.2064 
 TLC: Rf  0.38  (hexanes/TBME, 9:1) [I2] 
 
Preparation of (1R,3S,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-(2,4,6-trimethyl-phenyl)-
5-methyl-7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (V{6,2}) 
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Following General Procedure I, to a two-necked, 10-mL round-bottomed flask equipped 
with a nitrogen inlet adapter, rubber septum and a magnetic stir bar was added sequentially 
alcohol 22{6} (31 mg, 0.099 mmol), dimethylformamide (1.0 mL, ~0.1 M), then sodium hydride 
(3.6 mg, 0.148 mmol, 1.5 equiv) at 0 oC.  After 15 min, benzyl bromide (18 µL, 0.148 mmol, 1.5 
equiv) was added via syringe.  The solution was stirred for 2 hr then quenched onto ice water (10 
mL).  Extraction and purification by silica gel column chromatography as described in General 
Procedure I afforded 39 mg (98%) of benzyl ether V{6,2} as a clear, viscous oil. 
Data for V{6,2}: 
 1H-NMR: (500 MHz, CDCl3) 
7.32 (dd, J = 7.2, 7.2, 1 H, HC(19)), 7.29-7.25 (m, 1 H, HC(20)), 7.23 (d, J = 
7.2, 1 H, HC(18)), 6.86 (s, 2 H, HC(11)) 4.28 (d, J = 11.1, 1 H, HC(16)), 4.25 
(d, J = 14.1, 1 H, HC(2)), 4.17 (d, J = 11.0, 1 H, HC(16)), 4.07 (d, J = 13.8, 1 
H, HC(2)), 3.94 (dd, J = 9.3, 11.6, 1 H, HC(4)), 3.25 (dd, J = 6.9, 11.8, 1 H, 
HC(4)), 2.99 (dd, J = 9.1, 9.1, 1 H, HC(7a)), 2.54 (s, 3 H, H3C(13)) 2.52 (s, 3 
H, H3C(14)), 2.25 (s, 3 H, H3C(15)), 2.26-2.19 (m, 1 H, HC(5)), 2.15-2.09 (m, 
1 H, HC(7)), 2.01-1.98 (m, 1 H, HC(5a)), 1.90-1.84 (m, 2 H, H2C(6), 1.41 (s, 
3 H, H3C(8)), 1.13 (d, J = 6.9, 3 H, H3C(21)), 0.8-2.5 (br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
138.4, 138.0, 137.0, 137.0, 132.3, 132.1, 128.5, 127.6, 127.3, 87.5 (C(1 or 
7b)), 87.4 (C(1 or 7b)), 74.6 (C(4)), 71.8 (C(2)), 66.9 (C(16)), 64.4 (C(7a)), 
59.5 (C(5a)), 36.2 (C(5)), 33.0 (C(6)), 28.5 (C(15)), 25.6 (C(8)), 25.0 (C(13 or 
14)), 24.6 (C(13 or 14)), 20.5 (C(7)), 19.9 (C(21)) 
 IR: (CDCl3, film) 
3028 (w), 2950 (s), 2930 (s), 2865 (s), 2376 (s), 2330 (s), 2277 (m), 2241 (m), 
1610(m), 1454 (s), 1379 (m), 1348 (w), 1277 (w), 1173 (s), 1086 (s), 1063 (s), 
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1028 (s), 993 (w), 911 (s), 872 (w) 
 MS: (EI, 70 eV) 
400.3 (1), 389.2 (2), 298.2 (100), 281.2 (4), 147.1 (47), 124.1 (26) 
 Mol. Formula: C27H38BNO (403.41) 
 HRMS: C27H35NO, 389.2719) 
  Calcd: 389.2719 
  Found: 389.2719 
 TLC: Rf  0.25  (hexanes/TBME, 9:1) [I2] 
 
Preparation of (1R,3S,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-(1-naphthyl)-5-methyl-
7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane V{7,2} 
 
Following General Procedure I, to a two-necked, 10-mL round-bottomed flask equipped 
with a nitrogen inlet adapter, rubber septum and a magnetic stir bar was added sequentially 
alcohol 22{7} (38 mg, 0.118 mmol), dimethylformamide (1.2 mL, ~0.1 M), then sodium hydride 
(4.3 mg, 0.177 mmol, 1.5 equiv) at 0 oC.  After 15 min, benzyl bromide (21 µL, 0.177 mmol, 1.5 
equiv) was added via syringe.  The solution was stirred for 2 hr then quenched onto ice water (10 
mL).  Extraction and purification by silica gel column chromatography as described in General 
Procedure I afforded 45 mg (93%) of benzyl ether V{7,2} as a clear, viscous oil. 
Data for V{7,2}: 
 1H-NMR: (500 MHz, CDCl3) 
8.58 (d, J = 8.0, 0.6 H) , 8.53-8.50 (m, 1 H), 7.95-7.85 (m, 4 H), 7.54-7.48 (m, 
4 H), 7.31-7.25 (m, 4 H), 7.16-7.13 (m, 3 H), 4.71 (d, J = 13.5, 0.6 H), 4.47 
(d, J = 11.4, 1 H), 4.21 (d, J = 11.1, 0.6 H), 4.05-3.98 (m, 1.6 H), 3.91-3.84 
(m, 1.6 H), 3.78 (d, J = 10.5, 1 H), 3.73 (dd, J = 8.2, 11.8, 0.6 H), 3.60 (dd, J 
= 9.3, 9.3, 1 H), 3.30 (dd, J = 11.2, 11.2, 0.6 H), 3.25 (dd, J = 6.2, 12.5, 1 H), 
NaH, DMF
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3.04-2.95 (m, 0.6 H), 2.89 (dd, J=12.5, 12.5, 1 H), 2.79 (dd, J = 8.7, 8.7, 0.6 
H), 2.59-2.50 (m, 1 H), 2.45-2.37 (m, 0.6 H), 2.26-2.11 (m, 3 H), 2.03-1.80 
(m, 5H), 1.72 (s, 3 H), 1.35 (s, 1.8 H), 1.09 (d, J = 6.5, 1.8 H), 1.06 (d, J = 6.3, 
3 H) 
 13C-NMR: (126 MHz, CDCl3) 
138.13, 138.08, 136.6, 136.0, 135.1, 134.8, 131.4, 130.3, 129.8, 129.6, 129.2, 
128.4, 128.0, 127.7, 127.6, 126.4, 126.3, 126.2, 126.0, 125.9, 125.8, 125.78, 
126.76, 125.7, 124.6, 124.3, 88.8, 86.9, 85.3, 85.0, 73.5, 72.8, 72.4, 70.6, 67.2, 
66.8, 64.1, 63.4, 60.3, 54.8, 34.5, 33.7, 31.1, 28.7, 28.6, 27.7, 25.0, 25.3, 17.8, 
16.1 
 IR: (CDCl3, film) 
3050 (w), 2959 (s), 2929 (s), 2870 (m), 2397 (s), 2326 (s), 2279 (m), 2242 
(m), 1602 (w), 1509 (w), 1498 (w), 1455 (s), 1380 (s), 1336 (w), 1287 (w), 
1241 (w), 1173 (s), 1142 (m), 1113 (m), 1059 (s), 1026 (m), 959 (w), 911 (s), 
865 (w), 804 (s), 780 (s), 733 (s), 699 (s), 648 (m) 
 MS: (EI, 70 eV) 
426.2 (9), 408.2 (5), 398.2 (64), 382.2 (8), 306.1 (100), 290.1 (94), 270.1 (8), 
155.0 (11) 
 Mol. Formula: C28H34BNO (411.3867) 
 HRMS: C27H35NO, 412.2812) 
  Calcd: 412.2812 
  Found: 412.2640 
 TLC: Rf  0.40  (hexanes/TBME, 4:1) [I2, CAM] 
 
Preparation of (1R,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-5-methyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizine•Borane (β-V{2}) 
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Following General Procedure I, to a two-necked, 10-mL round-bottomed flask equipped 
with a nitrogen inlet adapter, rubber septum and a magnetic stir bar was added sequentially 
alcohol S3 (22 mg, 0.113 mmol), dimethylformamide (1.1 mL, ~0.1 M), then sodium hydride (4 
mg, 0.17 mmol, 1.5 equiv) at 0 oC.  After 15 min, benzyl bromide (20 µL, 0.17 mmol, 1.5 equiv) 
was added via syringe.  The solution was stirred for 2 hr then quenched onto ice water (10 mL).  
Extraction and purification by silica gel column chromatography as described in General 
Procedure I afforded 28 mg (88%) of benzyl ether β-V{3} as a clear, viscous oil. 
Data for β-V{2}: 
 1H-NMR: (500 MHz, CDCl3) 
7.35 (m, 4 H, HC(11), HC(12)), 7.28 (m, 1 H, HC(13)), 4.63 (d, J = 11.7, 1 H, 
HC(9)), 4.38 (d, J = 11.7, 1 H, HC(9)), 3.79–3.75 (m, 2 H, HC(2), HC(1)), 
3.26–3.21 (m, 2 H, HC(2), HC(4)), 3.04 (dd, J = 12.2, 12.2, 1 H, HC(4)), 2.40 
(dd, J = 7.9, 7.9, 1 H, HC(7a)), 2.07–2.01 (m, 1 H, HC(7)), 1.86–1.81 (m, 2 H, 
HC(5a), HC(5)), 1.81–1.73 (m, 1 H, HC(6)), 1.71–1.66 (m, 1 H, HC(6)), 1.60 
(s, 3 H, H3C(8)), 1.60–1.52 (m, 1 H, HC(7)), 1.00 (d, J = 5.9, 3 H, H3C(14)), 
0.8–2.5 (br, 3 H, (H3B)
3) 
 13C-NMR: (126 MHz, CDCl3) 
138.1 (C(10)), 128.5 (C(12)), 127.8 (C(13)), 127.7 (C(11)), 88.0 (C(7b)), 81.8 
(C(1)), 73.0 (C(4)), 70.8 (C(9)), 67.7 (C(2)), 60.9 (C(5a)), 58.2 (C(7a)), 35.4 
(C(5)), 30.6 (C(7)), 29.7 (C(6)), 25.0 (C(8)), 16.6 (C(14)) 
 IR: (CDCl3, film) 
2956 (s), 2915 (s), 2872 (s), 2383 (s), 2328 (s), 2262 (s), 1496 (w), 1455 (s), 
1379 (m), 1316 (w), 1273 (w), 1234 (w), 1177 (s), 1106 (m), 1067 (m), 1014 
(w), 913 (m), 862 (w), 798 (w) 
 MS: (ESI, Q-tof) 
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284.2 (70), 272.2 (100), 192.2 (35), 141 (12) 
 Mol. Formula: C18H28BNO 285.23 
 HRMS: C18H26NO, (272.2014) 
Calcd: 272.2014 
Found: 272.2008 
 TLC: Rf  0.24  (hexanes/TBME, 9:1) [I2] 
 
Preparation of (1R,3S,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-(tert-butyl)-5-methyl-7b-
methyl-2Hcyclopenta[gh]pyrrolizine•Borane (V{4,2}) 
 
Following General Procedure I, to a two-necked, 10-mL round-bottomed flask equipped 
with a nitrogen inlet adapter, rubber septum and a magnetic stir bar was added sequentially 
alcohol 24{4}(25 mg, 0.100 mmol), tetrahydrofuran (1.0 mL, ~0.1 M), then potassium hydride 
(6 mg, 0.149 mmol, 1.5 equiv) at 0 oC.  After 15 min, benzyl bromide (26 µL, 0.149 mmol, 1.5 
equiv) was added via syringe.  The solution was stirred for 2 hr then quenched onto ice water (10 
mL).  Extraction and purification by silica gel column chromatography as described in General 
Procedure I afforded 33 mg (97%) of benzyl ether V{4,2} as a clear, viscous oil. 
Data for V{4,2}: 
 1H-NMR: (500 MHz, CDCl3) 
7.38–7.33 (m, 4 H, HC(13), HC(14)), 7.30–7.27 (m, 1 H, HC(15)), 4.83 (d, J 
= 11.2, 1 H, HC(2)), 4.56 (d, J = 11.2, 1 H, HC(2)), 3.81 (d, J = 15.2, 1 H, 
HC(11)), 3.77 (d, J = 15.1, 1 H, HC(11)), 3.32 (dd, J = 8.0, 12.4, 1 H, HC(4)), 
3.15 (dd, J = 11.2, 12.0, 1 H, HC(4)), 2.59 (dd, J = 6.9, 9.6, 1 H, HC(7a)), 
2.57–2.48 (m, 1 H, HC(7)), 2.09–2.01 (m, 1 H, HC(5)), 1.80–1.72 (m, 3 H, 
H2C(6), HC(5a)), 1.65–1.59 (m, 1 H, HC(7)), 1.48 (s, 3 H, H3C(8)), 1.00 (s, 9 
H, H3C(10)), 0.72 (d, J = 6.6, 3 H, H3C(16)), 0.8–2.5 (br, 3 H, (H3B)
3) 
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 13C-NMR: (126 MHz, CDCl3) 
138.5 (C(12)), 128.6 (C(14)), 127.6 (C(15)), 127.2 (C(13)), 88.7 (C(1 or 7b)), 
86.8 (C(1 or 7b)), 74.0 (C(4)), 68.6 (C(2)), 68.5 (C(11)), 59.7 (C(5a)), 59.5 
(C(7a)), 39.2 (C(9)), 34.3 (C(5)), 31.4 (C(6)), 27.6 (C(10)), 24.6 (C(7)), 24.4 
(C(8)), 16.9 (C(16)) 
 IR: (CDCl3, film) 
2960 (s), 2871 (s), 2382 (s), 2328 (s), 2274 (s), 1728 (w), 1604 (w), 1497 (w), 
1455 (s), 1401 (w), 1378 (m), 1318 (w), 1285 (w), 1235 (w), 1175 (s), 1133 
(m), 1092 (s), 1061 (m), 1028 (m), 1007 (w), 977 (w), 955 (w), 926 (m), 913 
(m), 869 (w), 735 (s), 698 (s)  
 MS: (EI, 70 eV) 
338.2 (13), 270.1 (12), 236.2 (100), 221.2 (3.9), 204.1 (3), 178.1 (10), 164.1 
(3), 138.1 (3), 124.1 (4), 110.1 (10.2) 
 Mol. Formula: C22H36BNO (341.34) 
 HRMS: C22H33NO
+, (327.2562) 
  Calcd: 327.2562 
  Found: 327.2556 
 TLC: Rf  0.28  (hexanes/TBME, 9:1) [I2] 
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Variable Group R
4
:  Deborylation and N-Quaternization 
Parallel Synthesis Step II-III: General Procedure II 
 
A solution of borane adduct X (XX mg, XX mmol) in CH3OH (0.03 M) was transferred 
to a 250-mL, round-bottomed, flask fitted with a reflux condenser, a magnetic stir-bar, and a 
nitrogen inlet adapter with a rubber septum.  Lastly, 1.0 M aq. HCl solution (x.x mL, 5.0 equiv) 
was added via syringe. The resulting clear solution was immersed in an oil bath (preheated, 60 
oC) and stirred for 12 h. The mixture was allowed to cool to room temperature and was 
concentrated by rotary evaporation (15 mm Hg, 20-25 oC) whereupon a 0.1 M aq. NaOH 
solution (xx.x mL, 6.0 equiv) was added.  The resulting solution was tested to assure basicity by 
pH paper (typically pH ~11-14). The basic solution was extracted with Et2O (3 x 100 mL) and 
the combined extracts were dried (K2CO3).  The resulting floculant suspension was filtered 
(cotton plug), and concentrated by rotary evaporation (15 mm Hg, 20-25 oC) to furnish the crude 
intermediate amine as a pale-yellow oil.  The amine was dissolved in acetonitrile (0.2 M) and 
distributed among five 20-mL test tubes fitted in a Büchi SynCore reactor (Figure X) which were 
then evacuated and backfilled with N2.  An alkyl bromide (x.x mL, x.x mmol, 1.2 equiv) was 
added to each test tube via syringe (the solid bromides were added as solids) and the reactor was 
set to agitate at 200 rpm.  After 12 h, the individual reaction mixtures were concentrated by 
rotary evaporation (15 mm Hg, 20-25oC).  Each salt was purified by silica gel plug filtration (1.8 
cm x 5 cm, CH2Cl2/EtOAc, 1:1 (50 mL), then CH2Cl2/methanol 49:1, 24:1, 9:1 (50 mL each) 
afforded the product ammonium salts as a clear, sticky residues.  The residues were triturated 
with Et2O (~10 mL) in a 20-mL scintillation vial to free flowing solids which were then 
concentrated by rotary evaporation (15 mm Hg, 20-25oC).  The resulting solids were dried under 
vacuum (0.1 mm Hg, 20-25 oC) for 12 h to afford the final quaternary ammonium bromides X{x} 
as free flowing powers. 
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Preparation of Quaternary Ammonium Bromides IV{2-7,1-7,1-11}. Preparation of 
Quaternary Ammonium Bromides IV{2,2,R4} 
 
 Following General Procedure II, amino borane V{2,2} (210 mg, 0.74 mmol) was added 
to a 250-mL, round-bottomed flask as a solution in 150 mL of MeOH (~0.03 M).  The flask was 
fitted with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 M aq. 
HCl solution (24 mL, 5.0 equiv) was added via syringe.  The resulting solution was heated and 
then concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure 
II.  The resulting free amine was dissolved in acetonitrile and was distributed among six test 
tubes that were subsequently charged with benzyl bromide (tube 1, 23 mg, 0.30 mmol, 1.2 
equiv), 1-bromomethylnaphthalene (tube 2, 80 mg, 0.3 mmol, 1.2 equiv), 2-
bromomethylnaphthalene (tube 3, 80 mg, 0.3 mmol, 1.2 equiv).  After being agitated for 12 h, 
the reaction mixtures were worked up and the products isolated and purified as described in 
General Procedure II. 
 
Preparation of rel-(1S,3R,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-methyl-3-benzyl-7b-
methylcyclopenta[gh]pyrrolizinium Bromide (IV{2,2,1}) 
 
Data for IV{2,2,1}: 
 Yield: 63 mg (57%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.78-7.75 (m, 2 H), 7.48-7.42 (m, 3 H), 7.31-7.24 (m, 3 H), 7.18 (d, J = 7.1, 2 
H), 5.38 (d, J = 12.4, 1 H), 5.34 (d, J = 13.0, 1 H), 4.45 (d, J = 11.4, 1 H), 
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4.26-4.21 (m, 2 H), 3.86-3.78 (m, 1 H), 3.72 (dd, J = 6.8, 12.2, 1 H), 3.44 (d, J 
= 13.1, 1 H), 2.83-2.79 (m, 1 H), 2.68 (dd, J = 6.4, 13.5, 1 H), 2.49-2.40 (m, 1 
H), 2.27-2.20 (m, 1 H), 2.12 (s, 3 H), 2.12-2.04 (m, 1 H), 1.91-1.80 (m, 1 H), 
1.80-1.75 (m, 1 H), 1.75 (s, 3 H) 
 MS: (ESI, Q-tof) 
362.2 (100) 
 Mol. Formula: C25H32BrNO, (442.43) 
 HRMS: C25H32NO
+: (362.2484) 
Calcd: 362.2484 
Found: 362.2479 
 TLC: Rf  0.22  (CH2Cl2/MeOH, 9:1) [I2] 
 
Preparation of rel-(1S,3R,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-methyl-3-(1-
naphthylmethyl)-7b-methylcyclopenta[gh]pyrrolizinium Bromide (IV{2,2,2}) 
 
Data for IV{2,2,2}: 
 Yield: 71 mg (58%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.44-8.35 (m, 1 H), 8.17-8.10 (m, 1 H), 7.88-7.74 (m, 2 H), 7.59 (t, J = 7.2, 1 
H), 7.53-7.47 (m, 1 H), 7.34 (s, 1 H), 7.25-7.16 (m, 3 H), 7.12-7.07 (m, 2 H), 
5.60-5.42 (m, 2 H), 5.17-4.97 (m, 1 H), 4.41 (d, J = 11.4, 1 H), 4.13 (d, J = 
11.6, 1 H), 3.83-3.73 (m, 1 H), 3.51-3.44 (m, 1 H), 3.36-3.28 (m, 1 H), 2.93-
3.67 (m, 3 H), 2.33 (s, 3 H), 2.26-2.18 (m, 1 H), 2.11 (s, 1 H), 1.91-1.71 (m, 3 
H), 1.75 (s, 3 H) 
 MS: (ESI, Q-tof) 
412.3 (100) 
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 Mol. Formula: C29H34BrNO (492.49) 
 HRMS: C29H34NO
+: (412.2640) 
Calcd: 412.2640 
Found: 412.2636 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2] 
 
Preparation of rel-(1S,3R,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-methyl-3-(2-
naphthylmethyl)-7b-methylcyclopenta[gh]pyrrolizinium Bromide (IV{2,2,3}) 
 
Data for IV{2,2,3}: 
 Yield: 64 mg (53%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.21 (s, 1 H), 7.94-7.88 (m, 1 H), 7.83-7.74 (m, 3 H), 7.56-7.48 (m, 2 H), 
7.28-7.17 (m, 3 H), 7.13 (d, J = 7.4, 2 H), 5.56-5.34 (m, 2 H), 4.45-4.40 (m, 1 
H), 4.42 (d, J = 11.0, 1 H), 4.17 (d, J = 11.4, 1 H), 3.85-3.70 (m, 2 H), 3.47 (d, 
J = 13.0, 1 H), 2.88-2.69 (m, 2 H), 2.64-2.50 (m, 1 H), 2.28-2.17 (m, 1 H), 
2.19 (s, 3 H), 2.12-2.04 (m, 1 H), 1.91-1.73 (m, 3 H), 1.75 (s, 3 H) 
 MS: (ESI, Q-tof) 
412.3 (100) 
 Mol. Formula: C29H34BrNO (492.49) 
 HRMS: C29H34NO
+: (412.2640) 
Calcd: 412.2640 
Found: 412.2631 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2] 
 
Preparation of Quaternary Ammonium Bromides IV{2,3,1-3} 
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 Following General Procedure II, amino borane IV{2,3} (103 mg, 0.37 mmol) was added 
to a 50-mL round-bottomed flask as a solution in 12 mL of MeOH (0.03 M).  The flask was 
fitted with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. 
HCl solution (3.68 mL, 5.0 equiv) was added via syringe.  The resulting solution was heated and 
then concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure 
II.  The resulting free amine was dissolved in acetonitrile and was distributed among six test 
tubes that were subsequently charged with benzyl bromide (tube 1, 82 mg, 0.478 mmol, 4.0 
equiv), 1-bromomethylnaphthalene (tube 2, 79 mg, 0.358 mmol, 3.0 equiv), 2-
bromomethylnaphthalene (tube 3, 79 mg, 0.358 mmol, 3.0 equiv).  After being agitated for 12 h, 
the reaction mixtures were worked up and the products isolated and purified as described in 
General Procedure II. 
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Preparation of rel-(1S,3R,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-methyl-3-benzyl-7b-
methylcyclopenta[gh]pyrrolizinium Bromide (IV{2,3,1}) 
 
Data for IV{2,3,1}: 
 Yield: 41 mg (51%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.79-7.73 (m, 2 H), 7.48-7.42 (m, 3 H), 5.35 (d, J = 12.3, 1 H), 5.17 (d, J = 
13.0, 1 H), 4.27-4.18 (m, 1 H), 3.84 (ddd, J = 6.0, 12.1, 12.1, 1 H), 3.79–3.73 
(m, 1 H), 3.32 (d, J = 12.9, 2 H), 3.30 (dd, J = 6.9, 15.2, 1 H), 3.11 (dd, J = 
6.4, 15.1, 1 H), 2.76-2.70 (m, 1 H), 2.66 (dd, J = 7.2, 14.7, 1 H), 2.53-2.42 (m, 
1 H), 2.19-2.00 (m, 2 H), 2.09 (s, 3 H), 1.86-1.72 (m, 3 H), 1.60 (s, 3 H), 1.47-
1.38 (m, 2 H), 1.30-1.15 (m, 6H), 0.84 (t, J = 6.9, 3 H). 
 MS: (ESI, Q-tof) 
356.3 (100) 
 Mol. Formula: C24H38BrNO (436.47) 
 HRMS: C24H38NO
+: (356.2953) 
Calcd: 356.2953 
Found: 356.2951 
 TLC: Rf  0.32  (CH2Cl2/MeOH, 9:1) [I2]
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Preparation of rel-(1S,3R,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-methyl-3-(1-naphthyl 
methyl)-7b-methylcyclopenta[gh]pyrrolizinium Bromide (IV{2,3,2}) 
 
Data for IV{2,3,2}: 
 Yield: 45 mg (51%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.42-8.36 (m, 1 H), 8.16-8.10 (m, 1 H), 7.85 (d, J = 7.7, 1 H), 7.82-7.76 (m, 1 
H), 7.61 (dd, J = 7.6, 7.6, 1 H), 7.51 (dd, J = 7.5, 7.5, 1 H), 7.41-7.33 (m, 1 
H), 5.53 (d, J = 12.5, 1 H), 5.31 (d, J = 12.9, 1 H), 5.06 (d, J = 12.6, 1 H), 
3.84-3.75 (m, 1 H), 3.35 (d, J = 12.9, 2 H), 3.25 (dd, J = 7.1, 15.2, 1 H), 2.99 
(dd, J = 6.3, 15.0, 1 H), 2.84-2.69 (m, 3 H), 2.30 (s, 3 H), 2.15-2.05 (m, 2 H), 
1.83-1.74 (m, 3 H), 1.60 (s, 3 H), 1.38-1.25 (m, 2 H), 1.22-1.09 (m, 6H), 0.79 
(t, J = 7.0, 3 H). 
 MS: (ESI, Q-tof) 
406.3 (100) 
 Mol. Formula: C28H40BrNO (486.53) 
 HRMS: C28H40NO
+: (406.3110) 
Calcd: 406.3110 
Found: 406.3099 
 TLC: Rf  0.35  (CH2Cl2/MeOH, 9:1) [I2]
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Preparation of rel-(1S,3R,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-methyl-3-(2-
naphthylmethyl)-7b-methylcyclopenta[gh]pyrrolizinium Bromide (IV{2,3,3}) 
 
Data for IV{2,3,3}: 
 Yield: 51 mg (57%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.21 (s, 1 H), 7.94-7.89 (m, 1 H), 7.83-7.74 (m, 3 H), 7.56-7.48 (m, 2 H), 
5.53-5.46 (m, 1 H), 5.27-5.17 (m, 1 H), 4.55-4.39 (m, 1 H), 3.87-3.73 (m, 2 
H), 3.35 (d, J = 12.9, 1 H), 3.26 (dd, J = 7.2, 13.6, 1 H), 3.04 (dd, 1 H, J = 6.9, 
13.3), 2.78-2.67 (m, 2 H), 2.65-2.54 (m, 1 H), 2.18-2.02 (m, 2 H), 2.16 (s, 3 
H), 1.88-1.72 (m, 3 H), 1.60 (s, 3 H), 1.45-1.29 (m, 2 H), 1.24-1.11 (m, 6H), 
0.80 (t, J = 6.8, 3 H) 
 MS: (ESI, Q-tof) 
406.3 (100) 
 Mol. Formula: C28H40BrNO (486.53) 
 HRMS: C28H40NO
+: (406.3110) 
Calcd: 406.3110 
Found: 406.3109 
 TLC: Rf  0.35  (CH2Cl2/MeOH, 9:1) [I2]
N
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Preparation of Quaternary Ammonium Bromides IV{3,2,R4} 
 
 Following General Procedure II, amino borane IV{2,3} (533 mg, 1.68 mmol) was added 
to a 50-mL round-bottomed flask as a solution in 56 mL of MeOH (0.03 M).  The flask was 
fitted with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. 
HCl solution (8.4 mL, 5.0 equiv) was added via syringe.  The resulting solution was heated and 
then concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure 
II.  The resulting free amine was dissolved in acetonitrile and was distributed among four test 
tubes that were subsequently charged with benzyl bromide (tube 1, 87 mg, 0.509 mmol, 1.2 
equiv), 1-bromomethylnaphthalene (tube 2, 116 mg, 0.509 mmol, 1.2 equiv), 2-
bromomethylnaphthalene (tube 3, 116 mg, 0.509 mmol, 1.2 equiv), 3,5-
bis(trifluoromethyl)benzyl bromide (tube 4, 156 mg, 0.509 mmol, 1.2 equiv).  After being 
agitated for 12 h, the reaction mixtures were worked up and the products isolated and purified as 
described in General Procedure II. 
  
1. HCl (aq), MeOH
    reflux, 6 h
2. NaOH (0.1 M, aq)
    Et2O
3. CH3CN, RT
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Preparation of rel-(1R,3R,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-isopropyl-3-benzyl-7b-
methylcyclopenta[gh]pyrrolizinium Bromide (IV{3,2,1}) 
 
Data for IV{3,2,1}: 
 Yield: 235 mg (99%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.82-7.77 (dd, J = 2.2, 7.2, 2 H), 7.44-7.37 (s, 3 H), 7.30-7.21 (m, 3 H), 7.19-
7.15 (m, 2 H), 5.50 (d, J = 12.5, 1 H), 4.77 (d, J = 13.4, 1 H), 4.62-4.53 (m, 1 
H), 4.46 (d, J = 11.3, 1 H), 4.21 (d, J = 11.3, 1 H), 3.91-3.82 (m, 1 H), 3.72 (d, 
J = 13.5, 1 H), 3.49 (dd, J = 7.2, 12.3, 1 H), 2.83-2.76 (m, 1 H), 2.73 (dd, J = 
8.2, 8.2, 1 H), 2.67-2.56 (m, 1 H), 2.42-2.32 (m, 1 H), 2.31-2.21 (m, 1 H), 
2.09-1.99 (m, 1 H), 1.96 (s, 3 H), 1.86-1.76 (m, 2 H), 1.69-1.59 (m, 1 H), 1.28 
(d, J = 6.8, 3 H), 1.05 (d, J = 6.8, 3 H) 
 MS: (ESI, Q-tof) 
390.3 (100) 
 Mol. Formula: C27H36BrNO (470.48) 
 HRMS: C27H36NO
+: (390.2797) 
Calcd: 390.2797 
Found: 390.2789 
 TLC: Rf  0.21  (CH2Cl2/MeOH, 9:1) [I2]
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Preparation of rel-(1R,3R,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-isopropyl-3-(1-
naphthylmethyl)-7b-methylcyclopenta[gh]pyrrolizinium Bromide (IV{3,2,2}) 
 
Data for IV{3,2, 2}: 
 Yield: 194 mg (74%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.35 (s, 1 H), 8.24 (s, 1 H), 7.66 (s, 1 H), 7.53 (dd, J = 7.9, 7.9, 1 H), 7.45-
7.40 (m, 2 H), 7.18-7.13 (m, 3 H), 7.02 (d, J = 5.9, 2 H), 6.99-6.89 (m, 1 H), 
5.62-5.49 (m, 2 H), 4.82 (d, J = 13.8, 1 H), 4.37 (d, J = 11.2, 1 H), 4.00 (d, J = 
11.3, 1 H), 3.76-3.67 (m, 1 H), 3.54 (d, J = 13.9, 1 H), 3.26-3.16 (m, 1 H), 
3.03-2.94 (m, 2 H), 2.78 (dd, J = 7.3, 7.3, 1 H), 2.39-2.16 (m, 2 H), 2.30 (s, 3 
H), 2.11-2.02 (m, 1 H), 1.85-1.75 (m, 2 H), 1.63-1.55 (m, 1 H), 1.35 (d, J = 
6.8, 3 H), 1.04 (d, J = 6.8, 3 H) 
 MS: (ESI, Q-tof) 
440.3 (100) 
 Mol. Formula: C31H38BrNO (520.54) 
 HRMS: C31H38NO
+: (440.2953) 
Calcd: 440.2953 
Found: 440.2960 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2]
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Preparation of rel-(1R,3R,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-isopropyl-3-(2-
naphthylmethyl)-7b-methylcyclopenta[gh]pyrrolizinium Bromide (IV{3,2,3}) 
 
Data for IV{3,2,3}: 
 Yield: 195 mg (75%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.22 (s, 1 H), 7.86-7.81 (m, 1 H), 7.74 (d, J = 8.3, 1 H), 7.64-7.55 (m, 2 H), 
7.45-7.42 (m, 2 H), 7.20-7.14 (m, 3 H), 7.11-7.08 (m, 2 H), 5.62 (d, J = 12.8, 
1 H), 4.92-4.82 (m, 1 H), 4.83 (d, J = 13.4, 1 H), 4.41 (d, J = 11.3, 1 H), 4.11 
(d, J = 11.2, 1 H), 3.87-3.78 (m, 1 H), 3.69 (d, J = 13.4, 1 H), 3.49-3.41 (m, 1 
H), 2.95-2.89 (m, 1 H), 2.82-2.71 (m, 2 H), 2.37 (hept, J = 6.9, 1 H), 2.29-
2.21 (m, 1 H), 2.10-2.02 (m, 1 H), 2.07 (s, 3 H), 1.86-1.75 (m, 2 H), 1.68-1.60 
(m, 1 H), 1.33 (d, J = 6.8, 3 H), 1.03 (d, J = 6.7, 3 H) 
 MS: (ESI, Q-tof) 
440.3 (100) 
 Mol. Formula: C31H38BrNO (520.54) 
 HRMS: C31H38NO
+: (440.2953) 
Calcd: 440.2953 
Found: 440.2960 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2] 
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Preparation of rel-(1R,3R,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-isopropyl-3-(3,5-
trifluoromethyl benzyl)-7b-methylcyclopenta[gh]pyrrolizinium Bromide (IV{3,2,5}) 
 
Data for IV{3,2,5}: 
 Yield: 199 mg (66%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.32 (s, 2 H), 7.83 (s, 1 H), 7.25-7.19 (m, 3 H), 7.15-7.10 (m, 2 H), 5.88 (d, J 
= 12.7, 1 H), 5.17-5.09 (m, 1 H), 4.88 (d, J = 13.2, 1 H), 4.47 (d, J = 11.5, 1 
H), 4.16 (d, J = 11.5, 1 H), 3.94-3.85 (m, 1 H), 3.47 (d, J = 13.1, 1 H), 3.02-
2.93 (m, 2 H), 2.80-2.70 (m, 2 H), 2.38 (hept, J = 6.7, 1 H), 2.31-2.22 (m, 1 
H), 2.12-1.99 (m, 1 H), 2.04 (s, 3 H), 1.91-1.77 (m, 2 H), 1.74-1.65 (m, 1 H), 
1.31 (d, J = 6.7, 3 H), 1.02 (d, J = 6.7, 3 H) 
 MS: (ESI, Q-tof) 
526.3 (100) 
 Mol. Formula: C29H34BrF6NO (606.48) 
 HRMS: C29H34NOF6
+: 526.2545) 
Calcd: 526.2545 
Found: 526.2549 
 TLC: Rf  0.30  (CH2Cl2/MeOH, 9:1) [I2]
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Preparation of rel-(1R,3R,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-phenyl-3-(3,5-
trifluoromethylbenzyl)-7b-methylcyclopenta[gh]pyrrolizinium Bromide (IV{5,2,5}) 
 
Following General Procedure II, benzyl ether IV{5,2} (69 mg, 0.268 mmol) was added to 
a 50-mL round-bottomed flask as a solution in 8.9 mL of MeOH (0.03 M).  The flask was fitted 
with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. HCl 
solution (1.3 mL, 5.0 equiv) was added via syringe.  The resulting solution was heated and then 
concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure II.  
The resulting free amine (30 mg, 0.09 mmol) was dissolved in acetonitrile along with 3,5-
bis(trifluoromethyl)benzyl bromide (33 mg, 0.108 mmol, 2.0 equiv) and was allowed to react for 
12 h.  Purification of described in General Procedure II afforded 44 mg (75%) of the quaternary 
ammonium ion IV{5,2,5} as a free flowing white power. 
Data for IV{5,2,5}: 
 Yield: 44 mg (75%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.12 (s, 1 H), 7.93 (s, 1 H), 7.76 (d, J = 7.5, 1 H), 7.64 (dd, J = 7.6, 7.6, 1 H), 
7.55 (dd, J = 7.3, 7.3, 1 H), 7.30-7.24 (m, 1 H), 7.12 (dd, J = 2.1, 7.5, 1 H), 
5.59 (d, J = 12.5, 1 H), 4.80 (s, 1 H), 4.59 (d, J = 13.0, 1 H), 4.37 (d, J = 11.6, 
1 H), 4.07 (d, J = 11.0, 1 H), 3.91 (d, J = 11.0, 1 H), 3.62 (d, J = 13.1, 1 H), 
3.44-3.39 (m, 1 H), 3.32 (dd, J = 8.1, 8.1, 1 H), 3.15-3.08 (m, 1 H), 2.61-2.45 
(m, 1 H), 2.26 (s, 3 H), 2.16-2.03 (m, 1 H), 2.01-1.95 (m, 1 H), 1.87 (ddd, J = 
7.8, 14.5, 14.3, 1 H) 
 MS: (ESI, Q-tof) 
560.2 (100) 
 Mol. Formula: C32H32BrF6NO (640.50) 
 HRMS: C20H38NO3
+: (560.2388) 
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    reflux, 6 h
2. NaOH (0.1 M, aq)
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Calcd: 560.2388 
Found: 560.2388 
 TLC: Rf  0.32  (CH2Cl2/MeOH, 9:1) [I2] 
 
Preparation of Quaternary Ammonium Bromides V{1-7,1-7,1-11}.  
Preparation of Quaternary Ammonium Bromides V{1,2,R
4
} 
 
 Following General Procedure II, amino borane V{1,2} (533 mg, 1.68 mmol) was added 
to a 50-mL round-bottomed flask as a solution in 37 mL of MeOH (0.03 M).  The flask was 
fitted with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. 
HCl solution (5.5 mL, 5.0 equiv) was added via syringe.  The resulting solution was heated and 
then concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure 
II.  The resulting free amine was dissolved in acetonitrile and was distributed among seven test 
tubes that were subsequently charged with benzyl bromide (tube 1, 40 mg, 0.235 mmol, 1.5 
equiv), 1-bromomethylnaphthalene (tube 2, 42 mg, 0.188 mmol, 1.2 equiv), 2-
bromomethylnaphthalene (tube 3, 42 mg, 0.188 mmol, 1.2 equiv), 3,5-bis(trifluoromethyl)benzyl 
bromide (tube 4, 58 mg, 0.188 mmol, 1.2 equiv), 3,5-bis(t-butyl)benzyl bromide (tube 5, 54 mg, 
0.188 mmol, 1.2 equiv), 4-methoxybenzyl bromide (tube 6, 38 mg, 0.188 mmol, 1.2 equiv), 1-
bromohexane (tube 7, 129 mg, 0.785 mmol, 5.0 equiv).  After being agitated for 12 h, the 
reaction mixtures were worked up and the products isolated and purified as described in General 
Procedure II. 
1. HCl (aq), MeOH
    reflux, 6 h
2. NaOH (0.1 M, aq)
    Et2O
3. CH3CN, RT, R
4-Br
N
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O
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V{1,2} V{1,2,R4}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-3-benzyl-5-methyl-7b-
methylcyclopenta[gh]pyrrolizinium Bromide (V{1,2,1}) 
 
Data for V{1,2,1}: 
 Yield: 63 mg (90%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.64 (d, J = 6.7, 2 H), 7.43-7.31 (m, 8H), 5.14 (d, J = 12.3, 1 H), 4.99-4.93 
(dd, J = 6.9, 17.2, 1 H), 4.65 (d, J = 12.3, 1 H), 4.63 (d, J = 11.7, 1 H), 4.57 
(d, J = 11.7, 1 H), 4.37 (dd, J = 11.9, 11.9, 1 H), 3.87 (dd, J = 6.2, 12.5, 1 H), 
3.10 (dd, J = 6.1, 11.5, 1 H), 2.88-2.82 (m, 2 H), 2.45-2.40 (s, 1 H), 2.15-2.06 
(m, 1 H), 2.06-1.95 (m, 1 H), 2.04 (s, 3 H), 1.93-1.78 (m, 3 H), 1.20 (d, J = 
6.4, 3 H) 
 MS: (ESI, Q-tof) 
362.2 (100) 
 Mol. Formula: C25H32BrNO (442.43) 
 HRMS: C25H32NO
+: (362.2484) 
Calcd: 362.2484 
Found: 362.2484 
 TLC: Rf  0.20  (CH2Cl2/MeOH, 9:1) [I2]
N
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-3-(1-naphthylmethyl)-5-
methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{1,2,2}) 
 
Data for V{1,2,2}: 
 Yield: 77 mg (99%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.25-8.16 (m, 2 H), 7.85-7.73 (m, 2 H), 7.53-7.47 (m, 1 H), 7.49 (dd, J = 7.6, 
14.6, 1 H), 7.40-7.26 (m, 7H), 5.54 (d, J = 13.0, 1 H), 5.25 (d, J = 13.0, 1 H), 
5.17-5.08 (m, 1 H), 4.72 (dd, J = 11.9, 11.9, 1 H), 4.64 (d, J = 11.8, 1 H), 4.49 
(d, J = 11.8, 1 H), 3.56 (dd, J = 6.1, 12.4, 1 H), 3.06 (dd, J = 5.9, 11.3, 1 H), 
2.91 (dd, J = 8.4, 16.9, 1 H), 2.74 (t, J = 11.8, 11.8, 1 H), 2.59-2.53 (m, 1 H), 
2.31 (s, 3 H), 2.04-1.75 (m, 5 H), 1.59 (s, 3 H), 1.21 (d, J = 6.3, 3 H) 
 MS: (ESI, Q-tof) 
412.3 (100) 
 Mol. Formula: C29H34BrNO (492.49) 
 HRMS: C29H34NO
+: (412.2640) 
Calcd: 412.2640 
Found: 412.2633 
 TLC: Rf  0.23  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
Br
MeO
Me
V{1,2,2}
219 
 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-3-(2-naphthylmethyl)-5-
methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{1,2,3}) 
 
Data for V{1,2,3}: 
 Yield: 65 mg (84%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.15 (s, 1 H), 7.91-7.82 (m, 1 H), 7.73-7.62 (m, 3 H), 7.52-7.44 (m, 2 H), 
7.39-7.28 (m, 5 H), 5.33 (d, J = 12.3, 1 H), 5.10 (dd, J = 6.9, 17.2, 1 H), 4.93 
(d, J = 12.4, 1 H), 4.65 (d, J = 14.1, 1 H), 4.62 (d, J =14.1, 1 H), 4.42 (dd, J = 
11.9, 11.9, 1 H), 3.94 (dd, J = 6.2, 12.4, 1 H), 3.11 (dd, J = 6.0, 11.4, 1 H), 
2.89 (dd, J = 8.5, 16.9, 1 H), 2.83 (dd, J = 11.4, 11.4, 1 H), 2.47-2.41 (m, 1 
H), 2.15-1.94 (m, 2 H), 2.13 (s, 3 H), 1.92-1.74 (m, 3 H), 1.20 (d, J = 6.4, 3 
H). 
 MS: (ESI, Q-tof) 
412.3 (100) 
 Mol. Formula: C29H34BrNO (492.49) 
 HRMS: C29H34NO
+: (412.2640) 
Calcd: 412.2640 
Found: 412.2625 
 TLC: Rf  0.24  (CH2Cl2/MeOH, 9:1) [I2]
N
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-3-(3,5-trifluoromethyl-
benzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{1,2,5}) 
 
Data for V{1,2,5}: 
 Yield: 84 mg (98%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.40 (s, 2 H), 7.90 (s, 1 H), 7.38-7.27 (m, 5 H), 5.58 (d, J = 12.4, 1 H), 5.32-
5.24 (m, 1 H), 5.13-5.04 (m, 1 H), 4.61 (d, J = 11.6, 1 H), 4.58 (d, J = 11.6, 1 
H), 4.44 (dd, J = 11.6, 11.6, 1 H), 3.83 (dd, J = 6.1, 12.5, 1 H), 3.06-3.00 (m, 
1 H), 2.95-2.84 (m, 2 H), 2.42-2.36 (m, 1 H), 2.26-2.15 (m, 1 H), 2.00-1.97 
(m, H), 2.09 (s, 3 H), 1.89-1.79 (m, 3 H), 1.19 (d, J = 6.2, 3 H). 
 MS: (ESI, Q-tof) 
498.2 (100) 
 Mol. Formula: C27H30BrF6NO (578.43) 
 HRMS: C27H30F6NO
+: (498.2232) 
Calcd: 498.2232 
Found: 498.2222 
 TLC: Rf  0.28  (CH2Cl2/MeOH, 9:1) [I2]
N
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Preparation of rel-(1S,3S,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-3-hexyl-5-methyl-7b-
methylcyclopenta[gh]pyrrolizinium Bromide (V{1,2,6}) 
 
Data for V{1,2,6}: 
 Yield: 65 mg (95%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.40–7.30 (m, 5 H), 4.63 (dd, J = 7.9, 14.6, 1 H), 4.60 (d, J = 11.5, 1 H), 4.57 
(d, J = 11.5, 1 H), 4.11 (dd, J = 6.2, 12.5, 1 H), 3.71–3.58 (m, 3 H), 3.49 (ddd, 
J = 4.4, 4.4, 12.2, 1 H), 3.31 (dd, J = 8.9, 12.5, 1 H), 2.84–2.78 (m, 1 H), 
2.37–2.20 (m, 2 H), 2.17 (s, 2 H), 2.13–2.02 (m, 1 H), 1.92–1.81 (m, 3 H), 
1.84 (s, 3 H), 1.80–1.64 (m, 2 H), 1.51–1.40 (m, 2 H), 1.36–1.27 (m, 4 H), 
1.16 (d, J = 6.3, 3 H), 0.89 (t, J = 7.1, 3 H) 
 MS: (ESI, Q-tof) 
356.3 (100) 
 Mol. Formula: C24H38BrNO (436.47) 
 HRMS: C24H38NO
+: (356.2953) 
Calcd: 356.2953 
Found: 356.2947 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
Br
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-3-(3,5-tert-butyl-
benzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{1,2,7}) 
 
Data for V{1,2,7}: 
 Yield: 84 mg (96%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.52–7.48 (m, 3 H), 7.40–7.28 (m, 5 H), 5.08 (d, J = 12.4, 1 H), 4.83 (dd, J = 
6.9, 16.8, 1 H), 4.62 (d, J = 11.9, 1 H), 4.54 (d, J = 11.9, 1 H) 4.52 (d, J = 
11.9, 1 H), 4.42 (dd, J = 11.7, 11.7, 1 H), 4.17 (dd, J = 6.2, 12.5, 1 H), 3.19 
(dd, J = 6.2, 11.6, 1 H), 3.00 (dd, J = 11.2, 11.2, 1 H), 2.90 (dd, J = 8.2, 16.4, 
1 H), 2.50–2.45 (m, 1 H), 2.22–2.12 (m, 1 H), 2.12–1.99 (m, 1 H), 2.10 (s, 3 
H), 1.95–1.80 (m, 3 H), 1.34 (s, 18H), 1.24 (d, J = 6.5, 3 H) 
 MS: (ESI, Q-tof) 
474.4 (100) 
 Mol. Formula: C33H48BrNO (554.64) 
 HRMS: C33H48NO
+: 474.3736) 
Calcd: 474.3736 
Found: 474.3723 
 TLC: Rf  0.32  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
Br
MeO
t-Bu
t-Bu
Me
V{1,2,7}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-3-(4-methoxy-benzyl)-5-
methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{1,2,8}) 
 
Data for V{1,2,8}: 
 Yield: 77 mg (99%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.56 (d, J = 8.6, 2 H), 7.40–7.31 (m, 5 H), 6.85 (d, J = 8.4, 2 H), 5.07 (d, J = 
12.4, 1 H), 5.00–4.90 (m, 1 H), 4.65–4.52 (m, 3 H), 4.31 (dd, J = 11.9, 1 H), 
3.90–3.82 (m, 1 H), 3.80 (s, 3 H), 3.07 (dd, J = 6.5, 11.2, 1 H), 2.83 (dd, J = 
8.03, 15.8, 2 H), 2.44–2.38 (m, 1 H), 2.14–2.05 (m, 1 H), 2.05–1.93 (m, 1 H), 
2.03 (s, 3 H), 1.91–1.76 (m, 3 H), 1.20 (d, J = 6.4, 3 H) 
 MS: (ESI, Q-tof) 
392.3 (100) 
 Mol. Formula: C26H34BrNO2 (472.46) 
 HRMS: C26H34NO2
+: (392.2590) 
Calcd: 392.2590 
Found: 392.2578 
 TLC: Rf  0.18  (CH2Cl2/MeOH, 9:1) [I2] 
N
H H
Br
MeO
OMe
Me
V{1,2,8}
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 Preparation of Quaternary Ammonium Bromides V{2,2,R4} 
 
 Following General Procedure II, amino borane V{2,2} (397 mg, 1.33 mmol) was added 
to a 50-mL round-bottomed flask as a solution in  44 mL of MeOH (0.03 M).  The flask was 
fitted with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. 
HCl solution (6.6 mL, 5.0 equiv) was added via syringe.  The resulting solution was heated and 
then concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure 
II.  The resulting free amine was dissolved in acetonitrile and was distributed among seven test 
tubes that were subsequently charged with benzyl bromide (tube 1, 48 mg, 0.279 mmol, 1.2 
equiv), 1-bromomethylnaphthalene (tube 2, 50 mg, 0.279 mmol, 1.2 equiv), 2-
bromomethylnaphthalene (tube 3, 50 mg, 0.279 mmol, 1.2 equiv), 3,5-bis(trifluoromethyl)benzyl 
bromide (tube 4, 70 mg, 0.279 mmol, 1.2 equiv), 3,5-bis(t-butyl)benzyl bromide (tube 5, 64 mg, 
0.279 mmol, 1.2 equiv), 4-methoxybenzyl bromide (tube 6, 70 mg, 0.279 mmol, 1.2 equiv), 1-
bromohexane (tube 7, 70 mg, 0.279 mmol, 1.2 equiv).  After being agitated for 12 h, the reaction 
mixtures were worked up and the products isolated and purified as described in General 
Procedure II. 
1. HCl (aq), MeOH
    reflux, 6 h
2. NaOH (0.1 M, aq)
    Et2O
3. CH3CN, RT, R
4-Br
N
H H
BH3
O N
H H
O
R4
Br
Me
MeMe
Me
Me
V{2,2} V{2,2,R
4}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-methyl-3-benzyl-5-
methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{2,2,1}) 
 
Data for V{2,2,1}: 
 Yield: 79 mg (74%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.80-7.77 (m, 2 H), 7.51–7.43 (m, 3 H), 7.38–7.29 (m, 3 H), 7.24 (d, J = 6.7, 2 
H), 5.20 (d, J = 12.2, 1 H), 4.86 (d, J = 12.2, 1 H), 4.51 (d, J = 13.5, 1 H), 4.49 
(d, J = 11.1, 11.1, 1 H), 4.41 (d, J = 11.0, 1 H), 4.37 (d, J = 11.0, 1 H), 3.24 
(d, J = 13.3, 1 H), 3.18 (dd, J = 6.7, 11.7, 1 H), 2.71 (dd, J = 8.4, 8.4, 1 H), 
2.59–2.52 (m, 1 H), 2.39–2.19 (m, 2 H), 2.16 (s, 3 H), 1.96 (m, 1 H), 1.89 (m, 
2 H), 1.84 (s, 3 H), 1.20 (d, J = 6.6, 3 H). 
 MS: (ESI, Q-tof) 
376.3 (100) 
 Mol. Formula: C26H34BrNO (456.46) 
 HRMS: C26H34NO
+: (376.2640) 
Calcd: 376.2640 
Found: 376.2638 
 TLC: Rf  0.22  (CH2Cl2/MeOH, 9:1) [I2] [I2]
N
H H
O
Me
13
Me
Me
V{2,2,1}
Br
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-methyl-3-(1-
naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{2,2,2}) 
 
Data for V{2,2,2}: 
 Yield: 91 mg (77%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.42 (d, J = 8.6, 1 H), 8.30 (d, J = 7.1, 1 H), 7.92-7.87 (m, 2 H), 7.66 (dd, J = 
7.6, 7.6, 1 H), 7.52 (m, 2 H), 7.30–7.21 (m, 3 H), 7.18–7.12 (m, 2 H), 5.53 (d, 
J = 12.9, 1 H), 5.43 (d, J = 12.9, 1 H), 4.61 (d, J = 13.2, 1 H), 4.44 (dd, J = 
11.7, 11.7, 1 H), 4.38 (d, J = 11.1, 1 H), 4.29 (d, J = 11.1, 1 H), 3.24 (d, J = 
13.3, 1 H), 2.98 (dd, J = 6.8, 11.6, 1 H), 2.78 (dd, J = 8.3, 8.3, 1 H), 2.62 (d, J 
= 9.5, 1 H), 2.36–2.20 (m, 2 H),2.31 (s, 3 H), 1.98–1.83 (m, 3 H), 1.92 (s, 3 
H), 1.10 (d, J = 6.5, 3 H) 
 MS: (ESI, Q-tof) 
426.3 (100) 
 Mol. Formula: C30H36BrNO (506.52) 
 HRMS: C30H36NO
+: (426.2797) 
Calcd: 426.2797 
Found: 426.2801 
 TLC: Rf  0.24  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
MeV{2,2,2}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-methyl-3-(2-
naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{2,2,3}) 
 
Data for V{2,2,3}: 
 Yield: 96 mg (81%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.27 (s, 1 H), 7.95 (d, J = 8.3, 1 H), 7.86–7.82 (m, 3 H), 7.57–7.52 (m, 2 H), 
7.31–7.22 (m, 3 H), 7.21-7.18 (m, 2 H), 5.32 (d, J = 12.2, 1 H), 5.07 (d, J = 
12.3, 1 H), 4.60 (d, J = 13.2, 1 H), 4.54 (dd, J = 11.4, 1 H), 4.40 (d, J = 11.0, 1 
H), 4.34 (d, J = 11.0, 1 H), 3.23 (d, J = 13.2, 1 H), 3.19 (dd, J = 7.2, 12.0, 1 
H), 2.73 (dd, J = 8.3, 8.3, 1 H), 2.59–2.52 (m, 1 H), 2.36–2.27  (m, 1 H), 
2.27–2.15 (m, 1 H), 2.2 (s, 3 H), 1.98–1.90 (m, 1 H), 1.90–1.85 (m, 2 H), 1.87 
(s, 3 H), 1.19 (d, J = 6.5, 3 H) 
 MS: (ESI, Q-tof) 
426.3 (100) 
 Mol. Formula: C30H36BrNO (506.52) 
 HRMS: C30H36NO
+: (426.2797) 
Calcd: 426.2797 
Found: 426.2806 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
Me
V{2,2,3}
228 
 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-methyl-3-(3,5-tri-
fluoromethylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{2,2,5}) 
 
Data for V{2,2,5}: 
 Yield: 98 mg (71%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.40 (s, 2 H), 7.98 (s, 1 H), 7.34–7.27 (m, 3 H), 7.23–7.18 (m, 2 H), 5.43 (d, J 
= 12.5, 1 H), 5.37 (d, J = 12.5, 1 H), 4.55 (d, J = 13.1, 1 H), 4.44 (d, J =11.1, 
1 H), 4.38 (d, J =11.1, 1 H), 4.36 (dd, J = 10.6, 10.6, 1 H), 3.24 (d, J = 13.1, 1 
H), 3.11 (dd, J = 6.1, 11.3, 1 H), 2.76 (dd, J = 8.0, 8.0, 1 H), 2.51–2.41 (m, 2 
H), 2.32–2.23 (m, 1 H), 2.16 (s, 3 H), 1.99–1.87 (m, 3 H), 1.82 (s, 3 H), 1.16 
(d, J = 6.2, 3 H) 
 MS: (ESI, Q-tof) 
512.2 (100) 
 Mol. Formula: C28H32BrF6NO (592.45) 
 HRMS: C28H32NOF6
+: (512.2388) 
Calcd: 512.2388 
Found: 512.2395 
 TLC: Rf  0.30  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
Me
CF3
CF3
V{2,2,5}
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Preparation of rel-(1S,3S,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-methyl-3-hexyl-5-
methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{2,2,6}) 
 
Data for V{2,2,6}: 
 Yield: 30 mg (28%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.33 (m, 5 H), 4.47 (d, J = 11.1, 1 H), 4.37 (d, J = 11.0, 1 H), 3.41 (dd, J = 
6.9, 6.9, 2 H), 3.01 (d, J = 8.9, 1 H), 2.92 (d, J = 8.9, 1 H), 2.82 (dd, J = 6.0, 
12.2, 1 H), 2.49 (dd, J = 11.8, 11.8, 1 H), 2.07-2.00 (m, 2 H), 1.94-1.81 (m, 5 
H), 1.72-1.63 (m, 3 H), 1.46-1.40 (m, 3 H), 1.36-1.34 (m, 8H), 0.97 (d, J = 
6.5, 3 H), 0.90 (t, J = 7.0, 3 H) 
 MS: (ESI, Q-tof) 
370.3 (100) 
 Mol. Formula: C25H40BrNO  (450.50) 
 HRMS: C25H40NO
+: (370.3110) 
Calcd: 370.3110 
Found: 370.3109 
 TLC: Rf  0.40  (CH2Cl2/MeOH, 9:1) [I2] 
N
H H
O
Me
Br
Me
Me
Me
V{2,2,6}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-methyl-3-(3,5-tert-
butyl-benzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{2,2,7}) 
 
Data for V{2,2,7}: 
 Yield: 109 mg (82%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.57 (d, J = 1.7, 2 H), 7.50 (s, 1 H), 7.34–7.27 (m, 3 H), 7.24-7.22 (m, 2 H), 
5.22 (d, J = 12.3, 1 H), 4.74 (d, J = 12.3, 1 H), 4.58 (dd, J = 11.2, 11.2, 1 H), 
4.47 (d, J = 13.2, 1 H), 4.41 (s, 2 H), 3.22 (d, J = 11.9, 1 H), 3.21 (d, J = 12.8, 
1 H), 2.65 (dd, J = 8.6, 8.6, 1 H), 2.61–2.56 (m, 1 H), 2.32–2.18 (m, 2 H), 
2.16 (s, 3 H), 2.00–1.92 (m, 1 H), 1.90–1.86 (m, 2 H), 1.84 (s, 3 H), 1.35 (s, 
18H), 1.23 (d, J = 6.6, 3 H) 
 MS: (ESI, Q-tof) 
488.4 (100) 
 Mol. Formula: C34H50BrNO (569.67) 
 HRMS: C20H38NO3
+: (488.3892) 
Calcd: 488.3892 
Found: 488.3893 
 TLC: Rf  0.33  (CH2Cl2/MeOH, 9:1) [I2] 
  
N
H H
O
Me
Br
Me
Me
V{2,2,7}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-methyl-3-(4-methoxy-
benzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{2,2,8}) 
 
Data for V{2,2,8}: 
 Yield: 88 mg (77%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.71 (d, J = 8.7, 2 H), 7.34–7.28 (m, 3 H), 7.22 (d, J = 6.7, 2 H), 6.94 (d, J = 
8.4, 2 H), 5.11 (d, J = 12.3, 1 H), 4.78 (d, J = 12.4, 1 H), 4.48–4.40 (m, 2 H), 
4.41 (d, J = 11.0, 1 H), 4.37 (d, J = 11.0, 1 H), 3.82 (s, 3 H), 3.20 (d, J = 13.3, 
1 H), 3.14 (dd, J = 6.7, 11.7, 1 H), 2.67 (dd, J = 8.4, 8.4, 1 H), 2.55–2.48 (m, 1 
H), 2.33–2.17 (m, 2 H), 2.11 (s, 3 H), 1.97–1.89 (m, 1 H), 1.88–1.83 (m, 2 H), 
1.81 (s, 3 H), 1.17 (d, J = 6.5, 3 H) 
 MS: (ESI, Q-tof) 
406.3 (100) 
 Mol. Formula: C27H36BrNO2 (486.48) 
 HRMS: C27H36NO2
+: (406.2746) 
Calcd: 406.2746 
Found: 406.2748 
 TLC: Rf  0.20  (CH2Cl2/MeOH, 9:1) [I2] 
Me
N
H H
O
Me
Br
Me
OMe
V{2,2,8}
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Preparation of Quaternary Ammonium Bromides V{2,3,R4} 
 
 Following General Procedure II, amino borane V{2,3} (397 mg, 1.35 mmol) was added 
to a xxx-mL round-bottomed flask as a solution in 45 mL of MeOH (0.03 M).  The flask was 
fitted with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. 
HCl solution (6.8 mL, 5.0 equiv) was added via syringe.  The resulting solution was heated and 
then concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure 
II.  The resulting free amine was dissolved in acetonitrile and was distributed among seven test 
tubes that were subsequently charged with benzyl bromide (tube 1, 38 mg, 0.220 mmol, 1.2 
equiv), 1-bromomethylnaphthalene (tube 2, 48 mg, 0.220 mmol, 1.2 equiv), 2-
bromomethylnaphthalene (tube 3, 48 mg, 0.220 mmol, 1.2 equiv), 3,5-bis(trifluoromethyl)benzyl 
bromide (tube 4, 67 mg, 0.220 mmol, 1.2 equiv), 3,5-bis(t-butyl)benzyl bromide (tube 5, 62 mg, 
0.220 mmol, 1.2 equiv), 4-methoxybenzyl bromide (tube 6, 44 mg, 0.220 mmol, 1.2 equiv), 1-
bromohexane (tube 7, 90 mg, 0.549 mmol, 3.0 equiv).  After being agitated for 12 h, the reaction 
mixtures were worked up and the products isolated and purified as described in General 
Procedure II. 
1. HCl (aq), MeOH
    reflux, 6 h
2. NaOH (0.1 M, aq)
    Et2O
3. CH3CN, RT, R
4-Br
N
H HMe
BH3
O N
H H
O
R4
Br
Me
MeMe
Me
MeMe Me
V{2,3} V{2,3,R
4}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-methyl-3-benzyl-5-
methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{2,3,1}) 
 
Data for V{2,3,1}: 
 Yield: 76 mg (92%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.80–7.76 (m, 2 H), 7.47–7.42 (m, 3 H), 5.17 (d, J = 12.2, 1 H), 4.80 (d, J = 
12.2, 1 H), 4.49 (dd, J = 11.3, 11.3, 1 H), 4.40 (d, J = 13.2, 1 H), 3.26 (t, J = 
6.6, 2 H), 3.18 (dd, J = 6.6, 11.6, 1 H), 3.13 (d, J = 13.2, 1 H), 2.58 (t, J = 8.1, 
8.1, 1 H), 2.55–2.51 (m, 1 H), 2.40–2.30 (m, 1 H), 2.21–2.08 (m, 1 H), 2.11 
(s, 3 H), 1.90–1.81 (m, 3 H), 1.68 (s, 3 H), 1.49–1.42 (m, 2 H), 1.32–1.19 (m, 
6H), 0.86 (t, J = 6.9, 3 H) 
 MS: (ESI, Q-tof) 
370.3 (100) 
 Mol. Formula: C25H40BrNO  (450.50) 
 HRMS: C25H40NO
+: (370.3110) 
Calcd: 370.3110 
Found: 370.3101 
 TLC: Rf  0.28  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me Me
V{2,3,1}
Br
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-methyl-3-(1-
naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{2,3,2}) 
 
Data for V{2,3,2}: 
 Yield: 90 mg (98%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.37 (d, J = 8.6, 1 H), 8.34 (d, J = 6.4, 1 H), 7.93 (dd, J = 8.2, 14.1, 1 H), 7.67 
(dd, J = 7.7, 7.7, 1 H), 7.55 (dd, J = 6.4, 14.3, 2 H), 5.51 (d, J = 12.9, 1 H), 
5.40 (d, J = 12.9, 1 H), 4.58 (d, J = 13.2, 1 H), 4.45 (dd, J = 11.6, 11.6, 1 H), 
3.30–3.21 (m, 1 H), 3.20–3.14 (m, 2 H), 3.02 (dd, J = 6.8, 11.7, 1 H), 2.70 
(dd, J = 8.1, 8.1, 1 H), 2.64–2.58 (m, 1 H), 2.42–2.30 (m, 1 H), 2.27 (s, 3 H), 
2.25–2.12 (m, 1 H), 1.93–1.79 (m, 3 H), 1.76 (s, 3 H), 1.44–1.34 (m, 2 H), 
1.27–1.12 (m, 9H), 0.83 (t, J = 6.8, 3 H) 
 MS: (ESI, Q-tof) 
420.3 (100) 
 Mol. Formula: C29H42BrNO (500.55) 
 HRMS: C29H42NO
+: (420.3266) 
Calcd: 420.3266 
Found: 420.3265 
 TLC: Rf  0.30  (CH2Cl2/MeOH, 9:1) [I2] 
  
N
H H
O
Me
Br
Me
Me
V{2,3,2}
Me
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-methyl-3-(2-
naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{2,3,3}) 
 
Data for V{2,3,3}: 
 Yield: 82 mg (90%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.26 (s, 1 H), 7.96 (d, J = 7.3, 1 H), 7.91–7.83 (m, 3 H), 7.59–7.52 (m, 2 H), 
5.29 (d, J = 12.3, 1 H), 5.02 (d, J = 12.3, 1 H), 4.55 (dd, J = 11.5, 11.5, 1 H), 
4.52 (d, J = 13.3, 1 H), 3.29–3.18 (m, 3 H), 3.15 (d, J = 13.2, 1 H), 2.66–2.60 
(m, 1 H), 2.56–2.53 (m, 1 H), 2.42–2.33 (m, 1 H), 2.21–2.12 (m, 1 H), 2.17 (s, 
3 H), 1.91–1.82 (m, 3 H), 1.72 (s, 3 H), 1.48–1.40 (m, 2 H), 1.30–1.17 (m, 
9H), 0.84 (t, J = 6.9, 3 H) 
 MS: (ESI, Q-tof) 
420.3 (100) 
 Mol. Formula: C29H42BrNO  (500.55) 
 HRMS: C29H42NO
+: (420.3266) 
Calcd: 420.3266 
Found: 420.3271 
 TLC: Rf  0.31  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
Me Me
V{2,3,3}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-methyl-3-(3,5-
trifluoromethylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide 
(V{2,3,5}) 
 
Data for V{2,3,5}: 
 Yield: 101 mg (95%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.26 (s, 1 H), 7.96 (d, J = 7.3, 1 H), 7.91–7.83 (m, 3 H), 7.59–7.52 (m, 2 H), 
5.29 (d, J = 12.3, 1 H), 5.02 (d, J = 12.3, 1 H), 4.55 (dd, J = 11.5, 11.5, 1 H), 
4.52 (d, J = 13.3, 1 H), 3.29–3.18 (m, 3 H), 3.15 (d, J = 13.2, 1 H), 2.66–2.60 
(m, 1 H), 2.56–2.53 (m, 1 H), 2.42–2.33 (m, 1 H), 2.21–2.12 (m, 1 H), 2.17 (s, 
3 H), 1.91–1.82 (m, 3 H), 1.72 (s, 3 H), 1.48–1.40 (m, 2 H), 1.30–1.17 (m, 
9H), 0.84 (t, J = 6.9, 3 H) 
 MS: (ESI, Q-tof) 
506.3 (100) 
 Mol. Formula: C27H38BrF6NO (586.49) 
 HRMS: C27H38NOF6
+: (506.2858) 
Calcd: 506.2858 
Found: 506.2859 
 TLC: Rf  0.39  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
Me
CF3
Me
CF3
V{2,3,5}
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Preparation of rel-(1S,3S,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-methyl-3-hexyl-5-
methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{2,3,6}) 
 
Data for V{2,3,6}: 
 Yield: 36 mg (44%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
4.31 (d, J = 13.1, 1 H), 3.80 (ddd, J = 5.7, 11.4, 11.4, 1 H), 3.73–3.61 (m, 4 
H), 3.55 (ddd, J = 5.0, 11.7, 11.7, 1 H), 3.36 (t, J = 6.7, 2 H), 2.65–2.50 (m, 2 
H), 2.33–2.15 (m, 2 H), 1.96–1.74 (m, 5 H), 1.88 (s, 3 H), 1.62–1.41 (m, 5 H), 
1.52 (s, 3 H), 1.38–1.24 (m, 7H), 1.13 (d, J = 6.7, 3 H), 0.91–0.87 (m, 6H) 
 MS: (ESI, Q-tof) 
364.4 (100) 
 Mol. Formula: C24H46BrNO (444.53) 
 HRMS: C24H46NO
+: (364.3579) 
Calcd: 364.3579 
Found: 364.357 
 TLC: Rf  0.42  (CH2Cl2/MeOH, 9:1) [I2] 
N
H H
O
Me
Br
Me
Me
Me
Me
V{2,3,6}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-methyl-3-(3,5-tert-
butylbenzyl)-5-methyl-7b-methyl-cyclopenta[gh]pyrrolizinium Bromide (V{2,3,7}) 
 
Data for V{2,3,7}: 
 Yield: 101 mg (99%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.55 (d, J = 1.7, 2 H), 7.49 (s, 1 H), 5.21 (d, J = 12.3, 1 H), 4.68 (d, J = 12.3, 1 
H), 4.59 (dd, J = 11.3, 11.3, 1 H), 4.33 (d, J = 13.1, 1 H), 3.27 (t, J = 6.7, 2 
H), 3.22 (dd, J = 6.5, 11.6, 1 H), 3.10 (d, J = 13.2, 1 H), 2.60–2.55 (m, 1 H), 
2.53 (dd, J = 8.6, 1 H), 2.31–2.22 (m, 1 H), 2.17–2.08 (m, 1 H), 2.12 (s, 3 H), 
1.90–1.80 (m, 3 H), 1.70 (s, 3 H), 1.52–1.44 (m, 2 H), 1.35 (s, 18H), 1.31–
1.20 (m, 6H), 1.26 (d, J = 6.5, 3 H), 0.86 (t, J = 6.9, 3 H) 
 MS: (ESI, Q-tof) 
482.4 (100) 
 Mol. Formula: C33H65BrNO (562.71) 
 HRMS: C33H56NO
+: (482.4362) 
Calcd: 482.4362 
Found: 482.4358 
 TLC: Rf  0.41  (CH2Cl2/MeOH, 9:1) [I2] 
N
H H
O
Me
Br
Me
Me
t-Bu
t-Bu
Me
V{2,3,7}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-methyl-3-(4-
methoxybenzyl)-5-methyl-7b-methyl-cyclopenta[gh]pyrrolizinium Bromide (V{2,3,8}) 
 
Data for V{2,3,8}: 
 Yield: 85 mg (98%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.70 (d, J = 8.7, 2 H), 6.94 (d, J = 8.7, 2 H), 5.09 (d, J = 12.4, 1 H), 4.73 (d, J 
= 12.4, 1 H), 4.44 (dd, J = 11.4, 11.4, 1 H), 4.36 (d, J = 13.2, 1 H), 3.82 (s, 3 
H), 3.26 (t, J = 6.6, 2 H), 3.16 (dd, J = 6.6, 11.7, 1 H), 3.11 (d, J = 13.2, 1 H), 
2.56 (dd, J = 8.1, 8.1, 1 H), 2.54–2.49 (m, 1 H), 2.38–2.29 (m, 1 H), 2.19–2.09 
(m, 1 H), 2.08 (s, 3 H), 1.88–1.81 (m, 3 H), 1.66 (s, 3 H), 1.51–1.40 (m, 2 H), 
1.33–1.19 (m, 9H), 0.86 (t, J = 6.9, 3 H) 
 MS: (ESI, Q-tof) 
400.3 (100) 
 Mol. Formula: C26H42BrNO2 (480.52) 
 HRMS: C26H42NO2
+: (400.3216) 
  Calcd: 400.3216 
Found: 400.3212 
 TLC: Rf  0.23  (CH2Cl2/MeOH, 9:1) [I2]
N
H HMe
O
Me
Br
Me
Me
OMe
V{2,3,8}
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Preparation of Quaternary Ammonium Bromides V{2,7,R4} 
 
 Following General Procedure II, amino borane V{2,7} (163 mg, 0.495 mmol) was added 
to a 50-mL round-bottomed flask as a solution in  17 mL of MeOH (0.03 M).  The flask was 
fitted with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. 
HCl solution (2.5 mL, 5.0 equiv) was added via syringe.  The resulting solution was heated and 
then concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure 
II.  The resulting free amine was dissolved in acetonitrile and was distributed among five test 
tubes that were subsequently charged with benzyl bromide (tube 1, 14 mg, 0.08 mmol, 1.2 
equiv), 1-bromomethylnaphthalene (tube 2, 17 mg, 0.08 mmol, 1.2 equiv), 2-
bromomethylnaphthalene (tube 3, 17 mg, 0.08 mmol, 1.2 equiv), 3,5-bis(trifluoromethyl)benzyl 
bromide (tube 4, 25 mg, 0.08 mmol, 1.2 equiv), 3,5-bis(t-butyl)benzyl bromide (tube 5, 23 mg, 
0.08 mmol, 1.2 equiv).  After being agitated for 12 h, the reaction mixtures were worked up and 
the products isolated and purified as described in General Procedure II. 
1. HCl (aq), MeOH
    reflux, 6 h
2. NaOH (0.1 M, aq)
    Et2O
3. CH3CN, RT, R
4-Br
N
H HMe
BH3
O N
H H
O
R4
Br
Me
MeMe
Me
Me
MeO MeO
V{2,7} V{2,7,R4}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxy-benzyloxy)-1-methyl-
3-benzyl-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{2,7,1}) 
 
Data for V{2,7,1}: 
 Yield: 25 mg (76%) free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.79-7.76 (m, 2 H), 7.47-.7.44 (m, 3 H), 7.14 (d, J = 8.6, 2 H), 6.84 (d, J = 
8.6, 2 H), 5.19 (d, J = 12.3, 1 H), 4.79 (d, J = 12.2, 1 H), 4.49 (dd, J = 11.5, 
11.5,1  H), 4.34 (d, J = 10.6, 1 H), 4.31 (d, J = 10.6, 1 H), 3.78 (s, 3 H), 3.18 
(d, J = 13.4, 1 H), 3.15 (dd, J = 7.5, 12.4, 1 H), 2.66 (dd, J = 8.5, 8.5, 1 H), 
2.56-2.52 (m, 1 H), 2.32-2.18 (m, 2 H), 2.14 (s, 3 H), 1.98-1.91 (m, 1 H), 
1.88-1.84 (m, 2 H), 1.82 (s, 3 H), 1.19 (d, J = 6.5, 3 H) 
 MS: (ESI, Q-tof) 
406.3 (100) 
 Mol. Formula: C27H36BrNO2 (486.48) 
 HRMS: C27H36NO2
+: (406.2746) 
Calcd: 406.2746 
Found: 406.2749 
 TLC: Rf  0.21  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
MeO
MeV{2,7,1}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxy-benzyloxy)-1-methyl-
3-(1-naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{2,7,2}) 
 
Data for V{2,7,2}: 
 Yield: 30 mg (85%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.39 (d, J = 8.6, 1 H), 8.32 (d, J = 6.5, 1 H), 7.97–7.86 (m, 2 H), 7.67 (dd, J = 
7.1, 7.1, 2 H), 7.57–7.51 (m, 2 H), 7.08 (d, J = 8.7, 2 H), 6.77 (d, J = 8.8, 2 
H), 5.54 (d, J = 12.9, 1 H), 5.39 (d, J = 12.9, 1 H), 4.56 (d, J = 13.3, 1 H), 4.46 
(dd, J = 11.7, 11.7, 1 H), 4.31 (d, J = 10.6, 1 H), 4.23 (d, J = 10.6, 1 H), 3.75 
(s, 3 H), 3.20 (d, J = 13.3, 1 H), 2.97 (dd, J = 6.8, 11.7, 1 H), 2.76 (dd, J = 8.5, 
8.5, 1 H), 2.65–2.60 (m, 1 H), 2.32–2.19 (m, 2 H), 2.30 (s, 3 H), 1.98–1.84 
(m, 3 H), 1.91 (s, 3 H), 1.11 (d, J = 6.5, 3 H) 
 MS: (ESI, Q-tof) 
456.3 
 Mol. Formula: C31H38BrNO2 (536.54) 
 HRMS: C31H38NO2
+: (456.2903) 
Calcd: 456.2903 
Found: 456.2906 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2] 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxy-benzyloxy)-1-methyl-
3-(2-naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{2,7,3}) 
N
7
H H
O
Me
Me
MeO
MeV{2,7,2}
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Data for V{2,7,3}: 
 Yield: 30 mg (85%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.26 (s, 1 H), 7.96 (d, J = 8.4, 1 H), 7.91–7.80 (m, 3 H), 7.60–7.51 (m, 2 H), 
7.12 (d, J = 8.6, 2 H), 6.80 (d, J = 8.6, 2 H), 5.32 (d, J = 12.3, 1 H), 5.03 (d, J 
= 12.3, 1 H), 4.60–4.50 (m, 2 H), 4.33 (d, J = 10.6, 1 H), 4.29 (d, J = 10.6, 1 
H), 3.74 (s, 3 H), 3.21–3.13 (m, 2 H), 2.71 (dd, J = 8.4, 8.4, 1 H), 2.58–2.53 
(m, 1 H), 2.36–2.15 (m, 2 H), 2.19 (s, 3 H), 1.98–1.90 (m, 1 H), 1.90–1.83 (m, 
2 H), 1.86 (s, 3 H), 1.20 (d, J = 6.5, 3 H) 
 MS: (ESI, Q-tof) 
456.3 (100) 
 Mol. Formula: C31H38BrNO2  (536.54) 
 HRMS: (C20H38NO3
+: (456.2903) 
Calcd: 456.2903 
Found: 456.2900 
 TLC: Rf  0.24  (CH2Cl2/MeOH, 9:1) [I2] 
N
H H
O
Me
Br
Me
MeO
Me
V{2,7,3}
244 
 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxybenzyloxy)-1-methyl-3-
(3,5-trifluoromethylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide 
(V{2,7,5}) 
 
Data for V{2,7,5}: 
 Yield: 33 mg (80%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.40 (s, 2 H), 7.97 (s, 1 H), 7.13 (d, J = 8.6, 2 H), 6.82 (d, J = 8.6, 2 H), 5.37 
(d, J = 12.5, 1 H), 5.37 (d, J = 12.5, 1 H), 4.37 (d, J = 10.9, 1 H), 4.37 (dd, J = 
7.2, 10.9, 1 H), 4.31 (d, J = 10.7, 1 H), 3.77 (s, 3 H), 3.21 (d, J = 13.1, 1 H), 
3.09 (dd, J = 6.2, 11.3, 1 H), 2.74 (dd, J = 8.0, 8.0, 1 H), 2.53–2.38 (m, 2 H), 
2.30–2.21 (m, 1 H), 2.15 (s, 3 H), 1.98–1.85 (m, 3 H), 1.81 (s, 3 H), 1.15 (d, J 
= 6.2, 3 H) 
 MS: (ESI, Q-tof) 
542.3 (100) 
 Mol. Formula: C29H34BrF6NO2 (622.48) 
 HRMS: C29H34F6NO2
+: (542.2494) 
Calcd: 542.2494 
Found: 542.2488 
 TLC: Rf  0.28  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
MeO
Me
CF3
CF3
V{2,7,5}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxybenzyloxy)-1-methyl-3-
(3,5-tert-butylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{2,7,7}) 
 
Data for V{2,7,7}: 
 Yield: 33 mg (82%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.57 (d, J = 1.7, 2 H), 7.50 (dd, J = 1.7, 1.7, 1 H), 7.16 (d, J = 8.7, 2 H), 6.85 
(d, J = 8.8, 2 H), 5.22 (d, J = 12.3, 1 H), 4.71 (d, J = 12.3, 1 H), 4.59 (dd, J = 
11.3, 1 H), 4.43 (d, J = 13.2, 1 H), 4.33 (s, 2 H), 3.79 (s, 3 H), 3.25–3.08 (m, 2 
H), 2.63 (dd, J = 8.7, 8.7, 1 H), 2.61-2.56 (m, 1 H), 2.30–2.12 (m, 2 H), 2.16 
(s, 3 H), 2.00–1.92 (m, 1 H), 1.90–1.84 (m, 2 H), 1.83 (s, 3 H), 1.35 (s, 18H), 
1.23 (d, J = 6.6, 3 H) 
 MS: (ESI, Q-tof) 
518.4 (100) 
 Mol. Formula: C35H52BrNO (598.70) 
 HRMS: C35H52NO2
+: (518.3998) 
Calcd: 518.3998 
Found: 518.3997 
 TLC: Rf  0.31  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
MeO
t-Bu
t-Bu
Me
V{2,7,7}
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 Preparation of Quaternary Ammonium Bromides V{3,2,R4} 
 
 Following General Procedure II, amino borane V{3,2} (456 mg, 1.39 mmol) was added 
to a 100-mL round-bottomed flask as a solution in 50 mL of MeOH (0.03 M).  The flask was 
fitted with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. 
HCl solution (7.0 mL, 5.0 equiv) was added via syringe.  The resulting solution was heated and 
then concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure 
II.  The resulting free amine was dissolved in acetonitrile and was distributed among seven test 
tubes that were subsequently charged with benzyl bromide (tube 1, 40 mg, 0.230 mmol, 1.2 
equiv), 1-bromomethylnaphthalene (tube 2, 51 mg, 0.230 mmol, 1.2 equiv), 2-
bromomethylnaphthalene (tube 3, 51 mg, 0.230 mmol, 1.2 equiv), 3,5-bis(trifluoromethyl)benzyl 
bromide (tube 4, 71 mg, 0.230 mmol, 1.2 equiv), 3,5-bis(t-butyl)benzyl bromide (tube 5, 65 mg, 
0.230 mmol, 1.2 equiv), 4-methoxybenzyl bromide (tube 6, 66 mg, 0.230 mmol, 1.2 equiv), 1-
bromohexane (tube 7, 95 mg, 0.573 mmol, 3.0 equiv).  After being agitated for 12 h, the reaction 
mixtures were worked up and the products isolated and purified as described in General 
Procedure II. 
1. HCl (aq), MeOH
    reflux, 6 h
2. NaOH (0.1 M, aq)
    Et2O
3. CH3CN, RT, R
4-Br
N
H H
BH3
O N
H H
O
R4
Br
Me Me
Me
Me
Me
Me
Me
Me
V{3,2} V{3,2,R4}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-isopropyl-3-benzyl-5-
methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{3,2,1}) 
 
Data for V{3,2,1}: 
 Yield: 91 mg (98%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.90–7.85 (m, 2 H), 7.45 (d, J = 5.3, 3 H), 7.32–7.25 (m, 3 H), 7.20–7.16 (m, 
2 H), 5.35 (d, J = 12.1, 1 H), 4.83 (d, J = 12.0, 1 H), 4.77 (d, J = 13.7, 1 H), 
4.53 (d, J = 11.0, 1 H), 4.18 (d, J = 11.0, 1 H), 3.83 (dd, J = 9.6, 12.2, 1 H), 
3.70 (d, J = 13.7, 1 H), 3.19 (dd, J = 9.9, 9.9, 1 H), 2.77 (dd, J = 8.0, 8.0, 1 H), 
2.53–2.33 (m, 4 H), 2.00 (s, 3 H), 1.96–1.86 (m, 2 H), 1.81–1.74 (m, 1 H), 
1.23 (d, J = 6.8, 3 H), 1.01 (d, J = 6.5, 6 H) 
 MS: (ESI, Q-tof) 
404.3 (100) 
 Mol. Formula: C28H38BrNO (484.51) 
 HRMS: C28H38NO
+: (404.2953) 
Calcd: 404.2953 
Found: 404.2955 
 TLC: Rf  0.23  (CH2Cl2/MeOH, 9:1) [I2] 
N
H H
O
Br
Me
Me
Me
Me
V{3,2,1}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-isopropyl-3-(1-
naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{3,2,2}) 
 
Data for V{3,2,2}: 
 Yield: 95 mg (93%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.37–8.30 (m, 2 H), 7.83 (d, J = 7.9, 1 H), 7.79 (d, J = 7.7, 1 H), 7.60 (t, J = 
7.6, 1 H), 7.49 (t, J = 7.4, 1 H), 7.45–7.36 (m, 1 H), 7.24–7.18 (m, 3 H), 7.11–
7.06 (m, 2 H), 5.73 (d, J = 12.8, 1 H), 5.61 (d, J = 12.7, 1 H), 4.90 (d, J = 
13.6, 1 H), 4.45 (d, J = 10.9, 1 H), 4.01 (d, J = 10.9, 1 H), 3.90 (dd, J = 11.4, 
11.4, 1 H), 3.66 (d, J = 13.6, 1 H), 2.89 (dd, J = 8.5, 11.9, 1 H), 2.81 (dd, J = 
6.6, 9.7, 1 H), 2.60–2.55 (m, 1 H), 2.54–2.43 (m, 2 H), 2.35–2.26 (m, 1 H), 
2.19 (s, 3 H), 2.02–1.85 (m, 2 H), 1.80–1.70 (m, 1 H), 1.24 (d, J = 6.8, 3 H), 
0.94 (d, J = 6.8, 3 H), 0.88 (d, J = 6.5, 3 H) 
 MS: (ESI, Q-tof) 
454.3 (100) 
 Mol. Formula: C32H40BrNO (534.57) 
 HRMS: C32H40NO
+: (454.3110) 
Calcd: 454.3110 
Found: 454.3105 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me
Me
V{3,2,2}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-isopropyl-3-(2-
naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{3,2,3}) 
 
Data for V{3,2,3}: 
 Yield: 94 mg (92%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.35 (s, 1 H), 7.97–7.92 (m, 1 H), 7.90 (dd, J = 1.7, 8.5, 1 H), 7.81–7.77 (m, 2 
H), 7.55–7.48 (m, 2 H), 7.24–7.19 (m, 3 H), 7.14–7.10 (m, 2 H), 5.49 (d, J = 
12.1, 1 H), 5.07 (d, J = 12.1, 1 H), 4.82 (d, J = 13.7, 1 H), 4.48 (d, J = 11.0, 1 
H), 4.10 (d, J = 10.9, 1 H), 3.91 (dd, J = 9.7, 12.1, 1 H), 3.71 (d, J = 13.6, 1 
H), 3.18 (dd, J = 7.1, 12.3, 1 H), 2.78 (dd, J = 6.9, 9.5, 1 H), 2.54–2.33 (m, 4 
H), 2.05 (s, 3 H), 1.97–1.87 (m, 2 H), 1.81–1.72 (d, J = 4.0, 1 H), 1.26 (d, J = 
6.8, 3 H), 1.04 (d, J = 6.2, 3 H), 1.00 (d, J = 6.8, 3 H) 
 MS: (ESI, Q-tof) 
454.3 (100) 
 Mol. Formula: C32H40BrNO (534.57) 
 HRMS: C32H40NO
+: (454.3110) 
Calcd: 454.3110 
Found: 454.3104 
 TLC: Rf  0.27  (CH2Cl2/MeOH, 9:1) [I2] 
  
N
H H
O
Me
Me
Me
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-isopropyl-3-(3,5-
trifluoromethyl-benzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide 
(V{3,2,5}) 
 
Data for V{3,2,5}: 
 Yield: 110 mg (93%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.48 (s, 2 H), 7.96 (s, 1 H), 7.31–7.23 (m, 2 H), 7.20–7.12 (m, 2 H), 5.84 (d, J 
= 12.3, 1 H), 5.25–5.18 (m, 1 H), 4.88 (d, J = 13.3, 1 H), 4.56 (d, J = 11.2, 1 
H), 4.18 (d, J = 11.2, 1 H), 3.61 (t, J = 11.9, 2 H), 3.57 (dd, J = 11.9, 11.9, 1 
H), 3.15–3.09 (m, 1 H), 2.77 (dd, J = 8.3, 8.3, 1 H), 2.60–2.49 (m, 1 H), 2.49–
2.32 (m, 3 H), 2.03 (s, 3 H), 1.96–1.89 (m, 2 H), 1.82–1,74 (m, 1 H), 1.25 (d, 
J = 6.7, 3 H), 1.04 (d, J = 6.6, 3 H), 0.99 (d, J = 6.8, 3 H) 
 MS: (ESI, Q-tof) 
540.3 (100) 
 Mol. Formula: C30H36BrF6NO  (620.51) 
 HRMS: C30H36F6NO
+: (540.2701) 
Calcd: 540.2701 
Found: 540.2692 
 TLC: Rf  0.31  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me
Me
Br
CF3
CF3
V{3,2,5}
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Preparation of rel-(1S,3S,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-isopropyl-3-hexyl-5-
methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{3,2,6}) 
 
Data for V{3,2,6}: 
 Yield: 66 mg (73%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.44 (d, J = 7.1, 2 H), 7.36 (t, J = 7.3, 2 H), 7.31 (t, J = 7.3, 1 H), 4.64 (dt, J = 
10.8, 20.1, 2 H), 4.16 (d, J = 14.0, 1 H), 3.97 (ddd, J = 5.0, 12.0, 12.0, 1 H), 
3.88 (dd, J = 8.4, 12.3, 1 H), 3.25-3.16 (m, 2 H), 2.60 (dd, J = 6.7, 9.6, 1 H), 
2.57–2.56 (m, 2 H), 2.39–2.31 (m, 1 H), 2.13–2.00 (m, 2 H), 1.94–1.84 (m, 2 
H), 1.77–1.66 (m, 2 H), 1.66 (s, 3 H), 1.57–1.51 (m, 1 H), 1.43–1.30 (m, 5 H), 
1.11 (d, J = 6.7, 3 H), 0.96 (d, J = 6.8, 3 H), 0.89 (t, J = 6.9, 3 H), 0.83 (d, J = 
6.6, 3 H) 
 MS: (ESI, Q-tof) 
398.3 (100) 
 Mol. Formula: C27H44BrNO  (478.55) 
 HRMS: C27H44NO
+: (398.3423) 
Calcd: 398.3423 
Found: 398.3417 
 TLC: Rf  0.39  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me
Me
Br
Me
V{3,2,8}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-isopropyl-3-(3,5-tert-
butylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{3,2,7}) 
 
Data for V{3,2,7}: 
 Yield: 115 mg (99%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.67 (d, J = 1.7, 2 H), 7.51 (s, 1 H), 7.32–7.24 (m, 3 H), 7.21–7.17 (m, 2 H), 
5.41 (d, J = 12.2, 1 H), 4.92 (d, J = 13.7, 1 H), 4.59 (d, J = 12.2, 1 H), 4.54 (d, 
J = 11.1, 1 H), 4.24 (d, J = 11.1, 1 H), 3.78 (dd, J = 8.2, 12.4, 1 H), 3.68 (d, J 
= 13.7, 1 H), 3.37 (dd, J = 8.1, 12.6, 1 H), 2.79 (dd, J = 8.2, 8.2, 1 H), 2.47–
2.31 (m, 4 H), 2.04 (s, 3 H), 2.00–1.88 (m, 2 H), 1.87–1.79 (m, 1 H), 1.37 (s, 
18H), 1.22 (d, J = 6.8, 3 H), 1.07 (t, J = 6.7, 6 H) 
 MS: (ESI, Q-tof) 
516.4 (100) 
 Mol. Formula: C36H54BrNO  (596.72) 
 HRMS: C36H54NO
+: (516.4205) 
Calcd: 516.4205 
Found: 516.4190 
 TLC: Rf  0.35  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me
t-Bu
t-Bu
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 Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-isopropyl-3-(4-
methoxy-benzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{3,2,8}) 
 
Data for V{3,2,8}: 
 Yield: 93 mg (94%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.80 (d, J = 8.7, 2 H), 7.34–7.25 (m, 3 H), 7.21–7.17 (m, 2 H), 6.96 (d, J = 
8.6, 2 H), 5.27 (d, J = 12.3, 1 H), 4.72 (d, J = 13.6, 2 H), 4.53 (d, J = 10.9, 1 
H), 4.19 (d, J = 10.9, 1 H), 3.84 (s, 3 H), 3.80 (dd, J = 9.5, 12.3, 1 H), 3.69 (d, 
J = 13.7, 1 H), 3.22 (dd, J =7.9, 12.1, 1 H), 2.76 (dd, J = 7.0, 9.2, 1 H), 2.53–
2.41 (m, 2 H), 2.41–2.34 (m, 2 H), 1.98 (s, 3 H), 1.95–1.87 (m, 2 H), 1.82–
1.73 (m, 1 H), 1.23 (d, J = 6.8, 3 H), 1.02 (d, J = 6.9, 3 H), 1.01 (d, J = 6.7, 3 
H) 
 MS: (ESI, Q-tof) 
434.3 (100) 
 Mol. Formula: C29H40BrNO2  (514.54) 
 HRMS: C29H40NO2
+: (434.3059) 
Calcd: 434.3059 
Found: 434.3055 
 TLC: Rf  0.20  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Br
Me
OMe
Me
Me
Me
V{3,2,8}
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Preparation of Quaternary Ammonium Bromides V{3,3,R4} 
 
 Following General Procedure II, amino borane V{3,3} (245 mg, 0.762 mmol) was added 
to a 100-mL round-bottomed flask as a solution in 23 mL of MeOH (0.03 M).  The flask was 
fitted with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. 
HCl solution (3.5 mL, 5.0 equiv) was added via syringe.  The resulting solution was heated and 
then concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure 
II.  The resulting free amine was dissolved in acetonitrile and was distributed among seven test 
tubes that were subsequently charged with benzyl bromide (tube 1, 20 mg, 0.115 mmol, 1.2 
equiv), 1-bromomethylnaphthalene (tube 2, 25 mg, 0.115 mmol, 1.2 equiv), 2-
bromomethylnaphthalene (tube 3, 25 mg, 0.115 mmol, 1.2 equiv), 3,5-bis(trifluoromethyl)benzyl 
bromide (tube 4, 35 mg, 0.115 mmol, 1.2 equiv), 3,5-bis(t-butyl)benzyl bromide (tube 5, 32 mg, 
0.115 mmol, 1.2 equiv), 4-methoxybenzyl bromide (tube 6, 23 mg, 0.115 mmol, 1.2 equiv), 1-
bromohexane (tube 7, 48 mg, 0.288 mmol, 3.0 equiv).  After being agitated for 12 h, the reaction 
mixtures were worked up and the products isolated and purified as described in General 
Procedure II. 
1. HCl (aq), MeOH
    reflux, 6 h
2. NaOH (0.1 M, aq)
    Et2O
3. CH3CN, RT, R
4-Br
N
H H
BH3
O N
H H
O
R4
Br
Me Me
Me
Me
Me
Me
Me
Me
V{3,3} V{3,3,R4}
Me Me
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-isopropyl-3-benzyl-5-
methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{3,3,1}) 
 
Data for V{3,3,1}: 
 Yield: 46 mg (99%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.90–7.82 (m, 2 H), 7.47–7.41 (m, 3 H), 5.17 (d, J = 12.1, 1 H), 5.00–4.94 (m, 
1 H), 4.54 (d, J = 13.6, 1 H), 4.00 (dd, J = 11.1, 11.1, 1 h), m, 2 H), 2.56–2.46 
(m, 1 H), 2.44–2.34 (m, 1 H), 2.24–2.16 (m, 1 H), 2.00–1.91 (m, 2 H), 1.96 (s, 
3 H), 1.77–1.67 (m, 1 H), 1.64–1.56 (m, 3 H), 1.48–1.40 (m, 2 H), 1.34–1.17 
(m, 3 H), 1.20 (d, J = 6.6, 3 H), 1.14 (d, J = 6.8, 3 H), 0.90 (d, J = 6.8, 3 H), 
0.85 (dd, J = 6.0, 7.0, 3 H) 
 MS: (ESI, Q-tof) 
398 (100) 
 Mol. Formula: C26H41BrNO (463.51) 
 HRMS: C20H38NO3
+: (398.3423) 
Calcd: 398.3423 
Found: 398.3416 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me
Br
Me
Me
V{3,3,1}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-isopropyl-3-(1-
naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{3,3,2}) 
 
Data for V{3,3,2}: 
 Yield: 50 mg (99%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.37 (d, J = 7.2, 1 H), 8.27 (d, J = 8.5, 1 H), 7.87 (t, J = 8.5, 2 H), 7.62 (t, J = 
7.7, 1 H), 7.54–7.44 (m, 2 H), 5.67 (d, J = 12.9, 1 H), 5.63 (d, J = 12.9, 1 H), 
4.72 (d, J = 13.6, 1 H), 4.09 (dd, J = 11.5, 11.5, 1 H), 3.50 (d, J = 13.5, 1 H), 
3.26 (dd, J = 6.9, 15.4, 1 H), 3.02 (dd, J = 8.1, 12.0, 1 H), 2.94 (dd, J = 6.1, 
14.9, 1 H), 2.74 (dd, J = 6.5, 9.7, 1 H), 2.72–2.60 (m, 2 H), 2.45 (m, 2 H), 
2.48–2.39 (m, 1 H), 2.18–2.08 (m, 1 H), 2.15 (s, 3 H), 2.00–1.94 (m, 2 H), 
1.75–1.65 (m, 1 H), 1.44–1.30 (m, 2 H), 1.27– 1.14 (m, 6H), 1.16 (d, J = 6.7, 
3 H), 1.10 (d, J = 6.4, 3 H), 0.84 (d, J = 6.8, 3 H), 0.81 (t, J = 6.9, 3 H) 
 MS: (ESI, Q-tof) 
448.3 (100) 
 Mol. Formula: C31H46BrNO (528.61) 
 HRMS: C31H46NO
+: (448.3579) 
Calcd: 448.3579 
Found: 448.3573 
 TLC: Rf  0.28  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me
Br
Me Me
V{3,3,2}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-isopropyl-3-(2-
naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{3,3,3}) 
 
Data for V{3,3,3}: 
 Yield: 46 mg (91%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.34 (s, 1 H), 7.95–7.92 (m, 1 H), 7.90 (dd, J = 1.7, 8.5, 1 H), 7.80–7.75 (m, 2 
H), 7.55–7.48 (m, 2 H), 5.36 (d, J = 12.1, 1 H), 5.20 (d, J = 12.0, 1 H), 4.62 
(d, J = 13.5, 1 H), 4.11–4.06 (dd, J = 10.8, 10.8, 1 H), 3.55 (d, J = 13.5, 1 H), 
3.30 (dd, J = 6.9, 15.4, 1 H), 3.20 (dd, J = 8.0, 12.0, 1 H), 3.00 (dd, J = 6.3, 
14.8, 1 H), 2.72–2.61 (m, 1 H), 2.70 (dd, J = 7.0, 9.7, 1 H), 2.60–2.56 (m, 1 
H), 2.44–2.33 (m, 1 H), 2.25–2.15 (m, 1 H), 2.02 (s, 3 H), 1.97–1.91 (m, 2 H), 
1.76–1.66 (m, 1 H), 1.44–1.32 (m, 2 H), 1.27–1.14 (m, 6H), 1.22 (d, J = 6.7, 3 
H), 1.18 (d, J = 6.7, 3 H), 0.89 (d, J = 6.8, 3 H), 0.81 (t, J = 7.0, 3 H) 
 MS: (ESI, Q-tof) 
448.4 (100) 
 Mol. Formula: C31H46BrNO (513.57) 
 HRMS: C31H46NO
+: (448.3579) 
Calcd: 448.3579 
Found: 448.3577 
 TLC: Rf  0.29  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me
Me
Br
Me
V{3,3,3}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-isopropyl-3-(3,5-
trifluoromethyl-benzyl)-5-methyl-7b-methyl-cyclopenta[gh]pyrrolizinium Bromide (V{3,3,5}) 
 
Data for V{3,3,5}: 
 Yield: 59 mg (99%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.49 (s, 2 H), 7.94 (s, 1 H), 5.70 (d, J = 12.2, 1 H), 5.37 (d, J = 12.3, 1 H), 
4.70 (d, J = 13.2, 1 H), 3.83 (dd, J = 11.0, 11.0, 1 H), 3.44 (d, J = 13.1, 1 H), 
3.36 (dd, J = 6.9, 15.3, 1 H), 3.26 (dd, J = 7.9, 11.9, 1 H), 3.08 (dd, J = 6.3, 
14.7, 1 H), 2.75–2.66 (m, 2 H), 2.58–2.53 (m, 1 H), 2.45–2.34 (m, 1 H), 2.23–
2.16 (m, 1 H), 2.01 (s, 3 H), 1.98–1.92 (m, 2 H), 1.76–1.68 (m, 1 H), 1.51–
1.38 (m, 2 H), 1.36–1.18 (m, 6 H), 1.21 (s, 3 H, J = 6.1), 1.16 (d, J = 6.8, 3 
H), 0.88 (d, J = 6.8, 3 H), 0.85 (t, J = 6.9, 3 H) 
 MS: (ESI, Q-tof) 
534.3 (100) 
 Mol. Formula: C29H42BrF6NO (599.51) 
 HRMS: C29H42F6NO
+: (534.3171) 
Calcd: 534.3171 
Found: 534.3167 
 TLC: Rf  0.32  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me
Br
Me
CF3
CF3
Me
V{3,3,5}
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Preparation of rel-(1S,3S,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-isopropyl-3-hexyl-5-
methyl-7b-methyl-cyclopenta[gh]pyrrolizinium Bromide (V{3,3,6}) 
 
Data for V{3,3,6}: 
 Yield: 43 mg (98%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
4.25 (d, J = 13.8, 1 H), 4.07 (d, J = 13.8, 1 H), 4.00–3.82 (m, 2 H), 3.56–3.33 
(m, 6H), 2.81–2.70 (m, 1 H), 2.55 (dd, J = 6.6, 9.6, 1 H), 2.49–2.40 (m, 1 H), 
2.21–2.12 (m, 3 H), 2.04–1.84 (m, 4 H), 1.81–1.64 (m, 2 H), 1.69 (s, 3 H), 
1.64–1.48 (m, 4 H), 1.48–1.20 (m, 6H), 1.09 (d, J = 6.7, 3 H), 1.05 (d, J = 6.7, 
3 H), 0.91–0.87 (m, 6H), 0.85 (d, J = 6.8, 3 H) 
 MS: (ESI, Q-tof) 
392.4 (100) 
Mol. Formula: C26H50BrNO (457.55) 
 HRMS: C26H50NO
+: (392.3892) 
Calcd: 392.3892 
Found: 392.3882 
 TLC: Rf  0.40  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me
Br
Me
Me
Me
V{3,3,6}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-isopropyl-3-(3,5-tert-
butylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{3,3,7}) 
 
Data for V{3,3,7}: 
 Yield: 56 mg (99%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.65 (d, J = 1.5, 2 H), 7.49 (s, 1 H), 5.25 (d, J = 12.2, 1 H), 4.71 (t, J = 12.8, 2 
H), 3.96 (dd, J = 8.8, 12.3, 1 H), 3.54 (d, J = 13.6, 1 H), 3.42 (dd, J = 8.1, 
12.3, 1 H), 3.39–3.33 (m, 1 H), 3.15 (dd, J = 6.0, 14.5, 1 H), 2.70 (dd, J = 7.0, 
9.0, 1 H), 2.60–2.50 (m, 1 H), 2.47–2.40 (m, 1 H), 2.40–2.32 (m, 1 H), 2.29–
2.20 (m, 1 H), 2.01 (s, 3 H), 1.99–1.92 (m, 2 H), 1.81–1.73 (m, 1 H), 1.49–
1.42 (m, 2 H), 1.38–1.20 (m, 6H), 1.36 (s, 18H), 1.22 (d, J = 6.8, 3 H), 1.14 
(d, J = 6.8, 3 H), 0.97 (d, J = 6.8, 3 H), 0.85 (t, J = 6.8, 3 H) 
 MS: (ESI, Q-tof) 
510.5 (100) 
 Mol. Formula: C35H60BrNO (605.80) 
 HRMS: C35H60NO
+: (510.4675) 
Calcd: 510.4675 
Found: 510.4674 
 TLC: Rf  0.35  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me
Br
Me
t-Bu
t-Bu
Me
V{3,3,7}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-isopropyl-3-(4-
methoxy-benzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{3,3,8}) 
 
Data for V{3,3,8}: 
 Yield: 48 mg (98%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.78 (d, J = 8.7, 2 H), 6.93 (d, J = 8.6, 2 H), 5.10 (d, J = 12.0, 1 H), 4.92–4.86 
(m, 1 H), 4.48 (d, J = 13.6, 1 H), 3.95 (dd, J = 10.4, 10.4, 1 H), 3.82 (s, 3 H), 
3.52 (d, J = 13.6, 1 H), 3.34 (dd, J = 6.8, 15.3, 1 H), 3.26–3.20 (m, 1 H), 3.09 
(dd, J = 6.2, 14.7, 1 H), 2.72–2.57 (m, 2 H), 2.51–2.46 (m, 1 H), 2.45–2.33 
(m, 1 H), 2.24–2.13 (m, 1 H), 1.97–1.91 (m, 2 H), 1.95 (s, 3 H), 1.75–1.67 (m, 
1 H), 1.48–1.41 (m, 2 H), 1.33–1.18 (m, 6H), 1.19 (d, J = 6.0, 3 H), 1.14 (d, J 
= 6.8, 3 H), 0.90 (d, J = 6.8, 3 H), 0.85 (t, J = 6.9, 3 H) 
 MS: (ESI, Q-tof) 
428.4 (100) 
 Mol. Formula: C28H46BrNO2 (493.54) 
 HRMS: C28H46NO2
+: (428.3529) 
Calcd: 428.3529 
Found: 428.3529 
 TLC: Rf  0.21  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me
Br
Me Me
OMe
V{3,3,8}
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Preparation of Quaternary Ammonium Bromides V{3,7,R4} 
 
 Following General Procedure II, amino borane V{3,7} (502 mg, 1.40 mmol) was added 
to a 100-mL round-bottomed flask as a solution in 50 mL of MeOH (0.03 M).  The flask was 
fitted with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. 
HCl solution (7.0 mL, 5.0 equiv) was added via syringe.  The resulting solution was heated and 
then concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure 
II.  The resulting free amine was dissolved in acetonitrile and was distributed among six test 
tubes that were subsequently charged with benzyl bromide (tube 1, 20 mg, 0.116 mmol, 1.2 
equiv), 1-bromomethylnaphthalene (tube 2, 26 mg, 0.116 mmol, 1.2 equiv), 2-
bromomethylnaphthalene (tube 3, 26 mg, 0.116 mmol, 1.2 equiv), 3,5-bis(trifluoromethyl)benzyl 
bromide (tube 4, 35 mg, 0.116 mmol, 1.2 equiv), 3,5-bis(t-butyl)benzyl bromide (tube 5, 33 mg, 
0.116 mmol, 1.2 equiv), 4-methoxybenzyl bromide (tube 6, 23 mg, 0.116 mmol, 1.2 equiv).  
After being agitated for 12 h, the reaction mixtures were worked up and the products isolated and 
purified as described in General Procedure II. 
1. HCl (aq), MeOH
    reflux, 6 h
2. NaOH (0.1 M, aq)
    Et2O
3. CH3CN, RT, R
4-Br
N
H H
BH3
O N
H H
O
R4
Br
Me Me
Me
Me
Me
Me
Me
Me
V{3,7} V{3,7,R4}
MeO MeO
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 Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxy-benzyloxy)-1-
isopropyl-3-benzyl-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{3,7,1}) 
 
Data for V{3,7,1}: 
 Yield: 38 mg (75%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.90–7.82 (m, 2 H), 7.49–7.42 (m, 3 H), 7.08 (d, J = 8.6, 2 H), 6.80 (d, J = 
8.6, 2 H), 5.31 (d, J = 12.1, 1 H), 4.83 (d, J = 12.1, 1 H), 4.72 (d, J = 13.7, 1 
H), 4.45 (d, J = 10.6, 1 H), 4.11 (d, J = 10.6, 1 H), 3.83 (dd, J = 9.62, 12.0, 1 
H), 3.77 (s, 3 H), 3.69 (d, J = 13.6, 1 H), 3.19 (dd, J = 7.9, 12.2, 1 H), 2.74 
(dd, J =6.86, 9.45, 1 H), 2.54–2.30 (m, 4 H), 1.98 (s, 3 H), 1.96–1.84 (m, 2 
H), 1.79–1.70 (m, 1 H), 1.22 (d, J = 6.8, 3 H), 1.01 (t, J = 7.1, 6 H). 
 MS: (ESI, Q-tof) 
434.3 (100) 
 Mol. Formula: C29H40BrNO2  (514.54) 
 HRMS: C29H40NO2
+: (434.3059) 
Calcd: 434.3059 
Found: 434.3058 
 TLC: Rf  0.22  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me
Br
MeO
Me
V{3,7,1}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxy-benzyloxy)-1-
isopropyl-3-(1-naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide 
(V{3,7,2}) 
 
Data for V{3,7,2}: 
 Yield: 42 mg (77%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.38 (d, J = 7.2, 1 H), 8.26 (d, J = 8.6, 1 H), 7.88 (t, J = 7.34, 2 H), 7.62 (t, J = 
7.2, 1 H), 7.56–7.46 (m, 2 H), 7.00 (d, J = 8.6, 2 H), 6.74 (d, J = 8.6, 2 H), 
5.73 (d, J = 12.8, 1 H), 5.58 (d, J = 12.8, 1 H), 4.87 (d, J = 13.7, 1 H), 4.38 (d, 
J = 10.6, 1 H), 3.96 (d, J = 10.9, 1 H), 3.96-3.92 (m, 1 H), 3.73 (s, 3 H), 3.67 
(d, J = 13.6, 1 H), 2.93 (dd, J = 7.5, 12.2, 1 H), 2.80 (dd, J = 6.5, 9.8, 1 H), 
2.57–2.40 (m, 3 H), 2.35–2.26 (m, 1 H), 2.16 (s, 3 H), 2.00–1.87 (m, 2 H), 
1.79–1.68 (m, 1 H), 1.23 (d, J = 6.8, 3 H), 0.94 (d, J = 6.8, 3 H), 0.90 (d, J = 
6.0, 3 H) 
 MS: (ESI, Q-tof) 
484.3 (100) 
 Mol. Formula: C33H42BrNO2  (564.60) 
 HRMS: C33H42NO2
+: (484.3216) 
Calcd: 484.3216 
Found: 484.3215 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me
Br
MeO
Me
V{3,7,2}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxybenzyloxy)-1-isopropyl 
-3-(2-naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{3,7,3}) 
 
Data for V{3,7,3}: 
 Yield: 38 mg (69%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.35 (s, 1 H), 7.96 (d, J = 8.3, 1 H), 7.91 (dd, J = 1.7, 8.3, 1 H), 7.85-7.81 (m, 
2 H), 7.56–7.45 (m, 2 H), 7.03 (d, J = 8.6, 2 H), 6.73 (d, J = 8.7, 2 H), 5.47 (d, 
J = 12.1, 1 H), 5.07 (d, J = 12.2, 1 H), 4.79 (d, J = 13.7, 1 H), 4.41 (d, J = 
10.6, 1 H), 4.04 (d, J = 10.6, 1 H), 3.90 (dd, J = 9.2, 12.1, 1 H), 3.71 (s, 3 H), 
3.16 (dd, J = 7.1, 12.6, 1 H), 2.76 (dd, J = 6.9, 9.4, 1 H), 2.52–2.33 (m, 5 H), 
2.04 (s, 3 H), 1.96–1.85 (m, 2 H), 1.78–1.69 (m, 1 H), 1.25 (d, J = 6.8, 3 H), 
1.05 (d, J = 6.1, 3 H), 0.99 (d, J = 6.8, 3 H) 
 MS: (ESI, Q-tof) 
484.3 (100) 
 Mol. Formula: C33H42BrNO2 (564.60) 
 HRMS: C33H42NO2
+: (484.3216) 
Calcd: 484.3216 
Found: 484.3221 
 TLC: Rf  0.26  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me
Br
MeO
Me
V{3,7,3}
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxy-benzyloxy)-1-isopropyl 
-3-(3,5-trifluoromethlybenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide 
(V{3,7,5}) 
 
Data for V{3,7,5}: 
 Yield: 52 mg (82%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.48 (s, 2 H), 7.96 (s, 1 H), 7.07 (d, J = 8.6, 2 H), 6.79 (d, J = 8.6, 2 H), 5.81 
(d, J = 12.4, 1 H), 5.27–5.20 (m, 1 H), 4.84 (d, J = 13.2, 1 H), 4.48 (d, J = 
10.8, 1 H), 4.12 (d, J = 10.8, 1 H), 3.76 (s, 3 H), 3.62 (dd, J = 9.5, 11.9, 1 h), 
3.57 (d, J = 13.4, 1 H) 3.14 (dd, J = 7.51, 11.0, 1 H), 2.75 (dd, J = 8.3, 8.3, 1 
H), 2.60–2.48 (m, 1 H), 2.48–2.31 (m, 3 H), 2.02 (s, 3 H), 1.95–1.87 (m, 2 H), 
1.80–1.71 (m, 1 H), 1.23 (d, J = 6.7, 3 H), 1.05 (d, J = 6.7, 3 H), 0.99 (d, J = 
6.8, 3 H) 
 MS: (ESI, Q-tof) 
570.3 (100) 
 Mol. Formula: C31H38BrF6NO2 (650.53) 
 HRMS: C31H38F6NO2
+: (570.2807) 
Calcd: 570.2807 
Found: 570.2805 
 TLC: Rf  0.31  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me
Br
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxy-benzyloxy)-1-isopropyl 
-3-(3,5-tert-butylbenzyl)-5-methyl-7b-methycyclopenta[gh]pyrrolizinium Bromide (V{3,7,7}) 
 
Data for V{3,7,7}: 
 Yield: 47 mg (78%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.67 (d, J = 1.7, 2 H), 7.51 (s, 1 H), 7.11 (d, J = 8.6, 2 H), 6.82 (d, J = 8.7, 2 
H), 5.37 (d, J = 12.2, 1 H), 4.87 (d, J = 13.7, 1 H), 4.61 (d, J = 12.2, 1 H), 4.46 
(d, J = 10.6, 1 H), 4.17 (d, J = 10.6, 1 H), 3.80 (dd, J = 8.21, 12.5, 1 H), 3.78 
(s, 3 H), 3.68 (d, J = 13.7, 1 H), 3.40 (dd, J = 8.0, 12.5, 1 H), 2.77 (dd, J = 
7.54, 8.9, 1 H), 2.45–2.31 (m, 4 H), 2.03 (s, 3 H), 1.99–1.86 (m, 2 H), 1.85–
1.76 (m, 1 H), 1.37 (s, 18H), 1.21 (d, J = 6.8, 3 H), 1.07 (d, J = 6.8, 6 H) 
 MS: (ESI, Q-tof) 
546.4 (100) 
 Mol. Formula: C37H56BrNO2 (626.75) 
 HRMS: C37H56NO2
+: (546.4311) 
Calcd: 546.4311 
Found: 546.4317 
 TLC: Rf  0.33  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxybenzyloxy)-1-isopropyl-
3-(4-methoxybenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{3,7,8}) 
 
Data for V{3,7,8}: 
 Yield: 35 mg (66%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.79 (d, J = 8.7, 2 H), 7.10 (d, J = 8.6, 2 H), 6.95 (d, J = 8.6, 2 H), 6.81 (d, J = 
8.7, 2 H), 5.23 (d, J = 12.2, 1 H), 4.75 (d, J = 12.4, 1 H), 4.66 (d, J = 13.7, 1 
H), 4.45 (d, J = 10.6, 1 H), 4.12 (d, J = 10.6, 1 H), 3.84 (s, 3 H), 3.83–3.73 (m, 
1 H), 3.77 (s, 3 H), 3.67 (d, J = 13.7, 1 H), 3.20 (dd, J = 8.1, 12.2, 1 H), 2.73 
(dd, J = 6.8, 9.5, 1 H), 2.52–2.28 (m, 4 H), 1.96 (s, 3 H), 1.94–1.85 (m, 2 H), 
1.75 (s, 1 H), 1.21 (d, J = 6.7, 3 H), 1.04–0.99 (m, 6H) 
 MS: (ESI, Q-tof) 
464.3 (100) 
 Mol. Formula: C30H42BrNO3 (544.56) 
 HRMS: C30H42NO3
+: (464.3165) 
Calcd: 464.3165 
Found: 464.3170 
 TLC: Rf  0.19  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Me
Me
Br
MeO OMe
Me
V{3,7,8}
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Preparation of Quaternary Ammonium Bromides V{4,2,R4} 
 
 Following General Procedure II, amino borane V{4,2} (102 mg, 0.300 mmol) was added 
to a 25-mL round-bottomed flask as a solution in 0 mL of MeOH (0.03 M).  The flask was fitted 
with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. HCl 
solution (1.5, 5.0 equiv) was added via syringe.  The resulting solution was heated and then 
concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure II.  
The resulting free amine was dissolved in acetonitrile and was distributed among one test tube 
that were subsequently charged with 3,5-bis(trifluoromethyl)benzyl bromide (tube 1, 281 mg, 
0.915 mmol, 5.0 equiv).  After being agitated for 12 h, the reaction mixtures were worked up and 
the products isolated and purified as described in General Procedure II. 
  
1. HCl (aq), MeOH
    reflux, 6 h
2. NaOH (0.1 M, aq)
    Et2O
3. CH3CN, RT, R
4-Br
N
H H
BH3
O N
H HMe
19
O
R4
Br
Me Me
Me
Me
Me
Me
Me
V{4,2} V{4,2,R4}
Me Me
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-tert-butyl-3-(3,5-
trifluoromethylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{4,2,5}) 
 
Data for V{4,2,5}: 
 Yield: 108 mg (93%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.53 (s, 2 H), 7.97 (s, 1 H), 7.31 (m, 3 H), 7.22-7.19 (m, 2 H), 5.71 (d, J = 
12.3, 1 H), 5.60 (d, J = 12.3, 1 H), 4.80 (d, J = 10.8, 1 H), 4.67 (d, J = 13.8, 1 
H), 4.24 (d, J = 10.8, 1 H), 3.84 (dd, J = 11.2, 1 H), 3.74 (d, J = 13.7, 1 H), 
3.12 (dd, 1 H, J = 7.9, 11.9, 1 H), 2.97 (dd, J = 6.8, 9.5, 1 H), 2.54-2.47 (m, 2 
H), 2.36-2.26 (m, 1 H), 2.00 (s, 3 H), 1.92-1.83 (m, 2 H), 1.79-1.72 (m, 1 H), 
1.17 (s, 9 H), 0.88 (d, J = 6.7, 3 H) 
 MS: (ESI, Q-tof) 
554.2 (100) 
 Mol. Formula: C31H38BrF6NO (634.53) 
 HRMS: C36H37F3NO
+: 554.2858 
Calcd: 554.2858 
Found: 554.2866 
 TLC: Rf  0.30  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
Me
Me
Me
CF3
CF3
V{4,2,5}
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Preparation of Quaternary Ammonium Bromides V{5,2,R4} 
 
 Following General Procedure II, amino borane V{5,2} (597 mg, 1.65 mmol) was added 
to a 100-mL round-bottomed flask as a solution in 50 mL of MeOH (0.03 M).  The flask was 
fitted with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. 
HCl solution (7.5, 5.0 equiv) was added via syringe.  The resulting solution was heated and then 
concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure II.  
The resulting free amine was dissolved in acetonitrile and was distributed among eight test tubes 
that were subsequently charged with benzyl bromide (tube 1, 44 mg, 0.259 mmol, 1.2 equiv), 1-
bromomethylnaphthalene (tube 2, 58 mg, 0.259 mmol, 1.2 equiv), 2-bromomethylnaphthalene 
(tube 3, 58 mg, 0.259 mmol, 1.2 equiv), 3,5-bis(trifluoromethyl)benzyl bromide (tube 4, 80 mg, 
0.259 mmol, 1.2 equiv), 3,5-bis(t-butyl)benzyl bromide (tube 5, 80 mg, 0.259 mmol, 1.2 equiv), 
4-methoxybenzyl bromide (tube 6, 52 mg, 0.259 mmol, 1.2 equiv), 4-trifluoromethylbenzyl 
bromide (tube 7, 20 mg, 0.085 mmol, 1.2 equiv), 4-cyanobenzyl bromide (tube 8, 17 mg, 0.085 
mmol, 1.2 equiv).  After being agitated for 12 h, the reaction mixtures were worked up and the 
products isolated and purified as described in General Procedure II. 
1. HCl (aq), MeOH
    reflux, 6 h
2. NaOH (0.1 M, aq)
    Et2O
3. CH3CN, RT, R
4-Br
N
H H
BH3
O N
H H
O
R4
Br
Me Me
Me Me
V{5,2} V{5,2,R4}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-phenyl-3-benzyl-5-
methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,2,1}) 
 
Data for V{5,2,1}: 
 Yield: 107 mg (95%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.77 (d, J = 8.2, 2 H), 7.67 (t, J = 7.5, 2 H), 7.57 (t, J = 7.3, 2 H), 7.42 (d, J = 
7.8, 2 H), 7.40–7.31 (m, 3 H), 7.31–7.24 (m, 2 H), 7.12 (d, J = 6.8, 2 H), 5.25 
(d, J = 12.0, 1 H), 5.03 (dd, J = 11.9, 11.9, 1 H), 4.30 (d, J = 13.1, 1 H), 3.99 
(d, J = 10.6, 1 H), 3.82 (d, J = 10.7, 1 H), 3.53 (d, J = 13.0, 1 H), 3.45 (dd, J = 
9.3, 9.3, 1 H), 3.36 (d, J = 12.1, 1 H), 2.98 (dd, J = 6.0, 11.4, 1 H), 2.85 (dd, J 
= 5.72, 9.75, 1 H), 2.49–2.39 (m, 1 H), 2.29 (s, 3 H), 2.27–2.15 (m, 2 H), 
1.98–1.91(m, 2 H), 1.30 (d, J = 6.3, 3 H) 
 MS: (ESI, Q-tof) 
438.3 (100) 
 Mol. Formula: C31H36BrNO (518.53) 
 HRMS: C31H36NO
+: (438.2797) 
Calcd: 438.2797 
Found: 438.2784 
 TLC: Rf  0.21  (CH2Cl2/MeOH, 9:1) [I2] 
  
N
H H
O
Me
Br
Me
V{5,2,1}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-phenyl-3-(1-
naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,2,2}) 
 
Data for V{5,2,2}: 
 Yield: 113 mg (92%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.91 (dd, J = 8.4, 14.2, 2 H), 7.85 (t, J = 8.3, 2 H), 7.74 (d, J = 7.7, 2 H), 7.67 
(t, J = 7.7, 2 H), 7.58 (d, J = 7.4, 1 H), 7.57–7.53 (m, 2 H), 7.51 (d, J = 7.2, 1 
H), 7.47 (dd, J = 5.7, 13.6, 2 H), 7.32–7.23 (m, 1 H), 7.10 (dd, J = 2.0, 7.4, 2 
H), 5.55 (d, J = 12.8, 1 H), 4.74 (d, J = 11.9, 1 H), 4.69 (d, J = 13.9, 1 H), 4.53 
(d, J = 12.8, 1 H), 3.98 (d, J = 11.0, 1 H), 3.91 (d, J = 11.0, 1 H), 3.62 (d, J = 
13.3, 1 H), 3.39 (dd, J = 9.1, 9.1, 1 H), 3.04 (d, J = 10.4, 1 H), 2.90 (dd, J = 
6.4, 11.5, 1 H), 2.55 (dd, J = 11.2, 21.0, 1 H), 2.46 (s, 3 H), 2.37–2.27 (m, 1 
H), 2.16 (d, J = 9.0, 1 H), 2.02–1.95 (m, 2 H), 1.22 (d, J = 6.4, 3 H) 
 MS: (ESI, Q-tof) 
488.3 (100) 
 Mol. Formula: C35H38BrNO (568.59) 
 HRMS: C35H38NO
+: (488.2953) 
Calcd: 488.2953 
Found: 488.2956 
 TLC: Rf  0.24  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
V{5,2,2}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-phenyl-3-(2-
naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,2,3}) 
 
Data for V{5,2,3}: 
 Yield: 110 mg (90%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.86–7.79 (m, 5 H), 7.75 (t, J = 7.7, 2 H), 7.68–7.60 (m, 3 H), 7.57–7.50 (m, 2 
H), 7.31–7.25 (m, 3 H), 7.12 (dd, J = 1.9, 7.5, 2 H), 5.48 (d, J = 12.1, 1 H), 
5.18 (dd, J = 11.9, 11.9, 1 H), 4.35 (d, J = 13.0, 1 H), 4.00 (d, J = 10.7, 1 H), 
3.84 (d, J = 10.7, 1 H), 3.53 (dd, J = 12.4, 12.4, 2 H), 3.47 (dd, J = 9.2, 9.2, 1 
H), 3.06 (dd, J = 6.0, 11.3, 1 H), 2.89 (dt, J = 2.75, 5.63, 10.2, 1 H), 2.51–2.40 
(m, 1 H), 2.35 (s, 3 H), 2.29–2.15 (m, 2 H), 1.99–1.93 (m, 2 H), 1.32 (d, J = 
6.4, 3 H) 
 MS: (ESI, Q-tof) 
488.3 (100) 
 Mol. Formula: C35H38BrNO (568.59) 
 HRMS: C35H38NO3
+: (488.2953) 
Calcd: 488.2953 
Found: 488.2943 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-phenyl-3-(3,5-
trifluoromethylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,2,5}) 
 
Data for V{5,2,5}: 
 Yield: 1 mg (85%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.93 (s, 2 H), 7.91 (s, 1 H), 7.76 (d, J = 7.42, 2 H), 7.72 (t, J = 7.7, 2 H), 7.63 
(t, J = 7.2, 1 H), 7.33–7.27 (m, 3 H), 7.13 (dd, J = 2.1, 7.3, 2 H), 5.96 (d, J = 
12.3, 1 H), 5.34 (dd, J = 11.7, 11.7, 1 H), 4.01 (d, J = 10.6, 1 H), 3.98 (d, J = 
13.1, 1 H), 3.84 (d, J = 10.6, 1 H), 3.58 (d, J = 13.2, 1 H), 3.49 (dd, J = 9.4, 
9.4, 1 H), 3.39 (d, J = 12.4, 1 H), 3.00 (dd, J = 6.1, 11.0, 1 H), 2.82 (dd, J = 
5.8, 10.2, 1 H), 2.51–2.40 (m, 1 H), 2.35 (s, 3 H), 2.31–2.18 (m, 2 H), 2.04–
1.92 (m, 2 H), 1.32 (d, J = 6.3, 3 H) 
 MS: (ESI, Q-tof) 
574.3 (100) 
 Mol. Formula: C33H34BrF6NO (654.52) 
 HRMS: C33H34NOF6
+: (574.2545) 
Calcd: 574.2545 
Found: 574.2541 
 TLC: Rf  0.28  (CH2Cl2/MeOH, 9:1) [I2]
N
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Me
Br
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-phenyl-3-(3,5-tert-
butylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,2,7}) 
 
Data for V{5,2,7}: 
 Yield: 113 mg (83%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.78 (d, J = 7.4, 2 H), 7.68 (t, J = 7.7, 2 H), 7.58 (t, J = 7.4, 1 H), 7.40 (s, 1 
H), 7.33–7.28 (m, 5 H), 7.18–7.13 (m, 2 H), 5.17 (d, J = 11.8, 1 H), 5.10 (dd, 
J = 11.9, 11.9, 1 H), 4.35 (d, J = 13.1, 1 H), 4.01 (d, J = 10.6, 1 H), 3.80 (d, J 
= 10.6, 1 H), 3.54 (d, J = 13.1, 1 H), 3.49 (dd, J = 9.4, 9.4, 1 H), 3.25 (d, J = 
12.0, 1 H), 2.92 (dd, J = 5.9, 11.4, 1 H), 2.90–2.85 (m, 1 H), 2.49–2.39 (m, 1 
H), 2.30 (s, 3 H), 2.25–2.15 (m, 2 H), 1.98–1.92 (m, 2 H), 1.31 (s, 18H), 1.30 
(d, J = 6.5, 3 H) 
 MS: (ESI, Q-tof) 
550.4 (100) 
 Mol. Formula: C39H52BrNO  (630.74) 
 HRMS: C39H52NO
+: (550.4049) 
Calcd: 550.4049 
Found: 550.4048 
 TLC: Rf  0.31  (CH2Cl2/MeOH, 9:1) [I2]
N
H HMe
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Me
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-phenyl-3-(4-
methoxybenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,2,8}) 
 
Data for V{5,2,8}: 
 Yield: 105 mg (89%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.76 (d, J = 7.5, 2 H), 7.67 (t, J = 7.7, 2 H), 7.57 (t, J = 7.4, 1 H), 7.36 (d, J = 
8.7, 2 H), 7.32–7.23 (m, 3 H), 7.16–7.10 (m, 2 H), 6.84 (d, J = 8.7, 2 H), 5.17 
(d, J = 12.1, 1 H), 4.98 (t, J = 11.9, 1 H), 4.28 (d, J = 13.0, 1 H), 3.99 (d, J = 
10.7, 1 H), 3.82 (d, J = 10.6, 1 H), 3.78 (s, 3 H), 3.52 (d, J = 13.1, 1 H), 3.44 
(dd, J = 9.3, 9.3, 1 H), 3.31 (d, J = 12.2, 1 H), 2.96 (dd, J = 6.0, 11.4, 1 H), 
2.84 (dd, J = 5.71, 10.1, 1 H), 2.50–2.38 (m, 1 H), 2.26 (s, 3 H), 2.25–2.15 (m, 
2 H), 1.98–1.89 (m, 2 H), 1.29 (d, J = 6.4, 1 H) 
 MS: (ESI, Q-tof) 
468.3 (100) 
 Mol. Formula: C32H38BrNO2  (548.55) 
 HRMS: C32H38NO2
+: (468.2903) 
Calcd: 468.2903 
Found: 468.2901 
 TLC: Rf  0.20  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
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Me
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-phenyl-3-(4-
trifluoromethylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,2,9}) 
 
Data for V{5,2,9}: 
 Yield: 35 mg (89%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.77 (m, 2 H), 7.69 (dd, J = 7.8, 7.8, 2 H), 7.64-7.57 (m, 5 H) 7.30 (m, 3 H), 
7.13 (m, 2 H), 5.50 (d, J = 12.1, 1 H), 5.12 (dd, J = 11.8, 11.8, 1 H), 4.21 (d, J 
= 13.1, 1 H), 4.01 (d, J = 10.7, 1 H), 3.84 (d, J = 10.7, 1 H), 3.57 (d, J = 13.1, 
1 1 H), 3.45 (dd, J = 9.3, 9.3, 1 H), 3.44 (d, J = 12.2, 1 H), 2.97 (dd, J = 6.1, 
11.3, 1 H), 2.82 (dd, J = 5.9, 10.1, 1 H), 2.46 (m, 1 H), 2.31 (s, 3 H), 2.25 (m, 
2 H), 1.96 (m, 2 H), 1.30 (d, J = 6.4, 3 H) 
 MS: (ESI, Q-tof) 
506.3 (100) 
 Mol. Formula: C32H35BrF3NO (586.53) 
 HRMS: C32H35F3NO
+: (506.2671) 
Calcd: 506.2671 
Found: 506.2670 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-phenyl-3-(4-
cyanobenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,2,10}) 
 
Data for V{5,2,10}: 
 Yield: 35 mg (95%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.77 (d, J = 7.4, 2 H), 7.71-7.63 (m, 6H), 7.60 (dd, J = 7.3, 7.3, 1 H), 7.31-
7.26 (m, 3 H), 7.13-7.10 (m, 2 H), 5.54 (d, J = 12.0, 1 H), 5.13 (dd, J = 11.8, 
11.8, 1 H), 4.16 (d, J = 13.2, 1 H), 4.01 (d, J = 10.6, 1 H), 3.83 (d, J = 10.6, 1 
H), 3.58 (d, J = 13.1, 1 H), 3.48-3.40 (m, 2 H), 2.94 (dd, J = 6.1, 11.2, 1 H), 
2.80 (dd, J = 5.8, 10.0, 1 H), 2.50-2.40 (m, 1 H), 2.30 (s, 3 H), 2.30-2.17 (m, 2 
H), 2.00-1.92 (m, 2 H), 1.29 (d, J = 6.3, 1 H) 
 MS: (ESI, Q-tof) 
463.3 (100) 
 Mol. Formula: C32H35BrN2O (543.54) 
 HRMS: C32H35N2O
+: 463.2749) 
Calcd: 463.2749 
Found: 463.2742 
 TLC: Rf  0.19  (CH2Cl2/MeOH, 9:1) [I2] 
N
H H
O
Me
Br
CN
Me
V{5,2,10}
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Preparation of Quaternary Ammonium Bromides V{5,3,R4} 
 
 Following General Procedure II, amino borane V{5,3} (403 mg, 1.13 mmol) was added 
to a 100-mL round-bottomed flask as a solution in 43 mL of MeOH (0.03 M).  The flask was 
fitted with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. 
HCl solution (6.9, 5.0 equiv) was added via syringe.  The resulting solution was heated and then 
concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure II.  
The resulting free amine was dissolved in acetonitrile and was distributed among six test tubes 
that were subsequently charged with benzyl bromide (tube 1, 37 mg, 0.215 mmol, 1.2 equiv), 1-
bromomethylnaphthalene (tube 2, 48 mg, 0.215 mmol, 1.2 equiv), 2-bromomethylnaphthalene 
(tube 3, 48 mg, 0.215 mmol, 1.2 equiv), 3,5-bis(trifluoromethyl)benzyl bromide (tube 4, 66 mg, 
0.215 mmol, 1.2 equiv), 3,5-bis(t-butyl)benzyl bromide (tube 5, 61 mg, 0.215 mmol, 1.2 equiv), 
4-methoxybenzyl bromide (tube 6, (43 mg, 0.215 mmol, 1.2 equiv).  After being agitated for 12 
h, the reaction mixtures were worked up and the products isolated and purified as described in 
General Procedure II. 
1. HCl (aq), MeOH
    reflux, 6 h
2. NaOH (0.1 M, aq)
    Et2O
3. CH3CN, RT, R
4-Br
N
H H
BH3
O N
H H
O
R4
Br
Me Me
Me
Me Me
Me
V{5,3} V{5,3,R4}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-phenyl-3-benzyl-5-
methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,3,1}) 
 
Data for V{5,3,1}: 
 Yield: 82 mg (89%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.65 (t, J = 8.1, 2 H), 7.62 (d, J = 8.07, 2 H), 7.53 (t, J = 7.2, 1 H), 7.41 (d, J = 
6.61, 2 H), 7.39–7.31 (m, 3 H), 5.22 (d, J = 12.0, 1 H), 5.02 (dd, J = 11.9, 
11.9, 1 H), 4.21 (d, J = 13.0, 1 H), 3.44 (d, J = 13.2, 1 H), 3.34 (d, J = 12.0, 1 
H), 3.31 (dd, J = 9.28, 9.28, 1 H), 2.98 (dd, J = 6.1, 11.4, 1 H), 2.90 (ddd, J = 
6.4, 8.8, 8.8, 1 H), 2.83 (dd, J = 6.0, 10.1, 1 H), 2.74 (ddd, J = 6.7, 8.8, 8.8, 1 
H), 2.40–2.30 (m, 1 H), 2.28–2.19 (m, 1 H), 2.25 (s, 3 H), 2.12–2.03 (m, 1 H), 
1.98–1.84 (m, 2 H), 1.41–1.34 (m, 2 H), 1.31 (d, J = 6.4, 3 H), 1.27–1.10 (m, 
6H), 0.84 (t, J = 7.2, 3 H) 
 MS: (ESI, Q-tof) 
432.3 (100) 
 Mol. Formula: C30H42BrNO (512.56) 
 HRMS: C30H42NO
+: (432.3266) 
Calcd: 432.3266 
Found: 432.3263 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me Me
V{5,3,1}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-phenyl-3-(1-
naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,3,2}) 
 
Data for V{5,3,2}: 
 Yield: 94 mg (93%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.93–7.87 (m, 3 H), 7.85 (d, J = 8.1, 1 H), 7.62-7.59 (m, 4 H), 7.58–7.44 (m, 4 
H), 5.54 (d, J = 12.8, 1 H), 4.71 (dd, J = 11.8, 11.8, 1 H), 4.63 (d, J = 13.3, 1 
H), 4.57 (d, J = 12.8, 1 H), 3.54 (d, J = 13.2, 1 H), 3.26 (dd, J = 8.9, 8.9, 1 H), 
3.01 (dd, J = 5.5, 10.1, 1 H), 2.93 (dd, J = 6.5, 11.5, 1 H), 2.87–2.87 (m, 2 H), 
2.56–2.46 (m, 1 H), 2.43–2.33(m, 1 H), 2.09–2.01 (m, 1 H), 2.01–1.91 (m, 2 
H), 1.36 (dd, J = 6.9, 14.0, 2 H), 1.26 (d, J = 6.4, 2 H), 1.24–1.07 (m, 8H), 
0.82 (t, J = 7.2, 3 H) 
 MS: (ESI, Q-tof) 
482.3 (100) 
 Mol. Formula: C34H44BrNO (562.62) 
 HRMS: C34H44NO
+: (482.3423) 
Calcd: 482.3423 
Found: 482.3428 
 TLC: Rf  0.28  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me Me
V{5,3,2}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-phenyl-3-(2-
naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,3,3}) 
 
Data for V{5,3,3}: 
 Yield: 103 mg (99%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.85–7.79 (m, 3 H), 7.73–7.66 (m, 4 H), 7.65–7.57 (m, 3 H), 7.56–7.50 (m, 2 
H), 5.44 (d, J = 12.1, 1 H), 5.14 (dd, J = 11.9, 11.9, 1 H), 4.27 (d, J = 13.0, 1 
H), 3.53 (d, J = 12.1, 1 H), 3.43 (d, J = 13.0, 1 H), 3.34 (dd, J = 9.3, 9.3, 1 H), 
3.06 (dd, J = 6.1, 11.3, 1 H), 2.91 (ddd, J = 6.38, 8.90, 8.90, 1 H), 2.87 (dd, J 
= 5.8, 10.2, 1 H), 2.75 (dd, J = 6.7, 15.5, 1 H), 2.44–2.19 (m, 2 H), 2.30 (s, 3 
H), 2.13–2.05 (m, 1 H), 1.97–1.87 (m, 2 H), 1.40– 1.34 (m, 2 H), 1.33 (d, J = 
6.4, 3 H), 1.28–1.09 (m, 7H), 0.83 (t, J = 7.2, 3 H) 
 MS: (ESI, Q-tof) 
482.3 (100) 
 Mol. Formula: C34H44BrNO (562.62) 
 HRMS: C34H44NO
+: (482.3423) 
Calcd: 482.3423 
Found: 482.3423 
 TLC: Rf  0.29  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me Me
V{5,3,3}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-phenyl-3-(3,5-
trifluoromethyl-benzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,3,5}) 
 
Data for V{5,3,5}: 
 Yield: 104mg (90%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.90 (s, 2 H), 7.69–7.63 (m, 4 H), 7.61–7.56 (m, 1 H), 5.92 (d, J = 12.3, 1 H), 
5.32 (dd, J = 11.6, 11.6, 1 H), 3.88 (d, J = 13.1, 1 H), 3.49 (d, J = 13.1, 1 H), 
3.39–3.32 (m, 2 H), 3.00 (dd, J = 6.0, 11.0, 1 H), 2.91 (dd, J = 6.5, 15.2, 1 H), 
2.79 (dd, J = 6.19, 10.1, 1 H), 2.75 (dd, J = 6.67, 15.4, 1 H), 2.43–2.20 (m, 2 
H), 2.30 (s, 3 H), 2.15-2.09 (m, 1 H), 2.00–1.89 (m, 2 H), 1.42-1.35 (m, 2 H), 
1.33 (d, J = 6.3, 3 H), 1.28–1.12 (m, 6H), 0.84 (t, J = 7.2, 3 H) 
 MS: (ESI, Q-tof) 
568.3 (100) 
 Mol. Formula: C32H40BrF6NO (648.56) 
 HRMS: C32H40NOF6
+: (568.3014) 
Calcd: 568.3014 
Found: 568.3007 
 TLC: Rf  0.39  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
CF3
CF3
Me
V{5,3,5}
285 
 
Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-phenyl-3-(3,5-tert-
butylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,3,7}) 
 
Data for V{5,3,7}: 
 Yield: 105 mg (93%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.67 (d, J = 7.3, 2 H), 7.62 (t, J = 7.7, 2 H), 7.52 (t, J = 7.2, 1 H), 7.40 (s, 1 
H), 7.30 (s, 2 H), 5.16 (d, J = 11.9, 1 H), 5.08 (dd, J = 11.9, 11.9, 1 H), 4.26 
(d, J = 12.9, 1 H), 3.44 (d, J = 12.9, 1 H), 3.34 (dd, J = 9.3, 9.3, 1 H), 3.22 (d, 
J = 12.0, 1 H), 2.95–2.87 (m, 2 H), 2.84 (dd, J = 5.8, 9.9, 1 H), 2.73 (dd, J = 
6.8, 15.5, 1 H), 2.39–2.29 (m, 1 H), 2.26 (s, 3 H), 2.23–2.15 (m, 1 H), 2.12–
2.05 (m, 1 H), 1.96–1.86 (m, 2 H), 1.42–1.35 (m, 2 H), 1.35–1.11 (m, 27H), 
0.84 (t, J = 7.2, 3 H) 
 MS: (ESI, Q-tof) 
544.5 (100) 
 Mol. Formula: C38H58BrNO (624.68) 
 HRMS: C38H58NO
+: (544.4518) 
Calcd: 544.4518 
Found: 544.4509 
 TLC: Rf  0.41  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
t-Bu
t-Bu
Me
V{5,3,7}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-phenyl-3-(4-
methoxybenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,3,8}) 
 
Data for V{5,3,8}: 
 Yield: 87 mg (90%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.67–7.59 (m, 4 H), 7.52 (t, J = 7.1, 1 H), 7.35 (d, J = 8.7, 2 H), 6.84 (d, J = 
8.8, 2 H), 5.13 (d, J = 12.2, 1 H), 4.94 (dd, J = 11.9, 11.9, 1 H), 4.19 (d, J = 
12.8, 1 H), 3.78 (s, 4 H), 3.42 (d, J = 13.2, 1 H), 3.33–3.26 (m, 2 H), 2.96 (dd, 
J = 6.0, 11.4, 1 H), 2.90 (ddd, J = 6.3, 8.7, 8.7, 1 H), 2.81 (dd, J = 6.0, 10.2, 1 
H), 2.73 (dd, J = 6.7, 15.4, 1 H), 2.42–2.29 (m, 1 H), 2.28–2.16 (m, 1 H), 2.22 
(s, 3 H), 2.10-2.03 (m, 1 H), 1.98–1.85 (m, 2 H), 1.40–1.34 (m, 2 H), 1.30 (d, 
J = 6.4, 3 H), 1.27–1.10 (m, 6H), 0.84 (t, J = 7.2, 3 H) 
 MS: (ESI, Q-tof) 
462.3 (100) 
 Mol. Formula: C31H44BrNO2 (542.59) 
 HRMS: C31H44NO2
+: (462.3372) 
Calcd: 462.3372 
Found: 462.3372 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
OMe
Me
V{5,3,8}
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Preparation of Quaternary Ammonium Bromides V{5,6,R4}: 
 
 Following General Procedure II, amino borane V{5,6} (80 mg, 0.161 mmol) was added 
to a 100-mL round-bottomed flask as a solution in 5.4 mL of MeOH (0.03 M).  The flask was 
fitted with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. 
HCl solution (0.8, 5.0 equiv) was added via syringe.  The resulting solution was heated and then 
concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure II.  
The resulting free amine was dissolved in acetonitrile and was distributed among three test tubes 
that were subsequently charged with benzyl bromide (tube 1, 8 mg, 0.048 mmol, 1.2 equiv), 3,5-
bis(t-butyl)benzyl bromide (tube 2, 15 mg, 0.048 mmol, 1.2 equiv), ), 4-methoxybenzyl bromide 
(tube 3, 10 mg, 0.048 mmol, 1.2 equiv).  After being agitated for 12 h, the reaction mixtures 
were worked up and the products isolated and purified as described in General Procedure II. 
  
1. HCl (aq), MeOH
    reflux, 6 h
2. NaOH (0.1 M, aq)
    Et2O
3. CH3CN, RT, R
4-Br
N
H H
BH2
O N
H HMe
O
R4
Br
Me Me
Me
V{5,7} V{5,6,R4}
CF3
F3C
CF3
F3C
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-(3,5-trifluoromethylbenzyloxy)-1-
phenyl-3-benzyl-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,6,1}) 
 
Data for V{5,6,1}: 
 Yield: 21 mg (79%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.79–7.75 (m, 2 H), 7.75 (s, 1 H), 7.69 (t, J = 7.8, 2 H), 7.60 (t, J = 7.3, 1 H), 
7.54 (s, 2 H), 7.44–7.33 (m, 5 H), 5.31 (d, J = 12.1, 1 H), 5.13 (dd, J = 11.9, 
11.9, 1 H), 4.34 (d, J = 13.0, 1 H), 4.16 (d, J = 12.0, 1 H), 3.95 (d, J = 12.0, 1 
H), 3.59 (d, J = 13.1, 1 H), 3.49 (dd, J = 9.4, 9.4, 1 H), 3.30 (d, J = 12.1, 1 H), 
3.04 (dd, J = 6.0, 11.4, 1 H), 2.90 (dd, J = 5.9, 10.3, 1 H), 2.45–2.20 (m, 2 H), 
2.31 (s, 3 H), 2.20–2.10 (m, 1 H), 2.02–1.92 (m, 2 H), 1.33 (d, J = 6.4, 3 H) 
 MS: (ESI, Q-tof) 
574.3 (100) 
 Mol. Formula: C33H34BrF6NO (654.52) 
 HRMS: C33H34NOF6
+: 574.2545) 
Calcd: 574.2545 
Found: 574.2549 
 TLC: Rf  0.28  (CH2Cl2/MeOH, 9:1) [I2] 
N
H H
O
Me
Br
CF3
F3C
Me
V{5,6,1}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-(3,5-trifluoromethylbenzyloxy)-1-
phenyl-3-(3,5-trifluoromethylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium 
Bromide (V{5,6,5}) 
 
Data for V{5,6,5}: 
 Yield: 21 mg (66%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.93 (s, 1 H), 7.89 (s, 2 H), 7.79 (s, 1 H), 7.76–7.70 (m, 3 H), 7.70–7.63 (m, 2 
H), 7.55 (s, 2 H), 6.00 (d, J = 12.3, 1 H), 5.41 (dd, J = 11.7, 11.7, 1 H), 4.16 
(d, J = 11.9, 1 H), 4.02 (d, J = 13.0, 1 H), 3.96 (d, J = 12.0, 1 H), 3.65 (d, J = 
13.1, 1 H), 3.52 (dd, J = 9.3, 9.3, 1 H), 3.34 (d, J = 12.4, 1 H), 3.09 (dd, J = 
11.0, 6.0, 1 H), 2.86 (dd, J = 5.8, 10.1, 1 H), 2.45–2.26 (m, 2 H), 2.36 (s, 3 H), 
2.24–2.15 (m, 1 H), 2.07–1.93 (m, 2 H), 1.35 (d, J = 6.3, 3 H) 
 MS: (ESI, Q-tof) 
710.2 (100) 
 Mol. Formula: C35H32BrF12NO (790.52) 
 HRMS: C35H32NOF12
+: 710.2292) 
Calcd: 710.2292 
Found: 710.2285 
 TLC: Rf  0.35  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
CF3
F3C
CF3
CF3
Me
V{5,6,5}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-(3,5-trifluoromethylbenzyloxy)-1-
phenyl-3-(4-methoxybenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide 
(V{5,6,8}) 
 
Data for V{5,6,8}: 
 Yield: 22 mg (82%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.80–7.72 (m, 3 H), 7.76 (t, J = 7.8, 2 H), 7.59 (t, J = 7.3, 1 H), 7.54 (s, 2 H), 
7.35 (d, J = 8.7, 2 H), 6.86 (d, J = 8.8, 2 H), 5.22 (d, J = 12.1, 1 H), 5.06 (dd, J 
= 12.0, 12.0, 1 H), 4.33 (d, J = 13.1, 1 H), 4.16 (d, J = 12.0, 1 H), 3.95 (d, J = 
12.0, 1 H), 3.79 (s, 3 H), 3.56 (d, J = 13.1, 1 H), 3.48 (dd, J = 9.3, 9.3, 1 H), 
3.25 (d, J = 12.2, 1 H), 3.02 (dd, J = 6.0, 11.5, 1 H), 2.88 (dd, J = 5.6, 10.3, 1 
H), 2.43–2.31 (m, 1 H), 2.31–2.18 (m, 2 H), 2.28 (s, 3 H), 2.18–2.10 (s, 1 H), 
2.01–1.91 (m, 2 H), 1.32 (d, J = 6.3, 3 H) 
 MS: (ESI, Q-tof) 
604.3 (100) 
 Mol. Formula: C34H36BrF6NO2 (684.55) 
 HRMS: C34H36NO2F6
+: 604.2650) 
Calcd: 604.2650 
Found: 604.2649 
 TLC: Rf  0.29  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
CF3
F3C
OMe
Me
V{5,6,8}
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Preparation of Quaternary Ammonium Bromides V{5,7,R4}: 
 
 Following General Procedure II, amino borane V{5,7} (606 mg, 1.55 mmol) was added 
to a 100-mL round-bottomed flask as a solution in 47 mL of MeOH (0.03 M).  The flask was 
fitted with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. 
HCl solution (7.0, 5.0 equiv) was added via syringe.  The resulting solution was heated and then 
concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure II.  
The resulting free amine was dissolved in acetonitrile and was distributed among five test tubes 
that were subsequently charged with benzyl bromide (tube 1, 34 mg, 0.199 mmol, 1.2 equiv), 1-
bromomethylnaphthalene (tube 2, 45 mg, 0.199 mmol, 1.2 equiv), 2-bromomethylnaphthalene 
(tube 3, 45 mg, 0.199 mmol, 1.2 equiv), 3,5-bis(trifluoromethyl)benzyl bromide (tube 4, 62 mg, 
0.199 mmol, 1.2 equiv), 3,5-bis(t-butyl)benzyl bromide (tube 5, 57 mg, 0.199 mmol, 1.2 equiv).  
After being agitated for 12 h, the reaction mixtures were worked up and the products isolated and 
purified as described in General Procedure II. 
1. HCl (aq), MeOH
    reflux, 6 h
2. NaOH (0.1 M, aq)
    Et2O
3. CH3CN, RT, R
4-Br
N
H H
BH3
O N
H H
O
R4
Br
Me Me
Me Me
V{5,7} V{5,7,R4}
MeO MeO
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxybenzyloxy)-1-phenyl-3-
benzyl-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,7,1}) 
 
Data for V{5,7,1}: 
 Yield: 89 mg (98%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.77 (d, J = 7.3, 2 H), 7.68 (t, J = 7.7, 2 H), 7.57 (t, J = 7.3, 1 H), 7.45–7.40 
(m, 2 H), 7.39–7.31 (m, 3 H), 7.04 (d, J = 8.7, 2 H), 6.81 (d, J = 8.7, 2 H), 
5.24 (d, J = 12.2, 1 H), 5.02 (dd, J = 11.9, 11.9, 1 H), 4.27 (d, J = 13.2, 1 H), 
3.92 (d, J = 10.2, 1 H), 3.77 (s, 3 H), 3.70 (d, J = 10.2, 1 H), 3.50 (d, J = 13.1, 
1 H), 3.44 (dd, J = 9.0, 9.0, 1 H) 3.35 (d, J = 12.1, 1 H), 2.96 (dd, J = 6.1, 
11.5, 1 H), 2.85 (dd, J = 5.5, 9.9, 1 H), 2.49–2.39 (m, 1 H), 2.29 (s, 3 H), 
2.25–2.11 (m, 2 H), 1.99–1.89 (m, 2 H), 1.29 (t, J = 7.1, 3 H). 
 MS: (ESI, Q-tof) 
468.3 (100) 
 Mol. Formula: C32H38BrNO2 (548.55) 
 HRMS: C32H38NO2
+: 468.2903) 
Calcd: 468.2903 
Found: 468.2899 
 TLC: Rf  0.21  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
MeO
Me
V{5,7,1}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxy-benzyloxy)-1-phenyl-
3-(1-naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,7,2}) 
 
Data for V{5,7,2}: 
 Yield: 95 mg (95%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.94 (d, J = 8.7, 1 H), 7.89 (d, J = 8.3, 1 H), 7.86–7.82 (m, 2 H), 7.74 (d, J = 
7.4, 2 H), 7.67 (t, J = 7.7, 2 H), 7.59-7.54 (m, 2 H), 7.52–7.43 (m, 2 H), 7.02 
(d, J = 8.7, 2 H), 6.78 (d, J = 8.7, 2 H), 5.54 (d, J = 12.8, 1 H), 4.73–4.64 (m, 
2 H), 4.52 (d, J = 12.8, 1 H), 3.91 (d, J = 10.9, 1 H), 3.83 (d, J = 10.9, 1 H), 
3.75 (s, 3 H), 3.59 (d, J = 13.3, 1 H), 3.38 (dd, J = 9.1, 9.1, 1 H), 3.02 (d, J = 
10.9, 1 H), 2.87 (dd, J = 6.2, 11.6, 1 H), 2.61–2.50 (m, 1 H), 2.45 (s, 3 H), 
2.35–2.26 (m, 1 H), 2.20–2.11 (m, 1 H), 1.98 (d, J = 10.1, 3 H), 1.22 (d, J = 
6.4, 3 H) 
 MS: (ESI, Q-tof) 
518.3 (100) 
 Mol. Formula: C36H40BrNO2 (598.61) 
 HRMS: C36H40NO2
+: 518.3059) 
Calcd: 518.3059 
Found: 518.3065 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
MeO
Me
V{5,7,2}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxybenzyloxy)-1-phenyl-3-
(2-naphthylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,7,3}) 
 
Data for V{5,7,3}: 
 Yield: 92 mg (92%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.86–7.78 (m, 5 H), 7.75 (t, J = 7.7, 3 H), 7.69–7.57 (m, 3 H), 7.56–7.48 (m, 2 
H), 7.03 (d, J = 8.7, 2 H), 6.80 (d, J = 8.7, 2 H), 5.46 (d, J = 11.9, 1 H), 5.15 
(dd, J = 11.9, 11.9, 1 H), 4.33 (d, J = 12.8, 1 H), 3.93 (d, J = 10.2, 1 H), 3.77 
(d, J = 10.3, 1 H), 3.76 (s, 3 H), 3.54 (d, J = 12.1, 1 H), 3.51–3.43 (m, 2 H), 
3.03 (dd, J = 6.0, 11.3, 1 H), 2.91–2.86 (m, 1 H), 2.51–2.40 (m, 1 H), 2.34 (s, 
3 H), 2.27–2.17 (m, 2 H), 1.99–1.93 (m, 2 H), 1.31 (d, J = 6.3, 3 H) 
 MS: (ESI, Q-tof) 
518.3 (100) 
 Mol. Formula: C36H40BrNO2 (598.61) 
 HRMS: C36H40NO2
+: 518.3059) 
Calcd: 518.3059 
Found: 518.3071 
 TLC: Rf  0.26  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
MeO
Me
V{5,7,3}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxybenzyloxy)-1-phenyl-3-
(3,5-trifluoromethylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide 
(V{5,7,5}) 
 
Data for V{5,7,5}: 
 Yield: 97 mg (85%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.92 (s, 2 H), 7.91 (s, 1 H), 7.81–7.68 (m, 4 H), 7.63 (t, J = 7.1, 1 H), 7.04 (d, 
J = 8.7, 2 H), 6.82 (d, J = 8.7, 2 H), 5.94 (d, J = 12.3, 1 H), 5.32 (dd, J = 11.6, 
11.6, 1 H), 3.94 (d, J = 10.3, 2 H), 3.78 (s, 3 H), 3.55 (d, J = 13.0, 1 H), 3.48 
(dd J = 9.4, 9.4, 1 H), 3.36 (d, J = 11.4, 1 H), 2.98 (dd, J = 5.7, 10.5, 1 H), 
2.84–2.78 (m, 1 H), 2.52–2.38 (s, 1 H), 2.34 (s, 3 H), 2.25 (s, 2 H), 2.03–1.93 
(m, 2 H), 1.31 (d, J = 6.3, 3 H) 
 MS: (ESI, Q-tof) 
604.3 (100) 
 Mol. Formula: C34H36BrF6NO2 (684.55) 
 HRMS: C34H36NO2F6
+: 604.2650) 
Calcd: 604.2650 
Found: 604.2635 
 TLC: Rf  0.29  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
MeO
CF3
CF3
Me
V{5,7,5}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-(4-methoxybenzyloxy)-1-phenyl-3-
(3,5-tert-butylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{5,7,7}) 
 
Data for V{5,7,7}: 
 Yield: 103 mg (94%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.78 (d, J = 7.5, 2 H), 7.68 (t, 2 H, J = 7.7), 7.57 (t, J = 7.4, 1 H), 7.40 (t, J = 
1.6, 1 H), 7.33 (d, J = 1.4, 2 H), 7.07 (d, J = 8.6, 2 H), 6.83 (d, J = 8.7, 2 H), 
5.17 (d, J = 11.7, 1 H), 5.09 (dd, J = 12.0, 12.0, 1 H), 4.33 (d, J = 13.0, 1 H), 
3.95 (d, J = 10.2, 1 H), 3.78 (s, 3 H), 3.73 (d, J = 10.2, 1 H), 3.51 (d, J = 13.6, 
1 H), 3.48 (dd, J = 9.4, 9.4 1 H), 3.24 (d, J = 12.0, 1 H), 2.92–2.84 (m, 2 H), 
2.51–2.38 (m, 1 H), 2.30 (s, 3 H), 2.27–2.12 (m, 2 H), 1.98–1.92 (d, J = 6.4, 2 
H), 1.31 (s, 18H), 1.29 (d, J = 6.3, 3 H) 
 MS: (ESI, Q-tof) 
580.4 (100) 
 Mol. Formula: C40H54BrNO2  (660.77) 
 HRMS: (C40H54NO2
+: 580.4155) 
Calcd: 580.4155 
Found: 580.4160 
 TLC: Rf  0.31  (CH2Cl2/MeOH, 9:1) [I2]
N
H HMe
O
Me
Br
MeO
t-Bu
t-Bu
V{5,7,7}
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 Preparation of Quaternary Ammonium Bromides V{6,2,R4} 
 
 Following General Procedure II, amino borane V{6,2} (110 mg, 0.273 mmol) was added 
to a 100-mL round-bottomed flask as a solution in 9.1 mL of MeOH (0.03 M).  The flask was 
fitted with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. 
HCl solution (1.4, 5.0 equiv) was added via syringe.  The resulting solution was heated and then 
concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure II.  
The resulting free amine was dissolved in acetonitrile and was distributed among three test tubes 
that were subsequently charged with benzyl bromide (tube 1, 13 mg, 0.073 mmol, 1.2 equiv), 
3,5-bis(trifluoromethyl)benzyl bromide (tube 2, (94 mg, 0.915 mmol, 5.0 equiv), 4-
methoxybenzyl bromide (tube 3, 15 mg, 0.073 mmol, 1.2 equiv).  After being agitated for 12 h, 
the reaction mixtures were worked up and the products isolated and purified as described in 
General Procedure II. 
  
1. HCl (aq), MeOH
    reflux, 6 h
2. NaOH (0.1 M, aq)
    Et2O
3. CH3CN, RT, R
4-Br
N
H H
BH3
O N
H H
O
R4
Br
Me Me
Me Me
V{6,2,R4}
Me
Me
Me
Me
Me
Me
V{6,2}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-(2,4,6-methylphenyl)-
3-benzyl-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{6,2,1}) 
 
Data for V{6,2,1}: 
 Yield: 25 mg (74%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.57-7.43 (m, 2 H), 7.44-7.38 (m, 3 H), 7.32-7.27 (m, 3 H), 7.20-7.14 (m, 3 
H), 6.98 (s, 1 H), 5.25 (d, J = 12.0, 1 H), 4.94 (dd, J = 11.6, 11.6, 1 H), 4.38 
(d, J = 13.2, 1 H), 4.22 (d, J = 10.3, 1 H), 4.13-4.07 (m, 2 H), 3.58 (d, J = 
13.2, 1 H), 3.37 (d, J = 12.0, 1 H), 3.11 (dd, J = 6.3, 11.4, 1 H), 2.83 (dd, J = 
5.9, 9.3, 1 H), 2.74 (s, 3 H), 2.52 (s, 3 H), 2.51-2.42 (m, 1 H), 2.34 (s, 3 H), 
2.26-2.17 (m, 2 H), 2.16 (s, 3 H), 1.94-1.83 (m, 2 H), 1.30 (d, J = 6.4, 3 H) 
 MS: (ESI, Q-tof) 
480.3 (100) 
 Mol. Formula: C34H42BrNO (560.61) 
 HRMS: C34H42NO
+: (480.3266) 
Calcd: 480.3266 
Found: 480.3260 
 TLC: Rf  0.26  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
Me
Me
Me
V{6,2,1}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-(2,4,6-trimethyl-
phenyl)-3-(3,5-trifluoromethylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium 
Bromide (V{6,2,5}) 
 
Data for V{6,2,5}: 
 Yield: 22 mg (65%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.11 (s, 2 H), 7.94 (s, 1 H), 7.34-7.29 (m, 3 H), 7.20-7.16 (m, 3 H), 7.02 (s, 1 
H), 5.82 (d, J = 12.2, 1 H), 5.22 (dd, J = 11.5, 11.5, 1 H), 4.25 (d, J = 10.3, 1 
H), 4.25-4.15 (m, 2 H), 4.13 (d, J = 10.2, 1 H), 3.57 (d, J = 13.1, 1 H), 3.30 
(d, J = 12.3, 1 H), 3.07 (dd, J = 6.2, 11.0, 1 H), 2.81-2.75 (m, 1 H), 2.76 (s, 3 
H), 2.45 (s, 3 H), 2.52-2.42 (m, 1 H), 2.35 (s, 3 H), 2.24 (s, 3 H), 2.28-2.20 
(m, 2 H), 1.90-1.84 (m, 2 H), 1.31 (d, J = 6.4, 3 H) 
 MS: (ESI, Q-tof) 
616.3 (100) 
 Mol. Formula: C36H40BrF6NO (696.60) 
 HRMS: C36H37F3NO
+: (616.3014) 
Calcd: 616.3014 
Found: 616.3024 
 TLC: Rf  0.30  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
CF3
CF3
Me
Me
Me
V{6,2,5}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-(2,4,6-methylphenyl)-
3-(4-methoxybenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{6,2,8}) 
 
Data for V{6,2,8}: 
 Yield: 28 mg (78%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.47 (d, J = 8.7, 2 H), 7.33-7.27 (m, 3 H), 7.19-7.16 (m, 2 H), 7.13 (s, 1 H), 
6.97 (s, 1 H), 6.90 (d, J = 8.7, 2 H), 5.16 (d, J = 12.2, 1 H), 4.90 (dd, J = 11.6, 
11.6, 1 H), 4.37 (d, J = 12.9, 1 H), 4.22 (d, J = 10.3, 1 H), 4.11 (dd, J = 9.3, 
9.3, 1 H), 4.09 (d, J = 11.3, 1 H), 3.81 (s, 3 H), 3.55 (d, J = 13.2, 1 H), 3.31 (d, 
J = 12.2, 1 H), 3.08 (dd, J = 6.4, 11.5, 1 H), 2.81 (dd, J = 6.0, 9.4, 1 H), 2.73 
(s, 3 H), 2.51 (s, 3 H), 2.50-2.42 (m, 1 H), 2.34 (s, 3 H), 2.24-2.16 (m, 2 H), 
2.14 (s, 3 H), 1.93-1.81 (m, 2 H), 1.29 (d, J = 6.4, 3 H) 
 MS: (ESI, Q-tof) 
510.3 (100) 
 Mol. Formula: C35H44BrNO2 (590.63) 
 HRMS: C35H44NO2
+: (510.3372) 
Calcd: 510.3372 
Found: 510.3382 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
Me
Me
Me
OMe
V{6,2,8}
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Preparation of Quaternary Ammonium Bromides V{7,2,R4} 
 
 Following General Procedure II, amino borane V{7,2} (258 mg, 0.627 mmol) was added 
to a 50-mL round-bottomed flask as a solution in 21 mL of MeOH (0.03 M).  The flask was 
fitted with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. 
HCl solution (3.1, 5.0 equiv) was added via syringe.  The resulting solution was heated and then 
concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure II.  
The resulting free amine was dissolved in acetonitrile and was distributed among five test tubes 
that were subsequently charged with benzyl bromide (tube 1, 25 mg, 0.149 mmol, 1.2 equiv), 
3,5-bis(trifluoromethyl)benzyl bromide (tube 2, 46 mg, 0.149 mmol, 1.2 equiv), 4-
methoxybenzyl bromide (tube 3, 30 mg, 0.149 mmol, 1.2 equiv), 4-cyanobenzyl bromide, (tube 
4, 29 mg, 0.149 mmol, 1.2 equiv), 4-trifluoromethylbenzyl bromide, (tube 5, 36 mg, 0.149 
mmol, 1.2 equiv).  After being agitated for 12 h, the reaction mixtures were worked up and the 
products isolated and purified as described in General Procedure II. 
1. HCl (aq), MeOH
    reflux, 6 h
2. NaOH (0.1 M, aq)
    Et2O
3. CH3CN, RT, R
4-Br
N
H H
BH3
O N
H H
O
R4
Br
Me Me
Me Me
V{7,2} V{7,2,R4}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-(1-naphthyl)-3-
benzyl-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{7,2,1}) 
 
Data for V{7,2,1}: 
 Yield: 70 mg (97%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.52 (d, J = 8.7, 1 H), 8.13-8.08 (m, 2 H), 8.03 (d, J = 7.2, 1 H), 7.74 (dd, J = 
7.4, 7.4, 1 H), 7.68-7.64 (m, 2 H), 7.29-7.26 (m, 3 H), 7.16 (dd, J = 7.5, 7.5, 1 
H), 7.11-7.08 (m, 2 H), 6.92 (dd, J = 7.8, 7.8, 2 H), 6.37 (d, J = 7.4, 1 H), 5.17 
(d, J = 12.0, 1 H), 5.08 (dd, J = 12.0, 12.0, 1 H), 4.65 (d, J = 13.0, 1 H), 4.12 
(d, J = 10.4, 1 H), 3.90 (d, J = 10.4, 1 H), 3.83 (dd, J = 9.5, 9.5, 1 H), 3.55 (d, 
J = 13.1, 1 H), 2.94 (dd, J = 5.9, 11.4, 1 H), 2.90-2.86 (m, 1 H), 2.76 (d, J = 
12.0, 1 H), 2.59-2.50 (m, 1 H), 2.35 (s, 3 H), 2.30-2.17 (m, 2 H), 1.99-1.95 
(m, 2 H), 1.31 (d, J = 6.3, 3 H) 
 MS: (ESI, Q-tof) 
488.3 (100) 
 Mol. Formula: C35H38BrNO (568.59) 
 HRMS: C35H38NO
+: (488.2953) 
Calcd: 488.2953 
Found: 488.2958 
 TLC: Rf  0.27  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
Me
V{7,2,1}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-(1-naphthyl)-3-(3,5-
trifluoromethylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{7,2,5}) 
 
Data for V{7,2,5}: 
 Yield: 40 mg (45%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.50 (d, J = 8.7, 1 H), 8.04-8.02 (m, 2 H), 8.04 (d, J = 7.3, 1 H), 7.77-7.73 (m, 
2 H), 7.71-7.63 (m, 2 H), 7.32 (s, 2 H), 7.29-7.27 (m, 3 H), 7.11-7.06 (m, 2 
H), 5.66 (d, J = 12.1, 1 H), 5.28 (dd, J = 11.8, 11.8, 1 H), 4.57 (d, J = 12.8, 1 
H), 4.09 (d, J = 10.3, 1 H), 3.87 (dd, J = 9.5, 9.5, 1 H), 3.82 (d, J = 10.3, 1 H), 
3.70 (d, J = 13.1, 1 H), 2.94 (d, J = 12.2, 1 H), 2.90-2.82 (m, 2 H), 2.62-2.53 
(m, 1 H), 2.46 (s, 3 H), 2.33-2.20 (m, 2 H), 2.03-1.96 (m, 2 H), 1.32 (d, J = 
6.3, 3 H) 
 MS: (ESI, Q-tof) 
624.3 (100) 
 Mol. Formula: C37H36BrF6NO (704.5823) 
 HRMS: C37H36F6NO
+: (624.6201) 
Calcd: 624.6201 
Found: 624.2696 
 TLC: Rf  0.35  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
CF3
CF3
Me
V{7,2,5}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-(1-naphthyl)-3-(4-
methoxybenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{7,2,8}) 
 
Data for V{7,2,8}: 
 Yield: 62 mg (82%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.52 (d, J = 8.7, 1 H), 8.12-8.07 (m, 2 H), 8.02 (d, J = 7.4, 1 H), 7.74 (dd, J = 
7.5, 7.5, 1 H), 7.67-7.63 (m, 2 H), 7.30-7.26 (m, 3 H), 7.12-7.09 (m, 2 H), 
6.43 (d, J = 8.7, 2 H), 6.29 (d, J = 7.5, 1 H), 5.08 (d, J = 12.1, 1 H), 5.00 (dd, J 
= 12.0, 12.0, 1 H), 4.64 (d, J = 13.1, 1 H), 4.12 (d, J = 10.3, 1 H), 3.89 (d, J = 
10.3, 1 H), 3.82 (dd, J = 9.4, 9.4, 1 H), 3.67 (s, 3 H), 3.53 (d, J = 13.2, 1 H), 
2.91 (dd, J = 5.9, 11.4, 1 H), 2.90-2.84 (m, 2 H), 2.70 (d, J = 12.1, 1 H), 2.60-
2.50 (m, 1 H), 2.32 (s, 3 H), 2.30-2.15 (m, 2 H), 1.98-1.94 (m, 2 H), 1.30 (d, J 
= 6.3, 3 H) 
 MS: (ESI, Q-tof) 
518.3 (100) 
 Mol. Formula: C36H40BrNO2 (598.61) 
 HRMS: C36H40NO2
+: (518.3059) 
Calcd: 518.3059 
Found: 518.3065 
 TLC: Rf  0.28  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
OMe
Me
V{7,2,8}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-(1-naphthyl)-3-(4-
trifluoromethylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{7,2,9}) 
 
Data for V{7,2,9}: 
 Yield: 59 mg (74%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.52 (d, J = 8.7, 1 H), 8.15-8.10 (m, 2 H), 8.04 (d, J = 7.4, 1 H), 7.79 (dd, J = 
7.5, 7.5, 1 H), 7.71-7.66 (m, 2 H), 7.30-7.25 (m, 3 H), 7.18 (d, J = 8.2, 2 H), 
7.12-7.09 (m, 2 H), 6.55 (d, J = 7.7, 2 H), 5.39 (d, J = 12.0, 1 H), 5.18 (dd, J = 
11.9, 11.9, 1 H), 4.55 (d, J = 13.1, 1 H), 4.14 (d, J = 10.3, 1 H), 3.92 (d, J = 
10.3, 1 H), 3.84 (dd, J = 9.3, J = 9.3, 1 H), 3.59 (d, J = 13.1, 1 H), 2.90 (dd, J 
= 5.9, 11.2, 1 H), 2.87-2.83 (m, 1 H), 2.75 (d, J = 12.0, 1 H), 2.60-2.50 (m, 1 
H), 2.36 (s, 3 H), 2.32-2.19 (m, 2 H), 2.01-1.95 (m, 2 H), 1.30 (d, J = 6.3, 3 H) 
 MS: (ESI, Q-tof) 
556.3 
 Mol. Formula: C36H37BrF3NO (636.58) 
 HRMS: C36H37F3NO
+: (556.2827) 
Calcd: 556.2827 
Found: 586.2837 
 TLC: Rf  0.30  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
O
Me
Br
CF3
Me
V{7,2,9}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-1-(1-naphthyl)-3-(4-
cyanobenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (V{7,2,10}) 
 
Data for V{7,2,10}: 
 Yield: 57 mg (76%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.50 (d, J = 8.6, 1 H), 8.16-8.11 (m, 2 H), 8.04 (d, J = 7.3, 1 H), 7.79 (dd, J = 
7.6, 7.6, 1 H), 7.71-7.66 (m, 2 H), 7.31-7.25 (m, 3 H), 7.22 (d, J = 8.5, 2 H), 
7.11-7.08 (m, 2 H), 6.54 (d, J = 7.9, 2 H), 5.47 (d, J = 12.4, 1 H), 5.22 (dd, J = 
11.7, 11.7, 1 H), 4.48 (d, J = 13.1, 1 H), 4.14 (d, J = 10.3, 1 H), 3.92 (d, J = 
10.3, 1 H), 3.84 (dd, J = 9.5, 9.5, 1 H), 3.59 (d, J = 13.1, 1 H), 2.89 (dd, J = 
5.9, 11.3, 1 H), 2.85-2.81 (m, 1 H), 2.73 (d, J = 11.9, 1 H), 2.59-2.51 (m, 1 H), 
2.35 (s, 3 H), 2.33-2.19 (m, 2 H), 2.02-1.96 (m, 2 H), 1.30 (d, J = 6.3, 3 H) 
 MS: (ESI, Q-tof) 
513.3 (100) 
 Mol. Formula: C36H37BrN2O  (593.60) 
 HRMS: C36H37N2O
+: (513.2906) 
Calcd: 513.2906 
Found: 513.2899 
 TLC: Rf  0.26  (CH2Cl2/MeOH, 9:1) [I2] 
  
N
H H
O
Me
Br
CN
Me
V{7,2,10}
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Preparation of Quaternary Ammonium Bromides β-V{1,2,R4} 
 
 Following General Procedure II, amino borane β-V{2} (164 mg, 0.589 mmol) was added 
to a 100-mL round-bottomed flask as a solution in 19 mL of MeOH (0.03 M).  The flask was 
fitted with a reflux condenser, a magnetic stir bar, and a nitrogen inlet adapter.  Lastly, 1.0 N aq. 
HCl solution (2.9, 5.0 equiv) was added via syringe.  The resulting solution was heated and then 
concentrated by rotary evaporation (15 mm Hg, 20-25 oC) as described General Procedure II.  
The resulting free amine was dissolved in acetonitrile and was distributed among seven test tubes 
that were subsequently charged with 1-bromomethylnaphthalene (tube 1, 22 mg, 0.104 mmol, 
1.2 equiv), 2-bromomethylnaphthalene (tube 3, 22 mg, 0.104 mmol, 1.2 equiv), 3,5-
bis(trifluoromethyl)benzyl bromide (tube 4, 31 mg, 0.104 mmol, 1.2 equiv), 3,5-bis(t-
butyl)benzyl bromide (tube 5, 29 mg, 0.104 mmol, 1.2 equiv), 4-methoxybenzyl bromide (tube 6, 
31 mg, 0.104 mmol, 1.2 equiv), 1-bromohexane (tube 7, 68 mg, 0.435 mmol, 5.0 equiv).  After 
being agitated for 12 h, the reaction mixtures were worked up and the products isolated and 
purified as described in General Procedure II. 
1. HCl (aq), MeOH
    reflux, 6 h
2. NaOH (0.1 M, aq)
    Et2O
3. CH3CN, RT, R
4-Br
Br
β-V{2} β-V{2,R4}
N
H H
O
BH3
Me
N
H H
O
Me
R4
Me Me
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-3-(1-naphthylmethyl)-5-
methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (β-V{1,2,2}) 
 
Data for β-V{1,2,2}: 
 Yield: 42 mg (98%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.48 (d, J = 8.6, 1 H), 8.30 (d, J = 7.2, 1 H), 7.94 (d, J = 8.2, 1 H), 7.87 (d, J = 
8.2, 1 H), 7.56 (dd, J = 7.3, 7.3, 1 H), 7.50–7.45 (m, 5 H), 7.43–7.37 (m, 1 H), 
7.32 (dd, J = 7.8, 7.8, 1 H), 4.87 (d, J = 12.6, 1 H), 4.59 (d, J = 12.6, 1 H), 
4.75 (dd, J = 11.9, 11.9, 1 H), 4.92–4.52 (m, 3 H), 4.12 (d, J = 3.4, 1 H), 4.03 
(d, J = 14.1, 1 H), 3.52 (d, J = 11.3, 1 H), 3.18 (dd, J = 5.8, 11.3, 1 H), 2.82 
(dd, J = 9.5, 9.5, 1 H), 2.69 (dd, J = 5.9, 10.3, 1 H), 2.24 (s, 3 H), 2.19–2.10 
(m, 2 H), 1.90–1.77 (m, 2 H), 1.73–1.63 (m, 1 H), 1.25 (d, J = 6.3, 3 H). 
 MS: (ESI, Q-tof) 
412.3 (100) 
 Mol. Formula: C29H34BrNO (492.49) 
 HRMS: C29H34NO
+: (412.2640) 
Calcd: 412.2640 
Found: 412.2632 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2] 
  
N
H H
Br
MeO
Me
V{1,2,2}β
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-3-(2-naphthylmethyl)-5-
methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (β-V{1,2,3}) 
 
Data for β-V{1,2,3}: 
 Yield: 39 mg (91%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.09 (s, 1 H), 7.90–7.84 (m, 3 H), 7.73 (dd, J = 1.7, 8.4, 1 H), 7.59–7.51 (m, 2 
H), 7.48–7.34 (m, 5 H), 5.39 (d, J = 11.9, 1 H), 4.79 (d, J = 11.8, 1 H), 4.77 
(d, J = 11.7, 1 H), 4.71 (dd, J = 11.9, 11.9, 1 H), 4.64 (d, J = 11.7, 1 H), 4.14–
4.08 (m, 2 H), 3.53 (d, J = 11.1, 1 H), 3.32 (dd, J = 6.0, 11.3, 1 H), 2.74 (dd, J 
= 9.2, 9.2, 1 H), 2.59 (dd, J = 5.9, 9.9, 1 H), 2.24–2.07 (m, 2 H), 2.10 (s, 3 H), 
1.89–1.77 (m, 2 H), 1.73–1.61 (m, 1 H), 1.26 (d, J = 6.3, 3 H). 
 MS: (ESI, Q-tof) 
412.3 (100) 
 Mol. Formula: C29H34BrNO (492.49) 
 HRMS: C20H38NO3
+: (412.2640) 
Calcd: 412.2640 
Found: 412.2639 
 TLC: Rf  0.26  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
Br
MeO
Me
V{1,2,3}β
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-3-(3,5-
bistrifluoromethylbenzyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (β-
V{1,2,5}) 
 
Data for β-V{1,2,5}: 
 Yield: 45mg (89%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.20 (s, 2 H), 7.94 (s, 1 H), 7.46–7.31 (m, 5 H), 5.84 (d, J = 12.1, 1 H), 4.96 
(dd, J = 11.7, 11.7, 1 H), 4.75 (d, J = 11.3, 1 H), 4.69 (d, J = 12.1, 1 H), 4.54 
(d, J = 11.3, 1 H), 4.13 (s, 1 H), 3.68 (dd, J = 14.1, 24.4, 2 H), 3.23 (dd, J = 
6.0, 11.0, 1 H), 2.76 (dd, J = 9.5, 9.5, 1 H), 2.57–2.48 (m, 1 H), 2.31–2.22 (m, 
1 H), 2.19–2.09 (m, 1 H), 2.11 (s, 3 H), 1.91–1.78 (m, 2 H), 1.75–1.65 (m, 1 
H), 1.24 (d, J = 6.3, 3 H). 
 MS: (ESI, Q-tof) 
498.2 (100) 
 Mol. Formula: C27H30BrF6NO (578.43) 
 HRMS: C27H30F6NO
+: (498.2232) 
Calcd: 498.2232 
Found: 498.2214 
 TLC: Rf  0.29  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
Br
MeO
CF3
CF3
Me
V{1,2,5}β
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-3-hexyl-5-methyl-7b-
methylcyclopenta[gh]pyrrolizinium Bromide β-V{1,2,6} 
 
Data for β-V{1,2,6}: 
 Yield: 33 mg (87%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.38–7.31 (m, 3 H), 7.27–7.24 (m, 2 H), 4.56 (d, J = 11.7, 1 H), 4.48 (d, J = 
11.7, 1 H), 4.39 (d, J = 13.3, 1 H), 4.25 (dd, J = 6.1, 11.1, 1 H), 4.12 (s, 1 H), 
4.03 (d, J = 12.7, 1 H), 3.57–3.50 (m, 1 H), 3.31–3.22 (m, 1 H), 3.05 (dd, J = 
11.9, 11.9, 1 H), 2.59–2.48 (m, 2 H), 2.17–2.05 (m, 2 H), 1.91–1.70 (m, 5 H), 
1.68 (s, 3 H), 1.38 (s, 1 H), 1.32–1.20 (m, 5 H), 1.15 (d, J = 6.3, 3 H), 0.86 (t, 
J = 6.8, 3 H) 
 MS: (ESI, Q-tof) 
356.3 (100) 
 Mol. Formula: C24H38BrNO (436.47) 
 HRMS: C24H38NO
+: (356.2953) 
Calcd: 356.2953 
Found: 356.2944 
 TLC: Rf  0.37  (CH2Cl2/MeOH, 9/1) [I2]
N
H H
Br
MeO
Me
Me
V{1,2,6}
312 
 
Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-3-(3,5-tert-butylbenzyl)-
5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (β-V{1,2,7}) 
 
Data for β-V{1,2,7}: 
 Yield: 42 mg (87%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.50–7.48 (m, 1 H), 7.41–7.31 (m, 5 H), 7.29 (d, J = 1.7, 2 H), 4.71 (d, J = 
11.3, 1 H), 4.58 (d, J = 11.3, 1 H), 4.68 (s, 2 H), 4.23 (s, 1 H), 4.18 (d, J = 
14.1, 1 H), 4.04 (d, J = 14.1, 1 H), 3.82 (dd, J = 11.8, 11.8, 1 H), 3.44 (dd, J = 
5.9, 11.1, 1 H), 2.73 (dd, J = 9.6, 9.6, 1 H), 2.70–2.61 (m, 1 H), 2.35 (dd, J = 
6.5, 10.1, 1 H), 2.16–2.08 (m, 2 H), 1.96–1.90 (m, 1 H), 1.93 (s, 3 H), 1.84–
1.75 (m, 1 H), 1.29 (s, 18H), 1.20 (d, J = 6.3, 3 H) 
 MS: (ESI, Q-tof) 
474.4 (100) 
 Mol. Formula: C33H48BrNO (554.64) 
 HRMS: C33H48NO
+: (474.3736) 
Calcd: 474.3736 
Found: 474.3723 
 TLC: Rf  0.30  (CH2Cl2/MeOH, 9:1) [I2]
N
H H
Br
MeO
t-Bu
t-Bu
Me
V{1,2,7}
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Preparation of rel-(1R,3R,5S,5aS,7aS,7bR) Octahydro-1-benzyloxy-3-(4-methoxybenzyl)-5-
methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (β-V{1,2,8}) 
 
Data for β-V{1,2,8}: 
 Yield: 39 mg (92%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
7.54 (d, J = 8.7, 2 H), 7.44–7.32 (m, 5 H), 6.93 (d, J = 8.7, 2 H), 5.07 (d, J = 
12.0, 1 H), 4.70 (d, J = 11.7, 1 H), 4.59 (d, J = 11.7, 1 H), 4.58 (d, J = 12.1, 1 
H), 4.41 (dd, J = 11.9, 11.9, 1 H), 4.09 (d, J = 3.0, 1 H), 4.02 (d, J = 14.0, 1 
H), 3.82 (s, 3 H), 3.60 (d, J = 11.7, 1 H), 3.25 (dd, J = 6.0, 11.3, 1 H), 2.68 
(dd, J = 9.1, 9.1, 1 H), 2.50 (dd, J = 5.8, 10.0, 1 H), 2.27–2.19 (m, 1 H), 2.16–
2.07 (m, 1 H), 2.01 (s, 3 H), 1.88–1.65 (m, 3 H), 1.22 (d, J = 6.3, 3 H) 
 MS: (ESI, Q-tof) 
392.3 (100) 
 Mol. Formula: C26H34BrNO2 (472.46) 
 HRMS: C26H34NO2
+: (392.2590) 
Calcd: 392.2590 
Found: 392.2582 
 TLC: Rf  0.19  (CH2Cl2/MeOH, 9:1) [I2] 
 
N
H H
Br
MeO
OMe
Me
V{1,2,8}
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7.4. Kinetic Analysis from Text. 
7.4.1. General Kinetic Analysis Procedure (Half-Life Determinations) 
N
Ot-Bu
O
Ph
Ph
50% KOH (aq)
cat (0.025 equiv)
1600 rpm
BnBr (1.2 equiv)
toluene, 2-4 oC
(cold room)
N
Ot-Bu
O
Ph
Ph
Ph
 
A 2–mL scintillation vial was fitted with a Teflon lined rubber septum and tert-butyl 2-
(diphenylmethyleneamino) acetate (100 mg, 0.0.34 mmol), and quaternary ammonium salt x (x.x 
mg, 0.025 equiv) were added. The liquid reagents, toluene (0.40 mL) and benzyl bromide (87.1 
mg, 0.41 mmol, 1.2 equiv) were added via syringe from stock solutions. Then, a 1.5 cm egg-
shaped a magnetic stir bar was placed in the vial, which was then transferred to a cold room that 
maintained the temperature at 2-4 oC.  The reaction mixture was allowed to equilibrate for at 
least 1 h with stirring.  Lastly, 50% aq. KOH (8.9 M, 0.66 mL, x  mmol, 17.8 equiv) was added 
and the stir rate was set to 1600 rpm.  Aliquots were taken at the indicated times and analyzed as 
follows.  Three seconds prior to the indicated time interval, the stirrer was turned off.  At the 
indicated time interval a 5-7 µL aliquot of the organic layer was removed and then was injected 
into acetonitrile (1-1.2 mL) containing glacial acetic acid (~5 µL).  This clear solution was 
filtered through a small plug of silica gel (0.5 x 1 cm) and the filtrate was analyzed by Reverse 
Phase-HPLC Method 1. 
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7.4.2. Analysis and Response Factors 
Eq 1: Response factor for X =  (mmol 3 * area internal standard ) 
  (mmol internal standard * area 3) 
(mmol internal standard *  
 
 
 
 
 
 
 
 
  
mmol 
Product
Area 
Product
mmol 
Standard
Area 
Standard
Response 
factor
2.34E-04 15.4376 9.73E-04 83.0799 1.296
2.34E-04 15.6277 9.73E-04 83.2519 1.283
2.34E-04 15.5967 9.73E-04 83.6868 1.292
2.34E-04 15.5909 9.73E-04 83.0982 1.283
3.90E-04 23.6288 9.73E-04 75.6462 1.285
3.90E-04 23.1749 9.73E-04 75.2265 1.302
3.90E-04 23.7759 9.73E-04 75.5066 1.274
3.90E-04 23.2827 9.73E-04 75.8688 1.308
6.25E-04 32.9563 9.73E-04 66.1806 1.289
6.25E-04 33.5899 9.73E-04 65.0608 1.244
6.25E-04 33.3643 9.73E-04 65.7796 1.266
6.25E-04 32.0052 9.73E-04 63.2008 1.268
7.81E-04 37.1393 9.73E-04 58.0562 1.254
7.81E-04 36.6825 9.73E-04 57.7248 1.263
7.81E-04 36.9887 9.73E-04 57.9599 1.257
7.81E-04 38.5104 9.73E-04 60.0839 1.252
9.37E-04 40.9315 9.73E-04 53.3471 1.255
9.37E-04 40.8334 9.73E-04 52.9797 1.249
9.37E-04 40.3293 9.73E-04 54.0078 1.290
9.37E-04 40.7821 9.73E-04 53.4912 1.263
Average 
Response 
Factor 1.274
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7.4.3. Kinetic data for Libraries IV and V: Table 5 in Text 
 
Table 5. entry 1. catalyst IV{2,2,1}: run 1 
 
      
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
 product 
% 
0 256.25 0.00 0.00 0.00 0.00 
2 256.25 24.72 0.88 10.88 3.21 
6 256.25 19.27 1.24 19.82 5.85 
10 256.25 26.00 3.38 39.99 11.80 
14 256.25 23.13 4.03 53.62 15.83 
20 256.25 29.08 6.96 73.63 21.74 
30 256.25 27.11 8.47 96.06 28.36 
40 256.25 29.32 10.63 111.46 32.91 
91 256.25 3.68 1.80 150.14 44.32 
133 256.25 27.68 16.75 186.06 54.93 
208 256.25 28.40 20.02 216.70 63.97 
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 ExpDec2Fit of Product
P
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c
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)
time (min)
Model ExpDec2
Equation
y = A1*exp(-x/t1)
 + A2*exp(-x/t2) 
+ y0
Reduced 
Chi-Sqr
1.91978
Adj. R-Square 0.99582
Value Standard Error
Product y0 115.77771 148.63871
Product A1 -86.7158 135.64985
Product t1 399.76785 1008.00597
Product A2 -29.64861 13.23678
Product t2 22.3907 9.67081
 
Half-life: 101.71 
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Table 5. entry 1. catalyst IV{2,2,1}: run 2 
 
      
time, 
min 
µmol 
standard 
area 
standard 
area 
product 
µmol 
product 
product, 
% 
16 256.25 25.88 4.64 55.07 16.25 
20 256.25 26.54 6.50 75.36 22.24 
30 256.25 28.39 9.62 104.20 30.75 
40 256.25 28.82 11.73 125.14 36.94 
60 256.25 26.52 13.16 152.64 45.05 
91 256.25 27.25 16.31 184.00 54.31 
133 256.25 27.10 18.70 212.15 62.62 
208 256.25 27.66 21.58 239.90 70.81 
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)
time (min)
Model ExpDec2
Equation
y = A1*exp(-x/t
1) + A2*exp(-x/t
2) + y0
Reduced 
Chi-Sqr
0.05564
Adj. R-Square 0.99985
Value Standard Error
Product y0 77.14961 0.78631
Product A1 -64.16186 14.5585
Product t1 8.12118 1.20394
Product A2 -61.76682 0.84841
Product t2 91.58025 4.23449
 
Half-life: 75.3 
Average: 93.5 
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Table 5. entry 2. catalyst IV{2,2,2}: run 1 
 
      
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.25 0.00 0.00 0.00 0.00 
4 256.25 24.76 3.05 37.91 11.19 
8 256.25 25.99 6.10 72.15 21.30 
12 256.25 24.40 7.68 96.78 28.57 
16 256.25 25.72 9.40 112.42 33.19 
20 256.25 25.36 10.48 127.08 37.52 
30 256.25 25.67 12.80 153.39 45.28 
40 256.25 25.86 14.19 168.78 49.83 
73 256.25 26.32 16.45 192.13 56.72 
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y = A1*exp(-x/
t1) + A2*exp(-
x/t2) + y0
Reduced 
Chi-Sqr
0.25944
Adj. R-Square 0.99924
Value Standard Erro
Product y0 60.99221 7.63597
Product A1 -31.8954 40.41672
Product t1 11.97563 7.02424
Product A2 -29.2930 33.18303
Product t2 37.53208 54.3723
 
Half-life: 40.64 
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Table 5. entry 2. catalyst IV{2,2,2}: run 2 
 
      
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.25 0.00 0.00 0.00 0.00 
4 256.25 25.34 2.55 30.96 9.14 
8 256.25 25.58 4.96 59.64 17.60 
12 256.25 25.75 6.90 82.41 24.32 
16 256.25 25.58 8.30 99.71 29.43 
20 256.25 26.02 9.80 115.79 34.17 
30 256.25 26.67 11.80 136.04 40.15 
40 256.25 26.53 12.84 148.82 43.93 
73 256.25 25.98 14.83 175.53 51.81 
200 256.25 27.08 19.81 224.93 66.39 
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y = A1*exp(-x/t1
) + A2*exp(-x/t2)
 + y0
Reduced 
Chi-Sqr
0.39018
Adj. R-Square 0.99903
Value Standard Error
Product y0 117.99532 156.29656
Product A1 -42.45418 4.66549
Product t1 15.36338 1.81564
Product A2 -76.02365 151.59105
Product t2 516.10347 1376.51143
 
Half-life: 62.97 
Average: 51.1 
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Table 5. entry 3. catalyst IV{3,2,1}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.39 0.00 0.00 0.00 0.00 
2 256.39 26.76 3.06 35.21 10.38 
4 256.39 28.32 5.77 62.71 18.49 
6 256.39 28.89 7.71 82.14 24.21 
8 256.39 29.19 9.67 101.89 30.04 
10 256.39 28.94 11.08 117.77 34.72 
12 256.39 28.98 12.57 133.44 39.34 
16 256.39 29.59 14.74 153.24 45.17 
20 256.39 29.81 17.48 180.37 53.17 
30 256.39 28.91 19.85 211.24 62.27 
40 256.39 29.20 22.57 237.79 70.10 
60 256.39 29.87 26.92 277.28 81.74 
102 256.39 30.72 29.40 294.44 86.80 
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y = A1*exp(
-x/t1) + A2*
exp(-x/t2) + 
Reduced 
Chi-Sqr
0.83169
Adj. R-Square 0.99886
Value Standard Error
product y0 89.35576 1.28873
product A1 -76.10726 3.17736
product t1 28.17403 2.27601
product A2 -13.18587 3.75305
product t2 4.20532 1.47477
 
Half-life: 18.69 
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Table 5. entry 3. catalyst IV{3,2,1}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.39 0.00 0.00 0.00 0.00 
2 256.39 27.01 3.23 36.82 10.85 
4 256.39 29.60 5.96 61.98 18.27 
6 256.39 29.77 7.76 80.14 23.63 
8 256.39 29.57 9.32 96.94 28.58 
10 256.39 30.06 11.14 114.05 33.62 
12 256.39 29.95 11.88 121.98 35.96 
16 256.39 29.44 14.51 151.61 44.69 
20 256.39 30.87 17.11 170.54 50.27 
30 256.39 29.86 20.08 206.92 61.00 
40 256.39 30.64 21.95 220.44 64.98 
60 256.39 30.68 25.33 253.96 74.87 
102 256.39 31.08 28.33 280.42 82.67 
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y = A1*exp(
-x/t1) + A2*
exp(-x/t2) +
Reduced 
Chi-Sqr
1.26308
Adj. R-Square 0.99801
Value Standard Error
product y0 85.75758 2.58913
product A1 -61.64405 9.10362
product t1 34.55423 7.92622
product A2 -23.27135 10.71182
product t2 7.32556 2.81586
 
Half-life: 20.26 
Average: 19.5 
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Table 5. entry 4. catalyst IV{3,2,5}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
produc
t % 
0 256.25 0.00 0.00 0.00 0.00 
2 256.25 24.58 2.35 29.44 8.69 
4 256.25 25.57 4.49 53.94 15.93 
6 256.25 25.66 6.17 73.91 21.82 
8 256.25 25.14 7.20 88.11 26.01 
10 256.25 26.04 8.49 100.21 29.58 
12 256.25 25.94 9.21 109.12 32.21 
16 256.25 26.33 10.93 127.60 37.67 
20 256.25 26.23 12.24 143.52 42.37 
32 256.25 26.27 14.67 171.71 50.69 
44 256.25 26.93 16.44 187.78 55.43 
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y = A1*exp(-x/t
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t2) + y0
Reduced 
Chi-Sqr
0.12308
Adj. R-Square 0.99958
Value Standard Error
Product y0 62.13558 1.98394
Product A1 -50.00511 2.39997
Product t1 21.7907 3.29196
Product A2 -12.26925 4.00896
Product t2 4.02305 1.07606
 
Half-life: 30.87 
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Table 5. entry 4. catalyst IV{3,2,5}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
 
produc
t % 
0 256.25 0.00 0.00 0.00 0.00 
2 256.25 24.86 2.54 31.40 9.27 
4 256.25 24.70 4.76 59.28 17.50 
6 256.25 21.18 5.12 74.28 21.92 
8 256.25 25.11 7.66 93.81 27.69 
10 256.25 24.90 9.01 111.32 32.86 
12 256.25 24.74 9.90 123.07 36.32 
16 256.25 25.31 11.60 140.98 41.61 
20 256.25 25.12 12.98 158.96 46.92 
30 256.25 25.71 16.36 195.75 57.77 
40 256.25 25.80 18.02 214.78 63.39 
60 256.25 26.35 19.94 232.64 68.66 
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Adj. R-Squa 0.99666
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Product y0 69.3733 1.24016
Product A1 -67.6734 1.26797
Product t1 17.0448 0.8478
 
Half-life: 21.32 
Average: 26.1 
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Table 5. entry 5. catalyst IV{5,2,5}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.39 0.00 0.00 0.00 0.00 
2 256.39 27.19 3.25 36.82 10.85 
4 256.39 29.90 6.61 68.03 20.06 
6 256.39 30.41 9.04 91.44 26.95 
10 256.39 30.58 12.45 125.27 36.93 
12 256.39 29.91 13.46 138.48 40.82 
16 256.39 30.40 16.26 164.58 48.52 
20 256.39 29.42 17.37 181.63 53.54 
30 256.39 30.58 20.90 210.26 61.98 
40 256.39 30.23 22.73 231.34 68.20 
60 256.39 31.58 25.57 249.10 73.43 
100 256.39 32.36 28.17 267.80 78.94 
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Reduced Chi-Sqr
0.29172
Adj. R-Square 0.99955
Value Standard Error
product y0 80.03936 0.88116
product A1 -26.87294 5.63652
product t1 6.57531 1.10509
product A2 -53.02913 5.17134
product t2 27.32956 3.10964
 
Half-life: 17.34 
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Table 5. entry 5. catalyst IV{5,2,5}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.39 0.00 0.00 0.00 0.00 
2 256.39 29.82 4.26 43.93 12.95 
4 256.39 27.52 6.65 74.40 21.93 
6 256.39 29.95 9.50 97.54 28.76 
8 256.39 29.82 11.49 118.56 34.95 
10 256.39 29.94 13.13 134.97 39.79 
12 256.39 30.30 14.79 150.15 44.26 
16 256.39 30.45 17.28 174.60 51.47 
20 256.39 30.67 19.13 191.86 56.56 
30 256.39 30.16 21.53 219.62 64.74 
40 256.39 29.81 23.14 238.82 70.40 
60 256.39 31.05 25.51 252.77 74.51 
100 256.39 30.92 26.98 268.53 79.16 
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exp(-x/t2) + 
Reduced 
Chi-Sqr
0.32906
Adj. R-Square 0.99945
Value Standard Error
product y0 79.48692 0.76882
product A1 -51.93129 6.09852
product t1 23.54747 2.77132
product A2 -27.10563 6.45595
product t2 6.12246 1.11107
 
Half-life: 15.21 
Average: 16.3 
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Table 5. entry 6. catalyst V{1,2,1}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.56 0.00 0.00 0.00 0.00 
4 255.56 27.21 4.43 49.94 14.74 
8 255.56 27.33 6.72 75.41 22.25 
12 255.56 27.16 8.73 98.59 29.09 
16 255.56 29.91 11.64 119.32 35.21 
20 255.56 29.53 13.60 141.24 41.68 
30 255.56 29.91 16.36 167.80 49.52 
40 255.56 29.90 18.63 191.13 56.40 
50 255.56 30.44 20.62 207.69 61.29 
60 255.56 30.81 22.69 225.84 66.65 
80 255.56 30.07 23.27 237.30 70.03 
110 255.56 30.53 25.32 254.36 75.07 
171 255.56 31.68 28.12 272.23 80.34 
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Reduced 
Chi-Sqr
1.10781
Adj. R-Square 0.99822
Value Standard Error
product y0 81.26985 1.57406
product A1 -22.6446 7.91889
product t1 9.58156 3.12628
product A2 -57.99726 7.0773
product t2 46.52473 7.61275
 
Half-life: 30.20 
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Table 5. entry 6. catalyst V{1,2,1}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.56 0.00 0.00 0.00 0.00 
4 255.56 29.55 4.71 48.90 14.43 
8 255.56 29.91 7.42 76.07 22.45 
12 255.56 29.44 9.01 93.82 27.69 
16 255.56 29.22 10.69 112.13 33.09 
20 255.56 29.56 12.35 128.13 37.81 
30 255.56 28.61 14.75 158.09 46.66 
40 255.56 29.70 17.39 179.60 53.00 
50 255.56 29.16 18.54 194.99 57.54 
60 255.56 29.42 20.62 214.93 63.43 
80 255.56 29.82 22.29 229.24 67.65 
110 255.56 30.31 24.38 246.69 72.80 
171 255.56 30.50 25.05 251.88 74.33 
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xp(-x/t2) + y
Reduced 
Chi-Sqr
0.38405
Adj. R-Square 0.99931
Value Standard Error
product y0 75.42048 0.57729
product A1 -65.27403 0.98021
product t1 36.96928 1.32683
product A2 -10.14638 1.27709
product t2 2.76826 0.77007
 
Half-life: 34.86 
Average: 32.5 
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Table 5. entry 7. catalyst V{1,2,8}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 207.64 0.00 0.00 0.00 0.00 
4 207.64 24.85 3.59 36.02 10.63 
8 207.64 24.92 6.09 60.85 17.96 
12 207.64 25.60 8.37 81.49 24.05 
16 207.64 23.43 9.41 100.12 29.55 
20 207.64 25.77 11.80 114.07 33.66 
30 207.64 25.98 14.70 140.97 41.60 
40 207.64 26.53 17.11 160.71 47.43 
50 207.64 25.81 18.26 176.26 52.02 
60 207.64 24.52 19.22 195.36 57.65 
80 207.64 26.25 22.73 215.75 63.67 
110 207.64 28.10 26.10 231.51 68.32 
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Reduced 
Chi-Sqr
0.31841
Adj. R-Square 0.99932
Value Standard Error
product y0 75.4088 1.94653
product A1 -61.45478 2.21989
product t1 49.76382 5.68746
product A2 -13.96174 3.48823
product t2 7.52396 2.01481
 
Half-life: 40.03 
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Table 5. entry 7. catalyst V{1,2,8}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 207.64 0.00 0.00 0.00 0.00 
4 207.64 26.10 3.12 36.65 10.81 
8 207.64 26.39 4.94 57.45 16.95 
12 207.64 29.65 7.04 72.83 21.49 
16 207.64 29.52 8.35 86.78 25.61 
20 207.64 27.16 8.76 98.92 29.19 
30 207.64 28.96 11.63 123.19 36.36 
40 207.64 29.36 13.83 144.42 42.62 
50 207.64 29.46 15.03 156.46 46.17 
60 207.64 29.47 16.33 169.89 50.14 
80 207.64 29.41 17.94 187.08 55.21 
110 207.64 29.96 20.93 214.24 63.23 
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x/t1) + A2*ex
p(-x/t2) + y0
Reduced Chi-Sqr
0.51472
Adj. R-Square 0.99859
Value Standard Error
product y0 72.76087 3.3136
product A1 -59.08191 1.85198
product t1 62.38813 9.4296
product A2 -13.45118 2.81246
product t2 6.35042 1.79395
 
Half-life: 59.51 
Average: 51.8 
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Table 5. entry 8. catalyst V{1,2,8}β: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
16 256.25 26.34 6.50 75.83 22.39 
20 256.25 26.25 7.92 92.75 27.38 
30 256.25 26.29 10.74 125.60 37.08 
40 256.25 26.64 12.32 142.18 41.97 
60 256.25 27.29 16.97 191.19 56.44 
98 256.25 27.81 22.36 247.18 72.97 
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Chi-Sqr
1.58531
Adj. R-Squa 0.99556
Value Standard Err
Product y0 99.5868 9.62076
Product A1 -93.9956 7.57211
Product t1 77.7006 15.70364
 
Half-life: 49.69 
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Table 5. entry 8. catalyst V{1,2,8}β: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
16 256.25 26.34 6.50 75.83 22.39 
20 256.25 26.25 7.92 92.75 27.38 
30 256.25 26.29 10.74 125.60 37.08 
40 256.25 26.64 12.32 142.18 41.97 
60 256.25 27.29 16.97 191.19 56.44 
98 256.25 27.81 22.36 247.18 72.97 
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Chi-Sqr
0.46026
Adj. R-Square 0.99854
Value Standard Error
Product y0 74.91425 2.18718
Product A1 -72.87025 1.71512
Product t1 54.08482 3.65321
 
Half-life: 58.05 
Average: 53.09 
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Table 5. entry 9. catalyst V{1,2,7}β: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.25 0.00 0.00 0.00 0.00 
2 256.25 27.23 4.88 55.14 16.28 
4 256.25 26.07 8.62 101.72 30.03 
8 256.25 26.65 14.06 162.24 47.90 
12 256.25 26.76 16.54 190.02 56.10 
20 256.25 26.93 21.61 246.81 72.86 
30 256.25 27.28 24.36 274.58 81.06 
40 256.25 29.40 27.13 283.70 83.75 
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Chi-Sqr
3.05089
Adj. R-Squar 0.99681
Value Standard Erro
Product y0 85.11026 1.63498
Product A1 -83.9338 1.85745
Product t1 10.2865 0.64217
 
Half-life: 8.97 
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Table 5. entry 9. catalyst V{1,2,7}β: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 208.20 0.00 0.00 0.00 0.00 
2 208.20 23.62 5.95 62.95 18.58 
4 208.20 24.23 9.56 98.56 29.09 
8 208.20 22.59 13.45 148.72 43.90 
12 208.20 22.57 16.33 180.79 53.36 
16 208.20 22.94 18.61 202.64 59.81 
20 208.20 23.13 21.00 226.82 66.95 
30 208.20 23.14 24.78 267.50 78.95 
40 208.20 23.55 26.77 283.99 83.82 
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 + y0
Reduced 
Chi-Sqr
0.73046
Adj. R-Square 0.99907
Value Standard Error
Product y0 93.84509 3.13925
Product A1 -75.85236 2.40614
Product t1 19.24288 2.61394
Product A2 -17.97422 4.29507
Product t2 2.13969 0.65414
 
Half-life: 10.60 
Average: 9.78 
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Table 5. entry 10. catalyst V{1,2,6}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.56 0.00 0.00 0.00 0.00 
4 255.56 28.44 3.96 42.69 12.60 
8 255.56 27.15 6.76 76.36 22.53 
12 255.56 29.11 10.32 108.70 32.08 
16 255.56 27.97 12.22 134.02 39.55 
20 255.56 29.35 14.96 156.34 46.14 
30 255.56 28.77 18.14 193.39 57.07 
40 255.56 28.95 20.82 220.59 65.10 
50 255.56 29.58 22.56 233.80 69.00 
60 255.56 29.79 23.99 246.98 72.89 
80 255.56 30.14 26.21 266.76 78.72 
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Reduced 
Chi-Sqr
0.6292
Adj. R-Square 0.99908
Value Standard Error
product y0 80.16946 0.81035
product A1 -79.92514 0.8263
product t1 23.96896 0.70266
 
Half-life: 23.35 
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Table 5. entry 10. catalyst V{1,2,6}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.56 0.00 0.00 0.00 0.00 
4 255.56 29.02 4.29 45.31 13.37 
8 255.56 29.23 6.90 72.36 21.35 
12 255.56 29.93 9.12 93.42 27.57 
16 255.56 28.13 10.95 119.36 35.22 
20 255.56 28.68 13.29 142.11 41.94 
30 255.56 29.54 17.97 186.62 55.07 
40 255.56 29.81 21.08 216.85 64.00 
50 255.56 30.10 22.38 228.01 67.29 
60 255.56 29.93 23.55 241.26 71.20 
80 255.56 30.62 25.89 259.29 76.52 
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Reduced 
Chi-Sqr
1.52527
Adj. R-Square 0.99769
Value Standard Erro
product y0 80.75033 1.49528
product A1 -80.11902 1.41956
product t1 27.26092 1.36722
 
Half-life: 26.11 
Average: 24.70 
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Table 5. entry 11. catalyst V{2,2,1}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 253.90 0.00 0.00 0.00 0.00 
1 253.90 34.13 3.52 31.37 9.25 
2 253.90 35.29 6.37 54.90 16.18 
3 253.90 35.39 8.42 72.40 21.34 
4 253.90 35.35 10.29 88.58 26.11 
5 253.90 35.27 11.97 103.26 30.44 
6 253.90 34.10 13.60 121.33 35.77 
7 253.90 34.07 15.16 135.36 39.90 
8 253.90 33.58 22.67 205.42 60.56 
9 253.90 33.34 26.12 238.37 70.27 
10 253.90 32.67 28.59 266.35 78.52 
12 253.90 32.57 29.36 274.33 80.87 
15 253.90 32.54 30.89 288.90 85.17 
30 253.90 31.83 30.80 294.45 86.80 
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Value Standard Erro
product y0 83.23379 1.1619
product A1 -81.38405 1.11379
product t1 22.67675 0.9611
 
Half-life: 20.31 
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Table 5. entry 11. catalyst V{2,2,1}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 253.90 0.00 0.00 0.00 0.00 
2 253.90 34.83 3.60 31.44 9.27 
4 253.90 36.36 6.40 53.59 15.80 
6 253.90 32.64 7.70 71.76 21.15 
8 253.90 34.71 10.17 89.20 26.30 
10 253.90 33.33 11.47 104.75 30.88 
12 253.90 33.93 13.11 117.55 34.65 
14 253.90 35.56 15.58 133.37 39.32 
30 253.90 33.63 22.09 199.87 58.92 
45 253.90 32.88 25.26 233.86 68.94 
60 253.90 32.65 27.78 258.92 76.33 
75 253.90 32.05 29.32 278.36 82.06 
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(-x/t1) + y0
Reduced 
Chi-Sqr
2.34308
Adj. R-Square 0.9968
Value Standard Erro
product y0 83.14164 1.63696
product A1 -80.7848 1.53558
product t1 23.6227 1.39359
 
Half-life: 21.05 
Average: 20.7 
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Table 5. entry 12. catalyst V{2,2,3}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.72 0.00 0.00 0.00 0.00 
4 255.72 29.68 4.91 50.72 14.98 
8.78 255.72 28.67 8.49 90.90 26.86 
12 255.72 28.94 10.82 114.74 33.90 
16 255.72 29.75 13.06 134.72 39.80 
20 255.72 29.62 14.89 154.25 45.57 
30 255.72 28.81 18.40 195.96 57.90 
40 255.72 31.25 21.00 206.24 60.93 
60 255.72 31.16 23.64 232.85 68.80 
80 255.72 31.93 25.61 246.18 72.73 
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Reduced 
Chi-Sqr
1.56585
Adj. R-Square 0.99723
Value Standard Error
product y0 72.89255 1.11701
product A1 -71.83618 1.29186
product t1 20.20463 0.93536
 
Half-life: 23.11 
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Table 5. entry 12. catalyst V{2,2,3}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.72 0.00 0.00 0.00 0.00 
4 255.72 27.69 4.69 51.97 15.36 
8 255.72 28.28 8.18 88.71 26.21 
12 255.72 28.93 11.08 117.55 34.73 
16 255.72 29.68 13.22 136.72 40.40 
20 255.72 29.82 14.99 154.26 45.58 
30 255.72 30.43 18.80 189.56 56.01 
40 255.72 30.83 20.98 208.84 61.70 
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Reduced 
Chi-Sqr
0.78807
Adj. R-Square 0.99815
Value Standard Error
product y0 67.97011 1.60152
product A1 -67.20291 1.50055
product t1 17.42559 0.96518
 
Half-life: 22.98 
Average: 23.0 
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Table 5. entry 13. catalyst V{2,2,5}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
60 254.41 36.71 2.62 21.80 6.44 
75 254.41 35.66 2.93 25.09 7.41 
90 254.41 35.96 3.30 28.02 8.28 
105 254.41 35.78 3.55 30.28 8.94 
147 254.41 36.21 4.41 37.14 10.97 
965 254.41 30.39 18.52 185.78 54.88 
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Half-life: 873.94 
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Table 5. entry 13. catalyst V{2,2,5}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
60 253.90 34.92 2.76 24.11 7.12 
75 253.90 35.03 3.15 27.44 8.11 
90 253.90 35.50 3.65 31.38 9.27 
105 253.90 34.23 3.67 32.70 9.66 
147 253.90 34.79 4.70 41.20 12.17 
965 253.90 30.66 17.67 175.71 51.90 
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Half-life: 925.55 
Average: 899.70 
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Table 5. entry 14. catalyst V{2,2,8}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
2 254.41 33.53 3.73 33.89 9.99 
4 254.41 33.08 6.57 60.53 17.84 
6 254.41 33.77 8.16 73.64 21.71 
8 254.41 32.74 9.76 90.92 26.80 
10 254.41 33.14 11.36 104.57 30.83 
12 254.41 32.39 12.27 115.56 34.07 
14 254.41 31.92 13.39 127.87 37.70 
16 254.41 31.72 14.30 137.50 40.53 
20 254.41 31.19 16.52 161.49 47.61 
30 254.41 30.48 19.93 199.37 58.77 
45 254.41 29.91 23.52 239.78 70.68 
60 254.41 29.68 25.93 266.33 78.51 
75 254.41 29.63 27.19 279.87 82.50 
90 254.41 29.43 28.47 294.99 86.96 
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Equation y = A1*exp
(-x/t1) + y0
Reduced 
Chi-Sqr
0.75642
Adj. R-Square 0.99882
Value Standard Error
product y0 90.03452 0.97648
product A1 -83.54538 0.85994
product t1 30.04857 1.02593
 
Half-life: 22.11 
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Table 5. entry 14. catalyst V{2,2,8}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.41 0.00 0.00 0.00 0.00 
2 254.41 31.93 3.65 34.84 10.27 
4 254.41 31.35 6.57 63.92 18.84 
6 254.41 32.35 8.46 79.73 23.50 
8 254.41 32.52 10.65 99.91 29.45 
10 254.41 32.90 12.39 114.84 33.85 
12 254.41 31.52 14.02 135.67 40.00 
14 254.41 33.05 15.54 143.33 42.25 
16 254.41 31.13 16.03 157.03 46.29 
20 254.41 30.42 18.58 186.26 54.91 
30 254.41 30.30 22.91 230.50 67.95 
45 254.41 30.07 26.39 267.59 78.88 
60 254.41 29.40 27.72 287.48 84.75 
75 254.41 29.57 29.57 304.93 89.89 
90 254.41 29.21 30.03 313.49 92.42 
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y = A1*ex
p(-x/t1) + 
Reduced 
Chi-Sqr
0.75259
Adj. R-Squar 0.99907
Value Standard Erro
product y0 94.05253 0.7725
product A1 -89.7264 0.79368
product t1 24.8591 0.70131
 
Half-life: 17.68 
Average: 19.9 
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Table 5. entry 15. catalyst V{2,2,7}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.15 0.00 0.00 0.00 0.00 
2 254.15 30.56 4.22 40.87 12.08 
4 254.15 30.95 7.77 74.29 21.97 
6 254.15 30.23 10.27 100.52 29.72 
8 254.15 30.23 12.49 122.27 36.15 
10 254.15 30.17 14.27 139.88 41.36 
15 254.15 30.16 17.81 174.72 51.66 
17 254.15 30.08 18.80 184.90 54.67 
20 254.15 29.52 20.07 201.15 59.48 
30 254.15 29.65 23.63 235.73 69.70 
60 254.15 29.91 29.48 291.59 86.22 
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y = A1*exp(-x
/t1) + A2*exp
(-x/t2) + y0
Reduced Chi-Sqr
0.03324
Adj. R-Square 0.99995
Value Standard Error
product y0 96.71522 1.43709
product A1 -28.59343 2.75299
product t1 5.98596 0.42868
product A2 -68.15795 1.53381
product t2 32.08172 2.55197
 
Half-life: 14.41 
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Table 5. entry 15. catalyst V{2,2,7}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.15 0.00 0.00 0.00 0.00 
2 254.15 29.99 3.71 36.58 10.82 
4 254.15 29.05 6.76 68.81 20.35 
6 254.15 29.29 9.41 95.07 28.11 
8 254.15 29.69 11.53 114.88 33.97 
10 254.15 29.47 13.27 133.24 39.39 
15 254.15 29.61 16.51 164.94 48.77 
17 254.15 29.33 17.28 174.23 51.51 
20 254.15 29.57 18.80 188.09 55.61 
30 254.15 29.73 22.03 219.19 64.81 
60 254.15 29.64 27.44 273.88 80.98 
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y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced 
Chi-Sqr
0.0588
Adj. R-Square 0.9999
Value Standard Error
product y0 108.11951 13.59295
product A1 -66.46465 8.84768
product t1 66.91779 27.38543
product A2 -41.83769 4.8203
product t2 7.85166 0.65201
 
Half-life: 15.77 
Average: 15.09 
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Table 5. entry 16. catalyst V{2,2,6}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 253.90 0.00 0.00 0.00 0.00 
1 253.90 37.44 0.64 5.18 1.53 
2 253.90 35.39 1.44 12.38 3.65 
3 253.90 37.18 2.35 19.26 5.68 
4 253.90 37.90 3.09 24.82 7.32 
5 253.90 37.06 3.59 29.51 8.70 
6 253.90 37.05 4.40 36.15 10.66 
7 253.90 37.04 4.99 41.04 12.10 
8 253.90 36.57 5.66 47.08 13.88 
9 253.90 33.55 6.07 55.01 16.22 
10 253.90 36.15 7.18 60.44 17.82 
12 253.90 33.39 8.37 76.33 22.50 
15 253.90 33.90 10.56 94.77 27.94 
30 253.90 34.54 19.40 170.96 50.40 
60 253.90 33.58 25.25 228.79 67.45 
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y = A2 + (A
1-A2)/(1 + e
xp((x-x0)/d
Reduced 
Chi-Sqr
0.13254
Adj. R-Square 0.99962
Value Standard Error
product A1 -32.94742 3.32226
product A2 69.95765 0.58972
product x0 10.1746 0.83145
product dx 13.57203 0.53574
 
Half-life: 29.51 
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Table 5. entry 16. catalyst V{2,2,6}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 253.90 0.00 0.00 0.00 0.00 
1 253.90 36.75 0.48 3.95 1.16 
2 253.90 37.89 1.27 10.22 3.01 
3 253.90 37.46 2.05 16.62 4.90 
4 253.90 35.99 2.83 23.90 7.05 
5 253.90 34.84 3.43 29.93 8.82 
6 253.90 36.78 4.44 36.71 10.82 
7 253.90 36.25 5.33 44.71 13.18 
8 253.90 34.29 5.54 49.14 14.49 
9 253.90 34.90 6.63 57.78 17.03 
10 253.90 36.00 7.52 63.55 18.73 
12 253.90 35.71 8.87 75.61 22.29 
15 253.90 35.54 11.23 96.18 28.35 
30 253.90 32.26 20.06 189.29 55.80 
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Equation
y = A2 + (A1-
A2)/(1 + exp(
(x-x0)/dx))
Reduced 
Chi-Sqr
0.08106
Adj. R-Square 0.99964
Value Standard Error
product A1 -68.28192 32.63878
product A2 110.21631 25.35949
product x0 11.18302 2.19612
product dx 22.83504 7.81252
 
Half-life: 26.60 
Average: 28.10 
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Table 5. entry 17. catalyst V{2,3,1}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.29 0.00 0.00 0.00 0.00 
2 254.29 33.61 4.18 37.86 11.11 
4 254.29 33.66 6.85 62.05 18.21 
6 254.29 33.00 9.12 84.26 24.73 
8 254.29 32.81 10.62 98.65 28.96 
10 254.29 33.00 12.50 115.48 33.90 
12 254.29 32.29 13.60 128.35 37.67 
15 254.29 30.85 15.89 156.99 46.08 
20 254.29 31.75 17.85 171.34 50.29 
30 254.29 30.76 20.88 206.92 60.74 
45 254.29 30.50 22.68 226.65 66.53 
61 254.29 29.34 23.54 244.52 71.77 
75 254.29 29.95 25.98 264.38 77.60 
90 254.29 29.85 26.40 269.53 79.12 
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y = A1*exp(-
x/t1) + A2*ex
p(-x/t2) + y0
Reduced Chi-Sqr
1.21948
Adj. R-Square 0.99825
Value Standard Error
product y0 92.34813 18.36619
product A1 -44.48087 15.23743
product t1 10.65946 2.75914
product A2 -46.82373 6.21754
product t2 69.54841 70.2637
 
Half-life: 19.64 
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Table 5. entry 17. catalyst V{2,3,1}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.29 0.00 0.00 0.00 0.00 
2 254.29 33.36 3.32 30.37 8.91 
4 254.29 34.48 5.80 51.31 15.06 
6 254.29 33.33 7.34 67.12 19.70 
8 254.29 33.52 8.82 80.19 23.54 
10 254.29 31.73 9.63 92.48 27.15 
12 254.29 33.09 11.49 105.85 31.07 
15 254.29 32.33 13.28 125.22 36.76 
20 254.29 32.18 15.43 146.14 42.90 
30 254.29 31.99 19.30 183.87 53.97 
45 254.29 31.07 21.90 214.87 63.07 
61 254.29 30.58 23.85 237.70 69.77 
75 254.29 30.08 24.75 250.81 73.62 
90 254.29 30.93 26.39 260.08 76.34 
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y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced 
Chi-Sqr
0.28643
Adj. R-Square 0.99954
Value Standard Error
product y0 78.91672 0.68021
product A1 -72.62102 0.70764
product t1 28.64359 1.02337
product A2 -6.28325 1.05527
product t2 1.98282 0.64961
 
Half-life: 26.38 
Average: 23.0 
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Table 5. entry 18. catalyst V{2,3,2}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 236.54 0.00 0.00 0.00 0.00 
2 236.54 25.92 1.49 16.32 4.82 
4 236.54 29.21 3.26 31.65 9.35 
8 236.54 28.68 5.53 54.71 16.16 
12 236.54 28.98 7.59 74.34 21.96 
16 236.54 28.96 8.92 87.41 25.83 
20 236.54 27.60 9.64 99.10 29.28 
36 236.54 27.81 13.26 135.33 39.98 
50 236.54 28.12 14.50 146.39 43.25 
75 236.54 28.75 16.84 166.23 49.12 
123 236.54 28.73 19.60 193.57 57.19 
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y = A1*exp(-
x/t1) + A2*ex
p(-x/t2) + y0
Reduced Chi-Sqr
0.03603
Adj. R-Square 0.9999
Value Standard Error
product y0 71.18379 3.99191
product A1 -44.028 1.99671
product t1 107.42336 22.39342
product A2 -27.16422 2.21559
product t2 12.14458 0.91413
 
 
Half-life: 78.80 
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Table 5. entry 18. catalyst V{2,3,2}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.10 0.00 0.00 0.00 0.00 
2 256.10 27.00 1.46 16.59 4.90 
4 256.10 29.31 2.81 29.44 8.70 
8 256.10 29.90 4.48 46.08 13.61 
12 256.10 29.55 5.71 59.39 17.55 
20 256.10 29.75 8.10 83.67 24.72 
36 256.10 29.76 11.60 119.73 35.37 
50 256.10 28.42 12.93 139.79 41.30 
75 256.10 29.28 16.26 170.66 50.42 
123 256.10 30.53 21.89 220.36 65.11 
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y = A1*exp(-
x/t1) + A2*ex
p(-x/t2) + y0
Reduced Chi-Sqr
0.44782
Adj. R-Square 0.99902
Value Standard Error
product y0 104.12828 24.92121
product A1 -86.73486 20.2423
product t1 154.36205 77.22474
product A2 -16.7475 4.86196
product t2 11.17593 3.36574
 
 
Half-life: 72.85 
Average: 75.8 
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Table 5. entry 19. catalyst V{2,3,3}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.01 0.00 0.00 0.00 0.00 
6 255.01 25.99 5.25 61.81 18.28 
10 255.01 27.03 7.41 83.90 24.81 
16 255.01 26.33 9.68 112.51 33.27 
20 255.01 29.01 12.06 127.22 37.62 
25 255.01 29.33 14.02 146.24 43.24 
30 255.01 28.85 15.10 160.12 47.34 
35 255.01 28.43 15.92 171.34 50.66 
40 255.01 28.72 16.75 178.40 52.75 
50 255.01 28.92 18.01 190.55 56.34 
60 255.01 29.23 18.95 198.42 58.67 
80 255.01 29.79 21.18 217.54 64.32 
170 255.01 30.32 26.47 267.08 78.97 
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y = A1*exp(-
x/t1) + A2*ex
p(-x/t2) + y0
Reduced Chi-Sqr
0.66965
Adj. R-Square 0.99847
Value Standard Error
product y0 104.19502 27.93013
product A1 -59.70231 22.11404
product t1 197.38762 167.17596
product A2 -43.95881 5.92724
product t2 14.99561 2.06662
 
 
Half-life: 35.12 
353 
 
Table 5. entry 19. catalyst V{2,3,3}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.01 0.00 0.00 0.00 0.00 
6 255.01 26.16 5.89 68.91 20.37 
10 255.01 29.21 9.38 98.22 29.04 
16 255.01 29.34 12.30 128.30 37.94 
20 255.01 29.24 13.71 143.44 42.41 
25 255.01 29.61 15.64 161.65 47.80 
30 255.01 29.73 17.39 178.95 52.91 
35 255.01 29.20 18.59 194.89 57.62 
40 255.01 29.13 19.14 201.11 59.46 
50 255.01 29.87 20.83 213.34 63.08 
60 255.01 29.93 22.11 226.09 66.85 
80 255.01 30.06 23.42 238.46 70.51 
170 255.01 29.85 26.84 275.24 81.38 
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y = A1*exp(
-x/t1) + A2*
exp(-x/t2) + 
Reduced 
Chi-Sqr
1.05118
Adj. R-Square 0.9979
Value Standard Error
product y0 85.35804 3.89846
product A1 -43.0817 10.18687
product t1 13.64173 2.7368
product A2 -41.67717 7.31176
product t2 73.2478 30.49192
 
 
Half-life: 26.32 
Average: 30.7 
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Table 5. entry 20. catalyst V{2,3,5}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.01 0.00 0.00 0.00 0.00 
10 255.01 28.52 3.06 32.81 9.70 
30 255.01 28.85 6.44 68.32 20.20 
90 255.01 30.33 10.69 107.86 31.89 
150 255.01 30.70 13.65 136.00 40.21 
190 255.01 30.55 15.17 151.89 44.91 
250 255.01 31.04 16.84 165.99 49.08 
307 255.01 30.36 17.77 179.13 52.97 
350 255.01 31.03 19.19 189.18 55.94 
402 255.01 30.45 19.76 198.61 58.72 
450 255.01 31.55 21.22 205.88 60.87 
500 255.01 31.34 21.34 208.38 61.61 
552 255.01 31.17 21.57 211.80 62.62 
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Equation
y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced 
Chi-Sqr
0.23693
Adj. R-Square 0.99945
Value Standard Error
product y0 68.68766 1.0616
product A1 -16.33313 1.25607
product t1 15.24821 2.11396
product A2 -52.41186 0.81578
product t2 247.68846 15.67047
 
 
Half-life: 255.43 
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Table 5. entry 20. catalyst V{2,3,5}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.01 0.00 0.00 0.00 0.00 
10 255.01 26.50 2.98 34.35 10.16 
90 255.01 28.16 11.13 121.02 35.78 
150 255.01 29.78 14.28 146.73 43.38 
190 255.01 30.52 16.19 162.30 47.99 
250 255.01 30.81 17.66 175.43 51.87 
307 255.01 30.74 19.45 193.66 57.26 
350 255.01 30.97 20.46 202.15 59.77 
402 255.01 31.00 21.96 216.83 64.11 
450 255.01 31.37 22.80 222.47 65.78 
500 255.01 31.74 23.65 228.02 67.42 
552 255.01 31.93 24.47 234.54 69.35 
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y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced Chi-Sqr
0.38243
Adj. R-Square 0.99924
Value Standard Error
product y0 81.92188 2.87198
product A1 -22.77018 1.73051
product t1 21.41345 3.01432
product A2 -59.15146 1.75156
product t2 351.21376 40.75206
 
 
Half-life: 216.64 
Average: 236.0 
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Table 5. entry 21. catalyst V{2,3,8}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.20 0.00 0.00 0.00 0.00 
5 256.20 28.79 5.65 60.30 17.81 
10 256.20 28.63 9.17 98.50 29.09 
15 256.20 28.98 11.81 125.30 37.01 
20 256.20 30.28 14.18 143.93 42.51 
25 256.20 28.60 15.20 163.43 48.27 
30 256.20 28.73 16.75 179.22 52.94 
40 256.20 29.92 19.51 200.44 59.21 
60 256.20 29.51 22.17 231.00 68.23 
80 256.20 29.86 24.33 250.49 73.99 
100 256.20 30.22 25.43 258.72 76.42 
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Equation
y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced Chi-Sqr
0.13346
Adj. R-Square 0.99977
Value Standard Error
product y0 80.41048 0.76549
product A1 -15.26234 2.0919
product t1 5.33283 0.84556
product A2 -65.15647 1.53792
product t2 35.33569 1.92005
 
 
Half-life: 27.04 
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Table 5. entry 21. catalyst V{2,3,8}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.39 0.00 0.00 0.00 0.00 
5 256.39 27.65 6.13 68.17 20.13 
10 256.39 30.73 10.12 101.33 29.93 
15 256.39 30.30 12.77 129.70 38.31 
20 256.39 30.19 14.46 147.41 43.54 
25 256.39 28.82 15.36 163.97 48.43 
30 256.39 29.41 17.21 179.98 53.16 
40 256.39 29.80 20.08 207.31 61.23 
60 256.39 30.07 22.71 232.35 68.63 
80 256.39 30.46 24.49 247.37 73.07 
100 256.39 31.23 26.01 256.23 75.68 
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y = A1*exp(-
x/t1) + A2*ex
p(-x/t2) + y0
Reduced Chi-Sqr
0.319
Adj. R-Square 0.99942
Value Standard Error
product y0 77.97521 0.73736
product A1 -66.19353 1.29176
product t1 30.2497 1.46302
product A2 -11.78078 1.74829
product t2 2.62729 0.86742
 
 
Half-life: 26.05 
Average: 26.5 
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Table 5. entry 22. catalyst V{2,3,7}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.39 0.00 0.00 0.00 0.00 
2 256.39 25.91 2.37 28.19 8.33 
4 256.39 28.47 4.94 53.39 15.78 
6 256.39 28.64 6.28 67.48 19.95 
8 256.39 27.17 7.32 82.93 24.52 
10 256.39 28.90 9.13 97.21 28.74 
12 256.39 29.34 10.30 108.02 31.94 
16 256.39 28.77 12.06 129.00 38.14 
20 256.39 29.15 13.51 142.56 42.15 
30 256.39 29.72 16.86 174.56 51.61 
40 256.39 29.78 18.60 192.22 56.84 
60 256.39 30.08 21.17 216.60 64.04 
94 256.39 30.67 24.57 246.41 72.86 
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Model ExpDec2
Equation
y = A1*exp(
-x/t1) + A2*
exp(-x/t2) + 
Reduced 
Chi-Sqr
0.3819
Adj. R-Square 0.99921
Value Standard Error
product y0 81.71851 4.55586
product A1 -52.30741 3.20714
product t1 53.53121 15.32541
product A2 -28.94071 6.58761
product t2 8.95641 1.67755
 
 
Half-life: 28.78 
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Table 5. entry 22. catalyst V{2,3,7}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.39 0.00 0.00 0.00 0.00 
2 256.39 25.82 2.34 27.91 8.23 
4 256.39 26.42 4.64 54.02 15.92 
6 256.39 28.33 6.72 72.96 21.51 
8 256.39 28.38 8.13 88.18 25.99 
10 256.39 28.38 9.42 102.13 30.11 
12 256.39 29.07 10.54 111.53 32.88 
16 256.39 29.06 12.50 132.34 39.01 
20 256.39 29.38 13.98 146.44 43.17 
30 256.39 29.19 16.52 174.11 51.33 
40 256.39 28.84 17.65 188.34 55.52 
60 256.39 30.40 20.94 211.96 62.48 
94 256.39 28.88 22.62 240.99 71.04 
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y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced Chi-Sqr
0.19068
Adj. R-Square 0.99958
Value Standard Error
product y0 86.20955 7.12505
product A1 -36.08307 3.73805
product t1 9.13304 0.86566
product A2 -49.99235 3.78668
product t2 79.14029 25.64121
 
 
Half-life: 28.92 
Average: 28.9 
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Table 5. entry 23. catalyst V{2,3,6}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.01 0.00 0.00 0.00 0.00 
2 255.01 27.08 2.49 28.16 8.32 
4 255.01 27.13 4.29 48.34 14.29 
6 255.01 29.86 6.51 66.72 19.73 
8 255.01 30.07 8.46 86.06 25.45 
10 255.01 30.29 9.72 98.22 29.04 
12 255.01 27.89 10.32 113.28 33.49 
14 255.01 30.06 12.41 126.37 37.36 
16 255.01 30.25 13.57 137.26 40.59 
20 255.01 30.66 16.02 159.92 47.28 
30 255.01 30.65 20.75 207.19 61.26 
45 255.01 30.98 24.49 241.87 71.51 
80 255.01 30.86 27.09 268.64 79.43 
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Equation y = A1*exp
(-x/t1) + y0
Reduced 
Chi-Sqr
0.62792
Adj. R-Square 0.99891
Value Standard Error
product y0 82.6276 0.90415
product A1 -81.77163 0.88629
product t1 23.27085 0.62828
 
 
Half-life: 21.38 
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Table 5. entry 23. catalyst V{2,3,6}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.01 0.00 0.00 0.00 0.00 
2 255.01 26.96 2.56 29.07 8.60 
4 255.01 27.36 4.59 51.39 15.19 
6 255.01 30.57 6.99 69.99 20.69 
8 255.01 27.52 7.93 88.13 26.06 
10 255.01 28.11 9.15 99.66 29.47 
12 255.01 28.49 10.54 113.17 33.46 
14 255.01 30.23 12.63 127.88 37.81 
16 255.01 30.25 13.91 140.70 41.60 
20 255.01 30.89 16.51 163.55 48.36 
30 255.01 30.71 21.00 209.22 61.86 
45 255.01 30.82 25.08 249.03 73.63 
80 255.01 31.85 27.86 267.71 79.16 
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Equation y = A1*exp
(-x/t1) + y0
Reduced 
Chi-Sqr
1.35276
Adj. R-Square 0.99768
Value Standard Erro
product y0 82.85738 1.29668
product A1 -81.90051 1.28121
product t1 22.70906 0.88454
 
 
Half-life: 20.74 
Average: 21.1 
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Table 5. entry 24. catalyst V{2,7,1}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.56 0.00 0.00 0.00 0.00 
4 255.56 28.62 5.86 62.79 18.53 
8 255.56 27.65 9.55 105.89 31.25 
12 255.56 28.89 13.00 138.01 40.73 
16 255.56 29.77 16.08 165.66 48.89 
20.5 255.56 28.83 17.44 185.51 54.75 
30 255.56 29.49 21.03 218.67 64.53 
40 255.56 29.83 22.61 232.49 68.61 
50 255.56 30.37 23.92 241.60 71.30 
60 255.56 30.90 25.32 251.30 74.16 
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Equation y = A1*exp(-
x/t1) + y0
Reduced 
Chi-Sqr
0.48572
Adj. R-Square 0.9992
Value Standard Error
product y0 74.57038 0.5602
product A1 -73.95047 0.70337
product t1 15.20992 0.37542
 
 
Half-life: 16.76 
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Table 5. entry 24. catalyst V{2,7,1}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.56 0.00 0.00 0.00 0.00 
4 255.56 28.43 5.87 63.27 18.67 
8 255.56 27.30 9.34 104.87 30.95 
12 255.56 28.46 12.96 139.69 41.23 
16 255.56 28.58 14.92 160.05 47.23 
20 255.56 29.02 17.14 181.11 53.45 
30 255.56 29.95 20.65 211.44 62.40 
40 255.56 29.51 22.64 235.26 69.43 
50 255.56 29.87 24.16 247.99 73.19 
60 255.56 30.33 24.81 250.87 74.04 
80 255.56 30.59 26.72 267.88 79.06 
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p(-x/t1) + 
Reduced 
Chi-Sqr
2.28757
Adj. R-Squar 0.99644
Value Standard Err
product y0 77.3566 1.07477
product A1 -75.7154 1.43138
product t1 17.1036 0.83274
 
 
Half-life: 17.41 
Average: 17.9 
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Table 5. entry 25. catalyst V{3,2,1}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.56 0.00 0.00 0.00 0.00 
5 255.56 28.69 1.64 17.54 5.18 
10 255.56 27.12 3.25 36.73 10.84 
20 255.56 30.07 6.76 68.91 20.34 
40 255.56 28.65 9.53 102.03 30.12 
60 255.56 28.24 11.05 120.02 35.43 
80 255.56 28.47 12.45 134.05 39.57 
100 255.56 28.27 13.51 146.60 43.28 
120 255.56 28.74 15.25 162.75 48.05 
140 255.56 28.82 16.24 172.79 51.01 
180 255.56 28.53 17.91 192.46 56.82 
242 255.56 30.12 21.65 220.42 65.07 
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y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced Chi-Sqr
0.51598
Adj. R-Square 0.99882
Value Standard Error
product y0 119.07447 39.88576
product A1 -94.55959 36.83803
product t1 430.72425 263.38196
product A2 -25.21216 3.16004
product t2 19.82802 3.20748
 
 
Half-life: 135.44 
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Table 5. entry 25. catalyst V{3,2,1}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.56 0.00 0.00 0.00 0.00 
5 255.56 29.84 1.76 18.08 5.34 
10 255.56 29.84 3.63 37.35 11.03 
20 255.56 30.44 6.81 68.66 20.27 
40 255.56 28.39 9.83 106.18 31.35 
60 255.56 29.35 11.44 119.56 35.30 
80 255.56 29.11 12.74 134.25 39.63 
100 255.56 29.90 14.52 148.93 43.97 
120 255.56 30.45 16.03 161.48 47.67 
140 255.56 29.84 17.29 177.66 52.45 
180 255.56 30.13 19.87 202.24 59.70 
242 255.56 31.08 21.97 216.76 63.99 
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y = A1*exp(
-x/t1) + A2*
exp(-x/t2) +
Reduced 
Chi-Sqr
1.82838
Adj. R-Square 0.99591
Value Standard Error
product y0 86.66031 16.42334
product A1 -20.97778 5.45648
product t1 16.44316 5.61606
product A2 -66.478 11.68145
product t2 216.26951 106.12804
 
 
Half-life: 128.77 
Average: 132.1 
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Table 5. entry 26. catalyst V{3,2,5}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.15 0.00 0.00 0.00 0.00 
2 254.15 27.34 0.87 9.42 2.78 
4 254.15 29.32 2.12 21.34 6.30 
6 254.15 29.61 3.19 31.87 9.41 
8 254.15 29.72 4.11 40.89 12.08 
10 254.15 29.68 4.89 48.72 14.39 
15 254.15 29.34 6.54 65.97 19.49 
30 254.15 29.45 9.31 93.56 27.64 
45 254.15 29.32 11.06 111.57 32.96 
60 254.15 29.64 12.53 125.01 36.93 
75 254.15 29.58 13.61 136.11 40.20 
90 254.15 29.64 14.75 147.16 43.47 
105 254.15 29.71 15.69 156.26 46.16 
120 254.15 29.75 16.46 163.63 48.33 
135 254.15 29.99 17.42 171.78 50.74 
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y = A1*exp(x/t1)
 + A2*exp(x/t2) 
+ y0
Reduced 
Chi-Sqr
0.02033
Adj. R-Square 0.99993
Value Standard Error
B y0 69.96055 2.76461
B A1 -50.65778 2.03582
B t1 -139.72585 14.42624
B A2 -20.79752 0.73366
B t2 -10.8851 0.517
 
 
Half-life: 130.13 
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Table 5. entry 26. catalyst V{3,2,5}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.14 0.00 0.00 0.00 0.00 
10 254.14 28.44 3.68 38.25 11.30 
15 254.14 28.41 5.99 62.41 18.43 
30 254.14 29.07 7.73 78.65 23.23 
45 254.14 28.46 10.43 108.41 32.02 
60 254.14 28.60 12.20 126.20 37.28 
75 254.14 28.54 13.35 138.43 40.89 
90 254.14 28.62 14.18 146.56 43.29 
105 254.14 28.94 15.28 156.15 46.12 
120 254.14 28.57 15.84 163.99 48.44 
135 254.14 28.73 16.73 172.26 50.88 
150 254.14 28.83 17.52 179.76 53.10 
165 254.14 28.91 18.25 186.72 55.15 
180 254.14 28.67 18.81 194.07 57.32 
180 254.14 28.86 19.37 198.53 58.64 
 
0 20 40 60 80 100 120 140 160 180 200
10
20
30
40
50
60
 product
 ExpGro2Fit of product
p
ro
d
u
c
t 
(%
)
time (min)
Model ExpGro2
Equation
y = A1*exp(x/t1
) + A2*exp(x/t2
) + y0
Reduced 
Chi-Sqr
0.04506
Adj. R-Square 0.9998
Value Standard Error
product y0 90.2291 7.26009
product A1 -61.91372 6.41889
product t1 -264.57476 48.43657
product A2 -26.47205 0.76742
product t2 -13.13883 0.81055
 
 
Half-life: 114.10 
Average: 122.1 
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Table 5. entry 27. catalyst V{3,2,7}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.15 0.00 0.00 0.00 0.00 
2 254.15 29.86 2.27 22.47 6.63 
4 254.15 29.68 4.47 44.52 13.14 
6 254.15 29.37 6.45 64.93 19.16 
8 254.15 30.37 8.41 81.90 24.17 
10 254.15 29.78 9.70 96.39 28.44 
15 254.15 29.73 12.58 125.19 36.94 
30 254.15 29.26 17.21 173.98 51.34 
45 254.15 29.54 19.79 198.16 58.47 
60 254.15 29.62 21.81 217.86 64.29 
75 254.15 29.58 23.79 237.88 70.20 
90 254.15 29.41 25.26 254.06 74.97 
105 254.15 29.54 27.15 271.89 80.23 
120 254.15 29.48 28.26 283.62 83.69 
135 254.15 29.98 29.16 287.66 84.88 
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y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced 
Chi-Sqr
0.58624
Adj. R-Square 0.99934
Value Standard Error
product y0 112.12485 11.50993
product A1 -74.9183 8.10031
product t1 127.98109 38.75781
product A2 -37.8694 3.75375
product t2 10.44133 1.15954
 
 
Half-life: 28.94 
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Table 5. entry 27. catalyst V{3,2,7}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.15 0.00 0.00 0.00 0.00 
2 254.15 29.40 2.25 22.67 6.69 
4 254.15 29.01 4.53 46.16 13.62 
6 254.15 29.07 6.52 66.36 19.58 
8 254.15 29.32 8.28 83.49 24.64 
10 254.15 29.11 9.62 97.81 28.86 
15 254.15 29.09 12.42 126.33 37.28 
30 254.15 29.45 17.41 174.90 51.61 
45 254.15 29.73 19.99 198.91 58.69 
60 254.15 29.74 21.86 217.44 64.16 
75 254.15 29.79 23.76 235.95 69.62 
90 254.15 29.62 25.49 254.59 75.13 
105 254.15 29.94 27.26 269.40 79.50 
120 254.15 30.03 28.77 283.42 83.63 
135 254.15 29.83 29.48 292.34 86.26 
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y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced Chi-Sqr
0.27425
Adj. R-Square 0.99969
Value Standard Error
product y0 136.92593 21.02298
product A1 -41.34474 2.33476
product t1 10.89864 0.72296
product A2 -96.17664 18.79307
product t2 206.58428 69.37246
 
 
Half-life: 28.33 
Average: 28.6 
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Table 5. entry 28. catalyst V{3,3,1}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.56 0.00 0.00 0.00 0.00 
5 255.56 29.16 4.31 49.86 14.74 
10 255.56 29.37 6.98 80.11 23.69 
20 255.56 29.35 10.33 118.66 35.09 
30 255.56 29.09 12.27 142.29 42.07 
40 255.56 30.01 14.42 162.06 47.92 
50 255.56 28.90 15.11 176.33 52.14 
60 255.56 28.93 16.58 193.29 57.15 
80 255.56 29.59 19.22 219.08 64.78 
100 255.56 29.73 21.92 248.60 73.50 
120 255.56 29.89 23.62 266.48 78.79 
140 255.56 30.80 24.90 272.64 80.61 
180 255.56 30.80 25.47 278.94 82.48 
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y = A1*exp(
-x/t1) + A2*
exp(-x/t2) + 
Reduced 
Chi-Sqr
2.26163
Adj. R-Square 0.99676
Value Standard Error
product y0 90.70048 3.03307
product A1 -16.83199 3.69032
product t1 5.35598 2.03382
product A2 -73.95223 2.39045
product t2 72.80953 9.42236
 
 
Half-life: 43.49 
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Table 5. entry 28. catalyst V{3,3,1}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.56 0.00 0.00 0.00 0.00 
5 255.56 29.96 3.82 43.01 12.72 
10 255.56 30.02 6.59 74.03 21.89 
20 255.56 30.27 10.46 116.51 34.45 
30 255.56 30.44 13.91 154.08 45.56 
40 255.56 29.44 15.26 174.81 51.69 
50 255.56 30.40 17.36 192.62 56.95 
60 255.56 29.64 18.61 211.73 62.60 
80 255.56 30.64 21.87 240.75 71.18 
100 255.56 31.73 23.80 252.94 74.79 
120 255.56 32.63 25.71 265.77 78.58 
140 255.56 30.82 24.68 269.98 79.83 
180 255.56 31.04 24.51 266.35 78.75 
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y = A1*ex
p(-x/t1) + y
Reduced 
Chi-Sqr
2.35227
Adj. R-Square 0.99676
Value Standard Error
product y0 80.81987 1.04755
product A1 -78.5579 1.3057
product t1 39.04017 1.75849
 
 
Half-life: 36.53 
Average: 41.8 
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Table 5. entry 29. catalyst V{3,3,3}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
produc
t % 
0 255.56 0.00 0.00 0.00 0.00 
4 255.56 27.02 4.25 48.19 14.23 
12 255.56 27.82 9.81 108.17 31.93 
16 255.56 30.85 13.03 129.53 38.24 
20 255.56 30.00 15.05 153.89 45.43 
25 255.56 30.97 17.76 175.82 51.91 
30 255.56 30.71 20.04 200.16 59.09 
40 255.56 30.55 22.70 227.88 67.28 
80 255.56 32.48 28.97 273.53 80.75 
128 255.56 31.54 28.50 277.06 81.79 
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(-x/t1) + y0
Reduced 
Chi-Sqr
1.1859
Adj. R-Square 0.99836
Value Standard Error
product y0 83.32212 0.90453
product A1 -82.75101 1.13212
product t1 25.17387 0.77416
 
 
Half-life: 22.90 
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Table 5. entry 29. catalyst V{3,3,3}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
produc
t % 
0 255.56 0.00 0.00 0.00 0.00 
4 255.56 26.40 4.96 57.66 17.02 
8 255.56 27.47 8.46 94.45 27.88 
12 255.56 27.94 11.37 124.75 36.83 
16 255.56 28.30 14.72 159.52 47.09 
20 255.56 30.12 17.62 179.39 52.96 
25 255.56 30.43 20.59 207.53 61.27 
30 255.56 30.47 21.98 221.19 65.30 
40 255.56 30.77 24.30 242.20 71.50 
60 255.56 31.45 26.51 258.53 76.32 
80 255.56 30.09 25.80 263.00 77.64 
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y = A1*exp(-x/t1
) + y0
Reduced 
Chi-Sqr
1.23319
Adj. R-Square 0.99811
Value Standard Error
product y0 79.30123 0.88934
product A1 -79.4149 1.1065
product t1 17.81262 0.60611
 
 
Half-life: 17.76 
Average: 20.3 
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Table 5. entry 30. catalyst V{3,3,5}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.20 0.00 0.00 0.00 0.00 
10 256.20 27.23 5.85 66.05 19.53 
18 256.20 26.67 8.61 99.32 29.37 
38 256.20 29.41 13.47 140.82 41.64 
60 256.20 29.58 16.14 167.75 49.60 
80 256.20 30.03 18.98 194.29 57.45 
100 256.20 29.54 19.32 201.07 59.45 
120 256.20 29.89 20.26 208.38 61.61 
140 256.20 30.14 21.05 214.71 63.48 
160 256.20 29.15 20.97 221.12 65.38 
180 256.20 29.91 22.10 227.15 67.16 
220 256.20 29.05 22.66 239.84 70.91 
240 256.20 29.14 22.88 241.37 71.37 
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y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced 
Chi-Sqr
1.16897
Adj. R-Square 0.99758
Value Standard Error
product y0 75.44889 3.05289
product A1 -32.28568 6.36513
product t1 15.72289 3.31913
product A2 -43.00399 4.16328
product t2 104.50244 28.62967
 
 
Half-life: 58.16 
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Table 5. entry 30. catalyst V{3,3,5}: run 2 
 
time,  
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.20 0.00 0.00 0.00 0.00 
10 256.20 27.58 5.81 64.73 19.14 
18 256.20 28.02 8.68 95.24 28.16 
38 256.20 28.07 12.84 140.60 41.57 
60 256.20 30.17 15.80 161.04 47.62 
80 256.20 30.99 17.93 177.93 52.61 
100 256.20 30.60 19.28 193.75 57.29 
120 256.20 30.63 20.33 204.06 60.34 
140 256.20 30.67 20.95 209.97 62.08 
160 256.20 30.37 21.41 216.75 64.09 
180 256.20 31.21 22.77 224.31 66.32 
220 256.20 30.58 23.05 231.68 68.50 
240 256.20 31.26 24.25 238.48 70.51 
 
0 50 100 150 200 250
-10
0
10
20
30
40
50
60
70
80
 product
 ExpDec2Fit of product
p
ro
d
u
c
t 
(%
)
time (min)
Model ExpDec2
Equation
y = A1*exp(-
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p(-x/t2) + y0
Reduced Chi-Sqr
0.29463
Adj. R-Square 0.99936
Value Standard Error
product y0 75.41098 1.62623
product A1 -29.84323 2.53985
product t1 13.96589 1.43256
product A2 -45.58713 1.47581
product t2 112.18377 13.65899
 
 
Half-life: 66.68 
Average: 62.4 
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Table 5. entry 31. catalyst V{3,3,8}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.33 0.00 0.00 0.00 0.00 
2 255.33 26.52 2.05 23.70 7.00 
4 255.33 27.29 3.76 42.19 12.47 
6 255.33 27.23 4.95 55.72 16.47 
8 255.33 27.28 5.97 67.09 19.83 
10 255.33 27.62 7.17 79.56 23.51 
12 255.33 27.77 8.01 88.38 26.12 
16 255.33 28.69 9.79 104.54 30.89 
20 255.33 30.72 11.89 118.56 35.04 
30 255.33 29.46 13.66 142.11 42.00 
43 255.33 30.90 16.92 167.76 49.58 
63 255.33 31.01 18.53 183.14 54.12 
118 255.33 31.79 23.73 228.76 67.61 
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y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced Chi-Sqr
0.49171
Adj. R-Square 0.99872
Value Standard Error
product y0 92.93697 25.98776
product A1 -59.91293 19.83247
product t1 137.59971 109.98304
product A2 -32.33763 6.32044
product t2 11.73411 2.11204
 
 
Half-life: 47.64 
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Table 5. entry 31. catalyst V{3,3,8}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.33 0.00 0.00 0.00 0.00 
2 255.33 26.97 2.20 24.97 7.38 
4 255.33 27.23 3.76 42.36 12.52 
6 255.33 27.48 4.98 55.49 16.40 
8 255.33 27.93 6.13 67.24 19.87 
10 255.33 27.67 7.04 77.98 23.04 
12 255.33 27.43 7.93 88.53 26.16 
16 255.33 28.15 9.63 104.82 30.98 
20 255.33 30.68 12.26 122.42 36.18 
30 255.33 31.09 15.24 150.18 44.38 
43 255.33 31.47 18.36 178.79 52.84 
63 255.33 30.86 20.97 208.21 61.53 
118 255.33 31.49 24.60 239.31 70.72 
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y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced 
Chi-Sqr
0.10369
Adj. R-Square 0.99977
Value Standard Error
product y0 73.27678 0.49082
product A1 -65.11125 0.5984
product t1 36.74057 1.00068
product A2 -8.04905 0.75754
product t2 3.41925 0.53348
 
 
Half-life: 37.79 
Average: 42.7 
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Table 5. entry 32. catalyst V{3,2,6}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
10 256.20 26.90 2.13 24.30 7.18 
20 256.20 26.70 4.67 53.73 15.89 
30 256.20 26.87 7.41 84.81 25.08 
40 256.20 29.62 9.75 101.18 29.92 
50 256.20 27.70 10.74 119.17 35.24 
60 256.20 29.34 12.59 131.94 39.01 
80 256.20 29.83 14.85 153.02 45.24 
100 256.20 30.27 17.07 173.36 51.26 
120 256.20 29.73 18.21 188.32 55.68 
150 256.20 29.73 19.35 200.15 59.18 
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y = A1*exp
(-x/t1) + y0
Reduced 
Chi-Sqr
0.70734
Adj. R-Square 0.99759
Value Standard Error
product y0 64.75938 1.45692
product A1 -67.08772 1.18382
product t1 61.6075 3.69324
 
 
Half-life: 93.28 
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Table 5. entry 32. catalyst V{3,2,6}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
10 256.20 26.73 2.62 30.10 8.90 
20 256.20 27.19 5.90 66.74 19.73 
30 256.20 29.53 9.86 102.63 30.35 
40 256.20 30.28 11.81 119.92 35.46 
50 256.20 30.47 12.96 130.75 38.66 
60 256.20 29.79 14.17 146.21 43.23 
80 256.20 29.94 16.19 166.29 49.17 
100 256.20 30.12 18.91 193.07 57.09 
120 256.20 30.31 20.74 210.36 62.20 
150 256.20 30.16 22.81 232.48 68.74 
190 256.20 30.27 25.06 254.48 75.24 
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p(-x/t2) + y0
Reduced Chi-Sqr
1.20976
Adj. R-Square 0.99714
Value Standard Error
product y0 99.27463 12.13599
product A1 -30.65126 6.33124
product t1 12.05056 5.58
product A2 -82.5375 7.31507
product t2 152.27126 49.00274
 
 
Half-life: 78.69 
Average:86.0 
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Table 5. entry 33. catalyst V{3,7,5}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.39 0.00 0.00 0.00 0.00 
5 256.39 26.33 4.17 48.77 14.42 
10 256.39 28.79 7.73 82.63 24.43 
20 256.39 27.41 10.31 115.72 34.21 
30 256.39 29.38 13.63 142.73 42.20 
40 256.39 28.17 13.99 152.77 45.17 
50 256.39 28.28 15.16 164.92 48.76 
60 256.39 28.50 16.19 174.75 51.67 
80 256.39 29.22 17.72 186.58 55.17 
100 256.39 29.51 18.91 197.21 58.31 
130 256.39 29.09 20.33 215.07 63.59 
170 256.39 29.65 22.37 232.15 68.64 
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exp(-x/t2) +
Reduced 
Chi-Sqr
0.4165
Adj. R-Square 0.99902
Value Standard Error
product y0 88.18285 10.30605
product A1 -35.79214 2.39224
product t1 11.52162 1.04736
product A2 -52.21357 8.15945
product t2 173.57044 62.33792
 
 
Half-life: 55.63 
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Table 5. entry 33. catalyst V{3,7,5}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.39 0.00 0.00 0.00 0.00 
5 256.39 29.06 4.49 47.58 14.07 
10 256.39 27.23 6.98 78.89 23.33 
20 256.39 29.71 10.90 112.84 33.36 
30 256.39 27.86 12.03 132.79 39.26 
40 256.39 28.12 13.50 147.74 43.68 
50 256.39 30.09 15.24 155.79 46.06 
60 256.39 30.40 16.48 166.85 49.33 
80 256.39 30.07 17.15 175.49 51.89 
100 256.39 28.97 17.97 190.81 56.42 
130 256.39 28.92 19.54 207.84 61.45 
170 256.39 29.59 21.27 221.20 65.40 
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(-x/t1) + A2
*exp(-x/t2) 
Reduced 
Chi-Sqr
0.31163
Adj. R-Square 0.99919
Value Standard Error
product y0 79.25593 5.25544
product A1 -31.86468 1.96423
product t1 10.36465 0.88402
product A2 -47.31301 3.61456
product t2 136.99403 31.57852
 
 
Half-life: 66.11 
Average: 60.9 
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Table 5. entry 34. catalyst V{3,7,8}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.25 0.00 0.00 0.00 0.00 
61 256.25 28.63 7.96 85.53 25.24 
100 256.25 30.50 11.00 110.89 32.73 
140 256.25 30.60 13.27 133.41 39.38 
180 256.25 30.39 15.23 154.08 45.48 
221 256.25 29.09 16.15 170.70 50.38 
260 256.25 30.75 18.01 180.08 53.15 
301 256.25 30.64 18.78 188.53 55.64 
340 256.25 31.11 19.28 190.56 56.24 
403 256.25 30.39 19.77 200.01 59.03 
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Product y0 64.1916 1.33028
Product A1 -57.8254 1.20911
Product t1 159.762 11.98614
 
 
Half-life: 224.43 
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Table 5. entry 34. catalyst V{3,7,8}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 338.81 0.00 0.00 0.00 0.00 
20 338.81 29.57 3.92 40.76 12.03 
61 338.81 30.19 8.52 86.83 25.63 
100 338.81 30.56 11.30 113.64 33.54 
140 338.81 30.50 13.26 133.64 39.44 
180 338.81 29.64 14.82 153.76 45.38 
221 338.81 31.68 16.61 161.23 47.59 
260 338.81 31.22 16.80 165.45 48.83 
301 338.81 31.99 17.95 172.55 50.93 
340 338.81 30.87 17.40 173.31 51.15 
403 338.81 32.14 18.97 181.46 53.56 
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Chi-Sqr
0.44045
Adj. R-Squar 0.99755
Value Standard Err
Product y0 54.16864 0.59317
Product A1 -50.3923 0.85759
Product t1 110.0667 5.09433
 
 
Half-life: 274.31 
Average: 249.4 
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Table 5. entry 35. catalyst V{4,2,5}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.66 0.00 0.00 0.00 0.00 
4 254.66 27.50 3.04 33.84 9.98 
8 254.66 27.78 5.04 55.54 16.38 
12 254.66 27.89 6.11 67.10 19.79 
16 254.66 30.42 7.78 78.35 23.11 
20 254.66 29.88 8.72 89.41 26.37 
30 254.66 30.57 11.05 110.71 32.65 
40 254.66 30.90 12.81 127.03 37.46 
60 254.66 30.84 15.14 150.45 44.37 
80 254.66 30.58 16.29 163.17 48.12 
105 254.66 30.82 18.19 180.83 53.33 
155 254.66 31.02 20.20 199.53 58.84 
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y = A1*exp(-x/t1) 
+ A2*exp(-x/t2) + 
y0
Reduced Chi-Sqr
0.40408
Adj. R-Square 0.99877
Value Standard Error
B y0 62.31721 1.37724
B A1 -13.02946 1.78568
B t1 5.78617 1.24966
B A2 -49.1645 1.22818
B t2 60.90001 5.6273
 
 
Half-life: 84.30 
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Table 5. entry 35. catalyst V{4,2,5}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.66 0.00 0.00 0.00 0.00 
4 254.66 28.46 2.78 29.88 8.81 
8 254.66 28.72 4.92 52.47 15.48 
12 254.66 28.94 6.47 68.52 20.21 
16 254.66 28.93 7.65 81.03 23.90 
20 254.66 29.20 8.49 89.14 26.29 
30 254.66 31.70 10.26 99.18 29.25 
40 254.66 29.66 10.69 110.45 32.57 
60 254.66 31.94 13.00 124.77 36.80 
105 254.66 31.89 15.07 144.80 42.70 
155 254.66 25.16 12.45 151.57 44.70 
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y = A1*exp(-x/t1
) + A2*exp(-x/t2
) + y0
Reduced 
Chi-Sqr
0.1964
Adj. R-Square 0.99926
Value Standard Error
B y0 60.18483 1.99733
B A1 -20.89576 2.66769
B t1 10.48354 1.40204
B A2 -39.15794 1.41417
B t2 76.54636 13.08246
 
 
Half-life: 103.94 
Average: 93.7 
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Table 5. entry 36. catalyst V{5,2,1}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.40 0.00 0.00 0.00 0.00 
2 255.40 30.92 4.56 45.16 13.36 
3 255.40 31.73 6.70 64.71 19.14 
4 255.40 30.98 8.65 85.56 25.32 
5 255.40 31.00 10.35 102.32 30.27 
6 255.40 31.26 12.08 118.43 35.04 
7 255.40 31.43 13.68 133.40 39.47 
8 255.40 31.08 14.85 146.42 43.32 
9 255.40 31.12 15.97 157.30 46.54 
10 255.40 31.16 17.20 169.16 50.05 
15 255.40 31.40 22.11 215.77 63.84 
30 255.40 31.47 30.54 297.42 88.00 
60 255.40 31.59 34.53 334.99 99.11 
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0.34685
Adj. R-Square 0.99956
Value Standard Error
Product y0 100.48919 0.60023
Product A1 -99.82977 0.62682
Product t1 14.49582 0.22609
 
 
Half-life: 9.88 
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Table 5. entry 36. catalyst V{5,2,1}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.40 30.32 0.00 0.00 0.00 
1 255.40 30.41 2.43 24.52 7.26 
2 255.40 31.06 4.39 43.34 12.82 
3 255.40 30.71 6.07 60.54 17.91 
4 255.40 30.96 7.80 77.19 22.84 
5 255.40 31.10 9.37 92.37 27.33 
6 255.40 31.36 10.79 105.45 31.20 
7 255.40 31.10 12.09 119.14 35.25 
8 255.40 31.19 13.31 130.83 38.71 
9 255.40 30.90 14.24 141.21 41.78 
10 255.40 31.28 15.50 151.89 44.94 
15 255.40 31.28 20.04 196.34 58.09 
30 255.40 31.48 29.85 290.62 85.98 
60 255.40 31.33 34.29 335.42 99.24 
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Chi-Sqr
0.84941
Adj. R-Square 0.99893
Value Standard Erro
Product y0 102.89447 1.0856
Product A1 -101.4632 1.05182
Product t1 17.50423 0.45255
 
 
Half-life: 11.40 
Average: 10.64 
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Table 5. entry 37. catalyst V{5,2,2}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.40 30.70 0.00 0.00 0.00 
1 255.40 30.18 1.76 17.84 5.28 
2 255.40 30.77 3.72 37.09 10.98 
3 255.40 30.79 5.35 53.22 15.75 
4 255.40 30.61 6.88 68.87 20.38 
5 255.40 30.75 8.31 82.80 24.51 
6 255.40 30.53 9.58 96.19 28.47 
7 255.40 30.72 10.91 108.82 32.21 
8 255.40 30.52 11.98 120.30 35.60 
9 255.40 30.75 13.19 131.52 38.93 
10 255.40 30.68 14.27 142.56 42.18 
15 255.40 30.39 19.11 192.70 57.01 
30 255.40 30.38 27.82 280.66 83.04 
60 255.40 30.88 32.71 324.63 96.05 
 
0 10 20 30 40 50 60
0
20
40
60
80
100  Product
 ExpDec1Fit of Product
P
ro
d
u
c
t 
(%
)
time (min)
Model ExpDec1
Equation
y = A1*ex
p(-x/t1) + 
Reduced 
Chi-Sqr
0.41574
Adj. R-Squar 0.99946
Value Standard Err
Product y0 100.3272 0.77619
Product A1 -100.365 0.74736
Product t1 17.92691 0.33344
 
 
Half-life: 12.37 
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Table 5. entry 37. catalyst V{5,2,2}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.40 30.35 0.00 0.00 0.00 
1 255.40 30.96 1.70 16.84 4.98 
2 255.40 31.19 3.83 37.63 11.13 
3 255.40 31.31 5.72 55.94 16.54 
4 255.40 31.13 7.39 72.80 21.53 
5 255.40 31.08 8.92 87.95 26.01 
6 255.40 30.90 10.26 101.79 30.10 
7 255.40 29.95 11.48 117.43 34.72 
8 255.40 30.73 12.82 127.93 37.82 
9 255.40 30.08 13.53 137.82 40.75 
10 255.40 31.15 14.94 146.98 43.46 
15 255.40 30.95 19.19 190.02 56.18 
30 255.40 31.37 26.86 262.37 77.58 
61 255.40 31.56 31.86 309.37 91.47 
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Chi-Sqr
0.70603
Adj. R-Square 0.99904
Value Standard Erro
Product y0 92.33428 0.89499
Product A1 -92.07423 0.89543
Product t1 15.55355 0.38849
 
 
Half-life: 12.09 
Average: 12.2 
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Table 5. entry 38. catalyst V{5,2,3}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.50 30.34 0.00 0.00 0.00 
1 254.50 30.93 2.51 24.76 7.30 
2 254.50 30.84 4.93 48.77 14.38 
3 254.50 30.79 6.86 68.01 20.05 
4 254.50 31.01 8.66 85.34 25.16 
5 254.50 30.92 10.29 101.67 29.97 
6 254.50 30.87 11.67 115.44 34.03 
7 254.50 30.94 12.98 128.16 37.78 
8 254.50 30.88 14.09 139.31 41.07 
9 254.50 30.98 15.15 149.40 44.04 
10 254.50 30.72 16.08 159.85 47.12 
15 254.50 30.93 20.89 206.29 60.81 
30 254.50 31.00 30.27 298.22 87.91 
60 254.50 31.44 35.19 341.84 100.77 
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Adj. R-Squar 0.99808
Value Standard Err
Product y0 103.32362 1.38921
Product A1 -101.3044 1.37087
Product t1 16.38958 0.54967
 
 
Half-life: 10.52 
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Table 5. entry 38. catalyst V{5,2,3}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.50 30.36 0.00 0.00 0.00 
1 254.50 30.46 2.23 22.33 6.58 
2 254.50 30.46 4.29 43.00 12.68 
3 254.50 31.04 6.37 62.70 18.48 
4 254.50 31.19 8.23 80.56 23.75 
5 254.50 30.81 9.87 97.86 28.85 
6 254.50 31.00 11.42 112.47 33.16 
7 254.50 30.74 12.81 127.22 37.50 
8 254.50 31.02 14.30 140.80 41.51 
9 254.50 30.91 15.77 155.76 45.92 
10 254.50 30.92 17.04 168.32 49.62 
15 254.50 30.90 22.60 223.31 65.83 
30 254.50 31.27 31.93 311.82 91.92 
60 254.50 31.16 35.23 345.31 101.80 
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0.64523
Adj. R-Squar 0.99928
Value Standard Erro
Product y0 105.11404 0.85241
Product A1 -105.4633 0.85626
Product t1 15.43655 0.30818
 
 
Half-life: 10.02 
Average: 10.3 
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Table 5. entry 39. catalyst V{5,2,5}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.10 0.00 0.00 0.00 0.00 
2 256.10 31.79 26.46 255.72 75.55 
4 256.10 28.81 8.72 92.99 27.48 
6 256.10 29.14 11.82 124.65 36.83 
8 256.10 27.37 13.47 151.26 44.69 
10 256.10 27.90 15.40 169.59 50.11 
12 256.10 18.46 11.89 197.83 58.45 
16 256.10 28.43 20.04 216.64 64.01 
20 256.10 28.82 22.64 241.45 71.34 
30 256.10 28.84 25.73 274.23 81.02 
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Adj. R-Square 0.99745
Value Standard Error
product y0 85.70557 1.79306
product A1 -85.05826 1.79197
product t1 11.04054 0.5642
 
 
Half-life: 9.58 
393 
 
Table 5. entry 39. catalyst V{5,2,5}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.10 0.00 0.00 0.00 0.00 
2 256.10 26.77 5.37 61.65 18.21 
4 256.10 27.58 9.07 101.12 29.88 
6 256.10 28.43 11.98 129.44 38.24 
8 256.10 28.49 14.57 157.20 46.44 
10 256.10 28.74 16.21 173.39 51.23 
12 256.10 29.15 17.70 186.55 55.12 
16 256.10 29.29 20.61 216.19 63.88 
20 256.10 29.62 22.41 232.47 68.69 
30 256.10 31.16 26.29 259.33 76.62 
40 256.10 30.56 26.41 265.63 78.48 
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Reduced 
Chi-Sqr
2.08516
Adj. R-Square 0.99659
Value Standard Erro
product y0 79.08388 1.22753
product A1 -77.03265 1.45595
product t1 9.60433 0.4525
 
 
Half-life: 9.36 
Average: 9.5 
394 
 
Table 5. entry 40. catalyst V{5,2,8}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.65 0.00 0.00 0.00 0.00 
4 255.65 27.72 5.38 59.53 17.60 
6 255.65 27.70 7.14 79.03 23.37 
8 255.65 27.81 8.83 97.43 28.81 
10 255.65 28.59 10.25 109.98 32.52 
12 255.65 28.39 11.55 124.79 36.90 
14 255.65 30.77 13.87 138.27 40.88 
16 255.65 29.02 14.23 150.49 44.50 
20 255.65 30.36 17.17 173.46 51.29 
30 255.65 31.25 22.12 217.10 64.19 
60 255.65 32.07 27.30 261.13 77.21 
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y = A1*exp
(-x/t1) + y0
Reduced 
Chi-Sqr
1.27875
Adj. R-Square 0.99724
Value Standard Error
product y0 81.11168 1.53668
product A1 -79.55186 1.50996
product t1 19.99032 0.89303
 
 
Half-life: 18.77 
395 
 
Table 5. entry 40. catalyst V{5,2,8}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.65 0.00 0.00 0.00 0.00 
4 255.65 27.79 5.43 59.41 17.57 
6 255.65 28.13 7.80 84.31 24.93 
8 255.65 28.11 9.65 104.42 30.88 
10 255.65 28.84 11.53 121.70 35.98 
12 255.65 28.93 13.05 137.24 40.58 
14 255.65 31.19 15.61 152.23 45.01 
16 255.65 31.56 16.63 160.35 47.41 
20 255.65 30.74 19.24 190.47 56.32 
30 255.65 31.02 23.39 229.42 67.83 
60 255.65 31.20 26.95 262.83 77.71 
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y = A1*exp
(-x/t1) + y0
Reduced 
Chi-Sqr
0.32971
Adj. R-Square 0.9994
Value Standard Error
product y0 80.27271 0.6605
product A1 -80.07007 0.69695
product t1 16.70201 0.34661
 
 
Half-life: 16.25 
Average: 17.5 
396 
 
Table 5. entry 41. catalyst V{5,2,9}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 253.42 0.00 0.00 0.00 0.00 
2 253.42 25.50 3.48 41.49 12.27 
4 253.42 25.88 5.77 67.85 20.06 
6 253.42 26.97 7.84 88.44 26.15 
8 253.42 26.88 9.70 109.75 32.45 
10 253.42 26.69 11.29 128.70 38.05 
12 253.42 27.22 12.46 139.15 41.14 
15 253.42 27.32 14.66 163.15 48.24 
20 253.42 27.99 17.51 190.27 56.26 
30 253.42 28.08 20.93 226.74 67.04 
45 253.42 28.64 23.35 247.92 73.30 
60 253.42 28.71 24.74 262.05 77.48 
75 253.42 29.06 25.50 266.90 78.92 
90 253.42 28.85 25.75 271.48 80.27 
105 253.42 29.08 25.50 266.62 78.83 
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x/t1) + y0
Reduced 
Chi-Sqr
1.05464
Adj. R-Square 0.99854
Value Standard Error
product y0 79.39081 0.53134
product A1 -77.3041 0.80191
product t1 16.35455 0.42735
 
 
Half-life: 15.82 
 
397 
 
Table 5. entry 41. catalyst V{5,2,9}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
& 
0 253.42 0.00 0.00 0.00 0.00 
2 253.42 25.07 3.53 42.87 12.66 
4 253.42 25.65 6.09 72.23 21.34 
6 253.42 26.76 8.34 94.76 27.99 
8 253.42 26.77 9.96 113.12 33.41 
10 253.42 27.20 11.47 128.20 37.87 
12 253.42 27.46 12.95 143.37 42.35 
15 253.42 27.53 14.88 164.32 48.54 
20 253.42 27.69 17.72 194.65 57.50 
30 253.42 28.88 20.93 220.31 65.08 
45 253.42 28.98 23.04 241.74 71.41 
60 253.42 28.72 24.77 262.30 77.48 
75 253.42 29.23 25.61 266.47 78.71 
90 253.42 29.23 25.59 266.29 78.66 
105 253.42 28.95 25.91 272.15 80.39 
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y = A1*exp(-x/
t1) + A2*exp(-
x/t2) + y0
Reduced Chi-Sqr
0.98487
Adj. R-Square 0.99858
Value Standard Error
product y0 79.79723 0.64838
product A1 -9.96808 3.26815
product t1 2.56305 1.19561
product A2 -69.75288 2.95174
product t2 18.9187 1.25396
 
 
Half-life: 16.15 
Average: 16.0 
398 
 
Table 5. entry 42. catalyst V{5,2,10}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 253.42 0.00 0.00 0.00 0.00 
1 253.42 25.96 1.91 22.38 6.62 
2 253.42 25.21 3.44 41.54 12.28 
3 253.42 25.69 4.52 53.57 15.84 
4 253.42 26.55 5.54 63.43 18.75 
5 253.42 26.43 6.74 77.52 22.92 
6 253.42 26.84 7.95 90.04 26.62 
7 253.42 26.59 8.91 101.87 30.12 
8 253.42 26.57 9.84 112.67 33.31 
9 253.42 26.74 11.18 127.15 37.60 
10 253.42 27.04 11.97 134.57 39.79 
15 253.42 27.28 15.22 169.64 50.16 
30 253.42 28.36 20.31 217.80 64.40 
45 253.42 28.39 22.86 244.83 72.39 
60 253.42 28.86 24.25 255.46 75.53 
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-x/t1) + y0
Reduced 
Chi-Sqr
1.08887
Adj. R-Square 0.99798
Value Standard Error
product y0 75.33361 0.84607
product A1 -74.1936 0.91049
product t1 13.99133 0.45817
 
 
Half-life: 15.03 
399 
 
Table 5. entry 42. catalyst V{5,2,10}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 253.42 0.00 0.00 0.00 0.00 
1 253.42 25.26 2.05 24.72 7.30 
2 253.42 25.36 3.67 43.97 12.99 
3 253.42 25.34 5.02 60.29 17.81 
4 253.42 25.40 6.28 75.18 22.21 
5 253.42 25.94 7.37 86.35 25.51 
8 253.42 26.95 10.43 117.63 34.74 
9 253.42 26.75 11.29 128.30 37.90 
10 253.42 26.91 12.00 135.60 40.05 
15 253.42 26.99 16.06 180.97 53.46 
30 253.42 27.85 20.91 228.38 67.46 
45 253.42 28.32 23.34 250.56 74.01 
60 253.42 28.77 24.47 258.73 76.42 
 
0 10 20 30 40 50 60
-10
0
10
20
30
40
50
60
70
80  product
 ExpDec1Fit of product
p
ro
d
u
c
t 
(%
)
time (min)
Model ExpDec1
Equation
y = A1*exp
(-x/t1) + y0
Reduced 
Chi-Sqr
1.16209
Adj. R-Square 0.99818
Value Standard Error
product y0 76.55488 0.85219
product A1 -74.79581 0.94028
product t1 13.34909 0.45618
 
 
Half-life: 13.82 
Average: 14.4 
 
400 
 
Table 5. entry 43. catalyst V{5,3,1}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.50 30.30 0.00 0.00 0.00 
1 254.50 30.28 2.33 23.48 6.91 
2 254.50 29.97 4.59 46.77 13.77 
3 254.50 30.29 6.56 66.10 19.47 
4 254.50 30.48 8.29 83.05 24.46 
6 254.50 30.13 11.03 111.78 32.92 
7 254.50 31.47 12.39 120.24 35.41 
8 254.50 31.69 14.03 135.26 39.83 
9 254.50 31.44 15.64 151.90 44.73 
10 254.50 31.91 16.71 159.93 47.10 
15 254.50 33.40 22.94 209.75 61.77 
30 254.50 31.08 30.20 296.73 87.39 
60 254.50 31.71 34.34 330.75 97.40 
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Chi-Sqr
1.14352
Adj. R-Squar 0.99865
Value Standard Erro
Product y0 100.3197 1.15013
Product A1 -99.3255 1.15847
Product t1 15.66262 0.448
 
 
Half-life: 10.65 
401 
 
Table 5. entry 43. catalyst V{5,3,1}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.18 29.59 0.00 0.00 0.00 
1 254.18 31.91 3.37 32.22 9.49 
2 254.18 29.77 5.79 59.37 17.48 
3 254.18 30.90 8.29 81.97 24.14 
4 254.18 30.84 10.14 100.43 29.58 
5 254.18 31.96 11.92 113.90 33.54 
6 254.18 32.07 13.09 124.69 36.72 
7 254.18 32.66 16.02 149.83 44.12 
8 254.18 31.76 16.98 163.23 48.07 
9 254.18 32.52 19.16 179.91 52.98 
10 254.18 32.38 20.21 190.57 56.12 
15 254.18 32.14 25.34 240.85 70.93 
30 254.18 31.21 31.91 312.28 91.97 
60 254.18 31.76 35.00 336.64 99.14 
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Reduced 
Chi-Sqr
0.71114
Adj. R-Squar 0.99927
Value Standard Erro
Product y0 99.93963 0.77146
Product A1 -98.3855 0.84063
Product t1 12.20467 0.24979
 
 
Half-life: 8.28 
Average: 9.5 
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Table 5. entry 44. catalyst V{5,3,2}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 257.76 0.00 0.00 0.00 0.00 
1 257.76 31.00 1.81 17.55 5.17 
2 257.76 32.13 3.66 34.16 10.06 
3 257.76 31.72 5.19 49.11 14.46 
4 257.76 30.77 6.36 62.04 18.27 
5 257.76 30.80 7.54 73.40 21.62 
6 257.76 31.17 8.83 84.96 25.02 
7 257.76 30.81 9.77 95.17 28.03 
8 257.76 30.68 10.74 105.03 30.93 
9 257.76 31.38 11.90 113.73 33.49 
10 257.76 30.79 12.57 122.48 36.07 
12 257.76 31.00 14.31 138.48 40.78 
15 257.76 30.76 16.22 158.16 46.58 
30 257.76 30.76 22.49 219.38 64.61 
60 257.76 30.76 28.71 280.03 82.47 
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y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced Chi-Sqr
0.03335
Adj. R-Square 0.99993
Value Standard Error
product y0 101.23648 5.64628
product A1 -67.18165 1.38468
product t1 46.99628 11.15838
product A2 -33.90648 6.04599
product t2 8.71452 0.94602
 
 
Half-life: 17.24 
403 
 
Table 5. entry 44. catalyst V{5,3,2}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 257.76 0.00 0.00 0.00 0.00 
1 257.76 29.81 1.28 12.88 3.79 
2 257.76 29.92 2.86 28.65 8.44 
3 257.76 30.28 4.23 41.93 12.35 
4 257.76 30.02 5.45 54.47 16.04 
5 257.76 29.89 6.55 65.74 19.36 
6 257.76 30.49 7.67 75.43 22.21 
7 257.76 29.93 8.56 85.82 25.27 
8 257.76 30.12 9.52 94.83 27.93 
9 257.76 29.93 10.27 102.92 30.31 
10 257.76 30.28 11.23 111.26 32.77 
12 257.76 30.50 12.71 125.05 36.83 
15 257.76 30.63 14.55 142.54 41.98 
30 257.76 30.68 21.26 207.87 61.22 
60 257.76 30.52 27.41 269.48 79.36 
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y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced Chi-Sqr
0.05942
Adj. R-Square 0.99987
Value Standard Error
product y0 92.28395 2.51075
product A1 -18.55163 4.68368
product t1 6.8548 1.1755
product A2 -74.10872 2.55079
product t2 34.32909 4.24484
 
 
Half-life: 20.08 
Average: 18.7 
404 
 
Table 5. entry 45. catalyst V{5,3,3}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 257.76 0.00 0.00 0.00 0.00 
1 257.76 30.12 2.41 24.02 7.07 
2 257.76 30.30 4.68 46.31 13.64 
3 257.76 30.35 6.69 66.15 19.48 
4 257.76 30.55 8.40 82.49 24.29 
5 257.76 30.36 10.01 98.90 29.13 
6 257.76 30.43 11.43 112.67 33.18 
7 257.76 30.47 12.73 125.38 36.92 
8 257.76 30.39 13.87 136.91 40.32 
9 257.76 30.21 14.91 148.04 43.60 
10 257.76 30.65 16.11 157.74 46.45 
12 257.76 30.26 17.92 177.72 52.34 
15 257.76 30.30 20.48 202.77 59.72 
30 257.76 30.38 28.44 280.94 82.73 
60 257.76 30.78 32.75 319.26 94.02 
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(-x/t1) + y0
Reduced 
Chi-Sqr
0.72486
Adj. R-Square 0.99894
Value Standard Erro
product y0 95.41508 0.88441
product A1 -93.83307 0.89704
product t1 15.05222 0.33896
 
 
Half-life: 10.92 
405 
 
Table 5. entry 45. catalyst V{5,3,3}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 257.76 0.00 0.00 0.00 0.00 
1 257.76 29.88 2.13 21.42 6.31 
2 257.76 29.89 4.12 41.36 12.18 
3 257.76 29.96 5.68 56.85 16.74 
4 257.76 30.11 7.04 70.11 20.65 
5 257.76 29.64 7.99 80.90 23.83 
6 257.76 30.32 9.26 91.57 26.97 
7 257.76 29.95 10.08 101.02 29.75 
8 257.76 30.42 11.33 111.77 32.92 
9 257.76 30.15 12.03 119.70 35.25 
10 257.76 30.70 13.16 128.65 37.89 
12 257.76 30.24 14.71 145.94 42.98 
15 257.76 30.51 16.87 165.82 48.83 
30 257.76 30.68 25.05 244.97 72.14 
60 257.76 30.78 30.88 300.95 88.63 
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y = A1*exp(-
x/t1) + A2*ex
p(-x/t2) + y0
Reduced Chi-Sqr
0.13505
Adj. R-Square 0.99976
Value Standard Error
product y0 95.14487 0.71517
product A1 -6.65093 0.72284
product t1 1.55705 0.30165
product A2 -88.66883 0.56686
product t2 22.69364 0.58446
 
 
Half-life: 15.32 
Average: 13.1 
406 
 
Table 5. entry 46. catalyst V{5,3,5}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.50 30.58 0.00 0.00 0.00 
1 254.50 30.50 3.65 35.48 10.45 
2 254.50 30.92 7.82 74.90 22.06 
3 254.50 31.16 11.93 113.39 33.39 
4 254.50 31.22 15.40 146.17 43.05 
5 254.50 31.37 18.29 172.71 50.86 
6 254.50 31.08 20.12 191.70 56.46 
7 254.50 31.39 21.82 205.96 60.65 
8 254.50 31.43 23.37 220.29 64.88 
9 254.50 31.14 24.16 229.81 67.68 
10 254.50 31.13 25.55 243.06 71.58 
15 254.50 30.76 29.22 281.35 82.86 
30 254.50 31.87 34.41 319.84 94.19 
60 254.50 31.57 35.40 332.19 97.83 
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(-x/t1) + y0
Reduced 
Chi-Sqr
2.37224
Adj. R-Square 0.9973
Value Standard Error
Product y0 96.00939 1.09043
Product A1 -96.60051 1.40071
Product t1 7.01325 0.22357
 
 
Half-life: 5.20 
407 
 
Table 5. entry 46. catalyst V{5,3,5}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
1 254.50 30.04 3.76 37.04 10.91 
2 254.50 30.20 8.44 82.74 24.37 
3 254.50 30.25 12.64 123.76 36.45 
4 254.50 30.14 16.23 159.49 46.97 
5 254.50 30.62 18.92 182.98 53.89 
6 254.50 31.01 21.74 207.61 61.14 
7 254.50 30.85 23.29 223.61 65.85 
8 254.50 30.86 24.90 238.97 70.38 
9 254.50 30.62 25.81 249.68 73.53 
10 254.50 30.59 27.05 261.93 77.14 
15 254.50 30.69 30.69 296.27 87.25 
30 254.50 31.23 34.88 330.87 97.44 
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Chi-Sqr
1.19361
Adj. R-Squar 0.99817
Value Standard Err
Product y0 96.58044 1.01218
Product A1 -100.5535 1.30229
Product t1 5.91194 0.18397
 
 
Half-life: 4.55 
Average: 4.9 
408 
 
Table 5. entry 47. catalyst V{5,3,8}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.50 29.74 0.00 0.00 0.00 
1 254.50 29.99 3.26 33.20 9.79 
2 254.50 30.59 5.95 59.44 17.52 
3 254.50 30.91 8.06 79.60 23.47 
4 254.50 30.38 9.85 99.03 29.19 
5 254.50 30.39 11.52 115.82 34.14 
6 254.50 30.34 12.97 130.60 38.50 
7 254.50 30.39 14.21 142.80 42.10 
8 254.50 30.47 15.45 154.90 45.66 
9 254.50 30.79 16.53 163.96 48.33 
10 254.50 30.65 17.40 173.45 51.13 
15 254.50 30.67 21.86 217.63 64.16 
30 254.50 30.64 29.95 298.50 88.00 
60 254.50 30.96 34.93 344.50 101.56 
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y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced 
Chi-Sqr
0.18749
Adj. R-Square 0.99976
Value Standard Error
product y0 105.25951 0.69178
product A1 -92.34092 1.03099
product t1 18.28545 0.58692
product A2 -12.9826 1.32615
product t2 2.06966 0.29228
 
 
Half-life: 9.43 
409 
 
Table 5. entry 47. catalyst V{5,3,8}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.50 29.91 0.00 0.00 0.00 
1 254.50 30.16 2.90 29.40 8.67 
2 254.50 30.26 5.46 55.11 16.25 
3 254.50 30.60 7.52 75.11 22.14 
4 254.50 30.66 9.30 92.67 27.32 
5 254.50 30.71 10.93 108.72 32.05 
6 254.50 30.90 12.44 122.97 36.25 
7 254.50 30.44 13.59 136.34 40.19 
8 254.50 30.59 14.88 148.55 43.79 
9 254.50 30.69 15.78 157.06 46.30 
10 254.50 30.79 16.84 167.07 49.25 
15 254.50 30.78 20.74 205.79 60.66 
30 254.50 31.10 28.59 280.72 82.75 
60 254.50 31.07 34.45 338.70 99.85 
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Equation
y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced 
Chi-Sqr
0.05036
Adj. R-Square 0.99993
Value Standard Error
product y0 106.49376 0.59773
product A1 -85.98834 0.85166
product t1 23.39875 0.67433
product A2 -20.50847 1.18719
product t2 3.47271 0.21407
 
 
Half-life: 10.27 
Average: 9.9 
410 
 
Table 5. entry 48. catalyst V{5,3,7}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.50 30.07 0.00 0.00 0.00 
1 254.50 30.50 2.89 28.12 8.27 
2 254.50 30.25 5.45 53.36 15.70 
3 254.50 30.14 7.83 76.92 22.63 
4 254.50 30.30 10.04 98.12 28.87 
5 254.50 30.59 11.96 115.84 34.08 
6 254.50 30.64 13.60 131.46 38.68 
7 254.50 30.59 15.06 145.80 42.90 
8 254.50 30.84 16.66 159.98 47.07 
9 254.50 30.84 17.90 171.90 50.57 
10 254.50 30.83 19.12 183.66 54.03 
15 254.50 30.91 23.32 223.45 65.74 
30.5 254.50 31.07 31.25 298.00 87.67 
60 254.50 31.21 35.34 335.39 98.67 
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Equation
y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced 
Chi-Sqr
0.1342
Adj. R-Square 0.99983
Value Standard Error
product y0 101.33209 0.70548
product A1 -20.73403 4.78328
product t1 4.44101 0.728
product A2 -80.85822 4.37993
product t2 17.38103 1.10354
 
 
Half-life: 8.88 
411 
 
Table 5. entry 48. catalyst V{5,3,7}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.50 29.87 0.00 0.00 0.00 
1 254.50 29.77 3.19 31.75 9.34 
2 254.50 29.02 5.77 58.93 17.34 
3 254.50 30.24 8.51 83.42 24.54 
4 254.50 30.51 10.67 103.54 30.46 
5 254.50 30.69 12.69 122.51 36.04 
6 254.50 30.81 14.29 137.38 40.42 
7 254.50 30.41 15.78 153.66 45.21 
8 254.50 31.00 17.58 168.03 49.44 
9 254.50 31.02 18.93 180.83 53.20 
10 254.50 31.00 20.17 192.74 56.70 
15 254.50 31.27 25.19 238.68 70.22 
30 254.50 31.05 31.52 300.69 88.46 
60 254.50 31.45 35.81 337.26 99.22 
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y = A1*exp(-x
/t1) + A2*exp(
-x/t2) + y0
Reduced Chi-Sqr
0.13583
Adj. R-Square 0.99983
Value Standard Error
product y0 101.47 0.87271
product A1 -32.78302 10.63663
product t1 5.85987 1.02793
product A2 -68.36759 10.06498
product t2 17.70493 2.1704
 
 
Half-life: 8.11 
Average: 8.5 
412 
 
Table 5. entry 49. catalyst V{5,6,1}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 127.15 0.00 0.00 0.00 0.00 
2 127.15 33.05 6.62 30.54 17.94 
4 127.15 31.93 11.55 55.14 32.38 
6 127.15 30.71 14.89 73.88 43.38 
8 127.15 31.05 17.22 84.49 49.62 
10 127.15 30.50 19.32 96.55 56.70 
12 127.15 29.38 20.46 106.16 62.34 
14 127.15 30.37 21.90 109.90 64.54 
16 127.15 28.77 22.43 118.83 69.78 
20.1 127.15 28.80 23.66 125.20 73.52 
29 127.15 28.34 26.12 140.43 82.47 
45 127.15 28.56 27.03 144.21 84.69 
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Reduced 
Chi-Sqr
2.02808
Adj. R-Squar 0.99698
Value Standard Err
product y0 84.47648 1.13497
product A1 -83.1299 1.40342
product t1 9.10664 0.37029
 
 
Half-life: 8.02 
413 
 
Table 5. entry 49. catalyst V{5,6,1}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 127.15 0.00 0.00 0.00 0.00 
2 127.15 32.14 7.05 33.45 19.64 
4 127.15 29.56 11.27 58.09 34.11 
6 127.15 30.08 14.59 73.89 43.39 
8 127.15 29.43 16.71 86.51 50.80 
10 127.15 29.77 18.83 96.37 56.59 
12 127.15 29.16 20.09 105.01 61.66 
14 127.15 28.18 21.87 118.31 69.47 
16 127.15 28.27 23.59 127.16 74.67 
20 127.15 28.10 25.42 137.85 80.95 
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y = A1*ex
p(-x/t1) + 
Reduced 
Chi-Sqr
4.30883
Adj. R-Squar 0.99336
Value Standard Erro
product y0 92.00354 4.5121
product A1 -89.9579 4.07292
product t1 10.09339 1.10902
 
 
Half-life: 7.69 
Average: 7.9 
414 
 
Table 5. entry 50. catalyst V{5,6,5}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 127.15 0.00 0.00 0.00 0.00 
2 127.15 31.62 6.70 32.30 18.97 
4 127.15 30.59 12.27 61.15 35.91 
6 127.15 29.39 15.31 79.41 46.63 
8 127.15 28.92 17.74 93.51 54.91 
10 127.15 29.19 19.73 103.02 60.50 
12 127.15 28.45 20.43 109.44 64.27 
14 127.15 29.24 21.26 110.81 65.07 
16 127.15 28.84 22.30 117.80 69.18 
20 127.15 28.18 22.78 123.23 72.37 
30 127.15 28.84 24.13 127.52 74.89 
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(-x/t1) + y0
Reduced 
Chi-Sqr
0.41865
Adj. R-Square 0.99931
Value Standard Erro
product y0 75.40992 0.50335
product A1 -76.00281 0.6696
product t1 6.20989 0.1342
 
 
Half-life: 6.80 
415 
 
Table 5. entry 50. catalyst V{5,6,5}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 127.15 0.00 0.00 0.00 0.00 
2 127.15 31.50 6.38 30.85 18.12 
4 127.15 30.76 12.01 59.52 34.95 
6 127.15 31.10 15.59 76.40 44.86 
8 127.15 30.24 17.76 89.49 52.55 
10 127.15 29.26 18.94 98.66 57.94 
12 127.15 28.78 20.52 108.66 63.81 
14 127.15 28.52 21.45 114.63 67.32 
16 127.15 28.24 22.11 119.29 70.05 
20 127.15 28.80 23.69 125.38 73.63 
30 127.15 28.64 24.35 129.59 76.10 
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(-x/t1) + y0
Reduced 
Chi-Sqr
0.56837
Adj. R-Square 0.99905
Value Standard Error
product y0 77.5717 0.63981
product A1 -77.81682 0.77998
product t1 6.97404 0.17854
 
 
Half-life: 7.24 
Average: 7.0 
416 
 
Table 5. entry 51. catalyst V{5,6,8}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 127.15 0.00 0.00 0.00 0.00 
2 127.15 32.43 6.54 30.74 18.05 
4 127.15 30.42 11.03 55.24 32.44 
6 127.15 29.48 14.20 73.44 43.13 
8 127.15 28.65 16.51 87.80 51.56 
10 127.15 29.23 18.60 96.95 56.93 
12 127.15 28.52 20.38 108.89 63.94 
14 127.15 29.10 20.79 108.92 63.96 
16 127.15 28.05 21.07 114.47 67.22 
20 127.15 27.34 22.60 125.98 73.98 
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p(-x/t1) + 
Reduced 
Chi-Sqr
1.32925
Adj. R-Squar 0.99778
Value Standard Err
product y0 77.58305 1.56693
product A1 -77.4109 1.53751
product t1 7.52159 0.40314
 
 
Half-life: 7.76 
417 
 
Table 5. entry 51. catalyst V{5,6,8}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 127.15 0.00 0.00 0.00 0.00 
2 127.15 30.98 8.63 42.44 24.92 
4 127.15 30.38 13.06 65.49 38.46 
6 127.15 29.47 16.87 87.23 51.22 
8 127.15 30.08 18.87 95.62 56.15 
10 127.15 29.88 20.33 103.70 60.90 
12 127.15 28.57 22.12 118.02 69.31 
14 127.15 28.37 23.03 123.74 72.67 
16 127.15 28.85 23.15 122.27 71.80 
20 127.15 28.15 23.34 126.33 74.18 
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(-x/t1) + y0
Reduced 
Chi-Sqr
3.57889
Adj. R-Square 0.99396
Value Standard Error
product y0 77.10686 1.76755
product A1 -76.2788 2.07059
product t1 5.77547 0.42555
 
 
Half-life: 5.98 
Average: 6.9 
418 
 
Table 5. entry 52. catalyst V{5,7,1}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.25 0.00 0.00 0.00 0.00 
2 256.25 25.44 4.44 53.72 15.86 
4 256.25 26.03 6.63 78.31 23.11 
6 256.25 25.40 8.12 98.28 29.01 
8 256.25 27.12 10.30 116.85 34.49 
10 256.25 27.69 11.81 131.21 38.73 
12 256.25 28.22 13.50 147.11 43.42 
16 256.25 28.69 16.26 174.29 51.44 
20 256.25 28.99 18.07 191.66 56.57 
30 256.25 29.22 22.53 237.09 69.98 
40 256.25 28.80 24.10 257.32 75.95 
60 256.25 30.16 28.47 290.23 85.66 
100 256.25 29.78 28.46 293.91 86.75 
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y = A1*exp(
-x/t1) + y0
Reduced 
Chi-Sqr
5.19553
Adj. R-Square 0.99297
Value Standard Error
B y0 87.09811 1.7874
B A1 -82.18901 2.02976
B t1 18.79789 1.21175
 
 
Half-life: 14.95 
419 
 
Table 5. entry 52. catalyst V{5,7,1}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.25 0.00 0.00 0.00 0.00 
2 256.25 26.29 3.24 37.89 11.18 
4 256.25 26.73 5.11 58.77 17.35 
6 256.25 27.04 6.67 75.80 22.37 
8 256.25 27.04 7.82 88.96 26.26 
10 256.25 28.74 9.73 104.08 30.72 
12 256.25 27.43 10.25 114.94 33.92 
16 256.25 29.99 13.19 135.21 39.91 
20 256.25 28.71 13.99 149.83 44.22 
30 256.25 30.03 18.20 186.38 55.01 
40 256.25 29.17 20.27 213.69 63.07 
60 256.25 30.69 24.98 250.25 73.86 
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y = A1*exp(-x/t
1) + A2*exp(-x/
t2) + y0
Reduced 
Chi-Sqr
0.17887
Adj. R-Square 0.99962
Value Standard Error
B y0 88.05391 1.96386
B A1 -12.03964 1.1119
B t1 2.5924 0.38981
B A2 -75.88843 1.25133
B t2 35.90989 2.23516
 
 
Half-life: 24.79 
Average: 19.9 
420 
 
Table 5. entry 53. catalyst V{5,7,2}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
2 251.85 30.89 2.92 27.72 8.20 
3 251.85 30.66 4.29 41.01 12.12 
4 251.85 30.58 5.57 53.42 15.79 
5 251.85 30.87 6.87 65.24 19.29 
6 251.85 33.65 7.58 66.05 19.53 
7 251.85 33.02 8.77 77.88 23.03 
8 251.85 30.62 9.88 94.56 27.96 
9 251.85 30.92 10.88 103.15 30.50 
10 251.85 30.35 11.67 112.71 33.32 
15 251.85 29.34 14.85 148.40 43.88 
60 251.85 30.99 28.51 269.71 79.75 
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y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced Chi-Sqr
0.01489
Adj. R-Square 0.99997
Value Standard Error
Product y0 84.79261 0.28509
Product A1 -82.05618 0.53908
Product t1 21.51406 0.34104
Product A2 -3.69455 0.65309
Product t2 2.82821 1.10465
 
 
Half-life: 18.65 
421 
 
Table 5. entry 53. catalyst V{5,7,2}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 251.85 30.39 0.00 0.00 0.00 
1 251.85 30.10 2.99 29.14 8.62 
2 251.85 30.99 2.98 28.15 8.32 
3 251.85 30.65 4.39 41.96 12.41 
4 251.85 30.60 5.66 54.23 16.03 
5 251.85 30.83 6.90 65.63 19.41 
6 251.85 30.67 7.94 75.87 22.43 
7 251.85 30.72 9.01 86.02 25.44 
8 251.85 30.86 9.97 94.67 27.99 
9 251.85 29.99 10.54 102.99 30.45 
10 251.85 30.84 11.50 109.33 32.33 
15 251.85 30.76 14.86 141.57 41.86 
30 251.85 30.67 22.20 212.21 62.75 
60 251.85 30.91 29.28 277.67 82.10 
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y = A1*exp(
-x/t1) + A2*
exp(-x/t2) +
Reduced 
Chi-Sqr
0.10664
Adj. R-Square 0.99979
Value Standard Error
Product y0 94.20728 1.88205
Product A1 -11.46234 2.96959
Product t1 4.97948 1.13464
Product A2 -82.97655 1.64837
Product t2 31.1196 2.5017
 
 
Half-life: 19.75 
Average: 19.2 
422 
 
Table 5. entry 54. catalyst V{5,7,3}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 253.86 32.27 0.00 0.00 0.00 
1 253.86 32.35 2.07 18.88 5.58 
2 253.86 32.52 4.12 37.46 11.07 
3 253.86 32.52 5.86 53.23 15.72 
4 253.86 31.81 7.22 67.10 19.82 
5 253.86 31.49 8.65 81.14 23.97 
6 253.86 31.70 10.04 93.53 27.63 
7 253.86 31.87 11.37 105.41 31.14 
8 253.86 31.21 12.53 118.65 35.05 
9 253.86 30.91 13.69 130.83 38.64 
10 253.86 31.46 14.90 139.92 41.33 
15 253.86 30.67 19.76 190.33 56.22 
30 253.86 30.70 28.99 278.95 82.40 
60 253.86 31.25 34.02 321.69 95.02 
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Chi-Sqr
0.63261
Adj. R-Squar 0.99916
Value Standard Erro
Product y0 99.6544 0.97116
Product A1 -99.5999 0.93148
Product t1 18.20118 0.4255
 
 
Half-life: 12.67 
423 
 
Table 5. entry 54. catalyst V{5,7,3}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 253.86 31.54 0.00 0.00 0.00 
1 253.86 31.62 2.41 22.53 6.65 
2 253.86 31.63 4.65 43.40 12.82 
3 253.86 31.62 6.49 60.63 17.91 
4 253.86 31.34 8.11 76.51 22.60 
5 253.86 31.66 9.81 91.56 27.04 
6 253.86 31.75 11.22 104.45 30.85 
7 253.86 31.50 12.59 118.07 34.87 
8 253.86 31.73 14.08 131.10 38.73 
9 253.86 31.75 15.22 141.66 41.84 
10 253.86 31.66 16.54 154.41 45.61 
15 253.86 30.96 21.53 205.52 60.71 
30 253.86 30.96 29.94 285.75 84.40 
61 253.86 31.34 35.12 331.08 97.79 
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(-x/t1) + y0
Reduced 
Chi-Sqr
0.26795
Adj. R-Square 0.99966
Value Standard Erro
Product y0 100.42395 0.5755
Product A1 -99.63222 0.56846
Product t1 16.55186 0.23385
 
 
Half-life: 11.27 
Average: 12.0 
424 
 
Table 5. entry 55. catalyst V{5,7,5}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.56 0.00 0.00 0.00 0.00 
2 255.56 29.45 3.56 37.09 10.95 
4 255.56 27.34 6.50 72.89 21.51 
6 255.56 30.72 9.91 98.95 29.20 
8 255.56 28.30 11.32 122.66 36.20 
10 255.56 30.46 13.89 139.82 41.26 
12 255.56 30.46 15.07 151.74 44.78 
16 255.56 30.57 17.16 172.16 50.81 
20 255.56 31.09 18.88 186.30 54.98 
30 255.56 30.89 20.78 206.23 60.86 
40 255.56 30.58 22.21 222.70 65.72 
60 255.56 31.29 25.34 248.30 73.28 
91 255.56 31.16 26.21 257.95 76.13 
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y = A1*exp(
-x/t1) + A2*
exp(-x/t2) + 
Reduced 
Chi-Sqr
0.72031
Adj. R-Square 0.9987
Value Standard Error
product y0 80.79132 3.28869
product A1 -38.21556 4.34218
product t1 41.03295 13.64388
product A2 -43.30253 6.60892
product t2 6.9275 0.97816
 
 
Half-life: 15.52 
425 
 
Table 5. entry 55. catalyst V{5,7,5}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.56 0.00 0.00 0.00 0.00 
2 255.56 26.57 2.99 34.56 10.20 
4 255.56 27.72 5.40 59.79 17.65 
6 255.56 27.49 7.48 83.50 24.64 
8 255.56 28.00 9.12 99.84 29.46 
10 255.56 30.00 10.97 112.11 33.09 
12 255.56 30.18 12.31 125.14 36.93 
16 255.56 30.66 14.91 149.17 44.02 
20 255.56 31.07 16.58 163.67 48.30 
30 255.56 30.81 19.58 194.85 57.50 
40 255.56 30.97 21.17 209.59 61.85 
60 255.56 31.23 24.07 236.42 69.77 
91 255.56 32.76 27.70 259.30 76.52 
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y = A1*exp(-x
/t1) + A2*exp(
-x/t2) + y0
Reduced Chi-Sqr
0.33575
Adj. R-Square 0.99938
Value Standard Error
product y0 82.66752 2.73359
product A1 -31.80271 5.44111
product t1 7.7149 1.13158
product A2 -50.54291 3.43853
product t2 43.51111 8.95411
 
 
Half-life: 21.63 
Average: 18.6 
426 
 
Table 5. entry 56. catalyst V{5,7,7}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
produc
t % 
0 256.10 0.00 0.00 0.00 0.00 
4 256.10 29.89 7.97 81.98 24.22 
6 256.10 28.26 9.50 103.27 30.51 
8 256.10 28.37 11.39 123.36 36.45 
12 256.10 28.78 14.65 156.49 46.23 
14 256.10 29.43 16.16 168.79 49.87 
16 256.10 29.14 17.32 182.66 53.97 
20 256.10 29.35 19.09 199.94 59.07 
30 256.10 29.90 22.72 233.47 68.98 
40 256.10 30.16 24.90 253.70 74.96 
60 256.10 31.00 27.36 271.27 80.15 
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y = A1*exp(-x
/t1) + A2*exp
(-x/t2) + y0
Reduced Chi-Sqr
0.12688
Adj. R-Square 0.99978
Value Standard Error
product y0 82.29526 0.49386
product A1 -10.06466 1.24055
product t1 1.57677 0.58314
product A2 -72.2264 0.94251
product t2 17.45517 0.51898
 
 
Half-life: 14.05 
 
427 
 
Table 5. entry 56. catalyst V{5,7,7}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
produc
t % 
0 256.10 0.00 0.00 0.00 0.00 
4 256.10 27.72 6.77 75.04 22.17 
6 256.10 27.82 8.87 97.97 28.95 
8 256.10 28.73 10.95 117.16 34.61 
12 256.10 28.53 14.22 153.17 45.26 
14 256.10 29.79 16.41 169.31 50.02 
16 256.10 30.08 16.83 171.95 50.80 
20 256.10 29.39 18.72 195.82 57.86 
30 256.10 29.89 22.72 233.53 69.00 
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y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced 
Chi-Sqr
0.61781
Adj. R-Square 0.99871
Value Standard Error
product y0 94.15907 23.69917
product A1 -17.52787 16.74635
product t1 3.85274 2.95185
product A2 -76.60799 8.6001
product t2 26.93429 20.15236
 
 
Half-life: 15.05 
Average: 14.6 
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Table 5. entry 57. catalyst V{7,2,1}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 253.42 0.00 0.00 0.00 0.00 
2 253.42 27.63 4.82 52.60 15.55 
4 253.42 27.94 7.66 82.68 24.45 
6 253.42 24.32 8.64 107.17 31.69 
8 253.42 28.15 12.03 128.89 38.11 
10 253.42 28.71 13.81 145.08 42.90 
12 253.42 28.84 14.91 155.96 46.11 
14 253.42 28.70 16.67 175.15 51.79 
16 253.42 29.05 18.64 193.56 57.23 
20 253.42 29.62 20.48 208.49 61.65 
30 253.42 30.02 23.70 238.12 70.41 
45 253.42 28.02 25.96 279.36 82.60 
60 253.42 29.91 25.28 254.89 75.36 
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y = A1*exp(-x/
t1) + y0
Reduced 
Chi-Sqr
2.33018
Adj. R-Square 0.99537
Value Standard Erro
product y0 75.90788 1.38324
product A1 -73.62465 1.57645
product t1 12.14292 0.60495
 
 
Half-life: 12.68 
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Table 5. entry 57. catalyst V{7,2,1}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.29 0.00 0.00 0.00 0.00 
2 254.29 26.42 3.12 35.70 10.55 
4 254.29 26.77 5.71 64.51 19.06 
6 254.29 27.34 8.26 91.41 27.00 
8 254.29 27.57 10.52 115.54 34.13 
10 254.29 27.66 11.65 127.43 37.64 
12 254.29 28.05 13.62 146.93 43.40 
14 254.29 28.46 15.29 162.62 48.04 
16 254.29 28.98 17.20 179.64 53.06 
20 254.29 29.28 19.71 203.76 60.19 
30 254.29 30.25 23.52 235.27 69.49 
45 254.29 30.37 24.70 246.06 72.68 
60 254.29 30.28 24.80 247.85 73.21 
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Equation y = A1*ex
p(-x/t1) + 
Reduced 
Chi-Sqr
1.56032
Adj. R-Squar 0.99723
Value Standard Err
product y0 75.55915 0.99376
product A1 -75.9255 1.17446
product t1 13.42677 0.50198
 
 
Half-life: 14.62 
Average: 13.7 
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Table 5. entry 58. catalyst V{7,2,5}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.32 0.00 0.00 0.00 0.00 
5 256.32 25.60 4.80 57.25 16.93 
10 256.32 27.18 8.84 99.23 29.34 
15 256.32 27.56 11.99 132.82 39.27 
20 256.32 27.80 13.77 151.10 44.68 
25 256.32 28.14 14.72 159.61 47.19 
30 256.32 27.86 14.56 159.55 47.18 
30 256.32 27.86 14.56 159.55 47.18 
35 256.32 28.35 16.03 172.59 51.03 
40 256.32 28.79 16.96 179.78 53.16 
45 256.32 29.12 17.74 185.94 54.98 
50 256.32 28.71 18.03 191.69 56.68 
85 256.32 29.47 21.12 218.69 64.66 
162 256.32 29.58 24.31 250.81 74.16 
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y = A1*exp(-
x/t1) + A2*ex
p(-x/t2) + y0
Reduced Chi-Sqr
1.13634
Adj. R-Square 0.99732
Value Standard Error
product y0 87.93893 12.83599
product A1 -43.86828 4.33912
product t1 10.09217 1.26845
product A2 -44.66815 8.97053
product t2 136.53055 81.87828
 
 
Half-life: 30.34 
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Table 5. entry 58. catalyst V{7,2,5}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.32 0.00 0.00 0.00 0.00 
5 256.32 27.41 5.20 57.86 17.11 
10 256.32 27.50 9.67 107.23 31.71 
15 256.32 28.66 13.05 138.89 41.07 
20 256.32 28.46 15.05 161.32 47.70 
25 256.32 24.42 17.36 216.87 64.12 
30 256.32 29.62 17.28 177.92 52.61 
35 256.32 29.38 18.52 192.33 56.87 
40 256.32 27.42 19.53 217.26 64.24 
45 256.32 29.80 19.32 197.72 58.46 
45 256.32 29.80 19.32 197.72 58.46 
50 256.32 27.04 20.92 236.01 69.78 
85 256.32 29.91 21.97 224.11 66.26 
162 256.32 30.38 24.15 242.53 71.71 
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y = A1*exp(
-x/t1) + A2*
exp(-x/t2) +
Reduced 
Chi-Sqr
1.56306
Adj. R-Square 0.9969
Value Standard Error
product y0 77.40588 10.25486
product A1 -25.8974 4.78741
product t1 105.73528 110.88563
product A2 -52.15178 7.45954
product t2 11.7324 1.78776
 
 
Half-life: 23.97 
Average: 28.7 
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Table 5. entry 59. catalyst V{7,2,8}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.33 0.00 0.00 0.00 0.00 
2 255.33 27.67 5.26 58.28 17.22 
4 255.33 28.27 8.02 86.91 25.68 
6 255.33 28.86 10.62 112.70 33.30 
8 255.33 28.75 12.54 133.67 39.50 
10 255.33 27.65 13.96 154.72 45.72 
12 255.33 28.63 16.32 174.67 51.62 
16 255.33 28.00 18.57 203.14 60.03 
20 255.33 29.86 22.69 232.81 68.80 
30 255.33 30.02 25.53 260.56 77.00 
 
0 5 10 15 20 25 30
-10
0
10
20
30
40
50
60
70
80
 product
 ExpDec1Fit of product
p
ro
d
u
c
t 
(%
)
time (min)
Model ExpDec1
Equation
y = A1*exp(
-x/t1) + y0
Reduced 
Chi-Sqr
3.17397
Adj. R-Square 0.9944
Value Standard Error
product y0 85.25662 3.2349
product A1 -82.75633 2.97123
product t1 13.05046 1.12858
 
 
Half-life: 11.14 
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Table 5. entry 59. catalyst V{7,2,8}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.33 0.00 0.00 0.00 0.00 
2 255.33 26.34 4.72 54.86 16.21 
4 255.33 26.97 7.96 90.38 26.71 
6 255.33 29.27 10.85 113.62 33.58 
8 255.33 29.81 12.90 132.54 39.17 
10 255.33 29.11 14.81 155.82 46.05 
12 255.33 29.59 16.66 172.50 50.98 
16 255.33 29.94 19.57 200.27 59.19 
20 255.33 30.07 20.44 208.22 61.53 
30 255.33 29.17 20.63 216.75 64.05 
40 255.33 29.65 21.94 226.79 67.02 
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y = A1*ex
p(-x/t1) + 
Reduced 
Chi-Sqr
1.97908
Adj. R-Squar 0.99572
Value Standard Err
product y0 67.40986 1.08926
product A1 -66.5365 1.38984
product t1 8.58938 0.43679
 
 
Half-life: 11.52 
Average: 11.3 
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Table 5. entry 60. catalyst V{7,2,9}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.78 0.00 0.00 0.00 0.00 
2 255.78 27.62 4.02 44.64 13.18 
4 255.78 27.55 6.93 77.19 22.80 
6 255.78 27.03 9.16 104.05 30.73 
8 255.78 28.48 11.40 122.91 36.30 
10 255.78 28.99 13.69 144.96 42.81 
12 255.78 31.19 16.39 161.33 47.64 
16 255.78 31.05 19.24 190.17 56.16 
20 255.78 31.15 22.06 217.35 64.19 
30 255.78 31.29 24.96 244.85 72.31 
40 255.78 30.88 26.79 266.21 78.62 
60 255.78 31.20 27.52 270.70 79.94 
100 255.78 30.73 28.15 281.20 83.04 
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y = A1*ex
p(-x/t1) + y
Reduced 
Chi-Sqr
1.04409
Adj. R-Square 0.99856
Value Standard Erro
product y0 82.19691 0.6646
product A1 -80.85774 0.88539
product t1 13.78309 0.36911
 
 
Half-life: 12.69 
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Table 5. entry 60. catalyst V{7,2,9}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.78 0.00 0.00 0.00 0.00 
2 255.78 26.49 4.38 50.77 14.99 
4 255.78 30.06 8.31 84.83 25.05 
6 255.78 30.17 11.33 115.21 34.02 
8 255.78 30.56 13.68 137.38 40.57 
10 255.78 29.91 15.26 156.56 46.24 
12 255.78 30.54 17.58 176.62 52.16 
16 255.78 31.44 20.94 204.44 60.38 
20 255.78 31.29 23.44 229.91 67.90 
30 255.78 31.34 25.96 254.24 75.08 
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Reduced 
Chi-Sqr
0.92928
Adj. R-Squar 0.99835
Value Standard Err
product y0 81.24571 1.49457
product A1 -80.0927 1.40588
product t1 11.66245 0.50981
 
 
Half-life: 10.91 
Average: 11.8 
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Table 5. entry 61. catalyst V{7,2,10}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
5 255.56 0.00 0.00 0.00 0.00 
10 255.56 26.68 1.84 21.09 6.22 
20 255.56 27.01 4.33 49.14 14.50 
30 255.56 18.12 6.64 112.40 33.17 
40 255.56 28.13 11.57 126.16 37.23 
51 255.56 28.40 13.57 146.51 43.24 
60 255.56 29.17 15.34 161.35 47.62 
76 255.56 29.27 16.61 174.00 51.35 
100 255.56 29.55 18.52 192.26 56.74 
156 255.56 29.42 20.25 211.06 62.29 
243 255.56 29.90 23.30 239.00 70.53 
301 255.56 31.69 26.47 256.14 75.59 
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y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced Chi-Sqr
0.22282
Adj. R-Square 0.99959
Value Standard Error
product y0 79.10754 0.7118
product A1 -30.72744 2.89111
product t1 15.1148 2.50614
product A2 -54.17447 3.09033
product t2 85.70312 7.20201
 
 
Half-life: 55.56 
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Table 5. entry 61. catalyst V{7,2,10}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
5 255.56 0.00 0.00 0.00 0.00 
10 255.56 29.37 2.87 29.95 8.84 
20 255.56 29.54 6.34 65.85 19.43 
30 255.56 28.55 11.10 119.28 35.20 
40 255.56 30.36 14.62 147.67 43.58 
51 255.56 30.03 16.23 165.75 48.92 
60 255.56 30.69 18.32 183.02 54.01 
76 255.56 30.40 19.24 194.07 57.27 
100 255.56 30.87 20.75 206.20 60.85 
156 255.56 30.88 22.62 224.62 66.29 
243 255.56 30.53 24.41 245.24 72.37 
301 255.56 32.08 27.11 259.17 76.48 
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y = A1*exp(-
x/t1) + A2*ex
p(-x/t2) + y0
Reduced 
Chi-Sqr
0.35419
Adj. R-Square 0.99925
Value Standard Error
product y0 76.94898 0.58811
product A1 -48.46284 3.40307
product t1 66.65652 5.93447
product A2 -36.19715 2.9646
product t2 11.4876 1.80409
 
 
Half-life: 41.56 
Average: 48.6 
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Table 5. entry 62. catalyst V{6,2,1}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.56 0.00 0.00 0.00 0.00 
2 255.56 25.94 3.41 40.37 11.92 
4 255.56 27.67 6.81 75.46 22.28 
6 255.56 28.04 9.36 102.40 30.23 
8 255.56 26.94 11.14 126.75 37.42 
10 255.56 28.96 14.12 149.50 44.14 
12 255.56 28.63 15.62 167.29 49.39 
16 255.56 27.38 17.36 194.51 57.42 
20 255.56 28.40 20.63 222.76 65.76 
28 255.56 29.80 24.84 255.60 75.46 
40 255.56 28.98 26.64 281.84 83.21 
64 255.56 28.67 26.89 287.62 84.91 
84 255.56 29.79 28.53 293.71 86.71 
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-x/t1) + y0
Reduced 
Chi-Sqr
0.64133
Adj. R-Square 0.99922
Value Standard Error
product y0 86.99457 0.53392
product A1 -86.60716 0.6967
product t1 14.26602 0.28098
 
 
Half-life: 12.13 
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Table 5. entry 62. catalyst V{6,2,1}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 255.56 0.00 0.00 0.00 0.00 
2 255.56 28.27 4.06 40.75 12.98 
4 255.56 26.56 6.91 73.81 23.51 
6 255.56 29.02 9.97 97.46 31.04 
8 255.56 27.59 11.47 117.98 37.58 
10 255.56 27.39 13.30 137.84 43.91 
12 255.56 27.83 15.19 154.90 49.34 
16 255.56 28.35 18.19 182.13 58.01 
20 255.56 30.14 21.18 199.42 63.52 
28 255.56 29.97 24.66 233.47 74.37 
40 255.56 31.60 29.33 263.38 83.89 
64 255.56 30.24 28.13 263.98 84.09 
84 255.56 30.01 28.39 268.47 85.52 
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(-x/t1) + y0
Reduced 
Chi-Sqr
0.81794
Adj. R-Square 0.99891
Value Standard Error
product y0 85.22931 0.65049
product A1 -83.84666 0.83544
product t1 14.09264 0.32563
 
 
Half-life: 12.22 
Average: 12.2 
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Table 5. entry 63. catalyst V{6,2,8}: run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.20 0.00 0.00 0.00 0.00 
2 256.20 27.02 4.06 46.15 13.64 
4 256.20 27.66 7.71 85.67 25.33 
6 256.20 30.18 10.90 111.07 32.84 
8 256.20 30.18 13.45 136.98 40.50 
10 256.20 28.06 13.63 149.31 44.15 
12 256.20 30.15 16.70 170.35 50.37 
16 256.20 30.63 19.19 192.60 56.95 
20 256.20 30.27 20.75 210.74 62.31 
30 256.20 30.20 24.46 248.95 73.61 
40 256.20 33.80 28.61 260.18 76.93 
60 256.20 30.25 27.87 283.29 83.76 
100 256.20 31.01 29.49 292.39 86.45 
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y = A1*ex
p(-x/t1) + 
A2*exp(-x
Reduced 
Chi-Sqr
0.71362
Adj. R-Squar 0.99903
Value Standard Erro
product y0 86.84008 0.89876
product A1 -64.5882 5.82165
product t1 20.08753 2.05187
product A2 -22.3678 6.18324
product t2 4.44843 1.13515
 
 
Half-life: 12.10 
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Table 5. entry 63. catalyst V{6,2,8}: run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 256.20 0.00 0.00 0.00 0.00 
2 256.20 27.12 4.67 52.94 15.65 
4 256.20 28.56 8.38 90.19 26.67 
6 256.20 28.66 10.97 117.73 34.81 
8 256.20 29.33 13.33 139.66 41.29 
10 256.20 28.66 14.37 154.10 45.56 
12 256.20 30.25 16.79 170.64 50.45 
16 256.20 30.08 18.74 191.52 56.63 
20 256.20 30.21 22.10 224.92 66.50 
30 256.20 30.88 25.76 256.41 75.82 
40 256.20 29.90 26.19 269.29 79.62 
60 256.20 29.90 27.53 283.02 83.68 
100 256.20 30.66 28.85 289.25 85.52 
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y = A1*exp(-
x/t1) + A2*e
xp(-x/t2) + y
Reduced 
Chi-Sqr
1.29259
Adj. R-Square 0.99824
Value Standard Error
product y0 85.65885 0.89419
product A1 -75.026 2.93507
product t1 15.57546 1.03419
product A2 -10.71708 3.37955
product t2 1.83462 0.93784
 
 
Half-life: 11.59 
Average: 11.8 
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Kinetic data for other Quaternary Ammonium Ions & Library VI: Table 6 in Text 
 
Table 6. entry 1. catalyst Me4NBr:  run 1 
 
time, 
min 
standard, 
µmol  
standard, 
area 
product, 
area 
product, 
µmol 
product, 
% 
0 256.52 1.00 0.00 0.00 0.00 
945 256.52 26.72 1.38 15.92 4.70 
1200 256.52 26.76 1.79 20.60 6.08 
1440 256.52 26.29 2.11 24.71 7.30 
2400 256.52 26.46 3.52 40.85 12.07 
2880 256.52 26.96 4.20 47.92 14.16 
3865 256.52 28.87 5.45 57.97 17.12 
4320 256.52 26.58 5.11 59.14 17.47 
5400 256.52 32.41 7.86 74.51 22.01 
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7.1536
Adj. R-Sq 0.98005
Value Standard 
product, Intercept 1.24 0.60471
product, Slope 0.00 2.01293
 
 
Half Life: 12,189 
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Table 6. entry 1. catalyst Me4NBr:  run 2 
 
time, 
min 
standard, 
µmol  
standard, 
area 
product, 
area 
product, 
µmol 
product, 
% 
0 256.5189 1 0 0 0 
945 256.5189 26.4729 1.1692 13.57261 4.009078 
1200 256.5189 26.4359 1.4746 17.1418 5.063343 
1440 256.5189 26.2949 1.7487 20.43713 6.03672 
2400 256.5189 28.4851 3.2886 35.47885 10.47974 
2880 256.5189 27.6143 3.5704 39.7337 11.73654 
3865 256.5189 26.3943 4.4777 52.134 15.39934 
4320 256.5189 30.0689 5.5762 56.98978 16.83364 
5400 256.5189 30.4851 6.9026 69.5827 20.55334 
6882 256.5189 30.011 8.3029 85.02086 25.11346 
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Sum of 
Squares
2.69709
Adj. R-S 0.99469
Value Standard
product, Intercept 0.79 0.3192
product, Slope 0.00 8.90161
 
 
Half Life: 13,298 
Average: 12,700 
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Table 6. entry 2. catalyst Me3NC16H33Br:  run 1 
 
time, 
min 
standard, 
µmol  
standard, 
area 
product, 
area 
product, 
µmol 
product, 
% 
0 256.52 1.00 0.00 0.00 0.00 
945 256.52 27.29 6.38 71.84 21.22 
1200 256.52 27.13 6.77 76.69 22.65 
1440 256.52 27.65 9.63 107.04 31.62 
2400 256.52 28.31 15.90 172.56 50.97 
2880 256.52 30.08 17.87 182.59 53.93 
3865 256.52 29.61 20.49 212.68 62.82 
4320 256.52 30.77 19.11 190.81 56.36 
5400 256.52 31.62 25.18 244.74 72.29 
6882 256.52 30.06 24.08 246.24 72.74 
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Equation y = A1*exp(-x/t1) + y0
Reduced 
Chi-Sqr
10.1617
2
Adj. R-S 0.98432
Value Standard
product, y0 82.294 4.76496
product, A1 -84.724 4.52402
product, t1 2721.8 381.116
 
Half Life: 2625.2 
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Table 6. entry 2. catalyst Me3NC16H33Br:  run 2 
 
time, 
min 
standard, 
µmol  
standard, 
area 
product, 
area 
product, 
µmol 
product, 
% 
0 256.52 1.00 0.00 0.00 0.00 
945 256.52 26.38 3.03 35.29 10.42 
1200 256.52 25.72 6.88 82.16 24.27 
1440 256.52 27.33 8.40 94.44 27.89 
2400 256.52 28.21 14.74 160.57 47.43 
2880 256.52 30.30 17.70 179.55 53.03 
3865 256.52 29.91 20.96 215.38 63.62 
4320 256.52 34.57 26.42 234.85 69.37 
6882 256.52 30.34 24.30 246.12 72.70 
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y = A1*exp(-x/t1) + 
y0
Reduce
d 
Chi-Sqr
28.2873
8
Adj. R-S 0.95941
Value Standar
product, y0 86.833 10.0768
product, A1 -92.04 9.24242
product, t1 3024.2 742.906
 
 
Half Life: 2769.8 
Average: 2697.5 (2700) 
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Table 6. entry 3. catalyst Et4NBr:  run 1 
 
time, 
min 
standard, 
µmol  
standard, 
area 
product, 
area 
product, 
µmol 
product, 
% 
0 256.52 30.00 0.00 0.00 0.00 
92 256.52 28.28 7.85 85.25 25.18 
256 256.52 28.49 12.33 132.95 39.27 
335 256.52 29.32 14.69 154.00 45.49 
557 256.52 29.61 17.87 185.45 54.78 
685 256.52 29.43 17.29 180.60 53.35 
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y = A1*exp(-x/t1) + y0
Reduced 
Chi-Sqr
10.19288
Adj. R-Sq 0.97759
Value Standard 
product, y0 56.326 4.96928
product, A1 -55.128 5.18677
product, t1 193.40 48.76271
 
Half Life: 418.7 
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Table 6. entry 3. catalyst Et4NBr:  run 2 
 
time, 
min 
standard, 
µmol  
standard, 
area 
product, 
area 
product, 
µmol 
product, 
% 
0 256.5189     #DIV/0! #DIV/0! 
92 256.5189 28.7187 5.1202 54.78962 16.18376 
256 256.5189 27.604 9.1588 101.963 30.11784 
335 256.5189 28.396 11.3346 122.6663 36.23317 
557 256.5189 29.7893 15.5333 160.2432 47.33264 
685 256.5189 32.0585 20.7519 198.9257 58.75867 
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y = A1*exp(-x/t1) + y0
Reduced 
Chi-Sqr
8.795
Adj. R-Sq 0.98041
Value Standard 
product, y0 79.535 17.1336
product, A1 -77.789 16.12456
product, t1 565.41 215.4026
 
Half Life: 547.6 
Average: 480 
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Table 6. entry 4. catalyst Bu3NBnBr:  run 1 
 
time, 
min 
standard, 
µmol  
standard, 
area 
product, 
area 
product, 
µmol 
product, 
% 
0 255.10 21.58 0.00 0.00 0.00 
1 255.10 21.28 0.63 5.85 1.73 
2 255.10 20.64 1.56 14.99 4.42 
3 255.10 21.06 2.73 25.65 7.56 
4 255.10 21.46 3.86 35.68 10.52 
5 255.10 21.60 5.03 46.17 13.61 
6 255.10 21.44 6.11 56.52 16.66 
7 255.10 21.17 7.17 67.14 19.79 
8 255.10 21.38 8.32 77.10 22.73 
9 255.10 21.03 9.27 87.35 25.75 
10 255.10 21.42 10.37 95.98 28.29 
15 255.10 21.98 16.08 145.01 42.75 
30 255.10 21.85 25.67 232.82 68.63 
60 255.10 22.05 33.50 301.14 88.77 
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y = A1*exp(-x/t1) + y0
Reduced 
Chi-Sqr
1.97815
Adj. R-Sq 0.99702
Value Standard 
product, y0 101.81 2.83955
product, A1 -104.50 2.58035
product, t1 27.697 1.59832
 
Half Life: 19.43 
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Table 6. entry 4. catalyst Bu3NBnBr:  run 2 
 
time, 
min 
standard, 
µmol  
standard, 
area 
product, 
area 
product, 
µmol 
product, 
% 
0.00 255.10 25.18 0.00 0.00 0.00 
1.00 255.10 21.74 0.29 2.66 0.78 
2.00 255.10 21.67 0.72 6.63 1.93 
3.00 255.10 21.63 1.53 14.00 4.08 
4.00 255.10 21.82 2.37 21.55 6.28 
5.00 255.10 21.58 3.28 30.18 8.79 
6.00 255.10 21.95 4.31 38.89 11.33 
7.00 255.10 21.87 5.29 47.90 13.95 
8.00 255.10 21.71 6.17 56.31 16.40 
9.00 255.10 21.72 7.28 66.42 19.35 
10.00 255.10 21.35 7.94 73.72 21.47 
15.00 255.10 21.38 13.25 122.81 35.78 
30.00 255.10 4.03 4.73 232.74 67.80 
60.00 255.10 21.80 34.13 310.28 90.39 
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y = A1*exp(-x/t1) + y0
Reduced 
Chi-Sqr
3.8403
Adj. R-S 0.99499
Value Standard
product, y0 107.96 5.27404
product, A1 -117.3 4.32803
product, t1 30.452 3.16641
 
Half Life: 21.46 
Average: 20.5 
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Table 6. entry 5. catalyst VI{1}:  run 1 
 
time, 
min 
standard, 
µmol  
standard, 
area 
product, 
area 
product, 
µmol 
product, 
% 
0 253.41 1.00 0.00 0.00 0.00 
30 253.41 25.64 1.48 17.03 5.08 
60 253.41 26.35 2.12 23.70 7.07 
120 253.41 27.37 3.37 36.29 10.83 
210 253.41 31.00 5.97 56.83 16.96 
300 253.41 27.21 6.92 75.02 22.38 
420 253.41 27.47 11.29 121.21 36.17 
600 253.41 28.78 11.18 114.55 34.18 
1276 253.41 30.38 18.22 176.93 52.79 
1620 253.41 31.46 24.71 231.72 69.14 
3640 253.41 32.23 25.41 232.52 69.37 
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) + A2*exp(-x/t2)
 + y0
Reduced Chi-S
qr
9.30535
Adj. R-Square 0.98338
Value Standard Error
product y0 517718.15807 --
product A1 -517667.47935 --
product t1 1.01166E8 --
product A2 -50.38562 9.02491
product t2 486.01249 141.42472
 
Half Life: 1006.1 
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Table 6. entry 5. catalyst VI{1}:  run 2 
 
time, 
min 
standard, 
µmol  
standard, 
area 
product, 
area 
product, 
µmol 
product, 
% 
0 253.41 31.27 0.00 0.00 0.00 
30 253.41 26.47 1.48 16.47 4.91 
60 253.41 30.29 2.75 26.82 8.00 
120 253.41 26.39 4.00 44.70 13.34 
210 253.41 29.20 7.10 71.67 21.38 
300 253.41 27.25 8.66 93.70 27.96 
420 253.41 26.73 8.55 94.35 28.15 
600 253.41 27.92 14.21 150.11 44.79 
1276 253.41 29.31 21.57 217.05 64.76 
1620 253.41 29.05 19.09 193.83 57.83 
3640 253.41 30.97 26.59 253.17 75.54 
4565 253.41 30.53 26.80 258.94 77.26 
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Equation y = A1*exp(-
x/t1) + y0
Reduced C
hi-Sqr
6.66074
Adj. R-Squa 0.98977
Value Standard Er
product y0 76.7078 2.61138
product A1 -75.290 2.75543
product t1 741.129 67.86858
 
Half Life: 768.1 
Average: 887.1 
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Table 6. entry 6. catalyst VI{2}:  run 1 
 
time, 
min 
standard, 
µmol  
standard, 
area 
product, 
area 
product, 
µmol 
product, 
% 
0 256.52 1.00 0.00 0.00 0.00 
3 256.31 30.26 0.05 0.50 0.15 
4 256.31 30.28 0.08 0.74 0.22 
5 256.31 30.44 0.11 1.04 0.31 
6 256.31 30.14 0.14 1.41 0.42 
7 256.31 30.31 0.18 1.80 0.53 
8 256.31 30.20 0.24 2.39 0.70 
10 256.31 30.35 0.33 3.21 0.95 
15 256.31 30.72 0.65 6.28 1.85 
30 256.31 30.62 1.42 13.79 4.06 
60 256.31 30.43 2.31 22.60 6.66 
120 256.31 31.17 4.45 42.40 12.49 
180 256.31 31.18 5.69 54.23 15.97 
240 256.31 30.90 6.99 67.23 19.80 
300 256.31 31.92 9.17 85.36 25.14 
360 256.31 31.41 10.30 97.47 28.71 
420 256.31 31.27 11.52 109.51 32.25 
480 256.52 28.27 10.39 112.92 33.35 
610 256.52 28.55 11.89 127.91 37.78 
795 256.52 28.46 13.83 149.32 44.11 
990 256.52 30.28 15.99 162.28 47.93 
1210 256.52 30.89 18.60 184.99 54.64 
2160 256.52 29.81 22.54 232.30 68.62 
2790 256.52 30.60 24.66 247.60 73.14 
0 500 1000 1500 2000 2500 3000
-10
0
10
20
30
40
50
60
70
80
 product, %
 ExpDec1 Fit of product, %
p
ro
d
u
c
t,
 %
time, min
Model ExpDec1
Equation
y = A1*exp(-
x/t1) + y0
Reduced 
Chi-Sqr
2.65389
Adj. R-Squar 0.99509
Value Standard Err
product, % y0 73.52547 1.59207
product, % A1 -72.7242 1.5709
product, % t1 826.0031 40.2714
Half Life: 932.2 
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Table 6. entry 6. catalyst VI{2}:  run 2 
time, 
min 
µmol 
standard 
area 
standard 
area 
product 
µmol 
product 
% 
product 
0 256.31 29.94 0.00 0.00 0.00 
3 256.31 30.15 0.06 0.60 0.18 
5 256.31 30.09 0.13 1.24 0.36 
6 256.31 29.90 0.16 1.61 0.47 
8 256.31 29.91 0.25 2.49 0.73 
9 256.31 30.22 0.30 2.96 0.87 
15 256.31 30.46 0.65 6.39 1.88 
30 256.31 30.31 1.55 15.20 4.48 
60 256.31 30.65 2.80 27.12 7.99 
120 256.31 30.61 5.12 49.76 14.65 
180 256.31 32.66 7.95 72.32 21.30 
240 256.31 30.84 9.51 91.65 26.99 
300 256.31 32.80 11.80 106.96 31.50 
480 256.52 27.94 11.11 122.17 36.09 
610 256.52 28.03 12.61 138.22 40.83 
795 256.52 30.03 14.93 152.78 45.13 
990 256.52 30.28 15.99 162.28 47.93 
1210 256.52 29.93 17.53 179.96 53.16 
2160 256.52 29.63 21.04 218.27 64.47 
2790 256.52 30.46 23.59 237.96 70.29 
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/t1) + A2*exp(
-x/t2) + y0
Reduced 
Chi-Sqr
0.62307
Adj. R-Squar 0.99886
Value Standard Err
% product y0 117.80616 48.86343
% product A1 -34.48511 3.6653
% product t1 215.36711 25.09614
% product A2 -83.96827 45.3395
% product t2 4850.4728 4100.06041
 
Half Life: 1065.36 
Average: 998.8
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Table 6. entry 7. catalyst VI{3}:  run 1 
 
time, 
min 
standard, 
µmol  
standard, 
area 
product, 
area 
product, 
µmol 
product, 
% 
0 248.76 30.00 0.00 0.00 0.00 
720 248.76 30.53 12.64 0.12 36.16 
1020 248.76 33.05 17.40 0.16 45.99 
1440 248.76 30.67 20.63 0.20 58.78 
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y = A1*exp(-
x/t1) + y0
Reduced 
Chi-Sqr
0.48888
Adj. R-Squar 0.99923
Value Standard Err
product, % y0 98.9469 8.59217
product, % A1 -98.90425 8.45415
product, % t1 1606.599 208.64029
 
Half Life: 1130.11 
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Table 6. entry 7. catalyst VI{3}:  run 2 
 
time, 
min 
standard, 
µmol  
standard, 
area 
product, 
area 
product, 
µmol 
product, 
% 
0 248.76 30.00 0.00 0.00 0.00 
720 248.76 32.27 14.05 0.13 38.03 
1020 248.76 32.11 18.67 0.17 50.80 
1440 248.76 31.09 21.04 0.20 59.11 
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y = A1*ex
p(-x/t1) + 
y0
Reduced 
Chi-Sqr
3.71066
Adj. R-Sq 0.99457
Value Standard
product, y0 82.536 12.4142
product, A1 -82.634 12.2134
product, t1 1120.5 295.674
 
Half Life: 1044.43 
Average: 1087 
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Tabular Summary of Kinetic Data 
table entry catalyst run 1 run 2 log(r1) log(r2) 
Avg. 
log(t1/2) 
deviation in 
log units 
3 1 I{1} 696.76 1174.28 2.84 3.07 2.96 0.160 
3 2 I{2} 771.90 739.64 2.89 2.87 2.88 0.013 
3 4 I{4} 321.30 328.70 2.51 2.52 2.51 0.007 
3 6 I{6} 10.30 15.80 1.01 1.20 1.11 0.131 
4 1 II{1,1} 199.60 161.90 2.30 2.21 2.25 0.064 
4 2 II{1,2} 190.00 167.20 2.28 2.22 2.25 0.039 
4 3 II{1,4} 269.80 325.60 2.43 2.51 2.47 0.058 
4 4 II{1,5} 325.60 366.30 2.51 2.56 2.54 0.036 
4 5 II{1,3} 216.90 272.80 2.34 2.44 2.39 0.070 
4 6 III{1,3} 70.80 73.80 1.85 1.87 1.86 0.013 
4 7 II{2,1} 9.50 10.70 0.98 1.03 1.00 0.037 
4 8 II{2,2} 23.00 13.60 1.36 1.13 1.25 0.161 
4 9 II{2,3} 12.10 12.10 1.08 1.08 1.08 0.000 
4 10 II{3,1} 10.20 13.10 1.01 1.12 1.06 0.077 
4 11 III{3,1} 10.20 19.40 1.01 1.29 1.15 0.197 
4 12 II{3,2} 6.70 6.50 0.83 0.81 0.82 0.009 
4 13 III{3,2} 10.60 8.40 1.03 0.92 0.97 0.071 
4 14 III{3,3} 14.10 12.90 1.15 1.11 1.13 0.027 
4 15 II{3,5} 20.00 5.40 1.30 0.73 1.02 0.402 
4 16 II{3,6} 5.00 4.18 0.70 0.62 0.66 0.055 
4 17 III{3,6} 6.70 4.20 0.83 0.62 0.72 0.143 
4 18 II{4,1} 18.40 16.60 1.26 1.22 1.24 0.032 
4 19 II{4,2} 15.40 9.20 1.19 0.96 1.08 0.158 
4 20 II{4,3} 18.20 27.30 1.26 1.44 1.35 0.125 
4 21 II{5,1} 13.56 20.72 1.13 1.32 1.22 0.130 
4 22 III{5,1} 9.20 13.20 0.96 1.12 1.04 0.111 
4 23 II{5,2} 4.80 9.10 0.68 0.96 0.82 0.196 
4 24 III{5,2} 11.90 10.50 1.08 1.02 1.05 0.038 
4 25 II{5,3} 12.90 12.40 1.11 1.09 1.10 0.012 
4 26 II{5,4} 22.60 19.70 1.35 1.29 1.32 0.042 
4 27 II{5,5} 32.40 31.28 1.51 1.50 1.50 0.011 
5 1 IV{2,2,1} 111.70 75.30 2.05 1.88 1.96 0.121 
5 2 IV{2,2,2} 40.64 62.97 1.61 1.80 1.70 0.134 
5 3 IV{3,2,1} 18.69 20.26 1.27 1.31 1.29 0.025 
5 4 IV{3,2,5} 30.87 21.32 1.49 1.33 1.41 0.114 
5 5 IV{5,2,5} 17.34 15.21 1.24 1.18 1.21 0.040 
5 6 V{1,2,1} 30.20 34.86 1.48 1.54 1.51 0.044 
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Tabular Summary of Kinetic Data (cont.) 
5 7 V{1,2,8} 40.03 59.51 1.60 1.77 1.69 0.122 
5 8 V{1,2,8}b 49.69 58.05 1.70 1.76 1.73 0.048 
5 9 V{1,2,7}b 8.97 10.60 0.95 1.03 0.99 0.051 
5 10 V{1,2,6} 23.35 26.11 1.37 1.42 1.39 0.034 
5 11 V{2,2,1} 20.31 21.05 1.31 1.32 1.32 0.011 
5 12 V{2,2,3} 23.11 22.98 1.36 1.36 1.36 0.002 
5 13 V{2,2,5} 873.94 925.55 2.94 2.97 2.95 0.018 
5 14 V{2,2,8} 22.11 17.68 1.34 1.25 1.30 0.069 
5 15 V{2,2,7} 14.41 15.77 1.16 1.20 1.18 0.028 
5 16 V{2,2,6} 29.51 26.60 1.47 1.42 1.45 0.032 
5 17 V{2,3,1} 19.64 26.38 1.29 1.42 1.36 0.091 
5 18 V{2,3,2} 78.80 72.85 1.90 1.86 1.88 0.024 
5 19 V{2,3,3} 35.12 26.32 1.55 1.42 1.48 0.089 
5 20 V{2,3,5} 255.43 216.64 2.41 2.34 2.37 0.051 
5 21 V{2,3,8} 27.04 26.05 1.43 1.42 1.42 0.011 
5 22 V{2,3,7} 28.78 28.92 1.46 1.46 1.46 0.001 
5 23 V{2,3,6} 21.38 20.74 1.33 1.32 1.32 0.009 
5 24 V{2,7,1} 16.76 17.41 1.22 1.24 1.23 0.012 
5 25 V{3,2,1} 135.40 128.77 2.13 2.11 2.12 0.015 
5 26 V{3,2,5} 130.13 114.10 2.11 2.06 2.09 0.040 
5 27 V{3,2,7} 28.94 28.33 1.46 1.45 1.46 0.007 
5 28 V{3,3,1} 43.49 36.53 1.64 1.56 1.60 0.054 
5 29 V{3,3,3} 22.90 17.76 1.36 1.25 1.30 0.078 
5 30 V{3,3,5} 58.16 66.68 1.76 1.82 1.79 0.042 
5 31 V{3,3,8} 47.64 37.79 1.68 1.58 1.63 0.071 
5 32 V{3,2,6} 93.28 78.69 1.97 1.90 1.93 0.052 
5 33 V{3,7,5} 55.63 66.11 1.75 1.82 1.78 0.053 
5 34 V{3,7,8} 224.43 274.31 2.35 2.44 2.39 0.062 
5 35 V{4,2,5} 84.30 103.94 1.93 2.02 1.97 0.064 
5 36 V{5,2,1} 9.88 11.40 0.99 1.06 1.03 0.044 
5 37 V{5,2,2} 12.37 12.09 1.09 1.08 1.09 0.007 
5 38 V{5,2,3} 10.52 10.02 1.02 1.00 1.01 0.015 
5 39 V{5,2,5} 9.58 9.36 0.98 0.97 0.98 0.007 
5 40 V{5,2,8} 18.77 16.25 1.27 1.21 1.24 0.044 
5 41 V{5,2,9} 15.82 16.15 1.20 1.21 1.20 0.006 
5 42 V{5,2,10} 15.03 13.82 1.18 1.14 1.16 0.026 
5 43 V{5,3,1} 10.65 8.28 1.03 0.92 0.97 0.077 
5 44 V{5,3,2} 17.24 20.08 1.24 1.30 1.27 0.047 
5 45 V{5,3,3} 10.92 15.32 1.04 1.19 1.11 0.104 
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Tabular Summary of Kinetic Data (cont.) 
5 46 V{5,3,5} 5.20 4.55 0.72 0.66 0.69 0.041 
5 47 V{5,3,8} 9.43 10.27 0.97 1.01 0.99 0.026 
5 48 V{5,3,7} 8.88 8.11 0.95 0.91 0.93 0.028 
5 49 V{5,6,1} 8.02 7.69 0.90 0.89 0.90 0.013 
5 50 V{5,6,5} 6.80 7.24 0.83 0.86 0.85 0.019 
5 51 V{5,6,8} 7.76 5.98 0.89 0.78 0.83 0.080 
5 52 V{5,7,1} 14.95 24.79 1.17 1.39 1.28 0.155 
5 53 V{5,7,2} 18.65 19.75 1.27 1.30 1.28 0.018 
5 54 V{5,7,3} 12.67 11.27 1.10 1.05 1.08 0.036 
5 55 V{5,7,5} 15.52 21.63 1.19 1.34 1.26 0.102 
5 56 V{5,7,7} 14.05 15.05 1.15 1.18 1.16 0.021 
5 57 V{7,2,1} 12.68 14.62 1.10 1.16 1.13 0.044 
5 58 V{7,2,5} 30.34 23.97 1.48 1.38 1.43 0.072 
5 59 V{7,2,8} 11.14 11.52 1.05 1.06 1.05 0.010 
5 60 V{7,2,9} 12.69 10.91 1.10 1.04 1.07 0.046 
5 61 V{7,2,10} 55.56 41.56 1.74 1.62 1.68 0.089 
5 62 V{6,2,1} 12.13 12.22 1.08 1.09 1.09 0.002 
5 63 V{6,2,8} 12.10 11.59 1.08 1.06 1.07 0.013 
6 1 Me4N 12189.00 13298.00 4.09 4.12 4.10 0.027 
6 2 Me3Ncetyl 2625.20 2769.80 3.42 3.44 3.43 0.016 
6 3 Et4N 418.70 547.60 2.62 2.74 2.68 0.082 
6 4 Bu3NBn 19.43 21.46 1.29 1.33 1.31 0.031 
6 5 VI{1} 1006.10 768.10 3.00 2.89 2.94 0.083 
6 6 VI{2} 932.20 1065.36 2.97 3.03 3.00 0.041 
6 7 VI{3} 1044.43 1130.11 3.02 3.05 3.04 0.024 
       AVE 0.059 
       MAX 0.402 
       MIN 0.000 
       AVG%a 4.52% 
a
 Avg% represents the average of the all the %errors for each catalyst where  
%error = Stdev./(log(t1/2))avg.*100 
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7.4.4. Stir-Rate Experiments (Figure 9): 
 
Catalyst V{3,2,8}; stir-rate 1296 rpm; run 1  
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
130 254.28 26.91 8.47 96.03 28.39 
180 254.28 27.23 10.03 112.33 33.21 
230 254.28 27.77 11.64 127.90 37.81 
342 254.28 29.09 16.11 169.02 49.96 
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 ExpDec1Fit of B
B
A
Model ExpDec1
Equation
y = A1*exp(-x/t
1) + y0
Reduced 
Chi-Sqr
0.04311
Adj. R-Square 0.9995
Value Standard Error
B y0 -46.95351 31.17476
B A1 64.66014 30.22095
B t1 -845.44725 306.05054
 
Half-life: 342.44 
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Catalyst V{3,2,8}; stir-rate 1296 rpm; run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
130 254.28 27.68 9.56 105.41 31.16 
180 254.28 27.91 10.95 119.68 35.38 
230 254.28 28.83 12.69 134.29 39.70 
342 254.28 28.28 15.84 170.86 50.51 
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A
Model ExpDec1
Equation
y = A1*exp(-x/
t1) + y0
Reduced 
Chi-Sqr
0.00323
Adj. R-Squar 0.99995
Value Standard Err
B y0 -41.56143 9.64746
B A1 62.9554 9.38436
B t1 -899.8351 105.3547
 
Half-life: 337.06 
Avg.: 339.8 
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Catalyst V{3,2,8}; stir-rate 1598 rpm; run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.70 0.00 0.00 0.00 0.00 
20 254.70 25.82 4.44 52.58 15.54 
80 254.70 27.76 8.71 95.93 28.36 
157 254.70 29.40 12.62 131.20 38.79 
220 254.70 27.92 14.71 161.03 47.60 
485 254.70 28.21 20.59 223.11 65.95 
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Model ExpDec2
Equation
y = A1*exp(-x/t1
) + A2*exp(-x/t2)
 + y0
Reduced 
Chi-Sqr
1.00254
Adj. R-Square 0.99818
Value Standard Error
B y0 80.11303 5.42529
B A1 -67.28146 3.63958
B t1 310.25693 60.15007
B A2 -12.8317 3.03371
B t2 9.27969 6.2973
 
Half-life: 249.42 
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Catalyst V{3,2,8}; stir-rate 1598 rpm; run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.70 0.00 0.00 0.00 0.00 
20 254.70 29.24 5.58 58.30 17.23 
80 254.70 27.51 9.12 101.35 29.96 
157 254.70 28.74 13.00 138.26 40.87 
220 254.70 29.20 15.55 162.79 48.12 
300 254.70 28.83 18.51 196.31 58.03 
381 254.70 27.32 18.60 208.04 61.50 
485 254.70 29.41 21.81 226.68 67.01 
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A
Model ExpDec2
Equation
y = A1*exp(-x/t1)
 + A2*exp(-x/t2) 
+ y0
Reduced 
Chi-Sqr
1.39396
Adj. R-Square 0.99743
Value Standard Error
B y0 78.84323 5.00152
B A1 -13.38688 3.32826
B t1 6.61419 8.69519
B A2 -65.45636 3.28226
B t2 280.8756 53.10083
 
Half-life: 230.18 
Average: 240.25 
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Catalyst V{3,2,8}; stir-rate 2000 rpm; run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.28 0.00 0.00 0.00 0.00 
10 254.28 26.76 4.15 47.31 13.98 
42 254.28 26.55 8.19 94.11 27.82 
88 254.28 30.38 12.94 129.91 38.40 
134 254.28 29.67 15.00 154.23 45.59 
219 254.28 30.63 17.72 176.58 52.20 
336 254.28 31.52 20.50 198.45 58.66 
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Model ExpDec2
Equation
y = A1*exp(-x/t
1) + A2*exp(-x/
t2) + y0
Reduced 
Chi-Sqr
0.65817
Adj. R-Square 0.99853
Value Standard Error
B y0 61.8485 1.76684
B A1 -15.51541 2.46122
B t1 8.76756 2.31251
B A2 -46.32658 1.73004
B t2 131.3993 17.01963
 
Half-life: 179.17 
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Catalyst V{3,2,8}; stir-rate 2000 rpm; run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.28 0.00 0.00 0.00 0.00 
10 254.28 20.02 4.46 67.99 20.10 
58 254.28 28.13 10.64 115.41 34.12 
109 254.28 28.61 13.49 143.93 42.55 
205 254.28 30.28 17.49 176.26 52.11 
276 254.28 30.95 19.86 195.85 57.90 
355 254.28 30.62 21.05 209.83 62.03 
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Model ExpDec2
Equation
y = A1*exp(-x/t1
) + A2*exp(-x/t2)
 + y0
Reduced 
Chi-Sqr
0.23546
Adj. R-Square 0.99952
Value Standard Error
B y0 71.53602 2.57435
B A1 -23.0419 1.40162
B t1 6.64031 0.82935
B A2 -48.49395 1.70804
B t2 218.81263 27.80929
 
Half-life: 171.61 
Average: 175.39 
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Catalyst V{3,2,8}; stir-rate 2500 rpm; run 1 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.28 0.00 0.00 0.00 0.00 
10 254.28 25.97 4.58 53.83 15.91 
30 254.28 27.31 8.10 90.49 26.75 
60 254.28 26.71 10.31 117.83 34.83 
90 254.28 26.98 12.15 137.38 40.61 
114 254.28 27.61 13.80 152.52 45.09 
177 254.28 28.32 16.19 174.39 51.55 
423 254.28 29.45 21.39 221.55 65.49 
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Model ExpDec2
Equation
y = A1*exp(-x/t
1) + A2*exp(-x/
t2) + y0
Reduced 
Chi-Sqr
0.38704
Adj. R-Square 0.9991
Value Standard Error
B y0 69.15532 1.24611
B A1 -49.45543 1.18466
B t1 164.71822 13.21601
B A2 -19.67032 1.48476
B t2 9.45303 1.36759
 
Half-life: 156.23 
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Catalyst V{3,2,8}; stir-rate 2500 rpm; run 2 
 
time, 
min 
μmol 
standard 
area 
standard 
area 
product 
μmol 
product 
product 
% 
0 254.28 0.00 0.00 0.00 0.00 
10 254.28 25.76 5.30 62.76 18.55 
38 254.28 27.04 9.27 104.66 30.94 
67 254.28 26.94 10.96 124.19 36.71 
123 254.28 27.63 14.59 161.11 47.62 
170 254.28 27.70 16.19 178.29 52.70 
202 254.28 28.59 18.03 192.49 56.90 
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Model ExpDec2
Equation
y = A1*exp(-x/t1) 
+ A2*exp(-x/t2) + 
y0
Reduced Chi-Sqr
0.50054
Adj. R-Square 0.99878
Value Standard Error
B y0 75.15859 9.1525
B A1 -54.31088 7.36648
B t1 187.19324 59.10473
B A2 -20.85034 2.25983
B t2 7.10746 1.37759
 
Half-life: 144.05 
Average: 150.1 
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7.5. Supplemental Information for Chapter 3 
7.5.1. Structures of Ring Flip Conformations 
Structures of Ring Flip Conformers. An annealing algorithm, as implemented in Spartan 08’ 
v.1.2.0 using the MMFF force field, primarily revealed three structurally unique conformers. To 
obtain relatively accurate populations, the geometry of each conformer was optimized at 
B3LYP/6-31G(d) and single point calculations (w/ SM8 solvation model) at M06-2X/6-31G(d) 
were determined.  
Table 24. 
 
R
2 
/ R
1 A B C 
H / H 3.4a (3.5b) 2.6 (2.6) 0.0 (0.0) 
H / Me 0.7 (1.0) 0.0 (0.1) 0.1 (0.0) 
i-Pr / Me 1.3 (1.1) 0.0 (0.0) 0.9 (0.6) 
Me / Me 0.8 (1.2) 0.0 (0.0) 0.2 (0.1) 
Ph / H 4.3 (4.3) 2.2 (1.8) 0.0 (0.0) 
Ph / Me 1.7 (2.3) 0.0 (0.0) 0.7 (0.8) 
a Relative energy (kcal/mol) determined 
geometry optimization at B3LYP/6-31G(d). b 
Relative energy determined of single point 
M06-2X/6-31G(d) with SM8 solvation model 
(toluene) on B3LYP geometries.  
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Coordinates of B3LYP/6-31G(d) structures from Table 24. 
 
 
 
1 H 0.5198445 -1.1056888 -1.3509511 
2 C -0.0922583 -1.0082444 -0.4550490 
3 N -0.0157838 0.4589136 -0.0240763 
4 C -1.4168565 1.0991912 -0.4268803 
5 C -2.1797497 -0.0055093 -1.1923938 
6 H 0.3437859 -1.6336214 0.3241349 
7 H -2.0365829 0.1039579 -2.2735631 
8 C 0.0563812 0.6277901 1.4913207 
9 C -2.1930640 1.2845401 0.9165661 
10 H -2.2133860 2.3507506 1.1668087 
11 C -3.6282226 0.7456975 0.6616719 
12 H -3.8565613 -0.0539597 1.3704370 
13 H -4.3793052 1.5275162 0.8028185 
14 C -3.6526426 0.2007102 -0.7913126 
15 H -4.2275007 -0.7242730 -0.8757283 
16 H -4.1094659 0.9281223 -1.4703696 
17 C -1.3018597 2.4022391 -1.2114489 
18 H -0.8000695 3.1945063 -0.6475354 
19 H -2.3195911 2.7540211 -1.4096019 
20 H -0.8075480 2.2841241 -2.1802766 
21 C 1.2048289 1.1224425 -0.6899363 
22 H 1.1790829 2.1677920 -0.3812190 
23 H 1.0183902 1.0759419 -1.7640275 
24 C 2.5366877 0.4936853 -0.3551663 
25 C 5.0428903 -0.6376078 0.2187232 
26 C 3.1166132 -0.4406959 -1.2267007 
27 C 3.2493414 0.8791752 0.7916913 
28 C 4.4900542 0.3124526 1.0802872 
29 C 4.3581432 -1.0070723 -0.9399430 
30 H 2.6105514 -0.7102229 -2.1508980 
31 H 2.8457365 1.6409479 1.4542971 
32 H 5.0308034 0.6237542 1.9688948 
33 H 4.7950535 -1.7251794 -1.6273030 
34 H 6.0121381 -1.0740846 0.4401849 
35 O -2.2417650 -1.9173191 0.3263249 
36 C -2.0633721 -3.3239963 0.4746302 
37 H -2.3891679 -3.8573093 -0.4286349 
38 H -2.6842513 -3.6288367 1.3185625 
39 C -1.5549644 -1.3554875 -0.7721557 
40 H -1.0176365 -3.5881612 0.6873306 
41 H 0.7495334 -0.1072357 1.9017597 
42 H -1.5816612 -2.0636112 -1.6123288 
43 H 0.4651909 1.6261336 1.6645167 
44 C -1.3766292 0.5376448 1.9906408 
45 H -1.4689048 0.9973841 2.9788143 
46 H -1.7004755 -0.5019087 2.0681529 
 
 
 
1 H 0.2093952 -0.7858366 -1.8801800 
2 C -0.1137017 -0.9618982 -0.8508370 
3 N -0.0821403 0.3860417 -0.1472861 
4 C -1.4825171 1.0460583 -0.4921321 
5 C -2.3795020 -0.1331075 -0.9972988 
6 H 0.5924910 -1.6425216 -0.3751505 
7 H -2.5475559 -0.0054101 -2.0713487 
8 C -0.0560873 0.2670642 1.3891273 
9 C -2.1021495 1.4689658 0.8569833 
10 H -1.8617937 2.5108939 1.0988036 
11 C -3.6112610 1.2559445 0.6428609 
12 H -4.0337241 2.1137016 0.1078151 
13 C -3.7167260 -0.0308978 -0.2151844 
14 H -3.8370115 -0.9134266 0.4163686 
15 C -1.3970536 2.1763867 -1.5126602 
16 H -0.8143861 3.0317102 -1.1609900 
17 H -2.4162233 2.5338532 -1.6928925 
18 H -1.0028048 1.8473154 -2.4799400 
19 C 1.1378407 1.1981480 -0.6193705 
20 H 1.0260163 2.1854731 -0.1680372 
21 H 1.0303272 1.3004985 -1.6998953 
22 C 2.4799495 0.6013891 -0.2685112 
23 C 5.0111290 -0.4476025 0.3509210 
24 C 3.0918696 -0.3366924 -1.1150717 
25 C 3.1729184 1.0313278 0.8732437 
26 C 4.4273531 0.5073033 1.1847495 
27 C 4.3445757 -0.8630616 -0.8037503 
28 H 2.6026299 -0.6409510 -2.0370631 
29 H 2.7451202 1.8005852 1.5117322 
30 H 4.9521170 0.8549326 2.0693691 
31 H 4.8069261 -1.5845444 -1.4707114 
32 H 5.9901625 -0.8525323 0.5887068 
33 O -1.8810550 -2.1097530 0.3780394 
34 C -1.5833281 -3.5039681 0.3769875 
35 H -2.1251987 -4.0199935 -0.4267460 
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36 H -1.9117638 -3.8922021 1.3424521 
37 C -1.5655802 -1.4435570 -0.8273356 
38 H -0.5070022 -3.6958786 0.2624823 
39 H 0.3591174 -0.7032359 1.6583424 
40 H -4.1535023 1.1757919 1.5900676 
41 H -4.5753771 0.0044679 -0.8901937 
42 H 0.6258566 1.0391127 1.7435177 
43 C -1.4742236 0.5180620 1.8924592 
44 H -2.0252552 -0.4215909 1.9457896 
45 H -1.7403469 -2.1185313 -1.6763250 
46 H -1.4530393 0.9582422 2.8933017 
 
 
 
1 H 0.1338311 -1.0576225 -1.8025175 
2 C -0.1990450 -1.0853486 -0.7615377 
3 N -0.1152530 0.3244692 -0.2238675 
4 C -1.4834663 1.0171139 -0.6576055 
5 C -2.4261059 -0.1661889 -1.0268952 
6 H 0.4705997 -1.7339594 -0.1949898 
7 H -2.6032905 -0.1716323 -2.1074931 
8 C -0.1472951 0.3456877 1.3065666 
9 C -2.0442792 1.6634022 0.6496143 
10 H -2.3451611 2.6950830 0.4432673 
11 C -3.2823530 0.8164953 1.0430758 
12 H -4.0722257 1.4383908 1.4742225 
13 C -3.7282709 0.1098307 -0.2504503 
14 H -4.2956829 -0.8035103 -0.0563771 
15 C -1.3314598 2.0111578 -1.8069816 
16 H -0.7401789 2.8912691 -1.5397746 
17 H -2.3363475 2.3652217 -2.0605168 
18 H -0.9160073 1.5617652 -2.7148929 
19 C 1.1366528 1.0577891 -0.7418639 
20 H 1.0527359 2.0805340 -0.3719333 
21 H 1.0379973 1.0780221 -1.8272565 
22 C 2.4604351 0.4583653 -0.3371839 
23 C 4.9708171 -0.5751251 0.3796686 
24 C 3.0545382 -0.5621667 -1.0957199 
25 C 3.1563369 0.9715125 0.7682473 
26 C 4.4013893 0.4560843 1.1279512 
27 C 4.2980440 -1.0799824 -0.7354188 
28 H 2.5585997 -0.9396674 -1.9869271 
29 H 2.7346385 1.7963208 1.3382560 
30 H 4.9297216 0.8683209 1.9822497 
31 H 4.7488798 -1.8655953 -1.3342731 
32 H 5.9431813 -0.9732534 0.6535856 
33 O -2.0559042 -1.9696510 0.5865606 
34 C -1.8323920 -3.3664762 0.7762730 
35 H -2.3765723 -3.9542905 0.0251953 
36 H -2.2114240 -3.6090815 1.7702190 
37 C -1.6813343 -1.4839630 -0.6883458 
38 H -0.7650312 -3.6248809 0.7275759 
39 H -0.7108412 -0.5328492 1.6174521 
40 H -1.8918862 -2.2503591 -1.4463753 
41 H 0.8747942 0.2657460 1.6748689 
42 H -3.0129458 0.0661176 1.7931020 
43 H -4.3641156 0.7720661 -0.8495520 
44 C -0.8866536 1.6262990 1.6632978 
45 H -0.2390321 2.5046834 1.5624613 
46 H -1.2384054 1.6001599 2.6988295 
 
 
 
1 H -0.6905810 1.7264974 -0.7987209 
2 C -0.0278715 1.2481814 -0.0786010 
3 N -0.0674870 -0.2551391 -0.3699974 
4 C 1.3212009 -0.5958881 -1.0671433 
5 C 2.0353184 0.7589253 -1.2709171 
6 H -0.4241415 1.4307501 0.9201390 
7 H 1.8450215 1.1441110 -2.2790880 
8 C -0.0650857 -1.1003616 0.9002713 
9 C 2.1547709 -1.3517685 0.0126525 
10 H 2.1962062 -2.4156710 -0.2505774 
11 C 3.5717755 -0.7131774 -0.0151872 
12 H 3.8201559 -0.3214382 0.9747308 
13 H 4.3387218 -1.4478888 -0.2743001 
14 C 3.5269770 0.4393414 -1.0545645 
15 H 4.0825548 1.3181728 -0.7200254 
16 H 3.9672416 0.1212216 -2.0054465 
17 C 1.1880920 -1.3975563 -2.3581337 
18 H 0.7269302 -2.3781840 -2.2044837 
19 H 2.2008529 -1.5809717 -2.7313956 
20 H 0.6460125 -0.8655212 -3.1453895 
21 C -1.3071429 -0.5759583 -1.2255075 
22 H -1.2465072 -1.6410612 -1.4503599 
23 H -1.1755251 -0.0219702 -2.1566672 
24 C -2.6308625 -0.2309901 -0.5859317 
25 C -5.1222135 0.3949249 0.5514531 
26 C -3.2624864 0.9891516 -0.8722103 
27 C -3.2860964 -1.1488640 0.2498740 
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28 C -4.5190847 -0.8356515 0.8197504 
29 C -4.4963034 1.3037299 -0.3032429 
30 H -2.8043698 1.6907147 -1.5662536 
31 H -2.8438675 -2.1231168 0.4415414 
32 H -5.0154132 -1.5581556 1.4606088 
33 H -4.9729545 2.2503997 -0.5388231 
34 H -6.0855175 0.6353893 0.9910383 
35 O 2.1498981 1.7954849 0.9369293 
36 C 1.9365406 2.9666305 1.7205181 
37 H 2.1732892 3.8720541 1.1453168 
38 H 2.6104459 2.8947178 2.5757419 
39 C 1.4117059 1.7542167 -0.2663706 
40 H 0.9024961 3.0369729 2.0875082 
41 H -0.7491428 -0.6606352 1.6271034 
42 H 1.3812414 2.7633806 -0.7009461 
43 H -0.4496881 -2.0853029 0.6181299 
44 C 1.3874424 -1.2092477 1.3474407 
45 H 1.6874039 -0.2713042 1.8226601 
46 C 1.6119335 -2.3617404 2.3301780 
47 H 2.6660636 -2.4188390 2.6197710 
48 H 1.3326608 -3.3256430 1.8869846 
49 H 1.0267903 -2.2265084 3.2463650 
 
 
 
1 H 0.3795492 -1.5438976 -1.6036144 
2 C 0.0317436 -1.3475491 -0.5860518 
3 N -0.0084202 0.1603680 -0.4245177 
4 C -1.3959606 0.5855237 -1.0597124 
5 C -2.2454313 -0.7292175 -1.1005962 
6 H 0.7472647 -1.7739854 0.1171229 
7 H -2.3685585 -1.0287566 -2.1461927 
8 C -0.0757595 0.6121371 1.0453454 
9 C -2.0875192 1.4834502 -0.0162770 
10 H -1.8766012 2.5448059 -0.1998856 
11 C -3.5796816 1.1471183 -0.1891245 
12 H -3.9937256 1.7069780 -1.0354782 
13 C -3.6178230 -0.3782528 -0.4668354 
14 H -3.7495880 -0.9408195 0.4596761 
15 C -1.2745999 1.2267010 -2.4391122 
16 H -0.7118889 2.1637165 -2.4298345 
17 H -2.2880336 1.4614780 -2.7802696 
18 H -0.8390105 0.5540813 -3.1858592 
19 C 1.2177828 0.8011849 -1.1018547 
20 H 1.0536236 1.8785531 -1.0435447 
21 H 1.1719785 0.5005863 -2.1491669 
22 C 2.5529470 0.4327942 -0.4999693 
23 C 5.0767367 -0.2023017 0.5569308 
24 C 3.2336441 -0.7219102 -0.9178283 
25 C 3.1730077 1.2813225 0.4296222 
26 C 4.4234380 0.9636324 0.9589651 
27 C 4.4830548 -1.0415968 -0.3883467 
28 H 2.7981947 -1.3648765 -1.6790509 
29 H 2.6918702 2.2109862 0.7241899 
30 H 4.8919729 1.6335112 1.6735952 
31 H 4.9990289 -1.9353913 -0.7257668 
32 H 6.0533587 -0.4462632 0.9640085 
33 O -1.7575444 -2.0040790 0.9417739 
34 C -1.4037486 -3.2683464 1.4981121 
35 H -1.8815250 -4.0878313 0.9448150 
36 H -1.7664001 -3.2666244 2.5273342 
37 C -1.4076316 -1.8442980 -0.4175074 
38 H -0.3160153 -3.4269488 1.5031493 
39 H -1.5317076 -2.8004931 -0.9443373 
40 H 0.2748672 -0.2034583 1.6762220 
41 H -4.1678771 1.4279870 0.6903183 
42 H -4.4453895 -0.6466024 -1.1283038 
43 H 0.6200427 1.4450979 1.1433591 
44 C -1.5077033 1.0605031 1.3512682 
45 H -2.0635799 0.1946441 1.7191921 
46 C -1.5555512 2.1638369 2.4134137 
47 H -2.5899386 2.4632041 2.6106833 
48 H -1.0032386 3.0547797 2.0905456 
49 H -1.1280894 1.8238929 3.3630083 
 
 
 
1 H 0.2436959 -1.5533281 -1.5343276 
2 C -0.1224335 -1.3518233 -0.5246822 
3 N -0.0951075 0.1516563 -0.3300833 
4 C -1.4798456 0.6695105 -0.9251961 
5 C -2.3580537 -0.6115628 -1.0661739 
6 H 0.5503452 -1.8236539 0.1920236 
7 H -2.4723035 -0.8652484 -2.1253882 
8 C -0.1532560 0.5249032 1.1562301 
9 C -2.1247542 1.5338362 0.2072846 
10 H -2.4507427 2.4892965 -0.2168820 
11 C -3.3539517 0.7320422 0.7070126 
12 H -4.1840342 1.3933385 0.9719734 
13 C -3.7098087 -0.2386507 -0.4311493 
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14 H -4.2568082 -1.1166756 -0.0792379 
15 C -1.3367478 1.4141391 -2.2506097 
16 H -0.7682022 2.3445640 -2.1650964 
17 H -2.3451865 1.6844739 -2.5807020 
18 H -0.8978475 0.7997121 -3.0435970 
19 C 1.1567941 0.7512989 -1.0051627 
20 H 1.0848691 1.8284802 -0.8650830 
21 H 1.0476603 0.5360171 -2.0679358 
22 C 2.4787932 0.2318421 -0.4923538 
23 C 4.9711272 -0.6929129 0.4186729 
24 C 3.0761721 -0.9003187 -1.0681596 
25 C 3.1689628 0.9142793 0.5219388 
26 C 4.4027706 0.4516246 0.9797347 
27 C 4.3099990 -1.3628858 -0.6126828 
28 H 2.5884821 -1.4156251 -1.8923899 
29 H 2.7533670 1.8273482 0.9424371 
30 H 4.9242987 0.9927072 1.7634516 
31 H 4.7604342 -2.2377753 -1.0720031 
32 H 5.9340286 -1.0511986 0.7702500 
33 O -1.9962387 -1.9706650 0.9385572 
34 C -1.7343661 -3.2744192 1.4553622 
35 H -2.2223814 -4.0428555 0.8412012 
36 H -2.1516310 -3.2980266 2.4633668 
37 C -1.5890481 -1.7806773 -0.4033584 
38 H -0.6576273 -3.4881782 1.5087722 
39 H -0.6229616 -0.3184057 1.6610420 
40 H -1.7466178 -2.7113494 -0.9655716 
41 H 0.8659112 0.6358565 1.5250513 
42 H -3.0920213 0.1597700 1.6017808 
43 H -4.3337428 0.2578413 -1.1836184 
44 C -1.0374508 1.7723399 1.2802389 
45 H -1.4985239 1.7392977 2.2742939 
46 C -0.3173144 3.1236863 1.1613910 
47 H -1.0142053 3.9357341 1.3932860 
48 H 0.0734005 3.3218443 0.1575632 
49 H 0.5145433 3.1936163 1.8710307 
 
N
CH3
O
H3C
CH3
Ph
A
H3C
CH3
H
 
 
1 H -0.6432235 1.5025948 0.1602147 
2 C -0.0190088 0.6744483 0.4808643 
3 N -0.3880143 -0.5306828 -0.3867244 
4 C 0.9402842 -0.9484878 -1.1495549 
5 C 1.9587195 0.1830536 -0.9046127 
6 H -0.2886139 0.4457113 1.5109321 
7 H 1.9715767 0.8646491 -1.7596537 
8 C -0.7257057 -1.7529578 0.4552609 
9 C 1.4774810 -2.1944052 -0.3769865 
10 H 1.3170357 -3.0869477 -0.9942425 
11 C 2.9901439 -1.9397077 -0.1482767 
12 H 3.2088538 -1.9169128 0.9220712 
13 H 3.6026667 -2.7315997 -0.5882996 
14 C 3.3070667 -0.5644922 -0.7867577 
15 H 4.0423028 -0.0005803 -0.2116053 
16 H 3.7193865 -0.6972307 -1.7935577 
17 C 0.7320570 -1.2471042 -2.6325197 
18 H 0.0572010 -2.0916248 -2.8047448 
19 H 1.7060468 -1.5325367 -3.0430780 
20 H 0.3808699 -0.3838966 -3.2048514 
21 C -1.5588366 -0.1687138 -1.3184927 
22 H -1.7134675 -1.0413709 -1.9531184 
23 H -1.1964401 0.6501103 -1.9425797 
24 C -2.8416276 0.2183103 -0.6215726 
25 C -5.2507081 0.9502137 0.6265446 
26 C -3.1700457 1.5695927 -0.4351519 
27 C -3.7581774 -0.7602935 -0.2048513 
28 C -4.9506347 -0.3979545 0.4198614 
29 C -4.3627343 1.9339281 0.1895587 
30 H -2.5058996 2.3478053 -0.8047645 
31 H -3.5519538 -1.8121013 -0.3856679 
32 H -5.6503395 -1.1672519 0.7324424 
33 H -4.6028224 2.9845594 0.3223402 
34 H -6.1816048 1.2328720 1.1088357 
35 O 2.1898802 0.4207643 1.4697239 
36 C 2.0272984 1.0197436 2.7520227 
37 H 2.5395557 1.9847514 2.8289167 
38 H 2.4802481 0.3251824 3.4626214 
39 C 1.4962698 0.9855699 0.3484528 
40 H 0.9718331 1.1590298 3.0258313 
41 H -1.4046285 -1.4618269 1.2578604 
42 H -1.2452104 -2.4547945 -0.2050597 
43 C 0.6133196 -2.3312212 0.8966057 
44 H 1.0378015 -1.6911866 1.6769739 
45 C 0.4960565 -3.7596277 1.4334794 
46 H 1.4813867 -4.1441665 1.7150707 
47 H 0.0744367 -4.4362497 0.6803348 
48 H -0.1413015 -3.8006431 2.3232816 
49 C 1.7682272 2.5207511 0.2344083 
50 H 1.3691538 2.9687047 1.1554036 
51 C 1.0588870 3.2263184 -0.9357821 
52 H 1.2549675 4.3013639 -0.8761301 
53 H -0.0301074 3.1070230 -0.9290907 
54 H 1.4303703 2.8921611 -1.9111721 
55 C 3.2751907 2.8260250 0.1729508 
56 H 3.4421838 3.9034812 0.2702547 
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57 H 3.7045097 2.5171695 -0.7875293 
58 H 3.8333408 2.3232968 0.9665508 
 
 
 
1 H -0.2955992 1.6013457 -0.8962640 
2 C -0.0520100 0.9930126 -0.0251415 
3 N -0.3605642 -0.4415368 -0.4144015 
4 C 0.9467804 -0.9324405 -1.1585672 
5 C 2.0687598 0.0728062 -0.7322649 
6 H -0.7054995 1.2937989 0.7938824 
7 H 2.3568787 0.6501336 -1.6139609 
8 C -0.5282126 -1.3940636 0.7840921 
9 C 1.3281674 -2.2783710 -0.5111133 
10 H 0.9033408 -3.1218944 -1.0701495 
11 C 2.8663625 -2.2701386 -0.5465879 
12 H 3.2202747 -2.5842734 -1.5351530 
13 C 3.2642847 -0.8012695 -0.2566199 
14 H 3.4327380 -0.6476349 0.8095664 
15 C 0.8020470 -1.0106000 -2.6760008 
16 H 0.0526427 -1.7370440 -3.0019313 
17 H 1.7652233 -1.3390175 -3.0797739 
18 H 0.5829000 -0.0406862 -3.1346599 
19 C -1.6330663 -0.4885030 -1.2810102 
20 H -1.7402279 -1.5311675 -1.5864391 
21 H -1.4168050 0.1088526 -2.1672303 
22 C -2.8897908 0.0086145 -0.6061184 
23 C -5.2624959 0.9339177 0.5812185 
24 C -3.2493212 1.3635226 -0.6844445 
25 C -3.7587844 -0.8810052 0.0437733 
26 C -4.9328773 -0.4210424 0.6393822 
27 C -4.4228995 1.8249592 -0.0900172 
28 H -2.6238671 2.0617501 -1.2355917 
29 H -3.5354500 -1.9448035 0.0655758 
30 H -5.5964687 -1.1232058 1.1350066 
31 H -4.6887945 2.8750498 -0.1653764 
32 H -6.1803221 1.2906288 1.0388945 
33 O 1.6809147 0.5450141 1.6023824 
34 C 1.3012252 1.3143002 2.7406084 
35 H 2.0006768 2.1337230 2.9380061 
36 H 1.3246646 0.6243730 3.5873282 
37 C 1.4508276 1.0800656 0.2917957 
38 H 0.2873153 1.7281531 2.6540325 
39 H -0.7691053 -0.8054440 1.6681083 
40 H 3.2968198 -2.9703080 0.1768092 
41 H 4.1880066 -0.5276175 -0.7730321 
42 H -1.3852906 -2.0273483 0.5544348 
43 C 0.7381661 -2.2453458 0.9148460 
44 H 1.4342974 -1.7219169 1.5732769 
45 C 0.4481611 -3.6310416 1.5003883 
46 H 1.3705468 -4.2160056 1.5744123 
47 H -0.2572684 -4.1943375 0.8769236 
48 H 0.0258760 -3.5573773 2.5085295 
49 C 2.0191270 2.5286384 0.1723966 
50 H 1.5227917 3.1153537 0.9567315 
51 C 1.7218420 3.2450649 -1.1572405 
52 H 2.1911118 4.2337311 -1.1439028 
53 H 0.6530246 3.4097551 -1.3312313 
54 H 2.1331410 2.7113520 -2.0219310 
55 C 3.5307925 2.5489033 0.4562939 
56 H 3.8783047 3.5813513 0.5632670 
57 H 4.0971925 2.0987428 -0.3673859 
58 H 3.7840045 2.0095837 1.3727821 
 
 
 
1 H -0.0797628 1.5393565 -0.9356138 
2 C 0.1477138 0.9866704 -0.0256314 
3 N -0.3100134 -0.4382642 -0.2656361 
4 C 0.9286110 -1.1583006 -0.9510059 
5 C 2.1416904 -0.2127706 -0.6914385 
6 H -0.4333409 1.4174983 0.7904206 
7 H 2.4557145 0.2273479 -1.6414837 
8 C -0.5204721 -1.2021188 1.0431184 
9 C 1.1677011 -2.4616836 -0.1206614 
10 H 1.2527239 -3.3110099 -0.8067159 
11 C 2.5094288 -2.2478654 0.6260990 
12 H 3.0877533 -3.1747868 0.6849650 
13 C 3.2475101 -1.1404749 -0.1423265 
14 H 3.9680471 -0.6100441 0.4824837 
15 C 0.7323153 -1.4224845 -2.4434836 
16 H -0.0707587 -2.1341351 -2.6537826 
17 H 1.6607112 -1.8665500 -2.8177637 
18 H 0.5618865 -0.5084077 -3.0217737 
19 C -1.5938272 -0.4381733 -1.1218896 
20 H -1.8211810 -1.4835238 -1.3199752 
21 H -1.3185728 0.0356696 -2.0639143 
22 C -2.7885889 0.2533276 -0.5096221 
23 C -5.0693980 1.5070123 0.5496343 
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24 C -2.9965556 1.6297692 -0.6891587 
25 C -3.7584202 -0.4893857 0.1814921 
26 C -4.8887769 0.1327503 0.7119187 
27 C -4.1246176 2.2533561 -0.1577348 
28 H -2.2882475 2.2181850 -1.2670662 
29 H -3.6430086 -1.5657041 0.2858106 
30 H -5.6322599 -0.4579745 1.2384537 
31 H -4.2737012 3.3182373 -0.3097271 
32 H -5.9515476 1.9921619 0.9565290 
33 O 1.9440046 0.5747507 1.5734088 
34 C 1.7055189 1.5146101 2.6201062 
35 H 2.4541357 2.3138306 2.6336190 
36 H 1.7820228 0.9469329 3.5500104 
37 C 1.6689264 0.9621497 0.2178424 
38 H 0.7045349 1.9646117 2.5653984 
39 H 0.1277051 -0.7208214 1.7727236 
40 H -1.5596260 -1.0856305 1.3507869 
41 H 2.3208210 -1.9143841 1.6505357 
42 H 3.7997224 -1.5657348 -0.9892708 
43 C -0.0552099 -2.6453432 0.8079834 
44 H 0.2839353 -3.0331547 1.7755130 
45 C -1.1139455 -3.6258207 0.2790406 
46 H -0.7008054 -4.6397033 0.2591635 
47 H -1.4506214 -3.4028701 -0.7393349 
48 H -1.9951792 -3.6445397 0.9300331 
49 C 2.3427010 2.3329928 -0.1187477 
50 H 1.9323299 3.0562987 0.5985646 
51 C 2.0370763 2.8975340 -1.5189877 
52 H 2.5856058 3.8357740 -1.6511486 
53 H 0.9788085 3.1343879 -1.6730490 
54 H 2.3600903 2.2285123 -2.3253692 
55 C 3.8654269 2.2748045 0.0986014 
56 H 4.2867623 3.2843497 0.0611061 
57 H 4.3580120 1.6871443 -0.6846865 
58 H 4.1255661 1.8328912 1.0640781 
 
 
 
1 H -0.6629321 1.7304631 -0.5540411 
2 C -0.0352914 1.1291275 0.1017335 
3 N -0.1404179 -0.3146996 -0.3926412 
4 C 1.2407187 -0.6229844 -1.1195543 
5 C 2.0319241 0.7028291 -1.1054352 
6 H -0.4468730 1.1939946 1.1090103 
7 H 1.8990303 1.2322650 -2.0553979 
8 C -0.2072390 -1.3357241 0.7377155 
9 C 2.0097571 -1.5913864 -0.1695693 
10 H 1.9976297 -2.5983002 -0.6038784 
11 C 3.4607866 -1.0425577 -0.0826915 
12 H 3.7187442 -0.8362329 0.9589263 
13 H 4.1865765 -1.7688173 -0.4585682 
14 C 3.4977058 0.2666945 -0.9164758 
15 H 4.0946973 1.0459458 -0.4373579 
16 H 3.9415947 0.0818588 -1.9007984 
17 C 1.0850149 -1.2011608 -2.5235903 
18 H 0.5696961 -2.1665525 -2.5290999 
19 H 2.0923364 -1.3764955 -2.9150155 
20 H 0.5828851 -0.5223577 -3.2193263 
21 C -1.3800583 -0.4503683 -1.2977616 
22 H -1.3556586 -1.4690598 -1.6852725 
23 H -1.2176893 0.2372118 -2.1296496 
24 C -2.6998186 -0.1651877 -0.6201560 
25 C -5.1814043 0.3545437 0.5897457 
26 C -3.2862728 1.1068132 -0.7076039 
27 C -3.3950093 -1.1824982 0.0526033 
28 C -4.6232736 -0.9235604 0.6589049 
29 C -4.5153422 1.3671442 -0.1022902 
30 H -2.7958215 1.8955063 -1.2738527 
31 H -2.9877882 -2.1896799 0.0872598 
32 H -5.1498308 -1.7225439 1.1721649 
33 H -4.9579966 2.3553264 -0.1836554 
34 H -6.1410068 0.5552305 1.0566488 
35 O 2.1386492 1.3198373 1.2189406 
36 C 1.9115741 2.1679835 2.3419853 
37 H 2.3218861 3.1714242 2.1865854 
38 H 2.4331059 1.6999590 3.1791009 
39 C 1.4322797 1.6026975 0.0113089 
40 H 0.8452315 2.2533993 2.5964784 
41 H -0.8612846 -0.9593704 1.5255411 
42 H -0.6648051 -2.2337528 0.3122548 
43 C 1.2278714 -1.6246961 1.1636432 
44 H 1.5850532 -0.8054757 1.7926499 
45 C 1.5115742 3.0915640 -0.3587316 
46 H 2.5579869 3.4101889 -0.3956057 
47 H 0.9878925 3.7263016 0.3625533 
48 H 1.0668347 3.2706281 -1.3424659 
49 C 1.3508000 -2.9389661 1.9398338 
50 H 2.3922189 -3.1204500 2.2241835 
51 H 1.0127212 -3.7940954 1.3418788 
52 H 0.7593797 -2.9130077 2.8615445 
 
474 
 
 
 
1 H -0.3607072 1.6792425 -1.2934282 
2 C -0.0307064 1.2887369 -0.3272994 
3 N -0.0773439 -0.2238452 -0.4349243 
4 C 1.3049537 -0.6117951 -1.1068912 
5 C 2.2204490 0.6417676 -0.9171057 
6 H -0.7320972 1.6224304 0.4379670 
7 H 2.3885388 1.0941754 -1.8988225 
8 C -0.0796592 -0.9428268 0.9265589 
9 C 1.9208315 -1.7097478 -0.2184620 
10 H 1.6607605 -2.7105836 -0.5857177 
11 C 3.4323939 -1.4334504 -0.3021089 
12 H 3.8444432 -1.8761910 -1.2158551 
13 C 3.5599319 0.1123524 -0.3338596 
14 H 3.7070782 0.5141362 0.6697805 
15 C 1.1888400 -1.0087432 -2.5760996 
16 H 0.5947127 -1.9126757 -2.7354707 
17 H 2.1999312 -1.2211437 -2.9387662 
18 H 0.7917497 -0.2052268 -3.2051573 
19 C -1.3147648 -0.6563113 -1.2429179 
20 H -1.2022149 -1.7302589 -1.3989670 
21 H -1.2306731 -0.1589835 -2.2099932 
22 C -2.6441106 -0.3530011 -0.5925668 
23 C -5.1468503 0.1669992 0.5729479 
24 C -3.2558075 0.9017495 -0.7425746 
25 C -3.3235920 -1.3522857 0.1202890 
26 C -4.5639442 -1.0942323 0.7032797 
27 C -4.4942192 1.1622103 -0.1577301 
28 H -2.7776237 1.6749033 -1.3385172 
29 H -2.8949286 -2.3484929 0.2019204 
30 H -5.0781625 -1.8808182 1.2471687 
31 H -4.9564878 2.1363608 -0.2861819 
32 H -6.1146352 0.3686160 1.0221634 
33 O 1.7566552 1.4993892 1.3035887 
34 C 1.3302693 2.4863707 2.2399319 
35 H 1.8898389 3.4215215 2.1314913 
36 H 1.5323625 2.0669134 3.2274832 
37 C 1.4315457 1.6932881 -0.0722316 
38 H 0.2551991 2.7017189 2.1621347 
39 H -0.4386357 -0.2504252 1.6870989 
40 H 3.9778781 -1.8800964 0.5353674 
41 H 4.4126261 0.4301521 -0.9393254 
42 H -0.7997046 -1.7576331 0.8430077 
43 C 1.3234189 -1.4972922 1.1885263 
44 H 1.9034773 -0.7300245 1.7050688 
45 C 1.7097173 3.1288676 -0.5374393 
46 H 2.7514435 3.3927526 -0.3285947 
47 H 1.0674877 3.8588053 -0.0353972 
48 H 1.5446345 3.2265636 -1.6148371 
49 C 1.2953081 -2.7643457 2.0493492 
50 H 2.3109686 -3.1367929 2.2174437 
51 H 0.7196795 -3.5655098 1.5691823 
52 H 0.8525504 -2.5707416 3.0326180 
 
 
 
1 H -0.2060110 1.5804765 -1.3290000 
2 C 0.1411743 1.2603380 -0.3438143 
3 N 0.0025068 -0.2496245 -0.2965731 
4 C 1.3579168 -0.8053464 -0.9197838 
5 C 2.3285006 0.4113691 -0.9218352 
6 H -0.5043338 1.7073595 0.4132933 
7 H 2.4949975 0.7390339 -1.9528243 
8 C -0.0022076 -0.7792598 1.1414496 
9 C 1.9111901 -1.8326026 0.1195328 
10 H 2.1704515 -2.7608068 -0.4002821 
11 C 3.1914254 -1.1882135 0.7150516 
12 H 3.9666398 -1.9373365 0.9007899 
13 C 3.6346939 -0.1214901 -0.2997603 
14 H 4.2286486 0.6732659 0.1581401 
15 C 1.1888715 -1.3959653 -2.3187633 
16 H 0.5575287 -2.2885321 -2.3366027 
17 H 2.1827575 -1.6991631 -2.6641158 
18 H 0.8077867 -0.6731801 -3.0477170 
19 C -1.2684662 -0.6844349 -1.0554512 
20 H -1.2683400 -1.7725089 -1.0411795 
21 H -1.1238530 -0.3548026 -2.0843133 
22 C -2.5719754 -0.1539310 -0.5085547 
23 C -5.0520229 0.7698913 0.4333368 
24 C -3.0769039 1.0880252 -0.9241887 
25 C -3.3449931 -0.9386298 0.3613487 
26 C -4.5747279 -0.4790008 0.8331924 
27 C -4.3042458 1.5497871 -0.4512311 
28 H -2.5250547 1.6902276 -1.6415029 
29 H -2.9966454 -1.9270254 0.6522146 
30 H -5.1636022 -1.1014302 1.5001102 
31 H -4.6842904 2.5103351 -0.7861876 
32 H -6.0120245 1.1269278 0.7940847 
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33 O 2.0163537 1.5333734 1.1966597 
34 C 1.7181847 2.6569518 2.0244734 
35 H 2.3250919 3.5292316 1.7609603 
36 H 1.9658620 2.3496471 3.0423181 
37 C 1.6353489 1.5940841 -0.1804808 
38 H 0.6552734 2.9350907 1.9891336 
39 H 0.5235306 -0.0316659 1.7326937 
40 H -1.0346005 -0.8500916 1.4836549 
41 H 2.9615424 -0.7095237 1.6703307 
42 H 4.2462218 -0.5725506 -1.0902329 
43 C 0.7839435 -2.0978281 1.1442884 
44 H 1.2214439 -2.2078387 2.1433621 
45 C -0.0318698 -3.3704425 0.8666255 
46 H 0.6040770 -4.2523845 0.9957922 
47 H -0.4349062 -3.4176078 -0.1511470 
48 H -0.8686907 -3.4641177 1.5676163 
49 C 1.9837980 2.9457244 -0.8178536 
50 H 3.0492283 3.1574423 -0.6822462 
51 H 1.4140371 3.7703918 -0.3793124 
52 H 1.7747934 2.9320342 -1.8920354 
  
 
 
1 H -0.3642392 1.0594903 -0.4555663 
2 C -0.1813268 0.2713646 0.2704891 
3 N -0.9750422 -0.9417811 -0.2092436 
4 C 0.0939551 -1.9266605 -0.8504536 
5 C 1.4520311 -1.1883273 -0.7731607 
6 H -0.5807332 0.5961642 1.2314140 
7 H 1.6634000 -0.6995941 -1.7292592 
8 C -1.6063390 -1.7459444 0.9283295 
9 C 0.1968529 -3.1324497 0.1316488 
10 H -0.3296766 -3.9903011 -0.3018607 
11 C 1.7107413 -3.4299310 0.2829390 
12 H 1.9888112 -3.4278306 1.3398258 
13 H 1.9612391 -4.4177350 -0.1131584 
14 C 2.4724488 -2.3140894 -0.4824935 
15 H 3.3259973 -1.9516907 0.0918845 
16 H 2.8578711 -2.6948290 -1.4343054 
17 C -0.2450860 -2.3773191 -2.2696225 
18 H -1.1846556 -2.9355025 -2.3245275 
19 H 0.5474279 -3.0612202 -2.5914313 
20 H -0.2717486 -1.5564175 -2.9922822 
21 C -2.0665910 -0.4684511 -1.1869128 
22 H -2.5774077 -1.3712878 -1.5224093 
23 H -1.5342406 -0.0388169 -2.0363856 
24 C -3.0502261 0.5290060 -0.6199524 
25 C -4.9020901 2.3944477 0.3713009 
26 C -2.8710206 1.9031346 -0.8420009 
27 C -4.1914848 0.1021305 0.0768507 
28 C -5.1068346 1.0283347 0.5751265 
29 C -3.7874524 2.8303724 -0.3465937 
30 H -2.0247326 2.2533354 -1.4287490 
31 H -4.3839127 -0.9589627 0.2132926 
32 H -5.9868048 0.6823406 1.1089270 
33 H -3.6372947 3.8895324 -0.5331102 
34 H -5.6191280 3.1148497 0.7535892 
35 O 1.6998890 -0.6497491 1.5531458 
36 C 1.8607517 0.2209671 2.6721771 
37 H 2.6978881 0.9103540 2.5285252 
38 H 2.0650217 -0.4296011 3.5247771 
39 C 1.3277860 -0.0637346 0.3000829 
40 H 0.9518337 0.8033988 2.8809374 
41 H -2.0054891 -1.0587761 1.6751605 
42 H -2.4395663 -2.2942959 0.4825323 
43 C -0.5339215 -2.7034562 1.4185034 
44 H -0.9863081 -3.5513225 1.9411220 
45 H 0.1517292 -2.2030941 2.1028574 
46 C 2.1855626 1.1689779 -0.0194696 
47 C 3.8348758 3.3999598 -0.5216324 
48 C 1.7348156 2.4721501 0.2385532 
49 C 3.4861701 1.0059961 -0.5195856 
50 C 4.3013390 2.1085986 -0.7717612 
51 C 2.5492727 3.5781632 -0.0125102 
52 H 0.7439772 2.6463853 0.6507629 
53 H 3.8727745 0.0125239 -0.7192454 
54 H 5.3026654 1.9562939 -1.1639044 
55 H 2.1769114 4.5770680 0.1952812 
56 H 4.4695319 4.2587696 -0.7187513 
 
 
 
1 H 0.1252478 -0.9585853 -1.0528866 
2 C 0.1222039 -0.4556126 -0.0837638 
3 N 0.9359726 0.8122443 -0.2574655 
4 C -0.0826708 1.8446615 -0.8830538 
5 C -1.5005360 1.2603153 -0.5716566 
6 H 0.6128176 -1.0991509 0.6459802 
7 H -1.9537616 0.9414188 -1.5133729 
8 C 1.3979506 1.4384865 1.0758356 
9 C 0.0320951 3.1316482 -0.0413584 
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10 H 0.7418724 3.8356235 -0.4905241 
11 C -1.4046121 3.6810911 -0.0291762 
12 H -1.5694651 4.3771091 0.7991394 
13 H -1.5992601 4.2385055 -0.9524582 
14 C -2.3103918 2.4274081 0.0606575 
15 H -2.5410316 2.1900811 1.1000233 
16 H -3.2596406 2.5843625 -0.4588202 
17 C 0.1124088 2.0812441 -2.3791967 
18 H 1.0824217 2.5226326 -2.6234076 
19 H -0.6544706 2.7944618 -2.6987768 
20 H -0.0308294 1.1754395 -2.9777237 
21 C 2.1633380 0.5287916 -1.1425202 
22 H 2.6354788 1.4992059 -1.3076057 
23 H 1.7676441 0.1720491 -2.0936471 
24 C 3.1545051 -0.4598526 -0.5739692 
25 C 5.0401623 -2.2920326 0.4169347 
26 C 3.0059573 -1.8365172 -0.8065542 
27 C 4.2833191 -0.0147644 0.1306234 
28 C 5.2166442 -0.9238973 0.6280763 
29 C 3.9375970 -2.7466692 -0.3091942 
30 H 2.1724267 -2.2019675 -1.4014986 
31 H 4.4536324 1.0500846 0.2709884 
32 H 6.0868406 -0.5622030 1.1673765 
33 H 3.8111522 -3.8076966 -0.5026320 
34 H 5.7696470 -3.0000967 0.7987055 
35 O -1.3522796 0.3450197 1.6687250 
36 C -1.4491215 -0.6966656 2.6409370 
37 H -2.4059048 -1.2225251 2.5732368 
38 H -1.3726809 -0.2011765 3.6108909 
39 C -1.3117205 -0.0374651 0.2880316 
40 H -0.6353271 -1.4295853 2.5506360 
41 H 1.3363706 0.6788703 1.8529507 
42 H 2.4441151 1.7066015 0.9404309 
43 C 0.5340485 2.6697901 1.3390055 
44 H 1.1193813 3.4477660 1.8372287 
45 H -0.3006355 2.4042862 1.9878795 
46 C -2.3514164 -1.1109597 -0.0362079 
47 C -4.3328261 -3.0434041 -0.5512769 
48 C -2.0066689 -2.4513147 -0.2535097 
49 C -3.7094106 -0.7574692 -0.0652284 
50 C -4.6907188 -1.7128473 -0.3222023 
51 C -2.9887626 -3.4101376 -0.5132016 
52 H -0.9693963 -2.7737039 -0.2168690 
53 H -4.0051934 0.2712642 0.1182488 
54 H -5.7355930 -1.4171810 -0.3445352 
55 H -2.6989696 -4.4431143 -0.6823464 
56 H -5.0969510 -3.7876717 -0.7544690 
 
 
 
1 H -0.0568727 1.0352842 -0.9471305 
2 C -0.0572682 0.4556547 -0.0224455 
3 N -0.9210149 -0.7562527 -0.2724311 
4 C 0.0460223 -1.8198185 -0.9510334 
5 C 1.4843082 -1.3213471 -0.6166842 
6 H -0.5065757 1.0571259 0.7682021 
7 H 1.9753258 -1.0008057 -1.5390459 
8 C -1.3749088 -1.4295591 1.0236777 
9 C -0.1946627 -3.1460469 -0.1635761 
10 H -0.3457032 -3.9670165 -0.8708962 
11 C 1.0906389 -3.3836894 0.6678066 
12 H 1.3393650 -4.4474631 0.7250472 
13 C 2.1923161 -2.5596292 -0.0202143 
14 H 2.9931172 -2.2928888 0.6717945 
15 C -0.1658370 -1.9682953 -2.4565998 
16 H -1.1456969 -2.3797158 -2.7148954 
17 H 0.5853751 -2.6782437 -2.8184678 
18 H -0.0108790 -1.0349567 -3.0080085 
19 C -2.1421885 -0.3975819 -1.1391375 
20 H -2.6583632 -1.3398344 -1.3293124 
21 H -1.7364814 -0.0350903 -2.0834872 
22 C -3.0903454 0.6161483 -0.5463884 
23 C -4.9094175 2.4916658 0.4849506 
24 C -2.8979048 1.9902034 -0.7590014 
25 C -4.2263621 0.1959874 0.1630487 
26 C -5.1269934 1.1269375 0.6804352 
27 C -3.7974530 2.9217234 -0.2419630 
28 H -2.0556075 2.3376595 -1.3526983 
29 H -4.4238143 -0.8659384 0.2926456 
30 H -6.0033591 0.7857026 1.2230600 
31 H -3.6384694 3.9810978 -0.4199884 
32 H -5.6134652 3.2171003 0.8815338 
33 O 1.4572184 -0.4977373 1.6506641 
34 C 1.6164538 0.4942604 2.6665386 
35 H 2.5749427 1.0129494 2.5747911 
36 H 1.5841951 -0.0487478 3.6130899 
37 C 1.3709445 -0.0495108 0.2896304 
38 H 0.8068161 1.2378012 2.6558141 
39 H -0.5906161 -1.2446934 1.7555301 
40 H -2.3012697 -0.9624564 1.3556121 
41 H 0.9531245 -3.0276788 1.6937038 
42 H 2.6408661 -3.1326875 -0.8405664 
43 C -1.4588275 -2.9098197 0.6802507 
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44 H -2.3717984 -3.1449258 0.1211513 
45 H -1.4708037 -3.5207937 1.5874312 
46 C 2.4411512 0.9996046 -0.0262812 
47 C 4.4680773 2.8918975 -0.5240877 
48 C 2.1409817 2.3646434 -0.1295841 
49 C 3.7800828 0.6013970 -0.1606071 
50 C 4.7834181 1.5364126 -0.4086651 
51 C 3.1441779 3.3032061 -0.3809053 
52 H 1.1220366 2.7221621 -0.0073899 
53 H 4.0467502 -0.4468568 -0.0707305 
54 H 5.8122347 1.2043438 -0.5131219 
55 H 2.8867543 4.3553482 -0.4608027 
56 H 5.2490897 3.6202416 -0.7205578 
 
 
 
1 H -0.2405960 1.3054757 -0.2959095 
2 C -0.1026377 0.3939335 0.2795629 
3 N -0.9728690 -0.6698657 -0.3891809 
4 C 0.0322420 -1.6612055 -1.1129561 
5 C 1.4373099 -1.0427879 -0.9460894 
6 H -0.4776782 0.5711585 1.2877448 
7 H 1.7029421 -0.4699521 -1.8399084 
8 C -1.7194099 -1.5516410 0.6054632 
9 C 0.0188115 -2.9661997 -0.2593704 
10 H -0.5396749 -3.7378826 -0.8032797 
11 C 1.5056054 -3.3731506 -0.0832612 
12 H 1.7523982 -3.4330705 0.9795028 
13 H 1.7061843 -4.3557142 -0.5190738 
14 C 2.3563688 -2.2738990 -0.7726460 
15 H 3.2525919 -2.0400601 -0.1964660 
16 H 2.6859504 -2.6086786 -1.7626558 
17 C -0.3110188 -1.9383292 -2.5751478 
18 H -1.2857275 -2.4201079 -2.7004707 
19 H 0.4381726 -2.6403752 -2.9554024 
20 H -0.2652043 -1.0478690 -3.2077763 
21 C -1.9666141 0.0220047 -1.3400152 
22 H -2.5266773 -0.7797893 -1.8217888 
23 H -1.3543559 0.5146382 -2.0967366 
24 C -2.8964998 1.0175020 -0.6867757 
25 C -4.6439400 2.8937723 0.4610574 
26 C -2.6184865 2.3910996 -0.7571841 
27 C -4.0819125 0.6008567 -0.0609805 
28 C -4.9450983 1.5311896 0.5156681 
29 C -3.4838995 3.3234563 -0.1847274 
30 H -1.7337460 2.7402733 -1.2851998 
31 H -4.3468578 -0.4528158 -0.0403638 
32 H -5.8596479 1.1933571 0.9937356 
33 H -3.2575784 4.3831590 -0.2544313 
34 H -5.3210497 3.6182713 0.9035484 
35 O 1.7119123 -0.7925380 1.4235051 
36 C 1.9607064 -0.0749664 2.6308697 
37 H 2.8704050 0.5293132 2.5630027 
38 H 2.0870899 -0.8362597 3.4033400 
39 C 1.3838191 -0.0399950 0.2479787 
40 H 1.1211613 0.5768672 2.9117356 
41 H -2.1222695 -0.9314512 1.4071324 
42 H -2.5568945 -1.9921752 0.0555390 
43 C -0.7476192 -2.6409238 1.0425251 
44 H -0.0445886 -2.2219000 1.7671497 
45 C 2.3208014 1.1620641 0.0653530 
46 C 4.1076664 3.3252621 -0.2136554 
47 C 1.9621848 2.4525843 0.4827316 
48 C 3.6019978 0.9740479 -0.4746682 
49 C 4.4848671 2.0436968 -0.6174206 
50 C 2.8445461 3.5255548 0.3415116 
51 H 0.9915723 2.6416344 0.9344833 
52 H 3.9195706 -0.0131798 -0.7924838 
53 H 5.4681888 1.8738061 -1.0461906 
54 H 2.5416808 4.5160114 0.6686531 
55 H 4.7938491 4.1591079 -0.3278605 
56 C -1.4609443 -3.8413727 1.6710750 
57 H -0.7372328 -4.6136971 1.9507047 
58 H -2.1787188 -4.2900558 0.9735607 
59 H -2.0023627 -3.5548131 2.5793733 
 
 
 
1 H 0.0594885 1.2386758 -1.0171604 
2 C -0.0032961 0.6405679 -0.1060544 
3 N -0.9103952 -0.5283804 -0.4272571 
4 C 0.0358057 -1.5696973 -1.1457387 
5 C 1.4876279 -1.1499448 -0.7407759 
6 H -0.4579816 1.2446208 0.6785910 
7 H 2.0011961 -0.7787604 -1.6314551 
8 C -1.4555907 -1.2557243 0.8159127 
9 C -0.2153225 -2.9245762 -0.4574883 
10 H -0.9719738 -3.5118529 -0.9934603 
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11 C 1.1688415 -3.5963231 -0.4803925 
12 H 1.3472515 -4.0549674 -1.4595199 
13 C 2.1729975 -2.4446486 -0.2196629 
14 H 2.3816517 -2.3454068 0.8468156 
15 C -0.1319917 -1.6126493 -2.6625068 
16 H -1.1267770 -1.9382593 -2.9780182 
17 H 0.5841965 -2.3439622 -3.0509954 
18 H 0.1035718 -0.6571803 -3.1431720 
19 C -2.0920996 -0.0584890 -1.2961085 
20 H -2.6271523 -0.9675977 -1.5767120 
21 H -1.6523058 0.3718929 -2.1963381 
22 C -3.0255618 0.9307798 -0.6381818 
23 C -4.8018843 2.7745414 0.5185796 
24 C -2.7621274 2.3089042 -0.6916557 
25 C -4.2107478 0.4954646 -0.0268133 
26 C -5.0903061 1.4095671 0.5527932 
27 C -3.6400886 3.2239679 -0.1124037 
28 H -1.8783157 2.6743120 -1.2089990 
29 H -4.4660427 -0.5615210 -0.0249793 
30 H -6.0054720 1.0562544 1.0181903 
31 H -3.4248123 4.2869134 -0.1670367 
32 H -5.4892905 3.4872081 0.9643877 
33 O 1.3664501 -0.4534991 1.5785008 
34 C 1.4865949 0.4763306 2.6551208 
35 H 2.4577835 0.9796750 2.6471338 
36 H 1.3913757 -0.1167158 3.5669452 
37 C 1.3831030 0.0674969 0.2436111 
38 H 0.6924788 1.2367067 2.6427164 
39 H -1.3557243 -0.5962025 1.6765296 
40 H 1.2478747 -4.3974252 0.2615765 
41 H 3.1258058 -2.6241607 -0.7250953 
42 H -2.5171105 -1.4221721 0.6353513 
43 C -0.7151355 -2.5879411 0.9641186 
44 H 0.1513334 -2.4191413 1.6073059 
45 C 2.5162200 1.0759527 0.0481580 
46 C 4.6647652 2.8709055 -0.2359384 
47 C 2.2882698 2.4521549 -0.0775603 
48 C 3.8418603 0.6145404 0.0496815 
49 C 4.9062453 1.5022202 -0.0936038 
50 C 3.3537750 3.3435673 -0.2242953 
51 H 1.2788514 2.8529881 -0.0531855 
52 H 4.0438773 -0.4455993 0.1701458 
53 H 5.9247788 1.1249972 -0.0944461 
54 H 3.1550277 4.4066227 -0.3244450 
55 H 5.4940109 3.5627155 -0.3497261 
56 C -1.5925730 -3.6760502 1.5907852 
57 H -1.0324119 -4.6112903 1.6919271 
58 H -2.4804193 -3.8815440 0.9796934 
59 H -1.9298862 -3.3886760 2.5927453 
 
 
 
1 H 0.1702856 1.1637474 -0.9260466 
2 C 0.1065350 0.5657409 -0.0159665 
3 N -0.8809854 -0.5464083 -0.2908206 
4 C -0.0223619 -1.7052103 -0.9570157 
5 C 1.4624446 -1.3294480 -0.6609171 
6 H -0.2797949 1.1928429 0.7876361 
7 H 1.9495320 -1.0274711 -1.5919401 
8 C -1.4213542 -1.1634410 1.0035621 
9 C -0.3511035 -2.9947494 -0.1361456 
10 H -0.6035575 -3.8039283 -0.8296235 
11 C 0.9453806 -3.3474726 0.6351287 
12 H 1.0973100 -4.4296450 0.6902226 
13 C 2.0842618 -2.6314006 -0.1088768 
14 H 2.9423242 -2.4463081 0.5400529 
15 C -0.2716944 -1.8668584 -2.4558639 
16 H -1.2896890 -2.1899877 -2.6899270 
17 H 0.4039699 -2.6510170 -2.8131180 
18 H -0.0405430 -0.9634332 -3.0295789 
19 C -2.0299161 -0.0188430 -1.1762875 
20 H -2.6584650 -0.8798932 -1.3945523 
21 H -1.5597345 0.3050620 -2.1045828 
22 C -2.8529616 1.0978227 -0.5792920 
23 C -4.4354462 3.1705272 0.4687473 
24 C -2.4777743 2.4397920 -0.7484643 
25 C -4.0522851 0.8142026 0.0926784 
26 C -4.8355288 1.8419313 0.6182764 
27 C -3.2591321 3.4679629 -0.2227429 
28 H -1.5831252 2.6890856 -1.3138802 
29 H -4.3904383 -0.2151387 0.1866538 
30 H -5.7619611 1.6043550 1.1323765 
31 H -2.9575442 4.5012442 -0.3662706 
32 H -5.0464191 3.9721094 0.8727636 
33 O 1.5216987 -0.5681258 1.6272748 
34 C 1.7822860 0.3782045 2.6655089 
35 H 2.7993662 0.7758332 2.6016101 
36 H 1.6634084 -0.1722502 3.6008568 
37 C 1.4772241 -0.0785302 0.2773444 
38 H 1.0713916 1.2160471 2.6517712 
39 H -0.6584738 -0.9800496 1.7571627 
40 H -2.3374746 -0.6427571 1.2797340 
41 H 0.8890022 -2.9716976 1.6603925 
42 H 2.4303875 -3.2383667 -0.9537715 
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43 C -1.5664703 -2.6705390 0.7630183 
44 H -1.4389218 -3.1650875 1.7331903 
45 C 2.6336417 0.8824466 -0.0185684 
46 C 4.8036347 2.6175439 -0.4847088 
47 C 2.4595622 2.2738572 -0.0011697 
48 C 3.9200260 0.3768063 -0.2589370 
49 C 4.9940620 1.2345081 -0.4917919 
50 C 3.5331691 3.1350326 -0.2357929 
51 H 1.4848277 2.7089357 0.2034966 
52 H 4.0897276 -0.6947440 -0.2674724 
53 H 5.9803077 0.8205993 -0.6804229 
54 H 3.3734237 4.2091990 -0.2203024 
55 H 5.6398546 3.2854112 -0.6687420 
56 C -2.9147761 -3.1380943 0.1927465 
57 H -2.9528712 -4.2323050 0.1835404 
58 H -3.0893923 -2.8082164 -0.8369045 
59 H -3.7499980 -2.7859303 0.8085678 
 
7.5.2. Tabular Catalyst Enantioselectivity Data: 
 
name ln(S/R) 
II{2,1} -0.120 
II{2,2} 0.000 
II{2,3} -0.080 
II{2,4} 0.000 
II{2,5} 0.000 
II{2,6} 0.040 
II{3,1} 0.080 
II{3,2} 0.080 
II{3,3} 0.040 
II{3,4} 0.040 
II{3,5} 0.040 
II{3,6} 0.120 
II{4,1} 0.040 
II{4,2} 0.000 
II{4,3} 0.040 
II{4,4} 0.000 
II{4,5} 0.000 
II{4,6} 0.000 
II{5,1} -0.120 
II{5,2} -0.160 
II{5,3} -0.080 
II{5,4} -0.201 
II{5,5} 0.000 
II{5,6} -0.080 
IV{5,2,5} 0.241 
V{1,2,1} 0.080 
V{1,2,2} 0.160 
V{1,2,3} 0.080 
V{1,2,4} 0.241 
V{1,2,7} 0.405 
V{1,2,8} 0.080 
V{1,2,6} -0.040 
V{2,2,1} -0.120 
V{2,2,2} -0.201 
V{2,2,3} -0.040 
V{2,2,5} 0.282 
V{2,2,7} 0.282 
V{2,2,8} -0.120 
V{2,2,6} 0.040 
V{2,7,2} -0.080 
V{2,7,3} -0.080 
V{2,7,5} 0.364 
V{2,7,7} 0.282 
 
 
 page 480 
 
Tabular Catalyst Enantioselectivity Data: (cont.) 
 
V{2,3,1} -0.160 
V{2,3,2} -0.080 
V{2,3,3} -0.120 
V{2,3,5} 0.282 
V{2,3,7} 0.323 
V{2,3,8} -0.201 
V{2,3,6} 0.120 
V{3,2,1} -0.282 
V{3,2,2} -0.323 
V{3,2,3} -0.241 
V{3,2,5} -0.575 
V{3,2,7} -0.490 
V{3,2,8} -0.241 
V{3,2,6} -0.282 
V{3,7,1} -0.241 
V{3,7,2} -0.364 
V{3,7,3} -0.323 
V{3,7,5} -0.405 
V{3,7,7} -0.447 
V{3,7,8} -0.405 
V{3,7,6} -0.364 
V{3,3,1} -0.405 
V{3,3,2} -0.282 
V{3,3,3} -0.323 
V{3,3,5} -0.490 
V{3,3,7} -0.405 
V{3,3,8} -0.405 
V{3,3,6} 0.040 
V{4,2,5} -0.532 
V{5,2,1} -0.080 
V{5,2,2} -0.040 
V{5,2,3} 0.040 
V{5,2,5} 1.450 
V{5,2,8} -0.241 
V{5,2,9} -0.040 
V{5,2,10} 0.000 
V{5,2,11} 0.241 
V{5,7,1} -0.080 
V{5,7,2} 0.000 
V{5,7,3} 0.040 
V{5,7,5} 1.450 
V{5,7,7} 0.532 
V{5,6,1} -0.040 
V{5,6,5} 1.450 
V{5,6,8} -0.160 
V{5,3,1} -0.201 
V{5,3,2} -0.080 
V{5,3,3} -0.040 
V{5,3,5} 1.325 
V{5,3,7} 0.447 
V{5,3,8} -0.323 
V{7,2,1} 0.040 
V{7,2,5} 1.450 
V{7,2,8} -0.080 
V{7,2,9} 0.160 
V{7,2,10} 0.080 
V{6,2,5} 1.153 
V{6,2,8} -0.120 
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7.5.3. CoMFA Model Development.  
 All of the CoMFA modeling is performed within the Sybyl X 1.1 software package. Each 
catalyst geometry is minimized using MMFF with Spartan starting from the desired conformer. 
Single point calculations are carried out on each MMFF conformer at the desired semi-empirical 
parameterization level. All structures are then imported as .mol2 files, while retaining 
electrostatic partial atomic charges, into Sybyl. A rigid-body, root mean square (RMS) 
alignment, as implemented in Sybyl under the align database option, is then performed on the 
library in question using the 5-5-5 core as the common substructure and the simplest catalyst 
(II{1,1}) as the template molecule. The inertial grid orientation option is chosen for the 
alignment. After the alignment, a region is created to compute the fields for which a grid is 
created that extends at least 4Å along the Cartesian axes. The volume of the grid is XXX. The 
probe atom used is the standard sp3 hybridized carbon atom with a +1 atomic charge. The grid 
spacing within each lattice point is chosen as 2Å. Any grid spacing smaller or larger typically 
produced worse results, with or without region focusing. Initially, a 2Å grid spacing produced 
1584 grid points for the region.  
 Each conformation library, as defined in table 1, was subjected to a number of CoMFA 
analyses while investigating different semi-empirical partial charges, cutoff energy combinations 
and field type (Tripos standard or Indicator). Smoothing functions were not applied in 
calculating the field values. For the electrostatic field, the distance dependence in the Coulombic 
expression was set to 1/r2. For grid points that exhibit steric energies exceeding the steric cutoff 
energy, the electrostatic energy for that grid point is set to the average of all the non-excluded 
electrostatic energies so that these grid points do not contribute to the regression analysis. For the 
steric energy, the exponent of the repulsive term is set to 12 so as to produce the standard 6-12 
Lennard-Jones potential. Other values (8 or 10) generally resulted in poorer result.  
 After the fields were calculated for all the catalysts in the library, a PLS regression was 
performed on the calculated interaction energies. All models reported below are generated from 
5 components (latent variables). For the Tripos standard fields, the q2LOO values are reported after 
2.0 kcal/mol filtering was applied in which grid points with a standard deviation of less than this 
value are dropped from the analysis. Column filtering was not applied when Indicator fields were 
used.  
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Table 25. The complete investigation semi-empirical partial atomic charges. The data that is 
boxed represents that in table 2 of the main paper. 
 Conformation Library 
(R2 / q2) 
  A B C D E 
PM3a_30b/30c_Stdd 0.699e / 0.482f 0.686 / 0.446 0.706 / 0.475 0.813 / 0.612 0.784 / 0.591 
PM3_30/15_Std 0.700 / 0.491 0.690 / 0.441 0.708 / 0.460 0.812 / 0.587 0.785 / 0.609 
PM3_15/30_Std 0.703 / 0.484 0.692 / 0.468 0.704 / 0.461 0.797 / 0.642 0.804 / 0.609 
PM3_30/30_Inde 0.729 / 0.485 0.734 / 0.533 0.712 / 0.477 0.799 / 0.640 0.768 / 0.527 
PM3_30/15_Ind 0.783 / 0.463 0.801 / 0.529 0.879 / 0.621 0.870 / 0.621 0.868 / 0.618 
PM3_15/30_Ind 0.707 / 0.450 0.694 / 0.454 0.724 / 0.466 0.811 / 0.609 0.795 / 0.557 
AM1_30/30_Std 0.712 / 0.485 0.683 / 0.440 0.705 / 0.479 0.810 / 0.621 0.780 / 0.590 
AM1_30/15_Std 0.714 / 0.496 0.685 / 0.429 0.707 / 0.472 0.812 / 0.607 0.781 / 0.594 
AM1_15/30_Std 0.723 / 0.506 0.688 / 0.452 0.701 / 0.441 0.791 / 0.634 0.801 / 0.613 
AM1_30/30_Ind 0.724 / 0.474 0.697 / 0.423 0.712 / 0.477 0.813 / 0.653 0.768 / 0.527 
AM1_30/15_Ind 0.796 / 0.503 0.817 / 0.533 0.906 / 0.671 0.896 / 0.635 0.866 / 0.641 
AM1_15/30_Ind 0.711 / 0.462 0.693 / 0.416 0.724 / 0.466 0.811 / 0.609 0.795 / 0.557 
MNDO_30/30_Std 0.728 / 0.547 0.697 / 0.465 0.711 / 0.493 0.815 / 0.612 0.794 / 0.574 
MNDO_30/15_Std 0.729 / 0.551 0.700 / 0.481 0.711 / 0.485 0.814 / 0.598 0.794 / 0.586 
MNDO_15/30_Std 0.734 / 0.545 0.705 / 0.498 0.709 / 0.460 0.803 / 0.641 0.812 / 0.636 
MNDO_30/30_Ind 0.724 / 0.474 0.697 / 0.423 0.712 / 0.477 0.835 / 0.648 0.768 / 0.527 
MNDO_30/15_Ind 0.797 / 0.484 0.754 / 0.442 0.835 / 0.619 0.924 / 0.778 0.782 / 0.474 
MNDO_15/30_Ind 0.711 / 0.462 0.693 / 0.416 0.724 / 0.466 0.810 / 0.604 0.795 / 0.557 
a Semi-empirical parameterization method for calculating partial atomic charges. b Steric cutoff 
energy (kcal/mol). c Electrostatic cutoff energy (kcal/mol). d Tripos standard field type. e 
Indicator field type. e R2. f q2LOO.  
7.5.4. Internal Cross-validation.  
All of the internal cross-validation for the CoMFA models was performed with Sybyl X. 
q2LMO represents an average of 100 runs aided by an spl script. Y-scrambling was performed such 
that 100% of the dependent variable data was scrambled such that each value was paired with the 
incorrect descriptor values. A PLS regression was then performed on each model. The reported 
R2scramb. values are obtained in the absence of column-filtering. The reported q
2
LOO,scramb. for 
models from Tripos Standard fields determined in the presence of 2 kcal/mol column filtering 
while the q2LOO,scramb. values for models determined from Indicator fields were determined in the 
absence of column filtering. 
7.5.5. External Cross-validation.  
 Internal cross-validation is considered a necessary but insufficient condition in assessing 
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the predictive capacity of a QSAR model (especially for 3-D QSAR).184 The use of an external 
dataset that was not used in the model development for prediction is considered to be a more 
realistic assessment of the predictive power of a model. The entire data set was divided into 
multiple training sets (data set used to develop the model) and test sets (dataset to be predicted 
by the model developed from the training set) in accordance with Tropsha’s criteria for the 
rational division of datasets for external validation.184 b The primary considerations in the 
division of the data set were that both the training and test sets would contain five compounds 
that spanned the range of e.r. and descriptor space of the entire dataset. Addressing the 
incorporation of catalysts within the entire e.r. range is relatively straightforward, although 
dividing the data based on their descriptor space is much less straightforward, particularly for 3-
D descriptors. There might be hundreds of interaction energies with which to assess the property 
range which is of a significantly higher order space that is difficult to probe directly. Multi-
dimensional descriptor space is difficult to think about and work with. Therefore, on the basis of 
the assumption that molecules with similar structures (as determined by some shape similarity 
metric) will have similar properties185, field similarity was used to segregate molecules based on 
their fields. This was performed employing a Tanimoto similarity metric (T) (Eq. 1) where F1 
and F2 represent the fields to be compared, E1 and E2 represent the interaction energies at grid 
point i, and n is the number of grid points.186  
011, 12 = 4 51,652,6764 51,62 + 4 52,62 − 4 51,652,6767676  ; −1/3 ≤ 0 ≤ 1 
                             
(Eq. 1) 
The catalysts with field properties in the middle of the field property spectrum were 
identified as having the largest number of of T coefficients (100 values generated by comparison 
to every catalyst in the dataset of 101) greater than a user-defined value (T = 0.55 produced a 
sufficient range of values). With catalysts in the middle of the property spectrum determined, 
catalysts located at the extremes were approximated (but not yet differentiated) by identifying 
the catalysts with fields of the lowest similarity (most dissimilar) to catalysts in the middle of the 
field property region. The extremes were then differentiated by locating catalysts exhibiting the 
lowest similarity among the catalysts most dissimilar to the catalysts in the middle property 
region. A similar procedure was performed for indentifying catalysts within the middle and 
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extremes. A more complete table of the results of all 30 training/test set splits is provided (from 
table 4 in the main text). 
Specific criteria have been suggested for evaluating the predictability of QSAR models 
based on external validation, which was determined through analyzing a number of QSAR 
models184b, and are reiterated here for ease of comparison: 
q2  > 0.5 | R2 > 0.6 | 
(R2-R0
2)
R2
> 0.1 or 
(R2-R_0
2)
R2
> 0.1 | 0.85 Š k Š 1.15 or 0.85 Š k' Š 1.15   
 
where q2 is that of the training set (q2 = q2LOO for this analysis), R
2 is the coefficient of 
determination for the test set, R20 and R′
2
0 are the squared coefficients of determination for the 
predicted versus observed and observed versus predicted values respectively, k and k' are the 
slopes for the predicted versus observed and observed versus predicted values respectively when 
the intercept is set to zero. These criteria were used to assess the predictive capacity of the 
CoMFA models for enantioselectivity. Both a complete table of the results of all 30 training/test 
set splits (Table 26) and a table that summarizes the data (Table 27) are provided. 
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Table 26. All training/test set splits with correlation parameters. 
entry q2LOO
a R2 b (R2-R20 )/R
2 (R2-R′20 )/R
2 k k′ 
1 0.883 0.933 0.016 0.021 1.084 0.849 
2 0.839 0.915 0.000 0.001 1.041 0.882 
3 0.838 0.925 0.000 0.000 1.106 0.925 
4 0.819 0.907 0.020 0.025 1.041 0.854 
5 0.416 0.793 0.003 0.007 0.913 0.867 
6 0.344 0.829 0.001 0.001 1.071 0.774 
7 0.632 0.908 0.000 0.000 1.174 0.774 
8 0.736 0.885 0.000 0.000 0.887 0.998 
9 0.466 0.737 0.007 0.000 0.805 0.922 
10 0.777 0.858 0.010 0.014 0.967 0.880 
11 0.781 0.900 0.004 0.002 1.011 0.890 
12 0.479 0.870 0.000 0.000 1.076 0.808 
13 0.917 0.916 0.004 0.002 1.240 0.742 
14 0.582 0.855 0.002 0.002 0.967 0.883 
15 0.503 0.874 0.001 0.001 1.067 0.873 
16 0.893 0.922 0.003 0.001 1.176 0.787 
17 0.734 0.877 0.013 0.013 0.948 0.925 
18 0.875 0.940 0.001 0.000 1.025 0.918 
19 0.814 0.859 0.006 0.008 0.840 1.016 
20 0.812 0.923 0.002 0.002 1.105 0.834 
21 0.546 0.807 0.006 0.004 0.828 0.911 
22 0.356 0.865 0.003 0.002 0.962 0.898 
23 0.893 0.917 0.000 0.001 1.046 0.878 
24 0.831 0.862 0.000 0.000 1.017 0.848 
25 0.837 0.901 0.004 0.006 1.089 0.825 
26 0.774 0.873 0.004 0.004 0.865 1.006 
27 0.797 0.888 0.001 0.001 0.860 1.032 
28 0.877 0.921 0.001 0.001 1.090 0.847 
29 0.865 0.897 0.000 0.000 1.027 0.876 
30 0.794 0.882 0.001 0.001 0.945 0.934 
a q2LOO for the training set. 
b R2 for the test set. 
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Table 27. Summary for external validation over 30 training/test set splits (67/34). 
 q2LOO
a R2 (R2-R20 )/R
2 (R2-R′20 )/R
2 k k′ 
Average 0.724 0.881 0.004 0.004 1.01 0.88 
C.I.b 0.063 0.016 0.002 0.002 0.04 0.03 
best q2LOO
c 0.917 0.916 0.004 0.002 1.24 0.74 
best R2 0.875 0.940 0.001 0.000 1.02 0.92 
worst q2LOO
d 0.344 0.829 0.001 0.001 1.07 0.77 
worst R2 0.436 0.737 0.007 0.000 0.81 0.92 
a q2LOO
 for the training set. b 95% confidence interval c Model containing highest value 
of q2LOO. 
d Model containing the lowest value of q2LOO. 
 
 
Contour Maps.  
 For the generation of interpretable contour maps for visualization of the best CoMFA 
model, 1.0 kcal/mol column filtering was applied to the model after region focusing was applied. 
The contours maps were similar to those in the absence of column filtering apart from 
eliminating some of the smaller contours that exhibited low deviation and were seemingly 
uninterpretable. The model results with 1.0 column filtering (R2 = 0.922, q2LOO = 0.868, 
electrostatic field contribution: 44%; steric field contribution: 56%) are similar to that in the 
absence of column filtering (R2 = 0.944, q2LOO = 0.890, electrostatic field contribution: 55%, 
steric field contribtution: 45%), so that the contours reflect the model accurately. The contour 
specifications for the contour maps were based on percent contributions. For the steric contour 
maps, the volume enclosing regions where increased steric bulk leads to increased 
enantioselectivity (green) was set to 65% and thus the volumne enclosing regions where 
decreased steric bulk leads to increased enantioselectivity was set to 35%. Hence, the green 
contours represent the top 65% of the energy range observed for the van der Walls potential and 
vice versa for the minimum 35%. For the electrostatic contour maps, the volume enclosing 
regions where increased positive charge leads to increased enantioselectivity (blue) was set to 
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75% and thus the volume enclosing regions where decreased positive charge leads to increased 
enantioselectivity was set to 25%. The physical interpretation of the percentiles remains the same 
as for the steric contours.   
 
7.6.  QSAR Modeling for Chapter 4 
Sequence for generating 3D-QSAR model 
1.  Obtain geometries for each compound 
2. Align molecules based on a common core 
3. Generate a grid that encompasses all of the molecular with defined lattice spacing and 
imensions given a point for the origin which could be the center of your scaffold 
a. Spl script q1.spl can be used. 
4. Calculate electrostatic energies using the grid file as input, using Jaguar, Gaussian, 
GAMESS, or other to calculate the energies (ie. B3LYP/6-31G(d,p)) 
5. Calculate steric energies using MMFF94 van der Waals potential using spl script q2.spl. 
6. Match the electrostatic and steric energy for each grid point and eliminate points based on 
cutoff energies using spl script q3.spl and use q4.spl to generate files contained the field 
data for each catalyst and the standard deviation at each point. 
7. Use a graphical user interface (eg. Maestro) to remove grid points that are of no interest 
and save new grid file. 
8. Use spl script q5.spl to reduce size of grid points based on a standard deviation threshold.  
9. Use spl script q6.spl to generate new files with reduced grid point size. 
10.  Use simulated annealing algorithms inq7.py in combination with statistical functions in 
classes from q8.py to generate QSAR models.  
11.  From the output, obtain the the models with the best correlation (or some other 
parameter) and visualize the grid point locations with maestro to see if models make 
sense 
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Example of Simulated Annealing Run 
 
n=12 data set 
Electrostatic scaling factor= 1.0 
Steric scaling factor= 1.0 
Initial configuration= 1 5 
R2= 0.218 
----------------------------------- 
Monte-Carlo steps= 1 
iteration= 1 
temperature= 1000 
configuration= 101 5 
R2= 0.895 
>>>>>>> 0.895 is the new best!! <<<<<<< 
clock time= 14:25:13 
----------------------------------- 
Monte-Carlo steps= 2 
iteration= 2 
temperature= 1000 
configuration= 134 5 
R2= 0.911 
>>>>>>> 0.911 is the new best!! <<<<<<< 
clock time= 14:26:35 
----------------------------------- 
Monte-Carlo steps= 3 
iteration= 3 
temperature= 984.14539 
configuration= 112 5 
R2= 0.913 
>>>>>>> 0.913 is the new best!! <<<<<<< 
clock time= 14:27:43 
----------------------------------- 
Monte-Carlo steps= 5 
iteration= 4 
temperature= 948.42085 
configuration= 134 838 
R2= 0.938 
>>>>>>> 0.938 is the new best!! <<<<<<< 
clock time= 14:29:45 
----------------------------------- 
Monte-Carlo steps= 6 
iteration= 5 
temperature= 934.76481 
configuration= 28 838 
R2= 0.911 
clock time= 14:31:07 
----------------------------------- 
Monte-Carlo steps= 7 
iteration= 6 
temperature= 913.2819 
configuration= 28 420 
R2= 0.901 
clock time= 14:32:10 
----------------------------------- 
Monte-Carlo steps= 8 
iteration= 7 
temperature= 895.02801 
configuration= 148 420 
R2= 0.957 
>>>>>>> 0.957 is the new best!! <<<<<<< 
clock time= 14:33:45 
----------------------------------- 
Monte-Carlo steps= 9 
iteration= 8 
temperature= 885.2104 
configuration= 148 579 
R2= 0.958 
>>>>>>> 0.958 is the new best!! <<<<<<< 
clock time= 14:35:21 
----------------------------------- 
Monte-Carlo steps= 10 
iteration= 9 
temperature= 869.13224 
configuration= 110 579 
R2= 0.904 
clock time= 14:36:51 
----------------------------------- 
Monte-Carlo steps= 11 
iteration= 10 
temperature= 844.45884 
configuration= 110 669 
R2= 0.926 
clock time= 14:37:50 
----------------------------------- 
Monte-Carlo steps= 12 
iteration= 11 
temperature= 831.7584 
configuration= 148 669 
R2= 0.928 
clock time= 14:39:42 
----------------------------------- 
Monte-Carlo steps= 13 
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iteration= 12 
temperature= 816.78546 
configuration= 111 669 
R2= 0.919 
clock time= 14:41:32 
----------------------------------- 
Monte-Carlo steps= 17 
iteration= 13 
temperature= 758.50032 
configuration= 148 832 
R2= 0.958 
clock time= 14:47:11 
----------------------------------- 
Monte-Carlo steps= 18 
iteration= 14 
temperature= 747.81851 
configuration= 37 832 
R2= 0.896 
clock time= 14:48:36 
----------------------------------- 
Monte-Carlo steps= 20 
iteration= 15 
temperature= 717.72264 
configuration= 148 430 
R2= 0.957 
clock time= 14:50:57 
----------------------------------- 
Monte-Carlo steps= 22 
iteration= 16 
temperature= 691.67161 
configuration= 134 579 
R2= 0.915 
clock time= 14:53:25 
----------------------------------- 
Monte-Carlo steps= 24 
iteration= 17 
temperature= 665.27818 
configuration= 148 572 
R2= 0.958 
clock time= 14:56:37 
----------------------------------- 
Monte-Carlo steps= 26 
iteration= 18 
temperature= 641.13137 
configuration= 124 832 
R2= 0.903 
clock time= 14:59:03 
----------------------------------- 
Monte-Carlo steps= 29 
iteration= 19 
temperature= 604.50786 
configuration= 27 430 
R2= 0.904 
clock time= 15:02:51 
----------------------------------- 
Monte-Carlo steps= 31 
iteration= 20 
temperature= 580.83447 
configuration= 134 430 
R2= 0.914 
clock time= 15:05:41 
----------------------------------- 
Monte-Carlo steps= 32 
iteration= 21 
temperature= 565.71706 
configuration= 134 876 
R2= 0.93 
clock time= 15:06:35 
----------------------------------- 
Monte-Carlo steps= 33 
iteration= 22 
temperature= 556.72066 
configuration= 112 876 
R2= 0.913 
clock time= 15:08:33 
----------------------------------- 
Monte-Carlo steps= 34 
iteration= 23 
temperature= 544.93406 
configuration= 123 876 
R2= 0.916 
clock time= 15:10:30 
----------------------------------- 
Monte-Carlo steps= 37 
iteration= 24 
temperature= 515.39839 
configuration= 112 2 
R2= 0.914 
clock time= 15:14:28 
----------------------------------- 
Monte-Carlo steps= 38 
iteration= 25 
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temperature= 506.04094 
configuration= 101 2 
R2= 0.899 
clock time= 15:15:43 
----------------------------------- 
Monte-Carlo steps= 40 
iteration= 26 
temperature= 486.0803 
configuration= 123 5 
R2= 0.909 
clock time= 15:17:40 
----------------------------------- 
Monte-Carlo steps= 41 
iteration= 27 
temperature= 478.23233 
configuration= 123 2 
R2= 0.914 
clock time= 15:18:31 
----------------------------------- 
Monte-Carlo steps= 42 
iteration= 28 
temperature= 469.8513 
configuration= 134 2 
R2= 0.926 
clock time= 15:19:32 
----------------------------------- 
Monte-Carlo steps= 44 
iteration= 29 
temperature= 454.48385 
configuration= 134 822 
R2= 0.931 
clock time= 15:21:19 
----------------------------------- 
Monte-Carlo steps= 45 
iteration= 30 
temperature= 445.64956 
configuration= 112 822 
R2= 0.921 
clock time= 15:22:44 
----------------------------------- 
Monte-Carlo steps= 48 
iteration= 31 
temperature= 420.86134 
configuration= 123 822 
R2= 0.917 
clock time= 15:26:56 
----------------------------------- 
Re-setting temperature to T to T_max = 
462.13163 
----------------------------------- 
Monte-Carlo steps= 68 
iteration= 32 
temperature= 357.81805 
configuration= 148 838 
R2= 0.948 
clock time= 15:52:00 
----------------------------------- 
Monte-Carlo steps= 73 
iteration= 33 
temperature= 326.51664 
configuration= 134 420 
R2= 0.915 
clock time= 15:59:08 
----------------------------------- 
Monte-Carlo steps= 74 
iteration= 34 
temperature= 318.08599 
configuration= 110 420 
R2= 0.912 
clock time= 16:01:38 
----------------------------------- 
Monte-Carlo steps= 76 
iteration= 35 
temperature= 307.05445 
configuration= 110 571 
R2= 0.924 
clock time= 16:03:56 
----------------------------------- 
Re-setting temperature to T to T_max = 
347.1931 
----------------------------------- 
Monte-Carlo steps= 80 
iteration= 36 
temperature= 347.1931 
configuration= 36 669 
R2= 0.896 
clock time= 16:10:22 
----------------------------------- 
Monte-Carlo steps= 84 
iteration= 37 
temperature= 321.74688 
configuration= 111 538 
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R2= 0.919 
clock time= 16:17:14 
----------------------------------- 
Monte-Carlo steps= 85 
iteration= 38 
temperature= 315.85388 
configuration= 111 447 
R2= 0.915 
clock time= 16:18:16 
----------------------------------- 
Monte-Carlo steps= 86 
iteration= 39 
temperature= 309.86428 
configuration= 221 447 
R2= 0.901 
clock time= 16:20:05 
----------------------------------- 
Monte-Carlo steps= 87 
iteration= 40 
temperature= 303.45593 
configuration= 221 877 
R2= 0.9 
clock time= 16:21:18 
----------------------------------- 
Monte-Carlo steps= 88 
iteration= 41 
temperature= 297.8484 
configuration= 111 877 
R2= 0.898 
clock time= 16:22:42 
----------------------------------- 
Monte-Carlo steps= 89 
iteration= 42 
temperature= 292.29538 
configuration= 111 570 
R2= 0.917 
clock time= 16:23:42 
----------------------------------- 
Monte-Carlo steps= 90 
iteration= 43 
temperature= 287.78352 
configuration= 148 570 
R2= 0.925 
clock time= 16:25:18 
----------------------------------- 
Monte-Carlo steps= 94 
iteration= 44 
temperature= 268.8683 
configuration= 134 832 
R2= 0.931 
clock time= 16:29:50 
----------------------------------- 
Monte-Carlo steps= 101 
iteration= 45 
temperature= 235.50062 
configuration= 134 572 
R2= 0.91 
clock time= 16:39:30 
----------------------------------- 
Monte-Carlo steps= 110 
iteration= 46 
temperature= 196.71466 
configuration= 28 419 
R2= 0.907 
clock time= 16:53:35 
----------------------------------- 
Monte-Carlo steps= 112 
iteration= 47 
temperature= 189.44858 
configuration= 134 419 
R2= 0.92 
clock time= 16:57:28 
----------------------------------- 
Monte-Carlo steps= 113 
iteration= 48 
temperature= 186.35716 
configuration= 148 419 
R2= 0.948 
clock time= 16:59:01 
----------------------------------- 
Monte-Carlo steps= 115 
iteration= 49 
temperature= 179.44509 
configuration= 36 419 
R2= 0.91 
clock time= 17:02:08 
----------------------------------- 
Monte-Carlo steps= 131 
iteration= 50 
temperature= 133.27666 
configuration= 37 838 
R2= 0.907 
492 
 
clock time= 17:26:15 
----------------------------------- 
Monte-Carlo steps= 137 
iteration= 51 
temperature= 118.76524 
configuration= 110 419 
R2= 0.909 
clock time= 17:35:47 
----------------------------------- 
Monte-Carlo steps= 139 
iteration= 52 
temperature= 114.50719 
configuration= 111 571 
R2= 0.917 
clock time= 17:38:36 
----------------------------------- 
Monte-Carlo steps= 140 
iteration= 53 
temperature= 112.27939 
configuration= 148 571 
R2= 0.925 
clock time= 17:40:17 
----------------------------------- 
Monte-Carlo steps= 156 
iteration= 54 
temperature= 83.483824 
configuration= 27 832 
R2= 0.886 
clock time= 18:02:23 
----------------------------------- 
Monte-Carlo steps= 157 
iteration= 55 
temperature= 81.253853 
configuration= 27 420 
R2= 0.912 
clock time= 18:03:32 
----------------------------------- 
Monte-Carlo steps= 181 
iteration= 56 
temperature= 51.949478 
configuration= 27 587 
R2= 0.91 
clock time= 18:42:04 
----------------------------------- 
Monte-Carlo steps= 182 
iteration= 57 
temperature= 50.981169 
configuration= 148 587 
R2= 0.949 
clock time= 18:43:32 
----------------------------------- 
Monte-Carlo steps= 189 
iteration= 58 
temperature= 44.815362 
configuration= 124 822 
R2= 0.894 
clock time= 18:51:11 
----------------------------------- 
Monte-Carlo steps= 190 
iteration= 59 
temperature= 43.781149 
configuration= 124 298 
R2= 0.91 
clock time= 18:52:05 
----------------------------------- 
Monte-Carlo steps= 191 
iteration= 60 
temperature= 43.087129 
configuration= 148 298 
R2= 0.915 
clock time= 18:53:06 
----------------------------------- 
Monte-Carlo steps= 193 
iteration= 61 
temperature= 41.522102 
configuration= 124 514 
R2= 0.935 
clock time= 18:55:11 
----------------------------------- 
Monte-Carlo steps= 194 
iteration= 62 
temperature= 40.913489 
configuration= 124 883 
R2= 0.911 
clock time= 18:56:05 
----------------------------------- 
Monte-Carlo steps= 195 
iteration= 63 
temperature= 39.995737 
configuration= 148 883 
R2= 0.911 
clock time= 18:57:17 
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----------------------------------- 
Monte-Carlo steps= 196 
iteration= 64 
temperature= 39.26319 
configuration= 112 883 
R2= 0.888 
clock time= 18:58:28 
----------------------------------- 
Monte-Carlo steps= 203 
iteration= 65 
temperature= 34.277884 
configuration= 37 420 
R2= 0.894 
clock time= 19:07:50 
----------------------------------- 
 
 
7.7. Preparation of Compounds from Chapter 4 
7.7.1. Preparation of Compounds from Figure 21 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(2,3,4-trifluorophenyl)-5-
methyl-7b-methyl-2Hcyclopenta[gh] pyrrolizin-2-one (23a)  
 
To a 5-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added 21 (40 mg, 0.207 mmol) followed by THF (400 
µL).  The flask was immersed in an ice bath and 2,3,4-trifluorophenylmagnesium bromide (600 
µL, 0.331 mmol, 1.6 equiv, in THF) was added dropwise via syringe.  After being stirred for 10 
min, the cooling bath was removed and the reaction was stirred at room temperature for 20 min. 
The solution was cooled in an ice bath and sat. aq. NH4Cl (1.0 mL) is added.  The resulting 
mixture was transferred to a 60-mL separatory funnel using an additional 20 mL of water and 20 
mL of Et2O and the aqueous phase was extracted with diethyl ether (3 x 15 mL). The organic 
extracts were washed with water (2 x 20 mL), and brine (1x 20 mL), then the combinded organic 
extracts were dried (NaSO4).  The mixture was filtered through a cotton plug and concentrated 
by rotary evaporation (15 mm Hg, 20-25oC).  Purification by silica gel chromatography (5.0 cm 
x 8 cm column, gradient elution, EtOAc/Hexanes, 10, 20, 30, 50%, 25 mL each) afforded 66 mg 
(98%) of 23a. 
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 Data for 23a 
 1H-NMR: (500 MHz, CDCl3) 
6.89 – 6.80 (m, 2H, HC(13), HC(14)), 4.15 (ddd, J = 11.7, 7.4, 2.1 Hz, 1H, 
H2C(4)), 3.68 – 3.52 (m, 1H, OH), 2.73 (td, J = 7.3, 3.9 Hz, 1H, HC(7a)), 2.66 
– 2.56 (m, 1H, H2C(4)), 2.07 – 1.95 (m, 1H, H2C(7)), 1.86 – 1.62 (m, 4H, 
HC(5), HC(5a), H2C(6), H2C(7)), 1.58 – 1.47 (m, 1H, H2C(6)), 1.08 (dd, J = 
6.6, 2.0 Hz, 3H, H3C(15)), 0.95 (s, 3H, H3C(8)) 
 13C-NMR: (500 MHz, CDCl3) 
175.00 (C(2)), 151.89 (ddd, J = 3.2, 10.6, 78.8 Hz, C(12)), 149.89 (ddd, J = 
2,7, 6.8, 72.7 Hz, C(10)), 140.76 (dt, J = 14.1, 252 Hz, C(11)), 128.64 (d, J = 
8.9 Hz, C(14)), 121.77 (sept, J = 3.8 Hz, C(9)), 111.36 (dd, J = 3.62, 16.8 Hz, 
C(13)), 80.75 (C(1) or C(7b)), 75.60 (C(1) or C(7b)), 58.64 (C(5a)), 57.04 
(C(7a)), 51.12 (C(4)), 42.06 (C(5)), 30.17 (C(6)), 26.98 (C(7)), 24.11 (C(8)), 
17.66 (C(15)) 
 IR: (CDCl3, film) 
3271 (s), 3079 (w), 2965 (s), 2928 (s), 2885 (m), 1688 (s), 1631 (m), 1610 (s), 
1512 (s), 1477 (s), 1459 (s), 1381 (m), 1329 (w), 1291 (s), 1233 (s), 1202 (m), 
1182 (m), 1167 (s), 1149 (m), 1089 (w), 1053 (s), 1030 (m), 989 (m), 953 (m), 
908 (s), 866 (w), 838 (w), 826 (m), 733 (s), 679 (m), 649 (m) 
 MS: (ESI, Q-tof) 
326.1 (76) [M+1], 308.1 (100), 260.6 (6), 241.0 (2), 195.0 (2), 163.0 (3), 
79.0(2) 
 Mol. Formula: C17H18F3NO2  (325.33) 
 HRMS: C17H19F3NO2
+, (326.14) 
  Calcd:  326.1368 
  Found:  326.1367 
 TLC: Rf  0.27  (TBME/Hexanes, 3:7) [UV, I2] 
Preparation of (1R,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(2,3,4-trifluoropheny)-5-
methyl-7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (23b)  
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To a 5-mL round-bottomed flask equipped with a nitrogen inlet adapter, a rubber septum, 
a reflux condenser, and a magnetic stir bar was added 23a (65 mg, 0.2 mmol) then BH3•THF 
complex (3.0 mL, 3.0 mmol, 15 equiv). The reaction flask was immersed in an oil bath and 
heated to reflux (66 oC).  After being stirred for 12 h at reflux, the solution was allowed to reach 
room temperature and was quenched with methanol (5 mL) and concentrated by rotary 
evaporation (15 mm Hg, 20-25oC).  The resulting colorless oil was purified by silica gel column 
chromatography (5.0 mm x 8 cm column, gradient elution, TBME/Heaxanes, 5, 10, 15, 20, 25, 
30% 25 mL each) to afford 64 mg (98%) of 23b as a white solid. 
 
 Data for 23b 
 1H-NMR: (500 MHz, CDCl3) 
7.19 – 7.04 (m, 1H, HC(14)), 6.95 (q, J = 8.4, 7.6 Hz, 1H, HC(13)), 4.11 (d, J 
= 13.6 Hz, 1H, H2C(2)), 3.72 (dd, J = 13.4, 2.4 Hz, 1H, H2C(2)), 3.60 (dd, J = 
12.3, 7.9 Hz, 1H, H2C(4)), 3.23 (t, J = 11.6 Hz, 1H, H2C(4)), 2.80 (t, J = 7.7 
Hz, 1H, HC(7a)), 2.47 (dq, J = 13.4, 7.1, 6.6 Hz, 1H, HC(5)), 2.26 (m, 2H, 
H2C(7), OH), 1.93 (m, 4H, HC(5a), H2C(6), H2C(6), H2C(7)), 1.52 (s, 3H, 
H3C(8)), 1.01 (d, J = 6.6 Hz, 3H, H3C(15)) 
 13C-NMR: (500 MHz, CDCl3) 
152.48 – 147.50 (m, Ar), 141.58 (t, J = 15.7 Hz, Ar), 139.57 (t, J = 15.3 Hz, 
Ar)  129.39 (Ar), 120.74 (dt, J = 8.5, 4.4 Hz, Ar), 111.87 (dd, J = 17.1, 3.6 
Hz, Ar), 89.08 (C(1) or C(7b)), 77.63 (C(1) or C(7b)), 76.63 (d, J = 5.3 Hz, 
(C(2)), 74.39 (C(4)), 61.09 (C(7a)), 60.15 (C(5a)), 34.58 (C(5)), 31.26 (C(6)), 
25.05 (C(8)), 24.69 (C(7)), 17.51 (C(15)) 
 IR: (CDCl3, film) 
3455 (s), 2962 (s), 2931 (s), 2873 (m), 2383 (s), 2331 (s), 2274 (s), 1634 (m), 
1612 (m), 1514 (s), 1469 (s), 1381 (m), 1342 (w), 1299 (s), 1234 (m), 1168 
496 
 
(s), 1133 (m), 1043 (s), 1004 (s), 981 (w), 945 (m), 911 (s), 867 (w), 850 (w), 
811 (m), 734 (s), 697 (w), 636 (w)  
 MS: (ESI, Q-tof) 
  322.2 (2), 312.1 (100) (M-12) 
 Mol. Formula: C17H23BF3NO  (325.18) 
 HRMS: C17H21F3NO
+, (312.16) 
  Calcd:  312.1575 
  Found:  312.1565 
 TLC: Rf  0.27  (TBME/Hexanes, 1:3) [UV, I2] 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-1-(2,3,4-trifluorophenyl)-5-
methyl-7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (23c)  
 
To a two-necked, 5-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added washed potassium hydride (15.7 mg, 0.196 
mmol, 2.0 equiv) from the drybox followed by THF (200 µL). A solution of alcohol 23b (63.7 
mg, 0.142 mmol) in THF (1.0 mL) is added to the reaction vessel by cannulation. After 15 min 
of stirring, the flask is immersed in an ice bath. The benzyl bromide (47 µL, 0.392 mmol, 2.0 
equiv) is then added dropwise by syringe. The ice bath is removed and the solution is allowed to 
stir for 2 h at rt. This mixture was cooled in an ice bath and cold sat. aq. NH4Cl (1.0 mL) is 
added in one portion. The resulting mixture was transferred to a 60-mL separatory funnel using 
an additional 15 mL of water and 15 mL of Et2O and the aqueous phase was extracted with 
diethyl ether (3 x 15 mL). The organic extracts were washed with water (2 x 20 mL), and brine 
(1x 20 mL), then the combinded organic extracts were dried (NaSO4).  The floculant was filtered 
through a cotton plug and concentrated by rotary evaporation (15 mm Hg, 20-25oC).  Purification 
by silica gel chromatography (5.0 cm x 8 cm column, gradient elution, TBME/Hexanes, 2, 4, 6, 
8, 10, 12%, 25 mL each) afforded 70.8 mg (87%) of ether 23c.    
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 Data for 23c 
 1H-NMR: (500 MHz, CDCl3) 
7.34 − 7.27 (m, 3H, Ar), 7.24 – 7.15 (m, 3H, Ar), 7.01 (dd, J = 9.1, 16.4 Hz, 
1H, HC(13) or HC(14)), 4.18 (d, J = 10.9 Hz, 1H, H2C(15)), 4.14 (d, J = 13.3 
Hz, 1H, H2C(2)), 4.03 (d, J = 10.9 Hz, 1H, H2C(15)), 3.94 (d, J = 13.2 Hz, 
1H, H2C(2)), 3.41 (dd, J = 12.5, 7.5 Hz, 1H, H2C(4)), 3.14 (t, J = 11.9 Hz, 1H, 
H2C(4)), 2.94 (t, J = 8.7 Hz, 1H, HC(7a)), 2.66 − 2.57 (dq, J = 19.8, 8.4 Hz, 
1H, H2C(7)), 2.32 (ddt, J = 17.7, 13.5, 6.8 Hz, 1H, HC(5)), 2.03 (dt, J = 14.5, 
8.1 Hz, 1H, HC(7)), 1.99 – 1.80 (m, 3H, HC(5a), H2C(6), H2C(6)), 1.53 (s, 
3H, H3C(8)), 0.99 (d, J = 6.4 Hz, 3H, H3C(20)) 
 13C-NMR: (500 MHz, CDCl3) 
150.95 (m, Ar), 141.68 (m, Ar), 139.68 (m, Ar), 137.37 (Ar), 128.54 (Ar), 
127.89 (Ar), 127.42 (Ar), 126.25 (m), 122.43 (m), 111.63 (dd, J = 3.86, 17.4), 
88.11 (C(1) or C(7b)), 82.14 (C(1) or C(7b)), 73.07 (C(4)), 70.60 (C(2)), 
66.96 (C(15)), 60.94 (C(5a)), 59.98 (C(7a)), 34.18 (C(5)), 30.38 (C(6)), 25.82 
(C(7)), 25.12 (C(8)), 17.00 (C(20) 
 IR: (CDCl3, film) 
3065 (w), 3032 (w), 2960 (s), 2929 (s), 2871 (s), 2393 (s), 2329 (s), 2279 (s), 
2242 (w), 1634 (m), 1612 (m), 1516 (s), 1469 (s), 1381 (m), 1340 (m), 1301 
(s), 1234 (m), 1172 (s), 1137 (m), 1116 (s), 1081 (s), 1049 (s), 1030 (s), 997 
(m), 961 (w), 941 (w), 911 (s), 887 (w), 850 (m), 810 (m), 736 (s), 696 (s), 
669 (w), 648 (w), 596 (w) 
 MS: (ESI, Q-tof) 
  414.2 (100) [M-1], 412.2 (70), 402.2 (30), 322.2 (12), 214.1 (4) 
 Mol. Formula: C24H29BF3NO  (415.30) 
 HRMS: C24H28BF3NO
+, (414.22) 
  Calcd:  414.2216 
  Found:  414.2213 
 TLC: Rf  0.35  (TBME/Hexanes, 1:9) [UV, I2] 
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-(2,3,4-trifluorophenyl)-
3-(3,5-bistrifluoromethylphenylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium 
Bromide (23)  
 
 Data for 23: 
 Yield: 48 mg (91%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.24 (s, 2H), 7.97 (s, 1H), 7.53 – 7.44 (m, 1H), 7.26 (d, J = 3.3 Hz, 6H), 7.14 
– 7.02 (m, 2H), 5.79 (bs, 1H), 4.95 (bs, 2H), 4.11 (d, J = 10.9 Hz, 1H), 3.94 
(d, J = 10.9 Hz, 1H), 3.69 (d, J = 13.5 Hz, 1H), 3.42 (s, 1H), 2.97 (dd, J = 
11.2, 6.5 Hz, 1H), 2.70 (s, 1H), 2.48 (d, J = 47.6 Hz, 2H), 2.29 – 2.09 (m, 4H), 
2.05 – 1.89 (m, 2H), 1.21 (d, J = 6.3 Hz, 3H) 
 MS: (ESI, Q-tof) 
628.2 (100) [M-Br-] 
 Mol. Formula: C33H31BrF9NO  (708.50) 
 HRMS: C33H31F9NO
+, (628.23) 
  Calcd:  628.2262 
  Found:  628.2258 
 TLC: Rf  0.23  (CH2Cl2/MeOH, 9:1) [I2] 
Preparation of (1R,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(4-
trifluoromethoxyphenyl)-5-methyl-7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (24a)  
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To a 5-mL round-bottomed flask equipped with a nitrogen inlet adapter, a rubber septum, 
a reflux condenser, and a magnetic stir bar was added 21 (68 mg, 0.191 mmol) then BH3•THF 
complex (2.9 mL, 2.9 mmol, 15 equiv). The reaction flask was immersed in an oil bath and 
heated to reflux (66 oC).  After being stirred for 12 h at reflux, the solution was allowed to reach 
room temperature and was quenched with methanol (5 mL) and concentrated by rotary 
evaporation (15 mm Hg, 20-25oC).  The resulting colorless oil was purified by silica gel column 
chromatography (5.0 mm x 8 cm column, gradient elution, TBME/Heaxanes, 5, 10, 15, 20, 25, 
30% 25 mL each) to afford 66.7 mg (94%) of 24a as a white solid 
 
 Data for 24a 
 1H-NMR: (500 MHz, CDCl3) 
7.42 (d, 2H, HC(10, HC(14)), 7.19 (d, J = 8.3 Hz, 2H, HC(11), HC(13)), 4.04 
(d, J = 13.7 Hz, 1H, H2C(2)), 3.66 (d, J = 13.5 Hz, 1H, H2C(4)), 3.63 (dd, J = 
7.6, 12.0, 1H, H2C(4)), 3.25 (t, J = 11.5 Hz, 1H, H2C(4)), 2.69 (dd, J = 9.2, 
5.9 Hz, 1H, HC(7a)), 2.63 – 2.49 (m, 1H, HC(5)), 2.34 – 2.21 (m, 1H, 
H2C(7)), 2.06 – 1.90 (m, 3H, HC(5a), H2C(6), H2C(6)), 1.90 – 1.75 (m, 1H, 
H2C(7)), 1.53 (s, 3H, H3C(8)), 1.01 (d, J = 6.6 Hz, 3H, H3C(15)) 
 13C-NMR: (500 MHz, CDCl3) 
148.80 (m, C(12)), 143.71 (C(9)), 126.86 (C(10)), 121.21 (C(11)), 120.51 (q, 
J  = 257.5 Hz, C(16)),  89.74 (C(1) or C(7b)), 79.09 (C(1) or C(7b)), 78.81 
(C(2)), 74.52 (C(4)), 62.77 (C(7a)), 60.04 (C(5a)), 34.93 (C(5)), 31.49 (C(6)), 
25.16 (C(8)), 24.32 (C(7)), 17.61 (C(15)) 
 IR: (CDCl3, film) 
3468 (s), 2961 (s), 2930 (s), 2873 (m), 2381 (s), 2328 (s), 2272 (s), 1609 (w), 
1593 (w), 1508 (s), 1458 (s), 1410 (w), 1380 (s), 1335 (w), 1258 (s), 1221 (s), 
1169 (s), 1114 (m), 1085 (m), 1060 (m), 1017 (m), 1003 (m), 991 (m), 955 
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(m), 938 (m), 911 (s), 868 (w), 849 (m), 836 (m), 806 (w), 776 (w), 735 (s) 
 MS: (ESI, Q-tof) 
  352.2 (11) [M-3], 342.2 (100) 
 Mol. Formula: C18H25BF3NO2  (355.20) 
 HRMS: C18H22BF3NO2
+, (352.17) 
  Calcd:  352.1696 
  Found:  352.1695 
 TLC: Rf  0.28  (TBME/Hexanes, 1:3) [UV, I2] 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-1-(4-methoxyphenyl)-5-
methyl-7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (24b)  
 
To a two-necked, 5-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added washed potassium hydride (14.9 mg, 0.372 
mmol, 2.0 equiv) from the drybox followed by THF (200 µL). A solution of alcohol 24a (66 mg, 
0.186 mmol) in THF (1.0 mL) is added to the reaction vessel by cannulation. After 15 min of 
stirring, the flask is immersed in an ice bath. The benzyl bromide (44.2 µL, 0.372 mmol, 2.0 
equiv) is then added dropwise by syringe. The ice bath is removed and the solution is allowed to 
stir for 2 h at rt. This mixture was cooled in an ice bath and cold sat. aq. NH4Cl (1.0 mL) is 
added in one portion. The resulting mixture was transferred to a 60-mL separatory funnel using 
an additional 15 mL of water and 15 mL of Et2O and the aqueous phase was extracted with 
diethyl ether (3 x 15 mL). The organic extracts were washed with water (2 x 20 mL), and brine 
(1x 20 mL), then the combinded organic extracts were dried (NaSO4).  The mixture was filtered 
through a cotton plug and concentrated by rotary evaporation (15 mm Hg, 20-25oC).  Purification 
by silica gel chromatography (5.0 cm x 8 cm column, gradient elution, TBME/Hexanes, 2, 4, 6, 
8, 10, 12%, 25 mL each) afforded 70.8 mg (86%) of ether 24b.    
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 Data for 24b 
 1H-NMR: (500 MHz, CDCl3) 
7.47 (d, J = 8.8, 2H, HC(10)), 7.39 – 7.27 (m, 3H, HC(17), HC(18)), 7.25 (d, 
J = 8.4 Hz, 2H, HC(11)), 7.21 (d, J = 6.9 Hz, 2H, HC(16)), 4.15 (d, J = 11.0 
Hz, 1H, H2C(2) or H2C(14)), 4.12 (d, J = 13.5 Hz, 1H, H2C(2) or H2C(14)), 
3.99 (d, J = 11.0 Hz, 1H, H2C(2) or H2C(14)), 3.95 (d, J = 13.5 Hz, 1H), 
H2C(2) or H2C(14)), 3.44 (dd, J = 12.4, 7.6 Hz, 1H, H2C(4)), 3.20 (t, J = 11.8 
Hz, 1H, H2C(4)), 2.80 (t, J = 8.0 Hz, 1H, HC(7a)), 2.72 – 2.58 (m, 1H, 
H2C(7)), 2.43 (ddd, J = 16.9, 8.9, 5.5 Hz, 1H, HC(5)), 2.03 – 1.87 (m, 4H, 
HC(5a), H2C(6), H2C(6), H2C(7)), 1.55 (s, 3H, H3C(8)), 0.99 (d, J = 6.4 Hz, 
3H, H3C(5)). 
 13C-NMR: (500 MHz, CDCl3) 
148.93 (C(12)), 140.49 (C(15)), 137.68 (C(9)), 128.55 (C(17)), 128.16 
(C(10)), 127.81 (C(18)), 127.40 (C(16)), 120.93 (C(11)), 120.54 (q, J = 257.1 
Hz, C(13)) 88.91 (C(1) or C(7b)), 83.10 (C(1) or C(7b)), 73.50 (C(4)), 70.87 
(C(2) or C(14)), 66.52 (C(2) or C(14)), 61.59 (C(7a)), 60.61 (C(5a)), 34.48 
(C(5)), 30.72 (C(6)), 25.12 (C(8)), 24.69 (C(7)), 17.11 (C(19)) 
 IR: (CDCl3, film) 
3065 (w), 3032 (w), 2960 (s), 2929 (s), 2871 (s), 2386 (s), 2330 (s), 2276 (s), 
1607 (w), 1594 (w), 1509 (s), 1455 (s), 1411 (w), 1380 (s), 1341 (w), 1258 
(s), 1222 (s), 1171 (s), 1117 (s), 1085 (s), 1059 (s), 1016 (s), 992 (m), 956 (w), 
912 (m), 844 (m), 810 (w), 810 (w), 734 (s), 698 (s), 647 (w), 602 (w) 
 MS: (ESI, 70 eV) 
  442.2 (100) [M-3], 432.2 (28), 271.1 (6) 
 Mol. Formula: C25H31BF3NO2  (445.33) 
 HRMS: C25H28BF3NO2
+, (442.22) 
  Calcd:  442.2165 
  Found:  442.2159 
 TLC: Rf  0.27  (TBME/Hexanes, 1:9) [UV, I2] 
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Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-(2,3,4-trifluorophenyl)-
3-(3-trifluoromethylphenylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium 
Bromide (25)  
 
 Data for 25: 
 Yield: 17 mg (64%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.51 (d, J = 8.7 Hz, 1H), 8.10 (d, J = 8.0, 2H), 8.02 (d, J = 7.4 Hz, 1H), 7.96 
(d, J = 7.7 Hz, 1H), 7.75 (ddd, J = 8.4, 6.8, 1.3 Hz, 1H), 7.72 – 7.62 (m, 2H), 
7.47 (d, J = 7.8, 1H), 7.33 (t, J = 7.8 Hz, 1H), 7.31 – 7.26 (m, 3H), 7.11 – 7.08  
(m, 2H), 5.92 (s, 1H), 5.31 (d, J = 12.1 Hz, 1H), 5.17 (td, J = 12.0, 3.3 Hz, 
1H), 4.64 (d, J = 13.1 Hz, 1H), 4.09 (d, J = 10.3 Hz, 1H), 3.87 – 3.81 (m, 2H), 
3.65 (d, J = 13.0 Hz, 1H), 2.96 – 2.79 (m, 3H), 2.63 – 2.50 (m, 1H), 2.42 (s, 
3H), 2.31 – 2.19  (m, 2H), 2.02 – 1.94  (m, 2H), 1.31 (d, J = 6.2 Hz, 3H) 
 MS: (ESI, Q-tof) 
556.3 (100) [M-Br-] 
 Mol. Formula: C36H37BrF3NO  (636.58) 
 HRMS: C36H37F3NO
+, (556.28) 
  Calcd:  556.2827 
  Found:  556.2833 
 TLC: Rf  0.30  (CH2Cl2/MeOH, 9:1) [I2] 
 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-(1-naphthyl)-3-(2,3,4-
trifluorophenylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (26) 
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 Data for 26: 
 Yield: 22 mg (83%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.46 (d, J = 8.7 Hz, 1H), 8.07 (t, J = 8.3 Hz, 2H), 7.99 (d, J = 7.4 Hz, 1H), 
7.67 (t, J = 7.1 Hz, 1H), 7.63 (t, J = 7.7 Hz, 1H), 7.59 (ddd, J = 8.5, 6.9, 1.4 
Hz, 1H), 7.42 (bs, 1H), 7.31 – 7.23 (m, 4H), 7.12 – 7.06 (m, 2H), 6.79 (dd, J = 
8.1, 16.4 Hz, 1H), 5.13 (d, J = 12.7 Hz, 1H), 4.93 (t, J = 11.9 Hz, 1H), 4.47 (d, 
J = 13.0 Hz, 1H), 4.04 (d, J = 10.3 Hz, 1H), 3.89 (t, J = 9.4 Hz, 1H), 3.81 (d, J 
= 10.3 Hz, 1H), 3.78 (d, J = 13.1 Hz, 1H), 3.30 (d, J = 12.6 Hz, 1H), 3.03 (dd, 
J = 11.1, 5.8 Hz, 1H), 2.92 (dd, J = 10.9, 4.3 Hz, 1H), 2.67 – 2.52 (m, 1H), 
2.43 (s, 3H), 2.36 – 2.23 (m, 2H), 2.04 – 1.95 (m, 2H), 1.31 (d, J = 6.3 Hz, 
3H) 
 MS: (ESI, Q-tof) 
542.3 (100) [M-Br-] 
 Mol. Formula: C35H35BrF3NO  (622.56) 
 HRMS: C35H35F3NO
+, (542.27) 
  Calcd:  542.2671 
  Found:  542.2669 
 TLC: Rf  0.30  (CH2Cl2/MeOH, 9:1) [I2] 
 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-(1-naphthyl)-3-(3,5-
bismethylphenylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (27) 
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 Data for 27: 
 Yield: 20.4 mg (80%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.53 (d, J = 8.6 Hz, 1H), 8.10 (dd, J = 8.2, 6.3 Hz, 2H), 8.03 (d, J = 7.3 Hz, 
1H), 7.73 (dd, J = 8.2, 6.8 Hz, 1H), 7.69 – 7.61 (m, 2H), 7.35 – 7.20 (m, 5H), 
7.10 – 7.08 (m, 2H), 6.80 (s, 1H), 6.03 (s, 2H), 5.08 – 4.94 (m, 2H), 4.73 (d, J 
= 13.1 Hz, 1H), 4.08 (d, J = 10.4 Hz, 1H), 3.82 (dd, J = 10.4, 7.3 Hz, 2H), 
3.56 (d, J = 13.1 Hz, 1H), 2.98 (dd, J = 11.4, 5.8 Hz, 1H), 2.96 – 2.90 (m, 
1H), 2.82 (d, J = 11.9 Hz, 1H), 2.56 (dq, J = 14.0, 11.0, 10.1 Hz, 1H), 2.37 (s, 
3H), 2.30 – 2.14 (m, 2H), 2.02 – 1.94 (m, 2H), 1.93 (s, 6H), 1.33 (d, J = 6.3 
Hz, 3H) 
 MS: (ESI, Q-tof) 
516.3 (100) [M-Br-] 
 Mol. Formula: C37H42BNO  (596.64) 
 HRMS: C37H42NO
+, (516.33) 
  Calcd:  516.3266 
  Found:  516.3259 
 TLC: Rf  0.33  (CH2Cl2/MeOH, 9:1) [I2] 
 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-(1-naphthyl)-3-(2,3-
difluorophenylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (28)  
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 Data for 28: 
 Yield: 17.5 mg (68%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.48 (d, J = 8.6 Hz, 1H), 8.12 – 7.98 (m, 3H), 7.72 – 7.62 (m, 2H), 7.59 (ddd, 
J = 8.4, 6.9, 1.4 Hz, 1H), 7.30 – 7.24 (m, 3H), 7.16 – 7.00 (m, 4H), 6.87 – 
6.82 (m, 1H), 5.04 (d, J = 12.7 Hz, 1H), 4.84 – 4.77 (m, 1H), 4.53 (d, J = 13.1 
Hz, 1H), 4.05 (d, J = 10.4 Hz, 1H), 3.95 (t, J = 9.3 Hz, 1H), 3.86 – 3.74 (m, 
2H), 3.32 (d, J = 12.6 Hz, 1H), 3.09 (dd, J = 5.8, 11.2 Hz, 1H), 2.94 – 2.89 
(m, 1H), 2.65– 2.55 (m, 1H), 2.42 (s, 3H), 2.36 – 2.26 (m, 2H), 2.04 – 1.98 
(m, 2H), 1.31 (d, J = 6.3 Hz, 3H) 
 MS: (ESI, Q-tof) 
524.3 (100) [M-Br-] 
 Mol. Formula: C35H36BrF2NO  (604.57) 
 HRMS: C35H36F2NO
+, (524.28) 
  Calcd:  524.2765 
  Found:  524.2765 
 TLC: Rf  0.31  (CH2Cl2/MeOH, 9:1) [I2] 
 
7.7.2. Preparation of Compounds for Scheme 22 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(3-quinoline)-5-methyl-7b-
methyl-2Hcyclopenta[gh] pyrrolizin-2-one (30)  
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To a 5-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added THF (0.325 mL) and the flask was immersed in 
an IPA/CO2(s) bath. Next, n-BuLi (197 µL, 0.492 mmol, 1.9 equiv) is added and then 3-
bromoquinoline is added by cannulation as a solution in THF (0.65 mL) dropwise while 
maintaining an internal temperature < -70 oC. After strring for 1 h at -78 oC, ketoamide 21 is 
added by cannulation as a solution in THF (325 µL). The solution is allowed to stir for 3 h at -78 
oC. The IPA/CO2(s) bath is removed and allowed to stir at rt for 1 h. The solution is cooled in an 
ice bath and sat. aq. NH4Cl (1.0 mL) is added. The mixture was transferred to a 60-mL 
separatory funnel with 20 mL of Et2O and 20 mL of H2O. The layers were separated and the 
aqueous extract was washed with Et2O (2 x 15 mL). The organic extracts were washed with H2O 
(1 x 25 mL), brine (1 x 25 mL), and the combined organic extracts were dried over Na2SO4, 
filtered (cotton plug), and concentrated by rotary evaporation (15 mm Hg, 20-25oC).  The 
resulting oil was purified by silica gel column chromatography (5 mm x 10 cm, gradient elution, 
EtOAc/Hexanes, 10, 20, 30, 40, 60% 25 mL each) to afford 30 (72.3 mg, 867%) as a pale yellow 
solid. 
 
 Data for 30: 
 1H-NMR: (500 MHz, CDCl3) 
9.05 (d, J = 2.0 Hz, 1H, HC(17)), 8.05 (d, J = 8.4 Hz, 1H, HC(15)), 7.95 (s, 
1H, HC(10)), 7.75 – 7.59 (m, 2H, HC(12), HC(14)), 7.48 (t, J = 7.5 Hz, 1H, 
HC(13)), 4.20 (dd, J = 11.7, 7.2 Hz, 1H, H2C(4)), 4.01 (bs, 1H, OH), 2.69 (dd, 
J = 9.2, 7.2 Hz, 1H, HC(7a)), 2.63 (dd, J = 11.7, 10.1 Hz, 1H, H2C(4)), 2.03 
(m, 1H, H2C(7)), 1.80 (m, 3H, HC(5a), H2C(6), H2C(7)), 1.72 – 1.63 (m, 1H, 
HC(5)), 1.54 – 1.45 (m, 1H, H2C(6)), 1.06 (d, J = 6.7 Hz, 3H, H3C(16)), 0.90 
(s, 3H, H3C(8)) 
 13C-NMR: (500 MHz, CDCl3) 
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175.62 (C(2)), 150.20 (C(17)), 147.55 (C(16)), 136.47 (C(9)), 132.87 (C(10)), 
129.76 (C(12) or C(14)), 129.22 (C(15)), 128.19 (C(12) or C(14)), 127.17 
(C(11)), 127.01 (C(13)), 81.62 (C(1)), 75.52 (C(7b)), 59.00 (C(5a)), 57.78 
(C(7a)), 51.20 (C(4)), 41.84 (C(5)), 30.31 (C(6)), 27.34 (C(7)), 24.23 (C(8)), 
17.78 (C(16)) 
 IR: (CDCl3, film) 
3358 (s), 3065 (m), 2958 (s), 2929 (s), 2870 (s), 1693 (s), 1622 (w), 1605 (w), 
1573 (m), 1495 (s), 1460 (s), 1404 (s), 1378 (s), 1357 (s), 1332 (s), 1313 (m), 
1285 (m), 1250 (w), 1230 (s), 1204 (s), 1181 (m), 1136 (s), 1078 (s), 1057 
(m), 1035 (m), 1026 (w), 997 (w), 976 (w), 960 (w), 912 (s), 865 (w), 808 
(w), 787 (w) 
 MS: (ESI, Q-tof) 
  323.2 (100) [M+1] 
 Mol. Formula: C20H22N2O2  (322.17) 
 HRMS: C20H23N2O2
+, (323.17) 
  Calcd:  323.1760 
  Found:  323.1748 
 TLC: Rf  0.24  (EtOAc/Hexanes, 2:3) [UV, I2] 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-1-(3-quinoline)-5-methyl-
7b-methyl-2Hcyclopenta[gh] pyrrolizin-2-one (31)  
 
To a two-necked, 5-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added washed potassium hydride (17 mg, 0.196 
mmol, 2.0 equiv) from the drybox followed by THF (400 µL). A solution of alcohol 30 (70.7 
mg, 0.219 mmol) in THF (1.0 mL) is added to the reaction vessel by cannulation. After 15 min 
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of stirring, the flask is immersed in an ice bath. The benzyl bromide (27.4 µL, 0.230 mmol, 1.05 
equiv) is then added dropwise by syringe. The ice bath is removed and the solution is allowed to 
stir for 2 h at rt. This mixture was cooled in an ice bath and H2O (1.0 mL) is added in one 
portion. The resulting mixture was transferred to a 60-mL separatory funnel using an additional 
15 mL of water and 15 mL of Et2O and the aqueous phase was extracted with diethyl ether (3 x 
15 mL). The organic extracts were washed with water (2 x 20 mL), and brine (1x 20 mL), then 
the combinded organic extracts were dried (NaSO4).  The mixture was filtered through a cotton 
plug and concentrated by rotary evaporation (15 mm Hg, 20-25oC).  Purification by silica gel 
chromatography (5.0 cm x 8 cm column, gradient elution, EtOAc/Hexanes, 5, 10, 20, 30, 40%, 
25 mL each) afforded 66 mg (73%) of ether 31.    
 
 Data for 31: 
 1H-NMR: (500 MHz, CDCl3) 
9.15 (d, J = 2.3 Hz, 1H, HC(17)), 8.27 (d, J = 2.3 Hz, 1H, HC(10)), 8.16 (d, J 
= 8.4 Hz, 1H, HC(12)), 7.88 (dd, J = 8.3, 1.5 Hz, 1H, HC(15)), 7.78 (ddd, J = 
8.4, 6.8, 1.5 Hz, 1H, HC(13)), 7.61 (t, J = 7.5 Hz, 1H, HC(14)), 7.36 – 7.16 
(m, 5H, HC(20), HC(21), HC(22)), 5.24 (d, J = 11.4 Hz, 1H, H2C(18)), 4.31 
(dd, J = 11.7, 6.2 Hz, 1H, H2C(4)), 4.11 (d, J = 11.4 Hz, 1H, H2C(18)), 2.83 
(dd, J = 9.8, 7.4 Hz, 1H, HC(7a)), 2.64 (dd, J = 10.0, 11.7, 1H, H2C(4)), 2.19 
– 2.03 (m, 2H, H2C(7), H2C(7)), 1.86 – 1.76 (m, 3H, HC(5), HC(5a), H2C(6)), 
1.59 (m, 1H, H2C(6)), 1.12 (d, J = 5.9 Hz, 3H, H3C(23)), 0.90 (s, 3H, H3C(8)) 
 13C-NMR: (500 MHz, CDCl3) 
174.60 (C(2)), 150.54 (C(17)), 147.87 (C(16)), 139.01 (C(19)), 135.62 
(C(10)), 133.02 (C(9)), 130.20 (C(13)), 129.34 (C(12)), 128.32 (C(15)), 
128.20 (C(14)), 127.50 (C(20) or C(21) or C(22)), 127.32 (C(20) or C(21) or 
C(22)), 127.24 (C(20) or C(21) or C(22)), 127.20 (C(11)), 86.25 (C(1) or 
C(7b)), 74.48 (C(1) or C(7b)), 66.81 (C(18)), 59.23 (C(5a)), 58.50 (C(7a)), 
50.84 (C(4)), 42.13 (C(5)), 30.43 (C(6)), 27.60 (C(7)), 24.31 (C(8)), 17.69 
(C(23)) 
 IR: (CDCl3, film) 
3089 (w), 3065 (w), 3033 (w), 2959 (s), 2928 (s), 2870 (s), 1693 (s), 1682 (s), 
509 
 
1620 (w), 1606 (w), 1585 (w), 1571 (m), 1495 (s), 1461 (s), 1453 (s), 1394 
(s), 1371 (s), 1331 (m), 1312 (w), 1285 (m), 1253 (w), 1230 (s), 1204 (m), 
1181 (m), 1145 (s) , 1096 (s), 1065 (s), 1029 (s), 1015 (w), 1000 (s), 959 (w), 
909 (s), 864 (w), 832 (w), 810 (w), 789 (w) 
 MS: (ESI, Q-tof) 
  413.2 (100) [M+1], 338.3 (18), 307.2 (6) 
 Mol. Formula: C27H28N2O2  (412.52) 
 HRMS: C27H29N2O2
+, (413.22) 
  Calcd:  413.2229 
  Found:  413.2226 
 TLC: Rf  0.46  (EtOAC/Hexanes, 1:1) [UV, I2] 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-1-(3-quinoline)-5-methyl-
7b-methyl-2Hcyclopenta[gh] pyrrolizin-2-thione (32) 
 
To a 5-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added 31 (48 mg, 0.116 mmol) followed by 
Lawesson’s reagent (71 mg, 0.175 mmol) and toluene (600 µL). The reaction flask was place in 
an oil bath at 110 oC. After 4 h, the oil bath is removed and DMAP (42.6 mg, 0.349 mmol) is 
added. The mixture was concentrated by rotary evaporation (15 mm Hg, 20-25oC).  Purification 
by silica gel chromatography (5 mm x 6 cm column, gradient elution, Et2O/CH2Cl2, 0, 1, 2, 4, 
8%, 20 mL each) afforded 48.2 mg (75%) of 32. 
 
 Data for 32: 
 1H-NMR: (500 MHz, CDCl3) 
9.14 (d, J = 2.3 Hz, 1H, HC(17)), 8.45 (d, J = 2.3 Hz, 1H, HC(10)), 8.14 (d, J 
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= 8.5 Hz, 1H, HC(12)), 7.88 (d, J = 8.1 Hz, 1H, HC(15)), 7.77 (ddd, J = 8.5, 
6.7, 1.4 Hz, 1H, HC(13)), 7.60 (t, J = 7.5 Hz, 1H, HC(14)), 7.27 (dt, J = 10.9, 
7.2 Hz, 4H, H2C(20), H2C(21)), 7.21 (t, J = 6.9 Hz, 1H, HC(22)), 5.66 (d, J = 
11.7 Hz, 1H, H2C(18)), 4.88 (dd, J = 11.9, 6.3 Hz, 1H, H2C(4)), 4.14 (d, J = 
11.7 Hz, 1H, H2C(18)), 2.98 (dd, J = 9.8, 7.4 Hz, 1H, HC(7a)), 2.92 (t, J = 
10.4 Hz, 1H, H2C(4)), 2.22 – 2.02 (m, 2H, H2C(7), H2C(7)), 1.97 – 1.76 (m, 
3H, HC(5), HC(5a), H2C(6)), 1.62 – 1.51 (m, 1H, H2C(6)), 1.16 (d, J = 5.9 
Hz, 3H, H3C(23)), 0.90 (s, 3H, H3C(8)) 
 13C-NMR: (500 MHz, CDCl3) 
201.28 (C(2)), 150.65 (C(17)), 147.76 (C(16)), 139.21 (C(19)), 136.09 
(C(10)), 132.94 (C(9)), 130.26 (C(13)), 129.25 (C(12)), 128.51 (C(15)), 
128.11 (C(21)), 127.33 (C(20)), 127.28 (C(14)), 127.14 (C(11)), 127.11 
(C(22)), 92.81 (C(1) or C(7b)), 80.83 (C(1) or C(7b)), 67.25 (C(18)), 60.63 
(C(7a)), 58.59 (C(5)), 54.07 (C(4)), 40.29 (C(5a)), 30.86 (C(6)), 27.73 (C(7)), 
23.08 (C(8)), 17.94 (C(23)) 
 IR: (CDCl3 film) 
3064 (w), 3030 (w), 2954 (s), 2929 (s), 2869 (s), 1621 (w), 1605 (w), 1572 
(m), 1470 (s), 1454 (s), 1431 9s), 1378 (m), 1355 (m), 1330 (m), 1289 (m), 
1268 (w), 1251 (s), 1201 (m), 1177 (m), 1154 (w), 1125 (s), 1096 (m), 1054 
(m), 1026 (m), 994 (w), 961 (w), 909 (w), 854 (w), 802 (w), 788 (m), 724 9s), 
705 (m), 647 (m) 
 MS: (ESI, Q-tof) 
429.2 (100) [M+1], 323.2 (8) 
 Mol. Formula: C27H28N2OS (428.59) 
 HRMS: C27H29N2OS
+: (429.20) 
Calcd: 429.2001 
Found: 429.2001 
 TLC: Rf  0.27  (CH2Cl2) [UV, I2] 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-1-(3-quinoline)-5-methyl-
7b-methyl-2Hcyclopenta[gh] pyrrolizine (33)  
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To a 5-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, and 
a magnetic stir bar was added raney nickel (40 mg) which is then washed with H2O (3 x 10 mL) 
followed by THF (3 x 10 mL). Thioamide 32 (57 mg, 0.143 mmol) is added to the reaction flask 
in THF (1.0 mL). The mixture is stirred vigorously for 12 h at rt. The mixture is filtered with 
celite and rinsed with ethanol (3 x 20 mL) and concentrated by rotary evaporation (15 mm Hg, 
20-25 oC). The resulting yellow oil is purified by silica gel column chromatography (2 cm x 8 
cm, MeOH/CH2Cl2, 1, 2, 3, 4, 6, 8%, 25 mL each) to furnish 33 (28.6 mg, 50%) as a white solid.   
 
 Data for 33: 
 1H-NMR: (500 MHz, CDCl3) 
9.25 (d, J = 2.3 Hz, 1H), 8.53 (s, 1H), 8.13 (d, J = 8.4 Hz, 1H), 7.95 (d, J = 7.7 
Hz, 1H), 7.73 (ddd, J = 8.5, 6.8, 1.4 Hz, 1H), 7.58 (t, J = 7.5 Hz, 1H), 7.30 
(dd, J = 7.9, 6.3 Hz, 2H), 7.28 – 7.21 (m, 3H), 4.11 (s, 2H), 3.92 (s, 1H), 3.34 
(d, J = 9.6 Hz, 1H), 3.00 (dd, J = 12.3, 6.2 Hz, 1H), 2.64 (d, J = 14.6 Hz, 1H), 
2.46 (t, J = 9.3 Hz, 1H), 2.29 – 2.03 (m, 3H), 1.72 (ddd, J = 15.0, 9.5, 4.4 Hz, 
3H), 1.04 (d, J = 6.4 Hz, 3H), 0.94 – 0.76 (m, 3H) 
 13C-NMR: (500 MHz, CDCl3) 
151.28, 147.57, 138.63, 134.42, 129.53, 129.21, 128.43, 127.56, 127.51, 
127.34, 126.81, 85.12, 77.41, 77.16, 76.91, 67.31, 62.41, 61.43, 60.61, 60.13, 
37.93, 31.73, 29.66, 29.40, 27.85, 22.80, 16.72, 14.26 
 MS: (ESI, Q-tof) 
399.2 (100) [M+1] 
Mol. Formula:  C27H30N2O (398.54) 
 HRMS: C27H31N2O
+: (399.24) 
Calcd: 399.2436 
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Found: 399.2432 
 IR: (CDCl3 film) 
 3052 (w), 3032 (w), 2952 (s), 2921 (s), 2858 (s), 1618 (w), 1606 (w), 1572 
(w), 1495 (s), 1454 (s), 1417 (w), 1372 (s), 1327 (m), 1276 (w), 1246 (m), 
1219 (w), 1147 (m), 1116 (s), 1092 (s), 1053 (m), 1040 (m), 1026 (m), 967 
(w), 910 (s), 859 (w), 789 (m), 733 (s), 698 (m), 643 (w) 
 TLC: Rf  0.33  (MeOH/CH2Cl2 1:19) [UV, I2] 
 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-(3-quinoline)-3-(3,5-
bistrifluoromethylphenylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide 
(35) 
 
 Data for 35: 
 Yield: 19 mg (38%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
9.13 (d, J = 2.5 Hz, 1H), 8.82 (s, 1H), 8.19 – 8.17 (m, 3H), 8.11 (d, J = 8.1 
Hz, 1H), 7.94 (s, 1H), 7.84 (t, J = 7.2, 1H), 7.68 (t, J = 6.2 Hz, 1H), 7.30 – 
7.19 (m, 3H), 7.13 – 7.06 (m, 2H), 5.64 (d, J = 12.2 Hz, 1H), 5.06 (bs, 1H), 
4.69 (bs, 1H), 4.45 (bs, 1H), 4.19 (d, J = 11.0 Hz, 1H), 3.94 (d, J = 11.0 Hz, 
1H), 3.79 (d, J = 13.2 Hz, 1H), 3.46 (t, J = 8.7 Hz, 1H), 2.99 (dd, J = 11.3, 6.7 
Hz, 1H), 2.74 – 2.48 (m, 3H), 2.28 (s, 3H), 2.21 – 2.15  (m, 1H), 2.11 – 1.96 
(m, 2H), 1.24 (d, J = 6.3 Hz, 3H) 
 MS: (ESI, Q-tof) 
625.3 (100) [M-Br-] 
 Mol. Formula: C36H35BrF6N2O  (705.57) 
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 HRMS: C36H35F6N2O
 +, (625.27) 
  Calcd:  625.2654 
  Found:  625.2666 
 TLC: Rf  0.22  (CH2Cl2/MeOH, 9:1) [I2] 
Preparation of Compound 36 from Scheme 23 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(2-naphthyl)-5-methyl-7b-
methyl-2Hcyclopenta[gh] pyrrolizin-2-one (36a)  
 
To a 5-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added 21 (40 mg, 0.207 mmol) followed by THF (400 
µL).  The flask was immersed in an ice bath and 2-naphthylmagnesium bromide (600 µL, 0.414. 
mmol, 1.5 equiv, in THF) was added dropwise via syringe.  After being stirred for 10 min, the 
cooling bath was removed and the reaction was stirred at room temperature for 20 min. The 
solution was cooled in an ice bath and sat. aq. NH4Cl (1.0 mL) is added.  The resulting mixture 
was transferred to a 60-mL separatory funnel using an additional 20 mL of water and 20 mL of 
Et2O and the aqueous phase was extracted with diethyl ether (3 x 15 mL). The organic extracts 
were washed with water (2 x 20 mL), and brine (1x 20 mL), then the combinded organic extracts 
were dried (NaSO4).  The mixture was filtered through a cotton plug and concentrated by rotary 
evaporation (15 mm Hg, 20-25oC).  Purification by silica gel chromatography (5.0 cm x 8 cm 
column, gradient elution, EtOAc/Hexanes, 10, 20, 30, 50%, 25 mL each) afforded 63 mg (95%) 
of 36a. 
 
 Data for 36a 
 1H-NMR: (500 MHz, CDCl3) 
7.87 – 7.75 (m, 4H, ArH), 7.63 (dd, J = 8.5, 1.9 Hz, 1H, ArH), 7.52 – 7.43 (m, 
2H, ArH), 4.25 (dd, J = 11.7, 7.2 Hz, 1H, H2C(4)), 3.32 (s, 1H, OH), 2.73 (dd, 
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J = 9.5, 7.2 Hz, 1H, HC(7a)), 2.67 (dd, J = 11.7, 10.1 Hz, 1H, H2C(4)), 2.06 – 
2.00 (m, 1H, H2C(7)), 1.90 – 1.66 (m, 4H, HC(5), HC(5a), H2C(6), H2C(7)), 
1.55 – 1.50 (m, 1H, H2C(6)), 1.09 (d, J = 6.6 Hz, 3H, H3C(19)), 0.94 (s, 3H, 
H3C(8))) 
 13C-NMR: (500 MHz, CDCl3) 
176.42 (Ar), 141.03 (Ar), 133.04 (Ar), 132.97 (Ar), 128.71 (Ar), 128.47 (Ar), 
127.64 (Ar), 126.40 (Ar), 126.33 (Ar), 125.26 (Ar), 124.96 (Ar), 83.05 (C(1) 
or C(7b)), 75.46 (C(1) or C(7b)), 58.84 (C(5a)), 57.88 (C(7a)), 51.11 (C(4)), 
41.94 (C(5)), 30.31 (C(6)), 27.32 (C(7)), 24.08 (C(8)), 17.80 (C(19)) 
 IR: (CDCl3, film) 
3306 (s), 3053 (s), 2962 (s), 2926 (s), 2869 (s), 1679 (s), 1632 (m), 1599 (w), 
1503 (w), 1451 (s), 1422 (s), 1365 (s), 1352 (s), 1327 (m), 1310 (m), 1292 
(m), 1247 (m), 1230 (s), 1207 (s), 1168 (w), 1139 (s), 1115 (w), 1094 (m), 
1078 (s), 1062 (m), 1037 (m), 1022 (m), 979 (w), 967 (w), 953 (m), 907 (s), 
868 (s), 816 (s), 805 (s), 732 (s), 652 (s) 
 MS: (ESI, Q-tof) 
  322.2 (42) [M+1], 304.2 (100), 178.9 (2), 142.0 (2), 100.1 (11) 
 Mol. Formula: C21H23NO2  (321.41) 
 HRMS: C21H24NO2
+, (322.18) 
  Calcd:  322.1807 
  Found:  322.1812 
 TLC: Rf  0.18  (EtOAc/Hexanes, 1:3) [UV, I2] 
Preparation of (1R,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(2-naphthyl)-5-methyl-7b-
methyl-2Hcyclopenta[gh]pyrrolizine•Borane (36b)  
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To a 5-mL round-bottomed flask equipped with a nitrogen inlet adapter, a rubber septum, 
a reflux condenser, and a magnetic stir bar was added sequentially 36a (84.6 mg, 0.263 mmol) 
and BH3•THF complex (4.0 mL, 1.0 M solution, 15 equiv).  The reaction flask was immersed in 
an oil bath and heated to reflux (66 oC).  After being stirred for 12 h at reflux, the solution was 
allowed to reach room temperature and was quenched with methanol (5 mL) and concentrated by 
rotary evaporation (15 mm Hg, 20-25oC).  The resulting colorless oil was purified by silica gel 
column chromatography (5.0 mm x 8 cm column, gradient elution, hexanes/TBME, 5, 10, 15, 20, 
30% 25 mL each) to afford 84.3 mg (98%) of 36b as a white solid 
 
 Data for 36b 
 1H-NMR: (500 MHz, CDCl3) 
7.86 – 7.77 (m, 4H, ArH), 7.54 – 7.47 (m, 2H, ArH), 7.45 (dd, J = 8.6, 2.0 Hz, 
1H, ArH), 4.20 (d, J = 13.7 Hz, 1H, H2C(2)), 3.72 (d, J = 13.6 Hz, 1H, 
H2C(2)), 3.68 (dd, J = 12.2, 8.0 Hz, 1H, H2C(4)), 3.29 (dd, J = 12.3, 10.7 Hz, 
1H, H2C(4)), 2.82 (dd, J = 9.1, 6.0 Hz, 1H, HC(7a)), 2.61 (dddd, J = 14.2, 
10.4, 6.2, 2.2 Hz, 1H, HC(5)), 2.43 – 2.25 (m, 1H, H2C(7)), 2.03 (s, 1H, OH), 
2.0 – 1.86 (m, 4H, H2C(6), H2C(6), HC(5a), H2C(7)), 1.57 (s, 3H, H3C(8)), 
1.03 (d, J = 6.6 Hz, 3H, H3C(19)), 2.0 – 1.4 (m, 3H, H3B) 
 13C-NMR: (500 MHz, CDCl3) 
142.09 (C(9)), 132.96 (C(12) or C(17)), 132.73 (C(12) or C(17)), 129.00 
(ArH), 128.30 (ArH), 127.64 (ArH), 126.72 (ArH), 126.60 (ArH), 123.60 
(ArH), 123.45 (ArH), 89.70 (C(1) or C(7b)), 79.47 (C(1) or C(7b)), 78.72 
(C(2)), 74.53 (C(4)), 62.64 (C(7a)), 59.91 (C(5a)), 34.82 (C(5)), 31.54 (C(6)), 
25.12 (C(8)), 24.22 (C(7)), 17.68 (C(19)) 
 IR: (CDCl3, film) 
3466 (s), 3058 (m), 2960 (s), 2928 (s), 2871 (s), 2392 (s), 2351 (s), 2327 (s), 
2271 (s), 2241 (s), 1633 (w), 1600 (w), 1505 (m), 1455 (s), 1380 (s), 1341 
(m), 1310 (m), 1275 (m), 1233 (m), 1171 (s), 1132 (s), 1060 (m), 1002 (s), 
979 (m), 948 (m), 911 (s), 858 (s), 816 (s), 733 (s)   
 MS: (ESI, Q-tof) 
  318.2 (70) [M-3], 308.2 (100), 180.2 (3), 100.1 (6) 
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 Mol. Formula: C21H28BNO  (321.26) 
 HRMS: C21H25BNO
+, (318.20) 
  Calcd:  318.2029 
  Found:  318.2035 
 TLC: Rf  0.22  (TBME/Hexanes, 1:4) [UV, I2] 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-1-(2-naphthyl)-5-methyl-
7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (36c)  
 
To a two-necked, 5-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added washed potassium hydride (21 mg, 2.0 equiv) 
from the drybox followed by THF (0.4 mL). A solution of alcohol 36b in THF (0.9 mL) is added 
to the reaction vessel by cannulation. After 15 min of stirring, the flask is immersed in an ice 
bath. The benzyl bromide (62 µL, 2.0 equiv) is then added dropwise by syringe. The ice bath is 
removed and the solution is allowed to stir for 2 h at rt. This mixture was cooled in an ice bath 
and cold sat. aq. NH4Cl (1.0 mL) is added in one portion. The resulting mixture was transferred 
to a 60-mL separatory funnel using an additional 15 mL of water and 15 mL of Et2O and the 
aqueous phase was extracted with diethyl ether (3 x 15 mL). The organic extracts were washed 
with water (2 x 20 mL), and brine (1x 20 mL), then the combinded organic extracts were dried 
(NaSO4).  The floculant was filtered through a cotton plug and concentrated by rotary 
evaporation (15 mm Hg, 20-25oC).  Purification by silica gel chromatography (5.0 cm x 8 cm 
column, gradient elution, hexanes/TBME, 2, 4, 6, 8, 10%, 25 mL each) afforded 101 mg (94%) 
of ether 36c.    
 
 Data for 36c 
 1H-NMR: (500 MHz, CDCl3) 
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7.98 – 7.80 (m, 4H, ArH), 7.55 (m, 3H, ArH), 7.32 (m, 3H, HC(23), HC(23), 
HC(24)), 7.23 (d, J = 7.3 Hz, 2H, HC(22), HC(22)), 4.33 (d, J = 13.3 Hz, 1H, 
H2C(2)), 4.21 (d, J = 11.1 Hz, 1H, H2C(20)), 4.07 (d, J = 13.3 Hz, 1H, 
H2C(2)), 4.02 (d, J = 11.2 Hz, 1H, H2C(20)), 3.52 (dd, J = 12.2, 7.8 Hz, 1H, 
H2C(4)), 3.26 (t, J = 11.6 Hz, 1H, H2C(4)), 2.93 (t, J = 8.4 Hz, 1H, HC(7a)), 
2.85 – 2.71 (m, 1H, H2C(7)), 2.53 (m, 1H, HC(5)), 2.11 – 1.87 (m, 4H, 
HC(5a), H2C(6), H2C(6), H2C(7)), 1.58 (s, 3H, H3C(8)), 1.02 (d, J = 6.5 Hz, 
3H, H3C(19)) 
 13C-NMR: (500 MHz, CDCl3) 
139.01 (C(19) or C(21), 137.93 (C(19) or (C(21)), 132.93 (C(12) or C(17)), 
132.77 (C(12) or C(17)), 129.05 (C(Ar)), 128.46 (C(Ar)), 128.38 (C(Ar)), 
127.65 (C(Ar)), 127.45 (C(22)), 126.60 (C(Ar)), 124.89 (C(Ar)), 124.75 
(C(Ar)), 88.90 (C(2) or C(20)), 83.40 (C(2) of C(20)), 73.49 (C(4)), 70.51 
(C(2)), 66.48 (C(20)), 61.77 (C(7a)), 60.32 (C(5a)), 34.40 (C(5)), 30.85(C(6)), 
25.07(C(8)), 24.40(C(7)), 17.26 (C(19)) 
 IR: (CDCl3, film) 
3060 (m), 3031 (m), 2958 (s), 2928 (s), 2870 (s), 2385 (s), 2328 (s), 2274 (s), 
2241 (m), 1633 (w), 1501 (w), 1497 (m), 1455 (s), 1379 (s), 1348 (w), 1336 
(w), 1284 (m), 1271 (m), 1236 (w), 1172 (s), 1136 (s), 1115 (s), 1085 (s), 106 
1 (s), 1027 (s), 996 (w) 947 (w), 911 (s), 859 (s), 819 (s), 735 (s)  
 MS: (ESI, Q-tof) 
408.3 (100) [M-3], 398.2 (40), 308.2 (3), 195.0 (4), 180.2 (11), 158.0 (4), 
142.0 (4), 100.1 (23), 79.0 (5) 
 Mol. Formula: C28H34BNO  (411.39) 
 HRMS: C28H31BNO
+, (408.25) 
  Calcd:  408.2499 
  Found:  408.2500 
 TLC: Rf  0.32  (TBME/Hexanes, 1:9) [UV, I2] 
 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-(2-naphthyl)-3-(3,5-
bistrifluoromethylphenylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide 
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(36) 
 
 Data for 36: 
 Yield: 30 mg (74%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.25 (d, J = 1.9 Hz, 1H), 8.22 (d, J = 8.6 Hz, 1H), 8.02 – 7.98  (m, 2H), 7.95 
(s, 2H), 7.89 (s, 1H), 7.74 (dd, J = 8.6, 1.9 Hz, 1H), 7.71 – 7.67  (m, 2H), 7.31 
– 7.27 (m, 3H), 7.18 – 7.09 (m, 2H), 5.93 (d, J = 12.2 Hz, 1H), 5.36 (t, J = 
11.6 Hz, 1H), 4.12 (d, J = 13.4 Hz, 1H), 4.06 (d, J = 10.6 Hz, 1H), 3.84 (d, J = 
10.5 Hz, 1H), 3.73 – 3.59 (m, 2H), 3.39 (d, J = 12.2 Hz, 1H), 2.99 (dd, J = 
11.1, 6.0 Hz, 1H), 2.87 (dd, J = 11.7, 4.7 Hz, 1H), 2.56 – 2.54 (m, 1H), 2.44 
(s, 3H), 2.35 – 2.36 (m, 2H), 2.10 – 1.97 (m, 2H), 1.34 (d, J = 6.3 Hz, 3H) 
 MS: (ESI, Q-tof) 
624.2 (100) [M-Br-] 
 Mol. Formula: C37H36BrF6NO  (704.58) 
 HRMS: C37H36F6NO
+, (624.27) 
  Calcd:  624.2701 
  Found:  624.2693 
 TLC: Rf  0.28  (CH2Cl2/MeOH, 9:1) [I2] 
 
Preparation of Compounds from Table 18 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(6-methoxy-2-naphthyl)-5-
methyl-7b-methyl-2Hcyclopenta[gh] pyrrolizin-2-one (37a)  
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To a 5-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added 21 (40 mg, 0.207 mmol) followed by THF (400 
µL). The flask was immersed in an ice bath and 2-(6-methoxy)-naphthylmagnesium bromide 
(600 µL, 0.331 mmol, 1.6 equiv, in THF) was added dropwise via syringe.  After being stirred 
for 10 min, the cooling bath was removed and the reaction was stirred at room temperature for 20 
min. The solution was cooled in an ice bath and sat. aq. NH4Cl (1.0 mL) is added.  The resulting 
mixture was transferred to a 60-mL separatory funnel using an additional 20 mL of water and 20 
mL of Et2O and the aqueous phase was extracted with diethyl ether (3 x 15 mL). The organic 
extracts were washed with water (2 x 20 mL), and brine (1x 20 mL), then the combinded organic 
extracts were dried (NaSO4).  The mixture was filtered through a cotton plug and concentrated 
by rotary evaporation (15 mm Hg, 20-25oC).  Purification by silica gel chromatography (5.0 cm 
x 8 cm column, gradient elution, EtOAc/Hexanes, 10, 20, 30, 50%, 25 mL each) afforded 58.3 
mg (80.1%) of 37a. 
 
 Data for 37a 
 1H-NMR: (500 MHz, CDCl3) 
7.73 – 7.67  (m, 3H, HC(10), HC(12), HC18)), 7.58 (dd, J = 8.6, 1.9 Hz, 1H, 
HC(17)), 7.13 (dd, J = 8.9, 2.5 Hz, 1H, HC(13)), 7.10 (s, 1H, HC(15)), 4.23 
(dd, J = 11.7, 7.2 Hz, 1H, H2C(4)), 3.91 (s, 3H, H3C(19)), 3.32 (bs, 1H, OH), 
2.72 (t, J = 7.2 Hz, 1H, HC(7a)), 2.65 (t, J = 11.1 Hz, 1H, H2C(4)), 2.07 – 
1.96 (m, 1H, H2C(7)), 1.90 – 1.65 (m, 4H, HC(5), HC(5a), H2C(6), H2C(7)), 
1.54 – 1.49  (m, 1H, H2C(6)), 1.09 (d, J = 6.6 Hz, 3H, H3C(20)), 0.93 (s, 3H, 
H3C(8)) 
 13C-NMR: (500 MHz, CDCl3) 
176.53 (C(2)), 158.11 (C(14)), 138.78 (C(9) or C(16)), 134.23 (C(9) or 
C(16)), 129.91 (C(12)), 128.37, 127.51 (C(18)), 125.48 (C(17)), 125.13 
520 
 
(C(10)), 119.08 (C(13)), 105.68 (C(15)), 83.00 (C(1) or C(7b)), 75.42 (C(1) or 
C(7b)), 58.85 (C(5a)), 57.92 (C(7a)), 55.42 (C(19)), 51.07 (C(4)), 41.96 
(C(5)), 30.32 (C(6)), 27.33 (C(7)), 24.04 (C(8)), 17.78 (C(20) 
 IR: (CDCl3, film) 
3393 (s), 3060 (w), 2957 (s), 2960 (s), 2870 (s), 1693 (s), 1634 (s), 1607 (s), 
1504 (m), 1484 (m), 1480 (m), 1392 (s), 1356 (m), 1314 (w), 1267 (s), 1222 
(s), 1203 (m), 1179 (m), 1135 (m), 1077 (w), 1034 (s), 910 (s), 853 (s), 810 
(m), 732 (s), 698 (w), 667 (w), 646 (m) 
 MS: (ESI, Q-tof) 
  352.2 (13) [M+1], 334.2 (100), 178.9 (6), 142.0 (6) 
 Mol. Formula: C22H25NO3  (351.44) 
 HRMS: C22H26NO3
+, (352.19) 
  Calcd:  352.1913 
  Found:  352.1918 
 TLC: Rf  0.22  (TBME/Hexanes, 1:3) [UV, I2] 
Preparation of (1R,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(6-methoxy-2-naphthyl)-5-
methyl-7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (37b)  
 
To a 5-mL round-bottomed flask equipped with a nitrogen inlet adapter, a rubber septum, 
a reflux condenser, and a magnetic stir bar was added 37a (57 mg, 0.162 mmol) then BH3•THF 
complex (2.8 mL, 2.4 mmol, 15 equiv). The reaction flask was immersed in an oil bath and 
heated to reflux (66 oC).  After being stirred for 12 h at reflux, the solution was allowed to reach 
room temperature and was quenched with methanol (5 mL) and concentrated by rotary 
evaporation (15 mm Hg, 20-25oC).  The resulting colorless oil was purified by silica gel column 
chromatography (5.0 mm x 8 cm column, gradient elution, hexanes/TBME, 5, 10, 25, 20, 25, 
30% 25 mL each) to afford 52 mg (91%) of 37b as a white solid 
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 Data for 37b 
 1H-NMR: (500 MHz, CDCl3) 
7.78 – 7.66 (m, 3H, ArH), 7.41 (dd, J = 8.5, 2.0 Hz, 1H, ArH), 7.16 (dd, J = 
8.9, 2.5 Hz, 1H, ArH), 7.10 (d, J = 2.5 Hz, 1H, HC(15)), 4.18 (d, J = 13.7 Hz, 
1H, H2C(2)), 3.91 (s, 3H, H3C(19)), 3.73 (d, J = 13.7 Hz, 1H, H2C(2)), 3.69 
(dd, J = 12.3, 8.2 Hz, 1H, H2C(4)), 3.30 (t, J = 11.2 Hz 1H, H2C(4)), 2.83 (dd, 
J = 9.0, 5.9 Hz, 1H, HC(7a)), 2.61 (ddt, J = 17.3, 14.5, 7.3 Hz, 1H, HC(5)), 
2.35 (m, 1H, H2C(7)), 2.06 – 1.86 (m, 5H, HC(5a), H2C(6), H2C(6), H2C(7), 
OH), 1.56 (s, 3H, H3C(8)), 1.03 (d, J = 6.5 Hz, 3H, H3C(20)) 
 13C-NMR: (500 MHz, CDCl3) 
158.25 (C(14)), 139.92 (Ar), 134.00 (Ar), 129.77 (Ar), 128.40 (Ar), 
127.85(Ar), 124.10 (Ar), 123.33 (Ar), 119.56 (C(15)), 105.65 (C(15)), 89.70 
(C(1) or C(7b)), 79.46 (C(1) or C(7b)), 78.77 (C(2)), 74.54 (C(4)), 62.55 
(C(7a)), 59.95 (C(5a)), 55.48 (C(19)), 34.84 (C(5)), 31.60 (C(6)), 25.16 
(C(8)), 24.29 (C(7)), 17.73 (C(20)) 
 IR: (CDCl3, film) 
3474 (s), 3060 (w), 2959 (s), 2961 (s), 2871 (m), 2841 (m), 2376 (s), 2328 (s), 
2272 (s), 2243 (m), 1633 (s), 1607 (s), 1504 (m), 1485 (s), 1460 (s), 1412 (w), 
1388 (s), 1340 (m), 1311 (w), 1258 (s), 1225 (s), 1168 (s), 1135 (s), 1061 (m), 
1033 (s), 1002 (m), 980 (w), 938 (m), 910 (s), 854 (s), 812 (m), 732 (s), 679 
(m), 648 (m) 
 MS: (ESI, Q-tof) 
  348.2 (100) [M-3], 338.2 (47), 238.1 (3), 149.0 (2) 
 Mol. Formula: C22H30BNO2  (351.29) 
 HRMS: C22H27BNO2
+, (348.21) 
  Calcd:  348.2135 
  Found:  348.2124 
 TLC: Rf  0.21  (TBME/Hexanes, 1:3) [UV, I2] 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-1-(6-methoxy-2-naphthyl)-
5-methyl-7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (37c)  
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To a two-necked, 5-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added washed potassium hydride (11.4 mg, 2.0 equiv) 
from the drybox followed by THF (400 µL). A solution of alcohol 37b (50 mg, 0.142 mmol) in 
THF (1.0 mL) is added to the reaction vessel by cannulation. After 15 min of stirring, the flask is 
immersed in an ice bath. The benzyl bromide (34 µL, 0.285 mmol, 2.0 equiv) is then added 
dropwise by syringe. The ice bath is removed and the solution is allowed to stir for 2 h at rt. This 
mixture was cooled in an ice bath and cold sat. aq. NH4Cl (1.0 mL) is added in one portion. The 
resulting mixture was transferred to a 60-mL separatory funnel using an additional 15 mL of 
water and 15 mL of Et2O and the aqueous phase was extracted with diethyl ether (3 x 15 mL). 
The organic extracts were washed with water (2 x 20 mL), and brine (1x 20 mL), then the 
combinded organic extracts were dried (NaSO4).  The floculant was filtered through a cotton 
plug and concentrated by rotary evaporation (15 mm Hg, 20-25oC).  Purification by silica gel 
chromatography (5.0 cm x 8 cm column, gradient elution, TBME/Hexanes, 2, 4, 6, 8, 10%, 25 
mL each) afforded 53.4 mg (85%) of ether 37c.    
 
 Data for 37c 
 1H-NMR: (500 MHz, CDCl3) 
7.77 (t, J = 9.4 Hz, 2H, Ar), 7.74 (s, 1H, HC(10)), 7.49 (dd, J = 8.7, 1.9 Hz, 
1H, Ar), 7.35 – 7.24 (m, 3H, Ar), 7.24 – 7.18 (m, 3H, Ar), 7.15 (d, J = 2.5 Hz, 
1H, HC(15)), 4.28 (d, J = 13.3 Hz, 1H, H2C(2)), 4.18 (d, J = 11.2 Hz, 1H, 
H2C(20)), 4.03 (d, J = 13.3 Hz, 1H, H2C(2)), 3.99 (d, J = 11.1 Hz, 1H, 
H2C(20)), 3.94 (s, 3H, H3C(19)), 3.50 (dd, J = 12.3, 7.9 Hz, 1H, H2C(4)), 3.23 
(dd, J = 8.4, 11.4,1H, H2C(4)), 2.90 (t, J = 8.3 Hz, 1H, HC(7a)), 2.81 – 2.70 
(m, 1H, H2C(7)), 2.57 – 2.40 (m, 1H, HC(5)), 2.08 – 1.84 (m, 4H, HC(5a), 
H2C(6), H2C(6), H2C(7)), 1.55 (s, 3H, H3C(8)), 0.99 (d, J = 6.5 Hz, 3H, 
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H3C(25)) 
 13C-NMR: (500 MHz, CDCl3) 
158.31 (C(14)), 138.09 (Ar), 136.76 (Ar), 134.16 (Ar), 129.86 (Ar), 128.46 
(Ar), 128.19 (Ar), 127.87 (Ar), 127.63 (Ar), 127.47 (Ar), 125.33 (Ar), 124.79 
(Ar), 119.33 (C(13)), 105.81 (C(15)), 88.94 (C(1) or C(7b)), 83.42 (C(1) or 
C(7b)), 73.56 (C(4)), 70.63 (C(2)), 66.43 (C(20)), 62.00 (C(7a)), 60.35 
(C(5a)), 55.49 (C(19)), 34.46 (C(5)), 30.94 (C(7)), 25.10 (C(8)), 24.41 (C(6)), 
17.31 (C(25)) 
 IR: (CDCl3, film) 
3062 (w), 3030 (w), 2959 (s), 2926 (s), 2870 (s), 2385 (s), 2328 (s), 2274 (s), 
2241 (s), 1633 (s), 1608 (s), 1503 9s), 1485 (s), 1454 (s), 1412 (w), 1389 (s), 
1380 (s), 1339 (m), 1268 (s), 1211 (s), 1168 (s), 1137 (m), 1114 (m), 1085 (s), 
1061 (s), 1029 (s), 959 (w), 911 (s), 854 (s), 810 (m), 734 (s), 697 (m), 680 
(w), 648 (w)  
 MS: (ESI, Q-Tof) 
  438.3 (100) [M-3], 428.3 (25), 269.1 (10) 
 Mol. Formula: C29H36BNO2  (441.41) 
 HRMS: C29H33NO2
+, (438.26) 
  Calcd:  438.2604 
  Found:  438.2602 
 TLC: Rf  0.34  (TBME/Hexanes, 1:9) [UV, I2] 
 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-(6-methoxy-2-
naphthyl)-3-(3,5-bistrifluoromethylphenylmethyl)-5-methyl-7b-
methylcyclopenta[gh]pyrrolizinium Bromide (37) 
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 Data for 37 
 Yield: 34 mg (61%), free-flowing white powder 
 
 1H-NMR: (500 MHz, CDCl3) 
8.15 (d, J = 2.1 Hz, 1H), 8.10 (d, J = 8.6 Hz, 1H), 7.97 (s, 2H), 7.88 (d, J = 9.3 
Hz, 2H), 7.69 (dd, J = 8.5, 2.1 Hz, 1H), 7.33 (dd, J = 8.9, 2.5 Hz, 1H), 7.31 – 
7.23 (m, 4H), 7.16 – 7.08 (m, 2H), 5.91 (d, J = 12.5, 1H), 5.35 (t, J = 11.5 Hz, 
1H), 4.07 (d, J = 13.7 Hz, 1H), 4.04 (d, J = 10.7 Hz, 1H), 3.99 (s, 3H), 3.83 
(d, J = 10.6 Hz, 1H), 3.68 – 3.56 (m, 2H), 3.38 (d, J = 12.3 Hz, 1H), 2.98 (dd, 
J = 11.0, 6.0 Hz, 1H), 2.85 (dd, J = 10.2, 5.1 Hz, 1H), 2.57 – 2.43 (m, 1H),  (s, 
3H), 2.31 – 2.24 (m, 2H), 2.06 – 1.94 (m, 2H), 1.33 (d, J = 6.3 Hz, 3H) 
 MS: (ESI, Q-tof) 
654.2 (100) [M-Br-] 
 Mol. Formula: C38H38BrF6NO2  (734.61) 
 HRMS: C38H38F6NO2
+, (654.28) 
  Calcd:  654.2807 
  Found:  654.2803 
 TLC: Rf  0.26  (CH2Cl2/MeOH, 9:1) [I2] 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(2-anthracenyl)-5-methyl-
7b-methyl-2Hcyclopenta[gh] pyrrolizin-2-one (38a)  
 
 To a 5-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added 2-bromoanthracene (80 mg, 0.311 mmol, 1.5 
equiv) followed by THF (1.0 mL). The flask was immersed in an IPA/CO2(s) bath and stirred for 
20 min.  Then, t-BuLi (304 µL, 0.518 equiv, 2.5 equiv, 1.7 M) was added dropwise over 5 min 
via syringe. After being stirred for 1 h, 21 (40 mg, 0.207 mmols) in THF (1.1 mL) is added by 
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cannulation dropwise. After 10 min, the IPA/CO2(s) bath is removed and solution was allowed to 
reach rt. After 40 min at rt, the solution is cooled in an ice bath and sat. aq. NH4Cl is added (1.0 
mL). The mixture was transferred to a 60-mL separatory funnel with 20 mL of Et2O and 20 mL 
of H2O. The layers were separated and the aqueous extract was washed with Et2O (2 x 15 mL).  
The organic extracts were washed with H2O (1 x 25 mL), brine (1 x 25 mL), and the combined 
organic extracts were dried over Na2SO4, filtered (cotton plug), and concentrated by rotary 
evaporation (15 mm Hg, 20-25oC).  The resulting pale-yellow oil was purified by silica gel 
column chromatography (5.0 mm x 5cm, gradient elution, EtOAc/CH2Cl2, 0,1,2,3,4% 20 mL 
each) to afford 38a (68 mg, 89%) as a white solid. 
 
 Data for 38a 
 1H-NMR: (500 MHz, CDCl3) 
8.36 (s, 1H, HC(12) or HC(19)), 8.34 (s, 1H, HC(12) or HC(19)), 8.03 – 7.93 
(m, 3H, HC(14), HC(17), HC(21)), 7.86 (s, 1H, HC(10)), 7.62 (dd, J = 8.7, 
1.9 Hz, 1H, HC(22)), 7.51 – 7.42 (m, 2H, HC(15), HC(16)), 4.27 (dd, J = 
11.6, 7.1 Hz, 1H, H2C(4)), 3.44 (bs, 1H, OH), 2.74 (dd, J = 9.6, 7.3 Hz, 1H, 
HC(7a)), 2.68 (t, J = 10.9 Hz, 1H, H2C(4)), 2.03 (m, 1H, H2C(7)), 1.91 – 1.67 
(m, 4H, HC(5), HC(5a), H2C(6), H2C(7)), 1.52 (m, 1H, H2C(6)), 1.09 (d, J = 
6.6 Hz, 3H, H3C(23)), 0.95 (s, 3H, H3C(8)) 
 13C-NMR: (500 MHz, CDCl3) 
176.41 (C(2)), 140.15 (C(9)), 132.08 (C(11) or C(13) or C(18) or C(20)), 
132.02 (C(11) or C(13) or C(18) or C(20)), 131.14 (C(11) or C(13) or C(18) 
or C(20)), 130.97 (C(11) or C(13) or C(18) or C(20)), 129.17 (C(21)), 128.28 
(C(14) or C(17)), 128.25 (C(14) or C(17)), 127.02 (C(12) or C(19)), 126.00 
(C(12) or C(19)), 125.65 (C(15) or C(16)), 125.59 (C(15) or C(16)), 125.07 
(C(10)), 124.69 (C(22)), 83.17 (C(1)), 75.52 (C(7b)), 58.88 (C(5a)), 57.61 
(C(7a)), 51.15 (C(4)), 41.94 (C(5)), 30.32 (C(6)), 27.30 (C(7)), 24.08 (C(8)), 
17.79 (C(23)) 
 IR: (CDCl3, film) 
3312 (s), 3048 (w), 2955 (s), 2923 (w), 2866 (s), 1688 (s), 1460 (m), 1447 
(m), 1420 (s), 1358 (m), 1229 (m), 1207 (m), 1139 (s), 1709 (m), 909 (s), 734 
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(s), 689 (w) 
 MS: (ESI, Q-tof) 
  372.2 (55) [M+1], 354.2 (100), 184.1 (3) 
 Mol. Formula: C25H25NO2  (371.19) 
 HRMS: C25H26NO2
+, (372.20) 
  Calcd:  372.1964 
  Found:  372.1961 
 TLC: Rf  0.27  (EtOAc/Hexanes, 1:3) [UV] 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(2-anthracenyl)-5-methyl-
7b-methyl-2Hcyclopenta[gh] pyrrolizin•Borane (38b)  
 
To a 5-mL round-bottomed flask equipped with a nitrogen inlet adapter, a rubber septum, 
a reflux condenser, and a magnetic stir bar was added 38a (56 mg, 0.151 mmol) then BH3•THF 
complex (1.5 mL, 1.5 mmol, 10 equiv). After being stirred for 12 h at rt, the solution was cooled 
in an ice bath was quenched with the slow addition of methanol (5 mL) and concentrated by 
rotary evaporation (15 mm Hg, 20-25oC).  The resulting colorless oil was purified by silica gel 
column chromatography (5.0 mm x 10 cm column, gradient elution, TBME/Hexanes, 2, 4, 6, 8, 
10, 12% 25 mL each) to afford 38 mg (68%) of 38b as a white solid 
 
 Data for 38b 
 1H-NMR: (500 MHz, CDCl3) 
8.39 (d, J = 4.4 Hz, 2H, ArH), 8.07 – 7.96 (m, 3H, ArH), 7.93 (d, J = 2.0 Hz, 
1H, ArH), 7.49 (dd, J = 6.5, 3.2 Hz, 2H, ArH), 7.42 (dd, J = 9.0, 1.9 Hz, 1H, 
ArH), 4.26 (d, J = 13.7 Hz, 1H, H2C(2)), 3.75 (d, J = 13.7 Hz, 1H, H2C(2)), 
3.70 (dd, J = 12.3, 8.0 Hz, 1H, H2C(4)), 3.37 – 3.26 (t, J = 11.2, 1H, H2C(4)), 
2.87 (dd, J = 9.0, 5.9 Hz, 1H, HC(7a)), 2.71 – 2.54 (m, 1H, HC(5)), 2.36 (m, 
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1H, H2C(7)), 2.08 – 1.88 (m, 5H, HC(5a), H2C(6), H2C(6), H2C(7), OH), 1.60 
(s, 3H, H3C(8)), 1.04 (d, J = 6.5 Hz, 3H, H3C(23)) 
 13C-NMR: (500 MHz, CDCl3) 
141.23 (C(9)), 132.24 (Ar), 132.18 (Ar), 130.95 (Ar), 130.81 (Ar), 129.55 
(Ar), 128.31 (Ar), 128.26 (Ar), 126.90 (Ar), 126.17 (Ar), 126.06 (Ar), 125.85 
(Ar), 125.83 (Ar), 123.44 (Ar), 123.28 (Ar), 89.78 (C(1) or C(7b)), 79.63 
(C(1) or C(7b)), 78.56 (C(2)), 74.61 (C(4)), 62.35 (C(7a)), 60.04 (C(5a)), 
34.92 (C(5)), 31.56 (C(6)), 25.21 (C(8)), 24.43 (C(7)), 17.70 (C(23)) 
 IR: (CDCl3, film) 
3592 (w), 3516 (m), 3051 (w), 2956 (s), 2960 (s), 2871 (m), 2379 (s), 2327 
(s), 2255 (s), 1627 (w), 1458 (s), 1379 (s), 1341 (w), 1307 (w), 1269 (w), 
1232 (w), 1176 (s), 1138 (m), 1059 (w), 1003 (m), 979 (w), 948 (m), 908 (s), 
836 (w), 808 (w), 733 (s), 650 (s) 
 MS: (ESI, Q-tof) 
  370.2 (42) [M-1], 368.2 (44), 358.2 (100), 356.2 (4), 344.2 (5) 
 Mol. Formula: C25H30BNO  (371.32) 
 HRMS: C25H29BNO
+, (370.23) 
  Calcd:  370.2342 
  Found:  370.2344 
 TLC: Rf  0.27  (TBME/Hexanes, 1:9) [UV, I2] 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-1-(2-anthracenyl)-5-
methyl-7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (38c)  
 
To a two-necked, 5-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added washed potassium hydride (8 mg, 2.0 equiv) 
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from the drybox followed by THF (200 µL). A solution of alcohol 38b (37 mg, 0.1 mmol) in 
THF (800 µL) is added to the reaction vessel by cannulation. After 15 min of stirring, the flask is 
immersed in an ice bath. The benzyl bromide (24 µL, 2.0 equiv) is then added dropwise by 
syringe. The ice bath is removed and the solution is allowed to stir for 2 h at rt. This mixture was 
cooled in an ice bath and cold sat. aq. NH4Cl (1.0 mL) is added in one portion. The resulting 
mixture was transferred to a 60-mL separatory funnel using an additional 15 mL of water and 15 
mL of Et2O and the aqueous phase was extracted with diethyl ether (3 x 15 mL). The organic 
extracts were washed with water (2 x 20 mL), and brine (1x 20 mL), then the combinded organic 
extracts were dried (NaSO4).  The floculant was filtered through a cotton plug and concentrated 
by rotary evaporation (15 mm Hg, 20-25oC).  Purification by silica gel chromatography (5.0 cm 
x 8 cm column, gradient elution, hexanes/TBME, 1, 2, 3, 4, 6%, 25 mL each) afforded 34 mg 
(75%) of ether 38c.    
 
 Data for 38c 
 1H-NMR: (500 MHz, CDCl3) 
8.44 (s, 1H, ArH), 8.40 (s, 1H, ArH), 8.05 – 8.00 (m, 3H, ArH), 7.96 (s, 1H, 
ArH), 7.51 – 7.47 (m, 3H, ArH), 7.35 – 7.24 (m, 3H, HC(26), HC(27)), 7.20 
(d, J = 7.1 Hz, 2H, HC(25)), 4.33 (d, J = 13.2 Hz, 1H, H2C(2)), 4.20 (d, J = 
11.2 Hz, 1H, H2C(23)), 4.04 (d, J = 13.5 Hz, 1H, H2C(2)), 4.03 (d, J = 11.0 
Hz, 1H, H2C(23)), 3.49 (dd, J = 12.3, 7.8 Hz, 1H, H2C(4)), 3.22 (t, J = 11.7 
Hz, 1H, H2C(4)), 2.94 (t, J = 8.4 Hz, 1H, HC(7a)), 2.83 – 2.68 (m, 1H, 
H2C(7)), 2.53 – 2.44 (m, 1H, HC(5)), 2.05 – 1.88  (m, 4H, HC(5a), H2C(6), 
H2C(6), H2C(7)), 1.57 (s, 3H, H3C(8)), 0.99 (d, J = 6.5 Hz, 3H, H3C(28)) 
 13C-NMR: (500 MHz, CDCl3) 
138.33 (Ar), 138.00 (Ar), 132.24 (Ar), 131.04 (Ar), 130.83 (Ar), 129.53 (Ar), 
128.51 (C(26)), 128.29 (Ar), 127.71 (C(27)), 127.55 (C(25)), 126.98 (Ar), 
126.12 (Ar), 125.81 (Ar), 125.79 (Ar), 124.90 (Ar), 124.47 (Ar), 89.00 (C(1) 
or C(7b)), 83.53 (C(1) or C(7b)), 73.54 (C(4)), 70.43 (C(2)), 66.60 (C(23)), 
61.46 (C(7a)), 60.47 (C(5a)), 34.46 (C(5)), 30.89 (C(6)), 25.18 (C(8)), 24.66 
(C(7)), 17.28 (C(28)) 
 IR: (CDCl3, film) 
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3030 (w), 3052 (w), 2958 (s), 2912 (s), 2869 (s), 2383 (s), 2329 (s), 2275 (s), 
2222 (w), 1628 (w), 1496 (w), 1454 (s), 1379 (s), 1335 (w), 1307 (w), 1283 
(w), 1236 (w), 1170 (s), 1137 (m), 1116 (m), 1083 (s), 1061 (s), 1027 (m), 
909 (s), 812 (w), 734 (s), 701 (m), 647 (w) 
 MS: (ESI, Q-tof) 
460.3 (78) [M-1], 458.2 (100), 448.2 (36), 338.3 (4), 297.6 (3), 279.1 (22), 
258.1 (3) 
 Mol. Formula: C32H36BNO  (461.45) 
 HRMS: C32H35BNO
+, (460.28) 
  Calcd:  460.2812 
  Found:  460.2814 
 TLC: Rf  0.26  (TBME/Hexanes, 1:19) [UV, I2] 
 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-(2-anthracenyl)-3-(3,5-
bistrifluoromethylphenylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide 
(38) 
 
 Data for 38 
 Yield: 39 mg (52%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.59 (d, J = 11.7 Hz, 2H), 8.42 (s, 1H), 8.37 (d, J = 8.8 Hz, 1H), 8.09 (dd, J = 
5.1, 9.0 Hz, 2H), 7.99 (s, 2H), 7.89 (s, 1H), 7.65 (dt, J = 9.0, 1.6 Hz, 1H), 7.62 
– 7.55 (m, 2H), 7.35 – 7.27 (m, 3H), 7.16 – 7.14 (m, 2H), 5.89 (d, J = 12.2 
Hz, 1H), 5.36 (t, J = 11.6 Hz, 1H), 4.10 (d, J = 10.6 Hz, 1H), 3.90 (d, J = 10.6 
Hz, 1H), 3.72 (t, J = 9.3 Hz, 1H), 3.63 (d, J = 13.3 Hz, 1H), 3.49 (d, J = 11.5 
Hz, 1H), 3.01 (dd, J = 11.1, 6.0 Hz, 1H), 2.88 (dd, J = 8.7, 5.4 Hz, 1H), 2.57 – 
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2.44  (m, 2H), 2.38 – 2.25 (m, 2H), 2.11 – 2.00 (m, 2H), 1.58 (s, 3H), 1.34 (d, 
J = 6.3 Hz, 3H) 
 MS: (ESI, Q-tof) 
674.2 (100) [M-Br-] 
 Mol. Formula: C41H38BrF6NO  (754.64) 
 HRMS: C41H38F6NO
+, (674.74) 
  Calcd:  674.2858 
  Found:  674.2863 
 TLC: Rf  0.38  (CH2Cl2/MeOH, 9:1) [I2] 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(9-phenanthryl)-5-methyl-
7b-methyl-2Hcyclopenta[gh] pyrrolizin-2-one (39a)  
 
To a 5-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added 9-bromophenanthrene (100 mg, 0.518 mmol) 
followed by THF (1.0 mL). The flask was immersed in an IPA/CO2(s) bath and stirred for 20 min.  
Then, t-BuLi (1.6 M, 304 µL, 1.5 equiv) was added dropwise over 5 min via syringe. After being 
stirred for 1 h, 21 (40 mg, 0.207 mmols) in THF (1.1 mL) is added by cannulation dropwise. 
After 10 min, the IPA/CO2(s) bath is removed and solution was allowed to reach rt. After 40 min 
at rt, the solution is cooled in an ice bath and sat. aq. NH4Cl is added (1.0 mL). The mixture was 
transferred to a 60-mL separatory funnel with 20 mL of Et2O and 20 mL of H2O. The layers 
were separated and the aqueous extract was washed with Et2O (2 x 15 mL).  The organic extracts 
were washed with H2O (1 x 25 mL), brine (1 x 25 mL), and the combined organic extracts were 
dried over Na2SO4, filtered (cotton plug), and concentrated by rotary evaporation (15 mm Hg, 
20-25oC).  The resulting pale-yellow oil was purified by silica gel column chromatography (5.0 
mm x 5cm, gradient elution, EtOAc/CH2Cl2, 0,1,2,3,4% 20 mL each) to afford 39a (70.4 mg, 
92%) as a white solid. 
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 Data for 39a 
mp: 262-264˚C (hexanes) 
 1H-NMR: (500 MHz, CDCl3) 
8.76 – 8.68 (m, 1H, HC(12 or 15 or 22 or 18)), 8.63 (d, J = 8.3 Hz, 1H, HC(12 
or 15 or 22 or 18)), 8.55 – 8.40 (m, 1H, HC(12 or 15 or 22 or 18)), 7.80 (d, J = 
7.8 Hz, 1H, HC(12 or 15 or 22 or 18)), 7.73 – 7.60 (m, 3H), 7.57 − 7.53 (m, 
3H, HC(13 or 14 or 20 or 21), HC(13 or 14 or 20 or 21), HC(13 or 14 or 20 or 
21)), 7.54 (s, 1H, HC(10), HC(13 or 14 or 20 or 21)), 4.31 (dd, J = 11.5, 6.4 
Hz, 1H, H2C(4)), 3.60 (bs, 1H, OH), 3.01 (dd, J = 10.1, 7.5 Hz, 1H, HC(7a)), 
2.74 (dd, J = 11.6, 9.5 Hz, 1H, H2C(4)), 2.27 – 2.12 (m, 1H), 2.08 – 1.90 (m, 
1H), 1.87 – 1.68 (m, 3H, HC(5), HC(5a), H2C(6) ), 1.66 – 1.49 (m, 1H, 
H2C(6)), 1.11 (d, J = 6.1 Hz, 3H, H3C(11)), 0.89 (s, 3H, H3C(8)) 
 13C-NMR: (500 MHz, CDCl3) 
177.15 (C(2)), 136.81(C(9)), 131.90 (C(11) or C(16) or C(17) of C(23)), 
130.77 (C(11) or C(16) or C(17) of C(23)), 130.60 (C(11) or C(16) or C(17) 
of C(23)), 129.75 (C(11) or C(16) or C(17) of C(23)), 129.29 (C(12) or C(15) 
or C(22) of C(18)), 127.46 (C(12) or C(15) or C(22) of C(18)), 127.27 (C(13) 
or C(14) or C(20) of C(21)), 126.89 (C(13) or C(14) or C(20) of C(21)), 
126.44 (C(13) or C(14) or C(20) of C(21)), 126.40 (C(13) or C(14) or C(20) 
of C(21)), 125.77 (C(10)), 123.40 (C(12) or C(15) or C(22) or C(18)), 122.42 
(C(12) or C(15) or C(22) of C(18)), 84.26 (C(1) or C(7b)), 76.91 (C(1) or 
C(7b)), 76.00 (C(1) or C(7b)), 58.89 (HC(5a)), 57.51 (HC(7a)), 51.35 
(H2C(4)), 41.92 (HC(5)), 30.04 (H2C(6)), 26.97 (H2C(7)), 24.48(H3C(8)), 
17.71 (H3C(11)) 
 IR: (CDCl3, film) 
3512 (s), 3377 (s), 2959 (s), 2929 (s), 2871 (s), 1692 (s), 1493 (w), 1451 (m), 
1404 (m), 1336 (m), 1283 (m), 1213 (m), 1128 (m), 1072 (m), 1045 (m), 1026 
(m), 908 (s), 866 (w), 832 (w), 729 (s)   
 MS: (ESI, Q-tof) 
  372.2 (30) [M+1], 354.2 (100) 
 Mol. Formula: C25H25NO2  (371.47) 
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 HRMS: C25H26NO2
+, (372.20) 
  Calcd:  372.1964 
  Found:  372.1961 
 TLC: Rf  0.15  (EtOAc/CH2Cl2, 1:4) [UV] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(9-phenanthryl)-5-methyl-
7b-methyl-2Hcyclopenta[gh] pyrrolizin•Borane (39b)  
 
To a 5-mL round-bottomed flask equipped with a nitrogen inlet adapter, a rubber septum, 
a reflux condenser, and a magnetic stir bar was added 39a (69 mg, 0.186 mmol) then BH3•THF 
complex (2.8 mL, 2.8 mmol, 15 equiv). The reaction flask was immersed in an oil bath and 
heated to reflux (66 oC).  After being stirred for 12 h at reflux, the solution was allowed to reach 
room temperature and was quenched with methanol (5 mL) and concentrated by rotary 
evaporation (15 mm Hg, 20-25oC).  The resulting colorless oil was purified by silica gel column 
chromatography (5.0 mm x 8 cm column, gradient elution, hexanes/TBME, 2, 4, 6, 8, 10, 12% 
25 mL each) to afford 49 mg (71%) of 39b as a white solid 
 
 Data for 39b 
 1H-NMR: (500 MHz, CDCl3) 
8.73 (dd, J = 8.3, 1.6 Hz, 1H, HC(12) or HC(15) or HC(18) or HC(21)), 8.62 
(d, J = 8.3 Hz, 1H, HC(12) or HC(15) or HC(18) or HC(21)), 8.50 (dd, J = 
8.2, 1.6 Hz, 1H, HC(12) or HC(15) or HC(18) or HC(21)), 7.94 (s, 1H, 
HC(10)), 7.88 (dd, J = 7.8, 1.5 Hz, 1H, HC(12) or HC(15) or HC(18) or 
HC(21)), 7.71 – 7.55 (m, 4H, HC(13), HC(14), HC(19), HC(20)), 4.32 (d, J = 
13.4 Hz, 1H, H2C(2)), 4.02 (d, J = 13.4 Hz, 1H, H2C(2)), 3.65 (dd, J = 12.3, 
533 
 
7.4 Hz, 1H, H2C(4)), 3.25 (t, J = 8.1 Hz, 1H, HC(7a)), 3.22 (t, J = 12.8 Hz, 
1H, H2C(4)), 2.53 (m, 1H, HC(5)), 2.46 – 2.35 (m, 1H, H2C(7)), 2.26 (bs, 1H, 
OH), 2.12 (m, 1H, H2C(7)), 2.04 – 1.88 (m, 3H, HC(5a), H2C(6), H2C(6)), 
1.53 (s, 3H, H3C(8)), 1.06 (d, J = 6.5 Hz, 3H, H3C(23)) 
 13C-NMR: (500 MHz, CDCl3) 
136.91 (C(9)), 132.05 (C(11) or C(16) or C(17) or C(22)), 130.62 (C(11) or 
C(16) or C(17) or C(22)), 130.54 (C(11) or C(16) or C(17) or C(22)), 129.72 
(C(11) or C(16) or C(17) or C(22)), 129.53 (C(12) or C(15) or C(18) or 
C(21)), 127.70 (C(13) or C(14) or C(19) or C(20)), 127.18 (C(13) or C(14) or 
C(19) or C(20)), 127.13 (C(12) or C(15) or C(18) or C(21)), 126.49 (C(13) or 
C(14) or C(19) or C(20)), 126.44 (C(13) or C(14) or C(19) or C(20)), 125.79 
(C(10)), 123.71 (C(12) or C(15) or C(18) or C(21)), 122.42 (C(12) or C(15) or 
C(18) or C(21)), 88.07 (C(1) or C(7b)), 80.70 (C(1) or C(7b)), 76.11 (C(2)), 
74.45 (C(4)), 61.26 (C(5a)), 60.31 (C(7a)), 34.68 (C(5)), 30.75 (C(6)), 27.06 
(C(7)), 25.64 (C(8)), 17.33 (C(23)) 
 IR: (CDCl3, film) 
3587 (m), 3552 (s), 3448 (s), 3064 (m), 2960 (s), 2928 (s), 2870 (s), 2374 (s), 
2343 (s), 2275 (s), 2243 (s), 1599 (w), 1493 (m), 1458 (s), 1379 (s), 1342 (m), 
1316 (w), 1273 (w), 1171 (s), 1137 (m), 1110 (m), 1058 (s), 1004 (m), 966 
(m), 909 (s), 851 (w), 822 (w), 768 (m), 730 
 MS: (ESI, Q-tof) 
370.2 (100) [M-1], 358.2 (72), 220.0 (2), 195.0 (4), 185.1 (4), 158 (8), 142.0 
(5), 126 (10), 107.1 (4), 100.1 (43), 89.1 (4), 79.0 (10) 
 Mol. Formula: C25H30BNO  (371.32) 
 HRMS: C25H29BNO
+, (370.23) 
  Calcd:  370.2342 
  Found:  370.2339 
 TLC: Rf  0.30  (TBME/Hexanes, 1:9) [UV, I2] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-1-(9-phenanthryl)-5-
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methyl-7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (39c)  
 
To a two-necked, 5-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added washed potassium hydride (10 mg, 2.0 equiv) 
from the drybox followed by THF (0.4 mL). A solution of alcohol 39b (48 mg, 0.129 mmol) in 
THF (0.9 mL) is added to the reaction vessel by cannulation. After 15 min of stirring, the flask is 
immersed in an ice bath. The benzyl bromide (31 µL, 2.0 equiv) is then added dropwise by 
syringe. The ice bath is removed and the solution is allowed to stir for 2 h at rt. This mixture was 
cooled in an ice bath and cold sat. aq. NH4Cl (1.0 mL) is added in one portion. The resulting 
mixture was transferred to a 60-mL separatory funnel using an additional 15 mL of water and 15 
mL of Et2O and the aqueous phase was extracted with diethyl ether (3 x 15 mL). The organic 
extracts were washed with water (2 x 20 mL), and brine (1x 20 mL), then the combinded organic 
extracts were dried (NaSO4).  The floculant was filtered through a cotton plug and concentrated 
by rotary evaporation (15 mm Hg, 20-25oC).  Purification by silica gel chromatography (5.0 cm 
x 8 cm column, gradient elution, TBME/Hexanes, 1, 2, 3, 4, 6%, 25 mL each) afforded 36 mg 
(60%) of 39c.    
 
 Data for 39c 
 1H-NMR: (500 MHz, CDCl3) 
8.80 (dd, J = 11.3, 8.2 Hz, 2H), 8.75 – 8.65 (m, 2H), 8.62 (d, J = 8.5 Hz, 1H), 
8.23 (s, 1H), 8.15 (s, 1H), 8.03 (d, J = 7.8 Hz, 1H), 7.95 (d, J = 7.8 Hz, 1H), 
7.78 – 7.56 (m, 7H), 7.40 (s, 0H), 7.28 (pd, J = 8.0, 7.0, 2.2 Hz, 5H), 7.16 (d, 
J = 7.1 Hz, 3H), 4.84 (d, J = 13.4 Hz, 1H), 4.54 (d, J = 11.5 Hz, 1H), 4.29 (d, 
J = 11.2 Hz, 1H), 4.12 (d, J = 10.6 Hz, 1H), 4.07 (d, J = 13.4 Hz, 1H), 4.02 (d, 
J = 11.2 Hz, 1H), 3.91 (d, J = 10.6 Hz, 1H), 3.87 (d, J = 11.6 Hz, 1H), 3.77 (q, 
J = 10.9, 9.9 Hz, 2H), 3.33 (t, J = 11.1 Hz, 1H), 3.30 – 3.17 (m, 1H), 3.00 (tt, 
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J = 12.6, 7.5 Hz, 1H), 2.90 (t, J = 12.6 Hz, 1H), 2.84 (t, J = 8.9 Hz, 1H), 2.66 
– 2.50 (m, 1H), 2.50 – 2.37 (m, 1H), 2.35 – 2.13 (m, 3H), 2.13 – 1.89 (m, 5H), 
1.76 (s, 4H), 1.35 (s, 3H), 1.32 (s, 0H), 1.11 (d, J = 6.5 Hz, 2H), 1.07 (d, J = 
6.3 Hz, 3H) 
 13C-NMR: (500 MHz, CDCl3) 
138.16, 138.05, 134.34, 133.98, 131.91, 131.65, 131.25, 130.70, 130.55, 
130.19, 129.71, 129.28, 128.46, 128.43, 128.25, 127.99, 127.72, 127.62, 
127.60, 127.55, 127.21, 126.99, 126.91, 126.69, 126.62, 126.58, 126.33, 
123.75, 123.39, 122.72, 122.35, 88.85, 86.83, 85.30, 85.03, 77.41, 77.16, 
76.91, 73.60, 72.46, 72.26, 70.90, 67.27, 66.88, 63.74, 63.47, 60.49, 54.80, 
34.51, 33.76, 30.96, 28.79, 28.69, 27.85, 25.93, 25.43, 17.80, 16.14 
 IR: (CDCl3, film) 
3069 (m), 3031 (m), 2957 (s), 2927 (s), 2869 (m), 2397 (s), 2333 (s), 2279 (s), 
2241 (m), 1602 (w), 1531 (w), 1495 (m), 1454 (s), 1379 (s), 1339 (w), 1292 
(w), 1275 (w), 1240 (w), 1170 (s), 1142 (m), 1113 (s), 1077 (s), 1057 (s), 
1025 (m), 958 (w), 910 (s), 850 (w), 813 (w), 769 (w), 732 (s), 697 (m), 646 
(w), 622 (w) 
 MS: (EI, 70 eV) 
  460.3 [M-1] (82), 458.3 (100), 448.3 (58), 279.1 (5), 208.1 (4) 
 Mol. Formula: C32H36BNO  (461.45) 
 HRMS: C32H35BNO
+, (460.28) 
  Calcd:  460.2812 
  Found:  460.2811 
 TLC: Rf  0.24  (TBME/Hexanes, 1:19) [UV, I2] 
 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-(9-phenanthryl)-3-(3,5-
bistrifluoromethylphenylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide 
(39) 
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 Data for 39 
 Yield: 42 mg (82%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.96 (dd, J = 8.4, 1.4 Hz, 1H), 8.78 (d, J = 8.4 Hz, 1H), 8.63 (dd, J = 8.5, 1.3 
Hz, 1H), 8.34 (s, 1H), 8.01 (dd, J = 7.8, 1.4 Hz, 1H), 7.98 – 7.89 (m, 1H), 7.84 
(ddt, J = 8.4, 7.1, 1.4 Hz, 1H), 7.75 (dddd, J = 11.4, 5.8, 2.5, 1.2 Hz, 3H), 7.38 
(s, 2H), 7.30 – 7.27 (m, 3H), 7.17 – 7.07 (m, 2H), 5.63 (d, J = 12.2 Hz, 1H), 
5.28 (t, J = 11.8 Hz, 1H), 4.65 (d, J = 13.0 Hz, 1H), 4.19 (d, J = 10.3 Hz, 1H), 
4.04 (t, J = 9.4 Hz, 1H), 3.97 (d, J = 10.3 Hz, 1H), 3.72 (d, J = 13.1 Hz, 1H), 
3.06 (d, J = 12.1 Hz, 1H), 2.91 (dt, J = 7.4, 3.7 Hz, 1H), 2.85 (dd, J = 11.1, 5.9 
Hz, 1H), 2.65 – 2.53 (m, 1H), 2.53 (s, 3H), 2.41 – 2.22 (m, 2H), 2.11 – 1.98 
(m, 2H), 1.32 (d, J = 6.3 Hz, 3H) 
 MS: (ESI, Q-tof) 
674.3 (100) [M-Br-] 
 Mol. Formula: C41H38BrF6NO  (754.64) 
 HRMS: C41H38F6NO
+, (674.29) 
  Calcd:  674.2858 
  Found:  674.2839 
 TLC: Rf  0.38  (CH2Cl2/MeOH, 9:1) [I2] 
 
Preparation of Catalysts from Table 19 
Preparation of (1R,2S)-2-Phenyl-1-(1-butynyloxy)cyclohexane (40a)   
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To a two-necked, 25-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added washed potassium hydride (182 mg, 4.53 
mmol, 2.0 equiv) from the drybox followed by THF (4.5 mL). A solution of 11 (400 mg, 2.27 
mmol) in THF (3.4 mL) is added to the reaction vessel by cannulation. After 2 h of stirring, the 
flask is immersed in  IPA/CO2(s) bath. Next, trichloroethylene (224 µL, 4.53 mmol, 2.0 equiv) in 
THF (3.4 mL) is added dropwise by syringe and the IPA/CO2(s) bath is removed. After 1 h of 
stirring at rt, the reaction flask is immersed in a IPA/CO2(s) bath and nBuLi (2.3 mL, 5.67 mmols, 
in hexanes) is added dropwise by syringe and the resulting solution is allowed to stir at -78 oC for 
1 h. Next, iodoethane (730 µL, 9.1 mmol) in HMPA (1.0 mL) is added by cannulation and the 
IPA/CO2(s) bath is removed. After stirring for 3 h at rt, the solution is poured into a flask 
containing cold, sat. aq. NH4Cl (40 mL). The resulting mixture was transferred to a 125-mL 
separatory funnel and the aqueous phase was extracted with pentane (3 x 40 mL). The organic 
extracts were washed with water (2 x 40 mL), and brine (1x 20 mL), then the combinded organic 
extracts were dried (NaSO4). The mixture was filtered through a cotton plug and concentrated by 
rotary evaporation (15 mm Hg, 20-25oC).  Purification by basic alumina chromatography (20 
mm x 10 cm column, gradient elution, TBME/Hexanes, 0, 1, 2, 4, 6, 10%, 50 mL each). The 
resulting white solid was recrystallized from pentane at -78 oC furnishing 352 mg (68%) of ether 
40a.    
 
 Data for 40a 
 mp: 60-61 ˚C (pentane) 
 1H-NMR: (500 MHz, CDCl3) 
7.35 (t, J = 7.6 Hz, 2H, HC(13)), 7.31 – 7.23 (m, 3H, HC(14), HC(12)), 4.03 
(td, J = 10.8, 4.4 Hz, 1H, HC(6)), 2.76 (ddd, J = 12.5, 10.5, 3.9 Hz, 1H, 
HC(1)), 2.44 (ddd, J = 10.2, 4.7, 2.6 Hz, 1H, HC(5)), 2.10 (q, J = 7.4 Hz, 2H, 
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H2C(5)), 1.96 (tdd, J = 9.4, 4.7, 2.9 Hz, 2H, H2C(9), H2C(9)), 1.85 – 1.75 (m, 
1H, H2C(3)), 1.69 – 1.50 (m, 2H, H2C(2), H2C(5)), 1.50 – 1.32 (m, 2H, 
H2C(3), H2C(4)), 1.07 (t, J = 7.4 Hz, 3H, H3C(10)) 
 13C-NMR: (500 MHz, CDCl3) 
142.94 (C(11)), 128.50 (C(13)), 127.69 (C(12)), 126.67 (C(14)), 88.51 (C(6)), 
87.01 (C(7)), 49.21 (C(1)), 40.41 (C(8)), 34.01 (C(2)), 31.10 (C(5)), 25.75 
(C(3)), 24.87 (C(4)), 15.27 (C(10)), 11.21 (C(9)) 
 IR: (neat) 
3062 (w), 3029 (m), 2971 (s), 2934 (s), 2859 (s), 2254 (s), 1603 (m), 1494 
(m), 1462 (m), 1450 (s), 1372 (w), 1354 (w), 1331 (w), 1235 (s), 1209 (s), 
1122 (w), 1063 (w), 1031 (w), 999 (s), 976 (m), 929 (m), 900 (w), 867 (), 849 
(w), 819 (w), 780 (w), 754 (s) 
 MS: (ESI, Q-tof) 
229.4 (18) [M+1], 209.4 (24 ), 159.3 (15), 150.3 (13), 139.2 (3), 117 (3)  
Opt. Rot.: [α]24D   -68.3, (c = 1.10, EtOH) 
 Analysis: C16H20O (228.15) 
 Calcd: C, 84.16; H, 8.83 
  Found: C, 83.76; H, 9.03 
 TLC: Rf  0.29  (Hexanes) [UV, KMnO4] 
Preparation of (1R,2S)-2-Phenyl-1-(1-(Z)-butenyloxy)cyclohexane (40b)  
 
To a two-necked, 50-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was lithium aluminum hydride (114 mg, 2.85 mmol, 1.5 
equiv) followed by dimethoxyethane (5.2 mL). To this solution was added alkyne 40a (434 mg, 
1.9 mmol) in dimethoxyethane (2.2 mL) by cannulation. The reaction flask was placed in an oil 
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bath at 80 oC. After 1.5 h, the reaction flask is cooled in an ice bath. To the reaction mixture was 
slowly added 1.0 N NaOH (200 µL) followed by H2O (200 µL). Sodium sulfate (~300 mg) was 
added and solution was stirred at rt for 30 min. The suspension was filtered through a plug of 
deactivated silica gel (5% triethlamine in TBME) and washed with TBME (~25 mL). The filtrate 
was concentrated by rotary evaporation (15 mm Hg, 20-25oC). Purification by basic alumina 
chromatography (20 mm x 15 cm column, gradient elution, TBME/Hexanes, 0, 1, 2, 4, 8%, 100 
mL each). The colorless oil was distilled (95 oC, 0.06 torr) to afforded 254 mg, 58% of product 
40b as a colorless oil.    
 
 Data for 40b 
 bp: 95 oC / 0.06 torr 
 1H-NMR: (500 MHz, CDCl3) 
7.33 – 7.27 (m, 2H, HC(13)), 7.24 – 7.17 (m, 3H, HC(14), HC(12)), 5.81 (dt, 
J = 12.3, 1.4 Hz, 1H, HC(7)), 4.72 (dt, J = 12.4, 7.0 Hz, 1H, HC(8)), 3.71 (td, 
J = 10.3, 4.3 Hz, 1H, HC(6)), 2.63 (ddd, J = 12.4, 10.2, 3.8 Hz, 1H, HC(1)), 
1.94 – 1.86 (m, 1H, H2C(5)), 1.96 – 1.85 (m, 2H, H2C(2), H2C(4)), 1.80 – 1.74 
(m, 3H, H2C(9), H2C(9), H2C(3)), 1.52 (dtd, J = 13.0, 12.2, 11.6, 3.6 Hz, 1H, 
H2C(2)), 1.45 – 1.29 (m, 3H, H2C(3), H2C(4), H2C(5)), 0.84 (t, J = 7.4 Hz, 
3H, H3C(10)) 
 13C-NMR: (500 MHz, CDCl3) 
144.80 (C(7)), 144.10 (C(11)), 128.33 (C(13)), 127.84 (C(12)), 126.28 
(C(14)), 107.81 (C(8)), 82.34 (C(6)), 50.66 (C(1)), 34.29 (C(2)), 32.55 (C(5)), 
26.09 (C(3)), 25.04 (C(4)), 20.99 (C(9)), 15.17 (C(10)) 
 IR: (neat) 
3029 (m), 2933 (s), 2857 (s), 1668 (s), 1651 (s), 1603 (w), 1494 (m), 1449 
(m), 1373 (w), 1337 (w), 1253 (), 1170 (s), 1119 (m), 1066 (w), 1038 (m), 959 
(w), 921 (m), 848 (w), 753 (m), 698 (s)  
 MS: (ESI, Q-tof) 
231.2 (15) [M+1], 227.0 (5), 216.9 (10), 198.9 (5), 187.1 (12), 175.1 (5), 
160.1 (12), 159.1 (100), 153.1 (15), 129.1 (5), 117.1 (4), 111.1 (10), 91.1 (38), 
81.0 (8)  
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Opt. Rot.: [α]24D   -26.0, (c = 1.04, EtOH) 
 Analysis: C16H22O (230.17) 
 Calcd: C, 83.43; H, 9.63  
  Found: C, 83.34; H, 9.80  
 TLC: Rf  0.21  (TBME/Hexanes 1:19) [KMnO4] 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-5-ethyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizin-2-one (40c)  
 
To a 25-mL, two-necked, round-bottomed flask fitted with two rubber septa, a magnetic 
stir bar, a nitrogen inlet adaptor and an internal temperature probe, was added nitroalkene (E,E)-
1 (165 mg, 0.828 mmol) and chiral ether 40b(210 mg, 0.918 mmol, 1.1 equiv) via syringe.  The 
resulting yellow oil was then evacuated under high vacuum (~0.1 mm Hg) for 30 min.  The flask 
was backfilled with N2 and charged with CH2Cl2 (3.3 mL).  The solution was cooled to –85 
oC 
(internal temperature) using hexanes/N2 bath.  This yellow solution was sirred for 15 min, then 
freshly prepared TiCl2(Oi-Pr)2 solution (1.2 M in CH2Cl2, 1.9 mL, 4.48 mmol, 6.0 equiv) was 
added dropwise via syringe while maintaining an internal temperature ≤ –70 oC (ca. 15 min).  
After addition of the Lewis acid, the cooling bath was replaced with an acetone/CO2(s) bath and 
the resulting bright yellow solution was stirred for another 5 h while maintaining an internal 
temperature ≤ –75 oC.  During the course of the reaction, the yellow color gradually faded and a 
white precipitate formed.  After 5 h the reaction was quenched with triethylamine (2.9 mL, 4.5 
equiv, 1 M in MeOH) via syringe while maintaining an internal temperature of < –40 oC.  The 
cooling bath was then removed and the reaction mixture was allowed to warm to 0 oC (ca. 15 
min).  The resulting white suspension was then poured onto a biphasic mixture H2O (30 mL) and 
TBME (30 mL) in a 125-mL separatory funnel.  The aqueous was separated and was washed 
with TBME (2 x 20 mL).  The organic extracts were washed with H2O (2 x 30 mL) and brine (1 
x 30 mL).  The combined organic extracts were dried over NaHCO3/MgSO4 (1/1), filtered 
(cotton plug), and concentrated by rotary evaporation (15 mm Hg, 20-25 oC).  The resulting 
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residue was filtered through a pad of silica gel (5 mm x 4 cm), eluting with TBME (40 mL) to 
remove any remaining amine impurities.  The resulting clear solution was concentrated by rotary 
evaporation (15 mm Hg, 20-25 oC) to a pale-yellow residual oil. The oil was allowed to stand for 
8 h. The resulting mixture of nitroso acetals was diluted in MeOH (5 mL) and added to a test 
tube (5 mm x 14 cm) containing a spatula tip (~20 mg) of Raney Ni (previously washed with 
H2O (3 x 10 mL) and MeOH (3 x 10 mL) along with a magnetic stir bar.  The tube was placed in 
a steel autoclave, which was then pressurized with H2 (350 psi).  After 2 days the autoclave was 
carefully vented in a fume hood and the solution was filtered through a plug of Celite (5 cm x 5 
cm, cotton plug) with MeOH (25 mL).  The resulting clear solution was concentrated by rotary 
evaporation (15 mm Hg, 20-25 oC) and purified by silica gel column chromatography (2 cm x 8 
cm, EtOAC/Hexanes, 10, 20, 30, 50, 70, 90%, 25 mL each). The white solid was recrystallized 
from TBME/Hexanes affording 148 mg (85%) of a white crystalline solid.  
 
 Data for 40c 
 mp: 98-100 oC (TBME/Hexanes) 
 1H-NMR: (500 MHz, CDCl3) 
4.65 (dd, J =2.1, 6.7 Hz, 1H, HC(1)), 4.08 (dd, J = 11.8, 6.7 Hz, 1H, H2C(4)), 
3.20 – 3.15 (m, 1H, OH), 2.53 (t, J = 10.9 Hz, 1H, H2C(4)), 2.52 (dd, J = 10.0, 
13.9, 1H, HC(7a)), 1.87 (t, J = 6.7 Hz, 1H, HC(5a)), 1.84 – 1.72 (m, 2H, 
H2C(6), H2C(7)), 1.54 – 1.36 (m, 5H, HC(5), H2C(6), H2C(7), H2C(9), 
H2C(9)), 1.31 (s, 3H, H3C(8)), 0.90 (t, J = 7.1 Hz, 3H, H3C(10)) 
 13C-NMR: (500 MHz, CDCl3) 
175.87 (C(2)), 75.44 (C(7b)), 72.77 (C(1)), 56.48 (C(5a)), 52.12 (C(7a)), 
49.56 (C(5)), 49.08 (C(4)), 31.84 (C(6) or C(7)), 26.87 (C(9)), 25.41 (C(6) or 
C(7)), 24.24 (C(8)), 12.84 (C(10)) 
 MS: (ESI, Q-tof) 
210.1 (100) [M+1], 192.1 (5) 
Opt. Rot.: [α]24D   -14.0, (c = 1.06, EtOH) 
 IR: (CDCl3 film) 
 3306 (s), 3212 (s), 2955 (s), 2919 (s), 2864 (s), 1686 (s), 1458 (w), 1408 (m), 
1375 (w), 1329 (w), 1292 (w), 1257 (w), 1225 (m), 1143 (m), 1116 (w), 1053 
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(w), 913 (w), 879 (w), 799 (w), 722 (w) 
 Analysis: C12H17NO2 (207.13) 
 Calcd: C, 68.87; H, 9.15; N, 6.69  
  Found: C, 68.82; H, 9.33; N, 6.63  
 TLC: Rf  0.30  (EtOAc/Hexanes 3:2) [I2, KMnO4] 
 
Preparation of (1R,3R,5R,5aS,7aS,7bR)-Octahydro-1-[N-(3,5-Dinitrophenyl)carbamoxy]-5-
thyl-7b-methyl-2H-cyclopenta[gh]pyrrolizin-2-one  (40c-1) 
 
A 25 mL round-bottomed flask (A) was fitted with a reflux condenser, a nitrogen inlet 
adaptor, a rubber rubber septum and a magnetic stir bar. The apparatus was opened and 3,5-
dinitrobenzoylazide (23 mg, 0.097 mmol, 1.5 equiv) was added as a solid. The apparatus was 
evacuated and backfilled with N2 three times and toluene (1.8 mL) was added. The clear solution 
was immersed in a preheated (115 oC) oil bath and stirred at reflux for 30 min. In a separate, 
two-neck, 5 mL conical flask (B) fitted with a triangular a magnetic stir bar, rubber septum and a 
nitrogen inlet adaptor the starting alcohol was added (10 mg, 0.048 mmol) followed by toluene 
(1.0 mL). The resulting solution (B) was transferred to flask (A) via cannula. The resulting light 
yellow solution was heated to reflux for 2 h and then allowed to cool to room temperature. The 
reaction mixture was concentrated in vacuo, and the crude product was purified by column 
chromatography (hexane/EtOAc (3/1, 1/1)) to afford 10.5 mg (52%) of enantioenriched 40c-1 as 
a white solid. The sample was compared to racemate as previously described.  
Data for 40c-1: 
 1H-NMR: (500 MHz, CDCl3) 
10.20 (s, 1H), 8.59 (s, 1H), 8.53 (s, 1H), 5.92 (d, J = 6.8 Hz, 1H), 4.15 (dd, J = 
12.0, 7.1 Hz, 1H), 2.69 (t, J = 10.5 Hz, 2H), 2.02 (t, J = 7.2 Hz, 1H), 1.94 (dt, 
J = 12.3, 5.9 Hz, 1H), 1.85 (dt, J = 12.1, 6.2 Hz, 1H), 1.63 – 1.38 (m, 8H), 
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0.95 (t, J = 7.3 Hz, 3H, H3C(10)). 
 TLC: Rf  0.38  (hexanes/EtOAc, 3:1) [I2] 
 CHPLC: tR= 10.78 min (<1%) and 28.03 (>99%) (Naphthylleucine, 40 % IPA/Hexanes,         
1.5 mL/min, 254 nm, 2 mg/mL) 
Preparation of (3R,5S,5aS,7aS,7bR)-Octahydro-5-ethyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizin-1,2-one (40d)  
 
To a 25-mL, three-necked, round-bottomed flask fitted with a nitrogen inlet adapter, a 
magnetic stir bar, and an internal temperature probe was added 40c (114 mg, 0.545 mmol), 
CH2Cl2 (2.3 mL), and DMSO (456 µL).  The resulting solution was cooled to –12
 oC in an 
ice/salt bath.  To this solution was added diisopropylethylamine (475 µL, 2.73 mmol, 5.0 equiv) 
followed by the dropwise addition of a solution of SO3•pyridine complex (260 mg, 1.64 mmol, 
3.0 equiv) in DMSO (1.1 mL) while maintaining an internal temperature < –5 oC.  After being 
stirred for 20 min at –10 oC, the mixture was allowed to warm to room temperature.  The mixture 
was then cooled to 0 oC and diluted with CH2Cl2 (20 mL) and H2O (25 mL).  This mixture was 
poured into a 60-mL separatory funnel with CH2Cl2 (20 mL) and H2O (20 mL). The aqueous 
layer was separated washed with CH2Cl2 (2 x 25 mL).  The organic extracts were washed with 
1.0 N. aq. HCl (2 x 20 mL), H2O (1 x 20 mL), and brine (20 mL), the combined organic extracts 
dried over NaSO4, filtered (cotton plug), and rinsed with TBME (3 x 10 mL). The mixture was 
filtered through a cotton plug and concentrated by rotary evaporation (15 mm Hg, 20-25oC).  The 
crude oil was purified by silica gel chromatography (5 mm x 8 cm column, gradient elution, 
EtOAc/Hexanes, 20, 40, 60, 80, 90%, 25 mL each) to afford 40d (108 mg, 96%) as a colorless 
oil.    
 
 Data for 40d 
 1H-NMR: (500 MHz, CDCl3) 
4.36 (dd, J = 12.4, 8.0 Hz, 1H, H2C(4)), 3.00 (dd, J = 12.4, 8.3 Hz, 1H, 
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H2C(4)), 2.70 (dd, J = 9.0, 5.4 Hz, 1H, HC(7a)), 2.17 – 2.06 (m, 2H, HC(5a), 
H2C(7)), 2.06 – 1.98 (m, 1H, H2C(6)), 1.80 (qd, J = 7.9, 4.3 Hz, 1H, HC(5)), 
1.77 – 1.70 (m, 1H, H2C(7)), 1.62 – 1.48 (m, 2H, H2C(9), H2C(9)), 1.42 (s, 
3H, H3C(8)), 1.40 – 1.31 (m, 1H, H2C(6)), 0.94 (t, J = 7.4 Hz, 3H, H3C(10)) 
 13C-NMR: (500 MHz, CDCl3) 
203.42 (C(1)), 160.21 (C(2)), 74.06 (C(7b)), 55.60 (C(7a)), 54.97 (C(5a)), 
50.33 (C(4)), 48.63 (C(5)), 33.41 (C(6)), 30.61 (C(7)), 27.99 (C(9)), 24.89 
(C(8)), 12.86 (C(10)) 
 IR: (CDCl3, film) 
3501 (w), 3407 (w), 2958 (s), 1875 (s), 1759 (s), 1713 (s), 1461 (s), 1397 (s), 
1335 (m), 1311 (m), 1264 (m), 1226 (s), 1180 (s), 1119 (m), 1087 (m), 1053 
(m), 1024 (m), 1001 (w), 972 (w), 919 (m), 875 (w), 828 (w), 808 (w), 795 
(w), 777 (w), 729 (m), 677 (m), 647 (m), 614 (w) 
 MS: (EI, 70 eV) 
  208.1 (100) [M+1], 198.2 (12) 
Opt. Rot.: [α]24D   -21.3, (c = 1.02, EtOH) 
 Mol. Formula: C12H17NO2  (207.07) 
 HRMS: C12H18NO2
+, (208.13) 
  Calcd:  208.1338 
  Found:  208.1342 
 TLC: Rf  0.38  (EtOAc/Hexanes, 1:1) [UV, I2] 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(2-naphthyl)-5-ethyl-7b-
methyl-2Hcyclopenta[gh] pyrrolizin-2-one (40e)  
 
To a 5-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added 40d (40 mg, 0.193 mmol) followed by THF 
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(470 µL).  The flask was immersed in an ice bath and 2-naphthylmagnesium bromide (630 µL, 
0.386 mmol, 2.0 equiv, in THF) was added dropwise via syringe.  After being stirred for 10 min, 
the cooling bath was removed and the reaction was stirred at room temperature for 20 min. The 
solution was cooled in an ice bath and sat. aq. NH4Cl (1.0 mL) is added.  The resulting mixture 
was transferred to a 60-mL separatory funnel using an additional 20 mL of water and 20 mL of 
Et2O and the aqueous phase was extracted with diethyl ether (3 x 15 mL). The organic extracts 
were washed with water (2 x 20 mL), and brine (1x 20 mL), then the combinded organic extracts 
were dried (NaSO4).  The mixture was filtered through a cotton plug and concentrated by rotary 
evaporation (15 mm Hg, 20-25oC).  Purification by silica gel chromatography (5.0 cm x 6 cm 
column, gradient elution, EtOAc/Hexanes, 10, 20, 30, 50%, 25 mL each) afforded 57.9 mg 
(89%) of 40e. 
 
 Data for 40e 
 1H-NMR: (500 MHz, CDCl3) 
7.91 – 7.72 (m, 4H, ArH), 7.68 – 7.57 (m, 1H, ArH), 7.55 – 7.38 (m, 2H, 
ArH), 4.29 (dd, J = 11.7, 7.2 Hz, 1H, H2C(4)), 3.39 – 3.37  (m, 1H, OH), 2.73 
(t, J = 8.2 Hz, 1H, HC(7a)), 2.68 (t, J = 10.9 Hz, 1H, H2C(4)), 2.06 – 1.99 (m, 
1H, H2C(7)), 1.92 – 1.74 (m, 3H, HC(5a), H2C(6), H2C(7)), 1.64 – 1.55 (m, 
1H, HC(5)), 1.54 – 1.40  (m, 3H, H2C(6), H2C(18), H2C(18)), 0.95 (t, J = 7.1 
Hz, 3H, H3C(19)), 0.92 (s, 3H, H3C(8)) 
 13C-NMR: (500 MHz, CDCl3) 
176.25 (C(2)), 141.03 (C(9) or C(11) or C(16)), 133.05 (C(9) or C(11) or 
C(16)), 132.98 (C(9) or C(11) or C(16)), 128.69 (Ar), 128.46 (Ar), 127.64 
(Ar), 126.38 (Ar), 126.30 (Ar), 125.27 (Ar), 124.96 (Ar), 83.19 (C(1) or 
C(7b)), 75.32 (C(1) or C(7b)), 57.87 (C(7a)), 57.04 (C(5a)), 49.55 (C(4)), 
49.21 (C(5)), 31.17 (C(6)), 27.34 (C(7)), 26.97 (C(18)), 23.98 (C(8)), 12.88 
(C(19)) 
 IR: (CDCl3, film) 
3306 (s), 3051 (m), 2960 (s), 2926 (s), 2946 (s), 2860 (s), 1680 (s), 1505 (w), 
1460 (m), 1438 (w), 1419 (s), 1362 (s), 1316 (m), 1300 (w), 1271 (w), 1250 
(w), 1228 (m), 1206 (m), 1186 (w), 1165 (w), 1141 (m), 1113 (w), 1077 (m), 
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1025 (w), 967 (w), 908 (s), 864 (m), 814 (s), 730 (s), 650 (s), 622 (w) 
 MS: (ESI, Q-tof) 
  336.2 (60) [M+1], 318.2 (100) 
 Mol. Formula: C22H25NO2  (335.44) 
 HRMS: C22H26NO2
+, (336.20) 
  Calcd:  336.1964 
  Found:  336.1968 
 TLC: Rf  0.24  (EtOAc/Hexanes, 1:3) [UV, I2] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(2-naphthyl)-5-ethyl-7b-
methyl-2Hcyclopenta[gh] pyrrolizin•Borane (40f)  
 
To a 5-mL round-bottomed flask equipped with a nitrogen inlet adapter, a rubber septum, 
a reflux condenser, and a magnetic stir bar was added 40e (56 mg, 0.167 mmol) then BH3•THF 
complex (2.5 mL, 2.5 mmol, 15 equiv). The reaction flask was immersed in an oil bath and 
heated to reflux (66 oC).  After being stirred for 12 h at reflux, the solution was allowed to reach 
room temperature and was quenched with methanol (5 mL) and concentrated by rotary 
evaporation (15 mm Hg, 20-25oC).  The resulting colorless oil was purified by silica gel column 
chromatography (5.0 mm x 8 cm column, gradient elution, TBME/Heaxanes, 5, 10, 15, 20, 25, 
30% 25 mL each) to afford 55 mg (98%) of 40f as a white solid 
 
 Data for 40f 
 1H-NMR: (500 MHz, CDCl3) 
7.88 – 7.78 (m, 4H, ArH), 7.53 – 7.48 (m, 2H, ArH), 7.47 (dd, J = 8.6, 2.0 Hz, 
1H, ArH), 4.19 (d, J = 13.7 Hz, 1H, H2C(2)), 3.78 (dd, J = 12.3, 8.2 Hz, 1H, 
H2C(4)), 3.73 (d, J = 13.7 Hz, 1H, H2C(2)), 3.34 (dd, J = 12.2, 10.2 Hz, 1H, 
H2C(4)), 2.82 (dd, J = 9.2, 5.9 Hz, 1H, HC(7a)), 2.45 – 2.36 (m, 1H, HC(5)), 
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2.38 – 2.30 (m, 1H, H2C(7)), 2.06 – 1.98  (m, 4H, HC(5a), H2C(6), H2C(6), 
OH), 1.93 – 1.86  (m, 1H, H2C(7)), 1.57 (s, 3H, H3C(8)), 1.56 – 1.47 (m, 1H, 
H2C(7)), 1.45 – 1.34 (m, 1H, H2C(7)), 0.92 (t, J = 7.5 Hz, 3H, H3C(18)) 
 13C-NMR: (500 MHz, CDCl3) 
142.14 (C(9) or C(11) or C(16)), 133.00 (C(9) or C(11) or C(16)), 132.75 
(C(9) or C(11) or C(16)), 129.00 (Ar), 128.31 (Ar), 127.65 (Ar), 126.73 (Ar), 
126.60 (Ar), 123.59 (Ar), 123.47 (Ar), 89.67 (C(1) or C(7b)), 79.70 (C(1) or 
C(7b)), 78.77 (C(2)), 73.12 (C(4)), 62.80 (C(7a)), 58.47 (C(5a)), 42.38 (C(5)), 
32.63 (C(6)), 27.27 (C(17)), 25.32 (C(8)), 24.60 (C(7)), 12.91 (C18)) 
 IR: (CDCl3, film) 
3477 (s), 3058 (m), 2962 (s), 2926 (s), 2874 (s), 2383 (s), 2351 (s), 2327 (s), 
2272 (s), 2236 (s), 1633 (w), 1600 (m), 1506 (m), 1455 9s), 1379 (s), 1340 
(m), 1273 (m), 1232 (m), 1170 (s), 1132 (s), 1061 (m), 1018 (m), 987 (m), 
949 (m), 908 (s), 858 (m), 816 (m), 732 (s), 648 (m) 
 MS: (ESI, Q-tof) 
  332.2 (100) [M-3], 322.2 (55), 216.1 (12) 
 Mol. Formula: C22H30BNO  (335.29) 
 HRMS: C22H27BNO
+, (322.22) 
  Calcd:  332.2186 
  Found:  332.2188 
 TLC: Rf  0.31  (TBME/Hexanes, 1:4) [UV, I2] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-1-(2-naphthyl)-5-ethyl-7b-
methyl-2Hcyclopenta[gh]pyrrolizine•Borane (40g)  
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To a two-necked, 5-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added washed potassium hydride (13.2 mg, 0.328 
mmol, 2.0 equiv) from the drybox followed by THF (400 µL). A solution of alcohol 40f (55 mg, 
0.164 mmol) in THF (1.2 mL) is added to the reaction vessel by cannulation. After 15 min of 
stirring, the flask is immersed in an ice bath. The benzyl bromide (39 µL, 0.328 mmol, 2.0 equiv) 
is then added dropwise by syringe. The ice bath is removed and the solution is allowed to stir for 
2 h at rt. This mixture was cooled in an ice bath and cold sat. aq. NH4Cl (1.0 mL) is added in one 
portion. The resulting mixture was transferred to a 60-mL separatory funnel using an additional 
15 mL of water and 15 mL of Et2O and the aqueous phase was extracted with diethyl ether (3 x 
15 mL). The organic extracts were washed with water (2 x 20 mL), and brine (1x 20 mL), then 
the combinded organic extracts were dried (NaSO4).  The mixture was filtered through a cotton 
plug and concentrated by rotary evaporation (15 mm Hg, 20-25oC).  Purification by silica gel 
chromatography (5.0 cm x 8 cm column, gradient elution, TBME/Hexanes, 2, 4, 6, 8, 10, 12%, 
25 mL each) afforded 64.1 mg (92%) of ether 40g.    
 
 Data for 40g 
 1H-NMR: (500 MHz, CDCl3) 
7.94 – 7.84 (m, 3H, ArH), 7.81 (s, 1H, HC(10)), 7.59 – 7.50 (m, 3H, ArH), 
7.37 – 7.26 (m, 3H, HC(21), HC(23)), 7.26 – 7.21 (m, 2H, HC(22)), 4.32 (d, J 
= 13.4 Hz, 1H, H2C(2)), 4.20 (d, J = 11.0 Hz, 1H, H2C(19)), 4.09 (d, J = 13.4 
Hz, 1H, H2C(2)), 3.99 (d, J = 11.0 Hz, 1H, H2C(19)), 3.60 (dd, J = 12.3, 8.1 
Hz, 1H, H2C(4)), 3.30 (dd, J = 12.3, 10.6 Hz, 1H, H2C(4)), 2.91 – 2.83 (m, 
1H, HC(7a)), 2.80 (dd, J = 12.5, 7.6 Hz, 1H, H2C(7)), 2.38 – 2.27 (m, 1H, 
HC(5)), 2.07 – 1.84 (m, 4H HC(5a), HC(5), H2C(6), H2C(6), H2C(7)), 1.55 (s, 
3H, H3C(8)), 1.60 – 1.48 (m, 1H, H2C(24)), 1.39 – 1.25 (m, 1H, H2C(24)), 
0.80 (t, J = 7.4 Hz, 3H, H3C(25)) 
 13C-NMR: (500 MHz, CDCl3) 
139.04 (C(9) or C(11) or C(16) or C(20)), 137.85 C(9) or C(11) or C(16) or 
C(20)), 132.94 C(9) or C(11) or C(16) or C(20)), 132.84 C(9) or C(11) or 
C(16) or C(20)), 129.06 (Ar), 128.48 (C(28)), 128.39 (Ar), 127.72 (C(23)), 
127.68 (C(21)), 127.67 (Ar), 126.65 (Ar), 126.62 (Ar), 124.82 (C(10)), 124.69 
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(Ar), 88.82 (C(1) or C(7b)), 83.37 (C(1) or C(7b)), 72.40 (C(4)), 70.28 (C(2)), 
66.57 (C(19)), 62.57 (C(7a)), 58.63 (C(5a)), 41.68 (C(5)), 31.83 (C(6)), 27.01 
(C(24)), 25.08 (C(8)), 24.17 (C(7)), 12.84 (C25)) 
 IR: (CDCl3, film) 
3060 (m), 3031 (m), 2929 (s), 2960 (s), 2872 (s), 2390 (s), 2351 (s), 2327 (s), 
2274 (s), 2241 (s), 1949 (w), 1808 (w), 1633 (w), 1601 (m), 1497 (m), 1455 
(s), 1379 (s), 1350 (m), 1319 (w), 1270 (m), 1235 (m), 1171 (s), 1136 (s), 
1083 (s), 1062 (s), 1027 (s), 988 (m), 946 (w), 911 (s), 859 (s), 820 (s), 771 
(w), 737 (s), 697 (s), 673 (w), 647 (m), 607 (m) 
 MS: (ESI, Q-tof) 
422.3 (100) [M-3], 412.3 (28), 207.2 (2), 185.1 (5), 180.2 (9), 158.0 (6), 126.0 
(6), 100.1 (42), 89.1 (5), 79.0 (10) 
 Mol. Formula: C29H36BNO  (425.41) 
 HRMS: C29H33BNO
+, (422.27) 
  Calcd:  422.2655 
  Found:  422.2659 
 TLC: Rf  0.21  (TBME/Hexanes, 1:9) [UV, I2] 
 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-(2-naphthyl)-3-(3,5-
bistrifluoromethylphenylmethyl)-5-ethyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide 
(40) 
 
 Data for 40 
 Yield: 51 mg (97%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.25 (s, 1H), 8.21 (d, J = 8.7 Hz, 1H), 8.03 – 7.94 (m, 4H), 7.89 (s, 1H), 7.74 
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(dd, J = 8.7, 2.0 Hz, 1H), 7.70 – 7.67 (m, 2H), 7.35 – 7.26 (m, 3H), 7.18 – 
7.11 (m, 2H), 5.94 (d, J = 12.3 Hz, 1H), 5.27 (t, J = 11.0 Hz, 1H), 4.13 (d, J = 
13.5 Hz, 1H), 4.06 (d, J = 10.7 Hz, 1H), 3.84 (d, J = 10.6 Hz, 1H), 3.71 – 3.60 
(m, 2H), 3.42 (d, J = 9.5 Hz, 1H), 3.03 (dd, J = 11.0, 6.0 Hz, 1H), 2.89 (d, J = 
6.9 Hz, 1H), 2.60 – 2.45 (m, 1H), 2.44 (s, 3H), 2.33 – 2.23 (m, 1H), 2.19 – 
2.00 (m, 3H), 1.82 (p, J = 7.7 Hz, 2H), 0.96 (t, J = 7.4 Hz,, 3H) 
 MS: (ESI, Q-tof) 
638.3 (100) [M-Br-] 
 Mol. Formula: C38H38BrF6NO  (718.61) 
 HRMS: C38H38F6NO 
+, (638.29) 
  Calcd:  638.2858 
  Found:  638.2872 
 TLC: Rf  0.32  (CH2Cl2/MeOH, 9:1) [I2] 
Preparation of (1R,2S)-2-Phenyl-1-(2-prenyloxy)cyclohexane (43)  
 
To a two-necked, 50-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added washed sodium hydride (136 mg, 5.67 mmol, 
2.0 equiv) from the drybox followed by DMF (4.5 mL). A solution of alcohol 11 (500 mg, 2.84 
mmol) in THF (5.0 mL) is added to the reaction vessel by cannulation. After 10 min of stirring, 
tetrabutylammonium iodide (105 mg, 0.284 mmol, 0.1 equiv) is added followed by prenyl 
chloride (639 µL, 5.67 mmols, 2.0 equiv) by syringe. After 12 h of stirring at rt, the reaction flsk 
is placed in an ice bath and sat. aq. NH4Cl (5.0 mL) is added. The resulting mixture was 
transferred to a 125-mL separatory funnel using an additional 40 mL of Et2O and 40 mL. The 
aqueous phase was separated and was extracted with Et2O (2 x 40 mL). The organic extracts 
were washed with water (3 x320 mL), and brine (1x 20 mL), then the combinded organic 
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extracts were dried (NaSO4).  The mixture was filtered through a cotton plug and concentrated 
by rotary evaporation (15 mm Hg, 20-25oC).  Purification by silica gel chromatography (20 mm 
x 10 cm column, gradient elution, TBME/Hexanes, 1, 2, 4, 8, 10%, 100 mL each). The resulting 
oil was distilled (135 oC, 0.13 torr) to afforded 679 mg (98%) of ether 43.    
 
 Data for 43 
 bp: 135 ˚C / 0.13 torr 
 1H-NMR: (500 MHz, CDCl3) 
7.33 – 7.22 (m, 4H, HC(13), HC(14)), 7.19 (dtd, J = 7.1, 5.0, 2.5 Hz, 1H, 
HC(15)), 5.02 (t, J = 6.9 Hz, 1H, HC(4)), 3.77 (dd, J = 11.3, 6.7 Hz, 1H, 
H2C(3)), 3.53 (dd, J = 11.3, 7.0 Hz, 1H, H2C(4)), 3.32 (td, J = 10.1, 4.6 Hz, 
1H, HC(6)), 2.53 (ddd, J = 12.2, 10.2, 3.8 Hz, 1H, HC(1)), 2.19 (ddd, J = 7.7, 
4.2, 1.8 Hz, 1H, H2C(5)), 1.86 (ddt, J = 11.6, 4.6, 2.4 Hz, 2H, H2C(2), 
H2C(4)), 1.78 – 1.70 (m, 1H, H2C(3)), 1.62 (d, J = 1.4 Hz, 3H, H3C(10)), 1.57 
– 1.46 (m, 1H), 1.42 – 1.37 (m, 3H, H3C(11)), 1.34 (ddd, J = 12.4, 7.2, 2.4 Hz, 
2H) 
 13C-NMR: (500 MHz, CDCl3) 
145.09 (C(6)), 136.63 (C(9)), 128.16 (C(14)), 127.97 (C(13)), 126.06 (C(15)), 
121.65 (C(8)), 81.29 (C(6)), 65.73 (C(7)), 51.43 (C(5)), 34.23 (C(1)), 32.77 
(C(2), 26.21, 25.83, 25.37, 17.75 (10) 
 IR: (neat) 
3052 (w), 3027 (m), 2926 (s), 2850 (s), 1670 (w), 1602 (w), 1493 (m), 1447 
(s), 1375 (m), 1351 (m), 1240 (w), 1195 (w), 1118 (s), 1080 (s), 1028 (m), 
1011 (m), 983 (w), 952 (w), 903 (w), 865 (w), 848 (w), 754 (s), 698 (s) 
 MS: (ESI, Q-tof) 
245 (10) [M+1], 227 (90), 207 (5), 197 (5), 175 (12), 159 (100), 146 (5), 139 
(11), 117 (22) 
Opt. Rot.: [α]24D   -45.5, (c = 1.02, EtOH) 
 Analysis: C17H24O (244.18) 
 Calcd: C, 83.55; H, 9.90 
  Found: C, 83.52; H, 9.92 
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 TLC: Rf  0.74  (TBME/Hexanes 1:3) [UV, KMnO4] 
 
Preparation of (1R,2S)-2-Phenyl-1-(1-prenyloxy)cyclohexane (44)  
 
To a two-necked, 50-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added ether 43 (663 mg, 2.71 mmol), ethanol (12.2 
mL), H2O (1.4 mL), sodium carbonate (144 mg, 1.36 mmol, 0.5 equiv), and 
Rhodium(I)tri(triphenylphosphine)Chloride (250.7 mg, 0.271 mmol). The reaction flask is 
placed in a oil bath at 80 oC. After 2.5 h, the oil bath is removed and the solution is allowed to 
reach rt. The mixture was concentrated by rotary evaporation (15 mm Hg, 20-25oC). Purification 
by basic alumina chromatography (20 mm x 15 cm column, gradient elution, TBME/Hexanes, 0, 
1, 2, 4, 8%, 100 mL each) to afforded 188 mg of an inseparable mixture of the desired product 
44 (129 mg, 20%) and saturated side prouct 44-x.    
 
 Data for 44 
 1H-NMR: (500 MHz, CDCl3) 
7.34 – 7.28 (m, 3H, ArH), 7.28 – 7.17 (m, 4H, ArH), 5.77 (dt, J = 12.5, 0.9 
Hz, 1H, HC(7)), 4.67 (dd, J = 12.3, 7.4 Hz, 1H, HC(8)), 3.71 (td, J = 10.2, 4.2 
Hz, 1H, HC(6)), 3.43 (dt, J = 9.4, 6.2 Hz, 0.45H), 3.28 (td, J = 10.3, 4.2 Hz, 
0.45H), 2.98 (dt, J = 9.4, 6.8 Hz, 0.45H), 2.64 (ddd, J = 12.5, 10.1, 3.8 Hz, 
1H, HC(1)), 2.54 (ddd, J = 12.5, 10.1, 3.7 Hz, 0.43H), 2.29 – 2.16 (m, 1H, 
H2C(5)), 2.04 (sept, J = 6.3 Hz, 1H, HC(9)), 1.95 – 1.86 (m, 2H, H2C(2), 
H2C(4)), 1.80 – 1.74 (m, 1H, H2C(3)), 1.61 – 1.48 (m, 1H, H2C(2)), 1.47 – 
1.28 (m, 3H, H2C(3), H2C(4), H2C(5)), 1.22 (dq, J = 13.5, 6.7 Hz, 0.45H), 
1.13 (dq, J = 13.5, 6.5 Hz, 0.45H), 0.86 (d, J = 6.7 Hz, 3H, H3C(11) or 
H3C(10)), 0.83 (d, J = 6.7 Hz, 3H, H3C(10) or H3C(11)), 0.72 (d, J = 6.6 Hz, 
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11.19H), 0.62 (d, J = 6.5 Hz, 1.12H) 
 13C-NMR: (500 MHz, CDCl3) 
145.11, 144.09, 143.83 (C(7)), 128.34 C(14)), 128.12, 127.92 (C(13)), 127.89, 
126.29 (C(15)), 126.03, 113.56 (C(8)), 82.53 (C(6)), 82.48, 67.65, 51.37, 
50.85 (C(1)), 38.96, 34.23 (C(2)), 34.09, 34.06, 32.63 (C(5)), 27.30 (C(9)), 
26.25, 26.08 (C(3)), 25.32, 25.08 (C(4)), 24.57, 23.62 (C(10) or C(11)), 23.60 
(C(10) or C(11)), 22.79, 22.23 
 IR: (neat) 
3066 (w), 3028 (m), 2929 (s), 2856 (s), 1668 (s), 1650 (m), 1603 (w), 1493 
(m), 1448 (s), 1375 (w), 1360 (m), 1250 (w), 1168 (s), 1117 (s), 1070 (m), 
1036 (w), 948 (w), 923 (m), 871 (w), 848 (w), 815 (w), 754 (s), 698 (s) 
 TLC: Rf  0.24  (TBME/Hexanes 1:19) [UV, KMnO4] 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-5-isopropyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizin-2-one (41a)  
 
To a 25-mL, two-necked, round-bottomed flask fitted with two rubber septa, a magnetic 
stir bar, a nitrogen inlet adaptor and an internal temperature probe, was added nitroalkene (E,E)-
1 (95.6 mg, 0.48 mmol) and chiral propenyl ether 44 (129 mg, 0.528 mmol, 1.1 equiv) via 
syringe.  The resulting yellow oil was then evacuated under high vacuum (~0.1 mm Hg) for 30 
min.  The flask was backfilled with N2 and charged with CH2Cl2 (2.1 mL).  The solution was 
cooled to –85 oC (internal temperature) using hexanes/N2 bath.  This yellow solution was sirred 
for 15 min, then freshly prepared TiCl2(Oi-Pr)2 solution (1.2 M in CH2Cl2, 1.2 mL, 1.44 mmol, 
6.0 equiv) was added dropwise via syringe while maintaining an internal temperature ≤ –70 oC 
(ca. 15 min). After addition of the Lewis acid, the cooling bath was replaced with an 
acetone/CO2(s) bath and the resulting bright yellow solution was stirred for another 5 h while 
maintaining an internal temperature ≤ –75 oC.  During the course of the reaction, the yellow 
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color gradually faded and a white precipitate formed.  After 5 h the reaction was quenched with 
triethylamine (2.9 mL, 6.1 equiv, 1 M in MeOH) via syringe while maintaining an internal 
temperature of < –40 oC.  The cooling bath was then removed and the reaction mixture was 
allowed to warm to 0 oC (ca. 15 min).  The resulting white suspension was then poured onto a 
biphasic mixture H2O (30 mL) and TBME (30 mL) in a 125-mL separatory funnel.  The aqueous 
was separated and was washed with TBME (2 x 20 mL).  The organic extracts were washed with 
H2O (2 x 30 mL) and brine (1 x 30 mL).  The combined organic extracts were dried over 
NaHCO3/MgSO4 (1/1), filtered (cotton plug), and concentrated by rotary evaporation (15 mm 
Hg, 20-25 oC).  The resulting residue was filtered through a pad of silica gel (5 mm x 4 cm), 
eluting with TBME (40 mL) to remove any remaining amine impurities.  The resulting clear 
solution was concentrated by rotary evaporation (15 mm Hg, 20-25 oC) to a pale-yellow residual 
oil. The oil was allowed to stand for 8 h. The resulting mixture of nitroso acetals was diluted in 
MeOH (5 mL) and added to a test tube (5 mm x 14 cm) containing a spatula tip (~20 mg) of 
Raney Ni (previously washed with H2O (3 x 10 mL) and MeOH (3 x 10 mL) along with a 
magnetic stir bar.  The tube was placed in a steel autoclave, which was then pressurized with H2 
(350 psi).  After 2 days the autoclave was carefully vented in a fume hood and the solution was 
filtered through a plug of Celite (5 cm x 5 cm, cotton plug) with MeOH (25 mL).  The resulting 
clear solution was concentrated by rotary evaporation (15 mm Hg, 20-25 oC) and purified by 
silica gel column chromatography (2 cm x 8 cm, EtOAC/Hexanes, 10, 20, 30, 50, 70, 90%, 25 
mL each). The white solid was recrystallized from TBME/Hexanes affording 89.5 mg (83%) of a 
white crystalline solid.  
 Data for 41a 
 mp: 127-129 oC (TBME/Hexanes) 
 1H-NMR: (500 MHz, CDCl3) 
4.65(d, J = 6.4 Hz, 1H, HC(1)), 4.05 (dd, J = 7.4, 11.6 Hz, 1H, H2C(4)), 3.42 
(m, 1H, OH), 2.58 (t, J = 11.0 Hz, 1H, H2C(4)), 2.50 (dt, J = 10.1, 6.8 Hz, 1H, 
HC(7a)), 1.94 (t, J = 7.5 Hz, 1H, HC(5a)), 1.88 – 1.71 (m, 2H, H2C(6), 
H2C(7)), 1.58 – 1.37 (m, 3H, H2C(6), H2C(7), HC(9)), 1.29 (s, 3H, H3C(8)), 
1.33 – 1.25  (m, 1H, HC(5)), 0.92 (dd, J = 6.8, 2.4 Hz, 3H, H3C(10) or 
H3C(11)), 0.87 (dd, J = 6.8, 2.5 Hz, 3H, H3C(10) or H3C(11)) 
 13C-NMR: (500 MHz, CDCl3) 
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175.65 (C(2)), 75.48 (C(7b)), 72.83 (C(1)), 55.10 (C(5)), 54.97 (C(5a)), 52.31 
(C(7a)), 47.94 (C(4)), 32.78 (C(9)), 32.60 (C(6)), 25.34 (C(7)), 24.10 (C(8)), 
21.45 (C(10) or C(11)), 21.33 (C(10) or C(11)) 
 IR: (CDCl3 film) 
3306 (s), 2957 (s), 2871 (s), 1681 (s), 1453 (s), 1416 (s), 1380 (s), 1335 (s), 
1297 (m), 1260 (w), 1227 (m), 1179 (w), 1145 (m), 1114 (s), 1096 (m), 1034 
(w), 1004 (w), 962 (w), 910 (m), 848 (w), 796 (m), 734 (s), 665 (w), 646 (m) 
 MS: (ESI, Q-tof) 
224.2 (100) [M+1] 
Opt. Rot.: [α]24D   -13.0, (c = 1.02, EtOH) 
 Analysis: C13H21NO2 (223.16) 
 Calcd: C, 69.92; H, 9.48; N, 6.27  
  Found: C, 69.85; H, 9.58; N, 6.28  
 TLC: Rf  0.24  (EtOAc/Hexanes 3:2) [KMnO4] 
 
Preparation of (1R,3R,5R,5aS,7aS,7bR)-Octahydro-1-[N-(3,5-Dinitrophenyl)carbamoxy]-5-
isopropyl-7b-methyl-2H-cyclopenta[gh]pyrrolizin-2-one (40c-1) 
 
A 25 mL round-bottomed flask (A) was fitted with a reflux condenser, a nitrogen inlet 
adaptor, a rubber rubber septum and a magnetic stir bar. The apparatus was opened and 3,5-
dinitrobenzoylazide (23 mg, 0.097 mmol, 1.5 equiv) was added as a solid. The apparatus was 
evacuated and backfilled with N2 three times and toluene (1.8 mL) was added. The clear solution 
was immersed in a preheated (115 oC) oil bath and stirred at reflux for 30 min. In a separate, 
two-neck, 5 mL conical flask (B) fitted with a triangular a magnetic stir bar, rubber septum and a 
nitrogen inlet adaptor the starting alcohol was added (10 mg, 0.045 mmol) followed by toluene 
(1.0 mL). The resulting solution (B) was transferred to flask (A) via cannula. The resulting light 
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yellow solution was heated to reflux for 2 h and then allowed to cool to room temperature. The 
reaction mixture was concentrated in vacuo, and the crude product was purified by column 
chromatography (hexane/EtOAc (3/1, 1/1)) to afford 11.6 mg (60%) of enantioenriched 41a-1 as 
a white solid.  
Data for 41a-1: 
 1H-NMR: (500 MHz, CDCl3) 
9.83 (s, 1H), 8.64 – 8.58 (m, 0H), 8.54 (d, J = 2.0 Hz, 2H), 5.89 (d, J = 6.6 
Hz, 1H), 4.13 (dd, J = 11.9, 7.4 Hz, 1H), 2.86 – 2.64 (m, 2H), 2.09 (t, J = 7.4 
Hz, 1H), 2.01 – 1.92 (m, 1H), 1.92 – 1.78 (m, 1H), 1.73 – 1.59 (m, 2H), 1.59 – 
1.50 (m, 2H), 1.44 (s, 4H), 0.97 (d, J = 6.6 Hz, 3H), 0.92 (d, J = 6.6 Hz, 3H). 
 TLC: Rf  0.40  (hexanes/EtOAc, 3:1) [I2] 
 CHPLC: tR= 10.56 min (<1%) and 28.64 (>99%) (Naphthylleucine, 40 % IPA/Hexanes,         
1.5 mL/min, 254 nm, 2 mg/mL) 
Preparation of (3R,5S,5aS,7aS,7bR)-Octahydro-5-isopropyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizin-1,2-one (41b)  
 
To a 10-mL, three-necked, round-bottomed flask fitted with a nitrogen inlet adapter, a 
magnetic stir bar, and an internal temperature probe was added 41a (68.5 mg, 0.307 mmol), 
CH2Cl2 (1.3 mL), and DMSO (257 µL). The resulting solution was cooled to –12
 oC in an ice/salt 
bath.  To this solution was added diisopropylethylamine (267 µL, 1.53 mmol, 5.0 equiv) 
followed by the dropwise addition of a solution of SO3•pyridine complex (146 mg, 0.92 mmol, 
3.0 equiv) in DMSO (636 µL) while maintaining an internal temperature < –5 oC.  After being 
stirred for 20 min at –10 oC, the mixture was allowed to warm to room temperature.  The mixture 
was then cooled to 0 oC and diluted with CH2Cl2 (20 mL) and H2O (25 mL).  This mixture was 
poured into a 60-mL separatory funnel with CH2Cl2 (20 mL) and H2O (20 mL). The aqueous 
layer was separated washed with CH2Cl2 (2 x 25 mL).  The organic extracts were washed with 
1.0 N. aq. HCl (2 x 20 mL), H2O (1 x 20 mL), and brine (20 mL), the combined organic extracts 
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dried over NaSO4, filtered (cotton plug), and rinsed with TBME (3 x 10 mL). The mixture was 
filtered through a cotton plug and concentrated by rotary evaporation (15 mm Hg, 20-25oC).  The 
crude oil was purified by silica gel chromatography (5 mm x 8 cm column, gradient elution, 
EtOAc/Hexanes, 20, 40, 60, 80, 90%, 25 mL each) to afford 41b (66.2 mg, 97%) as a colorless 
oil.    
 Data for 41b 
 1H-NMR: (500 MHz, CDCl3) 
4.32 (dd, J = 12.4, 7.8 Hz, 1H, H2C(4)), 3.04 (dd, J = 12.3, 9.2 Hz, 1H, 
H2C(4)), 2.70 (dd, J = 8.6, 6.8 Hz, 1H, HC(7a)), 2.15 (dt, J = 7.2, 5.1 Hz, 1H, 
HC(5a)), 2.12 – 1.98 (m, 2H, H2C(6), H2C(7)), 1.74 – 1.68 (m, 1H, H2C(7)), 
1.65 – 1.59  (m, 1H, HC(9)), 1.56 – 1.49 (m, 1H, HC(5)), 1.45 – 1.38 (m, 1H, 
H2C(6)), 1.40 (s, 3H, H3C(8)), 0.95 (d, J = 6.5 Hz, 3H, H3C(10) or H3C(11)), 
0.90 (d, J = 6.4 Hz, 3H, H3C(10) or H3C(11)) 
 13C-NMR: (500 MHz, CDCl3) 
203.01 (C(1)), 159.90 (C(2)), 74.28 (C(7b)), 55.81 (C(7a)), 55.19 (C(5)), 
53.60 (C(5a)), 49.31 (C(4)), 34.26 (C(6)), 32.79 (C(9)), 30.07 (C(7)), 25.02 
(C(8)), 21.48 (C(10) or C(11)), 21.26 (C(10) or C(11)) 
 IR: (neat) 
3411 (m), 2960 (s), 2872 (s), 1764 (s), 1713 (s), 1463 (s), 1402 (s), 1370 (m), 
1333 (m), 1265 (w), 1232 (s), 1205 (w), 1182 (s), 1137 (w), 1123 (w), 1090 
(m), 1069 (w), 1037 (w), 1000 (w), 961 (w), 914 (s), 852 (w), 828 (w), 794 
(w), 730 (s), 678 (s), 646 (s) 
 MS: (ESI, Q-tof) 
222.1 (100) [M+1], 212.2 (28) 
Opt. Rot.: [α]24D   -2.2, (c = 1.1, EtOH) 
Mol. Formula:  C13H19NO2 (221.30) 
 HRMS: C13H20NO2
+: (350.2120) 
Calcd: 222.1494 
Found: 222.1501 
 TLC: Rf  0.21  (EtOAc/Hexanes 2:3) [UV, I2] 
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Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(2-naphthyl)-5-isopropyl-
7b-methyl-2Hcyclopenta[gh] pyrrolizin-2-one (41c)  
 
To a 5-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added 41b (25 mg, 0.123 mmol) followed by THF 
(300 µL).  The flask was immersed in an ice bath and 2-naphthylmagnesium bromide (400 µL, 
0.226. mmol, 2.0 equiv, in THF) was added dropwise via syringe.  After being stirred for 10 min, 
the cooling bath was removed and the reaction was stirred at room temperature for 20 min. The 
solution was cooled in an ice bath and sat. aq. NH4Cl (1.0 mL) is added.  The resulting mixture 
was transferred to a 60-mL separatory funnel using an additional 20 mL of water and 20 mL of 
Et2O and the aqueous phase was extracted with diethyl ether (3 x 15 mL). The organic extracts 
were washed with water (2 x 20 mL), and brine (1x 20 mL), then the combinded organic extracts 
were dried (NaSO4).  The mixture was filtered through a cotton plug and concentrated by rotary 
evaporation (15 mm Hg, 20-25oC).  Purification by silica gel chromatography (5.0 cm x 6 cm 
column, gradient elution, EtOAc/Hexanes, 10, 20, 30, 50%, 25 mL each) afforded 27.5 mg 
(76%) of 41c. 
 
 Data for 41c 
 1H-NMR: (500 MHz, CDCl3) 
7.89 – 7.74 (m, 4H, ArH), 7.62 (dd, J = 8.6, 1.9 Hz, 1H, ArH), 7.52 – 7.42 (m, 
2H, ArH), 4.27 (dd, J = 11.7, 7.5 Hz, 1H, H2C(4)), 3.38 (bs, 1H, OH), 2.74 (t, 
J = 10.5 Hz, 1H, H2C(4)), 2.74 (t, J = 9.2 Hz, 1H, HC(7a)), 2.06 – 2.01 (m, 
1H, H2C(7)), 1.98 – 1.90 (m, 1H, HC(5a)), 1.90 – 1.74 (m, 2H, H2C(6), 
H2C(7)), 1.64 – 1.48 (m, 2H, H2C(6), HC(19)), 1.48 – 1.35 (m, 1H, HC(5)), 
0.96 (d, J = 6.7 Hz, 3H, H3C(20) or H3C(21)), 0.93 (d, J = 6.6 Hz, 3H, 
H3C(20) or H3C(21)), 0.90 (s, 3H, H3C(8)) 
 13C-NMR: (500 MHz, CDCl3) 
176.00 (Ar), 140.91 (Ar), 133.07 (Ar), 133.00 (Ar), 128.70 (Ar), 128.47 (Ar), 
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127.65 (Ar), 126i.40 (Ar), 126.32 (Ar), 125.34 (Ar), 125.00 (Ar), 83.28 (C(1) 
or C(7b)), 75.44 (C(1) or C(7b)), 58.02 (C(7a)), 55.59 (C(5a)), 54.83 (C(5)), 
48.47 (C(4)), 32.88 (C(19)), 31.93 (C(6)), 27.29 (C(7)), 23.90 (C(8)), 21.49 
(C(20) or C(21)), 21.42 (C(20) or C(21)) 
 IR: (CDCl3 film) 
3319 (s), 3058 (w), 2951 (s), 2923 (s), 2868 (s), 2360 (w), 1682 (s), 1506 (w), 
1461 (m), 1417 (s), 1369 (m), 1279 (w), 1230 (w), 1199 (w), 1138 (m), 1101 
(w), 1080 (m), 1028 (w), 973 (w), 954 (w), 908 (s), 861 (w), 843 (w), 813 (s), 
732 (s)  
 MS: (ESI, Q-tof) 
350.2 (32) [M+1], 332.2 (100) 
 Mol. Formula: C23H27NO2 (349.47) 
 HRMS: C23H28NO2
+: (350.2120) 
Calcd: 350.2120 
Found: 350.2123 
 TLC: Rf  0.26  (EtOAc/Hexanes 1:3) [UV, KMnO4] 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(2-naphthyl)-5-isopropyl-
7b-methyl-2Hcyclopenta[gh] pyrrolizin•Borane (41d)  
 
To a 5-mL round-bottomed flask equipped with a nitrogen inlet adapter, a rubber septum, 
a reflux condenser, and a magnetic stir bar was added 41c (27 mg, 0.077 mmol) then BH3•THF 
complex (1.16 mL, 1.16 mmol, 15 equiv). The reaction flask was immersed in an oil bath and 
heated to reflux (66 oC).  After being stirred for 12 h at reflux, the solution was allowed to reach 
room temperature and was quenched with methanol (5 mL) and concentrated by rotary 
evaporation (15 mm Hg, 20-25oC).  The resulting colorless oil was purified by silica gel column 
chromatography (5.0 mm x 8 cm column, gradient elution, TBME/Heaxanes, 5, 10, 15, 20, 25, 
30% 25 mL each) to afford 26.5 mg (96%) of 41d as a white solid 
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 Data for 41d 
 1H-NMR: (500 MHz, CDCl3) 
7.93 – 7.79 (m, 4H, ArH), 7.58 – 7.46 (m, 3H, ArH), 4.23 (d, J = 13.7 Hz, 1H, 
H2C(2)), 3.74 (dd, J = 7.9, 12.5 Hz, 1H, H2C(4),  3.73 (d, J = 14.1, 1H, 
H2C(2)), 3.43 (dd, J = 12.4, 10.3 Hz, 1H, H2C(4)), 2.83 (dd, J = 8.9, 5.2 Hz, 
1H, HC(7a)), 2.34 (dtd, J = 13.3, 7.9, 5.1 Hz, 1H, H2C(7)), 2.27 – 2.19 (m, 
1H, HC(5)), 2.16 (td, J = 9.1, 4.6 Hz, 1H, HC(5a)), 2.07 – 2.03  (m, 2H, 
H2C(6), H2C(6)), 2.01 (bs, 1H, OH), 1.90 (ddt, J = 13.5, 9.0, 6.8 Hz, 1H, 
H2C(7)), 1.58 (s, 3H, H3C(8)) 1.62 – 1.54  (m, 1H, HC(17)), 0.97 (d, J = 6.6 
Hz, 3H, H3C(18) or H3C(19)), 0.89 (d, J = 6.6 Hz, 3H, H3C(18) or H3C(19)) 
 13C-NMR: (500 MHz, CDCl3) 
142.13 (Ar), 133.02 (Ar), 132.79 (Ar), 129.03 (Ar), 128.34 (Ar), 127.67 (Ar), 
126.74 (Ar), 126.62 (Ar), 123.62 (Ar), 123.53 (Ar), 89.93 (C(1) or C(7b)), 
79.96 (C(1) or C(7b)), 79.09 (C(2)), 72.66 (C(4)), 62.88 (C(7a)), 57.36 
(C(5a)), 48.11 (C(5)), 33.72 (C(6)), 33.31 (C(17)), 25.60 (C(8)), 25.27 (C(7)), 
21.68 (C(18) or C(19)), 21.50 (C(18) or C(19)) 
 IR: (CDCl3, film) 
3473 (s), 3058 (w), 2959 (s), 2871 (s), 2383 (s), 2351 (s), 2327 (s), 2272 (s), 
1600 (w), 1506 (w), 1469 (s), 1380 (m), 1337 (w), 1268 (w), 1233 (w), 1171 
(s), 1133 (m), 1062 (w), 1019 (w), 954 (w), 911 (s), 856 (m), 815 (m), 733 (s), 
647 (w) 
 MS: (EI, 70 eV) 
  346.2 (100) [M-3]+, 336.2 (50), 318.2 (3), 142.0 (3) 
 Mol. Formula: C23H32BNO  (349.26) 
 HRMS: C23H29BNO, (346.23) 
  Calcd:  346.2342 
  Found:  346.2342 
 TLC: Rf  0.27  (TBME/Hexanes, 1:3) [UV, I2] 
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Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-1-(2-naphthyl)-5-isopropyl-
7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (41e)  
 
To a two-necked, 5-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added washed potassium hydride (6.0 mg, 0.149 
mmol, 2.0 equiv) from the drybox followed by THF (200 µL). A solution of alcohol 41d (26 mg, 
0.074 mmol) in THF (0.8 mL) is added to the reaction vessel by cannulation. After 15 min of 
stirring, the flask is immersed in an ice bath. The benzyl bromide (17.7 µL, 0.149 mmol, 2.0 
equiv) is then added dropwise by syringe. The ice bath is removed and the solution is allowed to 
stir for 2 h at rt. This mixture was cooled in an ice bath and cold sat. aq. NH4Cl (1.0 mL) is 
added in one portion. The resulting mixture was transferred to a 60-mL separatory funnel using 
an additional 15 mL of water and 15 mL of Et2O and the aqueous phase was extracted with 
diethyl ether (3 x 15 mL). The organic extracts were washed with water (2 x 20 mL), and brine 
(1x 20 mL), then the combinded organic extracts were dried (NaSO4).  The mixture was filtered 
through a cotton plug and concentrated by rotary evaporation (15 mm Hg, 20-25oC).  Purification 
by silica gel chromatography (5.0 cm x 8 cm column, gradient elution, TBME/Hexanes, 2, 4, 6, 
8, 10, 12%, 25 mL each) afforded 30.5 mg (91%) of ether 41e.    
 
 Data for 41e 
 1H-NMR: (500 MHz, CDCl3) 
7.91 – 7.82 (m, 3H, ArH), 7.82 – 7.79 (m, 1H, ArH), 7.56 – 7.49 (m, 2H, 
ArH), 7.34 – 7.27 (m, 2H, ArH), 7.27 – 7.21 (m, 3H, HC(21), HC(22), 
HC(23)), 4.31 (d, J = 13.4 Hz, 1H, H2C(2)), 4.18 (d, J = 11.0 Hz, 1H, 
H2C(19)), 4.05 (d, J = 13.4 Hz, 1H, H2C(2)), 3.98 (d, J = 11.0 Hz, 1H, 
H2C(19)), 3.56 (dd, J = 12.4, 7.7 Hz, 1H, H2C(4)), 3.36 (dd, J = 12.4, 10.1 Hz, 
1H, H2C(4)), 2.87 – 2.73 (m, 2H, H2C(7), HC(7a)), 2.15 – 1.91 (m, 5H, 
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HC(5), HC(5a), H2C(6), H2C(6), H2C(7)), 1.52 (s, 3H, H3C(8)), 1.56 – 1.48 
(m, 1H, HC(24)), 0.88 (d, J = 6.7 Hz, 3H, H3C(25) or H3C(26)), 0.74 (d, J = 
6.6 Hz, 3H, H3C(25) or H3C(26))) 
 13C-NMR: (500 MHz, CDCl3) 
139.11 (Ar), 137.99 (Ar), 133.06 (Ar), 132.98 (Ar), 129.15 (Ar), 128.60 (Ar), 
128.53 (Ar), 127.85 (Ar), 127.80 (Ar), 127.78 (Ar), 126.77 (Ar), 126.73 (Ar), 
125.02 (Ar), 124.79 (Ar), 89.26 (C(1) or C(7b)), 83.61 (C(1) or C(7b)), 71.82 
(C(4)), 70.46, 66.68 (C(2)), 63.09 (C(7a)), 57.34, 47.06, 33.17 (C(8)), 25.44, 
25.43 (C(24)), 24.57 (C(7)), 21.77 (C(25) or C(26)), 21.25 (C(25) or C(26)) 
 IR: (CDCl3, film) 
3059 (m), 3030 (m), 2960 (s), 2919 (s), 2870 (s), 2369 (s), 2327 (s), 2274 (s), 
2240 (m), 1600 (m), 1497 (m), 1454 (s), 1379 (s), 1344 (m), 1295 (w), 1270 
(m), 1247 (w), 1170 (s), 1137 (s), 1084 (s), 1066 (s), 1045 (s), 1027 (s), 950 
(w), 934 (m), 911 (s), 869 (s), 819 (s), 734 (s), 697 (m), 647 (w), 605 (w) 
 MS: (EI, 70 eV) 
  436.3 (100) [M-3], 426.3 
 Mol. Formula: C30H38BNO  (439.44) 
 HRMS: C30H35BNO
+, (436.28) 
  Calcd:  436.2812 
  Found:  436.2815 
 TLC: Rf  0.40  (TBME/Hexanes, 1:9) [UV, I2] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-1-(2-naphthyl)-5-tertbutyl-
7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (48)  
 
To a two-necked, 100-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
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rubber septum and a magnetic stir bar was added α-diazopinacolone (1.1 g, 8.72 mmol, 1.0 
equiv) followed by toluene (23.6 mL). Indium(III) triflate (490 mg, 0.87 mmol, 0.1 equiv) is 
added in one portion. After 1h of stirring, a second portion of indium(III) triflate (490 mg, 0.87 
mmol, 0.1 equiv.) is added. After 1.5 h, sat. aq. NaHCO3 is added. The resulting mixture was 
transferred to a 125-mL separatory funnel using an additional 40 mL of sat. aq. NaHCO3 and 50 
mL of Et2O and the aqueous phase was extracted with diethyl ether (2 x 40 mL). The organic 
extracts were washed with water (1 x 40 mL), and brine (1x 40 mL), then the combinded organic 
extracts were dried (NaSO4).  The mixture was filtered through a cotton plug and concentrated 
by rotary evaporation (15 mm Hg, 20-25oC).  Purification by silica gel chromatography (20 mm 
x 10 cm column, gradient elution, TBME/Hexanes, 2, 4, 6, 8, 10, 15%, 50 mL each) afforded 
1.51 g (63%) 48.    
 
 Data for 48 
 1H-NMR: (500 MHz, CDCl3) 
7.32 – 7.21 (m, 4H, ArH), 7.21 – 7.14 (m, 1H, ArH), 3.78 (s, 2H, H2HC(7)), 
3.27 (td, J = 10.2, 4.3 Hz, 1H), 2.63 – 2.50 (m, 1H), 2.28 – 2.17 (m, 1H), 1.91 
– 1.77 (m, 2H), 1.76 – 1.67 (m, 1H), 1.65 – 1.22 (m, 7H), 1.20 (d, J = 0.8 Hz, 
2H), 0.88 (d, J = 0.8 Hz, 9H, H3C(10)). 
 TLC: Rf  0.22  (TBME/Hexanes, 1:9) [UV, I2] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-1-(2-naphthyl)-5-tertbutyl-
7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (49)  
 
To a two-necked, 100-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added 48 (429 mg, 1.56 mmol, 1.0 equiv) followed by 
MeOH (6.5 mL). Solution is cooled in an ice bath. Sodium borohydride (88.5 mg, 2.34 mmol, 
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1.5 equiv) is added in multiple portions. After 1 h, sat. aq. NH4Cl (10 mL) is added dropwise. 
The resulting mixture was transferred to a 125-mL separatory funnel using an additional 30 mL 
of sat. aq. NH4Cl and 40 mL of Et2O and the aqueous phase was extracted with diethyl ether (2 x 
30 mL). The organic extracts were washed with water (1 x 30 mL), and brine (1x 30 mL), then 
the combinded organic extracts were dried (NaSO4).  The mixture was filtered through a cotton 
plug and concentrated by rotary evaporation (15 mm Hg, 20-25oC).  Purification by silica gel 
chromatography (10 mm x 8 cm column, gradient elution, EtOAc/Hexanes, 5, 10, 20, 30%, 50 
mL each) afforded 424 mg (89%) of 49.    
 
 Data for 49 
 1H-NMR: (500 MHz, CDCl3) 
7.35 – 7.28 (m, 2H), 7.25 – 7.18 (m, 3H), 3.69 (dd, J = 9.0, 2.4 Hz, 1H), 3.36 
– 3.23 (m, 2H), 3.16 (ddd, J = 9.6, 2.4, 1.5 Hz, 1H), 3.08 (dd, J = 10.0, 3.0 Hz, 
0H), 2.96 (dt, J = 8.4, 3.2 Hz, 0H), 2.76 (dd, J = 9.7, 8.9 Hz, 1H), 2.54 (ddd, J 
= 12.4, 10.1, 3.6 Hz, 1H), 2.31 – 2.13 (m, 1H), 1.97 – 1.82 (m, 3H), 1.82 – 
1.66 (m, 3H), 1.65 – 1.47 (m, 3H), 1.42 – 1.28 (m, 5H), 0.77 (s, 9H), 0.74 (s, 
3H). 
 TLC: Rf  0.20  (TBME/Hexanes, 1:4) [UV, I2] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-1-(2-naphthyl)-5-tertbutyl-
7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (50)  
 
To a two-necked, 5-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added potassium hydride (11.6 mg, 0.289 mmol, 2.0 
equiv) followed by tetrahydrofuran (0.4 mL). Alcohol 49 (40 mg, 0.145mmol) is added as a 
solution in THF (0.4 mL) to the reaction vessel. After 15 minutes of stirring, the solution is 
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cooled in an ice bath and carbon disulfide (35 µL, 0.579 mmol, 4.0 equiv.) is added dropwise 
and the ice bath is removed. After 1.5 h, the solution is cooled in an ice bath and iodomethane 
(77 µL, 1.23 mmol, 8.5 equiv.) is added and the ice bath is removed. After stirring for 1 h, the 
solution is cooled in an ice bath and H2O (1 mL) is added. The resulting mixture was transferred 
to a 60-mL separatory funnel using an additional 20 mL of H2O is added and 20 mL of Et2O and 
the aqueous phase was extracted with diethyl ether (2 x 20 mL). The organic extracts were 
washed with water (2 x 20 mL), and brine (1x 20 mL), then the combinded organic extracts were 
dried (NaSO4).  The mixture was filtered through a cotton plug and concentrated by rotary 
evaporation (15 mm Hg, 20-25oC).  Purification by silica gel chromatography (5 mm x 8 cm 
column, gradient elution, DCM/Hexanes, 5, 10, 15, 20, 40%, 25 mL each) afforded 53 mg (99%) 
of 50.    
 
 Data for 50 
 1H-NMR: (500 MHz, CDCl3) 
7.31 – 7.21 (m, 4H), 7.21 – 7.17 (m, 2H), 7.17 – 7.10 (m, 1H), 5.41 (dd, J = 
5.8, 4.4 Hz, 0.3H), 5.37 (dd, J = 5.6, 4.1 Hz, 1H), 3.57 (dd, J = 11.4, 4.1 Hz, 
1H), 3.42 – 3.31 (m, 1.5H), 3.18 – 3.12 (m, 1H), 2.53 – 2.46 (m, 1.29H), 2.45 
(s, 1H), 2.43 (s, 3H), 2.21 – 2.08 (m, 1.48H), 1.87 – 1.75 (m, 3H), 1.75 – 1.65 
(m, 1.46H), 1.58 – 1.39 (m, 2H), 1.39 – 1.20 (m, 5.26H), 0.72 (s, 12H). 
 TLC: Rf  0.25  (DCM/Hexanes, 1:4) [UV, I2] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-1-(2-naphthyl)-5-tertbutyl-
7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (51)  
 
To a two-necked, 5-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added 50 (53 mg, 0.145 mmol, 1.0 equiv) followed by 
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decane (1.45 mL). The solution is warmed to 180 oC. After 24 h, the decane is removed in vauo 
(0.3 torr). Purification by silica gel chromatography (5 mm x 8 cm column, gradient elution, 
DCM/Hexanes, 10, 15, 20, 40%, 25 mL each) afforded 14 mg (3%) of 51.    
 
 Data for 51 
 1H-NMR: (500 MHz, CDCl3) 
7.34 – 7.27 (m, 2H, ArH), 7.27 – 7.19 (m, 3H, ArH), 5.66 (dd, J = 12.5, 0.9 
Hz, 1H, HC(7)), 4.74 (dd, J = 12.5, 1.0 Hz, 1H, HC(8)), 3.69 (td, J = 10.0, 4.5 
Hz, 1H), 2.64 (ddd, J = 11.8, 10.0, 3.7 Hz, 1H), 2.24 – 2.15 (m, 1H), 1.96 – 
1.84 (m, 2H), 1.83 – 1.74 (m, 1H), 1.61 – 1.50 (m, 1H), 1.48 – 1.27 (m, 5H), 
0.85 (d, J = 1.1 Hz, 9H, H3C(10)). 
 TLC: Rf  0.24  (DCM/Hexanes, 1:4) [UV, I2] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-5-tertbutyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizin-2-one (51a)  
 
To a 10-mL, two-necked, round-bottomed flask fitted with two rubber septa, a magnetic 
stir bar, a nitrogen inlet adaptor and an internal temperature probe, was added nitroalkene (E,E)-
1 (90.1 mg, 0.452 mmol) and chiral propenyl ether 51 (123 mg, 0.475 mmol, 1.05 equiv) via 
syringe.  The resulting yellow oil was then evacuated under high vacuum (~0.1 mm Hg) for 30 
min.  The flask was backfilled with N2 and charged with CH2Cl2 (2.1 mL).  The solution was 
cooled to –85 oC (internal temperature) using hexanes/N2 bath.  This yellow solution was sirred 
for 15 min, then freshly prepared TiCl2(Oi-Pr)2 solution (1.2 M in CH2Cl2, 1.2 mL, 1.44 mmol, 
6.0 equiv) was added dropwise via syringe while maintaining an internal temperature ≤ –70 oC 
(ca. 15 min). After addition of the Lewis acid, the cooling bath was replaced with an 
acetone/CO2(s) bath and the resulting bright yellow solution was stirred for another 5 h while 
maintaining an internal temperature ≤ –75 oC.  During the course of the reaction, the yellow 
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color gradually faded and a white precipitate formed.  After 5 h the reaction was quenched with 
triethylamine (2.9 mL, 6.1 equiv, 1 M in MeOH) via syringe while maintaining an internal 
temperature of < –40 oC.  The cooling bath was then removed and the reaction mixture was 
allowed to warm to 0 oC (ca. 15 min).  The resulting white suspension was then poured onto a 
biphasic mixture H2O (30 mL) and TBME (30 mL) in a 125-mL separatory funnel.  The aqueous 
was separated and was washed with TBME (2 x 20 mL).  The organic extracts were washed with 
H2O (2 x 30 mL) and brine (1 x 30 mL).  The combined organic extracts were dried over 
NaHCO3/MgSO4 (1/1), filtered (cotton plug), and concentrated by rotary evaporation (15 mm 
Hg, 20-25 oC).  The resulting residue was filtered through a pad of silica gel (5 mm x 4 cm), 
eluting with TBME (40 mL) to remove any remaining amine impurities.  The resulting clear 
solution was concentrated by rotary evaporation (15 mm Hg, 20-25 oC) to a pale-yellow residual 
oil. The oil was allowed to stand for 8 h. The resulting mixture of nitroso acetals was diluted in 
MeOH (5 mL) and added to a test tube (5 mm x 14 cm) containing a spatula tip (~20 mg) of 
Raney Ni (previously washed with H2O (3 x 10 mL) and MeOH (3 x 10 mL) along with a 
magnetic stir bar.  The tube was placed in a steel autoclave, which was then pressurized with H2 
(350 psi).  After 2 days the autoclave was carefully vented in a fume hood and the solution was 
filtered through a plug of Celite (5 cm x 5 cm, cotton plug) with MeOH (25 mL).  The resulting 
clear solution was concentrated by rotary evaporation (15 mm Hg, 20-25 oC) and purified by 
silica gel column chromatography (2 cm x 8 cm, EtOAC/Hexanes, 20, 30, 40, 60, 80%, 25 mL 
each) to afford affording 53.9 mg (50%) of a white crystalline solid.  
 Data for 51a 
 1H-NMR: (500 MHz, CDCl3) 
4.64 (dd, J = 6.5, 1.3 Hz, 1H), 3.96 (dd, J = 11.9, 7.9 Hz, 1H), 2.74 (ddd, J = 
12.0, 10.7, 1.4 Hz, 1H), 2.55 (dt, J = 10.5, 6.7 Hz, 1H), 2.12 – 2.01 (m, 1H), 
1.94 – 1.70 (m, 2H), 1.70 – 1.36 (m, 3H), 1.30 (s, 3H, H3C(8)), 0.91 (s, 9H, 
H3C(10)) 
 TLC: Rf  0.24  (EtOAc/Hexanes 3:2) [KMnO4] 
 
Preparation of (3R,5S,5aS,7aS,7bR)-Octahydro-5-tertbutyl-7b-methyl-
2Hcyclopenta[gh]pyrrolizin-1,2-one (51b)  
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To a 5-mL, three-necked, round-bottomed flask fitted with a nitrogen inlet adapter, a 
magnetic stir bar, and an internal temperature probe was added 51a (52 mg, 0.219 mmol), 
CH2Cl2 (1.5 mL), and DMSO (325 µL). The resulting solution was cooled to –12
 oC in an ice/salt 
bath.  To this solution was added diisopropylethylamine (179 µL, 1.03 mmol, 5.0 equiv) 
followed by the dropwise addition of a solution of SO3•pyridine complex (98 mg, 0.615 mmol, 
3.0 equiv) in DMSO (458 µL) while maintaining an internal temperature < –5 oC.  After being 
stirred for 20 min at –10 oC, the mixture was allowed to warm to room temperature.  The mixture 
was then cooled to 0 oC and diluted with CH2Cl2 (20 mL) and H2O (25 mL).  This mixture was 
poured into a 60-mL separatory funnel with CH2Cl2 (20 mL) and H2O (20 mL). The aqueous 
layer was separated washed with CH2Cl2 (2 x 25 mL).  The organic extracts were washed with 
1.0 N. aq. HCl (2 x 20 mL), H2O (1 x 20 mL), and brine (20 mL), the combined organic extracts 
dried over NaSO4, filtered (cotton plug), and rinsed with TBME (3 x 10 mL). The mixture was 
filtered through a cotton plug and concentrated by rotary evaporation (15 mm Hg, 20-25oC).  The 
crude oil was purified by silica gel chromatography (5 mm x 8 cm column, gradient elution, 
Et2O/DCM, 10, 20, 40, 50%, 25 mL each) to afford b1b (49 mg, 95%).    
 Data for 51b 
 1H-NMR: (500 MHz, CDCl3) 
4.25 (ddd, J = 12.3, 8.0, 1.8 Hz, 1H, HC(4)), 3.13 (ddd, J = 12.1, 10.2, 1.5 Hz, 
1H, HC(4)), 2.72 (dd, J = 8.3, 6.7 Hz, 1H), 2.27 – 2.16 (m, 1H), 2.16 – 1.99 
(m, 2H), 1.81 – 1.67 (m, 2H), 1.54 – 1.43 (m, 1H), 1.40 (s, 3H, H3C(8)), 0.93 
(s, 9H, H3C(10)). 
TLC:  Rf  0.21  (EtOAc/Hexanes 2:3) [UV, I2] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(2-naphthyl)-5-tertbutyl-
7b-methyl-2Hcyclopenta[gh] pyrrolizin-2-one (51c)  
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To a 5-mL, two-necked, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added 51b (49 mg, 0.123 mmol) followed by THF 
(700µL).  The flask was immersed in an ice bath and 2-naphthylmagnesium bromide (700 µL, 
0.351. mmol, 1.8 equiv, in THF) was added dropwise via syringe.  After being stirred for 10 min, 
the cooling bath was removed and the reaction was stirred at room temperature for 20 min. The 
solution was cooled in an ice bath and sat. aq. NH4Cl (1.0 mL) is added.  The resulting mixture 
was transferred to a 60-mL separatory funnel using an additional 20 mL of water and 20 mL of 
Et2O and the aqueous phase was extracted with diethyl ether (3 x 15 mL). The organic extracts 
were washed with water (2 x 20 mL), and brine (1x 20 mL), then the combinded organic extracts 
were dried (NaSO4).  The mixture was filtered through a cotton plug and concentrated by rotary 
evaporation (15 mm Hg, 20-25oC).  Purification by silica gel chromatography (5.0 cm x 6 cm 
column, gradient elution, EtOAc/Hexanes, 10, 20, 30, 50%, 25 mL each) afforded 68.4 mg 
(90%) of 51c. 
 
 Data for 51c 
 1H-NMR: (500 MHz, CDCl3) 
7.88 – 7.83 (m, 1H, ArH), 7.83 – 7.78 (m, 2H, ArH), 7.78 – 7.75 (m, 1H, 
ArH), 7.62 (dt, J = 8.7, 1.5 Hz, 1H, ArH), 7.51 – 7.44 (m, 2H, ArH), 4.16 (dd, 
J = 11.8, 7.9 Hz, 1H, HC(4)), 3.28 (s, 1H), 2.88 (td, J = 11.4, 1.3 Hz, 1H), 
2.77 (dd, J = 9.9, 7.0 Hz, 1H), 1.94 – 1.69 (m, 3H), 1.68 – 1.58 (m, 1H), 1.56 
– 1.50 (m, 1H), 1.18 (s, 3H, H3C(8)), 0.92 (s, 9H, H3C(20)). 
 TLC: Rf  0.26  (EtOAc/Hexanes 1:3) [UV, KMnO4] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-hydroxy-1-(2-naphthyl)-5-tertbutyl-
7b-methyl-2Hcyclopenta[gh] pyrrolizin•Borane (51d)  
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To a 5-mL round-bottomed flask equipped with a nitrogen inlet adapter, a rubber septum, 
a reflux condenser, and a magnetic stir bar was added 51c (68.4 mg, 0.188 mmol) then BH3•THF 
complex (2.7 mL, 2.7 mmol, 15 equiv). The reaction flask was immersed in an oil bath and 
heated to reflux (66 oC).  After being stirred for 12 h at reflux, the solution was allowed to reach 
room temperature and was quenched with methanol (5 mL) and concentrated by rotary 
evaporation (15 mm Hg, 20-25oC).  The resulting colorless oil was purified by silica gel column 
chromatography (5.0 mm x 8 cm column, gradient elution, TBME/Heaxanes, 5, 10, 15, 20, 25, 
30% 25 mL each) to afford 63.9 mg (94%) of 51d as a white solid 
 
 Data for 41d 
 1H-NMR: (500 MHz, CDCl3) 
7.87 (s, 1H, ArH), 7.86 – 7.77 (m, 2H, ArH), 7.57 – 7.49 (m, 3H, ArH), 4.29 
(d, J = 13.7 Hz, 1H, HC(2)), 3.74 (d, J = 13.6 Hz, 1H, HC(2)), 3.64 – 3.50 (m, 
2H), 2.84 (dd, J = 8.7, 4.4 Hz, 1H), 2.48 – 2.40 (m, 1H), 2.40 – 2.30 (m, 1H), 
2.24 (dt, J = 9.6, 5.6 Hz, 1H), 2.10 – 2.02 (m, 2H), 2.00 – 1.88 (m, 2H), 1.57 
(s, 3H), 0.93 (s, 9H). 
 TLC: Rf  0.27  (TBME/Hexanes, 1:3) [UV, I2] 
 
Preparation of (1S,3S,5S,5aS,7aS,7bR)-Octahydro-1-benzyloxy-1-(2-naphthyl)-5-isopropyl-
7b-methyl-2Hcyclopenta[gh]pyrrolizine•Borane (51e)  
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To a two-necked, 5-mL, round-bottomed flask equipped with a nitrogen inlet adapter, a 
rubber septum and a magnetic stir bar was added washed potassium hydride (6.0 mg, 0.149 
mmol, 2.0 equiv) from the drybox followed by THF (200 µL). A solution of alcohol 51d (26 mg, 
0.074 mmol) in THF (0.8 mL) is added to the reaction vessel by cannulation. After 15 min of 
stirring, the flask is immersed in an ice bath. The benzyl bromide (17.7 µL, 0.149 mmol, 2.0 
equiv) is then added dropwise by syringe. The ice bath is removed and the solution is allowed to 
stir for 2 h at rt. This mixture was cooled in an ice bath and cold sat. aq. NH4Cl (1.0 mL) is 
added in one portion. The resulting mixture was transferred to a 60-mL separatory funnel using 
an additional 15 mL of water and 15 mL of Et2O and the aqueous phase was extracted with 
diethyl ether (3 x 15 mL). The organic extracts were washed with water (2 x 20 mL), and brine 
(1x 20 mL), then the combinded organic extracts were dried (NaSO4).  The mixture was filtered 
through a cotton plug and concentrated by rotary evaporation (15 mm Hg, 20-25oC).  Purification 
by silica gel chromatography (5.0 cm x 8 cm column, gradient elution, TBME/Hexanes, 2, 4, 6, 
8, 10, 12%, 25 mL each) afforded 30.5 mg (91%) of ether 51e.    
 
 Data for 51e 
 1H-NMR: (500 MHz, CDCl3) 
7.89 – 7.79 (m, 4H, ArH), 7.56 – 7.48 (m, 3H, ArH), 7.34 – 7.28 (m, 2H, 
ArH), 7.28 – 7.22 (m, 1H, ArH), 4.33 (d, J = 13.4 Hz, 1H), 4.18 (d, J = 11.1 
Hz, 1H), 4.03 (d, J = 13.4 Hz, 1H), 3.98 (d, J = 11.1 Hz, 1H), 3.52 – 3.39 (m, 
2H), 2.86 – 2.81 (m, 1H), 2.81 – 2.75 (m, 1H), 2.30 – 2.21 (m, 1H), 2.21 – 
2.15 (m, 1H), 2.10 – 1.90 (m, 3H), 1.50 (s, 3H, H3C8))), 0.81 (s, 9H, 
H3C(25)). 
 TLC: Rf  0.40  (TBME/Hexanes, 1:9) [UV, I2] 
 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-(2-naphthyl)-3-(3,5-
bistrifluoromethylphenylmethyl)-5-isopropyl-7b-methylcyclopenta[gh]pyrrolizinium 
Bromide (42) 
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 Data for 42 
 Yield: 64.7 mg (95%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.26 (s, 1H), 8.20 (d, J = 8.7 Hz, 1H), 8.04 – 7.95 (m, 4H), 7.89 (s, 1H), 7.72 
(dd, J = 8.7, 1.9 Hz, 1H), 7.70 – 7.65 (m, 2H), 7.35 – 7.28 (m, 2H), 7.19 – 
7.13 (m, 2H), 6.25 (d, J = 12.3 Hz, 1H), 4.86 (t, J = 12.4 Hz, 1H), 4.19 (d, J = 
13.0 Hz, 1H), 4.06 (d, J = 10.7 Hz, 1H), 3.89 (d, J = 10.7 Hz, 1H), 3.69 (d, J = 
13.1 Hz, 1H), 3.64 (t, J = 9.4 Hz, 2H), 3.02 (dd, J = 11.4, 6.3 Hz, 1H), 2.89 – 
2.82 (m, 1H), 2.62 – 2.47 (m, 1H), 2.43 (s, 3H), 2.27 (dt, J = 14.3, 7.3 Hz, 
1H), 2.21 – 2.14 (m, 1H), 2.14 – 2.04 (m, 2H), 1.57 (s, 3H), 1.08 (s, 9H). 
 TLC: Rf  0.35  (CH2Cl2/MeOH, 9:1) [I2] 
 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-(2-naphthyl)-3-(3,5-
bistrifluoromethylphenylmethyl)-5-isopropyl-7b-methylcyclopenta[gh]pyrrolizinium 
Bromide (41) 
 
 Data for 41 
 Yield: 95 mg (97%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
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8.25 (s, 1H), 8.21 (d, J = 8.6 Hz, 1H), 8.04 – 7.95 (m, 4H), 7.89 (s, 1H), 7.73 
(dd, J = 8.6, 2.0 Hz, 1H), 7.70 – 7.67 (m, 2H), 7.32 – 7.27 (m, 3H), 7.15 – 
7.13 (m, 2H), 5.99 (d, J = 11.8 Hz, 1H), 5.26 (t, J = 11.8 Hz, 1H), 4.11 (d, J = 
12.8 Hz, 1H), 4.06 (d, J = 10.7 Hz, 1H), 3.85 (d, J = 10.6 Hz, 1H), 3.69 – 3.59 
(m, 2H), 3.43 (d, J = 12.1 Hz, 1H), 3.03 (dd, J = 11.1, 6.2 Hz, 1H), 2.93 (dd, J 
= 10.0, 6.2 Hz, 1H), 2.58 – 2.46 (m, 1H), 2.44 (s, 3H), 2.29 – 2.19 (m, 2H), 
2.15 – 2.03 (m, 2H), 1.92 – 1.84 (m, 1H), 1.05 (d, J = 6.6 Hz, 3H), 0.88 (d, J = 
6.5 Hz, 3H) 
 MS: (ESI, Q-tof) 
422.3 (100) [M-3], 412.3 (28), 207.2 (2), 185.1 (5), 180.2 (9), 158.0 (6), 126.0 
(6), 100.1 (42), 89.1 (5), 79.0 (10) 
 Mol. Formula: C39H40BrF6NO  (732.64) 
 HRMS: C39H40F6NO 
+, (652.30) 
  Calcd:  652.3014 
  Found:  652.3005 
 TLC: Rf  0.35  (CH2Cl2/MeOH, 9:1) [I2] 
 
Preparation of Catalysts from Figure 25 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-(2-naphthyl)-3-(3,5-
bismethoxyphenylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (49) 
 
 Data for 49 
 Yield: 38 mg (98%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
 8.71 (s, 1H), 8.32 – 8.17 (m, 1H), 7.87 (d, J = 8.6 Hz, 1H), 7.84 – 7.76 (m, 
1H), 7.72 (d, J = 8.7 Hz, 1H), 7.57 – 7.45 (m, 2H), 7.38 – 7.23 (m, 4H), 7.23 – 
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7.13 (m, 4H), 6.50 – 6.43 (m, 1H), 5.95 (d, J = 14.6 Hz, 1H), 5.83 (d, J = 12.0 
Hz, 1H), 4.72 – 4.61 (m, 1H), 4.17 (d, J = 11.3 Hz, 1H), 4.11 (d, J = 11.5 Hz, 
1H), 4.02 – 3.95 (m, 1H), 3.90 (s, 6H), 3.86 – 3.70 (m, 2H), 3.14 – 3.05  (m, 
1H), 3.03 – 2.94 (m, 1H), 2.64 (dd, J = 7.8, 15.6 Hz, 1H), 2.55 (t, J = 9.6 Hz, 
1H), 2.18 – 2.09 (m, 1H), 2.12 (s, 3H), 1.92 – 1.80 (m, 1H), 1.00 (d, J = 6.5 
Hz, 3H) 
 MS: (ESI, Q-tof) 
548.3 (100) [M-Br-] 
 Mol. Formula: C37H42BrNO3  (628.64) 
 HRMS: C37H42NO3
+, (548.32) 
  Calcd:  548.3165 
  Found:  548.3153 
 TLC: Rf  0.25  (CH2Cl2/MeOH, 9:1) [I2] 
 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-(2-naphthyl)-3-(3,5-
bisfluorophenylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (50) 
 
 Data for 50 
 Yield: 47 mg (95%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.24 (s, 1H), 8.19 (d, J = 8.7 Hz, 1H), 8.02 – 7.97 (m, 2H), 7.77 (dt, J = 8.7, 
1.7 Hz, 1H), 7.68 – 7.65 (m, 2H), 7.35 – 7.22 (m, 3H), 7.17 – 7.09 (m, 2H), 
7.09 – 7.00 (m, 2H), 6.80 (t, J = 8.5, Hz, 1H), 5.47 (d, J = 12.0 Hz, 1H), 5.08 
(t, J = 6.8 Hz, 1H), 4.34 (d, J = 13.2 Hz, 1H), 4.04 (d, J = 10.7 Hz, 1H), 3.82 
(d, J = 10.7 Hz, 1H), 3.71 – 3.55 (m, 2H), 3.32 (d, J = 10.2 Hz, 1H), 3.06 (dd, 
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J = 11.3, 6.1 Hz, 1H), 2.89 – 2.78 (m, 1H), 2.54 – 2.45 (m, 1H), 2.36 (s, 3H) 
2.42 – 2.21 (m, 2H), 2.05 – 1.93 (m, 2H), 1.31 (d, J = 6.4 Hz,, 3H) 
 MS: (ESI, Q-tof) 
524.2 (100) [M-Br-] 
 Mol. Formula: C35H36BrF2NO  (604.57) 
 HRMS: C35H36F2NO
+, (524.28) 
  Calcd:  524.2765 
  Found:  524.2751 
 TLC: Rf  0.31  (CH2Cl2/MeOH, 9:1) [I2] 
 
Preparation of rel-(1S,3R,5S,5aS,7aS,7bR) Octahydro-1-hexyloxy-1-(2-naphthyl)-3-(3,5-
bismethylphenylmethyl)-5-methyl-7b-methylcyclopenta[gh]pyrrolizinium Bromide (51) 
 
 Data for 51 
 Yield: 82 mg (98%), free-flowing white powder 
 1H-NMR: (500 MHz, CDCl3) 
8.23 (s, 1H), 8.16 (d, J = 8.6 Hz, 1H), 8.05 – 7.95 (m, 2H), 7.80 – 7.74 (d, J = 
8.7 Hz, 1H), 7.72 – 7.62 (m, 2H), 7.30 – 7.24 (m, 3H), 7.17 – 7.09 (m, 2H), 
6.94 (s, 1H), 6.81 (s, 2H), 5.13 (d, J = 12.1 Hz, 1H), 5.07 – 4.95 (m, 1H), 4.37 
(d, J = 13.0 Hz, 1H), 4.03 (d, J = 10.6 Hz, 1H), 3.81 (d, J = 10.6 Hz, 1H), 3.62 
(t, J = 9.3 Hz, 1H), 3.55 (d, J = 13.1 Hz, 1H), 3.25 (d, J = 12.2 Hz, 1H), 3.10 
(dd, J = 11.4, 5.9 Hz, 1H), 2.93 (d, J = 9.7 Hz, 1H), 2.58 – 2.43 (m, 1H), 2.37 
(s, 3H), 2.29 – 2.20 (m, 2H), 2.24 (s, 3H), 2.01 – 1.96 (m, 2H), 1.34 (dd, J = 
6.3, 2.3 Hz, 3H) 
 MS: (ESI, Q-tof) 
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516.3 (100) [M-Br- 
 Mol. Formula: C37H42BrNO  (596.64) 
 HRMS: C37H42NO
+, (516.33) 
  Calcd:  516.3266 
  Found:  516.3249 
 TLC: Rf  0.36  (CH2Cl2/MeOH, 9:1) [I2] 
 
7.8.  Supporting Information for Chapter 6 
Computational Methods 
All geometries were fully optimized at the M06-2X187 level of density functional theory 
using the 6-31+G(d,p) basis set for all atoms. For the TiCl4 mediated reaction, the M06
187 
density functional using the TZV basis set with added 2f polarization functions for titanium and 
the 6-31+G(d,p) basis set for all other atoms was used. The CPCM model188 was used for 
inclusion of dichloromethane for all optimizations. The nature of all stationary points was 
determined by semi-numerical (numerical differentiation of analytically computed first 
derivatives) computation of zero-point vibrational energies at 195 K and using the “quasi-
harmonic approximation”189 (with all frequencies below 80 cm-1 being replaced by 80 cm-1 for 
computing free energies) for reducing error from the use of the harmonic oscillator 
approximation for low frequency normal modes. The frequencies were scaled by 0.967 for M06-
2X/6-31+G(d,p) and 0.980 for M06/6-31G+(d,p) for calculating ZPE.190 The electronic energies 
were further refined using the 6-311+G(2d,2p) basis set. Interaction energy decomposition was 
performed using the LMO-EDA method.151 Natural population analysis and perturbation theory 
energy analysis were performed using NBO 3.1 within Gaussian09.191 All geometry 
optimizations and LMO-EDA were performed using the GAMESS192 program.  
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7.8.1.  Cartesian Coordinates and Energies for Structures from Figure 27, Figure 29, 
Figure 30, and Figure 32
 
1-CH3CHO 
 
 
C          0.23287       -0.40467        0.00051 
H          0.30915       -1.50849       -0.00183 
C         -1.15316        0.16091        0.00011 
H         -1.69277       -0.20745        0.87931 
H         -1.68965       -0.20724       -0.88096 
H         -1.12898        1.25109       -0.00002 
O          1.24450        0.26617       -0.00025 
 
E(0 K) =  -153.770052 
E(0 K) + ZPE = -153.715731 
H (195 K) = -153.712858 
G (195 K) = -153.730761 
 
 
1-BF3•OEt2 
 
B         -0.75702        0.00257        0.00187 
O          0.78354       -0.37268       -0.00092 
C          1.49277        0.00884       -1.20801 
H          2.47927       -0.44931       -1.16253 
H          1.56193        1.09782       -1.25137 
H          0.92071       -0.38285       -2.04470 
C          1.49870       -0.00698        1.20690 
H          0.88844       -0.33325        2.04467 
H          1.64427        1.07522        1.21998 
H          2.45214       -0.53264        1.19200 
F         -1.26624       -0.55353       -1.14632 
F         -1.26412       -0.55895        1.14844 
F         -0.79498        1.38131       -0.00000 
 
E(0 K) =  -479.618168 
E(0 K) + ZPE = -479.523899 
H (195 K) = -479.519407 
G (195 K) = -479.542547 
 
 
2-a  
 
C          3.41041        1.00202        1.01771 
H          4.48874        0.80217        1.04498 
H          3.20709        2.03561        1.29199 
C          2.94577        0.70721       -0.34549 
H          3.01740       -0.31117       -0.74551 
O          2.48545        1.59761       -1.07308 
H          2.94331        0.30163        1.71713 
B          2.10236        1.32073       -2.59194 
F          3.27695        1.50529       -3.27981 
F          1.13716        2.25279       -2.86439 
F          1.64365        0.02057       -2.64773 
 
E(0 K) =  -478.423414 
E(0 K) + ZPE = -478.353511 
H (195 K) = -478.349099 
G (195 K) = -478.372262 
 
 
2-b 
 
C         -0.86187        0.03403        0.68575 
H         -1.74684        0.02941        1.32786 
O         -1.09076        0.03644       -0.53221 
C          0.46513        0.02503        1.32491 
H          0.56712       -0.93947        1.83914 
H          0.46601        0.79082        2.10702 
H          1.28512        0.16770        0.62659 
B          0.04091       -0.02474       -1.65624 
F          0.73425       -1.18921       -1.40906 
F          0.80556        1.10514       -1.48525 
F         -0.66463       -0.03515       -2.82851 
 
 
E(0 K) =  -478.422059 
E(0 K) + ZPE = -478.351673 
H (195 K) = -478.347503 
G (195 K) = -478.370019 
 
 
E-crotylsilane 
 
C          0.40795       -0.40440        0.66445 
C         -0.56523        0.51416       -0.00946 
H         -0.38442        0.54947       -1.09138 
H         -0.46621        1.53707        0.37430 
Si        -2.36174       -0.05915        0.24876 
C         -2.58847       -1.68504       -0.67562 
H         -1.92151       -2.45411       -0.27270 
H         -2.35544       -1.55743       -1.73837 
H         -3.61864       -2.04585       -0.59181 
C         -3.52741        1.24848       -0.44786 
H         -3.40473        2.19898        0.08149 
H         -4.57101        0.93349       -0.34608 
H         -3.32617        1.42217       -1.51006 
C         -2.69633       -0.30718        2.08676 
H         -2.52383        0.61829        2.64611 
H         -2.04516       -1.08390        2.50046 
H         -3.73479       -0.61393        2.24942 
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C          1.09793       -1.38184        0.06673 
H          0.98915       -1.51392       -1.01172 
H          0.51725       -0.28386        1.74472 
C          2.02612       -2.32737        0.77316 
H          3.04178       -2.26586        0.36733 
H          1.69879       -3.36640        0.65580 
H          2.07201       -2.10354        1.84298 
 
E(0 K) =  -565.832123 
E(0 K) + ZPE -565.628236 
H (195 K) = -565.621278 
G (195 K) = -565.649705 
 
 
3 
 
C          3.27174        1.07217        0.94194 
H          4.27604        1.50992        0.85480 
H          2.63208        1.77062        1.48207 
C          2.78483        0.86875       -0.43657 
H          3.07103       -0.02028       -1.00624 
O          2.13687        1.76001       -1.01611 
H          3.36705        0.12158        1.46764 
B          1.78295        1.61856       -2.54251 
F          2.93900        1.95095       -3.21953 
F          0.75158        2.50136       -2.74278 
F          1.42392        0.29927       -2.74595 
C          0.40271       -0.40389        0.66327 
C         -0.56652        0.51101       -0.00549 
H         -0.39094        0.54340       -1.08761 
H         -0.46769        1.53402        0.38031 
Si        -2.36644       -0.06183        0.25265 
C         -2.58355       -1.68751       -0.67224 
H         -1.92027       -2.45806       -0.26582 
H         -2.34572       -1.55921       -1.73369 
H         -3.61412       -2.04835       -0.59377 
C         -3.51454        1.25302       -0.45419 
H         -3.38921        2.20284        0.07549 
H         -4.56098        0.94536       -0.36033 
H         -3.30275        1.42334       -1.51471 
C         -2.70226       -0.30618        2.08995 
H         -2.52876        0.61909        2.64916 
H         -2.05571       -1.08581        2.50576 
H         -3.74203       -0.60953        2.25045 
C          1.09820       -1.38180        0.06032 
H          0.98006       -1.51531       -1.01646 
H          0.52118       -0.28197        1.74328 
C          2.02817       -2.32240        0.76911 
H          3.04562       -2.26609        0.36117 
H          1.70352       -3.36132        0.64821 
H          2.07328       -2.10247        1.83998 
 
E(0 K) =  -1044.266175 
E(0 K) + ZPE = -1043.989710 
H (195 K) = -1043.978604 
G (195 K) = -1044.016383 
 
 
4
‡
 (syn-T3-L) 
 
C          3.06882        1.01002        0.94746 
H          3.99107        1.54945        0.70848 
H          2.40923        1.68931        1.49125 
C          2.44735        0.59659       -0.35972 
H          3.04982       -0.09608       -0.95826 
O          1.88363        1.57782       -1.02967 
H          3.32678        0.15269        1.57130 
B          1.82851        1.51756       -2.51900 
F          3.12533        1.68475       -3.02314 
F          0.97784        2.53732       -2.92971 
F          1.33980        0.26352       -2.92929 
C          0.40742       -0.09172        0.74318 
C         -0.60772        0.82289        0.28927 
H         -0.49264        1.08488       -0.76881 
H         -0.70579        1.71186        0.91935 
Si        -2.32815       -0.09677        0.36732 
C         -2.21454       -1.57039       -0.78967 
H         -1.51703       -2.32278       -0.40731 
H         -1.88300       -1.26871       -1.78817 
H         -3.19699       -2.04309       -0.88768 
C         -3.59712        1.15845       -0.20496 
H         -3.62198        2.02452        0.46249 
H         -4.59131        0.69987       -0.20756 
H         -3.37812        1.50634       -1.21867 
C         -2.64765       -0.64943        2.13280 
H         -2.61863        0.19394        2.82909 
H         -1.90970       -1.39080        2.45560 
H         -3.63782       -1.11098        2.20281 
C          1.19345       -0.86929       -0.08893 
H          0.89080       -0.91882       -1.13402 
H          0.59859       -0.14681        1.81795 
C          1.98849       -2.03905        0.43538 
H          2.92225       -2.16919       -0.12025 
H          1.40952       -2.95981        0.31838 
H          2.22565       -1.92524        1.49655 
 
E(0 K) =  -1044.256951 
E(0 K) + ZPE = -1043.979477 
H (195 K) = -1043.969449 
G (195 K) = -1044.004813 
 
 
5 
 
C          0.26147        0.63714        0.77449 
C          3.03811        1.46763       -0.17584 
H          3.66012        1.10252        0.64525 
H          3.69278        1.87152       -0.95157 
C         -0.79170        1.12291        0.03277 
H         -0.81801        0.90261       -1.03624 
H         -1.28655        2.03295        0.37333 
Si        -2.19875       -0.28551        0.71533 
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C         -1.67949       -1.95506        0.07824 
H         -0.93634       -2.43283        0.72247 
H         -1.27861       -1.88640       -0.93856 
H         -2.56580       -2.59777        0.05050 
C         -3.67121        0.41654       -0.19280 
H         -3.87530        1.44895        0.10034 
H         -4.54638       -0.19329        0.05676 
H         -3.51884        0.37422       -1.27443 
C         -2.31133       -0.13790        2.57030 
H         -2.41377        0.90505        2.88360 
H         -1.44033       -0.57425        3.06750 
H         -3.20037       -0.67859        2.91088 
O          1.42073        0.88378       -1.81258 
H          0.38319        1.02312        1.78990 
H          2.40508        2.28265        0.19130 
B          1.02044        0.03232       -2.91064 
F          2.06411       -0.14427       -3.84760 
F         -0.07876        0.64203       -3.54747 
F          0.61855       -1.26321       -2.46852 
C          2.02737       -1.02539        1.41508 
H          2.82306       -1.65064        1.00061 
H          1.37743       -1.67002        2.01456 
H          2.48414       -0.29289        2.08703 
C          1.24620       -0.34935        0.29161 
H          0.73130       -1.09221       -0.32282 
C          2.18500        0.35949       -0.77620 
H          2.83546       -0.45524       -1.13025 
 
E(0 K) =  -1044.262065 
E(0 K) + ZPE = -1043.982422 
H (195 K) = -1043.972469 
G (195 K) = -1044.007596 
 
 
6
‡ 
 
C          1.93993        2.57444        1.50279 
H          2.38365        3.17764        0.70658 
H          1.95975        3.15332        2.42914 
C         -0.77767       -0.95736        0.64998 
H         -1.76745       -0.52461        0.49092 
H         -0.73443       -1.74304        1.40546 
Si        -0.48700       -1.98671       -1.06560 
C         -1.43440       -3.55569       -0.69791 
H         -2.47003       -3.33586       -0.42428 
H         -0.96625       -4.11531        0.11658 
H         -1.44074       -4.18947       -1.59077 
C          1.33608       -2.32368       -1.31794 
H          1.91991       -1.41853       -1.50470 
H          1.45232       -2.97900       -2.18755 
H          1.75899       -2.84091       -0.45127 
C         -1.28515       -0.98712       -2.42815 
H         -0.81157       -0.01549       -2.58592 
H         -2.34464       -0.82410       -2.21021 
H         -1.21488       -1.54999       -3.36497 
H          2.55157        1.67831        1.65001 
B         -1.37537        1.69149        2.69876 
F         -2.28374        1.50918        1.62406 
F         -1.50041        3.02424        3.14614 
F         -1.68749        0.80613        3.74014 
C          1.36012        1.38448       -1.12360 
H          1.40372        2.41264       -1.49273 
H          1.13136        0.74105       -1.97589 
H          2.35088        1.11574       -0.74584 
C          0.29270        1.28373       -0.03077 
H         -0.70303        1.46381       -0.44882 
C          0.49806        2.21332        1.19346 
H         -0.09198        3.12914        1.07543 
O         -0.00708        1.42154        2.27291 
C          0.27559       -0.03877        0.67700 
H          1.22496       -0.36335        1.10665 
 
E(0 K) =  -1044.257775 
E(0 K) + ZPE = -1043.978259 
H (195 K) = -1043.968729 
G (195 K) = -1044.003007 
 
 
7
‡ 
 
C          0.10020        0.86614        1.75425 
H          0.08092        1.55621        0.89707 
O         -1.12800        0.16510        1.82548 
B         -2.12759        0.54031        0.90795 
F         -3.19221       -0.34806        0.91181 
F         -1.55741        0.47102       -0.51063 
F         -2.56121        1.86163        1.01774 
C          1.25178       -0.12839        1.51773 
H          2.16248        0.46977        1.39511 
C          1.10162       -0.97875        0.27847 
H          2.01525       -1.10591       -0.30177 
C          0.02730       -1.71436       -0.08770 
H         -0.89156       -1.70625        0.48574 
H          0.12315       -2.45138       -0.88003 
Si        -0.31089       -0.07530       -2.03174 
C         -1.79127       -0.92824       -2.77695 
H         -2.68287       -0.30446       -2.69643 
H         -1.98761       -1.87549       -2.26690 
H         -1.58307       -1.14503       -3.82927 
C          1.24537       -0.83205       -2.78623 
H          2.15193       -0.31950       -2.45389 
H          1.14487       -0.65309       -3.86537 
H          1.35996       -1.90786       -2.63602 
C         -0.04723        1.76522       -2.19864 
H          0.42430        1.96618       -3.16568 
H          0.63467        2.12206       -1.41930 
H         -0.98405        2.31783       -2.11771 
C          1.45674       -1.08523        2.70662 
H          2.20949       -1.84304        2.47212 
H          0.51567       -1.59198        2.93788 
H          1.79496       -0.53912        3.59027 
C          0.29607        1.69307        3.01816 
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H          1.27932        2.17409        3.02796 
H          0.20175        1.06205        3.90563 
H         -0.47385        2.46674        3.06575 
 
E(0 K) =  -1044.244049 
E(0 K) + ZPE = -1043.964141 
H (195 K) = -1043.954595 
G (195 K) = -1043.988757 
 
 
8
‡ 
 
C          0.89062        2.72791       -1.44472 
H          0.41702        3.63327       -1.83446 
H          1.78311        3.02153       -0.89064 
C          0.57341       -0.47827       -1.89450 
H          1.41625        0.18858       -1.75327 
H          0.78898       -1.45441       -2.31522 
H          1.18512        2.11933       -2.30146 
B          0.99484        1.78069        1.70061 
F         -0.12886        2.38926        2.28933 
F          1.96607        2.75832        1.45215 
F          1.49541        0.79716        2.55397 
C         -1.86389        1.98801       -2.31986 
H         -2.21950        2.95906       -1.96259 
H         -2.72295        1.43227       -2.70366 
H         -1.16514        2.15329       -3.14386 
C         -1.19227        1.22345       -1.17113 
H         -1.95955        1.02928       -0.40928 
C         -0.07850        2.02196       -0.49416 
H         -0.56140        2.78729        0.12116 
O          0.60075        1.12474        0.41069 
C         -0.70694       -0.11363       -1.65514 
H         -1.48793       -0.84334       -1.87242 
Si         0.33414       -1.02178        0.50190 
C         -0.97072       -0.73296        1.81846 
H         -0.92220       -1.59686        2.49194 
H         -1.95887       -0.75768        1.34586 
H         -0.86783        0.18672        2.38921 
C          2.18197       -1.20957        0.74192 
H          2.71986       -0.26434        0.69385 
H          2.57183       -1.90633       -0.00534 
H          2.34248       -1.64543        1.73415 
C         -0.20059       -2.75259       -0.09406 
H         -1.25498       -2.80013       -0.38392 
H         -0.06885       -3.42319        0.76550 
H          0.40921       -3.14583       -0.91132 
 
E(0 K) =  -1044.258176 
E(0 K) + ZPE = -1043.977131 
H (195 K) = -1043.967962 
G (195 K) = -1044.001218 
 
 
9
‡ 
 
Si        -1.16435       -0.33403        1.03095 
C         -2.52826       -1.59023        1.25163 
H         -2.69279       -1.72882        2.32313 
H         -2.24997       -2.55024        0.80992 
H         -3.45989       -1.24613        0.79597 
C          0.56705       -0.95257        1.35077 
H          0.56042       -1.51897        2.28532 
H          1.29281       -0.13866        1.43782 
H          0.89075       -1.62845        0.55396 
C         -1.67334        1.46176        1.14739 
H         -2.41014        1.69670        0.37431 
H         -0.81714        2.13201        1.02558 
H         -2.12673        1.64793        2.12252 
C         -1.26636       -0.70271       -1.25811 
H         -2.34819       -0.64655       -1.35516 
H         -0.79023       -1.68107       -1.27624 
C         -0.51324        0.41344       -1.43504 
H         -1.03093        1.36981       -1.53647 
O         -1.24737       -0.12875        3.51686 
C          0.63257        1.09639       -4.06959 
H          0.84423        2.14606       -3.84704 
H          0.98642        0.88203       -5.08065 
O          1.00682       -1.15409       -3.43265 
H         -0.45079        0.93950       -4.05289 
B          1.71674       -2.24739       -2.81466 
F          3.02567       -1.86814       -2.41617 
F          1.79323       -3.32447       -3.71607 
F          1.04112       -2.69925       -1.63482 
C          1.56561        1.77169       -1.09987 
H          2.63608        1.80973       -1.31993 
H          1.44692        1.88416       -0.01744 
H          1.08727        2.63282       -1.57782 
C          0.96923        0.45228       -1.59017 
H          1.41760       -0.38268       -1.04651 
C          1.32548        0.16270       -3.08731 
H          2.41302        0.31623       -3.14509 
C         -0.36881        0.04191        4.34632 
H          0.68634        0.08260        4.02207 
C         -0.63020        0.19845        5.80356 
H         -0.09988       -0.59433        6.34228 
H         -1.69800        0.15539        6.01658 
H         -0.20747        1.14978        6.14262 
 
E(0 K) =  -1198.089145 
E(0 K) + ZPE = -1197.752674 
H (195 K) = -1197.740563 
G (195 K) = -1197.780258 
 
 
10 
 
C          1.09769        3.39764        1.18186 
H          1.13320        4.14486        0.38341 
H          0.75100        3.88286        2.09623 
C         -0.89153       -0.71737        0.45490 
H         -1.78929       -0.11417        0.27725 
581 
 
H         -1.06651       -1.31508        1.35727 
Si        -0.67282       -1.93897       -1.00052 
C         -2.08591       -3.17545       -0.90860 
H         -3.05176       -2.66363       -0.96701 
H         -2.05561       -3.74414        0.02579 
H         -2.02427       -3.88235       -1.74214 
C          0.98865       -2.80603       -0.82350 
H          1.82358       -2.11420       -0.97783 
H          1.07732       -3.60530       -1.56643 
H          1.09511       -3.25376        0.17013 
C         -0.76134       -1.03700       -2.65351 
H          0.09596       -0.37793       -2.82156 
H         -1.67552       -0.43859       -2.72722 
H         -0.77544       -1.77257       -3.46510 
H          2.10521        3.00946        1.34518 
B         -0.80676        1.11102        2.95407 
F         -2.09858        1.14838        2.45858 
F         -0.51741        2.23500        3.70603 
F         -0.50782       -0.07582        3.58968 
C          1.91293        1.41792       -0.94205 
H          2.04550        2.35103       -1.49649 
H          2.08501        0.58905       -1.63592 
H          2.68090        1.36470       -0.16492 
C          0.51408        1.32045       -0.35467 
H         -0.23839        1.32103       -1.14737 
C          0.14925        2.29952        0.78273 
H         -0.88229        2.65522        0.71260 
O          0.17295        1.18162        1.75308 
C          0.30416        0.16648        0.64683 
H          1.20893       -0.40178        0.87969 
 
E(0 K) = -1044.281226 
E(0 K) + ZPE = -1044.000768 
H (195 K) = -1043.990797 
G (195 K) = -1044.026120 
 
 
11
‡ 
 
Si        -1.17817       -0.38459        1.11895 
C         -2.64165       -1.52087        1.35543 
H         -3.06457       -1.32600        2.34430 
H         -2.34631       -2.57129        1.28846 
H         -3.42095       -1.32575        0.61673 
C          0.52992       -1.07092        1.44027 
H          0.52059       -1.61593        2.38698 
H          1.27524       -0.27307        1.51359 
H          0.83566       -1.76351        0.65100 
C         -1.59656        1.43442        1.26492 
H         -2.34152        1.70802        0.51292 
H         -0.72474        2.08064        1.12824 
H         -2.03120        1.62198        2.24945 
C         -1.24069       -0.76797       -1.16164 
H         -2.31689       -0.72337       -1.30402 
H         -0.75369       -1.74172       -1.16113 
C         -0.49669        0.35825       -1.32138 
H         -1.02691        1.30473       -1.44899 
O         -1.14170       -0.21438        3.65717 
C         -0.12952        0.65999        4.14257 
H         -0.08374        1.52488        3.47965 
H          0.84332        0.15312        4.15326 
H         -0.37568        0.99280        5.15658 
C         -1.24505       -1.36915        4.47971 
H         -2.02190       -2.01392        4.06924 
H         -1.51732       -1.07872        5.50027 
H         -0.29293       -1.91496        4.50512 
C          0.70929        1.09772       -3.91065 
H          0.89258        2.14572       -3.65681 
H          1.10268        0.91383       -4.91299 
O          1.08728       -1.15931       -3.29751 
H         -0.37058        0.92011       -3.93673 
B          1.80108       -2.25372       -2.68571 
F          3.10607       -1.86991       -2.27956 
F          1.88657       -3.32263       -3.59689 
F          1.12337       -2.72099       -1.51361 
C          1.56015        1.73527       -0.90898 
H          2.63080        1.79437       -1.12357 
H          1.43730        1.82117        0.17534 
H          1.07087        2.59967       -1.36957 
C          0.98829        0.41783       -1.43142 
H          1.43037       -0.42159       -0.88969 
C          1.38476        0.15422       -2.92555 
H          2.47183        0.31830       -2.95085 
 
E(0 K) = -1199.279589 
E(0 K) + ZPE = -1198.918917 
H (195 K) = -1198.906721 
G (195 K) = -1198.946473 
 
 
12 
 
Si        -1.20437       -0.30914        1.69436 
C         -2.44433       -1.67269        1.46571 
H         -2.22198       -2.49255        2.15563 
H         -2.40153       -2.06652        0.44750 
H         -3.45856       -1.31478        1.66134 
C          0.55979       -0.83393        1.44003 
H          0.83572       -1.62073        2.15043 
H          1.27271       -0.00835        1.52063 
H          0.65084       -1.27272        0.44000 
C         -1.73322        1.42522        1.26666 
H         -2.48611        1.40535        0.47575 
H         -0.88534        2.01751        0.91268 
H         -2.16581        1.91320        2.14469 
C         -1.32560       -0.47579       -1.59680 
H         -2.40989       -0.38994       -1.58175 
H         -0.88388       -1.46555       -1.50740 
C         -0.54895        0.59664       -1.77942 
H         -1.02293        1.57354       -1.90423 
O         -1.34146       -0.16989        3.54506 
C          0.86709        0.99804       -4.40441 
582 
 
H          1.11236        2.05586       -4.27001 
H          1.28022        0.66749       -5.36099 
O          1.10448       -1.19559       -3.54800 
H         -0.22138        0.89035       -4.44487 
B          1.73582       -2.25676       -2.81677 
F          3.08281       -1.93444       -2.48301 
F          1.71953       -3.43178       -3.60252 
F          1.06960       -2.55831       -1.58640 
C          1.55402        1.91537       -1.44939 
H          2.64343        1.91026       -1.55560 
H          1.32061        2.13629       -0.40228 
H          1.15634        2.73727       -2.05438 
C          0.95449        0.57257       -1.87152 
H          1.33667       -0.20479       -1.20185 
C          1.43855        0.14359       -3.28137 
H          2.53403        0.25290       -3.27178 
C         -0.44757       -0.16185        4.40749 
H          0.59988       -0.25119        4.09222 
C         -0.76533       -0.02383        5.83323 
H         -0.30457       -0.85961        6.37199 
H         -1.84013        0.01066        6.00247 
H         -0.28078        0.88855        6.20165 
 
E(0 K) = -1198.101607 
E(0 K) + ZPE = -1197.764181 
H (195 K) = -1197.751870 
G (195 K) = -1197.792040 
 
 
13 
 
Si        -1.24153       -0.42830        1.81395 
C         -2.57862       -1.69328        1.57925 
H         -3.48656       -1.41500        2.12295 
H         -2.26260       -2.69543        1.88038 
H         -2.82504       -1.72891        0.51379 
C          0.49182       -1.00146        1.45843 
H          0.83609       -1.67502        2.25140 
H          1.19058       -0.16157        1.39245 
H          0.53430       -1.55509        0.51484 
C         -1.73489        1.32426        1.41629 
H         -2.48046        1.31522        0.61733 
H         -0.88721        1.92198        1.07068 
H         -2.18161        1.80427        2.29239 
C         -1.32052       -0.49995       -1.53975 
H         -2.40249       -0.39621       -1.58048 
H         -0.90050       -1.49880       -1.44421 
C         -0.52253        0.56451       -1.67034 
H         -0.97976        1.54842       -1.80343 
O         -1.16865       -0.28575        3.67482 
C         -0.14385        0.59961        4.21017 
H          0.00871        1.39815        3.48626 
H          0.77461        0.02849        4.35853 
H         -0.52005        1.00399        5.14848 
C         -1.36625       -1.46479        4.50252 
H         -2.28254       -1.94547        4.17135 
H         -1.47149       -1.12317        5.53159 
H         -0.50398       -2.12684        4.39616 
C          0.97719        1.04636       -4.21705 
H          1.21496        2.09912       -4.03653 
H          1.42006        0.75246       -5.17223 
O          1.21114       -1.17736       -3.43709 
H         -0.10914        0.93881       -4.29442 
B          1.81715       -2.25153       -2.70403 
F          3.13846       -1.92833       -2.28935 
F          1.85179       -3.40718       -3.52211 
F          1.08858       -2.60209       -1.51932 
C          1.58105        1.84099       -1.19927 
H          2.67405        1.81930       -1.25345 
H          1.30192        2.02883       -0.15663 
H          1.22779        2.69304       -1.79035 
C          0.98275        0.52518       -1.70055 
H          1.32747       -0.28620       -1.05198 
C          1.51895        0.15440       -3.10863 
H          2.61232        0.27398       -3.05852 
 
E(0 K) = -1199.293641 
E(0 K) + ZPE = -1198.932479 
H (195 K) = -1198.919879 
G (195 K) = -1198.960580 
 
 
14 
 
C         -0.30470        2.29567        2.66693 
C         -2.13784       -0.05615        1.77928 
H         -2.61989        0.79945        2.25768 
H         -2.80122       -0.44660        1.00355 
C         -0.63547        2.58554        3.92483 
H         -0.58356        1.83342        4.70884 
H         -0.96478        3.57996        4.20955 
O         -0.23180       -0.70796        0.39871 
H         -0.36561        3.07409        1.90259 
H         -1.97732       -0.83188        2.53161 
B         -0.05899       -2.10594        1.06522 
F         -1.24020       -2.80391        0.89146 
F          0.24798       -1.92673        2.39721 
F          0.98865       -2.69876        0.37038 
C          1.58410        1.08508        1.58323 
H          1.98305        0.11119        1.28781 
H          2.27026        1.53947        2.30171 
H          1.55316        1.72877        0.69475 
C          0.18751        0.94985        2.19833 
H          0.22765        0.27276        3.05656 
C         -0.82148        0.39740        1.17793 
H         -1.00910        1.18135        0.43999 
Si         0.00259       -0.61722       -1.37861 
C         -0.92607        0.89207       -1.96693 
H         -1.98143        0.87374       -1.67818 
H         -0.88319        0.87458       -3.06198 
H         -0.47993        1.83470       -1.63800 
C          1.83506       -0.46709       -1.67382 
583 
 
H          2.03367       -0.57668       -2.74522 
H          2.37737       -1.25047       -1.13952 
H          2.21422        0.50843       -1.35782 
C         -0.76189       -2.17012       -2.06288 
H         -0.75928       -2.10705       -3.15600 
H         -1.79632       -2.27159       -1.72399 
H         -0.20448       -3.05806       -1.75941 
 
E(0 K) = -1044.316487 
E(0 K) + ZPE = -1044.036788 
H (195 K) = -1044.026622 
G (195 K) = -1044.062069 
 
 
15 
 
C         -2.93577        1.75040        1.46812 
C         -0.06188        1.19261        2.23526 
H         -0.63033        1.84197        2.90420 
H          0.70029        0.66896        2.81779 
C         -3.08380        3.05899        1.26336 
H         -2.53084        3.57286        0.48012 
H         -3.76065        3.65514        1.86757 
O         -0.18169       -0.65948        0.72326 
H         -3.50713        1.26258        2.26113 
H          0.43385        1.81379        1.48272 
B          0.01178       -1.95397        0.97895 
F         -0.48671       -2.57503        2.05214 
F          0.72553       -2.68849        0.12423 
C         -2.88189       -0.21227       -0.06440 
H         -2.25748       -0.84421       -0.70063 
H         -3.63969        0.26133       -0.69346 
H         -3.39718       -0.85217        0.66193 
C         -2.04327        0.85060        0.65566 
H         -1.50928        1.45771       -0.08805 
C         -0.98650        0.19759        1.55843 
H         -1.49209       -0.42168        2.31142 
 
E(0 K) = -535.152439 
E(0 K) + ZPE = -534.986215 
H (195 K) = -534.979937 
G (195 K) = -535.007643 
 
 
(CH3)3SiF 
 
F         -0.06520       -1.08007        0.20261 
Si         0.04022       -0.77595       -1.42232 
C         -1.09551        0.66686       -1.75926 
H         -2.12698        0.42386       -1.48751 
H         -1.07531        0.92378       -2.82314 
H         -0.78445        1.54782       -1.18990 
C          1.82875       -0.36124       -1.75968 
H          1.97476       -0.14324       -2.82241 
H          2.48121       -1.19716       -1.49071 
H          2.13692        0.51799       -1.18608 
C         -0.51012       -2.33600       -2.28675 
H         -0.46446       -2.20352       -3.37240 
H         -1.54014       -2.58736       -2.01688 
H          0.13395       -3.17851       -2.01808 
 
E(0 K) = -509.147042 
E(0 K) + ZPE = -509.037093 
H (195 K) = -509.032061 
G (195 K) = -509.055800 
 
 
CH3CHO 
 
C          0.22928       -0.40071        0.00055 
H          0.29561       -1.51085       -0.00170 
C         -1.14977        0.15884        0.00017 
H         -1.69480       -0.21302        0.87702 
H         -1.69089       -0.21235       -0.87928 
H         -1.13557        1.25163        0.00002 
O          1.24613        0.26554       -0.00030 
 
E(0 K) = -153.787774 
E(0 K) + ZPE = -153.734326 
H (195 K) = -153.731440 
G (195 K) = -153.749366 
 
TiCl4 
 
Cl         1.02614        1.77141       -0.72328 
Cl         1.02614       -1.77141       -0.72328 
Cl        -2.04867        0.00000       -0.71926 
Cl        -0.00258        0.00000        2.16828 
Ti        -0.00075        0.00000       -0.00180 
 
E(0 K) = -2690.508679 
E(0 K) + ZPE = -2690.503149 
H (195 K) = -2690.498445 
G (195 K) = -2690.523568 
 
 
17 
 
C          0.25374       -0.91430        0.47770 
O         -0.25395        0.16768        0.18866 
Cl         2.16800        0.85535       -1.39084 
Cl        -1.52981        1.33040       -2.15360 
Cl         0.75729        3.71682       -2.17461 
Cl         0.04019        2.94351        0.95958 
H          1.25322       -1.16209        0.07489 
C         -0.40872       -1.89847        1.34654 
H          0.26836       -2.15736        2.16955 
H         -0.55644       -2.82672        0.77947 
H         -1.36246       -1.52733        1.72549 
Ti         0.25504        1.90454       -0.98246 
 
E(0 K) = -2844.315750 
584 
 
E(0 K) + ZPE = -2844.254045 
H (195 K) = -2844.247077 
G (195 K) = -2844.276845 
 
E-crotylsilane 
 
C          0.41036       -0.39751        0.66774 
C         -0.56064        0.52240        0.00901 
H         -0.38541        0.57048       -1.07669 
H         -0.47340        1.54609        0.40093 
Si        -2.35392       -0.06112        0.25173 
C         -2.57521       -1.69200       -0.66207 
H         -1.95835       -2.48093       -0.21498 
H         -2.28169       -1.58720       -1.71474 
H         -3.62216       -2.01797       -0.63136 
C         -3.52046        1.23679       -0.45766 
H         -3.39371        2.19674        0.05808 
H         -4.56584        0.92472       -0.34238 
H         -3.32990        1.39665       -1.52609 
C         -2.71557       -0.29872        2.08509 
H         -2.54566        0.62984        2.64445 
H         -2.07980       -1.08087        2.51765 
H         -3.76166       -0.59425        2.23303 
C          1.09049       -1.37875        0.06128 
H          0.96861       -1.50356       -1.02002 
H          0.52888       -0.28216        1.75094 
C          2.01399       -2.32957        0.74991 
H          3.03038       -2.27926        0.33731 
H          1.68281       -3.37077        0.63664 
H          2.07526       -2.11174        1.82317 
 
E(0 K) = -565.746788 
E(0 K) + ZPE = -565.545850 
H (195 K) = -565.538857 
G (195 K) = -565.567357 
 
 
18 
 
C          0.71992       -0.00536        1.03915 
C          1.41667        3.01648        0.28651 
H          1.81881        4.00183        0.00723 
H          0.35962        3.13893        0.53682 
C         -0.71251        0.19047        0.69430 
H         -0.83950        0.35693       -0.38677 
H         -1.13550        1.06304        1.21369 
Si        -1.78140       -1.31880        1.14939 
C         -1.24544       -2.78576        0.10242 
H         -0.19564       -3.04220        0.28974 
H         -1.35623       -2.56064       -0.96639 
H         -1.85701       -3.66740        0.33004 
C         -3.57190       -0.88181        0.76704 
H         -3.91216       -0.03463        1.37466 
H         -4.23761       -1.73105        0.96261 
H         -3.67561       -0.60507       -0.29031 
C         -1.54994       -1.70409        2.97636 
H         -1.82922       -0.84479        3.59853 
H         -0.50213       -1.95255        3.18759 
H         -2.16802       -2.55796        3.27890 
C          1.65289       -0.54012        0.23398 
H          1.35180       -0.85634       -0.77113 
C          1.59741        2.14141       -0.88659 
H          2.57863        1.66084       -1.04717 
O          0.72791        2.02339       -1.75700 
H          1.02447        0.28006        2.05233 
H          1.99468        2.66161        1.14372 
C          3.07627       -0.77708        0.61809 
H          3.77477       -0.29946       -0.08391 
H          3.32221       -1.84712        0.60969 
H          3.28861       -0.39099        1.62291 
Cl         0.57411        0.71426       -5.92531 
Cl         0.54949        3.52384       -4.22090 
Cl         2.66069        0.46445       -3.40227 
Cl        -1.11781        0.20262       -3.12954 
Ti         0.66081        1.35166       -3.78817 
 
E(0 K) = -3410.072102 
E(0 K) + ZPE = -3409.807459 
H (195 K) = -3409.793829 
G (195 K) = -3409.837140 
 
 
19
‡ 
 
C          0.62278        0.28152        0.93518 
C          1.62161        2.84684        0.19306 
H          1.93396        3.75262       -0.34453 
H          0.60109        3.01020        0.55207 
C         -0.77816        0.36911        0.57800 
H         -0.91917        0.46663       -0.50933 
H         -1.29703        1.18031        1.10507 
Si        -1.73746       -1.25479        1.00616 
C         -1.03393       -2.63192       -0.05401 
H          0.01600       -2.83280        0.19235 
H         -1.09867       -2.37897       -1.11975 
H         -1.59905       -3.55716        0.10992 
C         -3.51804       -0.88139        0.55291 
H         -3.90450       -0.03540        1.13311 
H         -4.16215       -1.74795        0.74195 
H         -3.59047       -0.62855       -0.51266 
C         -1.51737       -1.62399        2.83170 
H         -1.83489       -0.77520        3.44901 
H         -0.46627       -1.84181        3.05969 
H         -2.11257       -2.49718        3.12382 
C          1.63480       -0.17177        0.12462 
H          1.35347       -0.65047       -0.81751 
C          1.69240        1.72482       -0.78883 
H          2.70382        1.39834       -1.07806 
O          0.79394        1.67707       -1.70658 
H          0.91180        0.63255        1.93214 
H          2.30507        2.69941        1.03479 
C          3.01451       -0.45173        0.63407 
585 
 
H          3.77474       -0.27542       -0.13657 
H          3.10684       -1.50304        0.93336 
H          3.25495        0.16456        1.50878 
Cl         0.52586        0.76208       -5.83900 
Cl         0.49161        3.49609       -4.00751 
Cl         2.67937        0.36886       -3.46130 
Cl        -1.21583        0.12226       -3.14934 
Ti         0.63488        1.30347       -3.62755 
 
E(0 K) = -3410.061886 
E(0 K) + ZPE = -3409.796492 
H (195 K) = -3409.783648 
G (195 K) = -3409.825363 
 
 
20 
 
C          0.14639        0.63629        0.25657 
C          2.17075        2.67174       -0.49626 
H          2.65645        3.36385       -1.19157 
H          1.18490        3.08303       -0.24602 
C         -1.01907        0.58102       -0.46497 
H         -0.95567        0.31871       -1.52600 
H         -1.86603        1.19147       -0.14022 
Si        -1.71528       -1.24479        0.33476 
C         -0.51183       -2.58964       -0.10851 
H          0.41459       -2.54927        0.47473 
H         -0.26608       -2.56798       -1.17731 
H         -0.99483       -3.55146        0.10457 
C         -3.27256       -1.31271       -0.68238 
H         -3.93456       -0.46274       -0.49197 
H         -3.80979       -2.23596       -0.43199 
H         -3.02419       -1.34009       -1.74931 
C         -1.92211       -0.94285        2.15946 
H         -2.36796        0.03826        2.35884 
H         -0.95732       -1.00289        2.67755 
H         -2.57965       -1.70409        2.59347 
C          1.46291        0.18306       -0.23777 
H          1.31307       -0.66216       -0.92652 
C          2.04277        1.31277       -1.15669 
H          3.04229        0.94893       -1.45839 
O          1.24249        1.41739       -2.28986 
H          0.11002        1.06170        1.26697 
H          2.77832        2.62361        0.41377 
C          2.42209       -0.19550        0.88114 
H          3.37943       -0.53186        0.46938 
H          2.01998       -1.01207        1.49285 
H          2.62032        0.65085        1.54909 
Cl         1.17348        0.50639       -6.32083 
Cl         3.27605        1.75072       -4.23811 
Cl         0.22144       -0.98745       -3.60064 
Cl        -0.53474        2.64918       -4.38014 
Ti         1.07050        1.11811       -4.05343 
 
E(0 K) = -3410.074424 
E(0 K) + ZPE = -3409.805758 
H (195 K) = -3409.793057 
G (195 K) = -3409.834347 
 
 
S1 
 
C          0.18525        0.28514        0.74531 
H          0.82652        0.84143        0.03738 
C         -0.35935        1.25090        1.78973 
H         -0.99850        2.00159        1.31713 
H          0.45139        1.76137        2.31606 
H         -0.95672        0.69951        2.52365 
C          1.04469       -0.82952        1.36457 
H          0.41662       -1.35870        2.09501 
C          1.51388       -1.81903        0.29142 
H          2.14926       -1.31352       -0.44631 
H          0.65831       -2.25036       -0.23320 
H          2.09659       -2.62607        0.74347 
C          2.23425       -0.24758        2.07807 
H          2.89709        0.36887        1.46540 
C          2.53806       -0.45566        3.35921 
H          1.90153       -1.06582        3.99635 
H          3.42767       -0.02615        3.80980 
O         -0.90220       -0.31043        0.04562 
Si        -1.32357        0.21399       -1.50032 
C          0.04232       -0.24810       -2.70573 
H          0.98981        0.23227       -2.43866 
H         -0.22103        0.06984       -3.71998 
H          0.20138       -1.33107       -2.71515 
C         -1.55427        2.07890       -1.50547 
H         -1.80037        2.42104       -2.51639 
H         -0.63966        2.59436       -1.19248 
H         -2.36568        2.38092       -0.83579 
C         -2.91621       -0.67233       -1.92033 
H         -3.26376       -0.37209       -2.91410 
H         -3.69893       -0.43149       -1.19503 
H         -2.76829       -1.75643       -1.92356 
 
E(0 K) = -719.704914 
E(0 K) + ZPE = -719.440443 
H (195 K) = -719.432030 
G (195 K) = -719.463765 
 
 
S2
‡ 
 
C          3.50341        0.69086       -1.98077 
H          3.35864        0.44828       -3.03784 
H          4.22737       -0.01137       -1.55832 
H          3.92253        1.70160       -1.91715 
C          0.79247        1.90058       -1.94508 
H         -0.07376        2.22719       -1.36608 
H          0.43715        1.45179       -2.87908 
H          1.39648        2.77504       -2.20630 
C          2.28912        0.98586        0.76196 
H          3.08967        1.72709        0.84038 
586 
 
H          2.63998        0.05351        1.21759 
H          1.41875        1.32942        1.32598 
B          0.56864       -1.70763       -0.94904 
F          0.75104       -2.65968        0.02483 
F          1.90490       -1.27494       -1.45091 
F         -0.18750       -2.16828       -1.99659 
C         -1.06463        0.04529        0.02497 
H         -0.89999        1.06871        0.38750 
Si         1.87667        0.67884       -1.03088 
O          0.22345       -0.37986       -0.46370 
C         -2.08391        0.04548       -1.10446 
H         -1.68824        0.56766       -1.97784 
H         -2.99781        0.54697       -0.77868 
H         -2.33455       -0.97830       -1.39562 
C         -1.48349       -0.82933        1.21828 
H         -1.61250       -1.85800        0.85357 
C         -0.42841       -0.81366        2.33022 
H          0.53883       -1.15776        1.95899 
H         -0.73813       -1.46822        3.14900 
H         -0.31077        0.19894        2.73397 
C         -2.80287       -0.34561        1.76032 
H         -2.82397        0.69425        2.09533 
C         -3.89667       -1.09618        1.88534 
H         -4.81193       -0.69746        2.31170 
H         -3.90783       -2.13543        1.56428 
 
E(0 K) = -1044.278845 
E(0 K) + ZPE = -1043.999193 
H (195 K) = -1043.989735 
G (195 K) = -1044.023659 
 
 
S3 
 
C         -0.79190       -0.64487       -0.14748 
H         -0.54415       -1.03713       -1.14001 
C         -0.60497       -1.73427        0.89339 
H          0.45367       -1.96504        1.03014 
H         -1.11172       -2.63793        0.54817 
H         -1.02749       -1.44382        1.85617 
C         -2.20079       -0.04316       -0.21240 
H         -2.47832        0.29570        0.79110 
C         -2.27439        1.13183       -1.19372 
H         -2.03672        0.80252       -2.21169 
H         -1.58026        1.93053       -0.91771 
H         -3.28602        1.54394       -1.20215 
C         -3.15602       -1.13323       -0.62970 
H         -2.99352       -1.55740       -1.62302 
C         -4.16714       -1.57409        0.11716 
H         -4.35261       -1.16941        1.10937 
H         -4.83785       -2.34939       -0.23930 
O          0.21397        0.44118        0.05031 
Si         1.63264        0.40204       -1.07685 
B          0.29355        1.17540        1.36713 
F          1.57441        0.67388        1.95214 
B          1.88242        0.13530        3.49874 
F          1.27065        1.06367        4.27037 
F          3.23873        0.16123        3.49714 
F          1.32421       -1.09787        3.50402 
F         -0.72233        0.83836        2.19906 
F          0.43299        2.50781        1.13824 
C          2.46164       -1.23430       -0.75544 
H          2.75766       -1.32412        0.29388 
H          3.36796       -1.29027       -1.36717 
H          1.83150       -2.08751       -1.02239 
C          2.67875        1.87357       -0.64772 
H          3.54739        1.85560       -1.31539 
H          3.03630        1.85697        0.38307 
H          2.13525        2.80543       -0.81997 
C          0.91056        0.55990       -2.78566 
H          1.74921        0.62534       -3.48804 
H          0.32513        1.47920       -2.87797 
H          0.29482       -0.28987       -3.09060 
 
E(0 K) = -1368.903620 
E(0 K) + ZPE = -1368.609465 
H (195 K) = -1368.597402 
G (195 K) = -1368.636842 
 
 
S4
‡ 
 
B          2.06141       -0.18833        2.72728 
F          0.70857        0.10081        2.97989 
F          2.17295       -0.26909        1.23916 
Si         2.05165        0.63749       -0.57913 
B         -0.28095        1.26922        1.43154 
F         -1.42811        1.29761        2.09369 
F          0.59582        2.26632        1.57482 
F          2.40987       -1.42700        3.20114 
F          2.88812        0.81801        3.15292 
O         -0.04678        0.42451        0.38393 
C         -0.90729       -0.69945        0.01528 
H         -0.50405       -1.00941       -0.95578 
C          2.13883       -1.03349       -1.39673 
H          3.18514       -1.23659       -1.64695 
H          1.55245       -1.05765       -2.31835 
H          1.80203       -1.83034       -0.72974 
C          3.63412        1.46119       -0.03656 
H          4.05123        2.03599       -0.86873 
H          4.36623        0.73150        0.31439 
H          3.42110        2.15361        0.78402 
C          1.11185        1.90274       -1.58248 
H          0.86206        2.78489       -0.98681 
H          0.20030        1.49622       -2.02345 
H          1.78518        2.22100       -2.38833 
C         -0.73946       -1.80989        1.03682 
H          0.31801       -2.03414        1.19436 
H         -1.24361       -2.71163        0.68381 
H         -1.17919       -1.51871        1.99533 
C         -2.36830       -0.26439       -0.19301 
H         -2.81746       -0.06503        0.78618 
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C         -2.47763        0.98382       -1.07488 
H         -2.05769        0.79296       -2.06921 
H         -1.95336        1.84092       -0.64307 
H         -3.52687        1.26048       -1.20078 
C         -3.11929       -1.40716       -0.82854 
H         -2.79398       -1.69368       -1.83095 
C         -4.13679       -2.05075       -0.25763 
H         -4.48225       -1.78731        0.73947 
H         -4.65439       -2.85665       -0.76829 
 
E(0 K) = -1368.862810 
E(0 K) + ZPE = -1368.569957 
H (195 K) = -1368.557918 
G (195 K) = -1368.597312 
 
 
S5 
 
C         -0.35139        2.41740        0.52276 
H         -1.41128        2.34580        0.25092 
O          0.18220        1.04713        0.46258 
B         -0.05131       -0.02225        1.52752 
B          0.01276        0.01125       -0.64229 
O         -0.22216       -1.05983        0.42261 
F         -1.09329        0.24246       -1.40101 
F          1.16680       -0.21212       -1.33190 
F          1.05973       -0.19281        2.29415 
F         -1.20715        0.13642        2.23045 
C          0.32592       -2.42495        0.46740 
H          1.39502       -2.33499        0.24033 
C          0.09436       -2.96283        1.86960 
H          0.58355       -2.35437        2.62873 
H          0.49717       -3.97440        1.93227 
H         -0.97941       -3.01016        2.07798 
C         -0.37941       -3.28891       -0.59029 
H         -1.44616       -3.31042       -0.32990 
C         -0.16974        2.91149        1.94822 
H         -0.57089        3.92274        2.02640 
H          0.89574        2.94597        2.19724 
H         -0.69050        2.28309        2.66953 
C          0.40743        3.29955       -0.48132 
H          1.46344        3.29525       -0.17986 
C         -0.21854       -2.78121       -2.02970 
H          0.83935       -2.67199       -2.28977 
H         -0.71617       -1.82476       -2.19007 
H         -0.66617       -3.50494       -2.71545 
C          0.16421       -4.69448       -0.51433 
H          1.23249       -4.80128       -0.71431 
C         -0.57176       -5.77759       -0.26978 
H         -0.13363       -6.77070       -0.26282 
H         -1.63846       -5.70132       -0.07118 
C          0.29301        2.83461       -1.93944 
H          0.77314        3.57121       -2.58829 
H         -0.75606        2.74565       -2.23915 
H          0.78581        1.87707       -2.10898 
C         -0.11431        4.71222       -0.38700 
H         -1.16941        4.84598       -0.63470 
C          0.63020        5.77249       -0.07734 
H          0.21174        6.77399       -0.06221 
H          1.68454        5.66845        0.16877 
 
E(0 K) = -1070.324322 
E(0 K) + ZPE = -1069.988662 
H (195 K) = -1069.977389 
G (195 K) = -1070.015662 
 
 
S6 
 
C         -2.72997        1.55971       -0.16791 
C         -0.16491        0.88764        1.35825 
H         -0.84897        1.61833        1.79647 
H          0.31775        0.33366        2.16852 
C         -2.81793        2.87916       -0.33912 
H         -2.05410        3.42704       -0.88681 
H         -3.64984        3.45116        0.06042 
O         -0.11361       -1.12362       -0.03384 
H         -3.51657        1.04051        0.38579 
H          0.60436        1.42738        0.79700 
C         -2.20984       -0.29911       -1.73561 
H         -1.42170       -0.92188       -2.16466 
H         -2.71025        0.24052       -2.54429 
H         -2.94503       -0.96138       -1.26246 
C         -1.63223        0.68643       -0.71365 
H         -0.89072        1.32471       -1.21015 
C         -0.93305       -0.05931        0.44291 
H         -1.71651       -0.55853        1.03011 
B          1.10117       -0.91603       -0.68075 
F          1.52412       -2.02895       -1.38993 
F          1.27417        0.25823       -1.39356 
O          2.25837       -0.76433        0.48564 
C          3.57315       -0.39302        0.02235 
H          4.17836       -0.14667        0.89517 
H          3.44763        0.47781       -0.61518 
H          4.01172       -1.22623       -0.53277 
C          2.29623       -1.83999        1.44501 
H          2.83754       -1.48554        2.32262 
H          2.79586       -2.70507        1.00154 
H          1.26345       -2.07477        1.69178 
 
E(0 K) = -690.176774 
E(0 K) + ZPE = -689.929229 
H (195 K) = -689.920968 
G (195 K) = -689.952681 
 
 
syn-T1-L 
 
C         -2.67067       -0.94863       -1.36248 
H         -2.92463       -1.35089       -0.37847 
H         -3.53895       -1.08222       -2.01592 
C         -2.40485        0.52667       -1.29981 
588 
 
H         -1.91942        0.97475       -2.16840 
O         -3.37997        1.23409       -0.77944 
H         -1.83071       -1.49611       -1.78801 
C          0.05147        0.14004       -0.64364 
C          0.47582       -1.23089       -0.50083 
H          0.87389       -1.67649       -1.41647 
H         -0.26182       -1.87641       -0.01347 
Si         1.97288       -1.19006        0.76578 
C          3.25580        0.02952        0.14486 
H          2.90482        1.06319        0.22640 
H          3.51429       -0.16786       -0.90025 
H          4.16934       -0.06174        0.74114 
C          2.64822       -2.93920        0.78887 
H          1.88824       -3.65922        1.10496 
H          3.48817       -2.99945        1.48855 
H          3.00886       -3.22689       -0.20316 
C          1.27959       -0.67296        2.42939 
H          0.45120       -1.31995        2.73445 
H          0.92418        0.36221        2.41463 
H          2.06327       -0.74600        3.19043 
C         -0.96643        0.76162        0.05903 
H         -1.44369        0.17131        0.84433 
H          0.60704        0.75765       -1.35493 
B         -3.73544        2.60040       -1.28080 
F         -2.72856        3.06808       -2.13160 
F         -3.89465        3.44850       -0.18390 
F         -4.94843        2.49712       -1.97197 
C         -0.92311        2.25324        0.28739 
H         -0.23555        2.47981        1.10853 
H         -1.90918        2.63083        0.55887 
H         -0.58046        2.78356       -0.60583 
 
E(0 K) = -1044.249076 
E(0 K) + ZPE = -1043.972308 
H (195 K) = -1043.962023 
G (195 K) = -1043.998071 
 
 
syn-T2-L 
 
C         -3.56981        0.83241       -0.07775 
H         -3.60301        1.91143        0.08243 
H         -4.46679        0.54137       -0.63487 
C         -2.39504        0.43151       -0.93510 
H         -2.23044       -0.64599       -0.98657 
O         -2.32756        1.07602       -2.08331 
H         -3.56927        0.30750        0.87769 
C         -0.09650        0.10768       -0.35038 
C          0.14835       -1.22876        0.14336 
H          0.24425       -1.95788       -0.66742 
H         -0.57374       -1.55820        0.89809 
Si         1.89043       -1.22306        1.02945 
C          3.14972       -0.53522       -0.17908 
H          2.98161        0.52925       -0.37101 
H          3.10965       -1.06840       -1.13455 
H          4.16008       -0.64763        0.22626 
C          2.25080       -3.01067        1.46189 
H          1.45645       -3.43518        2.08243 
H          3.19155       -3.07475        2.01836 
H          2.34883       -3.61843        0.55736 
C          1.70859       -0.13912        2.54854 
H          0.96913       -0.55662        3.23894 
H          1.38706        0.86945        2.26831 
H          2.66163       -0.05471        3.07956 
C         -0.94048        1.05045        0.21610 
H         -1.34940        0.80180        1.19637 
H          0.41218        0.39580       -1.27267 
B         -1.45471        0.57709       -3.18309 
F         -1.02901       -0.72998       -2.88954 
F         -0.33325        1.41957       -3.26461 
F         -2.18218        0.59775       -4.36622 
C         -0.79439        2.51665       -0.10767 
H         -0.07429        2.97544        0.57632 
H         -1.74251        3.04809        0.00571 
H         -0.44244        2.64672       -1.13282 
 
E(0 K) = -1044.255851 
E(0 K) + ZPE = -1043.978159 
H (195 K) = -1043.968079 
G (195 K) = -1044.003588 
 
 
anti-T1-L 
 
C         -0.69565        0.01315        0.06863 
C         -1.98013        2.60978       -0.43867 
H         -2.34990        2.79414        0.57268 
H         -2.20286        3.49457       -1.04307 
C         -0.12082       -0.72137       -1.03291 
H          0.82049       -0.29370       -1.39351 
H         -0.82264       -0.90774       -1.85197 
Si         0.33719       -2.50658       -0.36261 
C          1.41068       -2.27957        1.15813 
H          0.83972       -1.84312        1.98414 
H          2.26100       -1.62422        0.94465 
H          1.80209       -3.24580        1.49160 
C          1.26524       -3.32586       -1.76835 
H          0.66460       -3.33569       -2.68253 
H          1.50538       -4.36084       -1.50484 
H          2.20118       -2.79733       -1.97187 
C         -1.26612       -3.38906        0.04946 
H         -1.93167       -3.42034       -0.81846 
H         -1.79258       -2.89938        0.87468 
H         -1.05475       -4.41961        0.35196 
C         -0.03777        0.98596        0.80045 
H          1.03452        1.07398        0.62498 
C         -0.48811        2.43464       -0.44328 
H         -0.05318        2.01023       -1.35318 
O          0.16688        3.45300        0.07075 
H         -1.73527       -0.20012        0.32942 
H         -2.49000        1.74721       -0.87151 
B          1.56470        3.71566       -0.38582 
589 
 
F          1.57663        3.72380       -1.78770 
F          2.42021        2.70200        0.07909 
F          1.93579        4.94699        0.13816 
C         -0.52517        1.43869        2.15189 
H         -1.59839        1.26722        2.27382 
H         -0.31276        2.50215        2.29556 
H         -0.00339        0.88503        2.93792 
 
E(0 K) = -1044.253716 
E(0 K) + ZPE = -1043.976119 
H (195 K) = -1043.966090 
G (195 K) = -1044.001628 
 
 
anti-T2-L 
 
C          2.37598        1.88849       -0.07874 
H          3.12646        2.62746       -0.37867 
H          1.64295        2.38754        0.55753 
C          1.75523        1.37383       -1.34524 
H          2.45246        0.85538       -2.01097 
O          0.93269        2.21322       -1.94202 
H          2.88149        1.09754        0.47866 
C         -0.00090        0.23260       -0.18735 
C          0.05134        0.25674        1.25434 
H         -0.29587        1.19674        1.69523 
H          1.01870       -0.05216        1.66125 
Si        -1.23401       -1.08596        1.88057 
C         -2.95799       -0.40613        1.59517 
H         -3.15630       -0.23152        0.53349 
H         -3.10185        0.53613        2.13285 
H         -3.70136       -1.12148        1.96158 
C         -0.86720       -1.30182        3.70571 
H          0.14080       -1.69718        3.86121 
H         -1.58278       -2.00296        4.14730 
H         -0.95276       -0.34775        4.23414 
C         -0.94376       -2.66078        0.90258 
H          0.10948       -2.95844        0.93233 
H         -1.23506       -2.53220       -0.14492 
H         -1.53863       -3.47882        1.32029 
C          0.92270       -0.36889       -1.02293 
H          1.74523       -0.89230       -0.53111 
H         -0.83688        0.74499       -0.66941 
B          0.78099        2.30963       -3.41974 
F          1.78121        1.55098       -4.04694 
F          0.91160        3.65751       -3.75862 
F         -0.48661        1.84407       -3.78642 
C          0.55666       -0.85921       -2.40245 
H          1.42864       -0.86864       -3.06059 
H         -0.21116       -0.22926       -2.85660 
H          0.17519       -1.88225       -2.33040 
 
E(0 K) = -1044.251666 
E(0 K) + ZPE = -1043.974577 
H (195 K) = -1043.964530 
G (195 K) = -1043.999981 
 
 
anti-T3-L 
 
C         -0.16914       -0.15851       -0.58182 
C          0.81658        0.63577       -1.13858 
C          2.13769       -0.85989       -1.32784 
H          1.69620       -1.27771       -2.23691 
O          2.18244       -1.64675       -0.28138 
B          1.49162       -2.96915       -0.29523 
F          1.31419       -3.34500        1.03097 
F          0.25879       -2.85540       -0.96585 
F          2.29722       -3.88854       -0.97419 
C          3.39201       -0.04046       -1.48470 
H          4.16995       -0.73852       -1.81433 
H          3.68895        0.36889       -0.51735 
H          3.31109        0.75465       -2.22256 
H         -0.89865       -0.60233       -1.26151 
C         -0.28356       -0.48875        0.81441 
H          0.63785       -0.30358        1.37617 
H         -0.65005       -1.50687        0.97269 
Si        -1.63475        0.68270        1.59416 
C         -3.19925        0.56468        0.56425 
H         -3.05444        0.98677       -0.43534 
H         -4.00634        1.12218        1.05037 
H         -3.52444       -0.47503        0.45693 
C         -0.93592        2.42428        1.59905 
H         -0.72171        2.77107        0.58319 
H         -0.01149        2.47265        2.18294 
H         -1.65660        3.11659        2.04595 
C         -1.91605        0.03598        3.33200 
H         -2.30531       -0.98616        3.30533 
H         -2.64590        0.66650        3.84996 
H         -0.98823        0.03874        3.91147 
H          1.42047        1.21579       -0.43876 
C          0.62361        1.20631       -2.52561 
H          1.56659        1.35350       -3.05515 
H          0.13123        2.18137       -2.46415 
H         -0.00755        0.54760       -3.12906 
 
E(0 K) = -1044.252924 
E(0 K) + ZPE = -1043.977111 
H (195 K) = -1043.966562 
G (195 K) = -1044.003233 
 
 
syn-T1-H 
 
C         -2.66964       -0.99510       -1.12003 
H         -2.95569       -1.34382       -0.12518 
H         -3.52557       -1.14223       -1.78900 
C         -2.38941        0.46685       -1.12421 
H         -1.83658        0.89871       -1.95920 
O         -3.31749        1.22048       -0.60611 
H         -3.24647        2.17083       -0.94618 
H         -1.83034       -1.57101       -1.50406 
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H         -2.85252        4.31721       -1.15466 
O         -3.01402        3.51775       -1.67354 
H         -3.70039        3.74737       -2.31546 
C          0.08339        0.13296       -0.38123 
C          0.47425       -1.26745       -0.28601 
H          0.73512       -1.70520       -1.25507 
H         -0.26748       -1.88265        0.23508 
Si         2.07787       -1.38884        0.81089 
C          3.40651       -0.28938        0.06787 
H          3.12634        0.76734        0.12358 
H          3.59743       -0.54271       -0.97939 
H          4.34280       -0.41582        0.62094 
C          2.58245       -3.19477        0.79982 
H          1.78558       -3.82843        1.20035 
H          3.47347       -3.33497        1.42016 
H          2.81721       -3.53045       -0.21456 
C          1.60922       -0.80317        2.53154 
H          0.84207       -1.44540        2.97552 
H          1.22688        0.22252        2.50688 
H          2.48556       -0.81888        3.18727 
C         -0.86724        0.75760        0.38311 
H         -1.36622        0.16439        1.15163 
H          0.62934        0.74878       -1.10098 
C         -0.90755        2.25147        0.55251 
H         -0.23661        2.54965        1.36405 
H         -1.91009        2.58763        0.82884 
H         -0.58541        2.76878       -0.35715 
 
E(0 K) = -796.4989445 
E(0 K) + ZPE = -796.200629 
H (195 K) = -796.190480 
G (195 K) = -796.225902 
 
 
syn-T2-H 
 
C          1.57186        1.59597       -0.95941 
O          1.15702        2.41135       -1.91013 
H          0.55934        3.09917       -1.50811 
H          0.11273        4.64209        0.05939 
O         -0.34342        3.93917       -0.42286 
H         -1.16477        4.33469       -0.74594 
C         -0.20633        0.58367        0.04071 
C          0.13939        0.26446        1.42412 
H          0.17119        1.15671        2.05843 
H          1.08203       -0.28871        1.50292 
Si        -1.22316       -0.88487        2.19805 
C         -2.89150       -0.05357        1.97905 
H         -3.17357        0.00275        0.92294 
H         -2.88676        0.95969        2.39294 
H         -3.66482       -0.62659        2.50058 
C         -0.77048       -1.05198        4.01092 
H          0.24328       -1.44523        4.13236 
H         -1.46322       -1.73546        4.51175 
H         -0.82817       -0.08148        4.51304 
C         -1.15691       -2.53024        1.29804 
H         -0.18839       -3.01952        1.44056 
H         -1.32574       -2.40219        0.22393 
H         -1.93347       -3.19941        1.68221 
C          0.30338       -0.04232       -1.07181 
H          0.99849       -0.86386       -0.90261 
H         -0.94537        1.37267       -0.11994 
C         -0.28969        0.06521       -2.44250 
H          0.48987        0.14443       -3.20552 
H         -0.95448        0.92674       -2.52759 
H         -0.86538       -0.84242       -2.64918 
C          2.83198        0.84184       -1.26782 
H          3.63475        1.58700       -1.28896 
H          2.78086        0.35828       -2.24521 
H          3.06099        0.11018       -0.49271 
H          1.50687        1.99106        0.05504 
E(0 K) = -796.5023165 
E(0 K) + ZPE = -796.202799 
H (195 K) = -796.192753 
G (195 K) = -796.228001 
 
 
syn-T2-H (Z-CH3CHOH
+) 
 
C          1.42526        1.61445       -0.93207 
O          0.92451        2.41139       -1.84939 
H          1.25028        2.19191       -2.77221 
H          1.21747        1.95491       -4.97572 
O          1.81509        1.80383       -4.23079 
H          2.65905        2.20056       -4.48658 
C         -0.32900        0.52261        0.08264 
C          0.01107        0.26994        1.48173 
H         -0.05636        1.17376        2.09613 
H          0.99934       -0.19154        1.59316 
Si        -1.22898       -1.01683        2.23878 
C         -2.98194       -0.37967        2.02443 
H         -3.26673       -0.33551        0.96836 
H         -3.09985        0.61881        2.45688 
H         -3.68324       -1.05098        2.53044 
C         -0.75654       -1.16292        4.04808 
H          0.28545       -1.47891        4.15620 
H         -1.39083       -1.90049        4.54922 
H         -0.88102       -0.20297        4.55825 
C         -0.98423       -2.62575        1.30249 
H          0.05416       -2.96719        1.36193 
H         -1.25055       -2.50917        0.24669 
H         -1.62136       -3.41003        1.72304 
C          0.23658       -0.11072       -0.99654 
H          0.97122       -0.88855       -0.79020 
H         -1.11150        1.25740       -0.12174 
C         -0.33376       -0.08331       -2.38142 
H          0.45964       -0.05766       -3.13513 
H         -0.99674        0.77255       -2.52484 
H         -0.90891       -0.99967       -2.54762 
C          2.72423        0.90696       -1.20294 
H          3.50086        1.67981       -1.22318 
H          2.71508        0.38500       -2.16222 
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H          2.96707        0.20985       -0.40044 
H          1.32210        2.02416        0.06932 
 
E(0 K) = -796.5027299 
E(0 K) + ZPE = -796.203743 
H (195 K) = -796.193766 
G (195 K) = -796.228748 
 
 
syn-T3-H 
 
C          0.44494       -0.16671        0.69417 
C          2.91384        1.27474        1.03042 
H          3.81686        1.88064        0.88815 
H          2.14539        1.90837        1.47561 
C         -0.58628        0.80369        0.31723 
H         -0.49744        1.11651       -0.72948 
H         -0.57059        1.68615        0.96708 
Si        -2.33787        0.00533        0.48695 
C         -2.45020       -1.38438       -0.77151 
H         -1.70445       -2.16028       -0.57082 
H         -2.29397       -1.01118       -1.78877 
H         -3.44002       -1.84987       -0.73025 
C         -3.58087        1.36507        0.12444 
H         -3.48708        2.18043        0.84837 
H         -4.60080        0.97238        0.18474 
H         -3.43245        1.77593       -0.87893 
C         -2.53758       -0.64972        2.23615 
H         -2.41627        0.15072        2.97285 
H         -1.80440       -1.43289        2.45446 
H         -3.53598       -1.07954        2.36507 
C          1.14148       -0.97486       -0.15445 
H          0.90441       -0.94010       -1.21978 
C          2.50419        0.79933       -0.31905 
H          3.09314        0.01400       -0.79569 
O          1.92090        1.65091       -1.09403 
H          1.88889        1.29975       -2.04840 
H          0.65608       -0.27093        1.76075 
H          3.16403        0.44044        1.68600 
H          1.14156        0.55408       -3.92565 
O          1.91184        0.48383       -3.34527 
H          2.68922        0.55344       -3.91680 
C          2.02439       -2.09676        0.30998 
H          2.99360       -2.09545       -0.20036 
H          1.55135       -3.05770        0.08529 
H          2.19629       -2.04744        1.38838 
 
E(0 K) = -796.5039829 
E(0 K) + ZPE = -796.205445 
H (195 K) = -796.195332 
G (195 K) = -796.230671 
 
 
anti-T1-H 
 
C         -0.08313       -0.15429       -0.76380 
C         -2.68386        0.57734       -2.01638 
H         -2.91132       -0.41264       -2.41904 
H         -3.55006        1.22103       -2.20554 
C          0.67061        0.93113       -0.14815 
H          0.23203        1.26659        0.79890 
H          0.82106        1.77867       -0.82543 
Si         2.45291        0.28938        0.30429 
C          2.23907       -1.22788        1.38931 
H          1.76717       -2.04652        0.83622 
H          1.62174       -1.00286        2.26503 
H          3.21337       -1.57816        1.74422 
C          3.28085        1.69412        1.22906 
H          3.29549        2.60646        0.62554 
H          4.31472        1.42744        1.47034 
H          2.75537        1.90526        2.16521 
C          3.34314       -0.13230       -1.29286 
H          3.37923        0.73298       -1.96159 
H          2.85018       -0.95643       -1.81790 
H          4.37200       -0.43851       -1.07888 
C         -1.00670       -0.93768       -0.12389 
C         -2.50773        0.51639       -0.53825 
H         -1.98529        1.32575       -0.02466 
O         -3.49989       -0.03663        0.10515 
H         -3.40694        0.13843        1.09167 
H          0.10169       -0.35346       -1.82214 
H         -1.81206        0.99883       -2.51535 
H         -2.86511       -0.17309        3.21267 
O         -2.83355        0.50475        2.52366 
H         -3.12459        1.32581        2.94243 
H         -1.11017       -0.79471        0.95369 
C         -1.56235       -2.20763       -0.69834 
H         -2.63873       -2.28075       -0.51095 
H         -1.08829       -3.06978       -0.21956 
H         -1.38075       -2.27423       -1.77415 
 
E(0 K) = -796.501713 
E(0 K) + ZPE = -796.201519 
H (195 K) = -796.191867 
G (195 K) = -796.226274 
 
 
anti-T2-H 
 
C          2.21611        2.00656        0.09013 
H          3.03377        2.70013       -0.13989 
H          1.44364        2.55032        0.63555 
C          1.71823        1.50916       -1.22223 
H          2.40696        0.89217       -1.80460 
O          0.94324        2.31523       -1.89479 
H          0.96209        2.13282       -2.88899 
H          2.61950        1.19836        0.70038 
H          0.40301        1.68951       -4.96646 
O          1.16730        1.88121       -4.40700 
H          1.69027        2.54068       -4.88271 
C         -0.02601        0.23895       -0.07401 
C          0.15625        0.06501        1.36396 
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H          0.04231        1.00098        1.92272 
H          1.10432       -0.42065        1.61730 
Si        -1.24815       -1.10355        2.02124 
C         -2.90731       -0.29985        1.66185 
H         -3.10324       -0.25268        0.58589 
H         -2.95624        0.71572        2.06707 
H         -3.71044       -0.88506        2.12120 
C         -0.95661       -1.29177        3.86427 
H          0.03176       -1.71558        4.06605 
H         -1.70892       -1.95941        4.29643 
H         -1.02813       -0.32443        4.37043 
C         -1.10292       -2.74177        1.11538 
H         -0.11840       -3.19681        1.26380 
H         -1.26209       -2.60924        0.04010 
H         -1.85827       -3.44385        1.48288 
C          0.69695       -0.38188       -1.05702 
H          1.51930       -1.03054       -0.74954 
H         -0.84650        0.88643       -0.39479 
C          0.21452       -0.52797       -2.47202 
H          1.03411       -0.44339       -3.19180 
H         -0.55518        0.21272       -2.70657 
H         -0.22865       -1.52031       -2.60061 
 
E(0 K) = -796.5017622 
E(0 K) + ZPE = -796.202831 
H (195 K) = -796.192843 
G (195 K) = -796.227835 
 
 
anti-T3-H 
 
C          0.26005        0.56497        0.72401 
C         -0.83618        0.96382       -0.15297 
H         -0.70992        0.58332       -1.17284 
H         -0.99800        2.04717       -0.15521 
Si        -2.48644        0.16627        0.48825 
C         -3.81956        0.71811       -0.71148 
H         -3.59966        0.36538       -1.72398 
H         -3.90728        1.80827       -0.73570 
H         -4.78807        0.30559       -0.41221 
C         -2.80892        0.77935        2.23266 
H         -2.03630        0.43319        2.92666 
H         -3.77133        0.39858        2.58920 
H         -2.84408        1.87245        2.27150 
C         -2.27306       -1.69859        0.44488 
H         -1.51354       -2.03961        1.15535 
H         -1.98760       -2.03822       -0.55592 
H         -3.21803       -2.18476        0.70819 
C          1.16634       -0.43451        0.47060 
H          1.06634       -0.98445       -0.46580 
C          2.16309        1.19597       -0.47761 
O          1.74668        1.11798       -1.71966 
H          1.09058        1.84153       -1.96223 
H          0.33354        1.07643        1.68632 
H          0.68522        3.78682       -2.82567 
O          0.20035        3.07726       -2.38145 
H         -0.56725        2.89614       -2.94023 
C          1.98606       -1.07676        1.55178 
H          2.93685       -1.45823        1.17557 
H          1.42959       -1.93610        1.94184 
H          2.17355       -0.39199        2.38305 
C          3.55646        0.70552       -0.23796 
H          4.20804        1.43902       -0.72717 
H          3.72715       -0.26794       -0.70062 
H          3.80565        0.68302        0.82166 
H          1.87359        2.09040        0.07624 
 
E(0 K) = -796.5007433 
E(0 K) + ZPE = -796.200894 
H (195 K) = -796.191156 
G (195 K) = -796.225727 
 
 
anti-T3-H (Z-CH3CHOH
+) 
 
C          0.24208        0.57109        0.74330 
C         -0.87041        0.95928       -0.12015 
H         -0.72685        0.61691       -1.15029 
H         -1.04889        2.04003       -0.10135 
Si        -2.50300        0.12834        0.50995 
C         -3.83715        0.63501       -0.70903 
H         -3.59507        0.27863       -1.71504 
H         -3.94689        1.72281       -0.74597 
H         -4.80069        0.20501       -0.41848 
C         -2.85348        0.75674        2.24406 
H         -2.07488        0.44010        2.94562 
H         -3.80834        0.36080        2.60412 
H         -2.91214        1.84953        2.26411 
C         -2.25049       -1.73301        0.49860 
H         -1.48669       -2.04353        1.21864 
H         -1.95207       -2.08322       -0.49482 
H         -3.18528       -2.23627        0.76630 
C          1.13970       -0.43745        0.49818 
H          1.01595       -1.01688       -0.41784 
C          2.10018        1.19168       -0.53249 
O          1.64276        1.06447       -1.75419 
H          2.09783        0.32236       -2.26080 
H          0.34605        1.10428        1.69146 
H          2.26376       -1.45827       -3.52559 
O          2.81589       -0.89719       -2.96377 
H          3.59818       -0.68571       -3.49197 
C          1.99412       -1.04944        1.56906 
H          2.95096       -1.40400        1.18062 
H          1.47099       -1.92364        1.97219 
H          2.17360       -0.35490        2.39389 
C          3.51188        0.79818       -0.22492 
H          4.14232        1.53880       -0.73212 
H          3.76143       -0.19314       -0.60835 
H          3.71805        0.85671        0.84294 
H          1.74141        2.10124       -0.05764 
 
E(0 K) = -796.5007181 
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E(0 K) + ZPE = -796.200648 
H (195 K) = -796.190879 
G (195 K) = -796.225525 
 
 
syn-T1-F 
 
C          0.68424        0.08931        0.43550 
C         -0.33136        0.98513        0.09252 
H         -0.49568        1.21423       -0.95998 
H         -0.61503        1.76292        0.79840 
C          1.47248       -0.69977       -0.39473 
H          1.23987       -0.68400       -1.46135 
C          3.27992        0.70173       -0.65881 
H          0.89275       -0.01291        1.50676 
Si        -2.51166       -0.26411        0.36443 
C         -1.94320       -1.24153       -1.14728 
H         -0.96393       -1.69602       -0.96822 
H         -1.84019       -0.57909       -2.01345 
H         -2.67111       -2.02168       -1.38607 
C         -3.23575        1.46432        0.09701 
H         -2.79215        1.95628       -0.77286 
H         -3.04281        2.09674        0.97000 
H         -4.31813        1.39317       -0.04545 
C         -1.87946       -0.73587        2.08413 
H         -1.45180        0.12301        2.60898 
H         -1.09083       -1.49056        1.99089 
H         -2.69582       -1.15398        2.68000 
F         -4.04267       -1.06654        0.53704 
O          4.25051       -0.04442       -0.90640 
C          2.18953       -1.91846        0.11276 
H          3.19493       -1.99287       -0.32511 
H          1.65422       -2.85082       -0.11487 
H          2.30717       -1.86733        1.20279 
H          3.14383        1.08059        0.36890 
C          2.65664        1.55380       -1.73864 
H          3.26283        2.46159       -1.85563 
H          1.63888        1.85260       -1.47561 
H          2.66155        1.01382       -2.68965 
 
E(0 K) = -819.6120356 
E(0 K) + ZPE = -819.349891 
H (195 K) = -819.340850 
G (195 K) = -819.373933 
 
 
syn-T2-F 
 
C          0.58677        0.35226        0.59175 
C         -0.40645        1.16478        0.04129 
H         -0.55496        1.16504       -1.03854 
H         -0.68460        2.07806        0.56186 
C          1.36778       -0.62120       -0.02135 
H          1.11869       -0.89222       -1.04757 
C          3.09591        0.76009       -0.57244 
H          0.80233        0.51449        1.65369 
Si        -2.63564        0.03850        0.46798 
C         -2.11669       -1.10772       -0.93693 
H         -1.09093       -1.45861       -0.79529 
H         -2.15548       -0.56608       -1.88833 
H         -2.79352       -1.96490       -0.99520 
C         -3.31262        1.75261        0.03084 
H         -2.73850        2.24554       -0.75673 
H         -3.28785        2.39696        0.91726 
H         -4.35423        1.65822       -0.29153 
C         -2.01193       -0.30117        2.22043 
H         -1.60735        0.60319        2.68344 
H         -1.20584       -1.04203        2.18584 
H         -2.82683       -0.69055        2.83741 
F         -4.20329       -0.66895        0.71496 
C          2.15597       -1.62066        0.77893 
H          3.04434       -1.96054        0.23061 
H          1.58013       -2.51547        1.05371 
H          2.51447       -1.15417        1.70367 
O          3.95884        0.69464        0.32656 
H          2.38047        1.59978       -0.59308 
C          3.35921        0.10399       -1.91490 
H          3.66836       -0.93637       -1.77444 
H          4.18732        0.63940       -2.39694 
H          2.48537        0.14648       -2.56883 
 
E(0 K) = -819.6100459 
E(0 K) + ZPE = -819.347694 
H (195 K) = -819.338619 
G (195 K) = -819.371906 
 
 
syn-T3-F 
 
C          0.61813        0.10317        0.31185 
C          3.46672        1.14629        0.41552 
H          4.41263        1.69033        0.29639 
H          2.73128        1.82576        0.85452 
C         -0.34521        0.99474       -0.17103 
H         -0.38029        1.16491       -1.24744 
H         -0.60703        1.84910        0.45216 
C          1.42179       -0.76690       -0.41090 
H          1.21521       -0.86969       -1.47575 
C          2.99153        0.70267       -0.95282 
H          3.48835       -0.20540       -1.34337 
O          2.52007        1.53552       -1.75351 
H          0.77785        0.09732        1.39541 
H          3.63713        0.29892        1.08557 
Si        -2.52694       -0.10565        0.07027 
C         -1.98983       -1.18368       -1.38458 
H         -0.99891       -1.61199       -1.21016 
H         -1.92706       -0.57116       -2.29095 
H         -2.71340       -1.98588       -1.55378 
C         -3.21697        1.61960       -0.30291 
H         -2.63594        2.13950       -1.06837 
H         -3.19477        2.23168        0.60628 
H         -4.25663        1.53812       -0.63430 
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C         -1.99824       -0.52383        1.84307 
H         -1.55472        0.34143        2.34438 
H         -1.23810       -1.31269        1.82082 
H         -2.85506       -0.87886        2.42235 
F         -4.09961       -0.84780        0.24675 
C          2.16247       -1.90040        0.24858 
H          3.20079       -1.98326       -0.10975 
H          1.69016       -2.87523        0.06981 
H          2.20405       -1.75350        1.33425 
 
E(0 K) = -819.6116318 
E(0 K) + ZPE = -819.349190 
H (195 K) = -819.340065 
G (195 K) = -819.373428 
 
 
anti-T1-F 
 
C          0.68424        0.08931        0.43550 
C         -0.33136        0.98513        0.09252 
H         -0.49568        1.21423       -0.95998 
H         -0.61503        1.76292        0.79840 
C          1.47248       -0.69977       -0.39473 
H          1.23987       -0.68400       -1.46135 
C          3.27992        0.70173       -0.65881 
H          0.89275       -0.01291        1.50676 
Si        -2.51166       -0.26411        0.36443 
C         -1.94320       -1.24153       -1.14728 
H         -0.96393       -1.69602       -0.96822 
H         -1.84019       -0.57909       -2.01345 
H         -2.67111       -2.02168       -1.38607 
C         -3.23575        1.46432        0.09701 
H         -2.79215        1.95628       -0.77286 
H         -3.04281        2.09674        0.97000 
H         -4.31813        1.39317       -0.04545 
C         -1.87946       -0.73587        2.08413 
H         -1.45180        0.12301        2.60898 
H         -1.09083       -1.49056        1.99089 
H         -2.69582       -1.15398        2.68000 
F         -4.04267       -1.06654        0.53704 
O          4.25051       -0.04442       -0.90640 
C          2.18953       -1.91846        0.11276 
H          3.19493       -1.99287       -0.32511 
H          1.65422       -2.85082       -0.11487 
H          2.30717       -1.86733        1.20279 
H          3.14383        1.08059        0.36890 
C          2.65664        1.55380       -1.73864 
H          3.26283        2.46159       -1.85563 
H          1.63888        1.85260       -1.47561 
H          2.66155        1.01382       -2.68965 
 
E(0 K) = -819.6134605 
E(0 K) + ZPE = -819.351442 
H (195 K) = -819.342288 
G (195 K) = -819.375729 
 
 
anti-T2-F 
 
C          0.68357        0.12422        0.41983 
C         -0.34745        0.95148       -0.03785 
H         -0.48397        1.04840       -1.11591 
H         -0.59879        1.83756        0.54334 
C          1.46430       -0.77558       -0.29678 
H          1.21694       -0.91590       -1.35137 
C          3.28826        0.43987       -0.66310 
H          3.51281       -0.37828       -1.37507 
H          0.90391        0.17567        1.49148 
Si        -2.47215       -0.17427        0.39870 
C         -1.97379       -1.36151       -0.98361 
H         -0.96724       -1.75465       -0.81463 
H         -1.96198       -0.82945       -1.94146 
H         -2.68593       -2.18842       -1.05259 
C         -3.21774        1.50898       -0.06168 
H         -2.66979        2.01406       -0.86054 
H         -3.20901        2.16489        0.81692 
H         -4.25821        1.37296       -0.37139 
C         -1.86452       -0.47839        2.16654 
H         -1.40986        0.41907        2.59626 
H         -1.09831       -1.26213        2.15723 
H         -2.69206       -0.80327        2.80327 
F         -4.04015       -0.90572        0.67207 
C          2.15631       -1.91913        0.39991 
H          3.00296       -2.29824       -0.18686 
H          1.48966       -2.76981        0.59755 
H          2.55820       -1.57605        1.36057 
O          3.96737        0.52569        0.38410 
C          2.67789        1.66493       -1.29968 
H          3.48418        2.24707       -1.76352 
H          2.18241        2.28350       -0.54682 
H          1.94862        1.39677       -2.06907 
 
E(0 K) = -819.6094134 
E(0 K) + ZPE = -819.347678 
H (195 K) = -819.338664 
G (195 K) = -819.371722 
 
 
anti-T3-F 
 
C          0.59417        0.33992        0.52508 
C          3.41199       -0.13330       -2.01442 
H          3.46648       -1.19602       -1.76930 
C         -0.38803        1.16564       -0.01624 
H         -0.54858        1.16716       -1.09404 
H         -0.67692        2.06921        0.51449 
C          1.36027       -0.63160       -0.10711 
H          1.10440       -0.88167       -1.13691 
C          3.07085        0.73427       -0.81725 
O          2.71408        1.91285       -0.99700 
H          0.80510        0.47888        1.59120 
H          2.67287        0.02771       -2.80378 
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Si        -2.60481        0.04958        0.49576 
C         -2.12747       -1.18234       -0.85006 
H         -1.05107       -1.36090       -0.88402 
H         -2.44151       -0.78487       -1.82257 
H         -2.65151       -2.12949       -0.68904 
C         -3.29625        1.74061       -0.00590 
H         -2.73681        2.20936       -0.81821 
H         -3.26690        2.41750        0.85593 
H         -4.34096        1.62506       -0.31064 
C         -1.96944       -0.19185        2.25945 
H         -1.51126        0.72270        2.64679 
H         -1.20352       -0.97504        2.27166 
H         -2.79131       -0.48968        2.91700 
F         -4.17439       -0.64659        0.78902 
C          2.12681       -1.66326        0.68016 
H          3.13064       -1.84876        0.26902 
H          1.62325       -2.63889        0.72498 
H          2.26343       -1.32293        1.71376 
H          4.39208        0.18237       -2.39510 
H          3.55302        0.44526        0.13439 
 
E(0 K) = -819.6083625 
E(0 K) + ZPE = -819.345360 
H (195 K) = -819.336376 
G (195 K) = -819.369424 
 
 
  
TS-a1 
 
E(195 K) = -872.714264 
G(195 K) = -872.409913 
 
 C           6.0   0.4368091839  -0.6264807398  -0.6893720498 
 C           6.0  -0.5724557795  -2.6587123862   0.4040993718 
 C           6.0   1.0241093939  -0.1749654226   0.6565121235 
 C           6.0   0.3144514037  -2.1534382257  -0.7551977615 
 H           1.0   1.3062016937  -2.6111993687  -0.7146126083 
 H           1.0  -0.1164008265  -3.5237439681   0.8971881195 
 H           1.0   1.1832506358   0.9110119238   0.6948495705 
 H           1.0  -0.1203295873  -2.4414827061  -1.7161052227 
 C           6.0  -0.9819665849  -0.0182761670  -0.8031516183 
 H           1.0  -1.4977590189  -0.4335846664  -1.6733167094 
 H           1.0  -0.9058097909   1.0648785635  -0.9331133896 
 SI         14.0   2.8229847500  -0.8458955211   1.0713560702 
 C           6.0   3.5082836161   0.2993732670   2.3887379086 
 H           1.0   3.5747930016   1.3308215529   2.0303703994 
 H           1.0   4.5142758137  -0.0276504041   2.6706937215 
 H           1.0   2.8875273225   0.2851622105   3.2903619174 
 C           6.0   2.7636976762  -2.6025500540   1.7398498976 
 H           1.0   2.4607713658  -3.3386818350   0.9908677021 
 H           1.0   2.0866299515  -2.6818963821   2.5968663014 
 H           1.0   3.7670624124  -2.8748048725   2.0844721366 
 C           6.0   3.7876665937  -0.7367557278  -0.5319277511 
 H           1.0   3.3939422717  -1.4235313279  -1.2875801499 
 H           1.0   4.8324838374  -1.0044151880  -0.3441717129 
 H           1.0   3.7643656677   0.2788281119  -0.9386406622 
 H           1.0  -1.5518410655  -2.9884937470   0.0452718805 
 C           6.0  -1.8605503205  -0.2833517426   0.4042123882 
 C           6.0  -0.7934070923  -1.6055858363   1.4681164037 
 H           1.0  -1.4719462680  -1.8738528790   2.2753772907 
 H           1.0   1.0501817520  -0.2576747378  -1.5154281730 
 H           1.0  -2.0095114852   0.5336607258   1.1101341971 
 O           8.0  -2.9556965213  -0.9924650626   0.1576565253 
 C           6.0   0.1143132096  -0.5925105119   1.7068738499 
 H           1.0   0.0545500683  -0.0309002520   2.6392084600 
 H           1.0  -3.6328940523  -0.8576505736   0.8792792424 
 H           1.0  -5.5497327733  -0.2388048931   1.8069629335 
 O           8.0  -4.6310365337  -0.4022444878   2.0579524887 
 H           1.0  -4.6612572367  -0.8690160754   2.9028181250 
 
 
TS-a2 
 
E(195 K) = -872.717268 
G(195 K) = -872.413289 
 
 H           1.0   0.3162195211  -0.7892937744   0.0768247203 
 C           6.0   0.0512508130  -0.6144496108   1.1225350136 
 C           6.0  -0.0112707011   1.0930280477   2.9910626805 
 C           6.0  -1.6830483595  -0.7968925071   2.7838653887 
 C           6.0  -0.8649576603  -0.0146550657   3.5746324426 
 C           6.0  -1.4383952233  -0.9148933005   1.3569635978 
 C           6.0   0.3971945383   0.8222368969   1.5235619534 
 H           1.0  -1.0846288031   0.0484687717   4.6384919806 
 H           1.0  -0.1093518103   1.5213088513   0.8524367619 
 H           1.0  -0.5860789556   2.0216645289   3.0708592976 
 H           1.0  -2.4314618118  -1.4269915283   3.2618031166 
 H           1.0  -1.7046234820  -1.9241102437   1.0145080105 
 H           1.0   1.4696448201   0.9896802681   1.3906822150 
 C           6.0   0.8211685427  -1.6146060473   2.0162534340 
 H           1.0   1.8989132386  -1.4374021431   1.9325291232 
 H           1.0   0.6133493036  -2.6381924524   1.6926815531 
 SI         14.0  -2.6977765853   0.1950709508   0.3502729144 
 C           6.0  -4.3121446765  -0.7600409074   0.3173418192 
 H           1.0  -4.1829122004  -1.7467826564  -0.1374283299 
 H           1.0  -5.0514757129  -0.2088679943  -0.2726719473 
 H           1.0  -4.7202673407  -0.8924293225   1.3244917997 
 C           6.0  -2.9753285714   1.8562633087   1.1850423305 
 H           1.0  -2.1178725323   2.5302872901   1.1084569633 
 H           1.0  -3.2268944375   1.7293741987   2.2434082164 
 H           1.0  -3.8252825810   2.3473478734   0.6988770319 
 C           6.0  -1.9747547897   0.3770154501  -1.3699585853 
 H           1.0  -1.0361002447   0.9391401034  -1.3661434390 
 H           1.0  -2.6870117503   0.9168085437  -2.0026619691 
 H           1.0  -1.7924535748  -0.6017593169  -1.8246387640 
 C           6.0   0.4448012967  -1.5126420254   3.4752696344 
 H           1.0   1.0818164073  -0.8891793510   4.1073870754 
 O           8.0   0.0538906898  -2.6466923119   4.0429014854 
 H           1.0   0.8705218510   1.2332028304   3.6246450903 
 H           1.0   0.0949944414  -2.5551282076   5.0340731482 
 H           1.0  -0.5529237896  -2.1584880328   7.1464569604 
 O           8.0   0.2153714893  -2.0354998448   6.5733816904 
 H           1.0   0.9807052562  -2.3294926073   7.0847851933 
 
 
TS-b1 
 
E(195 K) = -757.189334 
G(195 K) = -756.935374 
 
 C           6.0  -2.9427756569  -2.0622451355  -0.5188670145 
 H           1.0  -3.2101322331  -2.5064662551   0.4425594369 
 H           1.0  -3.7833355550  -2.2118355145  -1.2078439704 
 C           6.0  -2.7653340415  -0.5938918279  -0.3974987901 
 H           1.0  -2.2278209804  -0.0498053576  -1.1740511636 
 O           8.0  -3.6937931788   0.0471660140   0.2339185418 
 H           1.0  -3.6118021957   1.0509679598   0.0736209432 
 H           1.0  -2.0607372877  -2.5453443223  -0.9352650431 
 H           1.0  -3.4390684994   3.1635810236   0.3667648544 
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 O           8.0  -3.2194034792   2.4742657991  -0.2760376538 
 H           1.0  -3.4727992987   2.8280220729  -1.1400769737 
 C           6.0  -0.1737354416  -1.0700919756   0.4024754169 
 C           6.0   0.1435239897  -2.4677016912   0.6753177744 
 H           1.0   0.4108090189  -3.0222905167  -0.2306249941 
 H           1.0  -0.6536129074  -2.9846514075   1.2211816940 
 SI         14.0   1.7123811382  -2.5570324547   1.8197890625 
 C           6.0   3.1114186816  -1.6282733520   0.9793241547 
 H           1.0   2.8874602567  -0.5599193280   0.8984305213 
 H           1.0   3.3006595974  -2.0192548577  -0.0254260399 
 H           1.0   4.0325910921  -1.7345791799   1.5610229049 
 C           6.0   2.1149234259  -4.3793451255   2.0140818998 
 H           1.0   1.2808771254  -4.9216483486   2.4695410271 
 H           1.0   2.9918681307  -4.5000429140   2.6581936356 
 H           1.0   2.3387611638  -4.8376844262   1.0459421079 
 C           6.0   1.2612519834  -1.7628619286   3.4592787289 
 H           1.0   0.4348576030  -2.2942296959   3.9417899619 
 H           1.0   0.9654789644  -0.7180964154   3.3206346198 
 H           1.0   2.1201940503  -1.7835395668   4.1373275922 
 C           6.0  -1.1369441151  -0.3369575705   1.0331151504 
 H           1.0  -1.1549689351   0.7431263516   0.9209533925 
 H           1.0  -1.6932182253  -0.7617570083   1.8662222134 
 H           1.0   0.4196732606  -0.5738924354  -0.3672183402 
 
 
TS-b2 
 
E(195 K) = -757.191168 
G(195 K) = -756.935409 
 
 C           6.0   3.2978863346   1.0867330920   0.9782481766 
 H           1.0   4.1656082702   1.7359011044   0.8071661550 
 H           1.0   2.5224514448   1.6683666383   1.4790084403 
 C           6.0   2.8478241645   0.6265449785  -0.3604268155 
 H           1.0   3.4961601925  -0.0523886867  -0.9171070661 
 O           8.0   2.1005374069   1.4291320084  -1.0434007719 
 H           1.0   2.0205580522   1.1195110184  -2.0101485968 
 H           1.0   3.6172003668   0.2538994806   1.6040028867 
 H           1.0   1.1645266625   0.4697540809  -3.8642997234 
 O           8.0   1.9809481309   0.3951694911  -3.3509564162 
 H           1.0   2.7080267275   0.5343984385  -3.9734140384 
 C           6.0   0.9392291627  -0.6558446804   0.8511103409 
 C           6.0   1.0978985936  -0.8759789685   2.2876860063 
 H           1.0   0.9630363567   0.0422481937   2.8707139659 
 H           1.0   2.0535863570  -1.3504395250   2.5361426854 
 SI         14.0  -0.2749272859  -2.1016205653   2.9002488008 
 C           6.0  -1.9549670655  -1.3370335586   2.5535380665 
 H           1.0  -2.1409379004  -1.2617627277   1.4773591351 
 H           1.0  -2.0357522067  -0.3362226988   2.9892478515 
 H           1.0  -2.7454662099  -1.9585216166   2.9862031431 
 C           6.0   0.0139760765  -2.3340572687   4.7392737769 
 H           1.0   1.0073301678  -2.7505986415   4.9318107620 
 H           1.0  -0.7304644984  -3.0213747235   5.1537052374 
 H           1.0  -0.0692319062  -1.3803562514   5.2691052388 
 C           6.0  -0.0674552391  -3.7064424503   1.9477335694 
 H           1.0   0.9454527429  -4.1069445613   2.0583896467 
 H           1.0  -0.2628102206  -3.5553036526   0.8812369959 
 H           1.0  -0.7705032828  -4.4599938047   2.3165497087 
 C           6.0   1.6877610758  -1.2423323503  -0.1237172670 
 H           1.0   1.3827623757  -1.2107674376  -1.1652041664 
 H           1.0   2.4672169160  -1.9553450536   0.1391471791 
 H           1.0   0.1444365725   0.0250914288   0.5407853064 
 
 
TS-c1 
 
E(195 K) = -757.189449 
G(195 K) = -756.934111 
 
 C           6.0  -0.1676418667  -0.8325579049   0.3755505841 
 C           6.0  -2.8281001452  -2.1201898483  -0.3766226030 
 H           1.0  -3.0555647520  -2.5132124337   0.6161899471 
 H           1.0  -3.6704564115  -2.3564751407  -1.0381976960 
 C           6.0   0.6277535167  -0.2288455296  -0.6926807789 
 H           1.0   0.2179782565   0.7315128339  -1.0266913740 
 H           1.0   0.7541046144  -0.9045537211  -1.5464779635 
 SI         14.0   2.4246650507   0.1390327908  -0.0578828840 
 C           6.0   2.2808902710   1.2672993660   1.4351087455 
 H           1.0   1.7373382071   0.7781723758   2.2494468034 
 H           1.0   1.7563985301   2.1928464209   1.1770145374 
 H           1.0   3.2763603969   1.5345567937   1.8033767622 
 C           6.0   3.3119014653   0.9769993316  -1.4833492519 
 H           1.0   3.3084067837   0.3419720974  -2.3744064057 
 H           1.0   4.3529654857   1.1816320895  -1.2144012385 
 H           1.0   2.8319983612   1.9279600581  -1.7339182045 
 C           6.0   3.2271468823  -1.4976414111   0.3944322903 
 H           1.0   3.2190048028  -2.1875346985  -0.4552734765 
 H           1.0   2.7126241114  -1.9758826482   1.2338730895 
 H           1.0   4.2690941487  -1.3364572245   0.6887805736 
 C           6.0  -1.1197700228  -0.1871542919   1.1041567644 
 H           1.0  -1.2527527380   0.8876245853   0.9951237036 
 C           6.0  -2.7195937249  -0.6382853661  -0.3488861841 
 H           1.0  -2.1708795200  -0.1172126634  -1.1363810150 
 O           8.0  -3.6924609120  -0.0034860326   0.2102360637 
 H           1.0  -3.6333529338   0.9967473938   0.0081435614 
 H           1.0   0.0078034081  -1.8881598757   0.5883744161 
 H           1.0  -1.9262756530  -2.5836014357  -0.7741776848 
 H           1.0  -1.5826709055  -0.6643241426   1.9621198469 
 H           1.0  -3.4487951845   3.1029633554   0.2811171091 
 O           8.0  -3.2303215846   2.4074103598  -0.3552617183 
 H           1.0  -3.4728329231   2.7584139222  -1.2236882093 
 
TS-c2 
 
E(195 K) = -757.192915 
G(195 K) = -756.937875 
 
 C           6.0   0.6730404514  -0.4293965984   0.7725663210 
 C           6.0   3.1848839704   1.0431993882   1.0508041278 
 H           1.0   4.0785687317   1.6656749175   0.9179593344 
 H           1.0   2.3966181408   1.6659044561   1.4762069578 
 C           6.0  -0.3551281882   0.5507306448   0.4217065961 
 H           1.0  -0.2575058709   0.8989186921  -0.6134671012 
 H           1.0  -0.3550054211   1.4066741342   1.1061489986 
 SI         14.0  -2.1105468936  -0.2522562115   0.5444938620 
 C           6.0  -2.1991299251  -1.6338967137  -0.7241220704 
 H           1.0  -1.4559177905  -2.4102632751  -0.5172897134 
 H           1.0  -2.0285119601  -1.2544018827  -1.7367138190 
 H           1.0  -3.1895745108  -2.0994588437  -0.7002650791 
 C           6.0  -3.3453910242   1.1090560219   0.1604390122 
 H           1.0  -3.2685278757   1.9227442352   0.8881404746 
 H           1.0  -4.3653933358   0.7135251299   0.1989765061 
 H           1.0  -3.1779602666   1.5224212692  -0.8388731905 
 C           6.0  -2.3540874043  -0.9116773349   2.2860190857 
 H           1.0  -2.2389747933  -0.1145724566   3.0272785667 
 H           1.0  -1.6368293413  -1.7053619101   2.5181486110 
 H           1.0  -3.3609837861  -1.3281573903   2.3908245741 
 C           6.0   1.3862099517  -1.1794369696  -0.1091461625 
 H           1.0   1.1639294419  -1.1597085872  -1.1743258381 
 C           6.0   2.8124605304   0.5566338435  -0.3033823934 
 H           1.0   3.4043246537  -0.2334886299  -0.7667509131 
 O           8.0   2.2081484660   1.3835802262  -1.0816138730 
 H           1.0   2.1836403237   1.0304706064  -2.0409331535 
 H           1.0   2.0492330823  -1.9646915640   0.2417505784 
 H           1.0   0.8820182954  -0.5683928283   1.8338948232 
 H           1.0   3.4382273132   0.2178986978   1.7150710786 
 H           1.0   1.4346109795   0.3280412024  -3.9122658776 
 O           8.0   2.2047498291   0.2484516445  -3.3328812474 
 H           1.0   2.9833671990   0.3185557351  -3.9028410343 
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Table S1. Energy components at varying bond lengths along the intrinsic reaction coordinate for 
all three activation. Units are in kcal/mol.  
dC-C ∆Ees ∆Eex ∆Erep ∆Este ∆Eorb ∆Edisp ∆Eint ∆Ed 
syn-T1-L 
1.92 -41.97 -73.62 213.30 139.68 -102.59 -30.63 -35.50 39.54 
1.97 -36.50 -66.35 192.48 126.13 -89.85 -29.95 -30.17 34.26 
2.02 -31.70 -59.87 174.03 114.16 -78.71 -29.29 -25.54 29.50 
2.15 -21.80 -46.15 135.24 89.09 -56.41 -27.60 -16.73 19.78 
2.28 -14.64 -35.97 106.44 70.47 -41.45 -25.89 -11.51 13.29 
2.54 -4.97 -22.37 68.05 45.68 -25.47 -22.52 -7.28 6.31 
2.80 1.73 -13.22 42.64 29.42 -19.39 -18.44 -6.68 3.64 
syn-T2-L 
1.92 -48.32 -80.60 233.95 153.35 -106.96 -33.67 -35.60 35.43 
1.97 -42.95 -73.47 213.35 139.88 -94.75 -33.01 -30.83 30.61 
2.02 -38.17 -67.04 194.86 127.82 -83.98 -32.35 -26.68 26.27 
2.15 -27.86 -52.97 154.77 101.80 -61.86 -30.60 -18.53 17.29 
2.28 -19.55 -41.73 123.12 81.39 -46.36 -28.79 -13.31 11.01 
2.54 -7.72 -25.56 77.93 52.37 -28.31 -25.03 -8.68 4.18 
2.80 0.14 -14.49 47.19 32.70 -20.45 -20.41 -8.02 1.59 
syn-T3-L 
1.92 -44.94 -76.69 221.98 145.29 -103.42 -31.16 -34.24 33.40 
1.97 -39.78 -69.75 201.95 132.20 -91.43 -30.48 -29.48 28.52 
2.02 -35.16 -63.49 183.96 120.47 -80.98 -29.79 -25.46 24.28 
2.15 -25.11 -49.75 144.76 95.01 -59.92 -27.96 -17.98 15.98 
2.28 -16.90 -38.60 113.35 74.75 -45.16 -26.05 -13.36 10.49 
2.54 -4.95 -22.24 67.84 45.60 -27.34 -22.07 -8.77 4.35 
2.80 1.91 -12.29 40.22 27.93 -19.61 -18.01 -7.77 2.12 
anti-T1-L 
1.92 -43.08 -74.09 213.64 139.55 -100.34 -29.29 -33.17 34.37 
1.97 -37.72 -66.92 193.12 126.20 -88.24 -28.60 -28.36 29.48 
2.02 -32.96 -60.46 174.78 114.32 -77.67 -27.92 -24.23 25.14 
2.15 -22.88 -46.61 135.69 89.08 -56.47 -26.17 -16.44 16.48 
2.28 -15.26 -36.02 105.95 69.93 -42.01 -24.42 -11.75 10.74 
2.54 -4.59 -21.42 64.99 43.57 -25.86 -20.88 -7.77 4.63 
2.80 2.42 -11.62 37.65 26.03 -19.00 -16.56 -7.11 2.39 
anti-T2-L 
1.92 -47.15 -78.49 228.51 150.02 -105.29 -31.81 -34.23 36.72 
1.97 -41.67 -71.43 208.02 136.59 -93.18 -31.14 -29.40 31.80 
2.02 -36.76 -65.04 189.60 124.56 -82.62 -30.48 -25.31 27.50 
2.15 -26.20 -51.05 149.60 98.55 -61.09 -28.73 -17.46 18.82 
2.28 -17.84 -39.95 118.15 78.20 -45.87 -26.90 -12.40 12.73 
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Table S1. (cont.) Energy components at varying bond lengths along the intrinsic reaction 
coordinate for all three activation. Units are in kcal/mol.  
2.54 -6.11 -24.11 73.62 49.51 -27.58 -23.27 -7.45 5.52 
2.80 1.29 -13.67 44.39 30.72 -19.96 -19.04 -6.99 2.80 
anti-T3-L 
1.92 -42.27 -75.57 220.48 144.91 -107.07 -32.45 -36.88 27.15 
1.97 -36.74 -68.40 199.74 131.34 -94.26 -31.77 -31.42 23.66 
2.02 -31.87 -61.98 181.30 119.32 -83.06 -31.09 -26.70 20.47 
2.15 -21.80 -48.28 142.15 93.87 -60.43 -29.33 -17.69 13.76 
2.28 -14.38 -37.87 112.61 74.74 -44.96 -27.53 -12.14 8.94 
2.54 -4.05 -23.35 71.65 48.30 -27.71 -23.92 -7.37 3.33 
2.80 2.60 -13.58 44.27 30.69 -20.76 -19.60 -7.06 1.48 
dC-C ∆Ees ∆Eex ∆Erep ∆Este ∆Eorb ∆Edisp ∆Eint ∆Ed 
syn-T1-H 
2.10 6.73 -48.02 142.65 94.63 -101.12 -25.77 -25.53 23.63 
2.16 11.36 -42.46 126.78 84.32 -92.15 -25.01 -21.49 19.61 
2.22 15.40 -37.62 112.92 75.30 -84.58 -24.25 -18.13 16.16 
2.31 20.60 -31.48 95.33 63.85 -75.45 -23.14 -14.14 11.90 
2.40 24.98 -26.44 80.82 54.38 -68.55 -22.04 -11.23 8.61 
2.58 32.05 -18.56 58.18 39.62 -60.04 -19.80 -8.17 4.53 
2.76 37.24 -12.55 41.10 28.55 -55.65 -17.23 -7.10 2.55 
syn-T2-H 
2.10 -1.98 -59.63 174.64 115.01 -113.60 -27.38 -27.94 23.91 
2.16 3.14 -53.45 156.90 103.45 -104.38 -26.56 -24.35 20.25 
2.22 7.95 -47.65 140.37 92.72 -96.29 -25.68 -21.30 17.12 
2.31 14.65 -39.65 117.63 77.98 -85.76 -24.25 -17.38 13.06 
2.40 20.47 -32.75 98.01 65.26 -77.03 -22.83 -14.14 9.66 
2.58 29.74 -21.96 67.38 45.42 -64.79 -20.10 -9.73 4.84 
2.76 36.66 -13.49 43.27 29.78 -57.62 -16.71 -7.88 2.52 
syn-T3-H 
2.10 4.69 -52.39 154.09 101.70 -105.51 -26.12 -25.24 20.20 
2.16 9.46 -46.59 137.37 90.78 -96.65 -25.25 -21.66 16.64 
2.22 13.84 -41.30 122.16 80.86 -89.04 -24.33 -18.68 13.64 
2.31 19.76 -34.24 101.95 67.71 -79.63 -22.90 -15.06 9.98 
2.40 24.99 -28.11 84.53 56.42 -72.17 -21.46 -12.22 7.09 
2.58 33.22 -18.41 57.11 38.70 -62.17 -18.58 -8.82 3.46 
2.76 38.67 -11.82 38.40 26.58 -57.03 -15.82 -7.60 1.93 
anti-T1-H 
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Table S1. (cont.) Energy components at varying bond lengths along the intrinsic reaction 
coordinate for all three activation. Units are in kcal/mol.  
2.10 7.30 -48.88 144.16 95.28 -101.25 -25.28 -23.94 20.34 
2.16 11.93 -43.24 128.09 84.85 -92.62 -24.50 -20.34 16.69 
2.22 16.05 -38.25 113.84 75.59 -85.35 -23.68 -17.39 13.62 
2.31 21.44 -31.74 95.33 63.59 -76.51 -22.45 -13.93 9.94 
2.40 26.07 -26.24 79.67 53.43 -69.67 -21.20 -11.36 7.10 
2.58 33.42 -17.49 54.79 37.30 -60.78 -18.55 -8.61 3.74 
2.76 38.95 -10.70 35.38 24.68 -55.98 -15.27 -7.62 2.26 
anti-T2-H 
2.10 2.61 -53.42 158.08 104.66 -105.83 -27.63 -26.19 22.52 
2.16 7.57 -47.58 141.34 93.76 -96.91 -26.82 -22.39 18.74 
2.22 12.11 -42.30 126.22 83.92 -89.12 -25.98 -19.07 15.36 
2.31 18.19 -35.22 105.94 70.72 -79.51 -24.67 -15.27 11.43 
2.40 23.28 -29.33 89.05 59.72 -71.87 -23.42 -12.29 8.27 
2.58 31.20 -20.22 63.10 42.88 -61.76 -20.97 -8.65 4.02 
2.76 36.89 -13.37 43.70 30.33 -56.42 -18.14 -7.34 2.12 
anti-T3-H 
2.10 -2.00 -58.68 172.16 113.48 -111.96 -28.42 -28.90 25.89 
2.16 3.15 -52.53 154.57 102.04 -102.81 -27.61 -25.22 22.19 
2.22 7.82 -46.94 138.64 91.70 -94.83 -26.77 -22.08 18.98 
2.31 14.12 -39.46 117.34 77.88 -84.55 -25.47 -18.02 14.77 
2.40 19.65 -32.99 98.98 65.99 -76.12 -24.16 -14.64 11.16 
2.58 28.62 -22.89 70.34 47.45 -64.32 -21.65 -9.90 5.65 
2.76 35.10 -15.39 49.09 33.70 -58.13 -18.88 -8.20 3.10 
         
dC-C ∆Ees ∆Eex ∆Erep ∆Este ∆Eorb ∆Edisp ∆Eint ∆Ed 
syn-T1-F 
2.18 -7.67 -61.82 160.64 98.82 -88.65 -21.91 -19.41 23.91 
2.23 -1.69 -54.90 143.02 88.12 -80.95 -21.33 -15.84 20.66 
2.28 3.58 -48.78 127.49 78.71 -74.38 -20.74 -12.82 17.75 
2.38 12.64 -38.50 101.53 63.03 -63.80 -19.57 -7.70 12.35 
2.48 19.74 -30.62 81.65 51.03 -56.91 -18.42 -4.57 8.09 
2.68 30.77 -19.02 52.27 33.25 -51.12 -15.76 -2.86 2.56 
2.88 37.47 -11.69 33.53 21.84 -49.67 -13.00 -3.35 0.56 
syn-T2-F 
2.18 -6.82 -62.12 161.17 99.05 -88.06 -21.04 -16.87 22.77 
2.23 -0.66 -55.01 143.11 88.10 -80.64 -20.49 -13.68 19.82 
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Table S1. (cont.) Energy components at varying bond lengths along the intrinsic reaction 
coordinate for all three activation. Units are in kcal/mol.  
2.28 4.89 -48.60 126.95 78.35 -74.22 -19.94 -10.93 17.13 
2.38 14.44 -37.68 99.63 61.95 -63.93 -18.90 -6.44 12.08 
2.48 22.14 -29.23 78.53 49.30 -57.40 -17.88 -3.85 7.95 
2.68 33.27 -17.55 49.02 31.47 -52.35 -15.50 -3.11 2.86 
2.88 39.18 -10.48 30.83 20.35 -50.51 -12.85 -3.84 1.43 
syn-T3-F 
2.18 3.64 -55.45 146.93 91.48 -86.57 -22.13 -13.58 18.77 
2.23 9.18 -49.11 130.62 81.51 -79.65 -21.54 -10.50 15.68 
2.28 14.10 -43.47 116.14 72.67 -73.75 -20.95 -7.93 12.90 
2.38 22.52 -33.95 91.86 57.91 -64.84 -19.79 -4.20 8.06 
2.48 29.04 -26.68 73.18 46.50 -59.69 -18.56 -2.71 4.86 
2.68 38.15 -16.25 46.13 29.88 -55.22 -15.71 -2.89 1.82 
2.88 42.28 -9.87 29.23 19.36 -52.80 -12.62 -3.77 1.28 
anti-T1-F 
2.18 -2.22 -55.31 146.05 90.74 -81.91 -22.18 -15.56 19.55 
2.23 3.38 -48.91 129.69 80.78 -74.89 -21.64 -12.37 16.42 
2.28 8.32 -43.29 115.35 72.06 -69.04 -21.10 -9.76 13.66 
2.38 16.82 -33.84 91.31 57.47 -60.18 -19.99 -5.89 8.85 
2.48 23.60 -26.56 72.70 46.14 -55.17 -18.85 -4.27 5.47 
2.68 33.50 -16.11 45.77 29.66 -51.43 -16.04 -4.30 2.02 
2.88 38.60 -9.06 27.34 18.28 -49.32 -12.57 -4.99 1.51 
anti-T2-F 
2.18 -3.11 -59.25 155.28 96.03 -84.67 -21.85 -13.59 20.12 
2.23 3.00 -52.35 137.62 85.27 -77.22 -21.29 -10.23 16.81 
2.28 8.60 -46.00 121.57 75.57 -70.83 -20.73 -7.40 13.75 
2.38 18.38 -35.32 94.92 59.60 -62.89 -19.63 -4.53 8.57 
2.48 24.78 -27.84 75.63 47.79 -56.58 -18.46 -2.47 5.59 
2.68 34.43 -16.98 47.80 30.82 -52.27 -15.86 -2.88 2.37 
2.88 39.38 -10.46 30.90 20.44 -50.35 -13.13 -3.67 1.15 
anti-T3-F 
2.18 -0.08 -60.67 157.58 96.91 -93.17 -20.84 -17.18 24.03 
2.23 5.16 -53.25 139.19 85.94 -85.42 -20.39 -14.71 21.98 
2.28 10.56 -47.07 123.48 76.41 -78.95 -19.82 -11.80 19.16 
2.38 20.50 -36.66 97.02 60.36 -68.48 -18.55 -6.17 13.16 
2.48 27.18 -28.13 75.89 47.76 -60.73 -17.51 -3.29 9.01 
2.68 37.70 -16.70 46.80 30.10 -55.08 -14.86 -2.14 3.28 
2.88 42.84 -9.85 28.96 19.11 -53.15 -12.04 -3.25 1.92 
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Models for Arriving at Data in Table 22 
For each transition state, a plot of each component of the interaction energy as a function 
of the total distortion energy is constructed. From these plots, each interaction energy component 
is interpolated at a total distortion energy that leads to the optimum correlation coefficient 
between the electronic activation energy (∆E‡) and the sum of the interaction energy (the sum of 
the interapolated interaction energy components) and the chosen total distortion energy (Figure 
9). This procedure is performed for each activation manifold. Table 2 consists of all the 
interpolated interaction energy components at the indicated distortion energy. 
 
BF3-mediated transition states. Interpolated at ∆Ed
‡
= 33.0 kcal/mol. 
syn-T1-L 
∆Ees,d
 
 = −1.071 − 1.036∆Ed     R
2 = 0.9997 
∆Este,d
 
 = 36.391 + 2.622∆Ed     R
2 = 0.9993 
∆Eorb,d
 
 = −10.458 − 2.322∆Ed     R
2 = 0.9999 
∆Edisp,d
 
 = −21.899 − 0.347∆Ed + 3.21E-3(∆Ed)
2
  R
2 = 0.9974 
∆Eint,d
 
 = −1.939 − 0.652∆Ed − 5.00E-3(∆Ed)
2
  R
2 = 0.9974 
 
 
syn-T2-L 
∆Ees,d
 
 = −4.656 − 1.423∆Ed + 5.46E-3(∆Ed)
2   R2 = 0.9996 
∆Este,d
 
 = 44.647 + 3.488∆Ed − 1.20E-2(∆Ed)
2  R2 = 0.9998 
∆Eorb,d
 
 = −19.01 − 2.478∆Ed     R
2 = 0.9999 
∆Edisp,d =  −25.11 − 0.381∆Ed − 3.97E-3(∆Ed)
2  R2 = 0.999 
∆Eint,d
 
 = −4.854 − 0.721∆Ed − 4.20E-3(∆Ed)
2
  R
2 = 1.0 
∆E
∆Ed
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•
•
•
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•
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syn-T3-L 
∆Ees,d
 
 = −0.170 − 1.733∆Ed + 1.19E-2(∆Ed)
2   R2 = 0.9994 
∆Este,d
 
 = 33.329 + 4.265∆Ed − 2.76E-2(∆Ed)
2  R2 = 1.0 
∆Eorb,d
 
 = −16.414 − 2.814∆Ed + 6.30E-3(∆Ed)
2  R2 = 1.0 
∆Edisp,d
 
 = −21.83 − 0.467∆Ed + 5.65E-3(∆Ed)
2  R2 = 0.9973 
∆Eint,d
 
 = −5.112 − 0.746∆Ed − 3.89E-3(∆Ed)
2
  R
2 = 1.0 
 
anti-T1-L 
∆Ees,d
 
 = −0.516 − 1.447∆Ed + 6.14E-3(∆Ed)
2   R2 = 0.9998 
∆Este,d
 
 = 32.77 + 3.655∆Ed − 1.61E-2(∆Ed)
2   R2 = 0.9997 
∆Eorb,d
 
 = −15.69 − 2.464∆Ed      R
2 = 1.0 
∆Edisp,d
 
 = −20.70 − 0.398∆Ed + 4.33E-3(∆Ed)
2  R2 = 0.9977 
∆Eint,d
 
 = −3.635 − 0.705∆Ed − 4.50E-3(∆Ed)
2
  R
2 = 1.0 
∆E
∆Ed
-130
-80
-30
20
70
120
170
10 15 20 25 30 35 40
∆Ees
∆Este
∆Eorb
∆Edisp
∆Eint
•
•
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anti-T2-L 
∆Ees,d
 
 = 0.823 − 1.559∆Ed + 6.92E-3(∆Ed)
2  R2 = 0.9999 
∆Este,d
 
 = 32.577 + 3.804∆Ed − 1.66E-2(∆Ed)
2  R2 = 0.9999 
∆Eorb,d
 
 = −14.410 − 2.477∆Ed     R
2 = 1.0000 
∆Edisp,d
 
 = −22.32 − 0.419∆Ed + 4.39E-3(∆Ed)
2  R2 = 0.9982 
∆Eint,d
 
 = −2.659 − 0.713∆Ed − 4.02E-3(∆Ed)
2  R2 = 1.0000 
 
anti-T3-L 
∆Ees,d
 
 = −2.072 − 1.048∆Ed      R
2 = 0.9996 
∆Este,d
 
 = 39.273 + 3.085∆Ed − 8.94E-3(∆Ed)
2  R2 = 0.9999 
∆Eorb,d
 
 = −16.93 − 2.339∆Ed      R
2 = 1.0000 
∆Edisp,d
 
 = −23.8 − 0.357∆Ed + 3.46E-3(∆Ed)
2  R2 = 0.9980 
∆Eint,d
 
 = −2.894 − 0.719∆Ed − 4.27E-3(∆Ed)
2  R2 = 1.0000 
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Brønsted acid-mediated transition states interpolated at ∆Ed
‡
= 17.7 kcal/mol. 
syn-T1-H 
∆Ees,d
 
 = 36.87 − 1.448∆Ed − 7.36E-3(∆Ed)
2   R2 = 1.0000 
∆Este,d
 
 = 28.82 + 3.083∆Ed − 1.27E-2(∆Ed)
2   R2 = 1.0000 
∆Eorb,d
 
 = −51.03 − 1.983∆Ed − 6.04E-3(∆Ed)
2  R2 = 1.0000 
∆Edisp,d
 
 = −18.71 − 0.441∆Ed − 5.78E-3(∆Ed)
2  R2 = 0.9997 
∆Eint,d
 
 = −4.033 − 0.791∆Ed − 5.05E-3(∆Ed)
2  R2 = 1.0000 
 
syn-T2-H 
∆Ees,d
 
 = 39.24 − 2.085∆Ed + 1.51E-2(∆Ed)
2   R2 = 1.0000 
∆Este,d
 
 = 24.49 + 4.437∆Ed − 2.79E-2(∆Ed)
2   R2 = 1.0000 
∆Eorb,d
 
 = −51.60 − 2.653∆Ed + 2.48E-3(∆Ed)
2  R2 = 1.0000 
∆Edisp,d
 
 = −17.63 − 0.627∆Ed + 9.16E-3(∆Ed)
2  R2 = 1.0000 
∆Eint,d
 
 = −5.069 − 0.927∆Ed − 1.23E-3(∆Ed)
2  R2 = 1.0000 
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syn-T3-H 
∆Ees,d
 
 = 39.23 − 2.176∆Ed + 2.31E-2(∆Ed)
2   R2 = 1.0000 
∆Este,d
 
 = 26.03 + 4.587∆Ed − 4.16E-2(∆Ed)
2   R2 = 1.0000 
∆Eorb,d
 
 = −53.46 − 2.671∆Ed + 4.61E-3(∆Ed)
2  R2 = 1.0000 
∆Edisp,d
 
 = −17.18 − 0.695∆Ed + 1.25E-2(∆Ed)
2  R2 = 0.9999 
∆Eint,d
 
 = −5.363 − 0.959∆Ed − 1.25E-3(∆Ed)
2  R2 = 1.0000 
 
 
anti-T1-H 
∆Ees,d
 
 = 36.87 − 1.448∆Ed + 7.36E-3(∆Ed)
2   R2 = 1.0000 
∆Este,d
 
 = 28.82 + 3.084∆Ed − 1.E-227(∆Ed)
2   R2 = 1.0000 
∆Eorb,d
 
 = −51.03 − 1.983∆Ed − 5.78E-3(∆Ed)
2  R2 = 1.0000 
∆Edisp,d
 
 = −18.71 − 0.441∆Ed + 6.04E-3(∆Ed)
2  R2 = 0.9997 
∆Eint,d
 
 = −4.033 − 0.791∆Ed − 5.05E-3(∆Ed)
2  R2 = 1.0000 
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anti-T2-H 
∆Ees,d
 
 = 38.21 − 1.935∆Ed + 0.0158(∆Ed)
2   R2 = 0.9999 
∆Este,d
 
 = 27.66 + 4.143∆Ed − 3.23E-2(∆Ed)
2   R2 = 0.9999 
∆Eorb,d
 
 = −51.24 − 2.535∆Ed − 4.97E-3(∆Ed)
2  R2 = 1.0000 
∆Edisp,d
 
 = −19.36 − 0.564∆Ed + 8.76E-3(∆Ed)
2  R2 = 0.9998 
∆Eint,d
 
 = −4.749 − 0.888∆Ed − 2.83E-3(∆Ed)
2  R2 = 1.0000 
 
 
 
anti-T3-H 
∆Ees,d
 
 = 37.87 − 1.701∆Ed + 6.19E-3(∆Ed)
2   R2 = 1.0000 
∆Este,d
 
 = 27.29 + 3.564∆Ed − 9.02E-3(∆Ed)
2   R2 = 1.0000 
∆Eorb,d
 
 = −50.63 − 2.212∆Ed − 6.13E-3(∆Ed)
2  R2 = 1.0000 
∆Edisp,d
 
 = −19.07 − 0.528∆Ed + 6.45E-3(∆Ed)
2  R2 = 1.0000 
∆Eint,d
 
 = −4.564 − 0.874∆Ed − 2.55E-3(∆Ed)
2  R2 = 1.0000 
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Fluoride-mediated transition states interpolated at ∆Ed
‡= 18.1 kcal/mol. 
syn-T1-F 
∆Ees,d
 
 = 32.13 − 1.471∆Ed − 8.06E-3(∆Ed)
2   R2 = 1.0000 
∆Este,d
 
 = 30.95 + 2.312∆Ed + 2.20E-3(∆Ed)
2   R2 = 0.9999 
∆Eorb,d
 
 = −46.77 − 0.991∆Ed − 3.19E-2(∆Ed)
2  R2 = 1.0000 
∆Edisp,d
 
 = −15.97 − 0.334∆Ed + 3.57E-3(∆Ed)
2  R2 = 0.9998 
∆Eint,d
 
 = 0.292 − 0.476∆Ed − 1.46E-2(∆Ed)
2   R2 = 1.0000 
 
syn-T2-F 
∆Ees,d
 
 = 35.54 − 1.601∆Ed − 1.14E-2(∆Ed)
2   R2 = 1.0000 
∆Este,d
 
 = 28.37 + 2.391∆Ed + 3.13E-2(∆Ed)
2   R2 = 1.0000 
∆Eorb,d
 
 = −48.55 − 0.768∆Ed − 4.26E-2(∆Ed)
2  R2 = 0.9999 
∆Edisp,d
 
 = −15.77 − 0.286∆Ed + 2.41E-3(∆Ed)
2  R2 = 0.9998 
∆Eint,d
 
 =  − 0.428 − 0.263∆Ed − 2.03E-2(∆Ed)
2  R2 = 0.9997 
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syn-T3-F 
∆Ees,d
 
 = 38.41 − 2.000∆Ed + 8.10E-3(∆Ed)
2   R2 = 0.9996 
∆Este,d
 
 = 30.41 + 3.413∆Ed − 8.96E-3(∆Ed)
2   R2 = 1.0000 
∆Eorb,d
 
 = −53.09− 1.210∆Ed − 3.07E-2(∆Ed)
2  R2 = 0.9999 
∆Edisp,d
 
 = −16.68 − 0.436∆Ed + 7.86E-3(∆Ed)
2  R2 = 0.9977 
∆Eint,d
 
 =  − 0.941 − 0.233∆Ed − 2.37E-3(∆Ed)
2  R2 = 0.9994 
 
anti-T1-F 
∆Ees,d
 
 = 34.30 − 2.019∆Ed + 7.96E-3(∆Ed)
2   R2 = 0.9998 
∆Este,d
 
 = 28.68 + 3.246∆Ed − 4.00E-3(∆Ed)
2   R2 = 0.9998 
∆Eorb,d
 
 = −48.43− 1.030∆Ed − 3.50E-2(∆Ed)
2  R2 = 0.9999 
∆Edisp,d
 
 = −16.85 − 0.410∆Ed + 7.11E-3(∆Ed)
2  R2 = 0.9989 
∆Eint,d
 
 =  − 2.265 − 0.221∆Ed − 2.37E-2(∆Ed)
2  R2 = 0.9993 
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anti-T2-F 
∆Ees,d
 
 = 36.55 − 2.190∆Ed + 1.11E-2(∆Ed)
2   R2 = 0.9998 
∆Este,d
 
 = 27.87 + 3.759∆Ed − 1.92E-2(∆Ed)
2   R2 = 0.9990 
∆Eorb,d
 
 = −48.95− 1.333∆Ed − 2.14E-2(∆Ed)
2  R2 = 0.9971 
∆Edisp,d
 
 = −16.39 − 0.428∆Ed + 7.93E-3(∆Ed)
2  R2 = 0.9949 
∆Eint,d
 
 =  − 0.904 − 0.195∆Ed − 2.15E-2(∆Ed)
2  R2 = 0.9969 
 
anti-T3-F 
∆Ees,d
 
 = 36.58 − 0.801∆Ed − 2.95E-2(∆Ed)
2   R2 = 0.9988 
∆Este,d
 
 = 34.23 + 1.012∆Ed + 6.41E-2(∆Ed)
2   R2 = 0.9947 
∆Eorb,d
 
 = −54.28 − 0.216∆Ed − 5.58E-2(∆Ed)
2  R2 = 0.9941 
∆Edisp,d
 
 = −15.16 − 0.278∆Ed + 1.79E-3(∆Ed)
2  R2 = 0.9996 
∆Eint,d
 
 =  − 0.897 − 0.288∆Ed − 1.93E-2(∆Ed)
2  R2 = 0.9999 
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Models for Arriving at Data in Table 23 
BF3-mediated transition states. Interpolated at ∆Ed
‡
= 33.0 kcal/mol. 
syn-T1-L 
εΗΟΜΟ
‡= −0.291 − 8.90E-4∆Ed + 4.96E-6(∆Ed)
2  R2 = 0.9998 
εΗΟΜΟ= −0.277 − 5.34E-4∆Ed − 3.88E-6(∆Ed)
2  R2 = 0.9999 
εLUMO= −5.79E-2 − 1.99E-3∆Ed + 1.35E-5(∆Ed)
2  R2 = 1.0000 
∆q = 2.32E-2 + 2.395E-2∆Ed − 2.698E-4(∆Ed)
2  R2 = 0.9991 
syn-T2-L 
εΗΟΜΟ
‡= −0.293 − 9.85E-4∆Ed + 4.97E-6(∆Ed)
2  R2 = 1.0000 
εΗΟΜΟ= −0.278 − 5.49E-4∆Ed − 4.20E-6(∆Ed)
2  R2 = 0.9998 
εLUMO= −6.09E-2 − 1.96E-3∆Ed + 1.31E-5(∆Ed)
2  R2 = 0.9999 
∆q = 9.55E-2 + 1.75E-2∆Ed − 1.34E-4(∆Ed)
2  R2 = 0.9999 
syn-T3-L 
εΗΟΜΟ
‡= −0.294 − 1.08E-3∆Ed + 8.05E-6(∆Ed)
2  R2 = 1.0000 
εΗΟΜΟ= −0.276 − 4.73E-4∆Ed − 2.90E-6(∆Ed)
2  R2 = 1.0000 
εLUMO= −6.16E-2 − 2.19E-3∆Ed + 1.82E-5(∆Ed)
2  R2 = 0.9999 
∆q = 9.31E-2 + 1.91E-2∆Ed − 1.67E-4(∆Ed)
2  R2 = 0.9997 
anti-T1-L 
εΗΟΜΟ
‡= −0.294 − 1.08E-3∆Ed + 8.05E-6(∆Ed)
2  R2 = 0.9997 
εΗΟΜΟ= −0.276 − 4.73E-4∆Ed − 2.90E-6(∆Ed)
2  R2 = 1.0000 
εLUMO= −6.16E-2 − 2.19E-3∆Ed + 1.815E-5(∆Ed)
2  R2 = 0.9999 
∆q = 7.04E-2 + 1.845E-2∆Ed − 1.445E-4(∆Ed)
2  R2 = 0.9998 
 
anti-T2-L 
εΗΟΜΟ
‡= −0.293 − 1.03E-3∆Ed + 7.84E-6(∆Ed)
2  R2 = 0.9997 
εΗΟΜΟ= −0.277 − 4.63E-4∆Ed − 2.82E-6(∆Ed)
2  R2 = 0.9999 
εLUMO= −5.69E-2 − 2.18E-3∆Ed + 1.66E-5(∆Ed)
2  R2 = 0.9998 
∆q = 6.25E-2 + 1.88E-2∆Ed − 1.43E-4(∆Ed)
2  R2 = 0.9999 
anti-T3-L 
εΗΟΜΟ
‡= −0.295 − 1.13E-3∆Ed + 9.14E-6(∆Ed)
2  R2 = 0.9998 
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εΗΟΜΟ= −0.278 − 5.62E-4∆Ed − 4.05E-6(∆Ed)
2  R2 = 1.0000 
εLUMO= −6.20E-2 − 2.19E-3∆Ed + 1.83E-5(∆Ed)
2  R2 = 1.0000 
∆q = 7.97E-2 + 1.71E-2∆Ed − 1.195E-4(∆Ed)
2  R2 = 0.9999 
 
Brønsted acid-mediated transition states interpolated at ∆Ed
‡
= 17.7 kcal/mol. 
syn-T1-H 
εΗΟΜΟ
‡= −0.308 − 1.26E-3∆Ed + 1.24E-5(∆Ed)
2  R2 = 0.9997 
εΗΟΜΟ= −0.277 + 6.53E-4∆Ed − 7.05E-6(∆Ed)
2  R2 = 1.0000 
εLUMO= −8.32E-2 − 2.44E-3∆Ed + 2.63E-5(∆Ed)
2  R2 = 1.0000 
∆q = 1 − 0.939 + 2.09E-2∆Ed − 2.14E-4(∆Ed)
2  R2 = 0.9999 
syn-T2-H 
εΗΟΜΟ
‡= −0.310 − 1.62E-3∆Ed + 1.79E-5(∆Ed)
2  R2 = 0.9992 
εΗΟΜΟ= −0.276 + 3.70E-4∆Ed − 3.27E-7(∆Ed)
2  R2 = 0.9999 
εLUMO= −8.61E-2 − 2.50E-3∆Ed + 2.44E-5(∆Ed)
2  R2 = 1.0000 
∆q = 1 − 0.926 + 2.29E-2∆Ed − 2.69E-4(∆Ed)
2  R2 = 1.0000 
 
syn-T3-H 
εΗΟΜΟ
‡= −0.309 − 1.76E-3∆Ed + 2.47E-5(∆Ed)
2  R2 = 0.9999 
εΗΟΜΟ= −0.278 + 6.12E-4∆Ed − 5.97E-6(∆Ed)
2  R2 = 1.0000 
εLUMO= −8.39E-2 − 2.76E-3∆Ed + 3.80E-5(∆Ed)
2  R2 = 0.9999 
∆q = 1 − 0.921 + 2.43E-2∆Ed − 3.30E-4(∆Ed)
2  R2 = 0.9999 
anti-T1-H 
εΗΟΜΟ
‡= −0.308 − 1.64E-3∆Ed + 2.27E-5(∆Ed)
2  R2 = 0.9995 
εΗΟΜΟ= −0.276 + 6.07E-4∆Ed − 6.58E-6(∆Ed)
2  R2 = 0.9996 
εLUMO= −8.41E-2 − 2.68E-3∆Ed + 3.64E-5(∆Ed)
2  R2 = 0.9999 
∆q = 1 − 0.945 + 2.50E-2∆Ed − 3.44E-4(∆Ed)
2  R2 = 0.9998 
anti-T2-H 
εΗΟΜΟ
‡= −0.308 − 1.53E-3∆Ed + 1.73E-5(∆Ed)
2  R2 = 0.9999 
εΗΟΜΟ= −0.276 + 4.74E-4∆Ed − 3.61E-6(∆Ed)
2  R2 = 0.9997 
εLUMO= −8.22E-2 − 2.58E-3∆Ed + 2.76E-5(∆Ed)
2  R2 = 1.0000 
∆q = 1 − 0.930 + 2.33E-2∆Ed − 2.86E-4(∆Ed)
2  R2 = 0.9998 
anti-T3-H 
εΗΟΜΟ
‡= −0.305 − 1.83E-3∆Ed + 2.24E-5(∆Ed)
2  R2 = 0.9839 
εΗΟΜΟ= −0.276 + 3.51E-4∆Ed − 6.86E-6(∆Ed)
2  R2 = 1.0000 
εLUMO= −8.33E-2 − 2.43E-3∆Ed + 2.20E-5(∆Ed)
2  R2 = 1.0000 
∆q = 1 − 0.936 + 2.125E-2∆Ed − 2.13E-4(∆Ed)
2  R2 = 1.0000 
 
Fluoride-mediated transition states interpolated at ∆Ed
‡
= 18.1 kcal/mol. 
syn-T1-F 
εΗΟΜΟ
‡= −0.1883 + 1.44E-3∆Ed − 5.08E-5(∆Ed)
2  R2 = 0.9934 
εΗΟΜΟ= −0.189 + 2.86E-3∆Ed − 5.70E-5(∆Ed)
2  R2 = 0.9996 
εLUMO= 2.23E-2 − 2.63E-4∆Ed + 2.19E-6(∆Ed)
2  R2 = 0.9992 
∆q = − 4.69E-3 + 1.99E-2∆Ed − 1.215E-4(∆Ed)
2  R2 = 1.0000 
syn-T2-F 
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εΗΟΜΟ
‡= −0.200 + 2.71E-3∆Ed − 8.49E-5(∆Ed)
2  R2 = 0.9882 
εΗΟΜΟ= −0.199 + 3.93E-3∆Ed − 8.76E-5(∆Ed)
2  R2 = 0.9993 
εLUMO= 2.17E-2 − 1.852E-4∆Ed + 1.19E-8(∆Ed)
2  R2 = 0.9992 
∆q = − 2.53E-2 + 2.06E-2∆Ed − 9.91E-5(∆Ed)
2  R2 = 1.0000 
syn-T3-F 
εΗΟΜΟ
‡= −0.203 + 2.66E-3∆Ed − 9.12E-5(∆Ed)
2  R2 = 0.9974 
εΗΟΜΟ= −0.199 + 3.88E-3∆Ed − 9.28E-5(∆Ed)
2  R2 = 0.9996 
εLUMO= 2.18E-2 − 1.03E-4∆Ed  −1.26E-6(∆Ed)
2  R2 = 0.9975 
∆q = − 1.04E-2 + 2.06E-2∆Ed − 1.60E-4(∆Ed)
2  R2 = 1.0000 
anti-T1-F 
εΗΟΜΟ
‡= −0.202 + 2.74E-3∆Ed − 9.31E-5(∆Ed)
2  R2 = 0.9831 
εΗΟΜΟ= −0.199 + 4.05E-3∆Ed − 9.67E-5(∆Ed)
2  R2 = 0.9983 
εLUMO= 2.14E-2 − 1.52E-4∆Ed  −7.635E-7(∆Ed)
2  R2 = 0.9986 
∆q = − 9.48E-3 − 2.07E-2∆Ed + 1.46E-4(∆Ed)
2  R2 = 1.0000 
anti-T2-F 
εΗΟΜΟ
‡= −0.204 + 2.415E-3∆Ed − 7.16E-5(∆Ed)
2  R2 = 0.9974 
εΗΟΜΟ= −0.202 + 3.42E-3∆Ed − 7.40E-5(∆Ed)
2  R2 = 0.9978 
εLUMO= 2.17E-2 − 1.81E-4∆Ed  −2.67E-7(∆Ed)
2  R2 = 0.9992 
∆q = − 1.06E-2 − 2.155E-2∆Ed + 1.64E-4(∆Ed)
2  R2 = 0.9996 
 
anti-T3-F 
εΗΟΜΟ
‡= −0.203 + 3.18E-3∆Ed − 9.73E-5(∆Ed)
2  R2 = 0.9784 
εΗΟΜΟ= −0.205 + 4.78E-3∆Ed − 1.10E-4(∆Ed)
2  R2 = 0.9924 
εLUMO= 2.22E-2 − 1.89E-4∆Ed  −1.13E-6(∆Ed)
2  R2 = 0.9999 
∆q = 1.93E-2 − 1.80E-2∆Ed + 2.65E-5(∆Ed)
2  R2 = 0.9956 
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